<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html>
<head>
<title>Tumors and Tumor-Like Processes</title>
<link rel="shortcut icon" href="/assets/images/bookuniavatar.png" type="image/x-icon">
<link rel="stylesheet" href="/assets/et-line-font-plugin/style.css">
<link rel="stylesheet" href="/assets/bootstrap-material-design-font/css/material.css">
<link rel="stylesheet" href="/assets/tether/tether.min.css">
<link rel="stylesheet" href="/assets/bootstrap/css/bootstrap.min.css">
<link rel="stylesheet" href="/assets/socicon/css/socicon.min.css">
<link rel="stylesheet" href="/assets/dropdown/css/style.css">
<link rel="stylesheet" href="/assets/theme/css/style.css">
<link rel="stylesheet" href="/assets/mobirise/css/mbr-additional.css" type="text/css">
<link rel="stylesheet" href="/add/mixitup.css">
<script src="/add/pre.js"></script>
<meta property="og:image" content="http://BookUni.com/assets/images/bookuniavatar.png" />
<link rel="stylesheet" type="text/css" href="ovidbook.css">
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
</head>
<body>
<section id="ext_menu-0">
    <nav class="navbar navbar-dropdown navbar-fixed-top">
        <div class="container">
            <div class="mbr-table">
                <div class="mbr-table-cell">
                    <div class="navbar-brand">
                        <a href="/" class="navbar-logo"><img src="/assets/images/bookuniavatar.png" alt="BookUni" title="BookUni"></a>
                        <a class="navbar-caption" href="/">BookUni.com</a>
                    </div>
                </div>
                <div class="mbr-table-cell">
                    <button class="navbar-toggler pull-xs-right hidden-md-up" type="button" data-toggle="collapse" data-target="#exCollapsingNavbar"><div class="hamburger-icon"></div></button>
                    <ul class="nav-dropdown collapse pull-xs-right nav navbar-nav navbar-toggleable-sm" id="exCollapsingNavbar"><li class="nav-item nav-btn"><a class="nav-link btn btn-white btn-white-outline" href="https://www.paypal.me/BookUni" target="_blank">Donate</a></li><li class="nav-item nav-btn"><a class="nav-link btn btn-primary" href="#top">Top</a></li></ul>
                    <button hidden="" class="navbar-toggler navbar-close" type="button" data-toggle="collapse" data-target="#exCollapsingNavbar"><div class="close-icon"></div></button>
                </div>
            </div>
        </div>
    </nav>
</section>
<section class="mbr-section" style="padding-top: 120px; padding-bottom: 20px;">
    <div class="container">
        <div><input type="hidden" name="IL_IN_TAG" value="2"></div>
    </div>
</section>
<table id="booktitle" cellpadding="0" cellspacing="0">
<tr>
<td rowspan="2"><img src="files/6980f768ff2350a850f3ce2fe6f5c590.gif"></td>
<td><h1>Essentials of Skeletal Radiology<br>3rd Edition</h1></td>
</tr>
</table>
<div class="navlinks">
<span><a href="sid653929.html" title="Arthritic Disorders">&#8592;</a></span><span><a href="index.html" title="Top">&#8593;</a></span><span><a href="sid938315.html" title="Infection">&#8594;</a></span>
</div>
<div class="CHAPTER">
<div class="CHSO">
<div class="THD">
<div class="HNUM">11</div>
<div class="HD">Tumors and Tumor-Like Processes</div>
</div>
<div class="BY">
<div class="PN">Terry R. Yochum</div>
<div class="PN">Lindsay J. Rowe</div>
</div>
</div>
<div class="TBD">
<div class="TLV1" id="B01382540.0-3419" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]">
<div class="HD">METASTATIC BONE TUMORS</div>
<div class="TLV2" id="B01382540.0-3420" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]">
<div class="HD">GENERAL CONSIDERATIONS</div>
<div class="P">Metastatic bone tumors are the most common malignant tumors of the skeleton. Approximately 70&#x0025; of all malignant tumors are metastatic in origin, with only 30&#x0025; being primary in nature. (<a class="LK" href="sid806035.html#T1-11">Table 11-1</a>) Most malignant tumors of bone are metastases from a primary extraskeletal focus, the majority are epithelial in origin. The most common primary sites are in the breast, lung, prostate, kidney, thyroid, and bowel. Occasionally, a primary sarcoma of bone, such as a Ewing&#x2019;s tumor, will metastasize to another osseous site. Apparently, with the exception of tumors of the central nervous system and basal cell carcinoma of the skin, almost all tumors have reported incidences of metastases to bone. The usual route is via tumor emboli carried by the vascular system. Those bones that are rich in red bone marrow are predisposed to develop osseous metastases; the target sites are the axial skeleton, skull, and proximal extremities; involvement distal to the knee and elbow is rare. Jaffe (<a class="LK" href="sid806035.html#R1-11">1</a>) states that metastasis to the skeleton may be just as common as it is to the lung or liver. Metastasis is the most sinister complication of any malignancy and often heralds relentless progression of the disease process, eventually leading to death.</div>
<div class="TLV3" id="B01382540.0-3421" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[1]">
<div class="HD">Incidence</div>
<div class="P">The true incidence of metastatic bone disease is difficult to ascertain. Autopsy findings are the most accurate means of assessment because bone scans and plain films have inherent limitations. The overall frequency of skeletal metastasis in several large autopsy series is estimated to be from 20 to 35&#x0025; of all patients with malignancies. (<a class="LK" href="sid806035.html#R2-11">2</a>,<a class="LK" href="sid806035.html#R3-11">3</a>) In most cases the metastatic lesions are the cause of death in these patients. The validity of any autopsy incidence study depends on the number of bones examined and on the detailed nature of the examination.</div>
<div class="P">The relative frequency of skeletal metastasis varies considerably with the organ of primary involvement. Metastasis to bone represents the third most common site of metastatic carcinoma. (<a class="LK" href="sid806035.html#R4-11">4</a>) Cancers of the breast, prostate, lung, and kidney account for 80&#x0025; of all metastatic cancers to bone. (<a class="LK" href="sid806035.html#R3-11">3</a>) Metastases to bone tend to be multiple and affect primarily the axial skeleton. Solitary lesions occur in only 10&#x0025; of patients. (<a class="LK" href="sid806035.html#R5-11">5</a>) In females, carcinoma of the breast is responsible for approximately 70&#x0025; of all bony metastases, which places these women at an estimated fivefold increased risk for pathologic vertebral fracture. (<a class="LK" href="sid806035.html#R6-11">6</a>,<a class="LK" href="sid806035.html#R7-11">7</a>) The remaining 30&#x0025; are owing primarily to carcinomas of the thyroid, kidney, and uterus. (<a class="LK" href="sid806035.html#R6-11">6</a>) In males, carcinoma of the prostate is responsible for about 60&#x0025; of all skeletal metastases, whereas carcinoma of the lung causes an additional 25&#x0025;. (<a class="LK" href="sid806035.html#R6-11">6</a>) (<a class="LK" href="sid806035.html#T2-11">Table 11-2</a>)</div>
<a name="PG1138"> </a><div class="pagenum"><div>P.1138</div></div>
<br clear="all">
<div class="TB" id="T1-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[1]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-1 Overview of Common Malignant Bone Lesions</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Primary (30&#x0025;)</b></p></th>
<th align="center" valign="bottom" colspan="3" style="border-bottom: 1px solid black;" rowspan="1"><p><b>Secondary (70&#x0025;)</b></p></th>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Multiple myeloma (most common)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Lytic (75&#x0025;)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Blastic (15&#x0025;)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Mixed (10&#x0025;)</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteosarcoma (second most common)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Lung</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Prostate</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Prostate</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Chondrosarcoma (third most common)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Breast</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Breast</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Breast</p></td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Ewing&#x2019;s sarcoma (fourth most common)</p></td>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TB" id="T2-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[1]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-2 Most Common Causes for Osseous Metastases</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Population</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Lytic</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Blastic</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Female</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Breast (80&#x0025;)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Breast (10&#x0025;)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Male</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Lung (75&#x0025;)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Prostate (80&#x0025;)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Young (&#x003C; 20 years)</p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Neuroblastoma (80&#x0025;)</p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Hodgkin&#x2019;s (50&#x0025;)</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3422" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[2]">
<div class="HD">Clinical Features</div>
<div class="P">Most patients presenting with skeletal metastases are in their second half of life, most commonly past the 4th decade. Metastatic osseous lesions occurring in children &#x003C; 5 years of age usually are caused by neuroblastoma; between 10 and 20 years of age, Ewing&#x2019;s sarcoma and osteosarcoma are the most common causes; and between 20 and 35 years of age, Hodgkin&#x2019;s lymphoma is the most common source for skeletal metastases.</div>
<div class="P">Most patients present with a history of recent weight loss, appear cachectic, and experience anemia and fever in advanced stages of the disease. Often, the secondary skeletal deposits create the first symptoms of the carcinomatous process. This is particularly common with carcinoma of the thyroid, liver, and kidney. The principal signs and symptoms of metastatic bone disease are pain and pathologic fracture. The pain is usually insidious in onset with bouts of remission and exacerbation. Classically, the pain, when present, is persistent and nocturnal, but these characteristics are often lacking. Patients frequently harbor bony metastases without any overt symptoms. The diagnosis of metastatic bone disease in most cases is radiologic and cannot be determined by physical examination or inspection of the patient. It is not unusual to find osseous metastases 10-15 years after treatment for the primary neoplasm. This is particularly common in patients who have had radical mastectomies for carcinoma of the breast.</div>
<div class="P">Certain serologic findings may be present in patients with metastatic bone disease. An elevated erythrocyte sedimentation rate (ESR) is often present but is not pathognomonic of metastatic disease. Elevation of the serum calcium may occur in diffuse osteolytic metastatic carcinoma; however, in most cases the serum calcium levels are normal, even with diffuse lytic disease. Alkaline phosphatase is frequently elevated in blastic metastatic lesions of bone but overall is a relatively insensitive indicator of bone metastasis because liver disease and callus formation around a fracture will also raise the alkaline phosphatase enzyme. (<a class="LK" href="sid806035.html#R8-11">8</a>) The serum acid phosphatase or prostate specific antigen (PSA) is elevated &#x003E; 10 ng&#x002F;mL in patients with cancer of the prostate gland when the tumor has broken through the prostatic capsule and seeded Batson&#x2019;s venous plexus or has spread by direct extension. Recent research has suggested that patients with PSA values &#x003C; 10 ng&#x002F;mL should not undergo full body bone scans, as metastasis is rare in this stage (grade) of the disease. (<a class="LK" href="sid806035.html#R9-11">9</a>) However, it is still our opinion, as well as the opinions of many others, that to ensure the best prognostic outcome of patients with known prostatic carcinoma and bone pain, scintigraphy should still be done routinely irrespective of PSA value. (<a class="LK" href="sid806035.html#R10-11">10</a>,<a class="LK" href="sid806035.html#R11-11">11</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3423" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]">
<div class="HD">Pathologic Features</div>
<div class="P">Several events are involved in the development of a metastasis: (<span class="emph_I">a</span>) tumor cells or fragments capable of autonomous survival must be liberated, (<span class="emph_I">b</span>) a pathway of dissemination must be available, and (<span class="emph_I">c</span>) an appropriate environment for the establishment and growth of the implant must exist in the new site.</div>
<div class="TLV4" id="B01382540.0-3424" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[1]">
<div class="HD">Pathways of Metastasis</div>
<div class="P">Cancers metastasize through one of three routes: direct extension, lymphatic channels, or hematogenous dissemination.</div>
<div class="TLV5" id="B01382540.0-3425" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[1]/TLV5[1]">
<div class="HD"><span class="emph_I">Direct Extension.</span></div>
<div class="P">Direct invasion into a bone may occur from a soft tissue tumor lying adjacent to or near the bone. (<a class="LK" href="sid806035.html#F1-11">Fig. 11-1</a>) The tumors that most commonly do this are those that gain access to the peritoneal cavity and can seed anywhere within it. Carcinoma of the uterus is well known to cause direct extension to the iliac bones. Mechanical transport of tumor cells by instruments or gloves during surgery may produce implantation of uninvolved tissues and even of the incision itself. A much less common pathway of direct transplantation is the seeding of tumor along one of the natural pathways in the body, such as downstream seeding by an intestinal tumor or the seeding of the lower urinary tract from a higher lesion. Although this would seem at first to be a common and plausible mechanism, in actual fact it is rare.</div>
</div>
<div class="TLV5" id="B01382540.0-3426" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[1]/TLV5[2]">
<div class="HD"><span class="emph_I">Lymphatic Dissemination.</span></div>
<div class="P">Lymphatic channels uncommonly play a role in spreading tumor emboli to bone. It is thought that the absence of lymphatic channels in bone marrow is the reason for the relatively low incidence of lymphatic seeding of bone.</div>
</div>
<div class="TLV5" id="B01382540.0-3427" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[1]/TLV5[3]">
<div class="HD"><span class="emph_I">Hematogenous Dissemination.</span></div>
<div class="P">Spread through blood vessels, particularly the veins, is the most common pathway for tumor emboli. The arteries are thick walled and often resist tumor penetration, whereas the thin-walled veins offer little resistance to tumor penetration. The venous system, therefore, provides a frequent route for cancer cells that slough off to form tumor emboli. The three areas most commonly seeded in this manner are the lungs, liver, and axial skeleton.</div>
<div class="P">In 1940, Batson (<a class="LK" href="sid806035.html#R12-11">12</a>) described a series of epidural vertebral veins that are valveless and function as a venous lake or pool, where the blood flow is sluggish and subject to arrest and even reversal. Changes in intra-abdominal or intrathoracic pressure may tend to reflux blood flow in the direction of the paravertebral plexus. Batson&#x2019;s plexus provides a series of venous passageways by which cancer cells can be directly seeded into the bones, bypassing the liver and lungs, whose extensive capillary beds normally create an efficient filtration of the venous circulation. (<a class="LK" href="sid806035.html#F2-11">Fig. 11-2</a>) Batson (<a class="LK" href="sid806035.html#R12-11">12</a>) demonstrated that the prostatic venous plexus can drain into the vertebral venous plexus, bypassing the caval system. This provides the pathophysiologic basis for early metastasis
<a name="PG1139"> </a><div class="pagenum"><div>P.1139</div></div>
<br clear="all">
of prostate carcinoma to the pelvis, lumbar spine, and the remainder of the axial skeleton. (<a class="LK" href="sid806035.html#F3-11">Figs. 11-3</a> and <a class="LK" href="sid806035.html#F4-11">11-4</a>)</div>
<div class="FG" id="F1-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[1]/TLV5[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="482" src="files/36f6732b5fa9fda5bc3d0ee894717ab2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="36f6732b5fa9fda5bc3d0ee894717ab2.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="482" DISPLAY="INLINE"></div>
<div class="P">Figure 11-1 <span class="emph_B">METASTASIS BY DIRECT EXTENSION. A. AP Sacrum.</span> Observe the loss of trabecular patterns and destruction of the middle to lower portion of the sacrum because of direct extension of the tumor mass from carcinoma of the uterus. <span class="emph_B">B. AP Thoracic Spine.</span> Note the destruction of the pedicle, lamina, and half of the T2 vertebral body because of direct extension of bronchogenic carcinoma of the lung apex (Pancoast&#x2019;s tumor). <span class="emph_I">COMMENT:</span> The radiopaque material above the T2 level represents contrast material from a myelographic examination. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F2-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[1]/TLV5[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="379" height="700" src="files/2bc3e124884a79edb37b8df543ba2da7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2bc3e124884a79edb37b8df543ba2da7.gif" MIMETYPE="image/gif" WIDTH="379" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-2 <span class="emph_B">THE VERTEBRAL VEIN SYSTEM (BATSON&#x2019;S VENOUS PLEXUS).</span> This venous network is a common two-way avenue of metastatic spread of pelvic, abdominal, and thoracic tumors. A large portion of bony metastases results from dissemination of neoplastic cells through the vertebral vein system. (Adapted from <span class="emph_B">del Regato JA:</span> <span class="emph_I">Pathways of metastatic spread of malignant tumors.</span> Semin Oncol 4:33, 1977.)</div>
</td></tr>
</table></div>
</div>
</div>
<a name="PG1140"> </a><div class="pagenum"><div>P.1140</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3428" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[2]">
<div class="HD">Lytic Versus Blastic Lesions</div>
<div class="TLV5" id="B01382540.0-3429" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[2]/TLV5[1]">
<div class="HD"><span class="emph_I">Lytic Destruction.</span></div>
<div class="P">In considering the pathogenesis of the lytic lesion, it is important to emphasize certain pathologic factors. The greatest majority of tumor emboli are deposited within the bone marrow. Most metastatic bone tumors are present for some time before they are recognized because a large amount of destruction must occur in the medullary canal before a perceptible alteration of bone density can be appreciated on plain film radiographs (at least 30&#x0025; loss of bone density is necessary before detection). It is the pressure from the proliferating neoplasm on the surrounding trabecular structures and cortices that creates the so-called osteolytic lesion. These trabeculae may be partially or completely resorbed as the marrow is replaced by neoplastic tissue. It should be noted that the osteoclasts play little if any role in the pathogenesis of lytic metastases.</div>
<div class="P">Notably, the majority of metastatic lesions begin within the medullary cavity and secondarily destroy the adjacent cortex. Metastasis to the cortex occurs uncommonly and is most frequently found in association with carcinoma of the lung, breast, and kidney. (<a class="LK" href="sid806035.html#R13-11">13</a>,<a class="LK" href="sid806035.html#R14-11">14</a>) (<a class="LK" href="sid806035.html#F5-11">Fig. 11-5</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3430" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[2]/TLV5[2]">
<div class="HD"><span class="emph_I">Blastic Metastases.</span></div>
<div class="P">The increased density in osteoblastic metastasis is owing to the laying down of new bone, which is non-neoplastic in nature but is actually a reactive response of the local osteoid tissue to the presence of the tumor. (<a class="LK" href="sid806035.html#F6-11">Fig. 11-6</a>) Therefore, progressive radiopacity of a cancer metastasis may be regarded as a reflection of increased new bone formation as a result of a futile attempt at bone repair. (<a class="LK" href="sid806035.html#R15-11">15</a>) However, as a patient&#x2019;s disease progresses, enlargement of existing blastic lesions, along with the pressure of additional lesions, is often a grave clinical sign.</div>
<div class="FG" id="F3-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[2]/TLV5[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="300" height="700" src="files/65c5dfd0ae334e459005f4273eaa1fbc.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="65c5dfd0ae334e459005f4273eaa1fbc.gif" MIMETYPE="image/gif" WIDTH="300" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-3 <span class="emph_B">DISTRIBUTION OF SKELETAL METASTASES.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F4-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[2]/TLV5[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="489" src="files/a311851bc9b2cb02ee44e44e4c5c0bb8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a311851bc9b2cb02ee44e44e4c5c0bb8.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="489" DISPLAY="INLINE"></div>
<div class="P">Figure 11-4 <span class="emph_B">HEMATOGENOUS METASTASIS. A. Localized.</span> Note that the focal radiopacity involving the sacral base represents osteoblastic metastasis from hematogenous dissemination of a previously diagnosed carcinoma of the bladder. The curvilinear radiopacity anterior to the L4 and L5 vertebrae (<span class="emph_I">arrow</span>) is owing to contrast media within the ureter. <span class="emph_B">B. Diffuse.</span> Observe the homogeneous areas of radiopacity throughout the T12-L5 vertebrae. This demonstrates the diffuse nature of osteoblastic metastatic carcinoma from the prostate gland.</div>
</td></tr>
</table></div>
<a name="PG1141"> </a><div class="pagenum"><div>P.1141</div></div>
<br clear="all">
<div class="FG" id="F5-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[3]/TLV4[2]/TLV5[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="585" height="707" src="files/2dceb5337a8e2c4294bfd2cb68548aa9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2dceb5337a8e2c4294bfd2cb68548aa9.gif" MIMETYPE="image/gif" WIDTH="585" HEIGHT="707" DISPLAY="INLINE"></div>
<div class="P">Figure 11-5 <span class="emph_B">CORTICAL METASTASIS. A. Plain Film, Femur.</span> Observe at the mid-diaphysis of the femur a small, excavated defect in the cortex (<span class="emph_I">arrow</span>). <span class="emph_B">B. CT Scan, Femur.</span> Note that the cortical location of the defect is clearly demonstrated (<span class="emph_I">arrow</span>). <span class="emph_I">COMMENT:</span> This type of lesion is considered an uncommon expression of metastatic carcinoma, most commonly seen from a primary tumor of the lung, followed by the breast and kidney. It has been referred to as a <span class="emph_I">cookiebite lesion.</span> (Courtesy of John Duda, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="P">Certain benign conditions can simulate metastatic cancer. (<a class="LK" href="sid806035.html#T3-11">Table 11-3</a>)</div>
</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3431" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]">
<div class="HD">Radiologic Features</div>
<div class="TLV4" id="B01382540.0-3432" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]">
<div class="HD">Radiographic Imaging</div>
<div class="TLV5" id="B01382540.0-3433" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]/TLV5[1]">
<div class="HD"><span class="emph_I">Nuclear Imaging (Bone Scans).</span></div>
<div class="P">Bone-seeking radiopharma-ceuticals have greatly enhanced the early detection of metastatic bone lesions. Whereas the early lesion is often not demonstrated on plain film radiographs until the disease is well advanced, alterations of as little as 3-5&#x0025; in the metabolic activity of bone may be detected with bone scans. Technetium-99m-methylene diphosphonate (<sup>99m</sup>Tc-MDP) is the agent of choice because it renders a low radiation dose; has a convenient half-life for clinical use; and is a monoenergetic 140-keV photon, which is ideal for current imaging devices. (<a class="LK" href="sid806035.html#R16-11">16</a>) The radiation-emitting substance is taken up and concentrated in regions of high metabolic activity in bone.</div>
<div class="P">Metastases result in a marked increase in osteoid production and a disproportionate increase in immature woven bone and, therefore, cause a <span class="emph_I">hot spot</span> on bone scans. (<a class="LK" href="sid806035.html#R17-11">17</a>) Animal experiments have established that, after tumor implantation, there is new woven bone
<a name="PG1142"> </a><div class="pagenum"><div>P.1142</div></div>
<br clear="all">
laid down about the tumor even before bone destruction occurs. (<a class="LK" href="sid806035.html#R17-11">17</a>) It is this osteoblastic response of new bone, which is a reaction to the underlying bone destruction, that renders the bone scan positive. (<a class="LK" href="sid806035.html#F7-11">Fig. 11-7</a>) A number of benign conditions can also render positive bone scans; examples are Paget&#x2019;s disease, fibrous dysplasia, fractures, osteomyelitis, osteoid osteoma, osteoblastoma, arthritides, and ischemic necroses. (<a class="LK" href="sid806035.html#T3-11">Table 11-3</a>) Thus the presence of a positive scan must be correlated with clinical data as well as plain film radiographs before a diagnosis of metastasis is offered. (<a class="LK" href="sid806035.html#R18-11">18</a>) In one study, 88&#x0025; of solitary rib lesions found on bone scan in patients with proved extraskeletal cancers were benign and not metastatic in nature. (<a class="LK" href="sid806035.html#R19-11">19</a>)</div>
<div class="FG" id="F6-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]/TLV5[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="348" height="700" src="files/082952610dac3637cb097b47d7a676e3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="082952610dac3637cb097b47d7a676e3.gif" MIMETYPE="image/gif" WIDTH="348" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-6 <span class="emph_B">BLASTIC METASTASIS: SERIAL PROGRESSION. A. AP Pelvis.</span> Note the subtle circular radiopacities present in the proximal femora and ischium (<span class="emph_I">arrow</span>). <span class="emph_B">B. 1-Year Follow-Up.</span> Note the numerous diffuse blastic lesions scattered throughout the sacrum, pelvis, and proximal femora. <span class="emph_B">C. Diffuse Disease.</span> Observe the complete opacification of the bones of the pelvis and the proximal femora. This film was taken approximately 2 years after panel A. <span class="emph_I">COMMENT:</span> This is a relatively young female patient whose primary carcinoma was that of the parotid gland. The radiographic presentation in this case is somewhat more typical of prostate or breast metastases because parotid gland carcinoma with blastic lesions to bone is somewhat rare. (Courtesy of Lawrence A. Cooperstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Pittsburgh, Pennsylvania.)</div>
</td></tr>
</table></div>
<div class="TB" id="T3-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]/TLV5[1]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-3 Benign Conditions Simulating Osseous Metastatic Cancer</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Osteolytic</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Osteoblastic</b></p></th>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Neurofibromatosis</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Melorheostosis</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Enchondromatosis</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteopoikilosis</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Polyostotic fibrous dysplasia</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteopathia striata</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2" colspan="1"><p>Brown tumors (hyperparathyroidism)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteopetrosis</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Paget&#x2019;s disease</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Gout</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Sarcoidosis</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2" colspan="1"><p>Osteomyelitis (fungal, tuberculosis)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Tuberous sclerosis</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Histiocytosis X</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Secondary hyperparathyroidism (sclerotic form)</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Gorham&#x2019;s angiomatosis</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Chronic osteomyelitis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Sickle cell anemia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Mastocytosis</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Fluorosis</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="P">Bone scanning is definitely a more accurate and sensitive indicator of the status of bone metastasis than conventional radiography. (<a class="LK" href="sid806035.html#R20-11">20</a>,<a class="LK" href="sid806035.html#R21-11">21</a>) In several large series it was found that up to 40&#x0025; of cancer patients with abnormal scans have normal radiographs. (<a class="LK" href="sid806035.html#R22-11">22</a>,<a class="LK" href="sid806035.html#R23-11">23</a>) Bone scans may detect osseous metastases as early as 18 months before their detection on radiographs and have a reported sensitivity 50-80&#x0025; greater than conventional radiographs. (<a class="LK" href="sid806035.html#R24-11">24</a>) It has been estimated that 30-50&#x0025; of normal bone mineral must be lost before a bone metastasis is visible radiographically on plain film, whereas scans may be positive at 3-5&#x0025; destruction of bone. (<a class="LK" href="sid806035.html#R25-11">25</a>) In the vertebrae the necessary mineral loss may be as high as 50-70&#x0025;, and a lesion may need to be &#x003E; 1.5 cm before it can be detected on plain film radiographs. (<a class="LK" href="sid806035.html#R25-11">25</a>) Furthermore, it has been found that in nearly 50&#x0025; of patients with spinal metastases present at autopsy, the lesions were not detectable in premortem tomograms. (<a class="LK" href="sid806035.html#R25-11">25</a>)</div>
<div class="P">Generally, abnormalities are shown on bone scans as either focal or diffuse regions of increased or decreased radionuclide accumulation compared with that of other skeletal areas. Both lytic and blastic lesions appear on the bone scan as hot spots (areas of increased radionuclide concentration). A positive scan is non-specific, however, only in the sense that it reflects accelerated osteogenesis of any origin. Any positive scan must be correlated with the morphologic change on the plain film, which often allows appreciation of a characteristic pattern peculiar to a specific bone disorder other than metastases. About 5&#x0025; of metastatic lesions may be missed by bone scanning, either because the tumor provokes little or no bone reaction (as in myeloma) or because of technical problems. Single-photon emission computed tomography (SPECT) scanning of the vertebral column will reveal metastatic lesions with a higher diagnostic value than traditional planar scanning. (<a class="LK" href="sid806035.html#R26-11">26</a>)</div>
<div class="FG" id="F7-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]/TLV5[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="556" height="726" src="files/db787d8dca2bd34f80da866e5d8cce8b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="db787d8dca2bd34f80da866e5d8cce8b.gif" MIMETYPE="image/gif" WIDTH="556" HEIGHT="726" DISPLAY="INLINE"></div>
<div class="P">Figure 11-7 <span class="emph_B">POSITIVE BONE SCAN. A. AP Pelvis.</span> Observe the blastic metastatic lesions in both ischia and in the midportion of one ilium. These lesions are secondary to carcinoma of the breast. <span class="emph_B">B. Bone Scan.</span> Note the areas of increased radionuclide uptake (<span class="emph_I">arrows</span>), which correspond directly to the skeletal lesions visualized in panel A. <span class="emph_I">COMMENT:</span> Early lesions in metastatic carcinoma are often not demonstrated on plain film radiographs until the disease is well advanced. Alterations of as little as 3-5&#x0025; in the metabolic activity of bone may be detected with bone scans. These areas of increased radionuclide uptake have been referred to as hot spots. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3434" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]/TLV5[2]">
<div class="HD"><span class="emph_I">Conventional Radiography.</span></div>
<div class="P">The usual radiologic skeletal survey consists of a lateral view of the skull, anteroposterior (AP) and lateral views of the cervical, thoracic, and lumbosacral spine, AP view of the pelvis, AP view of the ribs, and a posteroanterior (PA) view of the chest. The detection of a given metastatic lesion depends on a number of factors: the size of the lesion, its location in bone, and the effect of the bony lesion on the cortex or surrounding trabeculae. There must be at least 30-50&#x0025; loss of bone density before it will be readily visible on a radiograph. In addition, the radiographs must be of optimum quality to adequately visualize the structures to be evaluated.</div>
<div class="P">Approximately 80&#x0025; of all osseous metastases are found in the central or axial skeleton. (<a class="LK" href="sid806035.html#R27-11">27</a>) The distribution is 28&#x0025; in the ribs and sternum, 39&#x0025; in the vertebrae, and 13&#x0025; in the pelvis. (<a class="LK" href="sid806035.html#R27-11">27</a>) Only 10&#x0025; are found in the skull, with a similar percentage in the proximal long bones. (<a class="LK" href="sid806035.html#R27-11">27</a>) Metastatic lesions distal to the knees and elbows are rare.</div>
<a name="PG1143"> </a><div class="pagenum"><div>P.1143</div></div>
<br clear="all">
<div class="FG" id="F8-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]/TLV5[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="231" src="files/e5885a9335a5bce82f0ac30659d0e93d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e5885a9335a5bce82f0ac30659d0e93d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="231" DISPLAY="INLINE"></div>
<div class="P">Figure 11-8 <span class="emph_B">OCCULT OSTEOLYTIC METASTATIC CARCINOMA: SACRAL ALA. A. AP Tilt-Up Lumbosacral.</span> Note that no bony pathology is seen in the sacroiliac joints or sacrum. <span class="emph_B">B. T2-Weighted Fat-Suppressed MRI, Lumbosacral.</span> Observe the large area of bright signal intensity in the left sacral ala, indicative of marrow replacement from metastatic tumor. <span class="emph_I">COMMENT:</span> This 44-year-old female patient was found to have an occult breast carcinoma with metastasis to the sacrum, which was not detected on conventional lumbosacral radiographs. MRI is the most sensitive imaging modality to determine marrow replacement. Approximately 50&#x0025; loss of bone mass is necessary before the earliest signs of osteolytic destruction can be determined on conventional radiographs. (Courtesy of Wes Williams, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Gunnison, Colorado.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3435" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]/TLV5[3]">
<div class="HD"><span class="emph_I">CT.</span></div>
<div class="P">CT is far more sensitive than plain film studies and is particularly useful in the detection and evaluation of cortical bone involvement and the presence of a soft tissue mass. However, some subtle areas of marrow replacement by malignant tissues may be overlooked. It is especially useful for localizing biopsy sites.</div>
</div>
<div class="TLV5" id="B01382540.0-3436" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[1]/TLV5[4]">
<div class="HD"><span class="emph_I">MRI.</span></div>
<div class="P">MRI is superior to CT in both the detection of bone lesions and the assessment of adjacent soft tissue involvement. The infiltration of tumor cells into the fatty bone marrow results in loss of the normally bright signal intensity seen on T1-weighted spin echo images. The affected areas become heterogeneously hyperintense on T2-weighted pulse sequences. (<a class="LK" href="sid806035.html#F8-11">Fig. 11-8</a>) Subtle areas of abnormal tissue are best detected on short tau inversion recovery (STIR) images. This technique is heavily T1 weighted and results in suppression of the normally bright signal originating from marrow fat. Abnormal tissues are, therefore, more conspicuous, appearing quite hyperintense relative to the adjacent dark gray or black appearance of the normal marrow. Recent advances allowing whole-body bone marrow scans using these techniques (T1 weighting and STIR images) have been shown to detect up to 91&#x0025; of metastatic lesions to bone, compared with approximately 85&#x0025; detected by bone scintigraphy. (<a class="LK" href="sid806035.html#R28-11">28</a>) Of clinical note, it has been estimated that after the discovery of metastatic disease up to 21&#x0025; of the primary sources will never be found, even after an extensive search. (<a class="LK" href="sid806035.html#R29-11">29</a>)</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3437" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[2]">
<div class="HD">Fundamental Roentgen Signs</div>
<div class="P">The roentgen signs of bone metastasis include alteration in bone density and architecture. They may be osteolytic, osteoblastic, or mixed. Osteolytic metastases are most common, representing approximately 75&#x0025; of all metastatic lesions. A <span class="emph_I">moth-eaten</span> or <span class="emph_I">permeative pattern</span> of bone destruction is classic and occurs most frequently with breast and lung carcinoma. (<a class="LK" href="sid806035.html#F9-11">Fig. 11-9</a>) These lesions are not detectable on plain films until approximately 30&#x0025; of a focal region of bone is destroyed. In lytic lesions, computed tomography may help when conventional radiography fails to demonstrate an abnormality in a region that is suspect for metastasis, either because of symptoms or because of radionuclide bone scanning. Osteoblastic metastases represent approximately 15&#x0025; of all lesions and are most commonly produced by carcinoma of the prostate, breast, and cecum, as well as bronchial carcinoid tumors. These lesions are much easier to perceive because of their increased radiopacity, even though their margins are typically ill defined. (<a class="LK" href="sid806035.html#F10-11">Fig. 11-10</a>) The blastic lesions may assume a diffuse, scattered pattern, creating a multiple <span class="emph_I">snowball appearance.</span> Mixed lesions represent approximately 10&#x0025; of all metastatic deposits. (<a class="LK" href="sid806035.html#F11-11">Fig. 11-11</a>) They are a combination of osteolytic and osteoblastic proliferation and occur most commonly with carcinoma of the breast and, occasionally, the lung. (<a class="LK" href="sid806035.html#T4-11">Tables 11-4</a> and <a class="LK" href="sid806035.html#T5-11">11-5</a>)</div>
<div class="FG" id="F9-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="398" src="files/526a8aea5f8c292c502d74879f0e42fa.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="526a8aea5f8c292c502d74879f0e42fa.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="398" DISPLAY="INLINE"></div>
<div class="P">Figure 11-9 <span class="emph_B">ISCHIAL METASTASIS. AP Hip.</span> Observe the loss of bone density and a moth-eaten pattern of bone destruction scattered throughout the ischium. The poor zone of transition around the lytic lesion suggests an aggressive disorder of bone. This lytic metastasis is secondary to carcinoma of the breast. Of incidental notation are degenerative changes surrounding the pubic articulation.</div>
</td></tr>
</table></div>
<a name="PG1144"> </a><div class="pagenum"><div>P.1144</div></div>
<br clear="all">
<div class="FG" id="F10-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="391" height="700" src="files/4fa2f35a9f4b50c2567498d8463e87cc.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4fa2f35a9f4b50c2567498d8463e87cc.gif" MIMETYPE="image/gif" WIDTH="391" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-10 <span class="emph_B">BLASTIC METASTATIC DISEASE. AP Hip.</span> Note the ill-defined area of radiopacity in the intertrochanteric space and adjacent to the lesser trochanter. This represents blastic metastasis from carcinoma of the prostate gland. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F11-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="483" height="700" src="files/be7ea8e5791bb00e234ac2e8339331e7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="be7ea8e5791bb00e234ac2e8339331e7.gif" MIMETYPE="image/gif" WIDTH="483" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-11 <span class="emph_B">MIXED METASTASIS: LATERAL LUMBAR SPINE.</span> Observe the diffuse osteolytic and osteoblastic lesions scattered throughout the entire lumbar spine. These lesions are secondary to carcinoma of the breast. Notice the mixed metastatic lesions in the visualized lower ribs (<span class="emph_I">arrows</span>). Of incidental notation is a calcified mesenteric lymph node (<span class="emph_I">arrowhead</span>).</div>
</td></tr>
</table></div>
<div class="TB" id="T4-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[2]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-4 Radiologic Presentations of Metastatic Carcinoma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>
<b>Primary Organ</b><br><b>Involvement</b>
</p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Lytic (&#x0025;)</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Mixed (&#x0025;)</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Blastic (&#x0025;)</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Breast</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>80</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Lung</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>75</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>20</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>5</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Renal</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>80</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Wilms&#x2019; tumor</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>80</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>20</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Urinary bladder</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>90</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Thyroid</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>90</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Prostate</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>80</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Salivary glands</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>100</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Neuroblastoma</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>80</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>15</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>5</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Esophagus</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>85</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>5</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Stomach</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>90</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Colon or rectum</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>75</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>5</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>20</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pancreas</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>80</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Liver<i><sup><a class="a" href="sid806035.html#N1-T4-C11">a</a></sup></i>
</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>70</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>30</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Gallbladder<i><sup><a class="a" href="sid806035.html#N1-T4-C11">a</a></sup></i>
</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>90</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Uterine cervix</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>90</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>8</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>2</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Uterine corpus</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>90</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Ovary</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>90</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>7</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>3</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Testis</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>75</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>5</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>20</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Skin carcinoma</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>95</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>5</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Malignant melanoma</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>90</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Carcinoid</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>5</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>15</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>80</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Hodgkin&#x2019;s lymphoma</p></td>
<td align="right" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>40</p></td>
<td align="right" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>10</p></td>
<td align="right" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>50</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5" rowspan="1"><p>
<i><sup><a name="N1-T4-C11" shape="rect" target="_blank">a </a></sup></i>Cancer of these organs rarely metastasizes to bone.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TB" id="T5-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[2]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-5 Radiologic Features of Metastatic Carcinoma to Bone</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" style="border-top: 1px solid black;" rowspan="1"><p>General</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Axial skeleton predilection</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Multiple sites</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Osteolytic metastases (75&#x0025;)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Cortical and trabecular destruction</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Lack of periosteal response</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Moth-eaten, permeative destruction</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Small or absent soft tissue mass</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Multiple sites</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Variants (lung, thyroid, kidney); solitary expansile soap bubble lesion</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Osteoblastic metastases (15&#x0025;)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Localized or diffuse increased bone density</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Poorly defined margins</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Multiple sites</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Mixed metastases (10&#x0025;)</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Combination of blastic and lytic features</p></td>
</tr>
</table></td></tr>
</table></div>
<a name="PG1145"> </a><div class="pagenum"><div>P.1145</div></div>
<br clear="all">
<div class="FG" id="F12-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="564" src="files/e17446eb25f0f49afb6e42715f5aefe2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e17446eb25f0f49afb6e42715f5aefe2.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="564" DISPLAY="INLINE"></div>
<div class="P">Figure 11-12 <span class="emph_B">BLOW-OUT METASTATIC PATTERN. A. Radius.</span> Observe the extensive destruction of the proximal radius, which creates an altered angulation of the meta-diaphyseal portion of this bone (renal primary). <span class="emph_B">B. Ilium.</span> Observe the extensive destruction of the iliac wing and supra-acetabular area. There is no destruction of the femoral head or disturbance of the joint space of the hip articulation. This presentation is consistent with a neoplasm (thyroid primary) rather than an infection. <span class="emph_B">C. Humerus.</span> Observe the grossly expansile mid-diaphyseal lesion of the humerus. There is a permeative pattern of bone destruction noted on both sides of the expanding lesion (renal primary). <span class="emph_B">D. Lumbar Spine.</span> Note the partial destruction of the L4 vertebral body and complete destruction of the L5 vertebral body.</div>
</td></tr>
</table></div>
<div class="TLV5" id="B01382540.0-3438" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[2]/TLV5[1]">
<div class="HD"><span class="emph_I">Blow-Out Metastatic Lesions.</span></div>
<div class="P">Lesions that vary from the common roentgen patterns previously described or that are atypical in their presentation deserve special consideration. Although most metastatic lesions are multiple, as many as 10&#x0025; may be solitary. (<a class="LK" href="sid806035.html#R5-11">5</a>) This more commonly occurs with carcinoma of the lung, thyroid, and kidney. Specific characteristics of the solitary lesion, such as a bubbly, highly expansile appearance, may suggest a renal or thyroid malignancy. This lesion is characteristically quite large and has been called the <span class="emph_I">blow-out metastatic pattern.</span> (<a class="LK" href="sid806035.html#F12-11">Fig. 11-12</a>) It is this type of metastasis that demonstrates bone expansion, a roentgen sign more frequently linked to primary tumors than to secondary ones. A solitary plasmacytoma or giant cell tumor may often give a similar appearance.</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3439" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[3]">
<div class="HD">Primary Versus Secondary Tumors: Differential Diagnosis</div>
<div class="P">It should be emphasized that the radiographic appearance of the osseous lesions of metastatic neoplasms does not permit a positive differentiation of metastatic neoplasm from primary malignant neoplasms of bone. A few helpful differential points do exist, however, allowing a fundamental differentiation of primary versus secondary malignant tumors. (<a class="LK" href="sid806035.html#T6-11">Table 11-6</a>) The presence of periosteal response is much more commonly found with primary malignant tumors than with secondary. The appearance of a soft tissue mass is rare in metastases but quite common in primary malignant tumors. Frequently, the length of the lesion is helpful,
<a name="PG1146"> </a><div class="pagenum"><div>P.1146</div></div>
<br clear="all">
with the long lesions (&#x003E; 6 cm) often representing a primary malignant tumor, and most metastatic tumors range between 2 and 4 cm in length. Most malignant tumors that expand bone are primary in nature, with the rare exception of the expansile metastatic tumors of renal and thyroid malignancies (blow-out lesions). Most primary tumors are solitary lesions, whereas metastatic lesions are usually multiple. These criteria should be used only as guidelines because occasional exceptions are seen. Definitive diagnosis of these lesions can be obtained only by biopsy.</div>
<div class="TB" id="T6-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[3]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-6 Malignant Bone Neoplasms: Differentiating Radiologic Features between Primary and Secondary Lesions</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Feature</b></p></th>
<th align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Primary</b></p></th>
<th align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Secondary</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Incidence</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>30&#x0025;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>70&#x0025;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion of bone</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Joint involvement</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Length of lesion</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x003E; 6 cm</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>2-4 cm</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Periosteal response</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Solitary lesion</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Multiple lesions</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Soft tissue mass</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>&#x2014;, Does not occur; &#x002B;, seldom occurs; &#x002B;&#x002B;, often occurs; &#x002B;&#x002B;&#x002B;, very commonly occurs.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F13-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[4]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="366" src="files/c0d932b60198206e9e51ae8d80d725dc.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c0d932b60198206e9e51ae8d80d725dc.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="366" DISPLAY="INLINE"></div>
<div class="P">Figure 11-13 <span class="emph_B">DIFFUSE PATTERNS OF SPINAL METASTATIC DISEASE. A. Multiple Ivory Vertebrae.</span> Observe the diffuse radiopacity from metastatic disease of the prostate gland involving the upper lumbar vertebrae. <span class="emph_B">B. Grossly Lytic Vertebrae.</span> Note the extensive resorption of the L1 and L3 vertebral bodies and pedicles. Pathologic collapse of the L1 vertebral body has occurred. These represent blow-out lesions from carcinoma of the thyroid gland. <span class="emph_B">C. Diffuse Mixed Metastasis.</span> Note the extensive lytic and blastic destruction scattered throughout the entire lumbar spine and lower thoracic vertebrae. There is a wedge-shaped pathologic compression fracture present at the L1 vertebra. Slight compression of the L4 vertebral body is also noted. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">A radiographic anthology of vertebral names.</span> J Manipulative Physiol Ther 8(<a class="LK" href="sid806035.html#R2-11">2</a>):4, 1985.)</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3440" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]">
<div class="HD">Specific Anatomic Location</div>
<div class="TLV4" id="B01382540.0-3441" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]">
<div class="HD">Spine</div>
<div class="P">The spine is the most common osseous site for metastasis to occur, accounting for approximately 40&#x0025; of all lesions. (<a class="LK" href="sid806035.html#R27-11">27</a>) The thoracic and lumbar spine are the regions most commonly affected. (<a class="LK" href="sid806035.html#F13-11">Figs. 11-13</a> and <a class="LK" href="sid806035.html#F14-11">11-14</a>) Cervical spine involvement does occur, but to a lesser extent. (<a class="LK" href="sid806035.html#F15-11">Figs. 11-15</a> and <a class="LK" href="sid806035.html#F16-11">11-16</a>) The atlas seems to be an infrequent site. (<a class="LK" href="sid806035.html#F17-11">Fig. 11-17</a>) The most frequently involved specific components of the spine in metastatic disease are the vertebral bodies and pedicles. One of the most difficult lesions to assess is a solitary vertebral metastasis.</div>
<div class="TLV5" id="B01382540.0-3442" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[1]">
<div class="HD"><span class="emph_I">Vertebral Body.</span></div>
<div class="P">The earliest and most subtle sign of osteolytic disease is a focal osteoporosis or radiolucency of a vertebral body, in contrast to the adjacent vertebral segments. (<a class="LK" href="sid806035.html#F18-11">Fig. 11-18</a>) This sign often occurs shortly before some trivial trauma induces a pathologic fracture. Bone scan may show increased uptake, and MRI reveals uniform marrow infiltration with decreased signal on T1-weighted studies and intermediate to increased signal intensity on T2-weighted images. (<a class="LK" href="sid806035.html#R30-11">30</a>) (<a class="LK" href="sid806035.html#F19-11">Fig. 11-19</a>)</div>
<div class="P">Pathologic compression fractures exhibit both anterior and posterior loss of height (vertebra plana). (<a class="LK" href="sid806035.html#F20-11">Fig. 11-20</a>; <a class="LK" href="sid806035.html#T7-11">Table 11-7</a>) Close inspection of endplate integrity may show it to be destroyed, a feature also seen in infection, which usually has co-existing loss
<a name="PG1147"> </a><div class="pagenum"><div>P.1147</div></div>
<br clear="all">
of disc height. (<a class="LK" href="sid806035.html#F21-11">Fig. 11-21</a>) MRI will characteristically delineate these ill-defined endplate irregularities and irregular nodular paravertebral soft tissue lesions as well as reveal abnormal signal involvement of the pedicles. (<a class="LK" href="sid806035.html#R31-11">31</a>) Wedge-shaped deformities can also occur. Pathological collapse of a vertebra is often a painful event. Vertebroplasty and kyphoplasty have shown to be safe, effective, and long-lasting techniques to reduce deformity and pain in these patients. (<a class="LK" href="sid806035.html#R32-11">32</a>)</div>
<div class="FG" id="F14-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="479" src="files/21b6a98b8fccac0f280d3a5015d32439.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="21b6a98b8fccac0f280d3a5015d32439.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="479" DISPLAY="INLINE"></div>
<div class="P">Figure 11-14 <span class="emph_B">SPINAL METASTASIS. A. Ivory Vertebra.</span> Note the diffuse, homogeneous radiopacity of the T10 vertebral body, representing blastic metastatic disease from carcinoma of the prostate gland. <span class="emph_B">B. Ivory Vertebra and Mixed Metastasis.</span> Observe the homogeneous radiopacity of the L4 vertebral body, without bone expansion. This represents blastic metastatic disease from carcinoma of the prostate gland. The visualized segments of L3, L5, and the sacrum demonstrate mixed lytic and blastic changes. A pathologic fracture is present in the L5 vertebral body. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">A radiographic anthology of vertebral names.</span> J Manipulative Physiol Ther 8(<a class="LK" href="sid806035.html#R2-11">2</a>):4, 1985.)</div>
</td></tr>
</table></div>
<div class="FG" id="F15-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="486" src="files/21085257aad4670e244e105d5b06a2dc.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="21085257aad4670e244e105d5b06a2dc.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="486" DISPLAY="INLINE"></div>
<div class="P">Figure 11-15 <span class="emph_B">CERVICAL SPINE METASTATIC DISEASE: SERIAL PROGRESSION. A. Initial Radiograph.</span> Observe that the initial radiographic examination of this patient demonstrates moderate osteoporosis with some spinal degenerative changes. No metastatic disease is evident at this time. <span class="emph_B">B. 1-Year Follow-Up.</span> Observe the homogeneous radiopacity (ivory vertebra) present at the C4 segment. A second blastic metastatic deposit is present in the spinous process of C2. These lesions are secondary to metastatic disease from carcinoma of the prostate gland. (Courtesy of Larry L. Sibley, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Plainview, Texas.)</div>
</td></tr>
</table></div>
<a name="PG1148"> </a><div class="pagenum"><div>P.1148</div></div>
<br clear="all">
<div class="FG" id="F16-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="489" src="files/c2062b005a856234252ffc8b0df00af7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c2062b005a856234252ffc8b0df00af7.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="489" DISPLAY="INLINE"></div>
<div class="P">Figure 11-16 <span class="emph_B">METASTATIC DISEASE OF THE CERVICAL SPINE: A SERIAL STUDY. A. Lateral Cervical Spine.</span> This 30-year-old female presented with pain in the cervical area. A few years before this radiograph was taken she had a radical mastectomy for carcinoma. <span class="emph_B">B. 1-Year Follow-Up.</span> Note the diffuse lytic metastatic disease present in the vertebral body of C4. There is extensive collapse and vanishing of the vertebral body of C5, along with its articular pillars, lamina, and spinous process. (Courtesy of Raymond Roscioli, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Easton, Pennsylvania.)</div>
</td></tr>
</table></div>
<div class="FG" id="F17-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[1]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="437" src="files/a96a634f74450e202dd83b48213befbd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a96a634f74450e202dd83b48213befbd.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="437" DISPLAY="INLINE"></div>
<div class="P">Figure 11-17 <span class="emph_B">METASTASIS TO THE ATLAS.</span> Observe the destruction of the most medial portion of the lateral mass of the atlas (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> This 30-year-old female presented with upper cervical pain. Two years before this radiograph was performed, she had a malignant pheochromocytoma removed from the adrenal gland. A total body bone scan revealed hot spots in two ribs and the L4 vertebral body, although plain films showed no abnormalities. Metastatic disease to the atlas is quite rare, as are primary tumors. (Courtesy of Teresa Shook, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Antioch, California.)</div>
</td></tr>
</table></div>
<div class="P">Bone weakening of the vertebral body may lead to disruption of the endplate either as an angular deformity or as Schmorl&#x2019;s nodes. (<a class="LK" href="sid806035.html#R30-11">30</a>,<a class="LK" href="sid806035.html#R33-11">33</a>) Smooth, curved endplate deformities are usually not associated with underlying malignancy. (<a class="LK" href="sid806035.html#R30-11">30</a>) Intrabody discal herniation owing to underlying malignant bone disease is referred to as a <span class="emph_I">malignant Schmorl&#x2019;s node.</span> This process is usually accentuated by significant or occult trauma. These defects within the vertebrae contain both tumor and disc material and predispose the disc to secondary degenerative changes. (<a class="LK" href="sid806035.html#R33-11">33</a>) Neoplasms can rarely locate within the intervertebral disc by direct or hematogenous spread. (<a class="LK" href="sid806035.html#R33-11">33</a>) Extensive involvement of the intervertebral disc or discal metastasis is indeed rare. (<a class="LK" href="sid806035.html#R33-11">33</a>) Invasion of any joint by any tumor is uncommon but is more likely in those joints that lack mobility, usually the sacroiliac joint and the disc and facet joint. (<a class="LK" href="sid806035.html#R34-11">34</a>,<a class="LK" href="sid806035.html#R35-11">35</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3443" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]">
<div class="HD"><span class="emph_I">Pedicle.</span></div>
<div class="P">The pedicle is an important, radiologically detectable site for osteolytic metastatic carcinoma. Any component of the neural arch can be involved, although the pedicle is by far the most common location. (<a class="LK" href="sid806035.html#F22-11">Fig. 11-22</a>) Destruction of the posterior vertebral body with contiguous involvement of the pedicle attachment results in loss of the cortical outline of the pedicle. (<a class="LK" href="sid806035.html#R36-11">36</a>) This has been referred to as the <span class="emph_I">one-eyed pedicle sign</span> or as the <span class="emph_I">winking owl sign</span> and is most commonly found in the lower thoracic and lumbar spine. (<a class="LK" href="sid806035.html#R37-11">37</a>,<a class="LK" href="sid806035.html#R38-11">38</a>) (<a class="LK" href="sid806035.html#F23-11">Figs. 11-23</a> and <a class="LK" href="sid806035.html#F24-11">11-24</a>) It is most easily visualized on the AP radiograph. (<a class="LK" href="sid806035.html#R38-11">38</a>) (<a class="LK" href="sid806035.html#F25-11">Figs. 11-25</a> and <a class="LK" href="sid806035.html#F26-11">11-26</a>) Most cases of pedicle destruction involve a single vertebra; however, multiple levels can be affected. (<a class="LK" href="sid806035.html#F27-11">Fig. 11-27</a>) Occasionally, bilateral pedicular destruction may occur and is referred to as the <span class="emph_I">blind vertebra.</span> (<a class="LK" href="sid806035.html#R39-11">39</a>) (<a class="LK" href="sid806035.html#F28-11">Figs. 11-28</a> and <a class="LK" href="sid806035.html#F29-11">11-29</a>; <a class="LK" href="sid806035.html#T8-11">Table 11-8</a>)</div>
<a name="PG1149"> </a><div class="pagenum"><div>P.1149</div></div>
<br clear="all">
<div class="FG" id="F18-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="493" src="files/3954d279799b803ef585ba0b82451611.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3954d279799b803ef585ba0b82451611.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="493" DISPLAY="INLINE"></div>
<div class="P">Figure 11-18 <span class="emph_B">SUBTLE SIGNS OF EARLY LYTIC METASTATIC CARCINOMA. A. Lateral Cervical Spine.</span> Observe the focal radiolucency of the vertebral body of C4 compared with the C3 and C5 vertebral segments. There is a subtle disruption in the superior vertebral cortical endplate of C4, representing early osteolytic change. <span class="emph_B">B. 6-Week Follow-Up.</span> Note the extensive osteolysis and collapse of the C4 vertebral body. Observe the increase in the retropharyngeal interspace anterior to C4 (<span class="emph_I">arrow</span>). This most likely represents hemorrhage and&#x002F;or soft tissue tumor extension. <span class="emph_I">COMMENT:</span> This 55-year-old female had a history of carcinoma of the uterine cervix 5 years before the initial radiographs were taken. The early signs of carcinoma were detected by the initial radiologist, resulting in proper referral. It is unusual for a metastatic tumor to move so rapidly; most metastatic tumors would take 6 months to show such progressive changes. (Courtesy of James F. Winterstein, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Chicago, Illinois.)</div>
</td></tr>
</table></div>
<div class="FG" id="F19-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="492" height="700" src="files/d4e5fb196772ed733d4b1efbdd5f8a7e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d4e5fb196772ed733d4b1efbdd5f8a7e.gif" MIMETYPE="image/gif" WIDTH="492" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-19 <span class="emph_B">METASTATIC MARROW INFILTRATION. MRI.</span> Note the low signal of the T2, T3 vertebral bodies due to neoplastic marrow infiltration (<span class="emph_I">arrows</span>). Note the overlying mass from a malignant melanoma (<span class="emph_I">arrowhead</span>). (Courtesy of Kenneth B. Reynard, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="FG" id="F20-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="477" height="700" src="files/e1e49dc60b189ac1a64588ddab84c016.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e1e49dc60b189ac1a64588ddab84c016.gif" MIMETYPE="image/gif" WIDTH="477" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-20 <span class="emph_B">VERTEBRAL PATHOLOGIC COLLAPSE. Lateral Cervical Spine.</span> Note the uniform collapse of the C3 vertebral body and, to a lesser extent, the C6 vertebral body. Compression of the posterior third of the vertebral body strongly suggests pathologic collapse, which is usually of neoplastic origin. This patient had carcinoma of the breast.</div>
</td></tr>
</table></div>
<a name="PG1150"> </a><div class="pagenum"><div>P.1150</div></div>
<br clear="all">
<div class="TB" id="T7-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-7 Solitary Vertebral Collapse</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Common Causes</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Uncommon Causes</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Metastatic carcinoma</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chordoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Myeloma (plasmacytoma)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chondrosarcoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Eosinophilic granuloma</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Hemangioma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Traumatic fracture (healthy bone)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Hydatid cyst</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Paget&#x2019;s disease</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ewing&#x2019;s sarcoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Infection (any cause)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteosarcoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Steroid abuse, Cushing&#x2019;s disease</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Giant cell tumor</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Malignant lymphoma</p></td>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F21-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="573" src="files/213243b42fd223ed13c3c440d1322891.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="213243b42fd223ed13c3c440d1322891.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="573" DISPLAY="INLINE"></div>
<div class="P">Figure 11-21 <span class="emph_B">AN UNUSUAL PRESENTATION OF METASTATIC DISEASE. A. AP Lumbar Spine.</span> Observe the destruction of one pedicle on L3 (<span class="emph_I">arrow</span>). Note the increase in bone density of the vertebral body of L2 and the generalized osteoporosis of the body of L3. <span class="emph_B">B. Lateral Lumbar Spine.</span> Observe the ivory vertebra at the L2 level (<span class="emph_I">arrow</span>). Note also the extreme loss of bone density at the L3 vertebral body with the destruction and loss of the cortical halo endplates on the superior and inferior surfaces of the L3 vertebral body (<span class="emph_I">arrow-head</span>). Observe the normal bone density and trabecular patterns of L4 (<span class="emph_I">crossed arrow</span>). <span class="emph_I">COMMENT:</span> This 60-year-old female had a previous history of primary carcinoma of the lung. It is quite unusual to have both an ivory vertebra and an adjacent grossly osteolytic vertebra from metastatic disease in the same spine. This patient had the additional classic one-eyed pedicle sign of osteolytic metastatic disease. (Courtesy of James F. Winterstein, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Chicago, Illinois.)</div>
</td></tr>
</table></div>
<div class="FG" id="F22-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="495" height="700" src="files/a113cf2985d9096d0f228f066c0502a7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a113cf2985d9096d0f228f066c0502a7.gif" MIMETYPE="image/gif" WIDTH="495" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-22 <span class="emph_B">OSTEOLYTIC METASTASIS. Lateral Cervical Spine.</span> Note that the spinous process, spinolaminar junction line, and the laminae have been destroyed at the C3 level (<span class="emph_I">arrow</span>). <span class="emph_I">COMMENT:</span> Congenital agenesis of an isolated neural arch is rare. Loss of the neural arch should be considered tumor induced until proven otherwise. (Courtesy of R. Scott Foster, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Memphis, Tennessee.)</div>
</td></tr>
</table></div>
<div class="FG" id="F23-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="559" src="files/2a3c078a7fa69810a5805e643c2d4e10.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2a3c078a7fa69810a5805e643c2d4e10.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="559" DISPLAY="INLINE"></div>
<div class="P">Figure 11-23 <span class="emph_B">ONE-EYED PEDICLE SIGN. A. AP Lumbar Spine.</span> Observe the unilateral destruction of the pedicle of L3, creating the one-eyed pedicle sign. The transverse process of L3 on the side of pedicle destruction has also been destroyed. <span class="emph_B">B. Lateral Lumbar Spine.</span> Observe the extensive destruction of the area of the pedicle of L3, with extension of the neoplasm into the posterior half of the vertebral body.</div>
</td></tr>
</table></div>
<a name="PG1151"> </a><div class="pagenum"><div>P.1151</div></div>
<br clear="all">
<div class="FG" id="F24-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="427" height="700" src="files/21e3e5806e53a82dd86a8fe9fde483ee.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="21e3e5806e53a82dd86a8fe9fde483ee.gif" MIMETYPE="image/gif" WIDTH="427" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-24 <span class="emph_B">ONE-EYED PEDICLE SIGN. A. AP Thoracic Specimen Radiograph. B. Axial Thoracic Specimen Radiograph.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F25-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="651" src="files/e53c43d3b24fe035562c99b69ff22ce1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e53c43d3b24fe035562c99b69ff22ce1.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="651" DISPLAY="INLINE"></div>
<div class="P">Figure 11-25 <span class="emph_B">ONE-EYED PEDICLE SIGN (WINKING OWL SIGN) OF LYTIC METASTATIC DISEASE. A. AP Thoracic Spine.</span> Observe the unilateral pedicle destruction at the T4 vertebra (<span class="emph_I">arrow</span>). <span class="emph_B">B. Myelographic Evaluation.</span> Note the block at the T4 level of the myelographic media as a result of extradural extension of the metastatic neoplasm. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F26-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="492" src="files/127745a3be791e937952d01aff95c0b9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="127745a3be791e937952d01aff95c0b9.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="492" DISPLAY="INLINE"></div>
<div class="P">Figure 11-26 <span class="emph_B">OSTEOLYTIC METASTATIC DISEASE: ONE-EYED PEDICLE SIGN. A. AP Lower Cervical Spine.</span> Observe the unilateral destruction of the pedicle of C6 (<span class="emph_I">arrows</span>), along with a portion of its articular pillar. <span class="emph_B">B. Oblique Cervical Spine.</span> Note the massive osteolysis of the articular pillar and pedicle of C6.</div>
</td></tr>
</table></div>
<a name="PG1152"> </a><div class="pagenum"><div>P.1152</div></div>
<br clear="all">
<div class="FG" id="F27-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[10]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="467" height="700" src="files/e7b37ecf378c448f7853a09c16c98f72.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e7b37ecf378c448f7853a09c16c98f72.gif" MIMETYPE="image/gif" WIDTH="467" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-27 <span class="emph_B">METASTASIS AT MULTIPLE VERTEBRAL LEVELS. AP Thoracic.</span> Observe the one-eyed pedicle signs at T8, T9, T11, and T12 (<span class="emph_I">arrows</span>). (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F28-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[11]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="466" height="700" src="files/1dc2159207fac1f6d46bc225ee499912.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1dc2159207fac1f6d46bc225ee499912.gif" MIMETYPE="image/gif" WIDTH="466" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-28 <span class="emph_B">BLIND VERTEBRA. AP Thoracic.</span> Observe the bilateral pedicular destruction at the T10 vertebral segment. This represents osteolytic metastasis from carcinoma of the breast.</div>
</td></tr>
</table></div>
<div class="FG" id="F29-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[12]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="499" src="files/7bc6e402e63d70bb88cb4e3a7811e13c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7bc6e402e63d70bb88cb4e3a7811e13c.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="499" DISPLAY="INLINE"></div>
<div class="P">Figure 11-29 <span class="emph_B">BLIND VERTEBRA. A. AP Lumbar Spine.</span> Note the bilateral pedicular destruction at the L3 vertebra. The spinous process and laminae have also been destroyed. Of incidental notation are rather large spondylophytes scattered throughout the lumbar spine. <span class="emph_B">B. Lateral Lumbar Spine.</span> Observe the complete destruction of the neural arch and pedicles of the L3 vertebra. The radiopaque densities in the area of the spinous process of L5 represent previous heavymetal injections in the soft tissue structures.</div>
</td></tr>
</table></div>
<a name="PG1153"> </a><div class="pagenum"><div>P.1153</div></div>
<br clear="all">
<div class="TB" id="T8-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-8 Radiologic Features of Spinal Metastasis</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="3" style="border-top: 1px solid black;" rowspan="1"><p>Location</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Lumbar and thoracic spine</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Vertebral body, pedicles</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>Signs</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Altered bone density</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Decreased: moth-eaten, permeative diffuse</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Increased: localized, ivory vertebra</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Cortical destruction</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Disc space unaffected</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pathologic collapse</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Decreased posterior vertebral body height</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Endplate disruption (malignant Schmorl&#x2019;s node)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pedicle destruction</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>One-eyed pedicle sign (winking owl sign)</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Blind vertebra (both pedicles destroyed)</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="P">The most common cause for a missing pedicle is osteolytic metastatic carcinoma; however, agenesis of a pedicle may also occur. (<a class="LK" href="sid806035.html#F30-11">Fig. 11-30</a>) The key to radiologic differentiation is to search for a stress-related reactive sclerosis and enlargement of the contralateral pedicle. (<a class="LK" href="sid806035.html#R40-11">40</a>,<a class="LK" href="sid806035.html#R41-11">41</a>) (<a class="LK" href="sid806035.html#T9-11">Table 11-9</a>) If this sign is present, it represents a firm assurance that osteolytic metastatic carcinoma has not occurred. Those cases of agenesis of the pedicle that create no stress hypertrophy of the opposite pedicle must be considered metastatic tumor until proven otherwise. (<a class="LK" href="sid806035.html#R40-11">40</a>,<a class="LK" href="sid806035.html#R41-11">41</a>) Previous radiographs in this circumstance will be helpful. Destruction of a pedicle in a patient &#x003C; 30 years of age is most commonly the result of aneurysmal bone cyst (ABC), osteoblastoma, metastases from neuroblastoma (&#x003C; 3 years), or cord tumor.</div>
<div class="TB" id="T9-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/TB[3]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-9 Differential Diagnosis of Pedicle Destruction</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="3" style="border-top: 1px solid black;" rowspan="1"><p>Congenital</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Agenesis (contralateral pedicular sclerosis)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Hypoplasia</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>Neoplasm</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Benign</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Aneurysmal bone cyst</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoblastoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Neurofibroma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoid osteoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Malignant</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Lytic metastasis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Myeloma (rare)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>Surgery</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Removal</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F30-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[2]/FG[13]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="482" src="files/8c69b427bf5e666aff2f1040223e6921.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8c69b427bf5e666aff2f1040223e6921.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="482" DISPLAY="INLINE"></div>
<div class="P">Figure 11-30 <span class="emph_B">MISSING PEDICLES: CONGENITAL VERSUS NEOPLASM. A. Metastatic Disease.</span> Observe the one-eyed pedicle sign present at the L1 segment as a result of diffuse osteolytic metastasis. There is also metastatic destruction of the lamina, spinous process, and a portion of the lateral body of L1. Note that the contralateral pedicle at L1 shows no evidence of sclerosis or enlargement. <span class="emph_B">B. Congenital Absence.</span> Note the agenesis of the pedicle of L4 (<span class="emph_I">arrow</span>), with compensatory sclerosis and hypertrophy of the contralateral pedicle (<span class="emph_I">arrowhead</span>). <span class="emph_I">COMMENT:</span> Sclerosis and enlargement of the pedicle adjacent to a missing pedicle are positive radiographic signs of congenital absence rather than of osteolytic metastatic disease.</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3444" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]">
<div class="HD"><span class="emph_I">Ivory Vertebra.</span></div>
<div class="P">Osteoblastic metastatic carcinoma may affect the vertebrae in either a diffuse or a localized form. (<a class="LK" href="sid806035.html#F31-11">Figs. 11-31</a>, <a class="LK" href="sid806035.html#F32-11">11-32</a> and <a class="LK" href="sid806035.html#F33-11">11-33</a>) When a singular vertebral body is involved exhibiting a diffuse homogeneous radiopacity, it has been called an <span class="emph_I">ivory vertebra.</span> (<a class="LK" href="sid806035.html#R33-11">33</a>,<a class="LK" href="sid806035.html#R37-11">37</a>) (<a class="LK" href="sid806035.html#T10-11">Tables 11-10</a> and <a class="LK" href="sid806035.html#T11-11">11-11</a>) The three most common causes for an ivory vertebra are osteoblastic metastatic carcinoma (usually from the prostate gland), Paget&#x2019;s
<a name="PG1154"> </a><div class="pagenum"><div>P.1154</div></div>
<br clear="all">
disease (osteitis deformans), and Hodgkin&#x2019;s disease (lymphoma). (<a class="LK" href="sid806035.html#F34-11">Figs. 11-34</a> and <a class="LK" href="sid806035.html#F35-11">11-35</a>)</div>
<div class="FG" id="F31-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="486" height="700" src="files/ccc27657057d1679755e06ce07616a2f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ccc27657057d1679755e06ce07616a2f.gif" MIMETYPE="image/gif" WIDTH="486" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-31 <span class="emph_B">IVORY VERTEBRAE: SPECIMEN RADIOGRAPH.</span> Note that two entire vertebral bodies exhibit homogeneous increase in density owing to metastatic carcinoma. Note the lack of expansion and normal anterior contours, helping exclude Paget&#x2019;s disease and Hodgkin&#x2019;s lymphoma, respectively. (Courtesy of Donald Resnick, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, San Diego, California.)</div>
</td></tr>
</table></div>
<div class="FG" id="F32-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="322" src="files/cbeb09f598634a147971f430b1541c39.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="cbeb09f598634a147971f430b1541c39.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="322" DISPLAY="INLINE"></div>
<div class="P">Figure 11-32 <span class="emph_B">DIFFUSE OSTEOBLASTIC METASTASIS. A. Lateral Cervical Spine. B. Lateral Thoracic Spine. C. Lateral Lumbar Spine.</span> Note that this 70-year-old male shows diffuse osteoblastic metastasis throughout the entire spine, secondary to primary carcinoma of the prostate gland. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F33-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="470" height="700" src="files/60ab11d8885ee0b89bb4d5acc7953e53.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="60ab11d8885ee0b89bb4d5acc7953e53.gif" MIMETYPE="image/gif" WIDTH="470" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-33 <span class="emph_B">LOCALIZED IVORY VERTEBRA.</span> Observe the localized osteoblastic response of a single thoracic vertebra (<span class="emph_I">arrow</span>). This represents osteoblastic metastasis from carcinoma of the breast. Of incidental notation are a number of circular radiopacities scattered throughout the lung field and superimposed on the spine, which represent calcified, healed tubercular granulomas (<span class="emph_I">arrowhead</span>).</div>
</td></tr>
</table></div>
<a name="PG1155"> </a><div class="pagenum"><div>P.1155</div></div>
<br clear="all">
<div class="TB" id="T10-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-10 Solitary Ivory Vertebra</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Common Causes</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Uncommon Causes</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoblastic metastasis</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Sarcoidosis</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Hodgkin&#x2019;s lymphoma</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chordoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Paget&#x2019;s disease</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Myeloma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Degenerative sclerosis</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteosarcoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteomyelitis (fungal or chronic)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ewing&#x2019;s sarcoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Idiopathic</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoid osteoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoblastoma</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Bone island</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TB" id="T11-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-11 Differential Diagnosis of an Ivory Vertebra</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Factor</b></p></th>
<th align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>
<b>Blastic</b><br><b>Metastases</b>
</p></th>
<th align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>
<b>Paget&#x2019;s</b><br><b>Disease</b>
</p></th>
<th align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>
<b>Hodgkin&#x2019;s</b><br><b>Disease</b>
</p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Age (years)</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x003E; 45</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x003E; 50</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>20-40</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Increased density</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Anterior scalloping</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Acid phosphatase</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;<i><sup>a</sup></i>
</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Alkaline phosphatase</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x002B;&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="4" rowspan="1"><p>Males, prostate.</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="4" rowspan="1"><p>&#x2014;, Does not occur; &#x002B;, seldom occurs; &#x002B;&#x002B;, often occurs; &#x002B;&#x002B;&#x002B;, very commonly occurs.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F34-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="327" src="files/56acc282141c95430f2794d39dbf4a32.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="56acc282141c95430f2794d39dbf4a32.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="327" DISPLAY="INLINE"></div>
<div class="P">Figure 11-34 <span class="emph_B">A SOLITARY IVORY VERTEBRA: DIFFERENTIAL DIAGNOSIS. A. Osteoblastic Metastasis.</span> Note the homogeneous increase in density without cortical thickening or vertebral expansion at L2. <span class="emph_B">B. Paget&#x2019;s Disease.</span> Observe the gross expansion and squaring off of the anterior vertebral body margin of the L4 vertebra. These radiographic signs negate the possibility of osteoblastic metastasis and support Paget&#x2019;s disease. <span class="emph_B">C. Hodgkin&#x2019;s Lymphoma.</span> Note the solitary ivory vertebra at T12, with anterior vertebral body scalloping (<span class="emph_I">arrow</span>). This anterior vertebral body scalloping is classic for Hodgkin&#x2019;s lymphoma and is thought to be related to contiguous lymphoid tissue pressing on the anterior surface of the vertebral body. Not all ivory vertebrae from Hodgkin&#x2019;s disease will show anterior scalloping; however, it is a classic sign when present. (Panel A courtesy of Douglas B. Hart, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Carina, Queensland, Australia. Panel B courtesy of Joseph W. Howe, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Los Angeles, California. Panel C courtesy of Paul E. Siebert, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="P">The radiographic differential diagnosis of a solitary ivory vertebra may be accomplished by inspecting the anterior aspect of the vertebra. The normal concavity of the vertebral body will be unaltered in patients with osteoblastic metastasis. Paget&#x2019;s disease usually creates a squaring off of the anterior surface of the vertebral body, as a result of the inherent cortical thickening and bone expansion. Rarely, Paget&#x2019;s disease may not expand the vertebral body, and if no other bony lesions are present, a biopsy may be required for final diagnosis.</div>
<div class="P">In Hodgkin&#x2019;s lymphoma there is often anterior scalloping of the ivory vertebral body, thus accentuating the anterior vertebral concavity. The pathogenesis of this is thought to be from contiguous lymph node tissue pressing on the vertebral body as a result of transmitted aortic pulsations. The sclerotic changes of the vertebral body occur secondary to hematogenous metastases. Not all ivory vertebrae from Hodgkin&#x2019;s disease will demonstrate anterior scalloping; however, it is a classic sign when present and should always be searched for. Clinical differentiation is also helpful because most Hodgkin&#x2019;s patients are generally much younger (20-40 years), whereas Paget&#x2019;s disease and osteoblastic metastatic carcinoma both occur in the &#x003E; 50-year age group. The alkaline phosphatase blood test is elevated in all three conditions, but the acid phosphatase and PSA should be elevated only when the blastic lesions are from the prostate gland as a primary source. (<a class="LK" href="sid806035.html#F36-11">Fig. 11-36</a>)</div>
<a name="PG1156"> </a><div class="pagenum"><div>P.1156</div></div>
<br clear="all">
<div class="FG" id="F35-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="480" height="700" src="files/11fb6cd60193b76946dce502c2c50646.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="11fb6cd60193b76946dce502c2c50646.gif" MIMETYPE="image/gif" WIDTH="480" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-35 <span class="emph_B">PAGET&#x2019;S DISEASE AND OSTEOBLASTIC METASTASIS WITHIN THE SAME PATIENT.</span> Observe the cortical thickening, the expansion of the posterior vertebral body margin (<span class="emph_I">arrows</span>), and the radiopacity of the L1 vertebral body. These changes are consistent with Paget&#x2019;s disease. Note also the nodular localized radiopacities in the vertebral bodies of T11 posteriorly and T12 anteriorly (<span class="emph_I">arrowheads</span>). These radiopacities represent osteoblastic metastatic disease from carcinoma of the prostate gland. The radiopaque material in the spinal canal represents residual contrast media from a previous myelographic examination.</div>
</td></tr>
</table></div>
<div class="FG" id="F36-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[1]/TLV5[3]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="493" src="files/d4e8087672f17f4b965f6e0dd87e7e55.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d4e8087672f17f4b965f6e0dd87e7e55.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="493" DISPLAY="INLINE"></div>
<div class="P">Figure 11-36 <span class="emph_B">IVORY VERTEBRA. A. AP Lumbar Spine.</span> Note the solitary ivory vertebra of L2. <span class="emph_B">B. Lateral Lumbar Spine.</span> Note the homogeneous radiopacity of the entire vertebral body of L2. There is no endplate thickening or vertebral body expansion, and the anterior concavity of the vertebral body is well maintained. These radiographic signs strongly support osteoblastic metastatic disease rather than Paget&#x2019;s disease. An additional supportive sign is a second lesion subtly present within the vertebral body of L3 (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3445" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[2]">
<div class="HD">Pelvis</div>
<div class="P">The sacrum and bones of the pelvis are involved in about 12&#x0025; of skeletal metastases and may show either lytic or blastic lesions. (<a class="LK" href="sid806035.html#R33-11">33</a>) (<a class="LK" href="sid806035.html#F37-11">Fig. 11-37</a>) Seeding from the viscera via Batson&#x2019;s venous plexus explains this high incidence in the pelvis as well as in the lumbar spine. (<a class="LK" href="sid806035.html#F38-11">Figs. 11-38</a> and <a class="LK" href="sid806035.html#F39-11">11-39</a>) Blow-out lesions of renal and thyroid origin often affect the bony pelvis. Lesions located in the sacral ala or the posterior ilium are often difficult to perceive on standard radiographs. (<a class="LK" href="sid806035.html#F40-11">Fig. 11-40</a>) With the advent of CT scans, a wide variety of lesions involving the osseous pelvis can be more readily seen. (<a class="LK" href="sid806035.html#R42-11">42</a>) The ability of CT to provide accurate measurements of tissue attenuation coefficients and to provide a cross-sectional scan for three-dimensional viewing has made it a powerful tool in musculoskeletal diagnosis, with a profound influence on patient management. (<a class="LK" href="sid806035.html#R42-11">42</a>) It provides information about the extent of the bony lesion, localization (for biopsy and radiation therapy), and relationships with other structures. (<a class="LK" href="sid806035.html#R42-11">42</a>) As equipment improves, it seems probable that CT will assume a more primary role in diagnostic evaluation, particularly of the pelvis, where the complexity of bones and the overlying bowel content prevent ideal evaluation with conventional radiographs. (<a class="LK" href="sid806035.html#R42-11">42</a>) (<a class="LK" href="sid806035.html#F41-11">Fig. 11-41</a>)</div>
<div class="P">Occasionally, blastic lesions affecting the pelvic rim, especially from carcinoma of the prostate, exhibit an expansion of bone. (<a class="LK" href="sid806035.html#F42-11">Fig. 11-42</a>) This occurs as a result of cortical thickening from endosteal or periosteal apposition of bone. The bony enlargement may mimic the appearance of Paget&#x2019;s disease. Usually, other skeletal lesions are present to assist in radiologic differentiation. Biopsy of the lesion may be necessary as a final step in diagnosis.</div>
<a name="PG1157"> </a><div class="pagenum"><div>P.1157</div></div>
<br clear="all">
<div class="FG" id="F37-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="405" src="files/13d3f5d47fc8976bbfbc3b253222e691.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="13d3f5d47fc8976bbfbc3b253222e691.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="405" DISPLAY="INLINE"></div>
<div class="P">Figure 11-37 <span class="emph_B">BLASTIC VERSUS LYTIC METASTATIC LESIONS OF THE PELVIS. A. AP Pelvis.</span> Note the diffuse nodular snowball metastatic deposits throughout the entire pelvis, sacrum, and proximal femora. <span class="emph_B">B. AP Pelvis.</span> Observe the diffuse osteolytic metastasis throughout all the bones of the pelvis, sacrum, and proximal femora. (Courtesy of Felix G. Bauer, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M7">DACBR(Hon)</a>, Sydney, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F38-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="485" height="700" src="files/5967c26a7282d20499a2a5c91e0eaf4b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5967c26a7282d20499a2a5c91e0eaf4b.gif" MIMETYPE="image/gif" WIDTH="485" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-38 <span class="emph_B">METASTATIC DISEASE TO THE PELVIS. AP Hip.</span> Note the diffuse osteolytic metastatic destruction in the ischial tuberosity and the supra-acetabular area (<span class="emph_I">arrow</span>). These lesions are secondary to carcinoma of the breast.</div>
</td></tr>
</table></div>
<div class="FG" id="F39-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="467" height="700" src="files/9232d0730535a098c16c9831df9224b7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9232d0730535a098c16c9831df9224b7.gif" MIMETYPE="image/gif" WIDTH="467" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-39 <span class="emph_B">METASTASIS ADJACENT TO THE HIP JOINT. AP Hip.</span> Observe the diffuse osteolytic destruction of the posterior superior surface of the acetabulum. Note the resorption of the cortical acetabular ridge above the femoral head. Observe the failure of this neoplasm to cross the joint space and affect the femoral head or attenuate the joint space, as might be expected if this were an infectious lesion. This metastatic lesion was secondary to carcinoma of the uterus.</div>
</td></tr>
</table></div>
<a name="PG1158"> </a><div class="pagenum"><div>P.1158</div></div>
<br clear="all">
<div class="FG" id="F40-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="472" src="files/4353e607b7d4d1e666ba3ab0bf4e355c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4353e607b7d4d1e666ba3ab0bf4e355c.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="472" DISPLAY="INLINE"></div>
<div class="P">Figure 11-40 <span class="emph_B">SACRAL ALA METASTASIS. AP Sacrum.</span> Observe the diffuse unilateral osteolytic destruction of the sacral ala. This lesion is secondary to carcinoma of the kidney and represents a blow-out lesion.</div>
</td></tr>
</table></div>
<div class="FG" id="F41-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[2]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="509" height="700" src="files/4ff667d040b896e4264ff529d598f1ec.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4ff667d040b896e4264ff529d598f1ec.gif" MIMETYPE="image/gif" WIDTH="509" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-41 <span class="emph_B">METASTATIC LESIONS. A. Plain Film, AP Hip.</span> Note the diffuse osteoblastic metastatic lesions scattered throughout the bones of the pelvis, sacrum, and proximal femora. These blastic lesions are secondary to carcinoma of the breast. <span class="emph_B">B. CT, Sacrum.</span> Note that the CT scan clearly demonstrates the nodular radiopacities scattered throughout both ilia and centrally in the sacrum. <span class="emph_I">COMMENT:</span> The majority of metastatic lesions from carcinoma of the breast are lytic (80&#x0025;), with only 10&#x0025; being blastic and 10&#x0025; mixed. (Courtesy of Steven P. Brownstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Springfield, New Jersey.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3446" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[3]">
<div class="HD">Skull</div>
<div class="P">Approximately 10&#x0025; of all metastatic lesions affect the calvaria. (<a class="LK" href="sid806035.html#R27-11">27</a>) Over 90&#x0025; of the calvarial metastatic deposits will be lytic lesions, with blastic lesions representing &#x003C; 10&#x0025;. (<a class="LK" href="sid806035.html#R27-11">27</a>) (<a class="LK" href="sid806035.html#F43-11">Fig. 11-43</a>) The most common causes for calvarial lytic metastasis are thyroid and breast carcinoma, and prostate and carcinoid tumors create most blastic lesions. Skull lesions usually start as small foci, 1-3 cm in diameter, that gradually increase in size. There are multiple, well-defined holes without sclerotic borders. The lesions of both metastatic disease and myeloma may affect any or all bones of the skull. One means to differentiate myeloma from metastasis is to note the symmetry of the hole size affecting the calvarial vault. (<a class="LK" href="sid806035.html#F44-11">Fig. 11-44</a>) Myeloma lesions are permeative and usually similar in size throughout, whereas most cases of metastatic disease demonstrate both large and small lesions simultaneously.
<a name="PG1159"> </a><div class="pagenum"><div>P.1159</div></div>
<br clear="all">
This is merely a guideline to differentiation because exceptions do occur.</div>
<div class="FG" id="F42-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="422" height="700" src="files/260dcb71b591af697d12c96c3d6ea11f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="260dcb71b591af697d12c96c3d6ea11f.gif" MIMETYPE="image/gif" WIDTH="422" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-42 <span class="emph_B">OSTEOBLASTIC METASTATIC DISEASE INVOLVING THE BRIM OF THE PELVIS. A. Obliteration of K&#x00F6;hler&#x2019;s Teardrop.</span> Note the osteoblastic metastatic disease affecting the pelvic brim, obliterating K&#x00F6;hler&#x2019;s teardrop. There is a minimal degree of bony expansion of the ischial tuberosity and the iliopectineal line. This form of presentation of blastic metastasis may be difficult to differentiate from Paget&#x2019;s disease. Occasionally, biopsy is required for definitive evaluation. <span class="emph_B">B. Diffuse Osteoblastic Metastasis.</span> Observe the diffuse increase in bone density affecting the entire pelvis and proximal femora. These lesions are secondary to carcinoma of the prostate gland and may mimic the diffuse involvement of Paget&#x2019;s disease. Bone expansion and cortical thickening are the cardinal radiographic signs to differentiate Paget&#x2019;s disease from osteoblastic metastatic carcinoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F43-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="434" src="files/4e3b47b7fd2c82c851002daa09b601e8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4e3b47b7fd2c82c851002daa09b601e8.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="434" DISPLAY="INLINE"></div>
<div class="P">Figure 11-43 <span class="emph_B">BLASTIC METASTASIS: LATERAL SKULL.</span> Observe the numerous well-defined radiopacities scattered throughout the calvaria. These represent osteoblastic metastatic deposits secondary to carcinoma of the prostate gland. <span class="emph_I">COMMENT:</span> Approximately 10&#x0025; of all metastatic lesions affect the calvaria, with &#x003E; 90&#x0025; of the calvarial metastatic deposits being lytic and only 10&#x0025; being blastic.</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3447" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[4]">
<div class="HD">Ribs and Sternum</div>
<div class="P">Approximately 28&#x0025; of metastatic bone lesions affect the ribs and sternum. (<a class="LK" href="sid806035.html#R27-11">27</a>) Rib metastasis is four times more common than sternal secondary involvement. (<a class="LK" href="sid806035.html#R43-11">43</a>) Both lytic and blastic lesions are encountered. (<a class="LK" href="sid806035.html#F45-11">Fig. 11-45</a>) The majority of the sternal cases have metastasized to the body rather than to the manubrium. (<a class="LK" href="sid806035.html#R43-11">43</a>) Routine chest roentgenograms can detect early metastasis when there is an observable, fortuitous cortical fracture and displacement. In widespread malignancy, metastasis to the skeletal chest wall is a well-recognized occurrence. (<a class="LK" href="sid806035.html#R43-11">43</a>) Any portion of the rib may be destroyed, either partially or completely. (<a class="LK" href="sid806035.html#F46-11">Fig. 11-46</a>) Permeative holes are often observed, and pathologic fracture is common. Multiple ribs may be involved. Chest wall metastases may create a so-called <span class="emph_I">extrapleural sign</span> (<a class="LK" href="sid806035.html#R43-11">43</a>), and the most common cause for the extrapleural sign is metastasis to the ribs. (<a class="LK" href="sid806035.html#F47-11">Fig. 11-47</a>) Blow-out lesions from renal and thyroid carcinoma are not common in the rib cage. (<a class="LK" href="sid806035.html#R43-11">43</a>)</div>
<div class="FG" id="F44-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="245" src="files/3e168209c58f0f45734e427c948a4cd8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3e168209c58f0f45734e427c948a4cd8.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="245" DISPLAY="INLINE"></div>
<div class="P">Figure 11-44 <span class="emph_B">MYELOMA VERSUS METASTATIC DISEASE: SKULL. A. Lytic Metastasis.</span> Note the diffuse osteolytic metastasis spread throughout the bony calvaria. Observe the poor zone of transition around these lytic lesions and their asymmetry in size. <span class="emph_B">B. Multiple Myeloma.</span> Note the diffuse permeative destructive lesions scattered throughout the entire calvaria. These permeative lesions are fairly symmetric in size. <span class="emph_I">COMMENT:</span> Multiple myeloma and lytic metastatic disease in the calvaria may look similar; however, one means of differentiation is to note the uniformity of the lesion size. Myeloma lesions are permeative, and they are usually similar in size throughout, whereas most cases of metastasis demonstrate both large and small lesions. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3448" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]">
<div class="HD">Extremities</div>
<div class="P">Metastatic disease commonly affects the proximal femur and humerus. Typical patterns of lytic, blastic, and mixed lesions prevail, with the occasional pathologic fracture. Non-traumatic avulsion of the lesser trochanter can be a marker for unsuspected underlying metastatic disease. (<a class="LK" href="sid806035.html#R44-11">44</a>) Rarely does the metastatic process cross the joint space, which helps differentiate it from osteomyelitis. Approximately 10&#x0025; of all metastatic lesions affect the long tubular bones (femur and humerus). (<a class="LK" href="sid806035.html#R37-11">37</a>) The scapula and clavicle are also involved in metastatic disease because shoulder lesions are not limited to the humerus. (<a class="LK" href="sid806035.html#F48-11">Fig. 11-48</a>)</div>
<div class="TLV5" id="B01382540.0-3449" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]/TLV5[1]">
<div class="HD"><span class="emph_I">Acral Metastasis.</span></div>
<div class="P">Metastatic lesions of bone rarely occur distal to the elbows and knees (<span class="emph_I">acral metastases</span>). (<a class="LK" href="sid806035.html#R37-11">37</a>) (<a class="LK" href="sid806035.html#F49-11">Fig. 11-49</a>) The most common site is the foot, with the hand following second in incidence. (<a class="LK" href="sid806035.html#R37-11">37</a>,<a class="LK" href="sid806035.html#R45-11">45</a>,<a class="LK" href="sid806035.html#R46-11">46</a>) The incidence of metastatic lesions to the foot and hand may be underestimated because asymptomatic lesions may never be recognized. These lesions may be missed because skeletal surveys for metastatic disease do not necessarily include radiographs of the foot and hand. The most frequent sources of these distant metastases are the lung, breast, and kidney, in decreasing order. (<a class="LK" href="sid806035.html#R45-11">45</a>,<a class="LK" href="sid806035.html#R46-11">46</a>) Most of these peripheral metastases are associated with disseminated disease, and in a few reported cases these were the cause of presenting signs and symptoms. (<a class="LK" href="sid806035.html#R47-11">47</a>) Besides routine radiographs, diagnostic modalities that are helpful in assessing these lesions include tomography and technetium bone scanning. CT may assist in determining the local extent of the osseous lesion, and a bone scan will help identify
<a name="PG1160"> </a><div class="pagenum"><div>P.1160</div></div>
<br clear="all">
other metastatic lesions. Peripheral metastatic lesions are usually lytic and lack the periosteal reaction so common to an infectious process.</div>
<div class="FG" id="F45-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]/TLV5[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="442" src="files/f253be08a614b7bdb6b60749380dec30.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f253be08a614b7bdb6b60749380dec30.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="442" DISPLAY="INLINE"></div>
<div class="P">Figure 11-45 <span class="emph_B">BLASTIC RIB LESIONS AND GYNECOMASTIA.</span> Note that this 59-year-old male demonstrates extensive bilateral metastases in nearly all the visualized rib structures. Because this patient has been on extensive estrogen therapy for his prostate carcinoma he has developed gynecomastia. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F46-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]/TLV5[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="325" src="files/5f10136c8ea3b810c90774ffc4ba4e1f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5f10136c8ea3b810c90774ffc4ba4e1f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="325" DISPLAY="INLINE"></div>
<div class="P">Figure 11-46 <span class="emph_B">RIB METASTASIS. A. Ribs.</span> Observe the near complete destruction of the posterior border of the eighth rib (<span class="emph_I">arrows</span>). Additional lytic lesions are also noted in the ninth and tenth lateral ribs (<span class="emph_I">arrowheads</span>). <span class="emph_B">B. Ribs.</span> Note the lytic destructive lesions of the posterior surfaces of the sixth and seventh ribs (<span class="emph_I">arrows</span>). In addition, there is a metastatic focus present at the inferior tip of the scapula (<span class="emph_I">arrowhead</span>). <span class="emph_B">C. Ribs.</span> Note the extensive destruction of the posterior sixth rib (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F47-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]/TLV5[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="465" height="700" src="files/7bd5282b0a323968de77617b890b9e17.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7bd5282b0a323968de77617b890b9e17.gif" MIMETYPE="image/gif" WIDTH="465" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-47 <span class="emph_B">EXTRAPLEURAL SIGN: RIB METASTASIS.</span> Observe the nodular radiopacity at the lateral wall of the rib cage. This represents metastatic disease of a rib. Observe the sharp attenuation of the lateral margin of the sixth rib in the area of the extrapleural mass (<span class="emph_I">arrow</span>). <span class="emph_I">COMMENT:</span> The most common cause of an extrapleural sign is rib metastasis. This often presents as a radiopaque mass, with sharp borders convex to the lung field and with the peripheral margins gradually tapering to the chest wall. This patient&#x2019;s primary carcinoma was in the thyroid gland.</div>
</td></tr>
</table></div>
<a name="PG1161"> </a><div class="pagenum"><div>P.1161</div></div>
<br clear="all">
<div class="FG" id="F48-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]/TLV5[1]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="222" src="files/7ee528e6f087e5fde807594ee2448a4f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7ee528e6f087e5fde807594ee2448a4f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="222" DISPLAY="INLINE"></div>
<div class="P">Figure 11-48 <span class="emph_B">METASTASIS: CLAVICLE. A. Destructive Lesion.</span> Note the extensive osteolytic metastasis to the distal clavicle. Observe the failure of the disease process to cross the joint space and involve the acromion process of the scapula. This 82-year-old patient has a previous history of carcinoma of the esophagus. <span class="emph_B">B. Pathologic Fracture.</span> Observe the pathologic fracture through a subtle osteolytic metastatic lesion induced by a coughing bout (<span class="emph_I">arrow</span>). Also note the opacity in the right upper lobe owing to carcinoma (<span class="emph_I">arrowheads</span>). (Panel A courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia. Panel B courtesy of Hardie B. Webb Jr., <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Winter Garden, Florida.)</div>
</td></tr>
</table></div>
<div class="P">No obvious predilection for any particular bone exists in the foot. (<a class="LK" href="sid806035.html#R45-11">45</a>,<a class="LK" href="sid806035.html#R46-11">46</a>) In the hand, however, there is a great predilection for the distal phalanx, particularly from bronchogenic carcinoma. (<a class="LK" href="sid806035.html#F50-11">Fig. 11-50</a>) Extensive osteolysis of the distal phalanx, often with the presence of a soft tissue mass, is the usual mode of presentation. The articular space is usually uninvolved. Occurrences in other bones of the hand, such as the proximal and middle phalanges and the carpal and metacarpal bones, have been documented. (<a class="LK" href="sid806035.html#R47-11">47</a>) (<a class="LK" href="sid806035.html#F51-11">Fig. 11-51</a>)</div>
<div class="FG" id="F49-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]/TLV5[1]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="311" src="files/08cc04487ba4d2195cd61245336b85df.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="08cc04487ba4d2195cd61245336b85df.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="311" DISPLAY="INLINE"></div>
<div class="P">Figure 11-49 <span class="emph_B">ACRAL METASTASES. A. Calcaneus. B. Tibia and Fibula. C. Radius. D. Humerus.</span> Note that this patient presented with metastatic lesions in the calcaneus, tibia and fibula, distal radius, and diaphysis of the humerus. This is an unusual presentation, with the primary tumor being a bronchogenic carcinoma. <span class="emph_I">COMMENT:</span> Metastatic lesions of bone are rare distal to the elbows and knees (acral metastases).</div>
</td></tr>
</table></div>
<div class="P">It has been suggested that the only way cancer cells can reach the peripheral bones is by the arterial route. (<a class="LK" href="sid806035.html#R38-11">38</a>) This may explain why half of the metastatic lesions to the foot and hands originate in the lungs. (<a class="LK" href="sid806035.html#R48-11">48</a>) The tumor cell foci may enter the pulmonary vein, reach the arterial side of the circulation, and then be transported to the peripheral skeletal sites. (<a class="LK" href="sid806035.html#R48-11">48</a>) Other investigators suggest that the low rate of metastasis in the distal extremities is logically explained by the fact that the tumor cells do not find suitable soil in
<a name="PG1162"> </a><div class="pagenum"><div>P.1162</div></div>
<br clear="all">
which to grow&#x2014;that is, the tissue may not be warm enough because of a gradient of metabolic rate. (<a class="LK" href="sid806035.html#R49-11">49</a>) The sparse amount of red marrow in the extremities may suggest that the soil is not rich enough to allow growth. The exact explanation for the lesions of the terminal phalanx is not available. The prognosis upon discovery of metastasis to the hand is approximately 3 months, which represents the prognosis of bronchogenic carcinoma. (<a class="LK" href="sid806035.html#R50-11">50</a>)</div>
<div class="FG" id="F50-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]/TLV5[1]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="498" height="700" src="files/a977bb44b30726e5d50a863d09bad874.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a977bb44b30726e5d50a863d09bad874.gif" MIMETYPE="image/gif" WIDTH="498" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-50 <span class="emph_B">BRONCHOGENIC CARCINOMA METASTASIS TO THE DISTAL PHALANX OF THE HAND.</span> Note the extensive destruction of the distal phalanx of the fifth finger. Soft tissue swelling indicates the possibility of hemorrhage and soft tissue tumor extension. Note the preservation of the joint space and the lack of tumor extension across the joint. <span class="emph_I">COMMENT:</span> Metastatic disease in the hand shows a great predilection for the distal phalanx, particularly when it is owing to bronchogenic carcinoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F51-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[5]/TLV4[5]/TLV5[1]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="387" height="700" src="files/284c77786274bc83a7c9e7c971ab2ecd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="284c77786274bc83a7c9e7c971ab2ecd.gif" MIMETYPE="image/gif" WIDTH="387" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-51 <span class="emph_B">ACRAL METASTASES: HAND.</span> Note the diffuse osteolytic destruction of nearly the entire portion of the fifth metacarpal. This patient had a hypernephroma 8 years before, having presented with pain in the hand. This lesion was confirmed as a metastatic tumor from the original primary carcinoma of the kidney.</div>
</td></tr>
</table></div>
</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3450" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[6]">
<div class="HD">Periosteal Response</div>
<div class="P">The presence of periosteal new bone formation associated with a metastatic bone tumor in the absence of pathologic fracture is rare. (<a class="LK" href="sid806035.html#R51-11">51</a>) The primary organs most frequently causing a metastatic periosteal response in adults are the prostate, lung, and breast; whereas in children, neuroblastoma is the most common cause. (<a class="LK" href="sid806035.html#R51-11">51</a>) Periosteal new bone, which is usually of a <span class="emph_I">sunburst,</span> or spiculated, nature, is essentially a reaction to the tumor by the involved bone rather than an inherent property ascribable to the specific histologic type of metastatic tumor. (<a class="LK" href="sid806035.html#F52-11">Fig. 11-52</a>) Furthermore, the bone involvement often seems to precede the periosteal reaction, which is found with the more destructive and rapidly growing lesions. The new bone formation usually occurs on that portion or side of a bone that was farthest removed from the main concentration of tumor growth. (<a class="LK" href="sid806035.html#R51-11">51</a>) A striking, perpendicular spiculation may be seen along the inner rim of the pelvis, at the ischial tuberosity, or along the proximal femoral shaft, simulating a primary malignant bone tumor. This occurs
<a name="PG1163"> </a><div class="pagenum"><div>P.1163</div></div>
<br clear="all">
in prostatic carcinoma in 5&#x0025; of metastatic cases. (<a class="LK" href="sid806035.html#R51-11">51</a>) Involvement of the vertebrae with this florid, spiculated periosteal new bone is uncommon. (<a class="LK" href="sid806035.html#R52-11">52</a>) Sunburst periosteal reaction in the cranial vault is a feature of metastatic neuroblastoma and chronic hemolytic anemias (thalassemia major).</div>
<div class="FG" id="F52-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="471" height="700" src="files/aafe5f4977b994c75bdc5f3bede589cc.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="aafe5f4977b994c75bdc5f3bede589cc.gif" MIMETYPE="image/gif" WIDTH="471" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-52 <span class="emph_B">PERIOSTEAL RESPONSE WITH METASTATIC BONE TUMORS.</span> Note the pathologic fracture in the proximal third of the humerus (<span class="emph_I">arrow</span>). A permeative pattern of bone destruction is scattered throughout the humeral head, metaphysis, and diaphysis. There is significant spiculated periosteal response present on the medial surface of the humerus (<span class="emph_I">arrowheads</span>). <span class="emph_I">COMMENT:</span> The periosteal response outlined in this case may be related to the associated pathologic fracture. In adults, the organs most frequently causing a metastatic periosteal response are the prostate, lung, and breast; in children, neuroblastoma is the most common cause.</div>
</td></tr>
</table></div>
<div class="TLV4" id="B01382540.0-3451" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[6]/TLV4[1]">
<div class="HD">Complications</div>
<div class="TLV5" id="B01382540.0-3452" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[1]">
<div class="HD"><span class="emph_I">Pathologic Fracture.</span></div>
<div class="P">Pathologic fracture through a metastasis can be a distressing and painful event and is the most common complication of osseous metastasis. In a child this carries the further ramifications of potential effects on bone growth by damage to the physis from the tumor, the pathologic fracture, or the tumor treatment (chemotherapy, radiotherapy).</div>
<div class="P">An extradural compression of the spinal cord may accompany a metastatic vertebral collapse, leaving the patient paraplegic. This complication is usually seen in the thoracic and lumbar spine, where vertebral body collapse is common. (<a class="LK" href="sid806035.html#F53-11">Fig. 11-53</a>) The humerus, ribs, cervical vertebrae (<a class="LK" href="sid806035.html#F54-11">Fig. 11-54</a>), and proximal femur are also documented sites of fracture. Pathologic fractures most commonly occur through lytic metastases and less frequently may develop in blastic lesions. (<a class="LK" href="sid806035.html#F55-11">Fig. 11-55</a>) One sixth of all fractures through skeletal metastases occur in the proximal fourth of the femur. (<a class="LK" href="sid806035.html#R53-11">53</a>) Fractures through this area of the proximal femur may produce an ischemic necrosis of the femoral head. A high proportion of the proximal femur pathologic fractures stem from breast carcinoma. (<a class="LK" href="sid806035.html#R53-11">53</a>) In the adult, pathologic fractures are highly unlikely when &#x003C; 50&#x0025; of the cortical bone is destroyed. (<a class="LK" href="sid806035.html#R54-11">54</a>) Fracture is much more likely when 50-5&#x0025; of the cortex is destroyed, and most likely (an incidence of &#x003E; 80&#x0025;) when &#x003E; 75&#x0025; of the cortex is destroyed. (<a class="LK" href="sid806035.html#R54-11">54</a>) Such statistical analyses are undoubtedly less applicable in children.</div>
<div class="FG" id="F53-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="468" height="700" src="files/af75ca5ed6d48abc6a4380710aa12c5f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="af75ca5ed6d48abc6a4380710aa12c5f.gif" MIMETYPE="image/gif" WIDTH="468" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-53 <span class="emph_B">PATHOLOGIC FRACTURE THROUGH A METASTATIC LESION.</span> Note the extensive collapse of the L1 vertebral body, with underlying osteolytic destruction. Note that there is collapse of the posterior portion of the vertebral body, which is an indication of a pathologic fracture. The primary lesion in this patient was carcinoma of the sigmoid colon.</div>
</td></tr>
</table></div>
<div class="FG" id="F54-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="464" height="700" src="files/108a144e61f69d72a1b67d27bf501dfd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="108a144e61f69d72a1b67d27bf501dfd.gif" MIMETYPE="image/gif" WIDTH="464" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-54 <span class="emph_B">PATHOLOGIC COLLAPSE: A COMPLICATION OF METASTATIC DISEASE. Lateral Cervical Spine.</span> Observe that the C3 vertebral body is severely collapsed, and underlying osteolytic destruction is apparent. This 26-year-old female had a 2-year history of pain in the foot and a recent episode of neck pain following trivial trauma. The primary tumor was a malignant synovioma in the foot, with the C3 vertebral lesion being a secondary metastatic focus.</div>
</td></tr>
</table></div>
<div class="FG" id="F55-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="469" height="700" src="files/530a05dcd5ac1eee30db28c7f93811c0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="530a05dcd5ac1eee30db28c7f93811c0.gif" MIMETYPE="image/gif" WIDTH="469" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-55 <span class="emph_B">PATHOLOGIC FRACTURE: PROXIMAL FEMUR.</span> Note the complete transverse fracture through a large lytic metastatic lesion in the metadiaphyseal area of the proximal femur. <span class="emph_I">COMMENT:</span> Pathologic fractures most commonly occur in lytic metastases and rarely develop in blastic lesions. One sixth of all fractures through skeletal metastases occur in the proximal femur. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
</div>
<a name="PG1164"> </a><div class="pagenum"><div>P.1164</div></div>
<br clear="all">
<div class="TLV5" id="B01382540.0-3453" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[2]">
<div class="HD"><span class="emph_I">Bone Expansion and Soft Tissue Mass.</span></div>
<div class="P">Metastatic tumors on occasion will produce bone expansion. It is not a common roentgen sign, except that carcinomas frequently expand ribs. Although uncommon elsewhere, it is more likely to expand small tubular bones or the pelvic rim. The capacity to expand bone, however, is not a specific feature of a type of carcinoma but rather a secondary effect from other characteristics related to bone size and shape.</div>
<div class="P">The presence of a soft tissue mass in association with a destructive osseous lesion usually denotes a primary malignant tumor, as a soft tissue mass is much less commonly associated with secondary neoplasm. (<a class="LK" href="sid806035.html#F56-11">Fig. 11-56</a>) The formation of an extraosseous soft tissue mass may occur in metastatic bone lesions, particularly when the skeletal site involves a small bone, such as a rib. Occasionally, a large component of the soft tissue mass is hemorrhage. CT and especially MRI are the best methods for demonstration because soft tissue extension is poorly seen on conventional radiographs. (<a class="LK" href="sid806035.html#R42-11">42</a>,<a class="LK" href="sid806035.html#R55-11">55</a>)</div>
</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3454" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[7]">
<div class="HD">Response to Therapy</div>
<div class="P">No definite means to accurately assess the response to therapy have yet been established. Many authors have found that pain relief is the most consistent indicator of response to treatment. (<a class="LK" href="sid806035.html#R33-11">33</a>,<a class="LK" href="sid806035.html#R37-11">37</a>,<a class="LK" href="sid806035.html#R38-11">38</a>,<a class="LK" href="sid806035.html#R56-11">56</a>) Palliative therapy is essential in patients with metastatic disease to ensure quality of life because morbidity and disability is usually high. (<a class="LK" href="sid806035.html#R57-11">57</a>) Bisphosphonates are common pharmaceutical agents currently used to treat lytic metastasis owing to their osteoclastic inhibiting effects. (<a class="LK" href="sid806035.html#R58-11">58</a>) They have shown to be effective in symptom relief as well as progression of the disease. (<a class="LK" href="sid806035.html#R57-11">57</a>) The demonstration of sclerosis in a previously lytic lesion is considered a sign of the healing process; however, this sign is somewhat unpredictable. (<a class="LK" href="sid806035.html#R59-11">59</a>) (<a class="LK" href="sid806035.html#F57-11">Fig. 11-57</a>) Bone scan seems to be the most reliable modality for assessing response to therapy. (<a class="LK" href="sid806035.html#R56-11">56</a>,<a class="LK" href="sid806035.html#R60-11">60</a>) A reduction in intensity of a lesion&#x2019;s uptake on serial bone scans is a sign of good response. On occasion, observer error is a
<a name="PG1165"> </a><div class="pagenum"><div>P.1165</div></div>
<br clear="all">
problem. In patients with sclerotic metastases, further sclerosis can occur in response to either successful or unsuccessful systemic therapy; similarly, patients with mixed, sclerotic, and lytic disease are often difficult to assess. (<a class="LK" href="sid806035.html#R56-11">56</a>,<a class="LK" href="sid806035.html#R60-11">60</a>)</div>
<div class="FG" id="F56-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[7]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="477" height="700" src="files/e835c3d23a1dac675e676a5530972de5.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e835c3d23a1dac675e676a5530972de5.gif" MIMETYPE="image/gif" WIDTH="477" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-56 <span class="emph_B">A METASTATIC LESION WITH SOFT TISSUE EXTENSION: LATERAL CERVICAL.</span> Observe the grossly destructive lytic lesion in the vertebral body of C2. There is extension of the soft tissue tumor anterior to the C2 body, creating a large increase in the retropharyngeal interspace (<span class="emph_I">arrows</span>), which measured &#x003E; 15 mm at C2. <span class="emph_I">COMMENT:</span> Most soft tissue masses are associated with primary malignant bone tumors rather than secondary neoplasms. On rare occasions metastatic tumors can produce soft tissue masses, and, often, a large component of the soft tissue mass is hemorrhage. The true incidence of this complication in metastases is not known. (Courtesy of Robert L. Mattin, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Perth, Western Australia, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F57-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[1]/TLV3[7]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="225" src="files/fa84b6c0af94f053135e0028075f6b73.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fa84b6c0af94f053135e0028075f6b73.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="225" DISPLAY="INLINE"></div>
<div class="P">Figure 11-57 <span class="emph_B">AVASCULAR NECROSIS AS A COMPLICATION OF RADIATION THERAPY. A. Ischium.</span> Note that this male patient demonstrates a metastatic lesion of a mixed variety, secondary to carcinoma of the prostate gland. Observe the normal bone integrity of the femoral head at this time. <span class="emph_B">B. 2-Year Follow-Up.</span> Note that this study, made 2 years after radiation treatment of the ischial metastatic focus, demonstrates remarkable remodeling of bone in the ischium. There is deformity of the femoral head, with fragmentation and radiopacity present. The joint space of the hip is not affected. The radiographic changes in the femoral head are those of avascular necrosis, which was caused by the radiation therapy. (Courtesy of Richard W. Hooke, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Dalby, Queensland, Australia.)</div>
</td></tr>
</table></div>
<div class="P">Failure to respond is often heralded by further osteolysis. It has been suggested that full assessment of the response of bone metastases to systemic treatment should include assessment of pain, blood tests, a full skeletal survey, and serial bone scans. On the basis of these four parameters, a rational decision as to continuation of treatment or change in regimen may be made. (<a class="LK" href="sid806035.html#R56-11">56</a>,<a class="LK" href="sid806035.html#R60-11">60</a>) It should be understood that when palliative irradiation is used during treatment, the therapeutic goal is for symptom control. (<a class="LK" href="sid806035.html#R61-11">61</a>) Irradiation generally needs to be provided for a period of 1 month before relief is noted. (<a class="LK" href="sid806035.html#R61-11">61</a>)</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3455" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]">
<div class="HD">NEUROBLASTOMA</div>
<div class="P">Neuroblastoma (sympathicoblastoma) is the second most common abdominal neoplasm in childhood, with Wilms&#x2019; tumor being the most common. (<a class="LK" href="sid806035.html#R62-11">1</a>) This malignant tumor arises in the adrenal gland in approximately 75&#x0025; of the patients; extra-adrenal sites are the posterior mediastinum (20&#x0025;) and the paravertebral sympathetic ganglionated chain (5&#x0025;). (<a class="LK" href="sid806035.html#R62-11">1</a>,<a class="LK" href="sid806035.html#R63-11">2</a>) There is some evidence that extra-adrenal tumors have a better prognosis than intraadrenal tumors, which are highly fatal. One factor that might explain this is the earlier detection and treatment of tumors that are not buried deep within the abdomen. About 80&#x0025; of neuroblastomas are found in children &#x003C; 2.5 years of age, the remainder occurring before age 5. (<a class="LK" href="sid806035.html#R62-11">1</a>,<a class="LK" href="sid806035.html#R64-11">3</a>)</div>
<div class="P">On plain films of the abdomen, a retroperitoneal mass may be seen displacing adjacent organs, particularly lowering the kidney. Approximately two thirds of the tumors demonstrate a granular pattern of calcification; this is seen both in adrenal and extra-adrenal sites. (<a class="LK" href="sid806035.html#F58-11">Figs. 11-58</a> and <a class="LK" href="sid806035.html#F59-11">11-59</a>)</div>
<div class="P">The neuroblastoma metastasizes early, and the metastases are often multiple, diffuse, and fairly symmetric. Monostotic lesions rarely occur. Most lesions are osteolytic and may be indistinguishable from those produced by leukemia. Skeletal metastases occur in &#x003E; 50&#x0025; of cases. (<a class="LK" href="sid806035.html#R65-11">4</a>) The spine, pelvis, and ends of the long bones are common sites. (<a class="LK" href="sid806035.html#F58-11">Fig. 11-58</a>) The epiphysis is usually spared. Spinal involvement creates vertebral collapse and widening of the paravertebral stripe. (<a class="LK" href="sid806035.html#R66-11">5</a>) Skull metastases produce a characteristic roentgen appearance of lytic lesions and diffuse widening of the sutures. Occasionally, spreading of the sutures may occur without actual metastases to the calvaria. Metastatic deposits from neuroblastoma present as plaques on the brain surface, thus causing the wide separation of the sutures, which is so classic in this disease. A soft tissue mass and a striking <span class="emph_I">sunburst spiculation of the skull tables</span> is frequently encountered. These skull changes are unique and are virtually pathognomonic of metastatic neuroblastoma. (<a class="LK" href="sid806035.html#F60-11">Fig. 11-60</a>)</div>
<div class="FG" id="F58-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="418" height="700" src="files/23d64010f36e8b4605c902a44aafc8c5.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="23d64010f36e8b4605c902a44aafc8c5.gif" MIMETYPE="image/gif" WIDTH="418" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-58 <span class="emph_B">NEUROBLASTOMA. A. Intravenous Pyelogram.</span> Observe the mottled, mixed radiolucency and radiopacity scattered throughout the lumbar spine, sacrum, pelvic bones, and visualized proximal femora. This radiographic appearance is consistent with malignant disease. There is no abnormality of the kidneys, ureters, or urinary bladder. <span class="emph_B">B. Close-Up of the Paraspinal Region.</span> Observe the granular calcification in the paraspinal region, just caudal to the inferior pole of the kidney (<span class="emph_I">arrows</span>). This punctate calcification is present within a paraspinal neuroblastoma (sympathicoblastoma) and is located within the paravertebral sympathetic ganglionated chain. <span class="emph_I">COMMENT:</span> Neuroblastoma is the second most common abdominal neoplasm in childhood, with Wilms&#x2019; tumor being the most common. This malignant tumor arises in the adrenal gland in approximately 75&#x0025; of patients; extra-adrenal sites are the posterior mediastinum (20&#x0025;) and the paravertebral sympathetic ganglionated chain (5&#x0025;). Neuroblastoma metastasizes early, and the metastases are often multiple, diffuse, and fairly symmetric. Most lesions are osteolytic and may be indistinguishable from those produced by leukemia. Skeletal metastases occur in &#x003E; 50&#x0025; of cases, with the spine, pelvis, and ends of the long bones being the most common sites.</div>
</td></tr>
</table></div>
<a name="PG1166"> </a><div class="pagenum"><div>P.1166</div></div>
<br clear="all">
<div class="FG" id="F59-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="439" height="700" src="files/2c4c1dcbfb455ce651b53b4f37c963b5.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2c4c1dcbfb455ce651b53b4f37c963b5.gif" MIMETYPE="image/gif" WIDTH="439" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-59 <span class="emph_B">NEUROBLASTOMA: HUGE POSTERIOR MEDIASTINAL MASS. A. AP Thoracic Spine.</span> Observe the diffuse sclerotic changes affecting nearly all bones visualized. There is destruction of the third rib on the right side. A calcified mass is seen in the posterior aspect of the right upper mediastinum (<span class="emph_I">arrow</span>). <span class="emph_B">B. T1-Weighted MRI, Coronal Thoracic Spine. C. T2-Weighted MRI, Sagittal Cervicothoracic Spine.</span> Observe the huge mediastinal mass engulfing the posterosuperior aspect of the right upper mediastinum (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> This 3-day-old infant was born with a posterior mediastinal neuroblastoma with diffuse metastasis to the skeletal structures. MRI is the most sensitive imaging modality to evaluate the spinal cord and its neurological components. Approximately 20&#x0025; of neuroblastomas occur in the posterior mediastinum, with the majority (75&#x0025;) occurring in the adrenal gland. The remaining 5&#x0025; occur in the paravertebral sympathetic ganglionated chain. (Courtesy of Loren Macey, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Department of Radiology, University Hospital, Denver, Colorado.)</div>
</td></tr>
</table></div>
<a name="PG1167"> </a><div class="pagenum"><div>P.1167</div></div>
<br clear="all">
<div class="FG" id="F60-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="501" height="700" src="files/38caea1823277269750ce3c8aea21eb3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="38caea1823277269750ce3c8aea21eb3.gif" MIMETYPE="image/gif" WIDTH="501" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-60 <span class="emph_B">METASTATIC NEUROBLASTOMA. Lateral Skull.</span> Observe the striking sunburst spiculation of the skull tables, along with gross widening of the sutures (<span class="emph_I">arrows</span>). Note the permeative destructive lesions affecting the calvaria (<span class="emph_I">arrowhead</span>). <span class="emph_I">COMMENT:</span> Skull metastases in neuroblastoma produce a characteristic roentgen appearance of lytic lesions and diffuse widening of the sutures. Metastatic deposits from neuroblastoma present as plaques on the brain surface, thus causing the wide separation of the sutures, which is so classic in this disease. A soft tissue mass and a striking sunburst spiculation on the skull tables are frequently encountered and virtually pathognomonic of metastatic neuroblastoma. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3456" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Metastatic Bone Tumors</div>
<div class="TLV2" id="B01382540.0-3457" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Metastatic bone tumors are the most common malignant tumors of the skeleton.</div></li>
<li class="LM"><div class="P">Central nervous system tumors and basal cell carcinoma rarely spread to bone; all others have the potential.</div></li>
<li class="LM"><div class="P">Metastasis is the most life-threatening complication of any malignancy.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3458" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">70&#x0025; of all malignant tumors are metastatic; 30&#x0025; are primary.</div></li>
<li class="LM"><div class="P">Autopsy series reveal 20-35&#x0025; of all patients with malignancies have osseous metastases.</div></li>
<li class="LM"><div class="P">Cancers of the breast, prostate, lung, and kidney account for 80&#x0025; of osseous metastases.</div></li>
<li class="LM"><div class="P">In females, breast carcinoma accounts for 70&#x0025; of all bony metastases; in males, the prostate is responsible for about 60&#x0025; of metastatic lesions, and the lung accounts for 25&#x0025;.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3459" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most occur after the age of 40.</div></li>
<li class="LM"><div class="P">Weight loss, cachexia, and bone pain, which is often worse at night, awakening the patient. Occasionally, pain is lacking in advanced disease.</div></li>
<li class="LM"><div class="P">Metastatic lesions may occur 10-15 years after surgery or treatment for the primary neoplasm.</div></li>
<li class="LM"><div class="P">Alkaline phosphatase enzyme may be elevated in blastic metastatic lesions; acid phosphatase is found elevated in prostatic carcinoma following rupture of the prostatic capsule.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3460" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Cancers metastasize by three routes: direct extension, lymphatic channels, and hematogenous dissemination (most common pathway).</div></li>
<li class="LM"><div class="P">Batson&#x2019;s venous plexus provides a rapid pathway for cancer cells to seed the bone, bypassing the liver and lungs.</div></li>
<li class="LM"><div class="P">Lytic lesions occur as a result of pressure erosion from the medullary tumor deposits and are unrelated to osteoclastic activity.</div></li>
<li class="LM"><div class="P">Blastic lesions represent a reactive repair response of local osteoid tissue to the presence of tumor.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3461" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Technetium bone scans (99mTc-MDP) are more accurate in detecting early bone metastases than are conventional radiographs.</div></li>
<li class="LM"><div class="P">3-5&#x0025; destruction of bone will render a positive, or hot scan, whereas plain films require at least 30&#x0025; loss of bone before it can be detected visually.</div></li>
<li class="LM"><div class="P">80&#x0025; of all metastases are located in the central or axial skeleton, with the spine and pelvis being the most common sites. Ribs, skull, humerus, and femur represent a lesser percentage.</div></li>
<li class="LM"><div class="P">Metastatic tumors are rare below the elbows and knees.</div></li>
<li class="LM"><div class="P">Fundamental roentgen signs are alteration in bone density and architecture.</div></li>
<li class="LM"><div class="P">75&#x0025; of all metastatic lesions are osteolytic, creating a moth-eaten or permeative pattern of bone destruction.</div></li>
<li class="LM"><div class="P">15&#x0025; of all metastatic lesions are osteoblastic in nature, creating a snowball pattern with diffuse lesions.</div></li>
<li class="LM"><div class="P">10&#x0025; of all metastatic lesions are solitary.</div></li>
<li class="LM"><div class="P">Blow-out lesions represent a bubbly, highly expansile appearance, usually found associated with renal or thyroid malignancy.</div></li>
<li class="LM"><div class="P">Vertebral body and pedicles are the most common sites for metastatic deposits.</div></li>
<li class="LM"><div class="P">Malignant Schmorl&#x2019;s node represents a neoplastic weakening of the vertebral endplate, allowing cartilaginous node formation.</div></li>
<a name="PG1168"> </a><div class="pagenum"><div>P.1168</div></div>
<br clear="all">
<li class="LM"><div class="P">Uniform vertebral collapse (vertebra plana) with compromise of the posterior third of the vertebral body can occur.</div></li>
<li class="LM"><div class="P">One-eyed pedicle sign, or the winking owl sign, represents metastasis to one pedicle.</div></li>
<li class="LM"><div class="P">Blind vertebra represents bilateral pedicular destruction from metastatic disease, leaving no eyes in the spine.</div></li>
<li class="LM"><div class="P">Ivory vertebra may be caused by osteoblastic metastasis, Paget&#x2019;s disease, and Hodgkin&#x2019;s lymphoma.</div></li>
<li class="LM"><div class="P">Rib metastases often create the extrapleural sign and represent its most common cause.</div></li>
<li class="LM"><div class="P">Metastatic deposits in the hand are most commonly from bronchogenic carcinoma and affect the distal phalanges by extensive osteolysis.</div></li>
<li class="LM"><div class="P">Periosteal response with metastatic tumors is rare in the absence of pathologic fracture; however, a sunburst pattern has been reported in prostate, lung, and breast carcinoma. A similar appearance is cited in the cranial vault in metastatic neuroblastoma.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3462" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[1]/TLV2[2]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Neuroblastoma (Sympathicoblastoma)</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Neuroblastoma represents the second most common abdominal neoplasm in childhood; Wilms&#x2019; tumor is most common.</div></li>
<li class="LM"><div class="P">75&#x0025; arise within the adrenal gland; 20&#x0025; in the posterior mediastinum; and 5&#x0025; in the sympathetic ganglionated chain.</div></li>
<li class="LM"><div class="P">80&#x0025; are found in children &#x003C; 2.5 years of age, the remainder before age 5.</div></li>
<li class="LM"><div class="P">Two thirds of all neuroblastomas show granular calcification radiographically.</div></li>
<li class="LM"><div class="P">Skeletal metastases are common (&#x003E; 50&#x0025; of cases) and are diffuse and fairly symmetric. They are seldom monostotic.</div></li>
<li class="LM"><div class="P">The spine, pelvis, skull, and ends of the long bones are common sites.</div></li>
<li class="LM"><div class="P">Skull deposits widen the sutures and create a classic sunburst spiculation of the skull tables, which is virtually pathognomonic of metastatic neuroblastoma.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV1" id="B01382540.0-3463" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]">
<div class="HD">PRIMARY MALIGNANT BONE TUMORS</div>
<div class="TLV2" id="B01382540.0-3464" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]">
<div class="HD">MULTIPLE MYELOMA</div>
<div class="TLV3" id="B01382540.0-3465" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Multiple myeloma occurs as a result of a malignant proliferation of plasma cells, which infiltrate the bone marrow. The first patient known to have multiple myeloma was seen in 1845, after severe recurrences of pain during a 17-month period. (<a class="LK" href="sid806035.html#R67-11">1</a>) His urine contained unusual &#x201C;animal matter&#x201D; that became soluble when boiled and formed again when cooled. (<a class="LK" href="sid806035.html#R67-11">1</a>) Although William MacIntyre recognized the effect of heat on the urine and outlined the clinical findings, it was the young physician and chemist Henry Bence Jones who described the protein in detail. (<a class="LK" href="sid806035.html#R68-11">2</a>) In 1873 von Rustizky named and outlined in detail the clinicopathologic features of this disease. (<a class="LK" href="sid806035.html#R69-11">3</a>) Multiple myeloma is occasionally referred to as Kahler&#x2019;s disease, after the clinician from Prague who lectured extensively on myeloma in the late nineteenth century. (<a class="LK" href="sid806035.html#R70-11">4</a>) In more recent times the diagnosis of myeloma was facilitated by Longsworth et al. (<a class="LK" href="sid806035.html#R71-11">5</a>) in 1939, with the development of electrophoretic techniques and with immunoelectrophoresis as described by Grabar and Williams. (<a class="LK" href="sid806035.html#R72-11">6</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3466" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Multiple myeloma is the most common primary malignant tumor of bone and accounts for 27&#x0025; of biopsied bone tumors. Together, myeloma and osteosarcoma account for almost half (46&#x0025;) of the primary malignant tumors of bone. (<a class="LK" href="sid806035.html#R73-11">7</a>) Multiple myeloma represents about 1&#x0025; of all types of malignant disease and slightly &#x003E; 10&#x0025; of hematologic malignancies. In the last 2 decades, the death rate from multiple myeloma has increased; however, it is likely that these increases are related to earlier and more improved diagnosis rather than representing an actual rise in incidence. (<a class="LK" href="sid806035.html#R74-11">8</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3467" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3468" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Typically 75&#x0025; of myeloma patients are between 50 and 70 years of age, with an average age of 60. It is rarely seen before the age of 40, but a few cases have been reported before the age of 30. (<a class="LK" href="sid806035.html#R75-11">9</a>) There is a male to female ratio of 2:1.</div>
</div>
<div class="TLV4" id="B01382540.0-3469" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The clinical picture of the disease comprises four types of abnormalities: anemia owing to replacement or alteration of the hematopoietic tissues by proliferating plasma cells, deossification of bones that house red marrow, production of abnormal serum and urinary proteins, and renal disease. (<a class="LK" href="sid806035.html#R76-11">10</a>) Pain is the cardinal initial symptom, often suggesting arthritis or neuralgia.</div>
<div class="P">Initially, the bone pain is intermittent; in later stages it becomes continuous. It is worse during the day and aggravated by exercise and weight bearing. The pain is often better at night with bedrest. Low back pain in myeloma patients is frequently misdiagnosed as disc or sciatic problems initially. A rapid onset of severe pain after slight strain or mild trauma usually indicates the development of a pathologic fracture. In the late stages of the disease, pathologic fractures occur in 20&#x0025; of patients. (<a class="LK" href="sid806035.html#R77-11">11</a>) Paraplegia may occur with vertebral collapse and is more common with a solitary presentation (plasmacytoma). (<a class="LK" href="sid806035.html#R73-11">7</a>) As the disease progresses, the pain becomes more severe and prolonged, often requiring narcotics for relief.</div>
<a name="PG1169"> </a><div class="pagenum"><div>P.1169</div></div>
<br clear="all">
<div class="P">Other common signs are weight loss, cachexia, anemia, and unexplained osteoporosis. Bacterial infections (particularly respiratory) occur in approximately 10&#x0025; of cases, with Gram-negative organisms predominating. The impairment of antibody response, deficiency of the uninvolved immunoglobulins, reduction of delayed hypersensitivity in some instances, and depression of activity of the neutrophils all contribute to infection susceptibility in these patients.</div>
</div>
<div class="TLV4" id="B01382540.0-3470" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">The spine is the most common site, with the lower thoracic and lumbar areas predominating. The marrow-rich flat bones of the pelvis, skull, ribs, clavicle, and scapula are also frequently involved. The diaphyses of the proximal long tubular bones (femur and humerus) are commonly affected. Skeletal involvement distal to the elbow and knee occurs in only 10&#x0025; of cases. (<a class="LK" href="sid806035.html#R76-11">10</a>) (<a class="LK" href="sid806035.html#F61-11">Fig. 11-61</a>; <a class="LK" href="sid806035.html#T12-11">Table 11-12</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3471" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]">
<div class="HD">Laboratory Findings</div>
<div class="TLV5" id="B01382540.0-3472" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[1]">
<div class="HD"><span class="emph_I">Blood Cytology.</span></div>
<div class="P">A normochromic normocytic anemia is common, along with rouleaux formation, thrombocytopenia, and an elevation in the ESR. Plasma cells in a peripheral blood smear are rare, except in patients with plasma cell leukemia.</div>
<div class="FG" id="F61-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="297" height="700" src="files/3e00253f6b86f49227dabb423aabfe5e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3e00253f6b86f49227dabb423aabfe5e.gif" MIMETYPE="image/gif" WIDTH="297" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-61 <span class="emph_B">SKELETAL DISTRIBUTION OF MULTIPLE MYELOMA.</span>
</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3473" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[2]">
<div class="HD"><span class="emph_I">Serum Calcium and Phosphorus.</span></div>
<div class="P">Hypercalcemia occurs in &#x003E; 30&#x0025; of cases and is secondary to the lytic destruction created by the myelomatoid tissue. Serum phosphorus is normal unless there is accompanying renal disease. (<a class="LK" href="sid806035.html#R76-11">10</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3474" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[3]">
<div class="HD"><span class="emph_I">Serum Proteins.</span></div>
<div class="P">Between 50&#x0025; and 60&#x0025; of patients with myeloma have elevated plasma proteins. Hyperglobulinemia with a reversal of the albumin to globulin (A:G) ratio is common. Other causes of A:G ratio reversal are sarcoidosis, chronic nephritis, chronic cirrhosis, and lymphogranuloma venereum. Serum electrophoresis confirms the abnormality in 80-90&#x0025; of patients with multiple lesions and represents the definitive examination in establishing the diagnosis. The myeloma cells secrete a characteristic monoclonal globulin that varies in each patient. Approximately 50&#x0025; of cases have G myeloma (IgG), 25&#x0025; have A myeloma (IgA), and 1-2&#x0025; have D myeloma (IgD), whereas IgE and IgM myelomas are rare. Protein electrophoresis demonstrates peaks between the &#x03B2;- and &#x03B3;-globulin elevations or a characteristic M spike in 90&#x0025; of patients. (<a class="LK" href="sid806035.html#R78-11">12</a>) Myeloma proteins are present in 90&#x0025; of patients with disseminated plasma cell lesions. Kyle (<a class="LK" href="sid806035.html#R74-11">8</a>) showed the electrophoretic patterns to be diagnostic of myeloma protein in 75&#x0025; of his study group. (<a class="LK" href="sid806035.html#T13-11">Table 11-13</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3475" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[4]">
<div class="HD"><span class="emph_I">Urine (Bence Jones&#x2019; Proteoses).</span></div>
<div class="P">Bence Jones&#x2019; protein is a light immunoglobulin representing a complete polypeptide chain. Its thermal behavior is peculiar in that it first coagulates and then dissolves at temperatures &#x003E; 60&#x00B0;C. Approximately 40&#x0025; of myeloma patients show detectable Bence Jones&#x2019; proteinuria by the heating method, with a higher percentage being detected by electrophoresis. (<a class="LK" href="sid806035.html#R74-11">8</a>) Bence Jones&#x2019; proteinuria may occur occasionally in other diseases, such as lymphoma, polycythemia vera, and metastatic disease (5&#x0025; of cases).</div>
</div>
<div class="TLV5" id="B01382540.0-3476" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[5]">
<div class="HD"><span class="emph_I">Uric Acid in the Blood.</span></div>
<div class="P">Hyperuricemia frequently occurs because of accelerated nucleic acid metabolism. This finding is not specific for myeloma because it occurs in leukemia and gout as well.</div>
</div>
<div class="TLV5" id="B01382540.0-3477" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[6]">
<div class="HD"><span class="emph_I">Bone Marrow.</span></div>
<div class="P">Aspiration biopsy of the sternum or the iliac bone is the favored method to study smears of bone marrow and reveals columns of plasma cells at varying degrees of maturity. (<a class="LK" href="sid806035.html#R76-11">10</a>) This procedure is strongly diagnostic; however, it may not render accurate findings in each case. The presence of &#x003E; 3&#x0025; plasma cells is considered abnormal, and when the plasma cells are &#x003E; 10&#x0025;, the diagnosis of myeloma is histologically ensured. (<a class="LK" href="sid806035.html#R76-11">10</a>)</div>
<div class="TB" id="T12-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[6]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-12 Anatomic Sites of Multiple Myeloma in 320 Cases</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Site</b></p></th>
<th align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Percentage</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Vertebrae</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>69</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ribs</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>59</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Skull</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>40</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Pelvis</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>40</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Femur</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>24</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Humerus</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>20</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Clavicle</p></td>
<td align="right" valign="bottom" rowspan="1" colspan="1"><p>15</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Scapula</p></td>
<td align="right" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>13</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Reprinted with permission from <b>Wilner D:</b> <i>Radiology of Bone Tumors and Allied Disorders.</i> Philadelphia, WB Saunders, 1982.</p></td>
</tr>
</table></td></tr>
</table></div>
<a name="PG1170"> </a><div class="pagenum"><div>P.1170</div></div>
<br clear="all">
<div class="TB" id="T13-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[3]/TLV4[4]/TLV5[6]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-13 Laboratory Findings in Multiple Myeloma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="top" colspan="3" style="border-top: 1px solid black;" rowspan="1"><p><b>Hematologic</b></p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Anemia (60&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Leukopenia (16&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Thrombocytopenia (13&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Lymphocytosis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Neutropenia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Eosinophilia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Rare circulating plasma cells or plasma cell leukemia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Elevated ESR</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Rouleaux&#x2019;s formation</p></td>
</tr>
<tr>
<td align="left" valign="top" colspan="3" rowspan="1"><p><b>Bone marrow abnormalities</b></p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Focal areas with collections or sheets of plasma cells</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>More than 15-20&#x0025; plasma cells overall</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Abnormal plasma cells</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Flaming plasma cells</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Morula&#x2019;s cells</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Mott&#x2019;s cells</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Thesaurocytes</p></td>
</tr>
<tr>
<td align="left" valign="top" colspan="3" rowspan="1"><p><b>Biochemical abnormalities</b></p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Hypercalcemia (30&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Hyperuricemia (60&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Azotemia with elevated BUN and serum creatinine (55&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Alkaline phosphatase usually within normal limits</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Lowered anion gap (in IgG myeloma only)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Rare hepatic dysfunction with hypophosphatemia</p></td>
</tr>
<tr>
<td align="left" valign="top" colspan="3" rowspan="1"><p><b>Immunoelectrophoretic abnormalities</b></p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Monoclonal serum spike in relation to a region on cellulose acetate electrophoresis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Immunoelectrophoresis of serum:</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>IgG peak (50&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>IgA peak (25&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>IgD peak (1&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>IgE peak (peak usually not present)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Immunoelectrophoresis of osmodialized urine:</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>&#x03BA; and &#x03BB; light chains with serum peak (20&#x0025; of patients)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Light chains with no serum (20&#x0025; of patients)</p></td>
</tr>
<tr>
<td align="left" valign="top" colspan="3" rowspan="1"><p><b>Urine abnormalities</b></p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Bence Jones&#x2019; proteinuria (40&#x0025; of patients)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>Courtesy of Alan H. Adams, <a class="a" href="sid108669.html#AB1-M8">DC</a>, <a class="a" href="sid108669.html#AB1-M4">DACBN</a>, Tallahassee, Florida.</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>BUN, blood urea nitrogen; ESR; erythrocyte sedimentation rate.</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3478" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="TLV4" id="B01382540.0-3479" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[4]/TLV4[1]">
<div class="HD">Osseous Involvement</div>
<div class="P">The cause of this diffuse disorder remains unknown; however it is estimated that the initial oncogenic event occurs 10-15 years before disease symptomology. (<a class="LK" href="sid806035.html#R79-11">13</a>) In the classic form the skeleton contains multiple, permeative lesions, which are filled by gelatinous, red, soft masses of neoplastic plasma cells. These focal collections of plasma cells are surrounded by areas of increased osteoclastic activity. With increased cellular activity, extensive bone destruction, pathologic fractures, and hypercalcemia become evident. Myeloma has been classified as a round cell disorder, reflecting the microscopic appearance of the nuclei, which are round to oval. Often, the destructive lesions within the marrow may appear round, as well. Other round cell neoplasms include Ewing&#x2019;s sarcoma and non-Hodgkin&#x2019;s lymphoma of bone (reticulum cell sarcoma). (<a class="LK" href="sid806035.html#R77-11">11</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3480" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[4]/TLV4[2]">
<div class="HD">Myeloma Kidney</div>
<div class="P">Renal involvement may occur in all forms of the disease. Precipitation of protein in the tubules produces extensive and numerous hyaline casts. The tubular cells swell and become engorged with the Bence Jones&#x2019; proteinaceous casts. These casts are accompanied by an inflammatory infiltrate in the surrounding interstitium, and permanent tubular damage will occur in up to 75&#x0025; of patients, causing renal failure. (<a class="LK" href="sid806035.html#R80-11">14</a>) Signs of renal failure usually occurs within 2 months of diagnosis (<a class="LK" href="sid806035.html#R80-11">14</a>), representing the second most common cause of death in myeloma patients, with pneumonia and respiratory failure being first.</div>
</div>
<div class="TLV4" id="B01382540.0-3481" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[4]/TLV4[3]">
<div class="HD">Amyloidosis</div>
<div class="P">Approximately 15&#x0025; of patients with classic multiple myeloma develop secondary amyloidosis. (<a class="LK" href="sid806035.html#R81-11">15</a>) The favorite target organs of amyloid are the kidney, heart, gastrointestinal tract, liver, and spleen. (<a class="LK" href="sid806035.html#R81-11">15</a>) Amyloid joint disease is a rare form of arthropathy. (<a class="LK" href="sid806035.html#R82-11">16</a>) The subcutaneous nodules, morning stiffness, weight loss, and symmetric involvement of diarthrodial joints may suggest rheumatoid arthritis initially; however, the non-inflammatory nature of amyloid arthropathy must be emphasized, and the severe early morning fatigue also helps distinguish it from rheumatoid disease. (<a class="LK" href="sid806035.html#R81-11">15</a>) Rarely, a circumscribed mass of amyloid around a joint is the first manifestation of myelomatosis. This presentation has been referred to as the <span class="emph_I">pad sign</span> of secondary amyloid arthropathy. (<a class="LK" href="sid806035.html#R83-11">17</a>) Amyloid deposits in the skeleton may undergo calcification, while infiltration of the kidney may lead to renal failure.</div>
</div>
<div class="TLV4" id="B01382540.0-3482" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[4]/TLV4[4]">
<div class="HD">Extraosseous Plasmacytoma</div>
<div class="P">The most common site for extramedullary plasmacytoma is the nasopharynx, with the nasal cavity, oral cavity, tonsils, sinuses, and larynx also affected. (<a class="LK" href="sid806035.html#R76-11">10</a>) Often these tumors will be locally invasive, eroding into adjacent bone.</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3483" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="TLV4" id="B01382540.0-3484" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[1]">
<div class="HD">Radionuclide Bone Scans</div>
<div class="P">It has long been held that conventional radiography is the best way to visualize myelomatoid deposits. (<a class="LK" href="sid806035.html#R84-11">18</a>,<a class="LK" href="sid806035.html#R85-11">19</a>) Bone scans are relatively insensitive to the presence of myeloma lesions and frequently produce a normal (<span class="emph_I">cold</span>) scan, except at the sites of pathologic fracture, which will be focally hot. (<a class="LK" href="sid806035.html#R84-11">18</a>,<a class="LK" href="sid806035.html#R85-11">19</a>) (<a class="LK" href="sid806035.html#F62-11">Fig. 11-62</a>) A major reason for the negative scan or non-reactivity of the deposits is the release of an osteoclast activating factor (OAF) by the plasma cells. High OAF levels are found in patients with myeloma, causing an osteoclastic process to predominate. The uptake of radionuclide into lesions depends on osteoblastic activity, which is deficient in patients with non-fractured myeloma deposits. (<a class="LK" href="sid806035.html#R84-11">18</a>,<a class="LK" href="sid806035.html#R85-11">19</a>) Therefore, conventional radiography (a skeletal survey) continues to be the principal method of demonstrating skeletal involvement in the routine diagnostic workup of a patient with suspected multiple myeloma.</div>
<a name="PG1171"> </a><div class="pagenum"><div>P.1171</div></div>
<br clear="all">
<div class="FG" id="F62-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="275" src="files/177aa56ffab9218dacdc266ebe5eeb40.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="177aa56ffab9218dacdc266ebe5eeb40.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="275" DISPLAY="INLINE"></div>
<div class="P">Figure 11-62 <span class="emph_B">MULTIPLE MYELOMA: COLD RADIONUCLIDE SCAN. A. Lateral Skull.</span> Note the multiple discrete osteolytic lesions distributed throughout the calvaria (raindrop skull). <span class="emph_B">B. Delayed Technetium Radionuclide Scan, Lateral Projection.</span> Note that this scan fails to demonstrate any coinciding tracer uptake corresponding to the osteolytic defects seen on the plain film. (Courtesy of William E. Litterer, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Elizabeth, New Jersey.)</div>
</td></tr>
</table></div>
<div class="FG" id="F63-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="555" src="files/9ffeca62186dde54b3c0d9bf409de828.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9ffeca62186dde54b3c0d9bf409de828.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="555" DISPLAY="INLINE"></div>
<div class="P">Figure 11-63 <span class="emph_B">OSTEOPOROSIS: THE EARLIEST RADIOGRAPHIC SIGN OF MYELOMA. A. Lateral Lumbar Spine.</span> Observe the gross osteoporosis throughout the lumbar spine. There is a compression fracture of the superior endplate of L2 (<span class="emph_I">arrow</span>). The radiopaque densities in the spinal canal represent contrast material from a previous myelogram. <span class="emph_B">B. Lateral Lumbar Spine.</span> Note the diffuse osteoporosis throughout the entire lumbar spine. There are pathologic fractures of the T12 and L2 vertebral bodies (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
</div>
<a name="PG1172"> </a><div class="pagenum"><div>P.1172</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3485" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]">
<div class="HD">Conventional Radiography</div>
<div class="TLV5" id="B01382540.0-3486" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[1]">
<div class="HD"><span class="emph_I">Osteoporosis.</span></div>
<div class="P">The mode of presentation controls the wide spectrum of roentgen findings in patients with multiple myeloma. Early in the disorder, the bones may appear normal, even though sternal biopsy and laboratory tests at this stage would be positive. Unless proper clinical workup is initiated, these patients may be labeled as neurotics. As the disease progresses, generalized and severe osteoporosis presents radiographically. This is usually most advanced within the spine, more frequently observed in the lower thoracic and lumbar regions. (<a class="LK" href="sid806035.html#R86-11">20</a>) The typical appearance is a diffuse loss of bone density with thinning of the cortex. In the spine the vertebral body may assume the same density as the intervertebral disc. At this stage, the bones are weak, and pathologic fracture is imminent. (<a class="LK" href="sid806035.html#F63-11">Fig. 11-63</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3487" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[2]">
<div class="HD"><span class="emph_I">Osteolytic Defects.</span></div>
<div class="P">The radiologic hallmark of multiple myeloma is the sharply circumscribed osteolytic defect. These radiolucent lesions have been historically referred to as <span class="emph_I">punched-out lesions.</span> They are multiple, round, and purely lytic. (<a class="LK" href="sid806035.html#F64-11">Fig. 11-64</a>) The most frequent sites are in bones with hematopoietic potential. This appearance is most common in the skull, pelvis, long bones, clavicles, and ribs. (<a class="LK" href="sid806035.html#F65-11">Figs. 11-65</a> and <a class="LK" href="sid806035.html#F66-11">11-66</a>) The pattern of widespread lytic lesions of the skull has been referred to as the <span class="emph_I">raindrop skull.</span> (<a class="LK" href="sid806035.html#R87-11">21</a>) (<a class="LK" href="sid806035.html#F67-11">Figs. 11-67</a> and <a class="LK" href="sid806035.html#F68-11">11-68</a>) Calvarial involvement may occasionally be differentiated from metastatic carcinoma by the more uniform size of the lytic lesions in myeloma. The co-existence of both large and small lesions is often the mode of presentation in metastatic disease.</div>
<div class="TLV6" id="B01382540.0-3488" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[2]/TLV6[1]">
<div class="HD">Spine.</div>
<div class="P">The lower thoracic and lumbar spine are usual sites; however, no spinal region is exempt. Early osteoporosis may be the only radiographic sign. As the disease progresses, pathologic vertebral collapse is inevitable. This often takes the configuration of a vertebra plana, compromising the posterior third of the vertebral body as well as its anterior two thirds. (<a class="LK" href="sid806035.html#F69-11">Fig. 11-69</a>) Pathologic fracture in the spine may be singular or multiple and has been called the <span class="emph_I">wrinkled vertebra of myeloma.</span> (<a class="LK" href="sid806035.html#F70-11">Figs. 11-70</a> and <a class="LK" href="sid806035.html#F71-11">11-71</a>) Demonstration of punched-out lesions in the spine is rare. The vertebral pedicles are involved much less frequently than the body. Jacobson et al. (<a class="LK" href="sid806035.html#R88-11">22</a>) suggested that the paucity of red marrow in the pedicles may allow their preservation with vertebral involvement. This has been called the <span class="emph_I">pedicle sign of multiple myeloma.</span> (<a class="LK" href="sid806035.html#R88-11">22</a>) (<a class="LK" href="sid806035.html#F72-11">Fig. 11-72</a>) Since Jacobson et al.&#x2019;s original paper in 1958, there have been numerous cases reported refuting this sign and demonstrating isolated pedicular or combined vertebral body and pedicular involvement in multiple myeloma. (<a class="LK" href="sid806035.html#R89-11">23</a>) Therefore, the usefulness of this pedicle sign to differentiate multiple myeloma from osteolytic metastatic carcinoma appears doubtful.</div>
<div class="FG" id="F64-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[2]/TLV6[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="334" src="files/74423e0708077185f491346ea18987e7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="74423e0708077185f491346ea18987e7.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="334" DISPLAY="INLINE"></div>
<div class="P">Figure 11-64 <span class="emph_B">PUNCHED-OUT LESIONS OF MULTIPLE MYELOMA. A. Skull. B. Proximal Femur. C. Humerus.</span> Note that the radiologic hallmark of multiple myeloma is the sharply circumscribed osteolytic defect that is clearly demonstrated on these radiographs. The lesions are multiple, round, and purely lytic. The most frequent sites are bones with hematopoietic potential. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV6" id="B01382540.0-3489" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[2]/TLV6[2]">
<div class="HD">Pelvis and Long Bones.</div>
<div class="P">Diffuse osteolytic round or oval lesions predominate without any reactive sclerosis. Medullary bone destruction abuts the endosteal surface of the cortex. The diaphysis is an area frequently involved in the long bones, which is consistent with the anatomic distribution of active red bone marrow. The humerus and femur are favored sites. (<a class="LK" href="sid806035.html#F73-11">Figs. 11-73</a>, <a class="LK" href="sid806035.html#F74-11">11-74</a>, <a class="LK" href="sid806035.html#F75-11">11-75</a> and <a class="LK" href="sid806035.html#F76-11">11-76</a>) Widespread disease throughout the pelvis and sacrum creates diffuse lytic lesions, which are fairly symmetric. (<a class="LK" href="sid806035.html#F77-11">Fig. 11-77</a>)</div>
</div>
</div>
<div class="TLV5" id="B01382540.0-3490" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]">
<div class="HD"><span class="emph_I">Osteoblastic Lesions.</span></div>
<div class="P">Sclerotic forms of multiple myeloma before treatment with radiotherapy or drugs are rare. (<a class="LK" href="sid806035.html#R90-11">24</a>,<a class="LK" href="sid806035.html#R91-11">25</a>) Sclerotic lesions may occur as a solitary focus or as multiple foci. Solitary blastic lesions are most common in the ribs, sternum, and ilium; however, other sites include vertebrae, skull, and long bones. Less than 3&#x0025; of patients present with sclerotic lesions. (<a class="LK" href="sid806035.html#R90-11">24</a>,<a class="LK" href="sid806035.html#R91-11">25</a>) A solitary ivory vertebra has been noted in some myeloma
<a name="PG1173"> </a><div class="pagenum"><div>P.1173</div></div>
<br clear="all">
patients. Differential diagnosis from osteoblastic metastasis, mastocytosis, lymphoma, and myelosclerosis may be difficult. (<a class="LK" href="sid806035.html#R90-11">24</a>,<a class="LK" href="sid806035.html#R91-11">25</a>) (<a class="LK" href="sid806035.html#T14-11">Table 11-14</a>)</div>
<div class="FG" id="F65-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="428" src="files/7c903062ea9dfcdb5c45d74d181eb044.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7c903062ea9dfcdb5c45d74d181eb044.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="428" DISPLAY="INLINE"></div>
<div class="P">Figure 11-65 <span class="emph_B">MULTIPLE MYELOMA. Ribs.</span> Observe the diffuse osteolytic lesions involving nearly all the visualized rib structures. Similar osteolytic defects are present within the visualized scapula and humeral head.</div>
</td></tr>
</table></div>
<div class="FG" id="F66-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="430" height="700" src="files/433a15de7d3c8ca39442b91e98466a31.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="433a15de7d3c8ca39442b91e98466a31.gif" MIMETYPE="image/gif" WIDTH="430" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-66 <span class="emph_B">MULTIPLE MYELOMA: RIBS. A. Pathologic Fractures.</span> Note the radiolucent defects scattered throughout the ribs, with numerous pathologic fractures (<span class="emph_I">arrows</span>). <span class="emph_B">B. Extrapleural Sign.</span> Observe the large, radiopaque, expansile lesions involving the ribs bilaterally (<span class="emph_I">arrows</span>). Smaller lytic expansile lesions are also noted involving the left rib cage (<span class="emph_I">arrowheads</span>). (Courtesy of Steven P. Brownstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Springfield, New Jersey.)</div>
</td></tr>
</table></div>
<div class="FG" id="F67-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="469" height="700" src="files/c5ac51d14c92f972bbe6c2aab8f805b8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c5ac51d14c92f972bbe6c2aab8f805b8.gif" MIMETYPE="image/gif" WIDTH="469" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-67 <span class="emph_B">MULTIPLE MYELOMA: RAINDROP SKULL. A. PA Skull. B. Lateral Skull.</span> Observe the diffuse, permeative, or punched-out lesions throughout the calvaria. <span class="emph_I">COMMENT:</span> Multiple myeloma of the skull may be differentiated from metastatic carcinoma by the more uniform size of the lytic lesions in myeloma. The co-existence of both large and small lesions is often the mode of presentation of metastatic disease.</div>
</td></tr>
</table></div>
<div class="FG" id="F68-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="482" src="files/58c46a218bf9ffaff4095e1edf2271b5.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="58c46a218bf9ffaff4095e1edf2271b5.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="482" DISPLAY="INLINE"></div>
<div class="P">Figure 11-68 <span class="emph_B">MULTIPLE MYELOMA. Lateral Skull.</span> Observe the osteolytic lesions scattered throughout the bones of the skull. This is advanced multiple myeloma of the calvaria.</div>
</td></tr>
</table></div>
<a name="PG1174"> </a><div class="pagenum"><div>P.1174</div></div>
<br clear="all">
<div class="FG" id="F69-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="499" src="files/7c066c215e7d006ba961d1d7ebc3b13d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7c066c215e7d006ba961d1d7ebc3b13d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="499" DISPLAY="INLINE"></div>
<div class="P">Figure 11-69 <span class="emph_B">PATHOLOGIC COLLAPSE, CREATING A VERTEBRA PLANA. A. Lateral Thoracic Spine.</span> Note the two pathologic fractures of the lower thoracic vertebrae secondary to multiple myeloma (<span class="emph_I">arrows</span>). Observe the gross osteoporosis and thinning of the cortical endplates of the remainder of the thoracic spine. <span class="emph_B">B. Lateral Thoracic Spine.</span> Observe two midthoracic vertebrae collapsed secondary to multiple myeloma (<span class="emph_I">arrows</span>). Observe the compromise of the posterior third of the vertebral body.</div>
</td></tr>
</table></div>
<div class="FG" id="F70-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="527" src="files/0bc092e9b1e72096a3ab342631ae3dd6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="0bc092e9b1e72096a3ab342631ae3dd6.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="527" DISPLAY="INLINE"></div>
<div class="P">Figure 11-70 <span class="emph_B">MULTIPLE MYELOMA: LUMBAR SPINE. A. Localized Involvement.</span> Observe the uniform collapse of the vertebral body of L3, creating a vertebra plana. Note the overall loss of bone density within the matrix of the L3 vertebral body. <span class="emph_B">B. Diffuse Involvement.</span> Note the diffuse destructive lesions throughout the entire lumbar spine and lower thoracic vertebrae from multiple myeloma. Pathologic fractures are present in the upper lumbar and lower thoracic regions. Of incidental and unrelated notation are two calcified gallstones within the abdomen (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<a name="PG1175"> </a><div class="pagenum"><div>P.1175</div></div>
<br clear="all">
<div class="FG" id="F71-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="514" src="files/f4e2f5108fc3fa73c8085491d6d842b9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f4e2f5108fc3fa73c8085491d6d842b9.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="514" DISPLAY="INLINE"></div>
<div class="P">Figure 11-71 <span class="emph_B">MULTIPLE MYELOMA: CERVICAL SPINE. A. Lateral Cervical Spine.</span> Observe the severe collapse of the C4 and C5 vertebral bodies as a result of multiple myeloma. A severe flexion deformity of the cervical spine, with a reversal of the cervical lordosis, is noted. <span class="emph_B">B. Lateral Cervical Spine.</span> Note the diffuse osteoporosis throughout the entire cervical spine. Some small punched-out lesions are present in the lamina and spinous processes of C2 and C3. There is a pathologic collapse of the C5 vertebral body, creating a vertebra plana secondary to multiple myeloma. (Courtesy of John A. Hinwood, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, and Judy Hinwood, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Springwood, Queensland, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F72-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="548" src="files/501076c61bab5f2e2c1a28326f8828c0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="501076c61bab5f2e2c1a28326f8828c0.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="548" DISPLAY="INLINE"></div>
<div class="P">Figure 11-72 <span class="emph_B">MULTIPLE MYELOMA: THE PEDICLE SIGN. A. AP Thoracic.</span> Observe the collapse of the T7 vertebral body (<span class="emph_I">arrow</span>). The pedicles have not been destroyed and are visualized on this frontal radiograph (<span class="emph_I">arrowheads</span>). <span class="emph_B">B. Lateral Thoracic.</span> Note the uniform collapse of the T7 vertebral body. Observe the collapse of the posterior third of the vertebral body, which strongly suggests a pathologic fracture, as was the case in this myeloma patient. This is a characteristic appearance for a vertebra plana or a wrinkled vertebra (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<a name="PG1176"> </a><div class="pagenum"><div>P.1176</div></div>
<br clear="all">
<div class="FG" id="F73-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="651" src="files/b885a01f0072e4392ec89b47d31fa1e2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b885a01f0072e4392ec89b47d31fa1e2.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="651" DISPLAY="INLINE"></div>
<div class="P">Figure 11-73 <span class="emph_B">MULTIPLE MYELOMA: HUMERUS. A. and B. Humeral Diaphysis.</span> Observe the well-defined, radiolucent, punched-out lesions in the diaphysis of these patients suffering from multiple myeloma. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F74-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[10]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="424" height="700" src="files/41a684c5664730a6d66a01843897fb83.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="41a684c5664730a6d66a01843897fb83.gif" MIMETYPE="image/gif" WIDTH="424" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-74 <span class="emph_B">MULTIPLE MYELOMA, HUMERUS, WITH PATHOLOGIC FRACTURE.</span> Observe the fine, permeative, punched-out lesions in the diaphysis of the humerus. This patient developed a pathologic fracture through the myelomatoid lesion after trivial trauma.</div>
</td></tr>
</table></div>
<div class="FG" id="F75-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[11]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="620" src="files/b3b29436b6fc321ed1b2c41985af044a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b3b29436b6fc321ed1b2c41985af044a.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="620" DISPLAY="INLINE"></div>
<div class="P">Figure 11-75 <span class="emph_B">MULTIPLE MYELOMA: FEMUR. A. Localized Involvement.</span> Observe the radiolucent destructive lesions within the diaphysis of the femur. <span class="emph_B">B. Diffuse Involvement.</span> Note the numerous radiolucent permeative lesions throughout the entire proximal femur and visualized ischium. <span class="emph_I">COMMENT:</span> There is a great predilection for multiple myeloma to affect the diaphysis of the long bones. Diaphyseal involvement in multiple myeloma is the result of this neoplasm developing in the red marrow within the shafts of the long bones. (Panel B reprinted with permission from <span class="emph_B">Yochum TR, Molyneux TP:</span> <span class="emph_I">Multiple myeloma.</span> ACA J Chiro June, 1983.)</div>
</td></tr>
</table></div>
<div class="FG" id="F76-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[12]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="620" src="files/929ae9222827bb12a8e7864dc969cf7b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="929ae9222827bb12a8e7864dc969cf7b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="620" DISPLAY="INLINE"></div>
<div class="P">Figure 11-76 <span class="emph_B">MULTIPLE MYELOMA IN A POODLE. A. Right Knee. B. Left Knee.</span> Observe the multiple radiolucent destructive lesions in the distal femora and proximal tibiae. It is interesting to note that the pattern of bone destruction and radiographic presentation is no different in this poodle than it is in humans. (Courtesy of Steven P. Brownstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Springfield, New Jersey, and William E. Litterer, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Elizabeth, New Jersey.)</div>
</td></tr>
</table></div>
<a name="PG1177"> </a><div class="pagenum"><div>P.1177</div></div>
<br clear="all">
<div class="FG" id="F77-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[3]/FG[13]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="502" height="700" src="files/2f7a2e30684e8a18119a268f575f718d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2f7a2e30684e8a18119a268f575f718d.gif" MIMETYPE="image/gif" WIDTH="502" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-77 <span class="emph_B">MULTIPLE MYELOMA. A. Pelvis.</span> Note the diffuse lytic destruction of the entire pelvis and proximal femora. Pathologic fractures of both pubic rami are present. <span class="emph_B">B. Multiple Myeloma and Paget&#x2019;s Disease of the Pelvis.</span> Note the unilateral cortical thickening and expansion of the pelvis (<span class="emph_I">arrows</span>). The diffuse increase in bone density with scattered radiolucencies is a classic radiographic presentation of Paget&#x2019;s disease. Observe in the opposite hemipelvis a diffuse loss of bone density, with cortical thinning. The permeative destructive lesions that are seen in this side of the pelvis are characteristic of multiple myeloma.</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3491" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[2]/TLV5[4]">
<div class="HD"><span class="emph_I">Diagnostic Criteria.</span></div>
<div class="P">Diagnostic criteria are presented in <a class="LK" href="sid806035.html#T15-11">Table 11-15</a>.</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3492" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[3]">
<div class="HD">Computed Tomography (CT)</div>
<div class="P">CT is particularly useful in defining lesions that are visible on plain film, as well as those that are not seen. (<a class="LK" href="sid806035.html#R92-11">26</a>) By using varying window widths, soft tissue components can be defined. Bone lesions may be the characteristic punched-out type or more diffusely permeative. The marrow, when diffusely infiltrated, may exhibit higher attenuation values because of fatty marrow replacement. (<a class="LK" href="sid806035.html#R92-11">26</a>) (<a class="LK" href="sid806035.html#F78-11">Fig. 11-78</a>)</div>
<div class="TB" id="T14-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[3]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-14 Roentgen Signs of Multiple Myeloma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="top" colspan="2" style="border-top: 1px solid black;" rowspan="1"><p>Early</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Normal radiographs</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Gross osteoporosis</p></td>
</tr>
<tr>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Late</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Diffuse, punched-out lesions</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Uniform vertebral collapse (compromise of the posterior third of the body)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Diaphyseal osteolytic lesions</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Rarely, sclerotic lesions (ivory vertebra)</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Pedicle sign (preservation of pedicles)</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TB" id="T15-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[3]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-15 Diagnostic Criteria</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="top" colspan="2" style="border-top: 1px solid black;" rowspan="1"><p>Require 10&#x0025; of abnormal, atypical, or immature plasma cells in the bone marrow, plus one of the following:</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>&#x2022;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Serum M-protein spike</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>&#x2022;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Urine M-protein spike or Bence Jones&#x2019; proteinuria</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>&#x2022;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Characteristic osteolytic lesions of bone</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>&#x2022;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Generalized osteoporosis&#x2014;qualifies if the marrow contains 30&#x0025; myeloma cells</p></td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x2022;</p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Biopsy-proven plasmacytoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Courtesy of Alan H. Adams, <a class="a" href="sid108669.html#AB1-M8">DC</a>, <a class="a" href="sid108669.html#AB1-M4">DACBN</a>, Tallahassee, Florida.</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3493" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[5]/TLV4[4]">
<div class="HD">Magnetic Resonance Imaging (MRI)</div>
<div class="P">MRI is highly sensitive to marrow infiltration from myeloma. A broad spectrum of appearances arises, from discrete foci to diffuse lesions, which may involve the entire bone. On T1-weighted images, the affected areas are low in signal intensity. With T2 weighting a heterogeneous increase in signal intensity occurs. (<a class="LK" href="sid806035.html#R93-11">27</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3494" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">In patients with multiple myeloma the overall prognosis is poor. (<a class="LK" href="sid806035.html#R94-11">28</a>) Over 90&#x0025; die within 3 years, with the median survival rate being 33 months. (<a class="LK" href="sid806035.html#R73-11">7</a>,<a class="LK" href="sid806035.html#R95-11">29</a>) Survival rates generally increase when the patient&#x2019;s age is &#x003C; 50. (<a class="LK" href="sid806035.html#R96-11">30</a>) Treatment is usually palliative, with the aim of minimizing the patient&#x2019;s suffering. (<a class="LK" href="sid806035.html#R94-11">28</a>) The two major forms of treatment are radiotherapy and chemotherapy. Plasma cells are characteristically radiosensitive, and radiotherapy is of established value in the control of localized symptomatic lesions, which typically transform to a blastic area. Of the chemotherapeutic agents presently available, melphalan and Cytoxan are the two drugs most useful in attempted long-term management, whereas melphalan combined with prednisone has become the standard of care. (<a class="LK" href="sid806035.html#R97-11">31</a>) The importance of ambulation and adequate hydration cannot be overemphasized. The constant threat of hypercalcemia, hypercalciuria, and hyperuricemia necessitate continual attention to these aspects of general care. Zoledronic acid has recently demonstrated to be of benefit in the treatment of related hypercalcemia seen in multiple myeloma. (<a class="LK" href="sid806035.html#R98-11">32</a>)</div>
<a name="PG1178"> </a><div class="pagenum"><div>P.1178</div></div>
<br clear="all">
<div class="FG" id="F78-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[1]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="380" src="files/d1590e2ad89e5a721439a271872d66e3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d1590e2ad89e5a721439a271872d66e3.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="380" DISPLAY="INLINE"></div>
<div class="P">Figure 11-78 <span class="emph_B">MULTIPLE MYELOMA: FEMUR. A. Plain film.</span> Note the subtle endosteal scalloping in the region of the greater trochanter (<span class="emph_I">arrow</span>). <span class="emph_B">B. Soft Tissue Window CT Scan.</span> Note the increased density of the marrow space owing to tumor mass and the clear demonstration of endosteal scalloping (<span class="emph_I">arrows</span>). No extraosseous extension is present. (Courtesy of William E. Litterer, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Elizabeth, New Jersey.)</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3495" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]">
<div class="HD">SOLITARY PLASMACYTOMA</div>
<div class="TLV3" id="B01382540.0-3496" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Solitary plasmacytoma represents a localized form of plasma cell proliferation. It is much less common than multiple myeloma. (<a class="LK" href="sid806035.html#R99-11">1</a>) Approximately 50&#x0025; of patients present before age 50. (<a class="LK" href="sid806035.html#R99-11">1</a>) Most commonly, patients complain of localized pain. Laboratory findings are occasionally normal, or the abnormal serum electrophoresis may disappear after tumor excision. (<a class="LK" href="sid806035.html#R100-11">2</a>) The mandible, ilium, vertebrae, ribs, and proximal femur and scapula are the favored sites. (<a class="LK" href="sid806035.html#F79-11">Figs. 11-79</a>, <a class="LK" href="sid806035.html#F80-11">11-80</a>, <a class="LK" href="sid806035.html#F81-11">11-81</a>, <a class="LK" href="sid806035.html#F82-11">11-82</a>, <a class="LK" href="sid806035.html#F83-11">11-83</a>, <a class="LK" href="sid806035.html#F84-11">11-84</a>, <a class="LK" href="sid806035.html#F85-11">11-85</a>, <a class="LK" href="sid806035.html#F86-11">11-86</a> and <a class="LK" href="sid806035.html#F87-11">11-87</a>) Pathologic fracture is common. (<a class="LK" href="sid806035.html#F88-11">Fig. 11-88</a>) Isolated cases have been reported in extramedullary sites affecting the soft tissues of the upper respiratory tract. (<a class="LK" href="sid806035.html#R101-11">3</a>) Rarely, solitary plasmacytoma can present as an ivory vertebra. (<a class="LK" href="sid806035.html#R102-11">4</a>) The typical roentgen appearance is a geographic radiolucent lesion, often highly expansile, with a <span class="emph_I">soap bubble internal architecture.</span> (<a class="LK" href="sid806035.html#F89-11">Fig. 11-89</a>) The radiographic differential diagnosis includes pseudo-tumor of hemophilia, hydatid disease of bone, fibrous dysplasia, giant cell tumor, brown tumor of hyperparathyroidism, and blow-out metastases from renal or thyroid origin.</div>
<div class="P">Often, these lesions initially appear benign; however, 70&#x0025; of patients who have what seems to be a solitary focus develop diffuse multiple myeloma and die within 5 years. (<a class="LK" href="sid806035.html#R99-11">1</a>) Progression to multiple myeloma has been documented in cases up to 23 years after the initial presentation of solitary plasmacytoma (<a class="LK" href="sid806035.html#R103-11">5</a>), emphasizing the importance of long-term follow-up with these patients. (<a class="LK" href="sid806035.html#R104-11">6</a>,<a class="LK" href="sid806035.html#R105-11">7</a>) The balance of the lesions remain localized and are treated quite successfully with local irradiation and&#x002F;or surgical excision. (<a class="LK" href="sid806035.html#R105-11">7</a>,<a class="LK" href="sid806035.html#R106-11">8</a>,<a class="LK" href="sid806035.html#R107-11">9</a>) (<a class="LK" href="sid806035.html#F90-11">Fig. 11-90</a>)</div>
<div class="FG" id="F79-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="490" src="files/9fbc405cd66f6d9e299f44f2bf2364d8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9fbc405cd66f6d9e299f44f2bf2364d8.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="490" DISPLAY="INLINE"></div>
<div class="P">Figure 11-79 <span class="emph_B">PLASMACYTOMA: MANDIBLE.</span> Observe the grossly destructive, highly expansile lesion of the mandible. <span class="emph_I">COMMENT:</span> Plasmacytoma is a more localized form of multiple myeloma and is somewhat less aggressive than the diffuse form of multiple myeloma.</div>
</td></tr>
</table></div>
<a name="PG1179"> </a><div class="pagenum"><div>P.1179</div></div>
<br clear="all">
<div class="FG" id="F80-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="480" src="files/1092199709a1f2147b7d682bbdd9f40d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1092199709a1f2147b7d682bbdd9f40d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="480" DISPLAY="INLINE"></div>
<div class="P">Figure 11-80 <span class="emph_B">PLASMACYTOMA: ILIUM. A. Localized Involvement. B. Diffuse Involvement.</span> Note the advanced osteolytic destruction of the ilium, the pattern of which assumes a soap bubble appearance.</div>
</td></tr>
</table></div>
<div class="FG" id="F81-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="330" src="files/405ff063acf4ae5bb6e4952915d9310b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="405ff063acf4ae5bb6e4952915d9310b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="330" DISPLAY="INLINE"></div>
<div class="P">Figure 11-81 <span class="emph_B">PLASMACYTOMA: T8. A. AP Thoracic Spine. B. Lateral Thoracic Spine.</span> Note the diffuse collapse of the T8 vertebral body, creating a vertebra plana. This is the typical appearance of a pathologic fracture, with compromise of the posterior third of the vertebral body. <span class="emph_B">C. CT.</span> Observe the large, lytic destructive lesion present within the vertebral body of T8. (Courtesy of Steven P. Brownstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Springfield, New Jersey.)</div>
</td></tr>
</table></div>
<a name="PG1180"> </a><div class="pagenum"><div>P.1180</div></div>
<br clear="all">
<div class="FG" id="F82-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="259" src="files/b754cacbba95fc72735d6633c4d1787f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b754cacbba95fc72735d6633c4d1787f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="259" DISPLAY="INLINE"></div>
<div class="P">Figure 11-82 <span class="emph_B">PLASMACYTOMA WITH POSTMANIPULATION PATHOLOGIC FRACTURE: C2. A. Premanipulation.</span> Note a subtle decrease in density of the C2 vertebral body (<span class="emph_I">arrow</span>). This was overlooked on initial review, and manipulation was administered by a medical practitioner. <span class="emph_B">B. Postmanipulation.</span> Note that this film, taken 4 days later, after unremitting neck pain, shows pathologic fracture through the axis body (<span class="emph_I">arrow</span>). (Reprinted with permission from <span class="emph_B">Montileone M:</span> <span class="emph_I">Solitary Plasmacytoma</span> &#x005B;Roentgenological Brief&#x005D;. ACA Council Roentgenology, 1981. Case courtesy of Felix Bauer, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M7">DACBR(Hon)</a>, Sydney, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F83-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="489" height="700" src="files/8f1753816689656ab58d0842747d3e68.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8f1753816689656ab58d0842747d3e68.gif" MIMETYPE="image/gif" WIDTH="489" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-83 <span class="emph_B">PLASMACYTOMA: C3.</span> Observe the diffuse loss of bone density of the C3 vertebral body. Subtle destruction of the cortical vertebral endplate superiorly and, to a lesser extent, inferiorly is noted. There is minimal expansion of the C3 vertebral body as well. <span class="emph_I">COMMENT:</span> This 64-year-old male had a sacral plasmacytoma 2 years previously, which was treated with radiation therapy. The classic signs of diffuse loss of bone density, when compared with the vertebral bodies above and below, along with disruption of the cortical vertebral endplate, are the earliest radiographic signs of malignant disease within a vertebral body. A similar appearance is often found in a metastatic lesion of the vertebral body. (Courtesy of Ronald H. Collett, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, DACBR, Winnipeg, Manitoba, Canada.)</div>
</td></tr>
</table></div>
<a name="PG1181"> </a><div class="pagenum"><div>P.1181</div></div>
<br clear="all">
<div class="FG" id="F84-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="515" src="files/b14dc895a12af94901a2ff703290a419.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b14dc895a12af94901a2ff703290a419.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="515" DISPLAY="INLINE"></div>
<div class="P">Figure 11-84 <span class="emph_B">PLASMACYTOMA: C3. A. Plain Film, Cervical Spine.</span> Note the extensive collapse of the C3 vertebral body, secondary to a solitary plasmacytoma. <span class="emph_B">B. Axial CT, C3.</span> Observe the lytic destruction of the vertebral body, transverse process, and a portion of one articular pillar. (Courtesy of William E. Litterer, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Elizabeth, New Jersey.)</div>
</td></tr>
</table></div>
<div class="FG" id="F85-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="332" src="files/975807aac376d4e23b5353673e0e3666.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="975807aac376d4e23b5353673e0e3666.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="332" DISPLAY="INLINE"></div>
<div class="P">Figure 11-85 <span class="emph_B">PLASMACYTOMA: L3. A. AP Lumbar Spine.</span> Observe the osteolytic destruction and collapse of the L3 vertebral body unilaterally. <span class="emph_B">B. AP Lumbar Spine. C. Lateral Lumbar Spine.</span> Note that the 1-year follow-up radiographs demonstrate complete collapse of the L3 vertebral body, secondary to localized multiple myeloma. Of incidental notation is scattered radiopaque contrast material present within the spinal canal from previous myelographic investigation.</div>
</td></tr>
</table></div>
<a name="PG1182"> </a><div class="pagenum"><div>P.1182</div></div>
<br clear="all">
<div class="FG" id="F86-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="432" src="files/ab8a6e6590bd1d13dd3f5341f9ba3616.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ab8a6e6590bd1d13dd3f5341f9ba3616.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="432" DISPLAY="INLINE"></div>
<div class="P">Figure 11-86 <span class="emph_B">PLASMACYTOMA: RIB.</span> Note the large extrapleural sign involving the left rib cage (<span class="emph_I">arrows</span>). This radiopacity represents bone destruction of the anterolateral surface of the left fourth rib, secondary to a solitary plasmacytoma (<span class="emph_I">arrowhead</span>). (Courtesy of Kenneth E. Yochum, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, St. Louis, Missouri.)</div>
</td></tr>
</table></div>
<div class="FG" id="F87-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="411" src="files/ba7db48ea53b28467eebee7b8b343679.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ba7db48ea53b28467eebee7b8b343679.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="411" DISPLAY="INLINE"></div>
<div class="P">Figure 11-87 <span class="emph_B">PLASMACYTOMA. Scapula.</span> Observe the soap bubble lytic lesions present in the superior portion of the scapula. These lesions have the typical destructive appearance of plasmacytoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F88-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[10]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="470" height="700" src="files/3f28b319fd3ff16d0d99bbf4f9533a5d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3f28b319fd3ff16d0d99bbf4f9533a5d.gif" MIMETYPE="image/gif" WIDTH="470" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-88 <span class="emph_B">MULTIPLE MYELOMA: C5 VERTEBRAL BODY AND NEURAL ARCH. Lateral Cervical Spine.</span> Observe the complete collapse and osteolytic destruction of the C5 vertebral body. The articular pillar, lamina, and spinous process of C5 are also destroyed. <span class="emph_I">COMMENT:</span> Neural arch involvement of multiple myeloma is somewhat unusual. This represented a solitary plasmacytoma. The lack of adjacent endplate destruction helps differentiate this from osteomyelitis. An infection that would have destroyed this much of the vertebral body would certainly have crossed the disc space and invaded the adjacent vertebral endplates. (Courtesy of Joel G. Green, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Salem, Massachusetts.)</div>
</td></tr>
</table></div>
<a name="PG1183"> </a><div class="pagenum"><div>P.1183</div></div>
<br clear="all">
<div class="FG" id="F89-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[11]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="433" src="files/b8c36d4997791cf91a658d6aec60e97b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b8c36d4997791cf91a658d6aec60e97b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="433" DISPLAY="INLINE"></div>
<div class="P">Figure 11-89 <span class="emph_B">PLASMACYTOMA. Clavicle.</span> Observe the expansile soap bubble lytic lesion present in the medial half of the clavicle. This is a typical appearance, but a somewhat unusual location for plasmacytoma. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F90-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/FG[12]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="568" src="files/7b013fdb0b7c7b97eab71b228a1a46d7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7b013fdb0b7c7b97eab71b228a1a46d7.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="568" DISPLAY="INLINE"></div>
<div class="P">Figure 11-90 <span class="emph_B">PLASMACYTOMA: RADIOTHERAPY CHANGES. A. Initial Lesion.</span> Note that a well-demarcated lesion with endosteal scalloping is readily appreciated (<span class="emph_I">arrow</span>). <span class="emph_B">B. Post-radiotherapy.</span> Observe that the lesion has become homogeneously sclerotic, characteristic of postradiation response.</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3497" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Multiple Myeloma</div>
<div class="TLV2" id="B01382540.0-3498" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">First patient documented with the disease was in 1845.</div></li>
<li class="LM"><div class="P">Henry Bence Jones described the proteinuria.</div></li>
<li class="LM"><div class="P">May be called Kahler&#x2019;s disease.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3499" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The most common primary malignant bone tumor.</div></li>
<li class="LM"><div class="P">Represents 10&#x0025; of hematologic malignancies and 27&#x0025; of biopsied bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3500" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">75&#x0025; of patients are between 50 and 70 years of age; 2:1 male preponderance.</div></li>
<li class="LM"><div class="P">Pain is the cardinal initial symptom; the pain is relieved with bedrest and aggravated by weight bearing.</div></li>
<li class="LM"><div class="P">Bacterial infections occur in 10&#x0025; of cases, most of which are respiratory in nature.</div></li>
<li class="LM"><div class="P">The spine, pelvis, skull, ribs, and scapula are the most frequently involved bones (the spine being the most common site).</div></li>
<li class="LM"><div class="P">Pathologic fracture is a common complication.</div></li>
<li class="LM"><div class="P">Laboratory findings reveal a normochromic normocytic anemia, thrombocytopenia, hypercalcemia, hyperglobulinemia with a reversed A:G ratio, hyperuricemia, and 40&#x0025; show Bence Jones&#x2019; proteinuria.</div></li>
<li class="LM"><div class="P">Protein electrophoresis is helpful in diagnosis.</div></li>
<li class="LM"><div class="P">Secondary amyloidosis is found in 15&#x0025; of patients with myeloma.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3501" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Myelogenous round cell proliferation of plasma cells is noted.</div></li>
<li class="LM"><div class="P">Myeloma kidney occurs as a result of permanent tubular damage, leading to renal failure.</div></li>
<li class="LM"><div class="P">The most common site for extramedullary plasmacytoma is the nasopharynx.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3502" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Bone scans are cold.</div></li>
<li class="LM"><div class="P">Gross osteoporosis may be the only early sign.</div></li>
<li class="LM"><div class="P">Punched-out lesions are the radiologic hallmark of myeloma.</div></li>
<li class="LM"><div class="P">Vertebra plana or wrinkled vertebra is characteristic.</div></li>
<li class="LM"><div class="P">Raindrop skull (lytic myeloma defects) and pedicle sign of myeloma (preservation of pedicles) occur.</div></li>
<li class="LM"><div class="P">Rarely, sclerotic lesions occur (1 &#x003C; 3&#x0025;); occasionally, an ivory vertebra.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3503" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Solitary Plasmacytoma</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Localized form of plasma cell proliferation.</div></li>
<li class="LM"><div class="P">The most common bones affected are mandible, ilium, vertebrae, ribs, proximal femur, and scapula.</div></li>
<li class="LM"><div class="P">70&#x0025; of solitary plasmacytoma lesions develop into diffuse multiple myeloma.</div></li>
<li class="LM"><div class="P">The typical lesion has a geographic, soap bubbled, highly expansile radiographic appearance.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3504" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[2]/TLV3[1]/SIDEBAR[1]/TLV1[1]/TLV2[7]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">90&#x0025; die within 3 years.</div></li>
<li class="LM"><div class="P">Treatment is usually radiotherapy, chemotherapy, and, on occasion, local excision.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<a name="PG1184"> </a><div class="pagenum"><div>P.1184</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3505" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]">
<div class="HD">CENTRAL OSTEOSARCOMA</div>
<div class="TLV3" id="B01382540.0-3506" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Osteosarcoma (osteogenic sarcoma) is a primary malignant tumor of bone; it is derived from undifferentiated connective tissue and forms neoplastic osteoid. Osteosarcoma can be divided into five distinct clinical types: central osteosarcoma, multicentric osteosarcoma, parosteal osteosarcoma (juxtacortical osteosarcoma), secondary osteosarcoma, and extraosseous osteosarcoma. (<a class="LK" href="sid806035.html#R108-11">1</a>) The following discussion concerns central osteosarcoma.</div>
</div>
<div class="TLV3" id="B01382540.0-3507" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Central osteosarcoma is the second most common primary malignant bone tumor (multiple myeloma is the most common). Osteosarcoma is approximately twice as common as chondrosarcoma and three times more frequent than Ewing&#x2019;s sarcoma. (<a class="LK" href="sid806035.html#R109-11">2</a>) It is calculated that approximately 1500 cases of osteosarcoma exist at any one time in the United States. (<a class="LK" href="sid806035.html#R109-11">2</a>) Osteosarcoma represents 20&#x0025; of all primary malignant bone tumors. (<a class="LK" href="sid806035.html#R110-11">3</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3508" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3509" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Osteosarcoma is encountered most commonly in the age group from 10 to 25 years (75&#x0025; of cases); few cases occur before age 5 or after age 30. (<a class="LK" href="sid806035.html#R111-11">4</a>,<a class="LK" href="sid806035.html#R112-11">5</a>) The median age for males and females is 18 and 17 years, respectively. (<a class="LK" href="sid806035.html#R109-11">2</a>) The Mayo Clinic has reported the occurrence of an osteosarcoma in a 35-month-old girl. (<a class="LK" href="sid806035.html#R113-11">6</a>) The diagnosis of primary osteogenic sarcoma in older patients should be accepted only after careful examination excludes association with other pre-existent bone disease (Paget&#x2019;s disease, fibrous dysplasia, irradiated bone, osteochondroma). (<a class="LK" href="sid806035.html#R109-11">2</a>)</div>
<div class="P">There is a 2:1 male predominance, which does not vary in any decade of life. The average age of onset is slightly earlier in the female. It is interesting to note that patients affected by osteosarcoma have been found to be taller than their peers in the corresponding age group. (<a class="LK" href="sid806035.html#R114-11">7</a>,<a class="LK" href="sid806035.html#R115-11">8</a>) No rational explanation for this has been offered. (<a class="LK" href="sid806035.html#R114-11">7</a>,<a class="LK" href="sid806035.html#R115-11">8</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3510" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Painful swelling at the site of the lesion is the presenting complaint in approximately 85&#x0025; of patients. (<a class="LK" href="sid806035.html#R116-11">9</a>) As in most primary malignant bone tumors, a history of antecedent trauma is frequently obtained; its true relationship to the development of osteosarcoma is questionable. The cause of osteosarcoma is unknown, but it has been stated that trauma reveals more malignant growths than it produces, which is known as <span class="emph_I">traumatic determinism.</span> (<a class="LK" href="sid806035.html#R117-11">10</a>) Systemic manifestations, such as loss of weight, fever, cachexia, are unusual features. The pain initially is insidious and transitory; however, it eventually becomes severe and persistent. The interval between the onset of symptoms and recognition of the tumor may be 6 months or longer. Minor restriction of joint mobility may occur, creating a limp if a weight-bearing bone is involved. Rarely, the acute onset of deep venous thrombosis in children with osteosarcoma can occur. (<a class="LK" href="sid806035.html#R118-11">11</a>,<a class="LK" href="sid806035.html#R119-11">12</a>) The mechanism for the development of such is external compression or tumor thrombus from a grossly palpable tumor.</div>
</div>
<div class="TLV4" id="B01382540.0-3511" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">The long bones of the extremities are the target sites for osteosarcoma. (<a class="LK" href="sid806035.html#R109-11">2</a>,<a class="LK" href="sid806035.html#R111-11">4</a>) (<a class="LK" href="sid806035.html#F91-11">Fig. 11-91</a>) The knee and shoulder are the most commonly affected joints. Huvos (<a class="LK" href="sid806035.html#R109-11">2</a>) stated that 41.5&#x0025; affect the femur (most of which are in the distal portion), 16&#x0025; affect the tibia and fibula (most in the proximal portion), and 15&#x0025; affect the humerus (usually proximal); therefore, 58&#x0025; of all osteosarcomas occur around the knee. The metaphysis abutting the physis is the classic location in 75&#x0025; of cases; however, diaphyseal, as well as epiphyseal, lesions have been reported (25&#x0025;). (<a class="LK" href="sid806035.html#R120-11">13</a>)</div>
<div class="P">Other bones that may be involved are the calvaria, sacrum, pelvis, mandible, maxilla, scapula, clavicle, ribs, hand, calcaneus, and spine. (<a class="LK" href="sid806035.html#R121-11">14</a>,<a class="LK" href="sid806035.html#R122-11">15</a>,<a class="LK" href="sid806035.html#R123-11">16</a>) (<a class="LK" href="sid806035.html#F92-11">Figs. 11-92</a>, <a class="LK" href="sid806035.html#F93-11">11-93</a>, <a class="LK" href="sid806035.html#F94-11">11-94</a>, <a class="LK" href="sid806035.html#F95-11">11-95</a> and <a class="LK" href="sid806035.html#F96-11">11-96</a>) Primary osteosarcoma of the spine is rare, making up &#x003C; 2&#x0025; of all osteosarcomas. (<a class="LK" href="sid806035.html#R124-11">17</a>) The distribution is fairly equal between the lumbar and the thoracic segments, but cervical involvement is less common. (<a class="LK" href="sid806035.html#R124-11">17</a>) The vertebral body is most commonly affected, which often leads to pathologic compression fracture. Osteosarcoma also occurs in vertebrae affected by Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R125-11">18</a>,<a class="LK" href="sid806035.html#R126-11">19</a>)
<a name="PG1185"> </a><div class="pagenum"><div>P.1185</div></div>
<br clear="all">
Although the incidence of spinal involvement in Paget&#x2019;s disease is high (44&#x0025;), a major study found that only 3.5&#x0025; of secondary osteosarcomas arising in pagetoid bone were located in the spine. (<a class="LK" href="sid806035.html#R127-11">20</a>)</div>
<div class="FG" id="F91-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="295" height="700" src="files/e34e1102b2361c78f2f453395c513157.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e34e1102b2361c78f2f453395c513157.gif" MIMETYPE="image/gif" WIDTH="295" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-91 <span class="emph_B">SKELETAL DISTRIBUTION OF OSTEOSARCOMA.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F92-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="430" src="files/639ee9e77186542ceedb944b267c0bbf.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="639ee9e77186542ceedb944b267c0bbf.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="430" DISPLAY="INLINE"></div>
<div class="P">Figure 11-92 <span class="emph_B">OSTEOSARCOMA. AP Sacrum.</span> Note that this 15-year-old female demonstrates an ivory osteosarcoma of the sacrum. <span class="emph_I">COMMENT:</span> Osteosarcoma of the spine is rare; however, when present, it is most commonly found within the sacrum. (Courtesy of Terry D. Sandman, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Chicago, Illinois.)</div>
</td></tr>
</table></div>
<div class="FG" id="F93-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[3]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="430" src="files/d4a789a8b7fe8d678ade783c29aa05b1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d4a789a8b7fe8d678ade783c29aa05b1.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="430" DISPLAY="INLINE"></div>
<div class="P">Figure 11-93 <span class="emph_B">OSTEOSARCOMA. Ilium.</span> Observe the grossly destructive lytic lesion on the posterior surface of the ilium, adjacent to the sacroiliac joint. This represents a lytic presentation of osteosarcoma in a 37-year-old female. (Courtesy of Friedrich H. W. Heuck, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Stuttgart, Germany.)</div>
</td></tr>
</table></div>
<div class="FG" id="F94-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[3]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="449" src="files/0b8d6f415a8ac6bbb9882e199d621de0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="0b8d6f415a8ac6bbb9882e199d621de0.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="449" DISPLAY="INLINE"></div>
<div class="P">Figure 11-94 <span class="emph_B">OSTEOSARCOMA. Rib.</span> Observe the radiopaque osteosarcoma affecting the anterior surface of the rib. This is a rare location for osteosarcoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F95-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[3]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="491" height="700" src="files/fdc3177c2f6408e5e08fb3d4b70d7361.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fdc3177c2f6408e5e08fb3d4b70d7361.gif" MIMETYPE="image/gif" WIDTH="491" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-95 <span class="emph_B">OSTEOSARCOMA. Hand.</span> Note the large ivory osteosarcoma present in the distal phalanx of the index finger. There is a large soft tissue mass associated with this lesion. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F96-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[3]/TLV4[3]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="471" src="files/723cfce5023da893ef933e9e375d4249.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="723cfce5023da893ef933e9e375d4249.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="471" DISPLAY="INLINE"></div>
<div class="P">Figure 11-96 <span class="emph_B">OSTEOSARCOMA. Calcaneus.</span> Observe the dense, radiopaque osteosarcoma of the posterior portion of the calcaneus. The large soft tissue mass associated with this osteosarcoma shows bone production within its matrix.</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3512" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[4]">
<div class="HD">Laboratory Findings</div>
<div class="P">The only pertinent and consistent laboratory finding is elevation of the alkaline phosphatase enzyme. These levels are highest with the sclerotic type of presentation and return to normal with tumor removal or treatment.</div>
</div>
<a name="PG1186"> </a><div class="pagenum"><div>P.1186</div></div>
<br clear="all">
<div class="TLV3" id="B01382540.0-3513" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[5]">
<div class="HD">Pathologic Features</div>
<div class="P">The cause of osteosarcoma is still widely unknown; however, several propagating factors leading to its development have been suggested in the recent literature. Included in this list are agents such as beryllium, viruses, radiation exposure, Paget&#x2019;s disease, electrical burns, and trauma. (<a class="LK" href="sid806035.html#R128-11">21</a>) The gross and microscopic pictures of osteosarcoma depend entirely on the predominant type of tumor tissue. Grossly, with little ossification, the tumor tends to be firm, but not hard, to the touch, consonant with the presence of sarcomatous stromal tissue. Yellowish dots and streaks reflect islands of new bone. When the tumor is heavily ossified, it is generally hard and densely compact. The adjacent cortex is often penetrated grossly by the tumor, with significant extension into the soft tissues. Considerable irregular periosteal reaction is the rule, with elevation of the periosteum by tumor tissue often apparent.</div>
<div class="P">The histologic appearance shows spindle-shaped stromal cells, but in highly anaplastic lesions, spheroid cells with multiple hyperchromatic nuclei are present. Intercellular collagenous material is frequently observed, with the sarcomatous stromal cells enmeshed in this material. The normal osseous tissue is destroyed by the sarcomatous stromal cells or by the other tumor tissue present in the lesion, with resorption and ultimate destruction of bone trabeculae.</div>
<div class="P">Osteosarcoma tends to grow in three basic patterns. Approximately half the tumors form a great deal of osseous neoplastic tissue, presenting as a sclerotic lesion (50&#x0025;); the remainder are composed of sarcomatous connective tissue stroma creating a
<a name="PG1187"> </a><div class="pagenum"><div>P.1187</div></div>
<br clear="all">
lytic presentation (25&#x0025;) or, if moderate osteoid matrix is present, a mixed pattern results (25&#x0025;). (<a class="LK" href="sid806035.html#F97-11">Fig. 11-97</a>)</div>
<div class="FG" id="F97-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="689" src="files/c7bd55476f9089a9d19042e847467a20.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c7bd55476f9089a9d19042e847467a20.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="689" DISPLAY="INLINE"></div>
<div class="P">Figure 11-97 <span class="emph_B">OSTEOSARCOMA: TIBIA. A. AP Knee. B. Lateral Knee.</span> Observe the diffuse ivory osteosarcoma in the proximal tibia. <span class="emph_I">COMMENT:</span> Approximately 50&#x0025; of the osteosarcomas present as a sclerotic lesion, rendering an ivory or sclerotic appearance.</div>
</td></tr>
</table></div>
<div class="FG" id="F98-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="310" src="files/aba7448b565a411a6f254189c12eed8f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="aba7448b565a411a6f254189c12eed8f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="310" DISPLAY="INLINE"></div>
<div class="P">Figure 11-98 <span class="emph_B">HYPERTROPHIC OSTEOARTHROPATHY DEVELOPING FROM OSTEOSARCOMA OF THE TIBIA. A. Lateral Knee.</span> Note the destruction of the posterior surface of the tibia, with a soft tissue mass (<span class="emph_I">arrows</span>). This lesion represents osteosarcoma of the tibia. <span class="emph_B">B. Chest.</span> Observe multiple cannonball metastases in the right and left lungs (<span class="emph_I">arrows</span>). Massive pleural effusion is noted on the left side (<span class="emph_I">arrowheads</span>). <span class="emph_B">C. Foot.</span> Observe the solid periosteal new bone formation (<span class="emph_I">arrows</span>) in the diaphyseal area of all five metatarsal bones. <span class="emph_I">COMMENT:</span> This patient demonstrates an interesting aspect of the pathologic manifestations of osteosarcoma of bone. Metastatic lesions in the lung created hypertrophic osteoarthropathy in the foot. This is somewhat unusual in osteosarcoma because most patients die before osteoarthropathy can develop.</div>
</td></tr>
</table></div>
<div class="FG" id="F99-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="736" height="653" src="files/a6fa8f2bd18a9c26f10b9b77d89cafff.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a6fa8f2bd18a9c26f10b9b77d89cafff.gif" MIMETYPE="image/gif" WIDTH="736" HEIGHT="653" DISPLAY="INLINE"></div>
<div class="P">Figure 11-99 <span class="emph_B">CANNONBALL METASTASES. Lung.</span> Note the multiple radiopacities scattered throughout both lungs, representing cannonball metastases from osteosarcoma of the distal femur. These radiopacities actually represent sarcomatous growth of bone within the lung parenchyma.</div>
</td></tr>
</table></div>
<div class="TLV4" id="B01382540.0-3514" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[5]/TLV4[1]">
<div class="HD">Metastases</div>
<div class="P">Metastases to the lungs by the hematogenous route are common and can lead to the development of hypertrophic osteoarthropathy. (<a class="LK" href="sid806035.html#F98-11">Fig. 11-98</a>) Multiple lesions are the usual presentation, and these actually represent sarcomatous bone growths within the lungs (<span class="emph_I">cannonball metastases</span>). (<a class="LK" href="sid806035.html#F99-11">Fig. 11-99</a>) Spontaneous pneumothorax is relatively common because subpleural nodules that have undergone excavation lead to rupture into the pleural space. Lung resection has often proved beneficial in these patients. (<a class="LK" href="sid806035.html#R129-11">22</a>) Skeletal metastases (<span class="emph_I">skip lesions</span>) are also found but do not occur with the same frequency as in Ewing&#x2019;s sarcoma and are poor prognostic signs. (<a class="LK" href="sid806035.html#R130-11">23</a>) At autopsy, the most frequent metastatic sites are the lungs (95&#x0025;), bones (50&#x0025;), and kidneys (12&#x0025;). (<a class="LK" href="sid806035.html#R131-11">24</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3515" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]">
<div class="HD">Radiologic Features</div>
<div class="P">Because of the relative frequency of osteosarcoma, the radiographic features are well established. (<a class="LK" href="sid806035.html#R132-11">25</a>) Osteosarcomas usually arise in the metaphyses (75&#x0025;) of long bones, most frequently at the distal end of the femur, the proximal end of the tibia, and the proximal end of the humerus. Rarely, they may affect the diaphysis or epiphysis (25&#x0025;) and may involve any bone, including the patella. (<a class="LK" href="sid806035.html#R133-11">26</a>,<a class="LK" href="sid806035.html#R134-11">27</a>) The epiphyseal plate functions as a barrier to tumor migration in some cases. (<a class="LK" href="sid806035.html#R134-11">27</a>) (<a class="LK" href="sid806035.html#F100-11">Fig. 11-100</a>)</div>
<div class="P">The classic presentation is that of a focal lesion in the metaphysis, creating either a mottled, permeative lesion with a poorly defined zone of transition or a dense ivory or sclerotic region filling the medullary space. (<a class="LK" href="sid806035.html#F101-11">Fig. 11-101</a>) Cortical disruption is common. Periosteal new bone formation occurs and is highly irregular. This periosteal reaction often takes place within an extracortical, dense soft tissue mass that displays transverse spicules or radiating striations. (<a class="LK" href="sid806035.html#F102-11">Figs. 11-102</a>, <a class="LK" href="sid806035.html#F103-11">11-103</a> and <a class="LK" href="sid806035.html#F104-11">11-104</a>) This characteristic pattern of periosteal response has been referred to as sunburst, or <span class="emph_I">sunray,</span> and is the appearance for which osteosarcoma is best known. (<a class="LK" href="sid806035.html#R135-11">28</a>)</div>
<div class="FG" id="F100-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="488" height="700" src="files/daa999ce0a2bb788c452a4dcac68b0a8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="daa999ce0a2bb788c452a4dcac68b0a8.gif" MIMETYPE="image/gif" WIDTH="488" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-100 <span class="emph_B">OSTEOSARCOMA. Proximal Femur.</span> Note the numerous radiopacities scattered throughout the metaphysis of the proximal femur. This neoplastic process has extended to the femoral capital epiphysis. This is a characteristic appearance for the sclerotic presentation of osteosarcoma. <span class="emph_I">COMMENT:</span> It is rare for osteosarcoma to cross the epiphyseal plate, which usually functions as an effective barrier to tumor extension. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F101-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="590" src="files/48f5bbe7682498e580e08330bc730d61.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="48f5bbe7682498e580e08330bc730d61.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="590" DISPLAY="INLINE"></div>
<div class="P">Figure 11-101 <span class="emph_B">THE RADIOGRAPHIC APPEARANCE OF LYTIC VERSUS SCLEROTIC OSTEOSARCOMA. A. Lytic Presentation: Proximal Humerus.</span> Note the focal lesion in the metaphysis of the proximal humerus, demonstrating mottled, permeative destruction. This appearance is characteristic of a lytic presentation in osteosarcoma. <span class="emph_B">B. Sclerotic Presentation: Proximal Humerus.</span> Note the dense radiopaque appearance to the humeral head and its metaphysis. A large soft tissue mass and spiculated periosteal response are associated with this sclerotic or ivory type of osteosarcoma. <span class="emph_I">COMMENT:</span> Approximately 50&#x0025; of osteosarcomas present as sclerotic lesions; the remainder are lytic in presentation. Of the lytic cases, 25&#x0025; have a mixed pattern if moderate osteoid matrix is present.</div>
</td></tr>
</table></div>
<a name="PG1188"> </a><div class="pagenum"><div>P.1188</div></div>
<br clear="all">
<div class="FG" id="F102-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="407" height="700" src="files/394ab47e678df0ee15b4d78481f93816.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="394ab47e678df0ee15b4d78481f93816.gif" MIMETYPE="image/gif" WIDTH="407" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-102 <span class="emph_B">OSTEOSARCOMA. Proximal Humerus.</span> Note the ill-defined, destructive lesion assuming the mixed pattern of presentation in the metaphysis and proximal diaphysis of the humerus. Malignant spiculated periosteal response is observed on both sides of the humeral cortex, with extension of the osteosarcoma into the soft tissue structures.</div>
</td></tr>
</table></div>
<div class="P">(<a class="LK" href="sid806035.html#F105-11">Fig. 11-105</a>) Occasionally, the periosteum is found to be elevated by tumor tissue on the upper and lower margins of the lesion, creating Codman&#x2019;s reactive triangles. (<a class="LK" href="sid806035.html#F106-11">Fig. 11-106</a>) This is a reactive response to the lifting of the periosteum and is not pathognomonic for osteosarcoma because it may also be found in benign conditions such as traumatic periostitis, osteomyelitis, eosinophilic granuloma, and thyroid acropachy.</div>
<div class="FG" id="F103-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="608" src="files/a17fcd1c505d07c7f7fafc4138aca4de.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a17fcd1c505d07c7f7fafc4138aca4de.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="608" DISPLAY="INLINE"></div>
<div class="P">Figure 11-103 <span class="emph_B">SCLEROTIC OSTEOSARCOMA: MALIGNANT PERIOSTEAL RESPONSE IN THE DISTAL FEMUR A. AP Knee. B. Lateral Knee.</span> Observe the increase in bone density in the metaphysis and distal diaphysis of the femur. There is a sunburst or malignant spiculated periosteal response present surrounding the entire distal metaphysis of the femur. This is a classic radiographic presentation for osteosarcoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F104-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="425" src="files/6e42c597233c008ef08896af344b2c74.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6e42c597233c008ef08896af344b2c74.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="425" DISPLAY="INLINE"></div>
<div class="P">Figure 11-104 <span class="emph_B">OSTEOSARCOMA OF THE MANDIBLE IN A HORSE.</span> Observe the spiculated periosteal new bone formation with sclerotic destruction of the mandible in this thoroughbred horse. The length of the lesion (&#x003E; 6 cm) suggests a primary neoplasm. The reactive skeletal changes in animals is no different than in <span class="emph_I">Homo sapiens.</span>
</div>
</td></tr>
</table></div>
<div class="P">As the lesions continue to grow, bone expansion may occur. Occasionally, pathologic fracture may follow some form of trivial trauma. Radiographically, 50&#x0025; of these lesions are radiopaque or sclerotic and may develop a roughened lobulated margin, referred to as the <span class="emph_I">cumulus cloud</span> appearance. (<a class="LK" href="sid806035.html#R109-11">2</a>) (<a class="LK" href="sid806035.html#F107-11">Fig. 11-107</a>) The remaining 50&#x0025; are split between a purely osteolytic lesion (25&#x0025;) and a mixed lesion (25&#x0025;). Soft tissue mass
<a name="PG1189"> </a><div class="pagenum"><div>P.1189</div></div>
<br clear="all">
formation is common in osteosarcoma and may grow to large dimensions. Ossification within this tumor mass is a frequent occurrence.</div>
<div class="FG" id="F105-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="337" src="files/c0aa237e30793478ebcd17f6a906194c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c0aa237e30793478ebcd17f6a906194c.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="337" DISPLAY="INLINE"></div>
<div class="P">Figure 11-105 <span class="emph_B">PERIOSTEAL RESPONSE IN OSTEOSARCOMA. A. Fibula.</span> Observe the spiculated periosteal response on the lateral surface of the proximal fibula (<span class="emph_I">arrows</span>). <span class="emph_B">B. AP Distal Femur. C. Lateral Distal Femur.</span> Observe the classic sunburst or spiculated periosteal response seen in the distal metadiaphyseal area of the femur (<span class="emph_I">arrows</span>). This sunburst appearance, the soft tissue mass, and the destructive lesion of the medullary portion of the femur are the cardinal radiographic features of osteosarcoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F106-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="599" src="files/0c34f55e83373cc57c6794a36751cf95.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="0c34f55e83373cc57c6794a36751cf95.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="599" DISPLAY="INLINE"></div>
<div class="P">Figure 11-106 <span class="emph_B">CODMAN&#x2019;S REACTIVE TRIANGLE AND OSTEOSARCOMA OF THE PROXIMAL TIBIA. A. AP Tibia. B. Lateral Tibia.</span> Note the mixed pattern of osteosarcoma in the proximal metaphysis of the tibia. There are large Codman&#x2019;s reactive triangles present surrounding the cortex of the proximal tibia (<span class="emph_I">arrows</span>). <span class="emph_BIT">COMMENT:</span> Codman&#x2019;s reactive triangle is frequently found in osteosarcoma of bone; however, it is not pathognomonic of osteosarcoma and can be found in infectious lesions, traumatic periostitis, and peculiar callus formations.</div>
</td></tr>
</table></div>
<div class="FG" id="F107-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[6]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="519" src="files/fc3347fb3218e45bc5df0407c127fcf2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fc3347fb3218e45bc5df0407c127fcf2.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="519" DISPLAY="INLINE"></div>
<div class="P">Figure 11-107 <span class="emph_B">THE CUMULUS CLOUD APPEARANCE OF OSTEOSARCOMA. Pelvis.</span> Observe the diffuse, sclerotic osteosarcoma affecting the ilium near the acetabulum. With closer inspection, note the lobulated margins of the medial surface of this osteosarcoma (<span class="emph_I">arrows</span>). This lobulated margin of osteosarcoma has been called the cumulus cloud appearance. (Courtesy of Friedrich H. W. Heuck, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Stuttgart, West Germany.)</div>
</td></tr>
</table></div>
<a name="PG1190"> </a><div class="pagenum"><div>P.1190</div></div>
<br clear="all">
<div class="P">CT and MRI allow demonstration of marrow infiltration, soft tissue mass, and response to therapy, though they have not been able to offer a reliable prognosis. (<a class="LK" href="sid806035.html#R136-11">29</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3516" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Amputation offers the best possibility of control when the lesion is accessible and metastasis has not occurred. Radiotherapy may be given for local control and pain. (<a class="LK" href="sid806035.html#F108-11">Fig. 11-108</a>) Prognosis is poor because of the tendency for early metastasis, which occurs in up to 62&#x0025; of patients. (<a class="LK" href="sid806035.html#R137-11">30</a>) Pulmonary metastases are often present before the primary lesion is discovered. Recognition of distant pulmonary metastases is important in the treatment and prognosis of osteosarcoma; the average time between recognition of pulmonary disease and death is 6 months. (<a class="LK" href="sid806035.html#R138-11">31</a>) When a solitary pulmonary metastasis is present, its removal is justifiable because of sporadic case reports of 5-year survival afterward. Generally, the sclerotic variety runs a slower, less aggressive clinical course, whereas the lytic presentation behaves in a rapidly fatal manner. (<a class="LK" href="sid806035.html#R139-11">32</a>) The best 5-year survival rate has been 20&#x0025;; however, one study using intensive chemotherapy offered an 80&#x0025; 5-year survival rate. (<a class="LK" href="sid806035.html#R140-11">33</a>,<a class="LK" href="sid806035.html#R141-11">34</a>) Age at diagnosis (&#x003E; 19), metastasis, large tumor size, and pathologic fracture are all documented factors that decrease the prognostic outcome. (<a class="LK" href="sid806035.html#R137-11">30</a>) On the other hand, tumors of the jaw and those affecting the surface of the bone are more often associated with a good prognosis. (<a class="LK" href="sid806035.html#R142-11">35</a>) Additional studies in this area of treatment are necessary for the future generations of patients who will require treatment.</div>
<div class="FG" id="F108-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="458" src="files/f52c401c668a4fd46600c5f267dc9d5d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f52c401c668a4fd46600c5f267dc9d5d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="458" DISPLAY="INLINE"></div>
<div class="P">Figure 11-108 <span class="emph_B">OSTEOSARCOMA: POSTRADIATION CHANGES. AP Shoulder.</span> Observe the osteolytic bone destruction in the proximal diaphysis of the humerus. The dense sclerotic metaphyseal region (<span class="emph_I">arrow</span>) represents tumor that has responded to the radiotherapy as evidenced by the dense sclerosis. An early crescent sign (<span class="emph_I">arrowheads</span>) in the subarticular zone of the humeral head signifies complicating early avascular necrosis secondary to radiation.</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3517" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Central Osteosarcoma</div>
<div class="TLV2" id="B01382540.0-3518" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A primary malignant tumor of undifferentiated connective tissue, which forms neoplastic osteoid.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3519" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The second most common primary malignant bone tumor, representing 20&#x0025; of all primary malignant bone tumors.</div></li>
<li class="LM"><div class="P">It is twice as common as chondrosarcoma, three times more frequent than Ewing&#x2019;s sarcoma.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3520" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">75&#x0025; of cases occur in the 10- to 25-year age range, with a 2:1 male predominance.</div></li>
<li class="LM"><div class="P">Painful swelling of the involved limb is a common presenting symptom.</div></li>
<li class="LM"><div class="P">The metaphyses of the distal femur, proximal tibia, and proximal humerus are the most common sites.</div></li>
<li class="LM"><div class="P">Only 3.5-7&#x0025; of cases occur within the spine.</div></li>
<li class="LM"><div class="P">Elevation of serum alkaline phosphatase is the only consistent laboratory finding.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3521" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Three basic patterns exist: 50&#x0025; of cases are sclerotic, 25&#x0025; are purely lytic, and 25&#x0025; are mixed lesions.</div></li>
<li class="LM"><div class="P">Metastases to the lungs by the hematogenous route are common; the multiple lesions are called cannonball metastases. Spontaneous pneumothorax is a common initial clinical presentation.</div></li>
<li class="LM"><div class="P">Skeletal metastases occur, but not as frequently as in Ewing&#x2019;s sarcoma.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3522" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The classic lesion presents as a permeative or ivory medullary lesion in the metaphysis of a long tubular bone.</div></li>
<li class="LM"><div class="P">A sunburst or sunray periosteal response is characteristic.</div></li>
<li class="LM"><div class="P">Often, Codman&#x2019;s reactive triangle is found associated with the destructive lesion.</div></li>
<li class="LM"><div class="P">Cortical disruption with soft tissue mass formation, often growing to large dimensions, occurs. The peripheral edge of an eccentric lobulated mass whose margins are roughened and irregular may be referred to as the cumulus cloud appearance.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3523" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[3]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A 20&#x0025; 5-year survival rate has been traditional; studies using intensive chemotherapy report an 80&#x0025; survival rate.</div></li>
<li class="LM"><div class="P">Amputation has offered the best treatment when the lesion is surgically accessible.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3524" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[4]">
<div class="HD">MULTICENTRIC OSTEOSARCOMA</div>
<div class="TLV3" id="B01382540.0-3525" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[4]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Multicentric osteosarcoma (sclerosing osteogenic sarcomatosis, osteosarcomatosis, childhood multifocal osteosarcoma) is a rare form of osteosarcoma in which multiple independent lesions occur
<a name="PG1191"> </a><div class="pagenum"><div>P.1191</div></div>
<br clear="all">
simultaneously. It is not clear whether these multiple lesions represent metastatic foci or simultaneous osteosarcomas, though classically it remains a distinct and separate entity. (<a class="LK" href="sid806035.html#R143-11">1</a>,<a class="LK" href="sid806035.html#R144-11">2</a>)</div>
<div class="FG" id="F109-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[4]/TLV3[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="782" src="files/a450cc802166bae2c91bf58c465383b3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a450cc802166bae2c91bf58c465383b3.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="782" DISPLAY="INLINE"></div>
<div class="P">Figure 11-109 <span class="emph_B">MULTICENTRIC OSTEOSARCOMA. A. AP Knee.</span> Observe the radiopacities scattered throughout the entire distal metaphysis of the femur, its distal epiphysis, and the proximal epiphyses of the tibia and fibula. <span class="emph_B">B. Lateral Cervical Spine.</span> Note the sclerotic density of the vertebral body and neural arch of C2 (<span class="emph_I">arrow</span>) and the expansion and sclerotic density of the posterior arch and tubercle of C1 (<span class="emph_I">arrowhead</span>). <span class="emph_B">C. T10 Vertebral Body.</span> Note the malignant ivory vertebra at the T10 vertebral body. <span class="emph_B">D. Right Shoulder. E. Left Shoulder.</span> Observe the bilateral lesions of multicentric osteosarcoma in both humeral heads and the glenoid fossae and coracoid process of both scapulae. <span class="emph_B">F. Distal Radius and Ulna.</span> Observe the sclerotic lesions of multicentric osteosarcoma in the metaphyses of the distal radius and ulna, with associated periosteal response. <span class="emph_BIT">COMMENT:</span> Multicentric osteosarcoma (osteosarcomatosis) is a rare form of osteosarcoma, in which multiple independent lesions occur simultaneously. These multiple lesions clearly do not represent metastatic foci; therefore, multicentric osteosarcoma is a distinct and separate entity. (Courtesy of Steven P. Brownstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Springfield, New Jersey, and William E. Litterer, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Elizabeth, New Jersey.)</div>
</td></tr>
</table></div>
</div>
<a name="PG1192"> </a><div class="pagenum"><div>P.1192</div></div>
<br clear="all">
<div class="TLV3" id="B01382540.0-3526" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[4]/TLV3[2]">
<div class="HD">Clinical Features</div>
<div class="P">There are approximately 20 known cases of multicentric osteosarcoma that have been reported. (<a class="LK" href="sid806035.html#R145-11">3</a>,<a class="LK" href="sid806035.html#R146-11">4</a>) Most patients were between the ages of 5 and 10 years. The clinical course of the disease is rapid and fatal. Pulmonary metastases occur early. Pain starts as an ache and then becomes more severe and multifocal. The alkaline phosphatase enzyme is elevated because the multifocal lesions are invariably blastic in nature. (<a class="LK" href="sid806035.html#R147-11">5</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3527" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[4]/TLV3[3]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiologic appearance is quite dramatic and easy to recognize. These lesions occur in the metaphyses of the long tubular bones; no specific bones are most common sites. Spinal involvement may occur, presenting as an irregular, nodular, radiopaque mass or creating an ivory vertebra. (<a class="LK" href="sid806035.html#F109-11">Fig. 11-109, <span class="emph_I">A-C</span></a>) Occasionally, flat bones, such as the pelvis, sternum, skull, and ribs, may be involved. The clearly radiopaque lesions are often bilateral and symmetric in distribution. (<a class="LK" href="sid806035.html#R148-11">6</a>) (<a class="LK" href="sid806035.html#F109-11">Fig. 11-109, <span class="emph_I">D-F</span></a>) In the early stages these lesions may resemble benign bone islands; however, as the disease progresses they fill the entire medullary canal at the metaphysis. (<a class="LK" href="sid806035.html#F109-11">Fig. 11-109<span class="emph_I">A</span></a>) Rarely, these tumors involve the epiphyses.</div>
<div class="P">The differential diagnosis may include heavy-metal poisoning (lead); however, the metaphyseal increase in density is oval or round in multifocal osteosarcoma and transverse, bandlike in metal poisoning. Other congenital disorders&#x2014;such as Engelmann&#x2019;s disease (diaphyseal sclerosis), melorheostosis (flowing hyperostosis), osteopetrosis, or osteopoikilosis (multiple metaphyseal lesions)&#x2014;can produce an increase in density; however, none assumes the classic round or large oval appearance of multifocal osteosarcoma.</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3528" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]">
<div class="HD">PAROSTEAL SARCOMA</div>
<div class="TLV3" id="B01382540.0-3529" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Parosteal sarcoma (juxtacortical osteosarcoma, parosteal osteosarcoma, surface osteosarcoma) is a tumor situated on the surface of a bone and is biologically different from its intramedullary counterpart. (<a class="LK" href="sid806035.html#R149-11">1</a>) This tumor is designated as a well-differentiated osteosarcoma that arises in a juxtacortical location within the periosteum. It is a relatively uncommon lesion representing 3-4&#x0025; of all osteosarcomas and about 1&#x0025; of all primary malignant bone tumors. (<a class="LK" href="sid806035.html#R150-11">2</a>) This tumor grows slowly in contrast to central osteosarcoma. The presenting symptoms are swelling or mass formation, with a dull, aching pain. Occasionally, the mass may interfere with joint function. Most patients have had symptoms for at least 1 year at the time of detection.</div>
</div>
<div class="TLV3" id="B01382540.0-3530" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">The typical age range is from 30 to 50 years; cases have been reported in the Mayo Clinic series with a range from 12 to 58 years. (<a class="LK" href="sid806035.html#R151-11">3</a>) There is no predilection for either sex, and no significant laboratory abnormalities are noted.</div>
</div>
<div class="TLV3" id="B01382540.0-3531" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]/TLV3[3]">
<div class="HD">Location</div>
<div class="P">The majority of cases involve the posterior surface of the distal femoral metaphysis (50&#x0025; of cases). (<a class="LK" href="sid806035.html#R150-11">2</a>) Other common sites are the proximal tibia and humerus (25&#x0025; of cases). Unusual sites are the ulna, radius, clavicle, metacarpal bones, phalanges, and mandible. (<a class="LK" href="sid806035.html#R152-11">4</a>,<a class="LK" href="sid806035.html#R153-11">5</a>,<a class="LK" href="sid806035.html#R154-11">6</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3532" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Most of these tumors are quite large, varying in size from 3 to 25 cm, with an average size of 10 cm. (<a class="LK" href="sid806035.html#R150-11">2</a>) Pathologically, the tumor presents as a lobulated, sessile, bony, hard mass, having an intimate, broad-based attachment to the underlying bone. Occasionally, a periosteal fibrous tissue layer separates the tumor mass from the cortical surface, creating a cleavage plane. (<a class="LK" href="sid806035.html#R155-11">7</a>) (<a class="LK" href="sid806035.html#F110-11">Fig. 11-110</a>) It is important pathologically to determine whether or not the tumor has involved the medullary canal, because this finding affects the overall prognosis negatively. The radiologist plays a key role here because biopsies are often not deep enough to tell.</div>
</div>
<div class="TLV3" id="B01382540.0-3533" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">Radiographically, this lesion is a dense (radiopaque) homogenous juxtacortical mass. The classic lesion affects the popliteal surface of the distal femur. (<a class="LK" href="sid806035.html#R156-11">8</a>) (<a class="LK" href="sid806035.html#F111-11">Figs. 11-111</a> and <a class="LK" href="sid806035.html#F112-11">11-112</a>) A peculiar radiolucent cleft separates the majority of the ossified mass from the cortex of the femur. (<a class="LK" href="sid806035.html#R156-11">8</a>) This cleft (1 to 3 mm in width) stops abruptly at the stalk of the tumor and has been referred to as the <span class="emph_I">cleavage plane</span> (<a class="LK" href="sid806035.html#R155-11">7</a>) or <span class="emph_I">string sign</span> (<a class="LK" href="sid806035.html#R150-11">2</a>) of parosteal sarcoma. (<a class="LK" href="sid806035.html#F110-11">Fig. 11-110<span class="emph_I">A</span></a>) This sign is present in only 30&#x0025; of cases. (<a class="LK" href="sid806035.html#R150-11">2</a>) The periphery of the tumor is usually lobular in outline, and no periosteal (spiculated or laminated) new bone formation can be recognized. (<a class="LK" href="sid806035.html#R156-11">8</a>) CT cannot identify satellite lesions or distinguish between high- and low-grade tumors. (<a class="LK" href="sid806035.html#R157-11">9</a>)</div>
<div class="P">The radiographic differential diagnosis is primarily with post-traumatic myositis ossificans. (<a class="LK" href="sid806035.html#R158-11">10</a>) This should not pose a real problem because most lesions of myositis are clearly separated from the bone. If, however, separation cannot be seen, the actual roentgen appearance usually provides the essential clues. The inner portions of sarcomas are uniformly dense, with a less dense peripheral margin. Myositis ossificans is less dense centrally and often has a halo-like rim of peripheral cortical bone. (<a class="LK" href="sid806035.html#R159-11">11</a>) Also, as demonstrated on serial films, myositis ossificans becomes smaller in size, whereas parosteal osteosarcoma becomes larger. These are general guidelines for radiographic differentiation; exceptions do occur.</div>
<div class="P">The treatment will vary, depending on the histologic aggressiveness of the tumor. En bloc resection for the less aggressive lesions seems helpful; however, a high rate of recurrence exists (&#x003E; 50&#x0025;). (<a class="LK" href="sid806035.html#R150-11">2</a>) Therefore, wider margins of the tumor should be resected. Amputation should be performed only in large lesions that are determined to be highly aggressive. The 5-year survival rate is estimated to be as high as 70&#x0025; following surgical excision. (<a class="LK" href="sid806035.html#R160-11">12</a>)</div>
<a name="PG1193"> </a><div class="pagenum"><div>P.1193</div></div>
<br clear="all">
<div class="FG" id="F110-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="508" src="files/45e6e8769a5426ce7a622b8140854280.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="45e6e8769a5426ce7a622b8140854280.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="508" DISPLAY="INLINE"></div>
<div class="P">Figure 11-110 <span class="emph_B">PAROSTEAL SARCOMA. A. AP Humerus.</span> Observe the large homogeneous radiopaque juxtacortical mass present in the proximal metadiaphyseal area of the humerus. At the caudal end of this mass a clearly defined cleavage plane is visualized (<span class="emph_I">arrows</span>). <span class="emph_B">B. Specimen Radiograph. C. Prosthesis.</span> Observe the metal prosthesis used in the treatment of this patient&#x2019;s parosteal sarcoma of the proximal humerus. <span class="emph_BIT">COMMENT:</span> The cleavage plane referred to previously actually represents a periosteal fibrous tissue layer separating the tumor from the cortical surface. This has also been referred to as the string sign of parosteal sarcoma and is present in only 30&#x0025; of cases. (Courtesy of Friedrich H. W. Heuck, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Stuttgart, West Germany.)</div>
</td></tr>
</table></div>
<div class="FG" id="F111-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="502" src="files/9476125ce516d7b384f55c8dca8c71b7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9476125ce516d7b384f55c8dca8c71b7.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="502" DISPLAY="INLINE"></div>
<div class="P">Figure 11-111 <span class="emph_B">PAROSTEAL SARCOMA: DISTAL FEMUR. A. Tomogram, Lateral Knee.</span> Observe the juxtacortical radiopaque mass on the posterior surface of the distal femur. <span class="emph_B">B. AP Knee. C. Lateral Knee.</span> Note that the postoperative radiographs demonstrate a prosthesis that has worked well for this 21-year-old patient. (Courtesy of Cynthia K. Peterson, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Toronto, Canada.)</div>
</td></tr>
</table></div>
<a name="PG1194"> </a><div class="pagenum"><div>P.1194</div></div>
<br clear="all">
<div class="FG" id="F112-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[5]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="585" height="714" src="files/ef2751254b6ee097d51c91142dafc18c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ef2751254b6ee097d51c91142dafc18c.gif" MIMETYPE="image/gif" WIDTH="585" HEIGHT="714" DISPLAY="INLINE"></div>
<div class="P">Figure 11-112 <span class="emph_B">PAROSTEAL SARCOMA. Distal Femur.</span> Observe the nodular ivory radiopaque mass on the posterior surface of the distal femur. This is the classic location for parosteal sarcoma.</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3534" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[6]">
<div class="HD">SECONDARY OSTEOSARCOMA</div>
<div class="TLV3" id="B01382540.0-3535" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[6]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Malignant degeneration of benign disorders, such as Paget&#x2019;s disease, polyostotic fibrous dysplasia, hereditary multiple exostosis (osteochondromas), and enchondromatosis (Ollier&#x2019;s disease), to osteosarcoma are documented. (<a class="LK" href="sid806035.html#R161-11">1</a>) (<a class="LK" href="sid806035.html#F113-11">Fig. 11-113</a>)</div>
<div class="P">Ionizing radiation may lead to the development of bone sarcoma. These changes may result from either internal (<a class="LK" href="sid806035.html#R162-11">2</a>) or external (<a class="LK" href="sid806035.html#R163-11">3</a>) radiation sources. Martland et al. (<a class="LK" href="sid806035.html#R164-11">4</a>) documented the watch-dial painters who had inadvertently ingested radium and mesothorium during their work by wetting their paint brushes with their tongues. These people developed bone sarcomas (usually osteosarcoma) 10-15 years later.</div>
<div class="P">Patients may develop postradiation sarcoma after treatment for breast cancer, Wilms&#x2019; tumor, and other primary carcinomas. The latent period varies from 5 to 40 years, with 15 years being average. (<a class="LK" href="sid806035.html#R162-11">2</a>,<a class="LK" href="sid806035.html#R163-11">3</a>)</div>
<div class="P">Bone sarcomas may develop in patients who have received injections of thorotrast, a radioactive contrast medium containing a 25&#x0025; colloidal thorium dioxide suspension (an &#x03B1; emitter). (<a class="LK" href="sid806035.html#R165-11">5</a>) This contrast medium was used for arteriography and other examinations in the 1950s. Osteosarcomas have been reported with the injection of as little as 50-75 mL of thorotrast. (<a class="LK" href="sid806035.html#R166-11">6</a>) Most of the reported cases occurred 15-25 years after injection. (<a class="LK" href="sid806035.html#R166-11">6</a>) Liver and spleen toxicity with tumor formation have been documented. (<a class="LK" href="sid806035.html#R166-11">6</a>) This contrast agent is no longer in current usage.</div>
<div class="P">The radiographic features of permeative, moth-eaten bone destruction with periosteal reaction and soft tissue mass is largely indistinguishable from those osteosarcomas arising de novo. (<a class="LK" href="sid806035.html#R167-11">7</a>)</div>
<div class="FG" id="F113-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[6]/TLV3[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="514" height="700" src="files/189c39ac5930942a66200698780ed5de.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="189c39ac5930942a66200698780ed5de.gif" MIMETYPE="image/gif" WIDTH="514" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-113 <span class="emph_B">PAGET&#x2019;S SARCOMA. Humerus.</span> Observe the pathologic fracture and extensive destruction of the proximal humerus. There is extensive cortical thickening of the visualized diaphysis of the humerus. These radiographic signs are consistent with malignant degeneration of Paget&#x2019;s disease to osteosarcoma, as was the histologic diagnosis in this case. <span class="emph_BIT">COMMENT:</span> Malignant degeneration of Paget&#x2019;s disease is a rare complication, occurring in 0.9-2&#x0025; of patients. The humerus, femur, tibia, pelvis, and sacrum are favorite sites. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3536" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[7]">
<div class="HD">EXTRAOSSEOUS OSTEOSARCOMA</div>
<div class="TLV3" id="B01382540.0-3537" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[7]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Occasionally, osteosarcomas may originate in an extraosseous site. The most common site is the soft tissues of the thigh, but they can also be found in the pleura, heart valves, dura of the brain, retroperitoneum, buttock, axilla, breast, and renal capsule. (<a class="LK" href="sid806035.html#R168-11">1</a>,<a class="LK" href="sid806035.html#R169-11">2</a>,<a class="LK" href="sid806035.html#R170-11">3</a>)</div>
<div class="P">The prognosis is similar to osteosarcoma, with metastases to the lung being common. Most occur between 30 and 50 years of age. The histologic features are identical to osseous osteosarcoma.</div>
<div class="P">The radiologic features are those of a large soft tissue mass, which is often not adjacent to a bone. The general appearance is non-specific. Occasionally, bone formation is present within the mass; this facilitates the proper diagnosis.</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3538" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]">
<div class="HD">CHONDROSARCOMA</div>
<div class="TLV3" id="B01382540.0-3539" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Chondrosarcoma is a malignant tumor of chondrogenic origin that remains essentially cartilaginous throughout its evolution. It
<a name="PG1195"> </a><div class="pagenum"><div>P.1195</div></div>
<br clear="all">
arises from chondroblasts and collagenoblasts, thus producing only cartilage and collagen. Chondrosarcomas of bone are usually classified as primary, arising de novo within a given bone, or secondary, arising in a pre-existing cartilaginous lesion (e.g., osteochondroma, enchondroma). In addition, chondrosarcomas may be either central (medullary or intraosseous) or peripheral (arising on the surface of the bone). Rarely, chondrosarcoma may arise in an extraosseous site.</div>
</div>
<div class="TLV3" id="B01382540.0-3540" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Chondrosarcoma is the third most common primary malignant bone tumor, following multiple myeloma and osteosarcoma. (<a class="LK" href="sid806035.html#R171-11">1</a>) The central type is five times more common than the peripheral presentation. (<a class="LK" href="sid806035.html#R172-11">2</a>) Chondrosarcomas make up about 10&#x0025; of all primary malignant bone tumors. (<a class="LK" href="sid806035.html#R173-11">3</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3541" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3542" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Most chondrosarcomas occur after the age of 40, the usual range being 40-60 years of age. Men are affected more than women in the ratio of 2:1.</div>
</div>
<div class="TLV4" id="B01382540.0-3543" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The initial symptom that calls attention to the presence of the tumor may be either pain or swelling, or a combination of both. Neither is diagnostic; in fact, many patients present with pain so late in the progression of the disease that it is not considered reliable in the workup of a patient suspected of chondrosarcoma. Rib lesions render pain, initially, in only one third of the cases. Peripheral chondrosarcoma is especially asymptomatic and usually presents with only minor discomfort and palpable swelling. (<a class="LK" href="sid806035.html#R173-11">3</a>) Pelvic tumors, however large, may remain hidden for a long time within the pelvic cavity. Once the mass reaches a large enough size, it will eventually compress on vital structures (bladder, bowel, lymphatic channels, blood vessels, or nerves), creating objective signs and symptoms that guide the clinician to the site of the lesion. Severe pain and disability may accompany osseous lesions when a pathologic fracture occurs, often spontaneously.</div>
<div class="P">Persistent and unrelenting pain in a previously diagnosed enchondroma should raise significant suspicion about malignant degeneration. Occasionally, a rapidly expanding, high-grade, central chondrosarcoma may cause early severe pain, which is commensurate with the degree of cortical destruction and size of the soft tissue mass. (<a class="LK" href="sid806035.html#R174-11">4</a>) The duration of symptoms, as reported by patients, varies considerably; it is &#x003C; 2 years for 75&#x0025; of the patients and &#x003C; 5 years for the rest. (<a class="LK" href="sid806035.html#R175-11">5</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3544" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">Chondrosarcoma may arise in any bone preformed in cartilage. (<a class="LK" href="sid806035.html#F114-11">Fig. 11-114</a>) The most common sites are the pelvis and proximal femur (50&#x0025;); other sites include proximal humerus (10&#x0025;), ribs (15&#x0025;), scapula (6&#x0025;), distal femur and proximal tibia (7&#x0025;), and craniofacial bones and sternum (5&#x0025;). (<a class="LK" href="sid806035.html#F115-11">Figs. 11-115</a> and
<a name="PG1196"> </a><div class="pagenum"><div>P.1196</div></div>
<br clear="all">
<a class="LK" href="sid806035.html#F116-11">11-116</a>) The remainder occur in the hand, foot, and spine. (<a class="LK" href="sid806035.html#R176-11">6</a>,<a class="LK" href="sid806035.html#R177-11">7</a>,<a class="LK" href="sid806035.html#R178-11">8</a>,<a class="LK" href="sid806035.html#R179-11">9</a>) When present in the foot, the lesions should be suspected as malignancies until proven otherwise. (<a class="LK" href="sid806035.html#R180-11">10</a>) Less than 2&#x0025; involve the epiphysis and are usually of the clear cell variety. (<a class="LK" href="sid806035.html#R181-11">11</a>)</div>
<div class="FG" id="F114-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="300" height="700" src="files/4a4d42a692e5b365771cc63d48d8339e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4a4d42a692e5b365771cc63d48d8339e.gif" MIMETYPE="image/gif" WIDTH="300" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-114 <span class="emph_B">SKELETAL DISTRIBUTION OF CHONDROSARCOMA.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F115-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[3]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="444" src="files/51eb5af25a75a3ba973ef458b47c8a0d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="51eb5af25a75a3ba973ef458b47c8a0d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="444" DISPLAY="INLINE"></div>
<div class="P">Figure 11-115 <span class="emph_B">CHONDROSARCOMA. Ilium.</span> Observe the <span class="emph_B">lytic</span> destructive lesion in the posterior surface of the ilium. There is mottled calcification within the central portion of the matrix of this cartilaginous tumor.</div>
</td></tr>
</table></div>
<div class="P">Chondrosarcoma is the most common primary malignant bone tumor of the hand, although representing only 4&#x0025; of the total malignant tumors of the hand. (<a class="LK" href="sid806035.html#R182-11">12</a>) (<a class="LK" href="sid806035.html#F117-11">Fig. 11-117</a>) Most lesions in the hand occur in the metacarpals or phalanges; rarely, the carpal bones may be involved. Two cases in the trapezoid have been demonstrated; one case affecting the trapezium has been recorded. (<a class="LK" href="sid806035.html#R176-11">6</a>,<a class="LK" href="sid806035.html#R183-11">13</a>,<a class="LK" href="sid806035.html#R184-11">14</a>) Although the number of cases of chondrosarcoma of the vertebral column is quite small, in those reported the lesions are fairly evenly distributed throughout the spinal column. (<a class="LK" href="sid806035.html#R178-11">8</a>,<a class="LK" href="sid806035.html#R179-11">9</a>) In the spine, extramedullary defect and compression fracture may be seen, resulting in subsequent neurological deficit. (<a class="LK" href="sid806035.html#R178-11">8</a>,<a class="LK" href="sid806035.html#R179-11">9</a>) Chondrosarcoma is also the most common primary malignant bone tumor of the chest wall, including the sternum and scapula. (<a class="LK" href="sid806035.html#R185-11">15</a>,<a class="LK" href="sid806035.html#R186-11">16</a>,<a class="LK" href="sid806035.html#R187-11">17</a>) (<a class="LK" href="sid806035.html#F118-11">Fig. 11-118</a>) It represents the third most common primary malignancy of the pelvis, following Ewing&#x2019;s sarcoma and osteosarcoma. (<a class="LK" href="sid806035.html#R188-11">18</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3545" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Chondrosarcomas are typically composed of faceted lobules of grayish white or bluish cartilaginous tissue and may be gritty to the touch because of the calcium contained within. These lobulated growths produce extrinsic pressure on the endosteum, creating a scalloped margin. The adjacent outer cortex is frequently broken in aggressive lesions, producing a large soft tissue mass. Cystic degeneration in a bulky tumor may be demonstrated grossly, on occasion.</div>
<div class="FG" id="F116-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="470" height="700" src="files/03022f60b05ea6acf730e71104a84d6c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="03022f60b05ea6acf730e71104a84d6c.gif" MIMETYPE="image/gif" WIDTH="470" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-116 <span class="emph_B">CHONDROSARCOMA. Proximal Femur.</span> Note the grossly expansile lytic destructive lesion in the proximal diaphysis of the femur. Observe the central calcification present within the lesion (<span class="emph_I">arrows</span>). There is obvious cortical disruption, as well as a soft tissue mass, present within the inner thigh (<span class="emph_I">arrowheads</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F117-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[4]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="402" src="files/306d7c1753f746dbb8b316786ffeb676.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="306d7c1753f746dbb8b316786ffeb676.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="402" DISPLAY="INLINE"></div>
<div class="P">Figure 11-117 <span class="emph_B">CHONDROSARCOMA: HAND. A. PA Finger. B. Lateral Finger.</span> Observe the grossly destructive lesion of the proximal phalanx of the third digit. There is calcification present within the matrix of this lesion. A rather large soft tissue mass is found associated with this patient&#x2019;s chondrosarcoma, and calcification is also noted in the soft tissue mass.</div>
</td></tr>
</table></div>
<a name="PG1197"> </a><div class="pagenum"><div>P.1197</div></div>
<br clear="all">
<div class="FG" id="F118-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[4]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="741" src="files/94b6f02cf8449f4790170e8d335f732b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="94b6f02cf8449f4790170e8d335f732b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="741" DISPLAY="INLINE"></div>
<div class="P">Figure 11-118 <span class="emph_B">CHONDROSARCOMA. Scapula. A. Pretreatment.</span> Note the large, lytic, expansile lesion in the scapula. Observe the faint calcification in the matrix of the lesion (<span class="emph_I">arrows</span>). <span class="emph_B">B. Post-Treatment.</span> Note that the patient was treated with a radical disarticulation of his left arm and scapula, with excision of the lateral half of his clavicle. <span class="emph_BIT">COMMENT:</span> Chondrosarcoma is the most common primary malignant bone tumor of the scapula.</div>
</td></tr>
</table></div>
<div class="P">Histologic sections of a typical chondrosarcoma demonstrate plump, cartilaginous cells, which contain multiple nuclei that are irregular in size. Hyperchromatism is marked, and mitotic figures may be present but generally are not numerous. Calcium is usually found on histologic section and is radiographically demonstrable in two thirds of the patients. (<a class="LK" href="sid806035.html#R171-11">1</a>) It is generally recognized that there is a relationship between the density of calcification in a chondrosarcoma and its degree of malignancy. (<a class="LK" href="sid806035.html#R189-11">19</a>) Myxoid tissue rarely calcifies, and because the degree of myxomatous histologic change is closely related to the grade of malignancy, it is not surprising that high-grade tumors are frequently associated with large areas of non-calcified tumor. (<a class="LK" href="sid806035.html#R190-11">20</a>) Approximately one third of the chondrosarcomas are purely lytic and show no matrix calcification. (<a class="LK" href="sid806035.html#R171-11">1</a>)</div>
<div class="P">Secondary chondrosarcoma arises in a pre-existing cartilaginous lesion. The most common disorder to exhibit this malignant degeneration is enchondromatosis, or Ollier&#x2019;s disease, and hereditary multiple exostosis (HME) or multiple osteochondromas. The incidence is highest in Ollier&#x2019;s disease, being approximately 50&#x0025; of patients; a much smaller percentage of solitary enchondromas undergo malignant change. (<a class="LK" href="sid806035.html#R172-11">2</a>,<a class="LK" href="sid806035.html#R191-11">21</a>) The incidence of malignant degeneration to chondrosarcoma in HME is 20&#x0025;; in solitary osteochondroma, 1&#x0025;. (<a class="LK" href="sid806035.html#R172-11">2</a>,<a class="LK" href="sid806035.html#R191-11">21</a>) (<a class="LK" href="sid806035.html#F119-11">Fig. 11-119</a>)</div>
<div class="P">In general, benign cartilaginous tumors (usually enchondromas) that are close to or involve the axial skeleton have a much higher rate of malignant degeneration than those that are in the distant appendicular skeleton. Other conditions in which chondrosarcoma may occur secondarily include Paget&#x2019;s disease (<a class="LK" href="sid806035.html#R192-11">22</a>,<a class="LK" href="sid806035.html#R193-11">23</a>), fibrous dysplasia, (<a class="LK" href="sid806035.html#R194-11">24</a>) and radiation-induced sarcoma. (<a class="LK" href="sid806035.html#R195-11">25</a>)</div>
<div class="FG" id="F119-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[4]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="489" height="700" src="files/a069946809009e38e593faf30a2d9558.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a069946809009e38e593faf30a2d9558.gif" MIMETYPE="image/gif" WIDTH="489" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-119 <span class="emph_B">CHONDROSARCOMA OF THE ILIUM SECONDARY TO MALIGNANT DEGENERATION OF A BENIGN OSTEOCHONDROMA.</span> Observe the broad, wide metaphysis of the proximal femur, which is characteristic of hereditary multiple exostosis (HME). There is calcification (<span class="emph_I">arrows</span>) within the soft tissue extensions associated with malignant degeneration of a previously benign osteochondroma of the ilium. <span class="emph_BIT">COMMENT:</span> The incidence of malignant degeneration of chondrosarcoma in HME is 20&#x0025;; in a solitary osteochondroma the incidence is 1&#x0025;.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3546" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="TLV4" id="B01382540.0-3547" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[5]/TLV4[1]">
<div class="HD">Central Chondrosarcoma</div>
<div class="P">Radiographs usually reveal a large, radiolucent, round or oval lesion with poorly defined margins. The contours of the bone are enlarged or expanded. Most lesions are in the metaphysis or diaphysis if a long bone is affected. (<a class="LK" href="sid806035.html#F120-11">Fig. 11-120</a>) Scalloping of the inner cortex (endosteum) is caused by the lobular outlines of the tumor. The cortex may be extensively eroded; this finding usually indicates an advanced stage. The slow progression of the tumor leads to fusiform expansion of the shaft and cortical thickening as a result of tumor invasion of the haversian systems. Purely epiphyseal lesions are rare; they occur in &#x003C; 2&#x0025; of chondrosarcomas, are usually of the <span class="emph_I">clear cell</span> variety, and most commonly involve the proximal femur and humerus. (<a class="LK" href="sid806035.html#R181-11">11</a>)</div>
<div class="P">The matrix of the lesion may have circular radiolucencies that represent large lobules of cartilage, imparting a bubbly appearance. Less commonly, a mottled permeating destructive pattern may be seen. (<a class="LK" href="sid806035.html#F121-11">Fig. 11-121</a>) Foci of irregularly scattered calcification in the tumor matrix occur in two thirds of the cases (one third of cases are purely lytic). (<a class="LK" href="sid806035.html#F122-11">Fig. 11-122</a>) These calcifications have been called <span class="emph_I">popcorn, fluffy, stippled, cotton wool, rings, and broken rings.</span> Periosteal new bone formation occurs occasionally, creating a laminated or spiculated pattern.</div>
<a name="PG1198"> </a><div class="pagenum"><div>P.1198</div></div>
<br clear="all">
<div class="FG" id="F120-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[5]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="685" src="files/4daf3fc31a7a12bdb42bf0f3ab68b87d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4daf3fc31a7a12bdb42bf0f3ab68b87d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="685" DISPLAY="INLINE"></div>
<div class="P">Figure 11-120 <span class="emph_B">CHONDROSARCOMA: DISTAL HUMERUS. A. AP Humerus. B. Lateral Humerus.</span> Observe the expansile lytic lesion in the distal diaphysis and metaphysis of the humerus. A mixed pattern of bone destruction, along with periosteal new bone formation, is seen around the peripheral cortices.</div>
</td></tr>
</table></div>
<div class="FG" id="F121-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[5]/TLV4[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="433" src="files/fc9385ae12008dd30ca0cfcbd864c3bd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fc9385ae12008dd30ca0cfcbd864c3bd.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="433" DISPLAY="INLINE"></div>
<div class="P">Figure 11-121 <span class="emph_B">CHONDROSARCOMA. AP Pelvis.</span> Note the ill-defined permeative destructive pattern present in the superior pubic ramus, inferior pubic ramus, and ischial tuberosity. Its radiographic appearance is aggressive, with a poor zone of transition surrounding the lesion. This represents a mixed infiltrating pattern of chondrosarcoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F122-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[5]/TLV4[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="495" src="files/d46f36b2320368c0a8a246570ffa059f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d46f36b2320368c0a8a246570ffa059f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="495" DISPLAY="INLINE"></div>
<div class="P">Figure 11-122 <span class="emph_B">CHONDROSARCOMA WITH MATRIX CALCIFICATION. A. Pelvis.</span> Observe the large soft tissue mass with matrix calcification surrounding the chondrosarcoma of the pelvis. <span class="emph_B">B. Proximal Humerus.</span> Note the expansile permeative lesion of the metaphysis of the proximal humerus. Stippled matrix calcification is present in the central portion of this chondrosarcoma. <span class="emph_B">C. Sacrum.</span> Observe the dense, homogeneous matrix calcification in the middle to lower portion of the sacrum. This lesion is characteristic of chondrosarcoma. <span class="emph_I">COMMENT:</span> Foci of irregularly scattered calcification in the tumor matrix of chondrosarcoma occur in two thirds of cases, with one third of cases being purely lytic. These calcifications have been called popcorn, fluffy, and stippled.</div>
</td></tr>
</table></div>
<a name="PG1199"> </a><div class="pagenum"><div>P.1199</div></div>
<br clear="all">
<div class="P">Eventually, a large soft tissue mass develops, with amorphous calcifications scattered throughout. (<a class="LK" href="sid806035.html#F123-11">Fig. 11-123</a>) In a juxtacortical or extraosseous tumor, the soft tissue mass may be the initial presenting radiologic sign when a destructive lesion in the adjacent bone may be hard to identify. An example of this is an early acetabular chondrosarcoma with a soft tissue mass extending into the pelvic cavity. (<a class="LK" href="sid806035.html#F124-11">Fig. 11-124</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3548" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[5]/TLV4[2]">
<div class="HD">Peripheral Chondrosarcoma</div>
<div class="P">This lesion demonstrates primarily a spiculated periosteal response and Codman&#x2019;s reactive triangle in the soft tissue area adjacent to the lesion. Cortical destruction may be present, but no medullary involvement occurs. The majority of the secondary chondrosarcomas present as peripheral lesions seeded from the osteocartilaginous cap of an osteochondroma. (<a class="LK" href="sid806035.html#R196-11">26</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3549" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Primary chondrosarcoma typically shows a slow clinical progression because spread is by direct extension rather than hematogenous routes. Irradiation and chemotherapy probably have no or little role in the curative treatment of this malignant tumor. (<a class="LK" href="sid806035.html#R197-11">27</a>,<a class="LK" href="sid806035.html#R198-11">28</a>) Radical removal of the lesion by local excision, segmented resection, or amputation is the treatment of choice. However, recent studies have suggested that total resection may increase the chance of prolonged recovery compared with partial resection. (<a class="LK" href="sid806035.html#R197-11">27</a>) In general, lesions farthest from the trunk offer the greatest possibility for initial surgical treatment by techniques other than amputation. In lesions near the trunk, radical removal at the time of initial observation is preferred because any recurrence is practically incurable. Curettage is only palliative but has been used and repeated to control some indolent lesions that are not amenable to complete removal.</div>
<div class="FG" id="F123-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="415" src="files/1b66f62842297dc6b03b2ae067f9fb5d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1b66f62842297dc6b03b2ae067f9fb5d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="415" DISPLAY="INLINE"></div>
<div class="P">Figure 11-123 <span class="emph_B">CHONDROSARCOMA OF THE HAND, WITH A LARGE SOFT TISSUE MASS. A. Initial Radiograph.</span> Observe the destruction of the second metacarpal head, with a large soft tissue mass. There are scattered calcifications present throughout the destructive lesion. <span class="emph_B">B. 2-Year Follow-Up.</span> Note the massive progression of the destructive lesion of the second metacarpal bone, with a large soft tissue mass noted about the hand. This soft tissue mass is so large it has caused some pressure erosion on the medial cortex of the mid-diaphysis of the third metacarpal bone. <span class="emph_BIT">COMMENT:</span> At the time of the initial diagnosis, surgery was recommended but refused by the patient. This allowed the drastic progression of the tumor, creating such a large soft tissue mass. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="P">The 5-year survival figures after early and adequate surgery approach 90&#x0025;. (<a class="LK" href="sid806035.html#R199-11">29</a>,<a class="LK" href="sid806035.html#R200-11">30</a>) In general, more cures are attained with chondrosarcomas than with most of the other primary malignant
<a name="PG1200"> </a><div class="pagenum"><div>P.1200</div></div>
<br clear="all">
bone tumors. (<a class="LK" href="sid806035.html#R199-11">29</a>,<a class="LK" href="sid806035.html#R200-11">30</a>) The location of the tumor and duration of symptoms appears not to influence the outcome, with histological grading remaining the primary marker of prognostic value. (<a class="LK" href="sid806035.html#R201-11">31</a>,<a class="LK" href="sid806035.html#R202-11">32</a>,<a class="LK" href="sid806035.html#R203-11">33</a>) When metastatic spread occurs, it is generally owing to invasion by the tumor of regional venous channels with access to the cardiopulmonary circulation by intravascular growth and extension. (<a class="LK" href="sid806035.html#R199-11">29</a>,<a class="LK" href="sid806035.html#R200-11">30</a>) Parenchymal metastases, usually pulmonary, are not uncommon. Metastases elsewhere, particularly to the skeleton, are infrequently encountered; similarly, extension of tumor to the regional lymph nodes is rarely reported. (<a class="LK" href="sid806035.html#R172-11">2</a>)</div>
<div class="FG" id="F124-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="428" height="700" src="files/6c1689a84317fc07d2a4ac015d615887.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6c1689a84317fc07d2a4ac015d615887.gif" MIMETYPE="image/gif" WIDTH="428" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-124 <span class="emph_B">CHONDROSARCOMA. Ilium.</span> Note the eccentrically placed lytic chondrosarcoma in the supra-acetabular area. Some small stippled calcifications are present within the matrix of the tumor.</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3550" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Chondrosarcoma</div>
<div class="TLV2" id="B01382540.0-3551" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Primary chondrosarcoma arises de novo.</div></li>
<li class="LM"><div class="P">Secondary chondrosarcoma arises in a pre-existing cartilaginous lesion (enchondroma, osteochondroma).</div></li>
<li class="LM"><div class="P">Central chondrosarcoma arises intramedullary.</div></li>
<li class="LM"><div class="P">Peripheral chondrosarcoma arises on the surface of the bone.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3552" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents the third most common primary malignant bone tumor, following myeloma and osteosarcoma.</div></li>
<li class="LM"><div class="P">It makes up 10&#x0025; of all primary malignant bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3553" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Age of presentation is 40-60 years, with 2:1 male predominance.</div></li>
<li class="LM"><div class="P">Pain usually presents late in the disease process, often after large soft tissue masses develop.</div></li>
<li class="LM"><div class="P">Severe pain follows pathologic fracture.</div></li>
<li class="LM"><div class="P">The most common sites are the pelvis, proximal femur and humerus, ribs, scapula, sternum, craniofacial bones, distal femur, and proximal tibia.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3554" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Lobules of grayish white or bluish cartilaginous tissue.</div></li>
<li class="LM"><div class="P">Malignant degeneration of Ollier&#x2019;s disease (enchondromatosis) is approximately 50&#x0025;; HME is 20&#x0025;; 1&#x0025; in solitary osteochondroma.</div></li>
<li class="LM"><div class="P">The closer the lesion is to the axial skeleton, the higher the potential for malignant degeneration.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3555" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Round or oval radiolucencies with ill-defined margins evident.</div></li>
<li class="LM"><div class="P">Lesions are metaphyseal or diaphyseal; &#x003C; 2&#x0025; are epiphyseal (clear cell variety).</div></li>
<li class="LM"><div class="P">Endosteal scalloping occurs secondary to pressure erosion from the enlarging lobular mass.</div></li>
<li class="LM"><div class="P">Popcorn matrix calcification in the lesion occurs in two thirds of cases; one third of the lesions are purely radiolucent.</div></li>
<li class="LM"><div class="P">Laminated or spiculated periosteal response occurs.</div></li>
<li class="LM"><div class="P">Metastatic disease is usually to lung; rare to bone.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3556" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Treatment consists of local excisions, segmental resection, or amputation.</div></li>
<li class="LM"><div class="P">Prognosis is good, with 90&#x0025; survival after early surgery.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3557" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]">
<div class="HD">EWING&#x2019;S SARCOMA</div>
<div class="TLV3" id="B01382540.0-3558" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Ewing&#x2019;s sarcoma is a primitive primary malignant tumor of bone; it is composed of tumor cells derived from the connective tissue framework of bone marrow. This highly malignant tumor was originally described in its classic form by James Ewing (<a class="LK" href="sid806035.html#R204-11">1</a>) in 1921. He described a rather specific radiographic appearance in a group of malignant pediatric bone tumors, which he called <span class="emph_I">diffuse endothelioma of bone, or endothelial myeloma.</span> (<a class="LK" href="sid806035.html#R204-11">1</a>) He wrote:</div>
<div class="QT">
<div class="P"><span class="emph_I">The radiographs give characteristic features on which a diagnosis may be based with considerable certainty. A large portion of the whole shaft is involved, but the ends are generally spared, contrary to the rule with osteogenic sarcoma. The shaft is slightly widened, but the main alteration is a diffuse fading of the bone structure. Bone production has been entirely absent. Some of the bones appear honeycombed. Perforation of the shaft and sharp limitation of the process are wanting. The central excavation with widened bony capsule, as seen in benign giant cell tumors, is missing. The radiograph is therefore rather specific. (<a class="LK" href="sid806035.html#R204-11">1</a>)</span></div>
</div>
<div class="P">Since Ewing&#x2019;s initial description, the diversity of radiographic manifestations of Ewing&#x2019;s sarcoma has become widely appreciated. The variety of histologic patterns that this tumor presents has caused some confusion; however, distinctive histopathologic criteria are now recognized. Oberling (<a class="LK" href="sid806035.html#R205-11">2</a>) suggested that Ewing&#x2019;s sarcoma originated from the marrow stem cell, which is derived from the primary reticulum; therefore, Ewing&#x2019;s sarcoma has been grouped with myeloma and non-Hodgkin&#x2019;s lymphoma (reticulum cell sarcoma) as a <span class="emph_I">round cell</span> tumor. These round cell tumors have a striking predilection for the marrow-rich diaphysis. Their appearance is radiographically similar, but they differ greatly in age incidence.</div>
</div>
<div class="TLV3" id="B01382540.0-3559" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Ewing&#x2019;s sarcoma represents approximately 7&#x0025; of all primary malignant bone tumors and is the fourth most common primary malignant bone tumor, with myeloma, osteosarcoma, and chondrosarcoma occurring more frequently (in decreasing order of incidence). Ewing&#x2019;s sarcoma demonstrates a racial predilection affecting both American and African blacks with a significantly lower incidence than the general population. (<a class="LK" href="sid806035.html#R206-11">3</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3560" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3561" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Ewing&#x2019;s sarcoma is found most commonly in the 10- to 25-year age range, with a peak at 15 years. It is rare before the age of 5 and after the age of 30; 50&#x0025; of cases occur &#x003C; 20 years of age. The youngest patient reported was 5 months old (<a class="LK" href="sid806035.html#R207-11">4</a>), and the oldest was age 83 years. (<a class="LK" href="sid806035.html#R208-11">5</a>) Patients in the younger age range (5-20 years) usually have lesions in the peripheral skeleton, whereas older patients (20-35 years) present with axial lesions. There is a 2:1 male to female ratio.</div>
</div>
<a name="PG1201"> </a><div class="pagenum"><div>P.1201</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3562" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Localized pain with swelling at the site of the lesion is a consistent presenting complaint. (<a class="LK" href="sid806035.html#R209-11">6</a>) A soft tissue mass is palpable in more than one third of the cases. (<a class="LK" href="sid806035.html#R209-11">6</a>) The pain initially is dull in nature; however, it usually becomes severe and persistent a few months before diagnosis. Systemic symptoms of slight to moderate fever, secondary anemia, leukocytosis, and increased ESR are common in Ewing&#x2019;s sarcoma. (<a class="LK" href="sid806035.html#R210-11">7</a>) Ewing&#x2019;s tumor seems to be the only primary malignant bone tumor with symptoms simulating an infection. (<a class="LK" href="sid806035.html#R210-11">7</a>) Local temperature elevation with dilated veins and associated tenderness accompanies the lesion, thereby suggesting an inflammatory condition. The inflammatorylike symptoms of Ewing&#x2019;s sarcoma may be explained by the fact that the tumor characteristically outgrows its blood supply, resulting in extensive degeneration and necrosis. (<a class="LK" href="sid806035.html#R211-11">8</a>) With such a clinical presentation, biopsy may be the only means of diagnosis.</div>
</div>
<div class="TLV4" id="B01382540.0-3563" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">Ewing&#x2019;s sarcoma is seen most frequently in the long tubular bones (50&#x0025;) and in the flat bones (40&#x0025;). (<a class="LK" href="sid806035.html#R212-11">9</a>) (<a class="LK" href="sid806035.html#F125-11">Fig. 11-125</a>) The lower extremity encompasses the largest portion of the tubular involvement. The femur is most commonly involved (23&#x0025;), with the tibia, fibula, and humerus following (9&#x0025;). (<a class="LK" href="sid806035.html#R212-11">9</a>) The diaphysis is the classic location for these tumors; however, more cases are being seen affecting the metaphysis and metadiaphyseal region.</div>
<div class="FG" id="F125-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="294" height="700" src="files/824977706fd0bd14dfb0ca9af7493465.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="824977706fd0bd14dfb0ca9af7493465.gif" MIMETYPE="image/gif" WIDTH="294" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-125 <span class="emph_B">SKELETAL DISTRIBUTION OF EWING&#x2019;S SARCOMA.</span>
</div>
</td></tr>
</table></div>
<div class="P">Of the flat bones the most frequently affected site is the pelvis (21&#x0025;) (<a class="LK" href="sid806035.html#R213-11">10</a>,<a class="LK" href="sid806035.html#R214-11">11</a>), with the innominate being the most common portion involved. (<a class="LK" href="sid806035.html#F126-11">Fig. 11-126</a>) It is the most common malignant lesion of childhood to affect the ischium and pubis; 10&#x0025; of all malignant rib lesions are Ewing&#x2019;s sarcoma. (<a class="LK" href="sid806035.html#R215-11">12</a>,<a class="LK" href="sid806035.html#R216-11">13</a>) The vast majority of the malignant costal tumors in children consist of Ewing&#x2019;s sarcoma. (<a class="LK" href="sid806035.html#R217-11">14</a>) Involvement of the scapula occurs in approximately 5&#x0025; of cases. (<a class="LK" href="sid806035.html#R212-11">9</a>) Spinal involvement is uncommon, occurring in only 3.5-7&#x0025; of all lesions in two large series. (<a class="LK" href="sid806035.html#R218-11">15</a>,<a class="LK" href="sid806035.html#R219-11">16</a>,<a class="LK" href="sid806035.html#R220-11">17</a>) The sacrum and lumbar spine are the most common sites. (<a class="LK" href="sid806035.html#R218-11">15</a>,<a class="LK" href="sid806035.html#R220-11">17</a>) (<a class="LK" href="sid806035.html#F127-11">Fig. 11-127</a>) Isolated cases have been reported in the feet and the mandible (horizontal ramus preferred). (<a class="LK" href="sid806035.html#R221-11">18</a>,<a class="LK" href="sid806035.html#R222-11">19</a>,<a class="LK" href="sid806035.html#R223-11">20</a>,<a class="LK" href="sid806035.html#R224-11">21</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3564" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Recent research in the field of genetics has identified a genetic alteration that has been linked to the expression of a chimeric protein and possible initiation of tumors within the family of Ewing&#x2019;s sarcoma. (<a class="LK" href="sid806035.html#R225-11">22</a>) Upon gross inspection of Ewing&#x2019;s sarcoma, the lesion principally occupies the medullary cavity and is usually soft, friable, and often hemorrhagic. Cystic areas of necrosis occur. Extraosseous tumor tissue is often identified because the cortex is frequently penetrated. The overlying skin may be red, with local venous dilation; ulceration may occur.</div>
<div class="P">Histologically, Ewing&#x2019;s sarcomas are extremely undifferentiated and consist of sheets of small, round, or oval cells in
<a name="PG1202"> </a><div class="pagenum"><div>P.1202</div></div>
<br clear="all">
which the nuclei are prominent and the cytoplasm is poorly visualized. The nuclei tend to be quite uniform in size and shape, and mitotic figures are numerous, while tumor giant cells and pleomorphism are conspicuously absent. This histologic pattern may be modified by large areas of ischemic necrosis (the rapidly growing tumor tends to outgrow its blood supply), so that in many tumors the preservable viable cells are found in cords or masses surrounding blood vessels with necrosis of the more remote areas.</div>
<div class="FG" id="F126-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="493" height="700" src="files/6c750a675fefe0f2c2913b03b1d9b9dd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6c750a675fefe0f2c2913b03b1d9b9dd.gif" MIMETYPE="image/gif" WIDTH="493" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-126 <span class="emph_B">EWING&#x2019;S SARCOMA: ILIUM.</span> Observe the diffuse, mottled pattern of bone destruction scattered throughout the entire iliac wing. There is no involvement of the femoral head that would suggest a joint disorder. <span class="emph_I">COMMENT:</span> Ewing&#x2019;s sarcoma in flat bones most frequently affects the pelvis, with the innominate being the most commonly involved bone.</div>
</td></tr>
</table></div>
<div class="FG" id="F127-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[4]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="220" src="files/c7ee7f883c2169d5e954f6d9162d07a1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c7ee7f883c2169d5e954f6d9162d07a1.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="220" DISPLAY="INLINE"></div>
<div class="P">Figure 11-127 <span class="emph_B">EWING&#x2019;S SARCOMA: L5. A. AP Lumbar Spine. B. Tomogram, L5.</span> Observe the lytic destruction of the pedicle of L5 and a portion of the vertebral body (<span class="emph_I">arrows</span>) in this 15-year-old patient. <span class="emph_I">COMMENT:</span> Ewing&#x2019;s sarcoma of the spine is uncommon, occurring in 3.5-7&#x0025; of lesions. When present, the sacrum and lumbar spine are the most common sites.</div>
</td></tr>
</table></div>
<div class="P">It may be impossible to differentiate a biopsy specimen from non-Hodgkin&#x2019;s lymphoma, neuroblastoma, leukemia, or eosinophilic granuloma. (<a class="LK" href="sid806035.html#R212-11">9</a>) It is important to correlate the patient&#x2019;s age, clinical features, and radiographic presentation before a histologic diagnosis is firmly established. A special laboratory staining procedure may be helpful in the differentiation of Ewing&#x2019;s sarcoma and non-Hodgkin&#x2019;s lymphoma. The demonstration of glycogen granules upon appropriate staining of the cells is common in Ewing&#x2019;s sarcoma and not found in non-Hodgkin&#x2019;s lymphoma. (<a class="LK" href="sid806035.html#R226-11">23</a>) Fine-needle aspiration cytology in conjunction with immunocytochemistry is currently an effective, non-traumatic method for a rapid and accurate diagnosis. (<a class="LK" href="sid806035.html#R227-11">24</a>)</div>
<div class="FG" id="F128-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[4]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="441" src="files/9e5eac5f17ebfbf382c8967adf01ad80.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9e5eac5f17ebfbf382c8967adf01ad80.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="441" DISPLAY="INLINE"></div>
<div class="P">Figure 11-128 <span class="emph_B">EWING&#x2019;S SARCOMA: DIAPHYSEAL INVOLVEMENT. A. AP Ulna. B. Lateral Ulna.</span> Observe the lytic destructive lesion in the diaphysis of the ulna. There is moderate expansion of the ulna noted. No characteristic periosteal response is present.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3565" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The classic presentation is that of a diaphyseal lesion (usually in the lower extremity), permeative in its appearance, with a wide zone of transition. (<a class="LK" href="sid806035.html#F128-11">Fig. 11-128</a>) A delicate, laminated, onion
<a name="PG1203"> </a><div class="pagenum"><div>P.1203</div></div>
<br clear="all">
skin, or onion peel periosteal response is noted in only 25-50&#x0025; of cases. (<a class="LK" href="sid806035.html#R212-11">9</a>) Cortical <span class="emph_I">saucerization</span> is an early and characteristic sign. (<a class="LK" href="sid806035.html#F129-11">Fig. 11-129</a>) This irregular defect effaces the outside of the bone occasionally, exhibiting a marginal scalloping effect. It occurs when the tumor grows through the haversian system and presents subperiosteally. Purely lytic lesions are uncommon, with a mixed lytic and sclerotic pattern predominating in the tubular bones. Approximately one third of the cases affecting flat bones demonstrate diffuse sclerosis. (<a class="LK" href="sid806035.html#R228-11">25</a>) This diffuse sclerosis represents normal bone formed as a reaction to the tumor cells rather than actual tumor bone. (<a class="LK" href="sid806035.html#R228-11">25</a>) Pathologic fracture is noted in approximately 5&#x0025; of cases. (<a class="LK" href="sid806035.html#R229-11">26</a>)</div>
<div class="FG" id="F129-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="375" height="700" src="files/2fc08048a44792b7541df1034491c60a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2fc08048a44792b7541df1034491c60a.gif" MIMETYPE="image/gif" WIDTH="375" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-129 <span class="emph_B">EWING&#x2019;S SARCOMA: CORTICAL SAUCERIZATION AND ONION SKIN PERIOSTEAL RESPONSE. Femur.</span> Observe the permeative destruction within the medullary portion of the mid-diaphysis of the femur. Disruption in the cortex, creating a saucerization appearance, is characteristic of Ewing&#x2019;s sarcoma (<span class="emph_I">arrows</span>). An additional radiographic sign of aggressive disease is the onion skin or laminated periosteal response seen adjacent to the cortical saucerization (<span class="emph_I">arrowheads</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F130-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="484" height="700" src="files/fcc422167d894f0eb29d279e31ad6a2f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fcc422167d894f0eb29d279e31ad6a2f.gif" MIMETYPE="image/gif" WIDTH="484" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-130 <span class="emph_B">EWING&#x2019;S SARCOMA: GROOMED OR TRIMMED WHISKERS EFFECT. First Metacarpal.</span> Note the mottled radiolucent and radiopaque destructive pattern scattered throughout the entire first metacarpal. A fine and delicate periosteal pattern of new bone formation is present around the metaphysis and diaphysis of the first metacarpal bone, causing the groomed or trimmed whiskers appearance (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="TB" id="T16-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-16 Features of Ewing&#x2019;s Sarcoma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Age</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>10-25 years</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Males 2:1</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Symptoms may simulate infection</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Location</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Femur</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Tibia, fibula</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Humerus</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Pelvis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Scapula</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Radiologic features</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Diaphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Permeative</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Laminated or onion skin periosteal response</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Cortical saucerization</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F131-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="585" height="748" src="files/73c95525f2e73fcd625786e2f4fb75ad.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="73c95525f2e73fcd625786e2f4fb75ad.gif" MIMETYPE="image/gif" WIDTH="585" HEIGHT="748" DISPLAY="INLINE"></div>
<div class="P">Figure 11-131 <span class="emph_B">EWING&#x2019;S SARCOMA: METASTASIS TO BONE. A. AP Distal Phalanx. B. Lateral Distal Phalanx.</span> Note the aggressive permeative pattern of bone destruction present throughout the distal phalanx of the index finger. A large soft tissue mass is seen associated with this destruction. <span class="emph_B">C. Ischial Tuberosity.</span> Observe the ill-defined pattern of radiolucency throughout the ischial tuberosity in this 21-year-old patient whose initial complaint was that of digital pain. This ischial lesion (<span class="emph_I">arrows</span>) represents a secondary site of metastasis from the primary Ewing&#x2019;s sarcoma of the distal phalanx of his index finger. <span class="emph_BIT">COMMENT:</span> Ewing&#x2019;s sarcoma is the most common primary malignant bone tumor to metastasize to bone; osteosarcoma may also. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1204"> </a><div class="pagenum"><div>P.1204</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3566" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[5]/TLV4[1]">
<div class="HD">Periosteal Bone Formation</div>
<div class="P">The delicate parallel, laminated, onion skin, or onion peel radiographic presentation is quite striking in its appearance when present. (<a class="LK" href="sid806035.html#F129-11">Fig. 11-129</a>) This appearance is caused by the splitting and thickening of the cortex by the tumor cells. The layering is continuous, with reactive ossification in the form of Codman&#x2019;s triangles occurring frequently. Osteomyelitis, traumatic periostitis, osteosarcoma, and malignant lymphoma may also show a Codman&#x2019;s reactive triangle; therefore, it is not pathognomonic.</div>
<div class="P">The sunray pattern of periosteal new bone formation may also occur in Ewing&#x2019;s sarcoma. These radiating spicules have been referred to as the <span class="emph_I">groomed or trimmed whiskers effect.</span> (<a class="LK" href="sid806035.html#R230-11">27</a>) (<a class="LK" href="sid806035.html#F130-11">Fig. 11-130</a>) It has been suggested that these perpendicular bone spicules are thinner and more hair-like than those in osteosarcoma. (<a class="LK" href="sid806035.html#R231-11">28</a>) This appearance is also found in metastatic neuroblastoma, in renal carcinoma, and, commonly, in osteosarcoma. (<a class="LK" href="sid806035.html#T16-11">Table 11-16</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3567" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[5]/TLV4[2]">
<div class="HD">Metastases</div>
<div class="P">Skeletal metastases occur frequently and early, leading to extensive bone destruction. Ewing&#x2019;s sarcoma is the most common primary malignant bone tumor to metastasize to bone. (<a class="LK" href="sid806035.html#R232-11">29</a>) (<a class="LK" href="sid806035.html#F131-11">Fig. 11-131</a>) The spine is a common site for metastasis. (<a class="LK" href="sid806035.html#R220-11">17</a>) Multiple lesions in the one bone occur and are described as <span class="emph_I">skip lesions,</span> a phenomenon also seen in osteosarcoma. (<a class="LK" href="sid806035.html#R233-11">30</a>) Secondary spread to the lungs is also a common occurrence, with the lung parenchyma and pleura being the favored locations. (<a class="LK" href="sid806035.html#R232-11">29</a>) (<a class="LK" href="sid806035.html#F132-11">Fig. 11-132</a>)</div>
<div class="FG" id="F132-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[5]/TLV4[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="476" height="700" src="files/2724cf4bed39d63c94f1dfb0d8bb3aec.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2724cf4bed39d63c94f1dfb0d8bb3aec.gif" MIMETYPE="image/gif" WIDTH="476" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-132 <span class="emph_B">CHEST CANNONBALL METASTASES.</span> Observe the multiple circular nodular metastatic lesions scattered throughout the central lung fields. These represent cannonball metastases, with sarcomatous growth within the lung parenchyma from Ewing&#x2019;s sarcoma of the femur.</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3568" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">The 5-year survival rate has been approximately 5&#x0025; for Ewing&#x2019;s sarcoma. Radiation therapy rendered in conjunction with effective chemotherapy in lesions detected early is increasing the survival rate. (<a class="LK" href="sid806035.html#R234-11">31</a>) Amputation may still be used in lesions around the knee. One study reported a 35&#x0025; 5-year survival rate in 107 patients. (<a class="LK" href="sid806035.html#R235-11">32</a>) Early detection, adequate surgical resection, tumor size, metastasis, and age remain the key prognostic indicators for determining the outcome of the disease process. (<a class="LK" href="sid806035.html#R234-11">31</a>,<a class="LK" href="sid806035.html#R235-11">32</a>,<a class="LK" href="sid806035.html#R236-11">33</a>,<a class="LK" href="sid806035.html#R237-11">34</a>) In the event of relapse, regardless of the treatment used, the prognosis is usually fatal. (<a class="LK" href="sid806035.html#R238-11">35</a>)</div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3569" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Ewing&#x2019;s Sarcoma</div>
<div class="TLV2" id="B01382540.0-3570" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Originally described in 1921 by James Ewing as endothelioma of bone, or endothelial myeloma.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3571" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents 7&#x0025; of all primary malignant bone tumors.</div></li>
<li class="LM"><div class="P">Fourth most common primary malignant bone tumor (myeloma, osteosarcoma, and chondrosarcoma occur more frequently, in decreasing order of incidence).</div></li>
<li class="LM"><div class="P">Incidence is lower among blacks in the United States and Africa.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3572" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most cases occur in the 10- to 25-year age range; rare &#x003C; 5 years and &#x003E; 30 years.</div></li>
<li class="LM"><div class="P">Male to female ratio is 2:1.</div></li>
<li class="LM"><div class="P">Localized pain with swelling at the site of the lesion is a common symptom.</div></li>
<li class="LM"><div class="P">May mimic infection; systemic signs of slight fever, secondary anemia, leukocytosis, and increased ESR are common.</div></li>
<li class="LM"><div class="P">Thought to be the only primary malignant bone tumor with symptoms simulating an infection.</div></li>
<li class="LM"><div class="P">The long tubular bones of the lower extremities (femur, tibia, and fibula) are the most likely sites; the innominate bone is the most common flat bone affected.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3573" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Histologically, undifferentiated sheets of small, round, or oval cells.</div></li>
<li class="LM"><div class="P">Classified as a round cell tumor, along with multiple myeloma and non-Hodgkin&#x2019;s lymphoma of bone.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3574" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Classic presentation is a diaphyseal permeative lesion with a delicate onion skin or peel periosteal response.</div></li>
<li class="LM"><div class="P">Cortical saucerization is a characteristic sign.</div></li>
<li class="LM"><div class="P">Pathologic fracture is noted in 5&#x0025; of cases.</div></li>
<li class="LM"><div class="P">One third of cases affecting flat bones present with diffuse sclerosis.</div></li>
<li class="LM"><div class="P">Occasionally, the sunray periosteal pattern occurs and has been called groomed, or trimmed, whiskers effect.</div></li>
<li class="LM"><div class="P">The most common primary malignant bone tumor to metastasize to bone.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3575" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Amputation is still used in lesions around the knee.</div></li>
<li class="LM"><div class="P">Radiation therapy along with chemotherapy in early lesions offers a 35&#x0025; 5-year survival rate.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<a name="PG1205"> </a><div class="pagenum"><div>P.1205</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3576" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]">
<div class="HD">FIBROSARCOMA</div>
<div class="TLV3" id="B01382540.0-3577" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Fibrosarcoma of bone is a primary malignant bone tumor that produces varying amounts of collagen and has no tendency to form tumor bone, osteoid, or cartilage, either in its primary site or in its metastases. (<a class="LK" href="sid806035.html#R239-11">1</a>) It presents as two types: medullary (or central) and periosteal fibrosarcoma. It is usually encountered during adult life in major long bones, especially those of the lower extremity. The majority of the medullary tumors arise de novo, but in many instances fibrosarcoma develops as a complication of a preexisting benign condition. (<a class="LK" href="sid806035.html#R240-11">2</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3578" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Fibrosarcoma of bone is relatively rare, representing only 2&#x0025; of all primary malignant bone tumors. (<a class="LK" href="sid806035.html#R239-11">1</a>,<a class="LK" href="sid806035.html#R240-11">2</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3579" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3580" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">The age distribution has a wide range, from 4 to 83 years; however, they are most often found in the 30- to 50-year age range. (<a class="LK" href="sid806035.html#R239-11">1</a>,<a class="LK" href="sid806035.html#R240-11">2</a>) The median age is 38 years. A definite sex predilection has not been observed.</div>
</div>
<div class="TLV4" id="B01382540.0-3581" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The chief complaints are local pain and swelling, which may refer to and limit the motion of the joint. (<a class="LK" href="sid806035.html#R241-11">3</a>) The average duration of symptoms at presentation is 2 years in medullary lesions and 20 months in periosteal lesions. (<a class="LK" href="sid806035.html#R239-11">1</a>) Approximately one third of the tumors present initially with a pathologic fracture. (<a class="LK" href="sid806035.html#R242-11">4</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3582" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">The tubular bones are more frequently involved in younger patients, the flat bones in older patients. (<a class="LK" href="sid806035.html#R243-11">5</a>) The most common sites are the long bones and innominate bones, but almost 50&#x0025; of cases occur around the knee. (<a class="LK" href="sid806035.html#R244-11">6</a>) (<a class="LK" href="sid806035.html#F133-11">Fig. 11-133</a>) The femur, tibia, and humerus represent sites for approximately two thirds of the tumors. (<a class="LK" href="sid806035.html#R239-11">1</a>,<a class="LK" href="sid806035.html#R240-11">2</a>) The classic locations within these bones are the condyles of the femur or the epicondyles of the humerus. (<a class="LK" href="sid806035.html#R239-11">1</a>) Other frequent sites include the innomi-nate bones, skull, and facial bones; rarely, the ribs, clavicles, scapulae, spine (<a class="LK" href="sid806035.html#F134-11">Fig. 11-134</a>), and small tubular bones may be involved. (<a class="LK" href="sid806035.html#R245-11">7</a>) It is extremely rare for multiple lesions to be present; however, in the cases reported multiple fibrosarcomas may mimic the radiologic appearance of multiple myeloma. (<a class="LK" href="sid806035.html#R246-11">8</a>)</div>
<div class="P">Most fibrosarcomas are medullary lesions with a ratio of 2:1, medullary to periosteal. (<a class="LK" href="sid806035.html#R239-11">1</a>) The classic location is the metaphysis, with the typical lesion being eccentrically placed. Extension into the epiphysis and even isolated mid-diaphyseal involvement occurs. (<a class="LK" href="sid806035.html#R245-11">7</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3583" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Inspection of the gross specimen reveals a fibrous mass that is fleshy, firm, and grayish white in color. (<a class="LK" href="sid806035.html#R240-11">2</a>) These tumors may grow to enormous size, creating large, hemorrhagic, necrotic central areas. (<a class="LK" href="sid806035.html#R247-11">9</a>)</div>
<div class="P">Microscopically, the cellular pattern varies greatly from poorly differentiated to more mature forms. Spindle-shaped fibroblasts are commonly found in the less malignant forms, with interlaced bundles of collagen fibers. (<a class="LK" href="sid806035.html#R248-11">10</a>) In the more highly malignant (undifferentiated) lesions, considerable irregularity and marked anaplasia of the fibroblasts are commonplace, with multiple nuclei and hyperchromatism. (<a class="LK" href="sid806035.html#R248-11">10</a>) These lesions are commonly referred to as <span class="emph_I">malignant fibrous histiocytoma</span> (MFH). (<a class="LK" href="sid806035.html#R249-11">11</a>) Necrosis, hemorrhage, and, on occasion, secondary calcification may be observed. Bony sequestration may be found histologically and radiographically. (<a class="LK" href="sid806035.html#R250-11">12</a>) Fibrosarcoma is the only primary malignant bone tumor in which sequestration can frequently be found. (<a class="LK" href="sid806035.html#R250-11">12</a>)</div>
<div class="P">Many fibrous tumors present histologically between a low grade and a high grade of cellular activity, posing a problem for
<a name="PG1206"> </a><div class="pagenum"><div>P.1206</div></div>
<br clear="all">
the pathologist in making definitive conclusions microscopically. This is often the case in evaluating patients with fibrosarcoma. Correlation of the clinical data with the radiographic signs is heavily relied on by most pathologists. Lichtenstein (<a class="LK" href="sid806035.html#R251-11">13</a>) provided a helpful rule of thumb: &#x201C;If a lesion suggests a primary malignant bone tumor but not any one in particular, then think of fibrosarcoma as a possibility, especially if the lesion is in the femur or tibia of an adult.&#x201D;</div>
<div class="FG" id="F133-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="296" height="700" src="files/d0d31896b2a16dcf54fb2579eaee348c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d0d31896b2a16dcf54fb2579eaee348c.gif" MIMETYPE="image/gif" WIDTH="296" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-133 <span class="emph_B">SKELETAL DISTRIBUTION OF FIBROSARCOMA.</span>
</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3584" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiologic findings in fibrosarcoma are generally those of a highly destructive, expanding lesion, which is usually medullary in its site of origin. The typical presentation is an eccentric, lytic lesion causing cortical thinning and endosteal erosion of a long bone. (<a class="LK" href="sid806035.html#F135-11">Fig. 11-135</a>) Most lesions at the time of detection measure &#x003E; 5 cm. (<a class="LK" href="sid806035.html#R240-11">2</a>) The lytic lesion usually demonstrates no matrix calcification and appears purely radiolucent. The non-invasive (low-grade anaplastic) type of lesion may appear benign initially, but as the tumor grows, breaking the cortex and producing a well-defined soft tissue mass, its malignant nature is revealed. Fibrosarcoma is one of the most common primary malignant bone tumors to produce a &#x201C;huge&#x201D; soft tissue mass, usually larger than any other neoplasm. (<a class="LK" href="sid806035.html#R252-11">14</a>) (<a class="LK" href="sid806035.html#F136-11">Fig. 11-136</a>) A permeating, destructive pattern showing poorly defined, fuzzy margins at the boundary of the tumor may be encountered. Seldom is there any significant periosteal reaction or a Codman&#x2019;s triangle. (<a class="LK" href="sid806035.html#T17-11">Table 11-17</a>)</div>
<div class="FG" id="F134-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="433" height="700" src="files/03288b37f4f193e902c7da58d9a2d382.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="03288b37f4f193e902c7da58d9a2d382.gif" MIMETYPE="image/gif" WIDTH="433" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-134 <span class="emph_B">FIBROSARCOMA: L5. A. AP Lumbar Spine. B. Oblique Lumbar Spine.</span> Observe the destructive osteolytic lesion of the L5 vertebral body. Destruction of the pedicle of the L5 vertebra is also noted. The destructive pattern has given a coarsened appearance to the remaining trabeculae. This is a rare site for fibrosarcoma.</div>
</td></tr>
</table></div>
<div class="TLV4" id="B01382540.0-3585" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[5]/TLV4[1]">
<div class="HD">Secondary Fibrosarcoma</div>
<div class="P">Secondary fibrosarcoma develops in the interior of a bone at the site of a pre-existing benign bone disorder. (<a class="LK" href="sid806035.html#R240-11">2</a>) Some of the pre-existing osseous conditions in which this may occur are fibrous dysplasia, Paget&#x2019;s disease, postradiation, chronic osteomyelitis, and bone infarct. (<a class="LK" href="sid806035.html#R253-11">15</a>,<a class="LK" href="sid806035.html#R254-11">16</a>,<a class="LK" href="sid806035.html#R255-11">17</a>,<a class="LK" href="sid806035.html#R256-11">18</a>) A variant fibrous neoplasm
<a name="PG1207"> </a><div class="pagenum"><div>P.1207</div></div>
<br clear="all">
has been known to complicate bone infarcts, creating a destructive lytic lesion adjacent to the infarction. It is termed <span class="emph_I">malignant fibrous histiocytoma of bone</span> (MFH). (<a class="LK" href="sid806035.html#R257-11">19</a>,<a class="LK" href="sid806035.html#R258-11">20</a>) Approximately 30&#x0025; of the fibrosarcomas in a Mayo Clinic series were secondary to other pre-existent bone lesions or followed prior radiation. (<a class="LK" href="sid806035.html#R244-11">6</a>)</div>
<div class="FG" id="F135-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[5]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="462" height="700" src="files/dea4b829b27ea0cfe864ed764dba5f8f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="dea4b829b27ea0cfe864ed764dba5f8f.gif" MIMETYPE="image/gif" WIDTH="462" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-135 <span class="emph_B">FIBROSARCOMA. Distal Femur.</span> Observe the eccentric permeative lesions in the distal diaphysis, metaphysis, and subarticular portion of the distal femur. Cortical disruption suggests malignant disease.</div>
</td></tr>
</table></div>
<div class="FG" id="F136-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[5]/TLV4[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="509" src="files/dc3266098e5ecfddddfb8ec22eacbfb0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="dc3266098e5ecfddddfb8ec22eacbfb0.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="509" DISPLAY="INLINE"></div>
<div class="P">Figure 11-136 <span class="emph_B">FIBROSARCOMA WITH A LARGE SOFT TISSUE MASS. A. AP Femur. B. Lateral Femur.</span> Note the radiolucent destructive lesion in the medial condyle of the distal femur. Observe the large soft tissue mass in the medial portion of the thigh and knee. This large soft tissue mass extends posteriorly, completely filling and distorting the popliteal fossa.</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3586" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[5]/TLV4[2]">
<div class="HD">Metastases</div>
<div class="P">Fibrosarcoma characteristically metastasizes late, except in the highly malignant aggressive lesions. Metastatic deposits to the lung and liver are common. This is one of the few primary bone tumors that may selectively metastasize to the lymphatic system. (<a class="LK" href="sid806035.html#R250-11">12</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3587" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">The treatment of choice for fibrosarcoma is amputation, which usually requires some form of joint disarticulation. (<a class="LK" href="sid806035.html#R239-11">1</a>) Even after surgical interventions the probability of metastases is usually &#x003E; 70&#x0025;. (<a class="LK" href="sid806035.html#R241-11">3</a>) The overall 5-year survival rate is approximately 30&#x0025; (<a class="LK" href="sid806035.html#R245-11">7</a>,<a class="LK" href="sid806035.html#R252-11">14</a>); age &#x003E; 40 years (<a class="LK" href="sid806035.html#R259-11">21</a>) and a medullary location of the tumor signify a poorer outcome. (<a class="LK" href="sid806035.html#R244-11">6</a>) Patients with medullary lesions had a uniformly poorer prognosis (17-27&#x0025; 5-year survival) compared with those with periosteal lesions (40-58&#x0025; 5-year survival). (<a class="LK" href="sid806035.html#R245-11">7</a>)</div>
<div class="TB" id="T17-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-17 Features of Fibrosarcoma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Age</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>30-50 years</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Location</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Femur, tibia (50&#x0025;)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Humerus</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Radiologic features</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Metaphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Eccentric</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Moth-eaten or permeative destruction</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Cortical disruption</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Wide zone of transition</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Large soft tissue mass</p></td>
</tr>
</table></td></tr>
</table></div>
<a name="PG1208"> </a><div class="pagenum"><div>P.1208</div></div>
<br clear="all">
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3588" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Fibrosarcoma</div>
<div class="TLV2" id="B01382540.0-3589" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Lesion presents as two types: medullary (or central) and periosteal.</div></li>
<li class="LM"><div class="P">Most arise de novo; some may complicate previous benign osseous disorders (Paget&#x2019;s, fibrous dysplasia, etc.).</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3590" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents 2&#x0025; of all primary malignant bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3591" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most commonly found in the 30- to 50-year age range.</div></li>
<li class="LM"><div class="P">Chief complaints are localized pain and swelling, with a long duration of symptoms.</div></li>
<li class="LM"><div class="P">One third of the tumors present initially with pathologic fracture.</div></li>
<li class="LM"><div class="P">50&#x0025; of cases occur about the knee, with the femur, tibia, and humerus being the most common bones involved.</div></li>
<li class="LM"><div class="P">The metaphysis is the classic location for this tumor.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3592" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The only primary malignant bone tumor in which sequestration is found.</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Lichtenstein&#x2019;s rule:</span> When any primary malignant-looking lesion in the tibia or femur is not definitively identified, fibrosarcoma should be given prime consideration.</div></li>
<li class="LM"><div class="P">One of the few primary malignant bone tumors that selectively spreads to the lymphatic system.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3593" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Highly destructive medullary lesion, lytic, and eccentrically placed within a long bone.</div></li>
<li class="LM"><div class="P">Produces the largest soft-tissue mass of all the primary malignant tumors.</div></li>
<li class="LM"><div class="P">Seldom is there periosteal response or Codman&#x2019;s triangle.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3594" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Secondary Fibrosarcoma</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Develops in the interior of the bone at the site of a preexisting benign bone disorder.</div></li>
<li class="LM"><div class="P">The most common conditions to undergo change to secondary fibrosarcoma are Paget&#x2019;s disease, fibrous dysplasia, osteomyelitis, postradiation, and bone infarct.</div></li>
<li class="LM"><div class="P">Malignant degeneration of bone infarction to malignant fibrous histiocytoma (MFH).</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3595" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[10]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[7]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Treatment of choice is amputation with joint disarticulation.</div></li>
<li class="LM"><div class="P">5-year survival rate is approximately 30&#x0025;.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3596" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]">
<div class="HD">CHORDOMA</div>
<div class="TLV3" id="B01382540.0-3597" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Chordoma is a rare primary malignant bone tumor that arises from the vestigial remnants of the notochord, which have persisted within the nucleus pulposus of the intervertebral disc, or from aberrant cell rests of notochordal tissue within the vertebral bodies. (<a class="LK" href="sid806035.html#R260-11">1</a>) It is a locally aggressive tumor that grows slowly, invades the surrounding soft tissue by direct extension, and seldom metastasizes. Chordomas have a distinct predilection for the ends of the axial skeleton (sacrococcygeal and spheno-occipital locations represent 85&#x0025; of cases). (<a class="LK" href="sid806035.html#R261-11">2</a>,<a class="LK" href="sid806035.html#R262-11">3</a>) Unfortunately, this tumor is usually not diagnosed until it is fairly far advanced and has grown to large proportions. Until recently, almost all patients with this disease eventually died of it.</div>
</div>
<div class="TLV3" id="B01382540.0-3598" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Chordomas are relatively infrequent tumors; approximately 1000 cases have been reported, with an estimated overall incidence of 1&#x0025; of all primary malignant bone tumors. (<a class="LK" href="sid806035.html#R261-11">2</a>) Some specialized major medical referral centers have reported an unusually high incidence of 4&#x0025;. (<a class="LK" href="sid806035.html#R261-11">2</a>) It makes up at least 40&#x0025; of sacral tumors. (<a class="LK" href="sid806035.html#R263-11">4</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3599" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3600" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">The greatest incidence of chordoma occurs between the ages of 40 and 70 years. (<a class="LK" href="sid806035.html#R262-11">3</a>) No age group is exempt, and cases have been reported in neonates. (<a class="LK" href="sid806035.html#R262-11">3</a>) Chordoma affects males more commonly than females in a ratio of approximately 2:1. (<a class="LK" href="sid806035.html#R264-11">5</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3601" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="TLV5" id="B01382540.0-3602" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[3]/TLV4[2]/TLV5[1]">
<div class="HD"><span class="emph_I">Sacrococcygeal Chordoma.</span></div>
<div class="P">Sacrococcygeal chordoma is a slow-growing lesion that may enlarge quite silently over the course of months or even years. Symptoms are caused by the mass effect of a slowly expanding tumor. Initial symptoms are often mild, such as perineal pain and numbness, and the patient may not seek medical care until the tumor is large. Symptoms eventually result from pressure by the tumor on such adjacent extravertebral structures as the intestinal and urinary tracts and emerging nerve roots. (<a class="LK" href="sid806035.html#R265-11">6</a>) Constipation is a common complaint because of local intrapelvic pressure of the tumor mass, while rectal bleeding is rare. (<a class="LK" href="sid806035.html#R265-11">6</a>) Urinary symptoms, such as frequency, urgency, and hesitancy, may be mild at first but later in the disease may become prominent, along with the development of urinary incontinence. As the lesion infiltrates the emerging pelvic nerves (sacral, pudendal, coccygeal), sciatic nerve motor and sensory disturbances may be observed.</div>
<a name="PG1209"> </a><div class="pagenum"><div>P.1209</div></div>
<br clear="all">
<div class="P">Patients with sacrococcygeal chordomas invariably have a presacral tumor mass that can be found on rectal examination. The mass is firm, fixed to the sacrum, and extrarectal. (<a class="LK" href="sid806035.html#R264-11">5</a>) Severe bladder dysfunction occurs late in the course of the disease as a result of either direct pressure from the mass or a neurogenic cord bladder.</div>
</div>
<div class="TLV5" id="B01382540.0-3603" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[3]/TLV4[2]/TLV5[2]">
<div class="HD"><span class="emph_I">Spheno-Occipital Chordoma.</span></div>
<div class="P">The symptoms of spheno-occipital chordoma result from a slowly expanding midline tumor at the base of the brain that produces increased intracranial pressure and encroachment on adjacent structures. This pressure produces early pontine or bulbar symptoms. The most consistent symptom is headache, often present for years. (<a class="LK" href="sid806035.html#R261-11">2</a>) Huvos (<a class="LK" href="sid806035.html#R261-11">2</a>) noted that &#x003E; 80&#x0025; of cases will present with headaches. Ocular disturbances are frequent, with complaints of blurred vision or diplopia. In most cases the tumor grows upward to produce cerebral involvement (hemiparesis), cerebellar involvement (ataxia), and cerebellar pontine angle involvement (deafness, dizziness, and tinnitus). (<a class="LK" href="sid806035.html#R260-11">1</a>) If the chordoma extends downward from the sphenoid area, it produces nasal discharge, local pain, and breathing difficulties because of nasal obstruction.</div>
</div>
<div class="TLV5" id="B01382540.0-3604" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[3]/TLV4[2]/TLV5[3]">
<div class="HD"><span class="emph_I">Vertebral Chordoma.</span></div>
<div class="P">Vertebral chordomas are slow-growing lesions that result in extrinsic pressure on nerve roots, the spinal cord, or adjacent extravertebral structures. In the cervical region the tumor often extends anteriorly and produces dysphagia, difficulty in breathing, and, occasionally, a palpable mass. (<a class="LK" href="sid806035.html#R266-11">7</a>) The sensory complaints include numbness in an arm or leg, usually followed by pain. Motor weakness develops in a significant number of patients, but paraplegia or quadriplegia occurs only as a late complication.</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3605" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">Chordomas may arise anywhere in the vertebral column from the region of the spheno-occipital synchondrosis to the tip of the coccyx. (<a class="LK" href="sid806035.html#R261-11">2</a>) An extensive analysis of the reported cases in the literature reveals a predilection toward the extremes of the vertebral column with approximately 50&#x0025; arising in the sacrococcygeal area (S3-S5), 35&#x0025; in the clivus of Blumenbach, and only 15&#x0025; in the true vertebrae. (<a class="LK" href="sid806035.html#R263-11">4</a>,<a class="LK" href="sid806035.html#R266-11">7</a>,<a class="LK" href="sid806035.html#R267-11">8</a>,<a class="LK" href="sid806035.html#R268-11">9</a>) (<a class="LK" href="sid806035.html#F137-11">Fig. 11-137</a>) The most common vertebral body involved by chordoma is C2 (<a class="LK" href="sid806035.html#R269-11">10</a>); the least involved area is within the thoracic spine. (<a class="LK" href="sid806035.html#R270-11">11</a>) Vertebral involvement is usually anterior, sparing the posterior elements. Intradural lesions are rare. (<a class="LK" href="sid806035.html#R271-11">12</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3606" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Chordomas originate from remnants of the fetal notochord and on gross inspection range from firm to semiliquid tumors, but they are usually soft, grayish, and semitransparent. (<a class="LK" href="sid806035.html#R272-11">13</a>,<a class="LK" href="sid806035.html#R273-11">14</a>) They are lobulated and well encapsulated in the soft tissues. Discoloration owing to old or recent hemorrhage may be noted. Occasionally, a chordoma contains focal calcification or ossification. Lesions at the base of the skull are small compared with sacral ones, presumably because lesions in the head lead to death before they can become large. (<a class="LK" href="sid806035.html#R267-11">8</a>,<a class="LK" href="sid806035.html#R269-11">10</a>)</div>
<div class="P">In the vertebral column usually more than one vertebral body is involved, either by spread along the posterior longitudinal ligament or by direct extension and destruction of the intervertebral disc. (<a class="LK" href="sid806035.html#R269-11">10</a>) Chordoma is the only primary malignant bone tumor that is known to cross the intervertebral disc and involve adjacent segments. (<a class="LK" href="sid806035.html#R262-11">3</a>,<a class="LK" href="sid806035.html#R264-11">5</a>,<a class="LK" href="sid806035.html#R269-11">10</a>)</div>
<div class="FG" id="F137-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="301" height="700" src="files/afaed5dc181d56b0aa26836a57a985ec.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="afaed5dc181d56b0aa26836a57a985ec.gif" MIMETYPE="image/gif" WIDTH="301" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-137 <span class="emph_B">SKELETAL DISTRIBUTION OF CHORDOMA.</span>
</div>
</td></tr>
</table></div>
<div class="P">Microscopically, the lesions may appear highly malignant, with cellular tissue elements composed of small, round, compact cells that show very little vacuolation of the cytoplasm. In other instances grossly distended vacuolated cells are characteristic and are called physaliphorous cells. These cells contain considerable intercellular mucin, indicating a more mature type of tumor. Because of these cellular variations, a chordoma may be incorrectly diagnosed as a fibrosarcoma or chondrosarcoma, particularly because cartilage tissue and calcification can be observed in the histologic section.</div>
</div>
<div class="TLV3" id="B01382540.0-3607" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiographic findings in almost all patients, regardless of location of the chordoma, are based on the pattern of bone involvement and the presence of a soft tissue mass. (<a class="LK" href="sid806035.html#R260-11">1</a>,<a class="LK" href="sid806035.html#R269-11">10</a>)</div>
<div class="TLV4" id="B01382540.0-3608" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[5]/TLV4[1]">
<div class="HD">Sacrococcygeal Chordoma</div>
<div class="P">To detect an early lesion it is essential to obtain optimum quality radiographs. These are best taken in the AP position, with a central ray angled 30&#x00B0; cephalad. Lateral radiographs are also helpful in detecting the presence of an anterior soft tissue mass. Tomograms may also be useful when gas and fecal material obscure the sacrum and coccyx.</div>
<a name="PG1210"> </a><div class="pagenum"><div>P.1210</div></div>
<br clear="all">
<div class="P">Some authors (<a class="LK" href="sid806035.html#R260-11">1</a>,<a class="LK" href="sid806035.html#R261-11">2</a>) state that the sacral lesions are usually midline; however, other studies reveal that many sacral chordomas may be eccentrically placed. (<a class="LK" href="sid806035.html#R274-11">15</a>) Irregular lytic areas of bone destruction are seen in up to 80&#x0025; of cases on plain film examination and at least 90&#x0025; on CT. (<a class="LK" href="sid806035.html#R263-11">4</a>) The lytic defect grows slowly, assuming an oval or circular shape with scalloped margins. (<a class="LK" href="sid806035.html#F138-11">Fig. 11-138</a>) As the tumor grows it causes cortical expansion and widening of the sacrum in the AP diameter. (<a class="LK" href="sid806035.html#F139-11">Fig. 11-139</a>)</div>
<div class="P">Centrally, the tumor usually contains incomplete septa and calcification. Amorphous calcification of the tumor mass may be noted on plain films in approximately 50&#x0025; of the cases. (<a class="LK" href="sid806035.html#R263-11">4</a>,<a class="LK" href="sid806035.html#R264-11">5</a>,<a class="LK" href="sid806035.html#R269-11">10</a>) (<a class="LK" href="sid806035.html#F140-11">Fig. 11-140</a>) A higher percentage (approaching 85&#x0025;) will show matrix calcification with the use of CT. (<a class="LK" href="sid806035.html#R275-11">16</a>) A soft tissue mass is noted on plain film in 78&#x0025; of the chordoma lesions, and CT scans reveal a soft tissue mass in 93&#x0025; of the patients. (<a class="LK" href="sid806035.html#R275-11">16</a>)</div>
<div class="P">The differential diagnosis of sacral chordoma lesions must include osteolytic metastatic carcinoma, chondrosarcoma, giant cell tumor, aneurysmal bone cyst, and plasmacytoma. These lesions seldom have a soft tissue mass associated with bone destruction. The most difficult lesion to differentiate is chondrosarcoma because it also produces a large soft tissue mass and frequently calcifies. Biopsy may be the only means of final differentiation.</div>
</div>
<div class="TLV4" id="B01382540.0-3609" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[5]/TLV4[2]">
<div class="HD">Spheno-Occipital Chordoma</div>
<div class="P">The radiographic manifestations of cranial chordomas are numerous and varied and may simulate other, more common brain tumors. Most lesions occur in the midline region of the clivus of Blumenbach or adjacent to the sella turcica. Extensive bone destruction of these areas eventually occurs, often showing flocculent calcification in a large soft tissue mass. (<a class="LK" href="sid806035.html#F141-11">Fig. 11-141</a>)</div>
<div class="FG" id="F138-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[5]/TLV4[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="483" src="files/7183bcbdd5b3f5524bb86dbcaf838218.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7183bcbdd5b3f5524bb86dbcaf838218.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="483" DISPLAY="INLINE"></div>
<div class="P">Figure 11-138 <span class="emph_B">CHORDOMA. A. AP Sacrum.</span> Observe the ill-defined loss of bone density in the middle to lower portion of the sacrum. The trabecular patterns appear to be washed out. <span class="emph_B">B. Tomogram, AP Sacrum.</span> Note that the tomographic evaluation of the sacral lesion reveals a large expansile chordoma of the sacrum much larger than can be appreciated on the initial plain film. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3610" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[5]/TLV4[3]">
<div class="HD">Vertebral Chordoma</div>
<div class="P">Roentgen signs include loss of vertebral bone density, partial or complete pathologic fracture, and often an associated large soft tissue mass. (<a class="LK" href="sid806035.html#F142-11">Fig. 11-142</a>) These radiographic signs are not unique to chordoma because myeloma and metastatic disease quite often present in a similar fashion (<a class="LK" href="sid806035.html#R269-11">10</a>); however, when contiguous vertebral bodies are involved, with destruction of the intervertebral disc, chordoma is the most likely diagnosis, providing that infection has been ruled out. Chordoma is the only primary malignant bone tumor that crosses the joint space. (<a class="LK" href="sid806035.html#R269-11">10</a>)</div>
<div class="P">A radiopaque vertebral body or an ivory vertebra resulting from chordoma may occur anywhere in the spine. The C2 vertebral
<a name="PG1211"> </a><div class="pagenum"><div>P.1211</div></div>
<br clear="all">
body is the most common vertebral body site to be involved, with either lytic or blastic lesions. (<a class="LK" href="sid806035.html#F143-11">Fig. 11-143</a>) Owing to the lack of pathognomonic findings on any imaging modality, diagnosis usually is not made before biopsy. (<a class="LK" href="sid806035.html#R276-11">17</a>) (<a class="LK" href="sid806035.html#T18-11">Table 11-18</a>)</div>
<div class="FG" id="F139-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[5]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="440" src="files/4581db1cb4c193b4a6ed4776f105d780.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4581db1cb4c193b4a6ed4776f105d780.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="440" DISPLAY="INLINE"></div>
<div class="P">Figure 11-139 <span class="emph_B">SACRAL CHORDOMA. AP Pelvis.</span> Observe the destructive lesion in the distal surface of the sacrum.</div>
</td></tr>
</table></div>
<div class="FG" id="F140-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[5]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="423" src="files/28fdffef99766d454f0eca5c89795504.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="28fdffef99766d454f0eca5c89795504.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="423" DISPLAY="INLINE"></div>
<div class="P">Figure 11-140 <span class="emph_B">SACRAL CHORDOMA. A. AP Sacrum. B. Tomogram, AP Sacrum.</span> Observe the grossly destructive lesion in the midportion of the sacrum. Flocculent calcification is scattered throughout the tumor matrix. <span class="emph_BIT">COMMENT:</span> Amorphous calcification of the tumor mass may be noted on plain films in approximately 50&#x0025; of chordomas. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Chordoma.</span> ACA J Chiro March, 1983.)</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3611" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">The treatment for chordomas varies according to location, with surgical resection being the only hope for permanent cure. (<a class="LK" href="sid806035.html#R264-11">5</a>) Overall, irrespective of location, the median survival rate after diagnosis is approximately 6.3 years. (<a class="LK" href="sid806035.html#R277-11">18</a>) The sacrococcygeal lesions are most amenable to resection; however, historically, resection above the S2 segment has been avoided for fear of denervation of the anorectal and urogenital structures. Because of this surgical rule, many lesions were inadequately removed, and recurrence rates were extremely high. Reoccurrence will usually occur within the first 2 years of resection. (<a class="LK" href="sid806035.html#R278-11">19</a>) Studies have reported on consequences of extensive surgical sacral resections, including sacral nerve roots, and have indicated that the extensive resections are tolerated reasonably well months and years later by the patients. (<a class="LK" href="sid806035.html#R279-11">20</a>,<a class="LK" href="sid806035.html#R280-11">21</a>) Gunterberg et al. (<a class="LK" href="sid806035.html#R279-11">20</a>) reported that if just the upper half of the body of the S1 vertebra remains bilaterally, the pelvic girdle retains sufficient strength to permit standing and will not lead to collapse of the bones of the pelvis.</div>
<div class="FG" id="F141-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="222" src="files/67cb13b090e82f38db0e9253d76eb498.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="67cb13b090e82f38db0e9253d76eb498.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="222" DISPLAY="INLINE"></div>
<div class="P">Figure 11-141 <span class="emph_B">SPHENO-OCCIPITAL CHORDOMA. A. AP Towne&#x2019;s Projection. B. Lateral Skull.</span> Observe the extensive destruction in the area of the clivus. Considerable flocculent calcification is present within the destructive soft tissue mass (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="P">The treatment of intracranial chordomas is quite discouraging because the operative mortality rate is high and complete resection is rarely attainable. (<a class="LK" href="sid806035.html#R261-11">2</a>) The same is also true for the vertebral body lesions. Irradiation has been the most commonly employed treatment for clivus and vertebral body lesions; however, recently proton beam irradiation has shown to improve the prognostic outcome of any lesion that has undergone incomplete resection. (<a class="LK" href="sid806035.html#R281-11">22</a>,<a class="LK" href="sid806035.html#R282-11">23</a>)</div>
<a name="PG1212"> </a><div class="pagenum"><div>P.1212</div></div>
<br clear="all">
<div class="FG" id="F142-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="406" src="files/38090be0b6a01945c76b9f9952a869fe.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="38090be0b6a01945c76b9f9952a869fe.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="406" DISPLAY="INLINE"></div>
<div class="P">Figure 11-142 <span class="emph_B">CHORDOMA: C2. A. Lateral Upper Cervical Spine.</span> Observe the subtle osteolytic destruction of the vertebral body and proximal lamina of C2. The retropharyngeal interspace has been dramatically increased with the presence of a soft tissue mass (<span class="emph_I">arrows</span>). <span class="emph_B">B. T2-Weighted MRI, Sagittal Cervical Spine.</span> Observe the destruction of the C2 vertebral body with a large extension of the tumor mass to the anterior soft tissue planes at the C2-C4 levels. <span class="emph_BIT">COMMENT:</span> Approximately 50&#x0025; of chordomas occur in the sacrococcygeal area, 35&#x0025; in the clivus, and 15&#x0025; in the spine. The most common vertebral body involved by chordoma is C2. (Reprinted with permission from <span class="emph_B">JNMS,</span> Vol. 5, No. 3, Fall 1997. Courtesy of Stephen F. Brown, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Dunmore, Pennsylvania.)</div>
</td></tr>
</table></div>
<div class="FG" id="F143-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="468" src="files/5652579d8910c33b5b0cdd97ab221434.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5652579d8910c33b5b0cdd97ab221434.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="468" DISPLAY="INLINE"></div>
<div class="P">Figure 11-143 <span class="emph_B">CERVICAL CHORDOMA. A. Lateral Cervical Spine. B. Tomogram, Lateral Cervical Spine.</span> Note that there is nearly complete collapse of the C2 vertebral body, the neural arch, and the spinous process (<span class="emph_I">arrows</span>). Extension of this neoplastic process has created a large soft tissue mass, increasing the retropharyngeal interspace anterior to C2 and C3 (<span class="emph_I">arrowheads</span>). <span class="emph_BIT">COMMENT:</span> Vertebral chordomas represent 15&#x0025; of all chordomas, with the vertebral body of C2 being the most common site. Approximately 50&#x0025; of chordomas arise in the sacrococcygeal area, and 35&#x0025; in the clivus of Blumenbach.</div>
</td></tr>
</table></div>
<a name="PG1213"> </a><div class="pagenum"><div>P.1213</div></div>
<br clear="all">
<div class="P">The main malignant potentials of chordoma lie in its critical locations adjacent to vital structures, its locally aggressive nature, and its extremely high recurrence rate. The prognosis for cranial chordomas is poor; they are usually fatal within 3 years of the initial diagnosis. The cranial chordomas with considerable cartilaginous calcified elements have a much better prognosis than other chordomas. Vertebral chordomas also carry a poor prognosis, with most patients succumbing to the disease within 3 years. The prognosis for sacrococcygeal chordomas is somewhat better, with 8.7&#x0025; of patients surviving 5 years later. (<a class="LK" href="sid806035.html#R260-11">1</a>,<a class="LK" href="sid806035.html#R269-11">10</a>) It has been suggested that sacral chordomas affecting children are more aggressive than those affecting adults, resulting in an increased rate of morbidity in children. (<a class="LK" href="sid806035.html#R283-11">24</a>)</div>
<div class="TB" id="T18-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-18 Features of Chordoma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Age</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>50 years old</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Septated</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Location</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Scalloped margins</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Sacrococcygeal (50&#x0025;)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Soft tissue mass</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Clivus (35&#x0025;)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Matrix calcification (50&#x0025;)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Vertebrae (15&#x0025;)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ivory vertebra (rarely)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Features</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Majority central</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Lytic destruction</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3612" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Chordoma</div>
<div class="TLV2" id="B01382540.0-3613" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A rare primary malignant bone tumor arising from the vestigial remnants of the notochord.</div></li>
<li class="LM"><div class="P">Locally aggressive, with a slow growth rate.</div></li>
<li class="LM"><div class="P">A distinct predilection for the ends of the axial skeleton, specifically, the sacrococcygeal and spheno-occipital regions.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3614" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A rare primary malignant bone tumor with an overall incidence of 1&#x0025;.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3615" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">
<span class="emph_I">Sacrococcygeal chordoma:</span> Early on, the lesion may be clinically silent; later, as the tumor expands, localized pain with pressure symptoms from the bladder and rectum are common.</div></li>
<li class="LM">
<div class="P"><span class="emph_I">Spheno-occipital chordoma</span></div>
<div class="P">The most consistent symptom is headaches, often present for years.</div>
<div class="P">Pressure from the enlarging midline mass may create ocular disturbances, increased intracranial pressure, ataxia, deafness, and tinnitus.</div>
</li>
<li class="LM">
<div class="P">Vertebral chordoma</div>
<div class="P">In the cervical spine, dysphagia is a common presenting symptom.</div>
<div class="P">Sensory complaints include numbness in an arm or leg, usually followed by pain.</div>
<div class="P">Motor weakness may occur, with vertebral body collapse, creating paraplegia or quadriplegia as a late complication.</div>
</li>
<li class="LM"><div class="P">
<span class="emph_I">Location:</span> 50&#x0025; arise in the sacrococcygeal area; 35&#x0025; in the clivus of Blumenbach; 15&#x0025; in the true vertebrae, with the C2 body being the most common site.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3616" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A lobulated, well-encapsulated mass is found on gross inspection.</div></li>
<li class="LM"><div class="P">Most sacral lesions are not midline.</div></li>
<li class="LM"><div class="P">In the spine, usually more than one vertebral body is involved.</div></li>
<li class="LM"><div class="P">The only primary malignant bone tumor that is known to cross the intervertebral disc, involving adjacent spinal segments.</div></li>
<li class="LM"><div class="P">Microscopically, grossly distended vacuolated cells are characteristic and are called physaliphorous cells.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3617" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Lytic destruction, along with a soft tissue mass, is the most common roentgen sign. This destruction occurs in the sacral or base of skull area.</div></li>
<li class="LM"><div class="P">50&#x0025; of the tumors show amorphous calcification on plain films, 70&#x0025; with CT scans.</div></li>
<li class="LM"><div class="P">Rarely, a spinal lesion can present as a solitary ivory vertebra.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3618" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[11]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Treatment varies according to location.</div></li>
<li class="LM"><div class="P">Sacrococcygeal lesions are most amenable to resection.</div></li>
<li class="LM"><div class="P">Treatment for intracranial chordomas is discouraging because operative mortality is high.</div></li>
<li class="LM"><div class="P">Radiation therapy is the most commonly employed treatment for clival and vertebral body lesions.</div></li>
<li class="LM"><div class="P">The prognosis for intracranial and vertebral lesions is poor, with most patients dying within 3 years of the initial diagnosis.</div></li>
<li class="LM"><div class="P">The 5-year survival for sacrococcygeal chordomas is 8.7&#x0025;.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<a name="PG1214"> </a><div class="pagenum"><div>P.1214</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3619" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]">
<div class="HD">NON-HODGKIN&#x2019;S LYMPHOMA OF BONE (RETICULUM CELL SARCOMA)</div>
<div class="TLV3" id="B01382540.0-3620" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Reticulum cell sarcoma is currently referred to as non-Hodgkin&#x2019;s lymphoma of bone. Older terms for the same entity are reticulosarcoma, lymphosarcoma, and round cell sarcoma. Reticulum cell sarcoma, or non-Hodgkin&#x2019;s lymphoma, is a rare, extranodal lymphoma histologically identical with others arising in lymphoid or soft tissues but presenting initially as a localized solitary bone lesion. (<a class="LK" href="sid806035.html#R284-11">1</a>) In 1939, Parker and Jackson (<a class="LK" href="sid806035.html#R285-11">2</a>) presented the first group of 17 cases of primary reticulum cell bone sarcoma, establishing it as a distinct clinical entity separate from the generalized form of this disease.</div>
</div>
<div class="TLV3" id="B01382540.0-3621" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Within the perspective of malignancy arising from lymphoid tissue, non-Hodgkin&#x2019;s lymphoma is the most common type; however, overall this tumor is rare. (<a class="LK" href="sid806035.html#R286-11">3</a>) It constitutes only 3-4&#x0025; of all primary malignant bone tumors and 2.5&#x0025; of all bone tumors. (<a class="LK" href="sid806035.html#R287-11">4</a>,<a class="LK" href="sid806035.html#R288-11">5</a>) The skeletal system may be secondarily involved in about 30&#x0025; of malignant lymphomas. (<a class="LK" href="sid806035.html#R289-11">6</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3622" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3623" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">The majority of patients are between 20 and 40 years of age; however, a significant number of cases are recorded from 40 to 50 years of age. (<a class="LK" href="sid806035.html#R287-11">4</a>) At least 50&#x0025; of the cases occur before the age of 40. (<a class="LK" href="sid806035.html#R287-11">4</a>) Most authorities show a 2:1 male preponderance.</div>
</div>
<div class="TLV4" id="B01382540.0-3624" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Localized pain of an intermittent nature is present in almost all patients. (<a class="LK" href="sid806035.html#R290-11">7</a>) The nature of the pain is dull and aching and it is not relieved by rest. (<a class="LK" href="sid806035.html#R291-11">8</a>) One of the most striking clinical features of non-Hodgkin&#x2019;s lymphoma of bone is the general well-being of the patient. (<a class="LK" href="sid806035.html#R285-11">2</a>) In no other bone sarcoma is the contrast between the comparative well-being of the patient and the size of the lesion so marked. (<a class="LK" href="sid806035.html#R285-11">2</a>) More than 50&#x0025; of the patients report having minor symptoms related to the lesion for &#x003E; 1 year. (<a class="LK" href="sid806035.html#R284-11">1</a>) A palpable mass or soft tissue swelling is also found in many cases. (<a class="LK" href="sid806035.html#R290-11">7</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3625" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">The femur, tibia, and humerus are the most frequently affected bones. Approximately 40&#x0025; of the tumors occur around the knee. Other involved sites are pelvic bones, ribs, scapulae, and vertebrae. Most lesions are diaphyseal in location or affect the metaphysis adjacent to the diaphysis.</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3626" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Upon gross examination, the tumor is generally firm but often friable tissue that is grayish white or white. Necrosis and hemorrhage are frequently present. Histologically, the tumor tissue is composed of cells that contain a fairly large ovoid or spherical single nucleus (round cell) with nucleoli often present. The cytoplasm may be sparse, and mitotic figures are commonly observed. The intercellular stroma is present in varying amounts, but in a typical lesion delicate strands of reticulum may be seen around tumor cells by using special stains. Definitive histologic differentiation of non-Hodgkin&#x2019;s lymphoma of bone from other lymphomas is difficult. (<a class="LK" href="sid806035.html#R292-11">9</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3627" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">Classically, the lesion begins in the medullary bone (bone marrow) as a permeative lytic process. (<a class="LK" href="sid806035.html#F144-11">Fig. 11-144</a>) As the tumor enlarges, patchy areas of bone destruction spread to affect the adjacent cortical bone. Periosteal response is minimal and, if present, assumes a <span class="emph_I">laminated pattern.</span> Midshaft lesions usually break the cortex at a later stage than do metaphyseal tumors. By the time the cortex is disrupted, the medullary lesion becomes quite large and is easily observed. (<a class="LK" href="sid806035.html#F145-11">Fig. 11-145</a>) In the later stages of the destructive process, a soft tissue mass can be demonstrated, a
<a name="PG1215"> </a><div class="pagenum"><div>P.1215</div></div>
<br clear="all">
sequel of direct extension of tumor through cortex and periosteum. (<a class="LK" href="sid806035.html#R293-11">10</a>,<a class="LK" href="sid806035.html#R294-11">11</a>) This lytic presentation may be confused with another round cell tumor, Ewing&#x2019;s sarcoma; however, the periosteal reactions are much less prominent, and the patients tend to be older in non-Hodgkin&#x2019;s lymphoma of bone. (<a class="LK" href="sid806035.html#F146-11">Fig. 11-146</a>)</div>
<div class="FG" id="F144-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="294" height="700" src="files/fcb56dc493f42ff57db7f2e8b7ee03c1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fcb56dc493f42ff57db7f2e8b7ee03c1.gif" MIMETYPE="image/gif" WIDTH="294" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-144 <span class="emph_B">SKELETAL DISTRIBUTION OF NON-HODGKIN&#x2019;S LYMPHOMA OF BONE (RETICULUM CELL SARCOMA).</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F145-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="423" height="700" src="files/988a2a3b6c000c6e2fd9141849d4a270.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="988a2a3b6c000c6e2fd9141849d4a270.gif" MIMETYPE="image/gif" WIDTH="423" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-145 <span class="emph_B">NON-HODGKIN&#x2019;S LYMPHOMA. Humerus.</span> Observe the multiple permeative lesions in the medullary portion of the diaphysis of the humerus. <span class="emph_I">COMMENT:</span> These lesions simulate the destructive appearance in multiple myeloma. Reticulum cell sarcoma, multiple myeloma, and Ewing&#x2019;s sarcoma are round cell tumors, and their patterns of destruction are often similar.</div>
</td></tr>
</table></div>
<div class="FG" id="F146-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="561" src="files/d1830e39ee1349fcaab34678992b0f6b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d1830e39ee1349fcaab34678992b0f6b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="561" DISPLAY="INLINE"></div>
<div class="P">Figure 11-146 <span class="emph_B">NON-HODGKIN&#x2019;S LYMPHOMA. A. Proximal Femur.</span> Note the extensive permeative destruction around the proximal diaphysis of the femur. Destruction of the cortices and pathologic fracture are noted. <span class="emph_B">B. Distal Femur.</span> Observe the permeative lesions affecting the distal diaphysis and metaphysis of the femur.</div>
</td></tr>
</table></div>
<div class="P">Pathologic fracture is common and may be the initial complaint. (<a class="LK" href="sid806035.html#F147-11">Fig. 11-147</a>) It occurs more frequently in this disease than with any other primary malignant bone tumor because the symptoms are so mild and the lesions are of such long duration. (<a class="LK" href="sid806035.html#R295-11">12</a>) Occasionally, the lesions may be sclerotic in presentation, mimicking an osteoblastic metastatic process. (<a class="LK" href="sid806035.html#R296-11">13</a>) Spinal involvement, including the sacrum, may cause vertebral collapse and destruction indistinguishable from metastatic disease or solitary plasmacytoma. (<a class="LK" href="sid806035.html#R287-11">4</a>,<a class="LK" href="sid806035.html#R296-11">13</a>) (<a class="LK" href="sid806035.html#T19-11">Table 11-19</a>) CT scanning will similarly reveal the osteosclerotic, osteolytic or mixed patterns during examination. (<a class="LK" href="sid806035.html#R297-11">14</a>)</div>
<div class="FG" id="F147-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="461" height="700" src="files/c8b6633ec0b0d39865aa183dea5a1129.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c8b6633ec0b0d39865aa183dea5a1129.gif" MIMETYPE="image/gif" WIDTH="461" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-147 <span class="emph_B">NON-HODGKIN&#x2019;S LYMPHOMA: PATHOLOGIC FRACTURE. Humerus.</span> Observe the pathologic fracture through the lytic destructive lesions of reticulum cell sarcoma in the proximal humerus of this 34-year-old female patient.</div>
</td></tr>
</table></div>
<div class="TB" id="T19-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-19 Features of Non-Hodgkin&#x2019;s Lymphoma of Bone (Reticulum Cell Sarcoma)</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Age</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>20-40 years</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Males 2:1</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Remarkably asymptomatic</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Location</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Long bones</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Pelvis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ribs</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Features</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Metaphyseal, diaphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Minimal periosteal response</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Moth-eaten destruction</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Cortical disruption</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Pathologic fracture</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Soft tissue mass</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<a name="PG1216"> </a><div class="pagenum"><div>P.1216</div></div>
<br clear="all">
<div class="TLV3" id="B01382540.0-3628" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">The treatment of choice for primary non-Hodgkin&#x2019;s lymphoma of bone is radiation therapy and adjuvant chemotherapy; however, there is no substantial evidence that this combined therapy is more beneficial than isolated therapies of radiation and&#x002F;or chemotherapy alone. (<a class="LK" href="sid806035.html#R284-11">1</a>,<a class="LK" href="sid806035.html#R290-11">7</a>) The prognosis for this tumor is better than that for the majority of the primary malignant bone tumors. The 5-year survival rate is approximately 48&#x0025;, whereas the 10-year survival rate is 33&#x0025;. (<a class="LK" href="sid806035.html#R296-11">13</a>) It is currently believed that these prognostic values are gradually increasing owing to new drug interventions in the treatment of this disease. (<a class="LK" href="sid806035.html#R286-11">3</a>) It is important to note that CT follow-up examinations will often not become negative for a period of &#x003E; 1 year after treatment. (<a class="LK" href="sid806035.html#R297-11">14</a>,<a class="LK" href="sid806035.html#R298-11">15</a>)</div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3629" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Non-Hodgkin&#x2019;s Lymphoma</div>
<div class="TLV2" id="B01382540.0-3630" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Also known as reticulum cell sarcoma of bone.</div></li>
<li class="LM"><div class="P">A rare extranodal lymphoma presenting initially as a localized solitary bone lesion.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3631" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents only 3-4&#x0025; of all primary malignant bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3632" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">20-40 years of age is the usual range; at least 50&#x0025; of the cases occur before age 40.</div></li>
<li class="LM"><div class="P">Male preponderance is 2:1.</div></li>
<li class="LM"><div class="P">There is localized pain of an intermittent nature.</div></li>
<li class="LM"><div class="P">A striking clinical feature is the contrast between the apparent well-being of the patient and the size of the lesion.</div></li>
<li class="LM"><div class="P">&#x003E; 50&#x0025; of patients report symptoms related to the lesion for &#x003E; 1 year.</div></li>
<li class="LM"><div class="P">The femur, tibia, and humerus are the most frequently affected bones.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3633" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Histologically, the tumor tissue is composed of cells that contain a fairly large, ovoid or spheroid single nucleus (round cell).</div></li>
<li class="LM"><div class="P">One of the round cell tumors, along with Ewing&#x2019;s sarcoma and multiple myeloma.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3634" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A permeative medullary destruction within the diaphysis or metaphysis of a long tubular bone represents the classic location.</div></li>
<li class="LM"><div class="P">Minimal laminated periosteal response may occur.</div></li>
<li class="LM"><div class="P">Development of a well-defined soft tissue mass.</div></li>
<li class="LM"><div class="P">Differential diagnosis includes Ewing&#x2019;s sarcoma, which may be done by age and the degree of periosteal response, which is greater in Ewing&#x2019;s sarcoma.</div></li>
<li class="LM"><div class="P">Pathologic fracture is found more frequently in this disease than with any other primary malignant bone tumor.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3635" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[12]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Radiation therapy, with adjuvant chemotherapy, is the treatment of choice.</div></li>
<li class="LM"><div class="P">5-year survival rate is approximately 48&#x0025;.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3636" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[13]">
<div class="HD">HODGKIN&#x2019;S LYMPHOMA OF BONE</div>
<div class="TLV3" id="B01382540.0-3637" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[13]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Hodgkin&#x2019;s lymphoma of bone may occur as a secondary manifestation of systemic Hodgkin&#x2019;s lymphoma (chest, liver, spleen, and nodes) or, rarely, as a primary bone lesion in the absence of nodal involvement. (<a class="LK" href="sid806035.html#R299-11">1</a>,<a class="LK" href="sid806035.html#R300-11">2</a>) Pain is the most common initial symptom; however, some clinically silent lesions exist and the majority of patients have other non-osseous lesions. (<a class="LK" href="sid806035.html#R301-11">3</a>) The lytic lesions are usually more symptomatic than the sclerotic ones. (<a class="LK" href="sid806035.html#R302-11">4</a>) Neurological signs may accompany spinal lesions, usually resulting from vertebral collapse and spinal cord compression. (<a class="LK" href="sid806035.html#R303-11">5</a>) Many patients report initial pain and intensification of existent pain after alcohol consumption. (<a class="LK" href="sid806035.html#R304-11">6</a>,<a class="LK" href="sid806035.html#R305-11">7</a>) Diagnosis is often difficult; however, immunohistochemical staining techniques of the involved lesions have been shown to aid in the diagnosis. (<a class="LK" href="sid806035.html#R301-11">3</a>) The prognosis of this condition has been good within the last 10 years with appropriate chemotherapeutic agents. (<a class="LK" href="sid806035.html#R301-11">3</a>,<a class="LK" href="sid806035.html#R306-11">8</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3638" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[13]/TLV3[2]">
<div class="HD">Location</div>
<div class="P">The primary site of skeletal involvement in Hodgkin&#x2019;s lymphoma is the vertebral body. The lower thoracic and upper lumbar spine is the target region. (<a class="LK" href="sid806035.html#R303-11">5</a>,<a class="LK" href="sid806035.html#R307-11">9</a>) Other bones may be involved, such as
<a name="PG1217"> </a><div class="pagenum"><div>P.1217</div></div>
<br clear="all">
the innominate, scapula, sternum, ribs, and femur. (<a class="LK" href="sid806035.html#F148-11">Fig. 11-148</a>) Between 10&#x0025; and 20&#x0025; of patients with Hodgkin&#x2019;s lymphoma develop skeletal disease.</div>
<div class="FG" id="F148-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[13]/TLV3[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="298" height="700" src="files/122d53e5169f420db44d7c934b170c12.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="122d53e5169f420db44d7c934b170c12.gif" MIMETYPE="image/gif" WIDTH="298" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-148 <span class="emph_B">SKELETAL DISTRIBUTION OF HODGKIN&#x2019;S LYMPHOMA OF BONE.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F149-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[13]/TLV3[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="321" src="files/99d7b333a79bc0263b96f39c55798f4e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="99d7b333a79bc0263b96f39c55798f4e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="321" DISPLAY="INLINE"></div>
<div class="P">Figure 11-149 <span class="emph_B">HODGKIN&#x2019;S LYMPHOMA OF BONE: IVORY VERTEBRA. A. Lateral Thoracic Spine.</span> Observe the ivory vertebra at the T12 level in this 34-year-old female who presented with an 11-year history of Hodgkin&#x2019;s lymphoma. There is scalloping of the anterior vertebral body (<span class="emph_I">arrows</span>). <span class="emph_B">B. AP Thoracic Spine. C. Lateral Thoracic Spine.</span> Observe the diffuse radiopacity throughout the entire vertebral body of T9 (ivory vertebra). No anterior vertebral scalloping is present in this case. <span class="emph_I">COMMENT:</span> The anterior and lateral scalloping of the vertebral body is characteristic in Hodgkin&#x2019;s lymphoma of the spine. When this radiographic sign is present in an ivory vertebra, it inevitably eliminates Paget&#x2019;s disease and osteoblastic metastatic disease from the differential diagnosis. (Pane A courtesy of Paul E. Siebert, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado. Panels B and C courtesy of Steven P. Brownstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Springfield, New Jersey.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3639" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[13]/TLV3[3]">
<div class="HD">Radiologic Features</div>
<div class="P">Radiographically, most lesions are osteolytic (75&#x0025;); sclerotic lesions also occur (15&#x0025;), and mixed destruction with a periosteal response occurs in 10&#x0025; of patients. (<a class="LK" href="sid806035.html#R308-11">10</a>) Polyostotic lesions are the case in two thirds of the patients. (<a class="LK" href="sid806035.html#R309-11">11</a>) With spinal involvement, scalloping of the anterior or lateral aspects of the vertebral body occurs. (<a class="LK" href="sid806035.html#R309-11">11</a>) Occasionally, a pronounced sclerotic reaction creates an ivory vertebra. (<a class="LK" href="sid806035.html#R307-11">9</a>,<a class="LK" href="sid806035.html#R310-11">12</a>) (<a class="LK" href="sid806035.html#F149-11">Fig. 11-149</a>) In the tubular bones, lytic destruction predominates, with both medullary and cortical destruction. An exuberant periosteal response may occur as the cortex is compromised.</div>
<div class="P">The treatment and prognosis of Hodgkin&#x2019;s lymphoma is directly related to the stage of the disease at discovery. Radiation coupled with chemotherapy offers the most effective form of therapy. Previous 5-year survival rates have generally been 10&#x0025;; however, with early effective treatment the current 5-year survival rate approaches 80&#x0025;. (<a class="LK" href="sid806035.html#R311-11">13</a>)</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3640" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[14]">
<div class="HD">SYNOVIAL SARCOMA</div>
<div class="TLV3" id="B01382540.0-3641" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[14]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Synovial sarcoma (synovioma) is a mesenchymal sarcoma with a histologic pattern that in varying degrees mimics synovial tissue. Synovioma is a relatively uncommon neoplasm that is predominantly observed in the 30- to 50-year age range. No sex predilection exists. Clinically, pain and a soft tissue mass at the site of the tumor are the most common complaints. A clinical impression of monoarticular arthritis may be gained. The lower limbs are more often involved, with the knee, hip, and ankle being the most common sites. (<a class="LK" href="sid806035.html#R312-11">1</a>) (<a class="LK" href="sid806035.html#F150-11">Fig. 11-150</a>) Other areas, such as the wrist, elbow, and feet, have been documented. (<a class="LK" href="sid806035.html#F151-11">Fig. 11-151</a>) The lesion is invariably solitary. Synovial sarcoma is the only primary malignant tumor that is in direct anatomic relationship with the joint surface, bursae, or tendon sheaths. Rarely, synovial sarcoma can occur in the midshaft area of a long bone as a result of dissection of synovial tissue down the tendon sheaths. (<a class="LK" href="sid806035.html#R313-11">2</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3642" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[14]/TLV3[2]">
<div class="HD">Radiologic Features</div>
<div class="P">Synovioma appears as a nodular soft tissue mass near a joint, averaging 7 cm in diameter. (<a class="LK" href="sid806035.html#F152-11">Fig. 11-152</a>) Calcification occurs in approximately one third of the patients, appearing as fine, granular specks within the rounded soft tissue mass. (<a class="LK" href="sid806035.html#R314-11">3</a>) (<a class="LK" href="sid806035.html#F153-11">Figs. 11-153</a> and <a class="LK" href="sid806035.html#F154-11">11-154</a>) Secondary bone destruction is uncommon, occurring in only 10&#x0025; of cases. (<a class="LK" href="sid806035.html#R314-11">3</a>) Bony destruction takes the form of erosive changes primarily from extrinsic pressure. When actual bone invasion occurs, the margins of the lesion are ragged and ill-defined, usually having a wide zone of transition with no surrounding sclerosis or thickening. (<a class="LK" href="sid806035.html#R314-11">3</a>) MRI shows differing results, depending on size. Lesions &#x003C; 5 cm often demonstrate a non-aggressive nature with homogenous signal intensity and circumscribed margins, whereas larger lesions show an inhomogeneous
<a name="PG1218"> </a><div class="pagenum"><div>P.1218</div></div>
<br clear="all">
septated mass with infiltrative margins close to a joint, tendon, or bursae. (<a class="LK" href="sid806035.html#R315-11">4</a>,<a class="LK" href="sid806035.html#R316-11">5</a>)</div>
<div class="FG" id="F150-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[14]/TLV3[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="297" height="700" src="files/b1d9de34a89248792671914eae88c3cc.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b1d9de34a89248792671914eae88c3cc.gif" MIMETYPE="image/gif" WIDTH="297" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-150 <span class="emph_B">SKELETAL DISTRIBUTION OF SYNOVIAL SARCOMA.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F151-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[14]/TLV3[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="430" src="files/1f1524269b0e77b9269b248eab25f4a6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1f1524269b0e77b9269b248eab25f4a6.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="430" DISPLAY="INLINE"></div>
<div class="P">Figure 11-151 <span class="emph_B">SYNOVIAL SARCOMA. Wrist.</span> Note the rather large soft tissue mass on the dorsal surface of the forearm. Scattered throughout the soft tissue mass are faint linear calcifications (<span class="emph_I">arrows</span>). There is a lytic destructive lesion associated with this synovial sarcoma in the distal surface of the radius (<span class="emph_I">arrowhead</span>). (Courtesy of C. H. Quay, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F152-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[14]/TLV3[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="478" height="700" src="files/4facb8ce1605950bc429d0c984854237.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4facb8ce1605950bc429d0c984854237.gif" MIMETYPE="image/gif" WIDTH="478" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-152 <span class="emph_B">SYNOVIAL SARCOMA. Lateral Knee.</span> Note the well-defined spherical soft tissue mass (<span class="emph_I">arrows</span>) posterior to the distal femur. This represents a synovial sarcoma in one of its more common locations. (Courtesy of C. H. Quay, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F153-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[14]/TLV3[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="480" height="700" src="files/177a86f5fbdea53b0d4b52f411b070f9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="177a86f5fbdea53b0d4b52f411b070f9.gif" MIMETYPE="image/gif" WIDTH="480" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-153 <span class="emph_B">SYNOVIAL SARCOMA. Proximal Femur.</span> Note the extensive destruction of the lesser trochanter. A soft tissue mass with scattered flocculent calcification is seen adjacent to the lesser trochanter. <span class="emph_BIT">COMMENT:</span> This case is somewhat interesting in that there is secondary bone destruction of the lesser trochanter and cortex of the femoral neck. Secondary bone destruction is uncommon in synovial sarcoma, occurring in only 10&#x0025; of cases. The secondary destruction occurs as a result of erosion of bone from extrinsic pressure.</div>
</td></tr>
</table></div>
<a name="PG1219"> </a><div class="pagenum"><div>P.1219</div></div>
<br clear="all">
<div class="FG" id="F154-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[14]/TLV3[2]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="502" src="files/aaae7ec88c687b30ea530f85ab7524e9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="aaae7ec88c687b30ea530f85ab7524e9.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="502" DISPLAY="INLINE"></div>
<div class="P">Figure 11-154 <span class="emph_B">SYNOVIAL SARCOMA. A. AP Knee. B. Lateral Knee.</span> Observe the nodular calcifications in the lateral portion of the soft tissues of the knee. There is no evidence of associated bone erosion in this patient. <span class="emph_I">COMMENT:</span> One third of patients with synovial sarcoma demonstrate fine, granular specks of calcification within the soft tissue mass.</div>
</td></tr>
</table></div>
<div class="P">The treatment of choice is usually surgical excision, followed by a course of irradiation (5000 R). (<a class="LK" href="sid806035.html#R313-11">2</a>) The 5-year survival rate for lower extremity lesions is 43&#x0025;, and for upper extremity synoviomas, 31&#x0025;. (<a class="LK" href="sid806035.html#R317-11">6</a>,<a class="LK" href="sid806035.html#R318-11">7</a>) It has been proposed that larger lesions at the time of diagnosis predispose the patient to a worse prognosis. (<a class="LK" href="sid806035.html#R319-11">8</a>) Metastasis of the lesions will occur in approximately 33&#x0025; of patients. (<a class="LK" href="sid806035.html#R319-11">8</a>) The lungs, lymph nodes, and bone are the common sites of metastasis. (<a class="LK" href="sid806035.html#R320-11">9</a>)</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3643" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[15]">
<div class="HD">ADAMANTINOMA</div>
<div class="TLV3" id="B01382540.0-3644" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[15]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Adamantinoma is a rare primary malignant bone tumor with a poorly understood histogenesis. (<a class="LK" href="sid806035.html#R321-11">1</a>) It has also been referred to as malignant angioblastoma, dermal inclusion tumor, ameloblastoma, primary epidermoid carcinoma of bone, and carcinoma sarcomatodes. (<a class="LK" href="sid806035.html#R322-11">2</a>) The pathogenesis is controversial regarding whether this tumor is epithelial or mesodermal in origin. A likely explanation is that the neoplasms develop from misplaced embryonal epithelium of the enamel germ cells of the teeth, which may be present as epithelial cell rests. (<a class="LK" href="sid806035.html#R323-11">3</a>) It is impossible to definitively determine the tumor&#x2019;s true origin histologically at this time because there is an overlap of the epithelial and the mesodermal hypotheses. (<a class="LK" href="sid806035.html#R324-11">4</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3645" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[15]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Approximately 165 cases have been reported in the literature, with all but 18 located in the tibia. (<a class="LK" href="sid806035.html#R325-11">5</a>) (<a class="LK" href="sid806035.html#F155-11">Fig. 11-155</a>) Other bones
<a name="PG1220"> </a><div class="pagenum"><div>P.1220</div></div>
<br clear="all">
affected are the jaw, ulna, humerus, femur, and fibula. (<a class="LK" href="sid806035.html#F156-11">Fig. 11-156</a>) The mid-diaphysis of the long bones is the location in 75&#x0025; of cases. (<a class="LK" href="sid806035.html#R325-11">5</a>) (<a class="LK" href="sid806035.html#F157-11">Fig. 11-157</a>) The lesions are extremely rare in the spine. (<a class="LK" href="sid806035.html#R326-11">6</a>) Most patients are between 10 and 40 years of age. (<a class="LK" href="sid806035.html#R327-11">7</a>) Pain with swelling around the growing lesion is the most common presenting symptom.</div>
<div class="FG" id="F155-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[15]/TLV3[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="297" height="700" src="files/44188371ceb37c3b77f0790e4ba569e1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="44188371ceb37c3b77f0790e4ba569e1.gif" MIMETYPE="image/gif" WIDTH="297" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-155 <span class="emph_B">SKELETAL DISTRIBUTION OF ADAMANTINOMA.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F156-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[15]/TLV3[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="215" src="files/c68c0543c1880676650cc64f5f55f6b6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c68c0543c1880676650cc64f5f55f6b6.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="215" DISPLAY="INLINE"></div>
<div class="P">Figure 11-156 <span class="emph_B">ADAMANTINOMA. A. Oblique Mandible. B. Panorex Tomogram, Mandible.</span> Observe the osteolytic, grossly expansile lesion of the mandible. A multichambered or bubbly lesion is present. (Courtesy of Leonard B. Welsh, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Tamworth, New South Wales, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F157-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[15]/TLV3[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="710" src="files/f7b3af576318017a590ea1396285d497.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f7b3af576318017a590ea1396285d497.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="710" DISPLAY="INLINE"></div>
<div class="P">Figure 11-157 <span class="emph_B">ADAMANTINOMA. A. AP Tibia. B. Lateral Tibia.</span> Note the highly destructive lesion in the mid-diaphysis of the tibia. Observe the expansion of bone, with lytic and scalloped margins of the cortical surfaces. (Courtesy of Peter Johnston, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3646" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[2]/TLV2[15]/TLV3[3]">
<div class="HD">Radiologic Features</div>
<div class="P">Radiographically, adamantinomas may be difficult to differentiate from other lesions because they can be situated in either the cortex or the medullary space. (<a class="LK" href="sid806035.html#R321-11">1</a>) Cortical lesions may assume a <span class="emph_I">lytic bone blister appearance,</span> may appear as <span class="emph_I">sawtooth loss of cortical bone</span> with ragged margins, or may present as a <span class="emph_I">multichambered, bubbly lesion.</span> (<a class="LK" href="sid806035.html#F156-11">Fig. 11-156</a>) The typical intramedullary lesion is usually one large, circumscribed area of radiolucency with a mottled increase in density scattered throughout the length of the lesion. Less commonly, a reticulated, <span class="emph_I">honeycombed type of presentation</span> occurs. Long-standing tumors produce marked cortical thickening and spool-shaped bulges of the outer cortex in an <span class="emph_I">eggshell fashion.</span> (<a class="LK" href="sid806035.html#R328-11">8</a>) (<a class="LK" href="sid806035.html#F157-11">Fig. 11-157</a>) Gradual expansion of bone with eventual cortical disruption and the development of a soft tissue mass occurs. Periosteal response is minimal and, if present, is usually of the laminated variety.</div>
<div class="P">The most difficult and almost indistinguishable differential diagnosis is fibrous dysplasia, though the presence of periosteal response, moth-eaten destruction, no bowing or ground glass appearance, and younger age should allow correct diagnosis. (<a class="LK" href="sid806035.html#R329-11">9</a>,<a class="LK" href="sid806035.html#R330-11">10</a>) Special imaging procedures such as MRI are becoming more useful in differentiation and diagnosis of adamantinomas. (<a class="LK" href="sid806035.html#R321-11">1</a>,<a class="LK" href="sid806035.html#R331-11">11</a>)</div>
<div class="P">The treatment of choice is amputation which has a cure rate of &#x003E; 90&#x0025;; however, en bloc resections have been recently shown to salvage the limb in up to 84&#x0025; of cases with survival rates as high as 87&#x0025; over 10 years. (<a class="LK" href="sid806035.html#R332-11">12</a>) Unfortunately, complications related to limb reconstruction is high in most of these cases. (<a class="LK" href="sid806035.html#R332-11">12</a>)</div>
</div>
</div>
</div>
<div class="TLV1" id="B01382540.0-3647" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]">
<div class="HD">PRIMARY QUASI-MALIGNANT BONE TUMOR</div>
<div class="TLV2" id="B01382540.0-3648" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]">
<div class="HD">GIANT CELL TUMOR</div>
<div class="TLV3" id="B01382540.0-3649" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Giant cell tumor is a neoplasm that originates from non-boneforming supportive connective tissue of the marrow. This highly vascular lesion is composed of spindle-shaped stromal cells interspersed among multinucleated giant cells. In 1818 Sir Astley Cooper (<a class="LK" href="sid806035.html#R333-11">1</a>) was the first to coin the term <span class="emph_I">giant cell tumor.</span> Since
<a name="PG1221"> </a><div class="pagenum"><div>P.1221</div></div>
<br clear="all">
his original description, a host of bone lesions have fallen under the umbrella of giant cell tumor. Around 1940 Jaffe et al. (<a class="LK" href="sid806035.html#R334-11">2</a>) started the in-depth naming of the giant cell tumor variants. The first to be identified was pigmented villonodular synovitis, followed by benign chondroblastoma, non-osteogenic fibroma, chondromyxoid fibroma, and aneurysmal bone cyst. (<a class="LK" href="sid806035.html#R335-11">3</a>,<a class="LK" href="sid806035.html#R336-11">4</a>,<a class="LK" href="sid806035.html#R337-11">5</a>,<a class="LK" href="sid806035.html#R338-11">6</a>,<a class="LK" href="sid806035.html#R339-11">7</a>) All of these lesions were considered giant cell tumor variants.</div>
<div class="P">Jaffe (<a class="LK" href="sid806035.html#R340-11">8</a>) classifies this tumor as being quasi-malignant because approximately 20&#x0025; of the lesions are malignant, and 80&#x0025; are benign. Stewart (<a class="LK" href="sid806035.html#R341-11">9</a>) in 1922 introduced the term <span class="emph_I">osteoclastoma</span> into the British orthopedic literature, where it has received wide and continued use.</div>
</div>
<div class="TLV3" id="B01382540.0-3650" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Giant cell tumor of bone is a relatively common primary neoplasm accounting for 5-8&#x0025; of all primary malignant bone tumors (<a class="LK" href="sid806035.html#R342-11">10</a>) and 15&#x0025; of all primary benign bone tumors. (<a class="LK" href="sid806035.html#R343-11">11</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3651" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3652" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">The incidence of all types of giant cell tumors is approximately the same in men and women; however, benign tumors predominate in female patients in a proportion of 3:2, the malignant tumors show a predilection for male patients in a ratio of 3:1. (<a class="LK" href="sid806035.html#R344-11">12</a>) The usual age range is 20-40 years; occurrence at other ages is exceptional. Recent research has noted an association with the formation of giant cell tumor in patients with Paget&#x2019;s disease occurring under the age of 50. (<a class="LK" href="sid806035.html#R345-11">13</a>,<a class="LK" href="sid806035.html#R346-11">14</a>) This association has been supported in 37 cases. (<a class="LK" href="sid806035.html#R345-11">13</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3653" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The chief complaint is pain of an intermittent, aching nature, with localized swelling and tenderness. Often, there is restricted movement of the involved adjacent joint. No physical signs or symptoms are characteristic of this tumor, which occasionally can grow to enormous size and remain clinically silent. Pathologic fracture often may be the precipitating factor to symptom production.</div>
</div>
<div class="TLV4" id="B01382540.0-3654" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">The most common sites are the distal femur, proximal tibia, distal radius, and proximal humerus, in decreasing order of incidence. (<a class="LK" href="sid806035.html#R347-11">15</a>) (<a class="LK" href="sid806035.html#F158-11">Fig. 11-158</a>) Involvement of the distal radius carries a more serious prognosis because most of these lesions are malignant. (<a class="LK" href="sid806035.html#F159-11">Fig. 11-159</a>) The sacrum is the most common spinal site, representing 8&#x0025; of cases. (<a class="LK" href="sid806035.html#R344-11">12</a>) Giant cell tumor is the most common benign tumor of the sacrum. (<a class="LK" href="sid806035.html#R347-11">15</a>) (<a class="LK" href="sid806035.html#F160-11">Figs. 11-160</a> and <a class="LK" href="sid806035.html#F161-11">11-161</a>) Spinal sites above the sacrum are rare. Other infrequent sites are the calcaneus, innominate, rib, carpal bones, and patella. (<a class="LK" href="sid806035.html#R348-11">16</a>,<a class="LK" href="sid806035.html#R349-11">17</a>,<a class="LK" href="sid806035.html#R350-11">18</a>,<a class="LK" href="sid806035.html#R351-11">19</a>,<a class="LK" href="sid806035.html#R352-11">20</a>) (<a class="LK" href="sid806035.html#F162-11">Fig. 11-162</a>)</div>
<div class="P">Patellar neoplastic disease is uncommon; however, most patellar tumors are benign (73&#x0025;) and are cartilaginous in origin (chondroblastomas or enchondromas) or giant cell tumors. (<a class="LK" href="sid806035.html#R353-11">21</a>) Giant cell tumor is the most common neoplasm of the patella. (<a class="LK" href="sid806035.html#R354-11">22</a>) Rarely, metastatic disease from any origin may affect the patella; this is the most common cause for malignancy in the patella. Multifocal giant cell tumors have been reported but are rare. (<a class="LK" href="sid806035.html#R355-11">23</a>) It is always important to rule out multiple brown tumors of hyperparathyroidism when polyostotic lesions are encountered.</div>
<div class="FG" id="F158-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="297" height="700" src="files/33fceea4938816d810c67c84a130f4ee.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="33fceea4938816d810c67c84a130f4ee.gif" MIMETYPE="image/gif" WIDTH="297" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-158 <span class="emph_B">SKELETAL DISTRIBUTION OF GIANT CELL TUMOR.</span>
</div>
</td></tr>
</table></div>
<div class="P">This tumor usually begins in the metaphyseal end of a long bone in or adjacent to the ossified epiphyseal line. It usually extends to the end of a long bone, abutting its joint surface, leaving the lesion subarticular. (<a class="LK" href="sid806035.html#F163-11">Fig. 11-163</a>). The lesion is limited to the metaphysis in only 1&#x0025; of cases. (<a class="LK" href="sid806035.html#R356-11">24</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3655" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Pathologically, a typical lesion consists of varying amounts of connective tissue stromal cells and giant cells. The stromal cells vary in appearance, being either plump, spindle shaped, or ovoid, generally with large nuclei. The giant cells are multinucleated, with a tendency for the nuclei to be in the center of the cell. The proportion of stromal cells to giant cells determines whether the lesion has a benign or malignant propensity. Many giant cells are found in the most benign lesions, and few or no giant cells in truly malignant lesions. The spindle cell stroma of the giant cell tumors requires the most meticulous attention, for it is on the
<a name="PG1222"> </a><div class="pagenum"><div>P.1222</div></div>
<br clear="all">
regularity or anaplasia in these cells that the clinical behavior of the tumor hinges.</div>
<div class="FG" id="F159-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="434" src="files/ec401e9b9c54167b5af5a4e1470852dc.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ec401e9b9c54167b5af5a4e1470852dc.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="434" DISPLAY="INLINE"></div>
<div class="P">Figure 11-159 <span class="emph_B">GIANT CELL TUMOR: DISTAL RADIUS. A. Oblique Wrist.</span> Observe the subarticular radiolucent expansile lesion of the entire distal surface of the radius, with a pathologic fracture. Of incidental notation is spotty disuse osteoporosis scattered throughout the carpal bones and the bases of the visualized metacarpals. <span class="emph_B">B. PA and Lateral Wrist.</span> Observe the grossly expansile, heavily trabeculated or soap bubble geographic lesion involving the subarticular surface of the distal radius. Owing to the extensive bone expansion, there is posterior and lateral displacement of the ulna. <span class="emph_I">COMMENT:</span> Giant cell tumor involving the distal radius carries a sinister prognosis because most of these lesions are malignant.</div>
</td></tr>
</table></div>
<div class="FG" id="F160-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[4]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="486" height="700" src="files/f75ff1a6b7dfc4aca87c7b0147460a24.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f75ff1a6b7dfc4aca87c7b0147460a24.gif" MIMETYPE="image/gif" WIDTH="486" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-160 <span class="emph_B">GIANT CELL TUMOR. AP Sacrum.</span> Observe the grossly expansile, geographic lesion involving the entire sacrum. This giant cell tumor was found in an 18-year-old male. Note that the peripheral margins of the majority of this lesion are well defined; however, this is a malignant giant cell tumor. <span class="emph_I">COMMENT:</span> Approximately 80&#x0025; of giant cell tumors are benign and 20&#x0025; are malignant. It is impossible to predict the histologic nature of giant cell tumors from a radiograph, even when they appear to fill the criteria for benign lesions. The only means for appropriate diagnosis is biopsy. (Courtesy of William E. Litterer, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Elizabeth, New Jersey.)</div>
</td></tr>
</table></div>
<div class="FG" id="F161-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[4]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="524" height="700" src="files/500f4a1091a886221d22eba9f3c0590f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="500f4a1091a886221d22eba9f3c0590f.gif" MIMETYPE="image/gif" WIDTH="524" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-161 <span class="emph_B">GIANT CELL TUMOR. A. AP Sacrum.</span> Observe the eccentric geographic lesion present within the sacral ala (<span class="emph_I">arrows</span>) without matrix calcification. <span class="emph_B">B. Tomogram, AP Sacrum.</span> Note that tomographic evaluation of the sacrum demonstrates a large geographic area of destruction limited to the sacral ala and not affecting the sacroiliac joint (<span class="emph_I">arrows</span>). (Courtesy of Allan J. Warrener, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1223"> </a><div class="pagenum"><div>P.1223</div></div>
<br clear="all">
<div class="FG" id="F162-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[4]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="468" height="700" src="files/34761dabd674b84dc62968e74502569c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="34761dabd674b84dc62968e74502569c.gif" MIMETYPE="image/gif" WIDTH="468" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-162 <span class="emph_B">GIANT CELL TUMOR. Ilium.</span> Observe the grossly expansile lytic lesion of the middle and posterior surfaces of the ilium. Note also the soap bubble matrix in this large malignant giant cell tumor of the ilium.</div>
</td></tr>
</table></div>
<div class="FG" id="F163-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[4]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="465" height="700" src="files/dc549e417e3b210cbbbfb88ad4e7f95c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="dc549e417e3b210cbbbfb88ad4e7f95c.gif" MIMETYPE="image/gif" WIDTH="465" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-163 <span class="emph_B">GIANT CELL TUMOR. Distal Femur.</span> Observe the eccentric lytic destruction of the medial condyle and metaphysis of the distal femur. There is a moderate soap bubble matrix alteration present within the central portion of the lesion. The location of this giant cell tumor is classic, in that it presents eccentrically and at the subarticular surface of the distal femur.</div>
</td></tr>
</table></div>
<div class="P">Giant cells are ubiquitous; they may be present in any lesion of bone, benign, malignant, or reactive. Their presence must be gauged in the context of other associated findings. The mere presence of occasional or even numerous giant cells does not permit tumor identification or classification.</div>
</div>
<div class="TLV3" id="B01382540.0-3656" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiographic appearance of giant cell tumor is characteristic. It is an eccentric, metaphyseal, multilobed radiolucent lesion of a long bone. (<a class="LK" href="sid806035.html#R357-11">25</a>) In an adult, it is located adjacent to the articular surface of the bone (subarticular). (<a class="LK" href="sid806035.html#F164-11">Fig. 11-164</a>) It is also subarticular in flat bones, occurring near the sacroiliac joint and acetabulum in the innominate. The cortex is thinned and expanded, and the endosteal margins show a wide zone of transition, suggesting a malignant lesion. (<a class="LK" href="sid806035.html#R357-11">25</a>) (<a class="LK" href="sid806035.html#F165-11">Fig. 11-165</a>) The lesion may traverse the entire shaft in a relatively thin bone, such as the fibula or ulna. (<a class="LK" href="sid806035.html#F166-11">Fig. 11-166</a>) A delicate periosteal reaction may develop, independent of infractions of the cortex.</div>
<div class="P">This sharply circumscribed lesion often expands bone, with a rather characteristic soap bubble pattern. (<a class="LK" href="sid806035.html#R356-11">24</a>) (<a class="LK" href="sid806035.html#F167-11">Fig. 11-167</a>) Most cases are purely lytic (60&#x0025;), and the soap bubble pattern is present in 40&#x0025; of cases. (<a class="LK" href="sid806035.html#R356-11">24</a>) These bubbles and delineating lines are really reactive trabeculae of bone formed by appositional bone growth and do not actually chamber the lesion because of their peripheral location. Thus the giant cell tumor, removing numerous trabeculae by its neoplastic growth, prompts reinforcement of the remaining trabeculae, resulting in the soap bubble pattern. (<a class="LK" href="sid806035.html#F168-11">Fig. 11-168</a>) If the tumor is very aggressive, a purely
<a name="PG1224"> </a><div class="pagenum"><div>P.1224</div></div>
<br clear="all">
lytic radiolucent lesion will be seen with cortical breakthrough and the development of a soft tissue mass. (<a class="LK" href="sid806035.html#F169-11">Fig. 11-169</a>)</div>
<div class="FG" id="F164-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="469" height="700" src="files/d97c8b5c17f5c3dc2989c0fa41a88299.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d97c8b5c17f5c3dc2989c0fa41a88299.gif" MIMETYPE="image/gif" WIDTH="469" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-164 <span class="emph_B">GIANT CELL TUMOR. Proximal Tibia.</span> Observe the well-defined geographic lesion within the lateral portion of the proximal tibia. This lesion is in its classic subarticular location and is eccentrically placed, typical for a giant cell tumor.</div>
</td></tr>
</table></div>
<div class="FG" id="F165-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="507" src="files/a4a973cfcb8e1060f088638b1aa66401.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a4a973cfcb8e1060f088638b1aa66401.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="507" DISPLAY="INLINE"></div>
<div class="P">Figure 11-165 <span class="emph_B">GIANT CELL TUMOR: PROXIMAL RADIUS. A. AP Elbow. B. Lateral Elbow.</span> Observe the expansile, geographic lesion within the radial head and metaphysis. This lesion assumes the classic subarticular location for giant cell tumor.</div>
</td></tr>
</table></div>
<div class="P">Involvement of flat bones, such as the ilium, rib, and sacrum, demonstrate the same roentgen appearance of an expanding, radiolucent, soap bubble lesion. Spinal involvement above the sacrum with expansion and lytic destruction of a vertebral body or neural arch is usually called an osteoblastoma or ABC radiographically, before biopsy. The cervical and lumbar spine are the most common sites. (<a class="LK" href="sid806035.html#F170-11">Fig. 11-170</a>) The radiologist alone cannot predict with any accuracy whether the giant cell tumor is benign or malignant. (<a class="LK" href="sid806035.html#F171-11">Fig. 11-171</a>) The approach to definitive diagnosis must be correlated by three means: radiologic, clinical, and histologic. Some of the most benign-appearing lesions have metastasized to distant sites, proving fatal for the patient. (<a class="LK" href="sid806035.html#T20-11">Table 11-20</a>)</div>
<div class="FG" id="F166-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="547" src="files/e94c7d82c0e6e8e766c9ebb81f099c97.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e94c7d82c0e6e8e766c9ebb81f099c97.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="547" DISPLAY="INLINE"></div>
<div class="P">Figure 11-166 <span class="emph_B">GIANT CELL TUMOR: DISTAL ULNA. A. PA Wrist.</span> Observe the lytic destructive lesion at the distal subarticular surface of the ulna. The soap bubble appearance is present in the matrix of this lesion. <span class="emph_B">B. 6-Month Follow-Up, PA Wrist.</span> Note the extensive expansion of the previously recognized giant cell tumor of the distal ulna. A heavier trabeculation or soap bubble appearance is present within the distal ulna.</div>
</td></tr>
</table></div>
<div class="FG" id="F167-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="528" height="700" src="files/732ddcc40565955e4d7b89556b05fe2d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="732ddcc40565955e4d7b89556b05fe2d.gif" MIMETYPE="image/gif" WIDTH="528" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-167 <span class="emph_B">GIANT CELL TUMOR. Proximal Tibia.</span> Note the grossly expansile, heavily trabeculated, geographic lesion involving the entire subarticular surface of the proximal tibia. (Courtesy of Joseph W. Howe, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Los Angeles, California.)</div>
</td></tr>
</table></div>
<a name="PG1225"> </a><div class="pagenum"><div>P.1225</div></div>
<br clear="all">
<div class="FG" id="F168-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="462" height="700" src="files/f666659863a8cea66fbb89256f1d567a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f666659863a8cea66fbb89256f1d567a.gif" MIMETYPE="image/gif" WIDTH="462" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-168 <span class="emph_B">GIANT CELL TUMOR, SOAP BUBBLE PATTERN. Distal Radius.</span> Observe the subarticular, expansile, geographic lesion in the distal portion of the radius. This tumor has removed numerous trabeculae by its neo-plastic growth, prompting reinforcement of the remaining trabeculae and rendering a classic soap bubble pattern. <span class="emph_BIT">COMMENT:</span> Giant cell tumors in the distal radius carry a higher incidence of malignancy than giant cell tumors at any other skeletal site.</div>
</td></tr>
</table></div>
<div class="FG" id="F169-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="461" height="700" src="files/609b67225444a0196340e7c024969cbf.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="609b67225444a0196340e7c024969cbf.gif" MIMETYPE="image/gif" WIDTH="461" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-169 <span class="emph_B">PATHOLOGIC FRACTURE IN GIANT CELL TUMOR. Proximal Humerus.</span> Observe the subarticular, expansile giant cell tumor of the proximal humerus. Heavy trabeculation or soap bubble trabecular changes are scattered throughout the lesion. Note the pathologic fracture and cortical offset through the metaphysis (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F170-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="433" src="files/3786f6cbd3c178a22ceab9bfdc4bc55e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3786f6cbd3c178a22ceab9bfdc4bc55e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="433" DISPLAY="INLINE"></div>
<div class="P">Figure 11-170 <span class="emph_B">GIANT CELL TUMOR. L3 Vertebra.</span> Observe the lytic expansile lesion of the vertebral body and a portion of the pedicle of the L3 vertebra. Note the loss of the anterior concavity of the vertebral body secondary to bony expansion (<span class="emph_I">arrows</span>) and the slightly chambered appearance. (Courtesy of Kelvin E. Brinsmead, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Kiama, New South Wales, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F171-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="535" src="files/10f65e358e230d263afa64a5160540e9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="10f65e358e230d263afa64a5160540e9.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="535" DISPLAY="INLINE"></div>
<div class="P">Figure 11-171 <span class="emph_B">MALIGNANT GIANT CELL TUMOR. A. Distal Femur.</span> Observe the gross cortical destruction of the distal femur and the medial condyle. There is an eccentric lytic lesion, with scalloping of the endosteum. This radiographic presentation strongly suggests a malignant giant cell tumor, which was confirmed at biopsy. <span class="emph_B">B. Proximal Fibula.</span> Observe the lytic destruction of the subarticular surface of the proximal fibula. There is a permeative pattern of bone destruction scattered throughout the matrix of the tumor, along with a break in the proximal cortex (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<a name="PG1226"> </a><div class="pagenum"><div>P.1226</div></div>
<br clear="all">
<div class="TB" id="T20-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-20 Features of Giant Cell Tumor</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Age</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>20-40 years</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Location</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Distal femur, proximal tibia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Distal radius</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Proximal humerus</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Sacrum, ilium</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Features</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Eccentric</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Metaphyseal&#x2014;epiphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Subarticular</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thin cortex</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Geographic</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Internal septation (soap bubble)</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3657" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">It is important to ensure that the giant cell tumor is completely removed the first time surgical intervention is performed. (<a class="LK" href="sid806035.html#R357-11">25</a>) The surgeon must plan an excision to minimize the likelihood of recurrence, while trying to preserve function of the involved limb. It has been suggested that incomplete excision is the primary risk factor for determining the risk of recurrence (<a class="LK" href="sid806035.html#R358-11">26</a>) owing to the contents of the tumor &#x201C;spilling over&#x201D; and contaminating nearby tissues. (<a class="LK" href="sid806035.html#R359-11">27</a>) In cases of incomplete excision, follow-up radiation therapy is recommended by some (<a class="LK" href="sid806035.html#R360-11">28</a>,<a class="LK" href="sid806035.html#R361-11">29</a>), whereas others have advocated that radiotherapy is associated with an increased risk of malignant degeneration and thus should be avoided when possible. (<a class="LK" href="sid806035.html#R362-11">30</a>,<a class="LK" href="sid806035.html#R363-11">31</a>) The surgeon contemplating curettage should remember that giant cell tumors tend to invade adjacent structures slowly. The trabeculae that are permeated by the osteoclasts of the tumor will persist for some time after involvement; the tumor, therefore, extends beyond the inner ridge of trabeculae.</div>
<div class="P">Recurrence rates of 12-50&#x0025; have been reported after curettage combined with liquid nitrogen freezing, bone packing, or grafting. (<a class="LK" href="sid806035.html#R364-11">32</a>) Curettage removes only the contents of the cavity. There is no removal of the contents of the area beyond the cavity that is formed by the reactive remnants of bone, unless a conscious effort is made to curette the ridge of trabeculae forming the outer shell of the cavity. Failure to do so accounts for the high recurrence rate. Sterilization of the cavity by means of phenol or liquid nitrogen is quite effective. (<a class="LK" href="sid806035.html#R365-11">33</a>) The cavity is usually reconstructed with an acrylic cement, which has also shown good results. (<a class="LK" href="sid806035.html#R366-11">34</a>) Complete resection is required occasionally, especially around the knee. Spinal lesions are usually inoperable, leaving radiation therapy as the only option for obtaining a cure. (<a class="LK" href="sid806035.html#R365-11">33</a>)</div>
<div class="P">The prognosis is excellent for the benign giant cell tumor; however, its malignant counterpart carries a poor prognosis with &#x003C; 10&#x0025; of cases having a 5-year survival rate (<a class="LK" href="sid806035.html#R365-11">33</a>) resulting from recurrence or metastasis. Although distant metastasis is relatively rare, it has been suggested that the expression of the p53 gene may predispose the patient to this unfortunate event. (<a class="LK" href="sid806035.html#R367-11">35</a>,<a class="LK" href="sid806035.html#R368-11">36</a>) Metastasis has been documented in only 50 cases, primarily affects the lung, and usually occurs within 3 years of surgical resection. (<a class="LK" href="sid806035.html#R367-11">35</a>) More recent studies have suggested that chemotherapy in combination with surgical excision may be of benefit in increasing the survival rates for patients with malignant variants of the tumor. (<a class="LK" href="sid806035.html#R369-11">37</a>)</div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3658" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Giant Cell Tumor</div>
<div class="TLV2" id="B01382540.0-3659" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Sir Astley Cooper in 1818 was the first to use the term giant cell tumor.</div></li>
<li class="LM"><div class="P">Quasi-malignant tumor: 80&#x0025; benign and 20&#x0025; malignant.</div></li>
<li class="LM"><div class="P">Osteoclastoma is a British term that has been used for giant cell tumor.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3660" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents 5-8&#x0025; of all primary malignant bone tumors and 15&#x0025; of all primary benign bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3661" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Benign tumors predominate in female patients in a proportion of 3:2; the malignant tumors affect males in a ratio of 3:1.</div></li>
<li class="LM"><div class="P">20-40 years is the usual age range.</div></li>
<li class="LM"><div class="P">Localized pain of an aching nature, which often restricts movement of the involved adjacent joint.</div></li>
<li class="LM"><div class="P">Most common sites of involvement are distal femur, proximal tibia, distal radius, and proximal humerus, in decreasing order of incidence.</div></li>
<li class="LM"><div class="P">The sacrum is the most common spinal site, representing 8&#x0025; of cases.</div></li>
<li class="LM"><div class="P">The most common benign tumor of the sacrum.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3662" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most lesions begin in the metaphysis and subsequently extend to the subarticular location, once the epiphyseal line has closed.</div></li>
<li class="LM"><div class="P">Characteristic lesion in a long bone is a radiolucent, eccentric metaphyseal defect that extends to a subarticular location.</div></li>
<li class="LM"><div class="P">Significant bone expansion with the production of a soap bubble appearance is noted.</div></li>
<li class="LM"><div class="P">Radiologic differentiation of benign versus malignant lesions is not feasible.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3663" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[3]/TLV2[1]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Treatment of choice is surgical curettage combined with liquid nitrogen freezing, bone packing, or grafting. Recurrence rates of 12-50&#x0025; are reported, with recurrence being merely an expression of inadequate removal.</div></li>
<li class="LM"><div class="P">Spinal lesions are usually inoperable, requiring radiation therapy for cure.</div></li>
<li class="LM"><div class="P">Prognosis for benign lesions is excellent; only 10&#x0025; survive 5 years with malignant lesions.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="TLV1" id="B01382540.0-3664" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]">
<div class="HD">PRIMARY BENIGN BONE TUMORS</div>
<div class="TLV2" id="B01382540.0-3665" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]">
<div class="HD">SOLITARY OSTEOCHONDROMA</div>
<div class="TLV3" id="B01382540.0-3666" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Osteochondroma is a bony exostosis projecting from the external surface of a bone; it usually has a hyaline-lined cartilaginous
<a name="PG1227"> </a><div class="pagenum"><div>P.1227</div></div>
<br clear="all">
cap. The first person to describe and clearly illustrate osteochondroma was Sir Astley Cooper, surgeon and anatomist at St. Thomas&#x2019; and Guy&#x2019;s Hospitals, London, in 1818. (<a class="LK" href="sid806035.html#R370-11">1</a>) When the lesion is seen in a single bone, it is called solitary osteochondroma; if two or three bones are involved, with no familial history, the condition is called multiple osteochondromas; when the tumors are widespread throughout the skeleton, there is usually a familial history and the condition is called hereditary multiple exostosis. The cause is not known, but it is thought that the solitary lesions arise from displaced cartilage from the physis and that hereditary multiple exostoses (HME) represents a congenital dysplasia leading to a tumor-like growth abnormality at the metaphysis.</div>
</div>
<div class="TLV3" id="B01382540.0-3667" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Osteochondroma represents the most common benign skeletal growth or tumor. (<a class="LK" href="sid806035.html#R371-11">2</a>) Including all forms of osteochondroma and HME, it represents 50&#x0025; of all benign bone neoplasms and 10-15&#x0025; of all primary bone tumors. (<a class="LK" href="sid806035.html#R372-11">3</a>) These figures could be higher because many lesions go unreported because of their silent nature.</div>
</div>
<div class="TLV3" id="B01382540.0-3668" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3669" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Most osteochondromas are encountered in childhood and adolescence, with 75&#x0025; of cases occurring before the age of 20. (<a class="LK" href="sid806035.html#R373-11">4</a>) Often, the lesions are not detected until later in life, when the patient is radiographed for other reasons. A 2:1 male predominance has been noted. (<a class="LK" href="sid806035.html#R373-11">4</a>)</div>
<div class="FG" id="F172-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[3]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="492" src="files/f856760303a6b6f9791ef2d70a826153.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f856760303a6b6f9791ef2d70a826153.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="492" DISPLAY="INLINE"></div>
<div class="P">Figure 11-172 <span class="emph_B">MULTIPLE OSTEOCHONDROMAS. A. AP Ankle.</span> Observe the metaphyseal broad-based (sessile) osteochondromas affecting the distal tibia and fibula. There is a significant alteration of the angulation of the tibia in its articulation with the talus, creating a tibial-talar slant. <span class="emph_B">B. Lateral Ankle.</span> Note the broad-based (sessile) osteochondroma on the plantar surface of the calcaneus.</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3670" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Most osteochondromas are asymptomatic unless they disturb surrounding blood vessels or nerves or are large enough to impair adjacent joint function. The most frequent complaint is a hard, painless mass near a joint. Occasionally, a fracture through the stalk of an osteochondroma causes a patient to present with severe pain and swelling. Some patients will present for surgical removal of an osteochondroma for cosmetic purposes, particularly if the mass is large and in a tightly compartmentalized space (hand, foot, forearm). Large spinal osteochondromas have been reported to produce bizarre neurological symptoms from cord compression, sciatica, and scoliosis. (<a class="LK" href="sid806035.html#R374-11">5</a>,<a class="LK" href="sid806035.html#R375-11">6</a>,<a class="LK" href="sid806035.html#R376-11">7</a>) Rarely, a traumatic popliteal artery pseudo-aneurysm may result from perforation or penetration of a sharply pointed osteochondroma arising from the posterior surface of the femur. (<a class="LK" href="sid806035.html#R377-11">8</a>) A rare case of death has occurred, complicating an odontoid osteochondroma. (<a class="LK" href="sid806035.html#R378-11">9</a>) Huge osteochondromas of the pelvis can produce symptoms of obstructive uropathy. (<a class="LK" href="sid806035.html#R379-11">10</a>)</div>
<div class="P">Pain and rapid growth may indicate malignant degeneration, requiring immediate removal. Complications include fracture (7&#x0025;), deformity with subsequent loss of motion (23&#x0025;), vascular injury (7&#x0025;), neurological compromise (10&#x0025;), adventitious bursae formation (27&#x0025;), and mechanical irritation. (<a class="LK" href="sid806035.html#R380-11">11</a>,<a class="LK" href="sid806035.html#R381-11">12</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3671" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">Osteochondroma can occur in any bone preformed in cartilage. It usually affects the long tubular bones: the femur (34&#x0025;), humerus (18&#x0025;), tibia (15&#x0025;). Other locations include the pelvis (8&#x0025;), scapula (5&#x0025;), and ribs (3&#x0025;). (<a class="LK" href="sid806035.html#R382-11">13</a>) Sporadic cases have been reported in the metacarpal bones, condylar process of the mandible, base of the skull, astragalus (talus), calcaneus, and the spine. (<a class="LK" href="sid806035.html#R383-11">14</a>,<a class="LK" href="sid806035.html#R384-11">15</a>,<a class="LK" href="sid806035.html#R385-11">16</a>,<a class="LK" href="sid806035.html#R386-11">17</a>,<a class="LK" href="sid806035.html#R387-11">18</a>) (<a class="LK" href="sid806035.html#F172-11">Fig. 11-172</a>) Spinal lesions usually are located near the
<a name="PG1228"> </a><div class="pagenum"><div>P.1228</div></div>
<br clear="all">
secondary centers of ossification at the tips of the transverse processes, spinous processes, laminae, and costovertebral joints. (<a class="LK" href="sid806035.html#R388-11">19</a>) Scapular lesions are not uncommon and arise from the inferior angle, superior angle (Luschka&#x2019;s tubercle), and coracoid process. (<a class="LK" href="sid806035.html#R389-11">20</a>) (<a class="LK" href="sid806035.html#F173-11">Fig. 11-173</a>) A rare case of osteochondroma has been documented at the distal clavicle, resulting in shoulder impingement syndrome of the rotator cuff. (<a class="LK" href="sid806035.html#R390-11">21</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3672" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Grossly, osteochondroma&#x2019;s most common form of presentation is as an exostosis arising from the metaphyseal region of a long bone. There are two types: <span class="emph_I">sessile</span> and <span class="emph_I">pedunculated</span>. Sessile osteochondroma is characterized by its flat plateau-like stalk producing a broad-based protuberance. Of the two types, this is the least common variety but seen most often in the proximal humerus and scapula. Conversely, pedunculated osteochondroma exhibits a base that has an elongated bony stalk merging continuously with the host bone. The cap of the exostosis is cartilaginous (hyaline) and is often lobulated in its appearance. The knee, hip, and ankle are the most common sites for the pedunculated osteochondroma.</div>
<div class="P">Osteochondromas can vary in size, with some reaching 10 cm. Histologically, the appearance of an actively growing osteochondroma shows foci of actively proliferating cartilage cells that closely resemble the normal epiphyseal growth plate. Consequently, an osteochondroma ceases to grow after closure of the normal epiphyseal growth plates.</div>
<div class="P">Malignant degeneration of a solitary osteochondroma occurs in approximately 1&#x0025; of cases, in contrast to the 20&#x0025; rate in the familial form of HME. (<a class="LK" href="sid806035.html#R391-11">22</a>) Most lesions, when they degenerate, transform to chondrosarcoma, but osteosarcoma and fibrosarcoma also occur. The pathologic distinction between an osteochondroma and an exostotic chondrosarcoma is often difficult because most of the chondrosarcomas are low grade, with only subtle malignant histologic features. (<a class="LK" href="sid806035.html#R392-11">23</a>) Patients with malignant degeneration of an osteochondroma average around 30 years of age, whereas the average age of those with chondrosarcoma is about 45. Plain radiographic distinction between these benign and malignant lesions is difficult. The thickness of the cartilaginous cap at the periphery of the tumor may provide a clue to malignancy because chondrosarcomas tend to have thicker cartilage, generally 3 cm or more. (<a class="LK" href="sid806035.html#R393-11">24</a>) The most common regions to be involved are the pelvis and shoulder girdle. (<a class="LK" href="sid806035.html#R372-11">3</a>,<a class="LK" href="sid806035.html#R393-11">24</a>) A cortical break or a growing soft tissue mass suggests malignancy. (<a class="LK" href="sid806035.html#T21-11">Table 11-21</a>)</div>
<div class="FG" id="F173-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="394" src="files/60454707cd92f9768cc29e4bc55ce8d5.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="60454707cd92f9768cc29e4bc55ce8d5.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="394" DISPLAY="INLINE"></div>
<div class="P">Figure 11-173 <span class="emph_B">SOLITARY OSTEOCHONDROMA, LUSCHKA&#x2019;S TUBERCLE. Scapula.</span> Note the solitary osteochondroma arising from the superior angle of the scapula (Luschka&#x2019;s tubercle). Observe the calcified osteocartilaginous cap.</div>
</td></tr>
</table></div>
<div class="P">Osteochondromas can develop as sequelae of radiation therapy for an unrelated malignant disorder. Most reported cases are included in evaluations of spinal changes after irradiation in childhood, usually for either Wilms&#x2019; tumor or neuroblastoma, which are two tumors that are more commonly irradiated.</div>
</div>
<div class="TLV3" id="B01382540.0-3673" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The knee (tibia and femur) is the location most commonly involved, with the metaphysis being the common place of origin.
<a name="PG1229"> </a><div class="pagenum"><div>P.1229</div></div>
<br clear="all">
The pedunculated type has an osteocartilaginous domed cap on a long, slender stalk. (<a class="LK" href="sid806035.html#F174-11">Figs. 11-174</a> and <a class="LK" href="sid806035.html#F175-11">11-175</a>) The cartilaginous cap usually shows irregularity and amorphous, spotty calcification, leaving the calcified areas dense and radiopaque. (<a class="LK" href="sid806035.html#F176-11">Figs. 11-176</a> and <a class="LK" href="sid806035.html#F177-11">11-177</a>) These exostoses invariably project away from the joint, owing to muscle pull; thus Greenfield (<a class="LK" href="sid806035.html#R394-11">25</a>) used the term <span class="emph_I">coat hanger exostosis.</span> (<a class="LK" href="sid806035.html#F178-11">Fig. 11-178</a>) En face visualization of an osteochondroma reveals a dense ring of cortex surrounding the base as it is seen superimposed upon the cartilage cap. (<a class="LK" href="sid806035.html#R394-11">25</a>) (<a class="LK" href="sid806035.html#F179-11">Fig. 11-179</a>)</div>
<div class="TB" id="T21-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-21 Features of Osteochondroma Suggesting Malignant Transformation</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Clinical</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>30 years of age</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Pelvis, shoulder</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>&#x003C; 1&#x0025; of solitary osteochondromas; 20&#x0025; in HME</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Increasing pain and mass at site of known osteochondroma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chondrosarcoma most common</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Radiologic</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thick, irregular calcified cap</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Bone destruction</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Soft tissue mass</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Altered appearance on sequential studies</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>HME, hereditary multiple exostosis.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F174-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="469" height="700" src="files/8c11cc48ab20dc84adc6ec9b471f93f4.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8c11cc48ab20dc84adc6ec9b471f93f4.gif" MIMETYPE="image/gif" WIDTH="469" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-174 <span class="emph_B">OSTEOCHONDROMA AND NON-OSSIFYING FIBROMA. Distal Femur.</span> Observe the solitary pedunculated osteochondroma of the metaphysis of the distal femur (<span class="emph_I">arrow</span>). In addition, there is a geographic lesion with endosteal scalloping noted in the medullary portion of the distal femur, which represents a non-ossifying fibroma (<span class="emph_I">arrowheads</span>). This is a coincidental occurrence of these two benign bone tumors.</div>
</td></tr>
</table></div>
<div class="P">Malignant transformation should be suspected when a cartilage cap is visualized that is &#x003E; 2 cm in adults and &#x003E; 3 cm in children. (<a class="LK" href="sid806035.html#R381-11">12</a>) It is also important to note that the cortex and spongiosa of the osteochondroma blend imperceptibly with the cortex and spongiosa of the host bone. (<a class="LK" href="sid806035.html#R382-11">13</a>) This feature differentiates an osteochondroma from parosteal sarcoma and periosteal chondrosarcoma, which show a <span class="emph_I">cleavage plane</span> between the normal bone and the neoplasm. Occasionally, the stalk of a pedunculated osteochondroma may fracture. (<a class="LK" href="sid806035.html#F180-11">Fig. 11-180</a>)</div>
<div class="P">The sessile osteochondroma creates a broad-based exostosis lacking an elongated projection and creating a long, asymmetric widening of the bone. (<a class="LK" href="sid806035.html#F181-11">Fig. 11-181</a>) Amorphous, spotty calcification is lacking. These lesions are found in the metaphysealdiaphyseal portion of the bone. The proximal humerus, scapula, and proximal femur are the most common sites. Osteochondromas are not found in the epiphyseal end of the bone, but an epiphyseal growth similar to osteochondroma does occur (Trevor&#x2019;s disease). (See <a class="LK" href="sid505815.html#B01382540-C8">Chapter 8</a>.) In the pelvis most osteochondromas occur near the anterosuperior iliac spine or the ischiopubic synchondrosis, creating an amorphous localized area of spotty calcification. Similar lesions are seen affecting the anterior surface of the ribs. If large enough, these lesions have been designated <span class="emph_I">cauliflower exostoses.</span> Large osteochondromas affecting the neural arch of the vertebrae may create an appearance called the <span class="emph_I">cauliflower spine.</span> (<a class="LK" href="sid806035.html#F182-11">Fig. 11-182</a>; <a class="LK" href="sid806035.html#T22-11">Table 11-22</a>)</div>
<div class="P">MRI is useful in determining the presence of malignant transformation. Thin cartilage caps down to 1 mm can be identified, as well as the overlying perichondrium. (<a class="LK" href="sid806035.html#R395-11">26</a>) In malignancy the cap thickens to &#x003E; 3 cm, and the perichondrium will be breached.</div>
<div class="FG" id="F175-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="619" src="files/d291da6aaa222c74539df7345d284886.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d291da6aaa222c74539df7345d284886.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="619" DISPLAY="INLINE"></div>
<div class="P">Figure 11-175 <span class="emph_B">SOLITARY OSTEOCHONDROMA. Distal Femur.</span> Note the pedunculated solitary osteochondroma, arising from the distal metaphysis of the femur.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3674" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Most solitary osteochondromas are asymptomatic and never require treatment. Large lesions that create symptoms should be widely surgically excised, with care taken to include the periosteal surface, helping ensure an effective cure.</div>
<div class="FG" id="F176-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="498" src="files/187d3345845465beb990857a8f25edc0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="187d3345845465beb990857a8f25edc0.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="498" DISPLAY="INLINE"></div>
<div class="P">Figure 11-176 <span class="emph_B">OSTEOCHONDROMA WITH A LARGE OSTEOCARTILAGINOUS CAP. A. Lateral Knee.</span> Observe the dense calcification within the cartilaginous cap of this large osteochondroma arising from the posterior cortical surface of the distal femur. <span class="emph_B">B. Oblique Knee.</span> Note the distinct stalk arising from the femoral metaphysis. The triangular radiolucency (<span class="emph_I">arrows</span>) represents the region of origin of the osteochondroma. (Courtesy of Paul E. Siebert, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="FG" id="F177-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="528" src="files/9997dfc89a20424d6940180a4d24e32b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9997dfc89a20424d6940180a4d24e32b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="528" DISPLAY="INLINE"></div>
<div class="P">Figure 11-177 <span class="emph_B">CAULIFLOWER OSTEOCHONDROMA. A. Lesser Trochanter of the Femur.</span> Observe the cauliflower exostosis arising from the lesser trochanter of the proximal femur. There are areas of increased density scattered throughout the osteochondroma, representing calcified islands of cartilage. <span class="emph_B">B. Postsurgery.</span> Because this solitary osteochondroma created some mechanical pressure on vital structures in the area of the groin, it was surgically removed.</div>
</td></tr>
</table></div>
<a name="PG1230"> </a><div class="pagenum"><div>P.1230</div></div>
<br clear="all">
<div class="FG" id="F178-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[6]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="606" src="files/7cd5fa76f43ab8e94670b80f0a9d68d9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7cd5fa76f43ab8e94670b80f0a9d68d9.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="606" DISPLAY="INLINE"></div>
<div class="P">Figure 11-178 <span class="emph_B">COAT HANGER EXOSTOSIS. A. Diagram. B. Distal Femur.</span> Observe the solitary osteochondroma arising from the metaphyseal cortex of the distal femur. These exostoses project away from the joint because of muscle pull and have been referred to as coat hanger exostoses. Note also the dense flocculent calcification of the cartilaginous cap. (Courtesy of Keith H. Charlton, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Brisbane, Queensland, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F179-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[6]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="243" src="files/4ad0e4d13bc2fd6d4cf6332a188eb516.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4ad0e4d13bc2fd6d4cf6332a188eb516.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="243" DISPLAY="INLINE"></div>
<div class="P">Figure 11-179 <span class="emph_B">CAULIFLOWER OSTEOCHONDROMA. A. AP Femur.</span> Note the large, lobulated solitary osteochondroma arising from the lesser trochanter of the femur. Its true point of origin cannot be determined from this frontal radiograph. <span class="emph_B">B. Oblique (Frog-Leg Projection) Femur.</span> Note that the point of origin of the large osteochondroma is now clearly seen to be the lesser trochanter of the proximal femur. Observe the flocculent areas of calcification scattered throughout this large osteochondroma. (Courtesy of Terry D. Sandman, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Chicago, Illinois.)</div>
</td></tr>
</table></div>
<div class="FG" id="F180-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[6]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="468" height="700" src="files/1fdc554a3907aacf717ce3e29058d6e2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1fdc554a3907aacf717ce3e29058d6e2.gif" MIMETYPE="image/gif" WIDTH="468" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-180 <span class="emph_B">FRACTURE OF AN OSTEOCHONDROMA. AP Femur.</span> Observe the small osteochondroma on the medial metaphysis of the distal femur, with a fracture of its distal surface (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<a name="PG1231"> </a><div class="pagenum"><div>P.1231</div></div>
<br clear="all">
<div class="FG" id="F181-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[6]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="265" src="files/833ed19059f3ac935c552887fa2878a2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="833ed19059f3ac935c552887fa2878a2.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="265" DISPLAY="INLINE"></div>
<div class="P">Figure 11-181 <span class="emph_B">SESSILE OSTEOCHONDROMAS. A-C. Humerus. D. Proximal Tibia.</span> Observe the broad-based exostoses along the cortical surfaces of the midportions of the humeri and the medial metaphysis of the proximal tibia. The radiolucent central matrix of all four lesions represents uncalcified cartilage (<span class="emph_I">arrows</span>). (Courtesy of Thomas G. Asbel, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Lakeville, Minnesota.)</div>
</td></tr>
</table></div>
<div class="FG" id="F182-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[6]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="476" src="files/5484253f1bfc0f62f304d4bbf24cd79a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5484253f1bfc0f62f304d4bbf24cd79a.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="476" DISPLAY="INLINE"></div>
<div class="P">Figure 11-182 <span class="emph_B">CAULIFLOWER SPINE. A. AP Lower Cervical Spine.</span> Observe the eccentric lobulated exostosis occurring off the articular pillar of C6 (<span class="emph_I">arrows</span>). <span class="emph_B">B. Oblique Cervical Spine.</span> Note the large, cauliflower exostosis arising from the articular pillar of C6 (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> Osteochondromas affecting the neural arch of the vertebrae are referred to as the cauliflower spine.</div>
</td></tr>
</table></div>
</div>
<a name="PG1232"> </a><div class="pagenum"><div>P.1232</div></div>
<br clear="all">
<div class="TLV3" id="B01382540.0-3675" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]">
<div class="HD">Subungual Exostosis</div>
<div class="P">A specific type of solitary osteochondroma that arises from the distal portion of the terminal phalanx of the toes, especially the great toe, is termed a subungual exostosis. (<a class="LK" href="sid806035.html#R396-11">27</a>) (<a class="LK" href="sid806035.html#F183-11">Fig. 11-183</a>) Its site of origin differs from the classic osteochondroma because it stems from the tip of the terminal phalanx, extending beneath or adjacent to the nail bed (<a class="LK" href="sid806035.html#R397-11">28</a>) and not in the metaphyseal portion of the bone. Its cap is fibrocartilaginous, in contrast to the hyaline cap of the typical osteochondroma. (<a class="LK" href="sid806035.html#R398-11">29</a>) These lesions may be painful and often require surgical removal. They typically occur in the 2nd-3rd decade of life and have a 2:1 female predominance. (<a class="LK" href="sid806035.html#R396-11">27</a>)</div>
<div class="TB" id="T22-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-22 Radiologic Features of Osteochondroma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Knee, shoulder, hip</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pedunculated type</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thin, elongated stalk</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Metaphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Blends with cortex and spongiosa</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Projects away from joint (coat hanger)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Lucent when en face</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Calcified cartilage cap (cauliflower, spotty)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Sessile type</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Broad based</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Metaphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Wide, broad metaphysis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Lucent when en face</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Calcified cartilage cap (uncommon)</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F183-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="509" src="files/a1a9d12dbe84702916bc9e031eb29d9a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a1a9d12dbe84702916bc9e031eb29d9a.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="509" DISPLAY="INLINE"></div>
<div class="P">Figure 11-183 <span class="emph_B">SUBUNGUAL EXOSTOSIS. A. Great Toe.</span> Observe the broad-based subungual exostosis occurring off the medial cortical surface of the distal phalanx. <span class="emph_B">B. Great Toe.</span> Note the bilobed subungual exostosis present involving the distal phalanx of the great toe. Notice the shadow of a separate nail covering the distal exostosis. (Courtesy of David M. Walker, <a class="LK" href="sid108669.html#AB1-M10">DPM</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3676" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Solitary Osteochondroma</div>
<div class="TLV2" id="B01382540.0-3677" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">First described and illustrated by Sir Astley Cooper, surgeon and anatomist.</div></li>
<li class="LM"><div class="P">Represents a bony exostosis on the external surface of a bone and usually has a hyaline-lined cartilaginous cap.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3678" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The most common benign skeletal growth or tumor; represents 50&#x0025; of all benign bone tumors and 10-15&#x0025; of all primary bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3679" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">75&#x0025; occur before age 20.</div></li>
<li class="LM"><div class="P">Male predominance is 2:1.</div></li>
<li class="LM"><div class="P">Most are asymptomatic, unless they disturb surrounding blood vessels or nerves.</div></li>
<li class="LM"><div class="P">The most frequent complaint is a painless hard mass near a joint.</div></li>
<li class="LM"><div class="P">Occasionally, a fractured stalk creates pain and swelling.</div></li>
<li class="LM"><div class="P">Cord compression from a spinal osteochondroma occasionally occurs.</div></li>
<li class="LM"><div class="P">Large pelvic osteochondromas may produce symptoms of obstructive uropathy.</div></li>
<li class="LM"><div class="P">Pain and rapid growth may herald the appearance of malignant degeneration.</div></li>
<li class="LM"><div class="P">The most common sites of involvement are the femur, humerus, tibia, pelvis, ribs, and scapula. Scapular involvement of the superior angle has been called Luschka&#x2019;s tubercle.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3680" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM">
<div class="P">Two types exist:</div>
<ul class="LS listtype_U">
<li class="LM"><div class="P">
<span class="emph_I">Sessile:</span> a broad, flat base and no stalk; common in the humerus and scapula.</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Pedunculated:</span> a long stalk attaching it to the host bone. Its cap is of hyaline cartilage and frequently calcifies. Common in the knee, hip, and ankle.</div></li>
</ul>
</li>
<li class="LM"><div class="P">Vary in size, with some reaching 10 cm.</div></li>
<li class="LM"><div class="P">Histologically resembles the normal epiphyseal growth plate.</div></li>
<li class="LM"><div class="P">Malignant degeneration occurs in 1&#x0025; of cases, appears around 30 years of age, and most commonly affects the bones of the pelvis and shoulder girdle.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3681" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Coat hanger exostoses represent pedunculated lesions growing away from the joints on the metaphysis of the involved bones.</div></li>
<li class="LM"><div class="P">En face visualization reveals a dense ring of cortex surrounding the base.</div></li>
<li class="LM"><div class="P">The cortex and spongiosa of both the lesion and host bone blend imperceptibly, representing a key radiologic feature.</div></li>
<li class="LM"><div class="P">Sessile form appears as an asymmetric bump lacking a stalk and having a broad-based attachment.</div></li>
<a name="PG1233"> </a><div class="pagenum"><div>P.1233</div></div>
<br clear="all">
<li class="LM"><div class="P">Pedunculated lesions appear as a lobulated cauliflower mass with a dense, amorphous calcified cap.</div></li>
<li class="LM"><div class="P">Large, dense spinal lesions may be called the cauliflower spine.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3682" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[1]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">No treatment is necessary in most cases because the lesions are clinically silent.</div></li>
<li class="LM"><div class="P">Symptomatic, large lesions are effectively treated by surgical excision.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3683" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]">
<div class="HD">HEREDITARY MULTIPLE EXOSTOSIS</div>
<div class="TLV3" id="B01382540.0-3684" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Hereditary multiple exostosis (HME) is an inherited autosomal dominant metaphyseal overgrowth that is characterized by multiple osteochondromas. (<a class="LK" href="sid806035.html#R399-11">1</a>) (<a class="LK" href="sid806035.html#F184-11">Fig. 11-184</a>) It was described originally in 1814 by Boyer. (<a class="LK" href="sid806035.html#R400-11">2</a>) It has also been called multiple osteochondromatosis, external chondromatosis and, by Keith and the British, diaphyseal aclasis&#x2014; <span class="emph_I">aclasis</span> referring to an alteration of the modeling process. (<a class="LK" href="sid806035.html#R401-11">3</a>,<a class="LK" href="sid806035.html#R402-11">4</a>) It is most frequently discovered between the ages of 2 and 10 years. Both sexes are equally affected; however, the condition appears to be somewhat less severe in female patients. (<a class="LK" href="sid806035.html#R403-11">5</a>) Genetic investigations have identified the responsible genes and further studies have revealed an association of growth disturbances among affected individuals. (<a class="LK" href="sid806035.html#R404-11">6</a>) The number of osteochondromas varies from a few to hundreds, with an average of 10. The metaphyseal portions of the long bones of the knee, ankle, shoulder, and wrist are most commonly affected; however, flat bone involvement has been reported. (<a class="LK" href="sid806035.html#R405-11">7</a>,<a class="LK" href="sid806035.html#R406-11">8</a>) (<a class="LK" href="sid806035.html#F185-11">Fig. 11-185</a>) The distribution is usually bilateral and may be symmetric. The elbows are usually spared. (<a class="LK" href="sid806035.html#F186-11">Fig. 11-186</a>) The hands are often involved in advanced cases. (<a class="LK" href="sid806035.html#F187-11">Fig. 11-187</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3685" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]">
<div class="HD">Radiologic Features</div>
<div class="P">The chief clinical complaint is painless, lumpy joints. This clinical presentation is the same as solitary osteochondroma (discussed earlier in this chapter). A characteristic <span class="emph_I">bayonet hand deformity</span> occurs about the wrist as a result of retardation of bone growth; the deformity is characterized by shortening of the ulna, outward bowing of the radius, and a subluxation of the radioulnar joint. (<a class="LK" href="sid806035.html#F188-11">Fig. 11-188</a>) This deformity occurs in about 30&#x0025; of patients. (<a class="LK" href="sid806035.html#R402-11">4</a>) Large osteochondromas in the distal tibia or fibula often cause pressure erosions of the adjacent bone, leaving a scalloped margin to the outer cortex. (<a class="LK" href="sid806035.html#F189-11">Fig. 11-189</a>)</div>
<div class="FG" id="F184-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="296" height="700" src="files/c0f8922a0fb9f24a6e9c583a4cdb6dea.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c0f8922a0fb9f24a6e9c583a4cdb6dea.gif" MIMETYPE="image/gif" WIDTH="296" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-184 <span class="emph_B">SKELETAL DISTRIBUTION OF HEREDITARY MULTIPLE EXOSTOSIS.</span>
</div>
</td></tr>
</table></div>
<div class="P">Pelvic lesions can become cauliflower-like and appear dense and large. (<a class="LK" href="sid806035.html#F190-11">Fig. 11-190</a>) At times differentiation from chondrosarcoma may be difficult radiographically. The ribs are most frequently involved at the costochondral junctions. (<a class="LK" href="sid806035.html#F191-11">Fig. 11-191</a>) Spinal cord compression can occur with a large vertebral lesion. (<a class="LK" href="sid806035.html#R407-11">9</a>) (<a class="LK" href="sid806035.html#T23-11">Table 11-23</a>)</div>
<div class="P">Malignant degeneration occurs in 5-25&#x0025; of cases. (<a class="LK" href="sid806035.html#R408-11">10</a>) Dahlin (<a class="LK" href="sid806035.html#R409-11">11</a>) believed this figure to be closer to 20&#x0025;. Most lesions develop into chondrosarcoma; however, fibrosarcoma and osteosarcoma have been reported. The pelvis and shoulder girdle are the most common sites. (<a class="LK" href="sid806035.html#R410-11">12</a>) (<a class="LK" href="sid806035.html#F192-11">Fig. 11-192</a>) The clinician must be suspicious of malignant degeneration when a known HME patient complains of pain or renewed growth of an osteochondroma.</div>
<div class="P">The treatment is surgical and is usually for cosmetic rather than symptomatic reasons. Recurrence of the tumor after adequate excision is highly suggestive of an aggressive lesion. Malignant degeneration, or the suspicion of such, is cause for surgical removal.</div>
<a name="PG1234"> </a><div class="pagenum"><div>P.1234</div></div>
<br clear="all">
<div class="FG" id="F185-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="690" src="files/5b456a4d83c6dc1dec118281bbb1aa01.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5b456a4d83c6dc1dec118281bbb1aa01.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="690" DISPLAY="INLINE"></div>
<div class="P">Figure 11-185 <span class="emph_B">HEREDITARY MULTIPLE EXOSTOSIS. A. AP Shoulder.</span> Note the several sessile osteochondromas involving the cortical margins of the proximal metaphysis of the humerus. <span class="emph_B">B and C. Bilateral Hands.</span> Observe multiple small osteochondromas (<span class="emph_I">arrows</span>) throughout the metacarpals, phalanges, distal radius, and ulna bilaterally. <span class="emph_B">D. AP Cervicothoracic Spine.</span> Note the multiple osteochondromas (<span class="emph_I">arrows</span>) involving the posterior surfaces of the first rib bilaterally. <span class="emph_B">E. Lateral Cervical Spine.</span> Observe the sessile osteochondroma arising from the posterior arch of the atlas (<span class="emph_I">arrow</span>). (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1235"> </a><div class="pagenum"><div>P.1235</div></div>
<br clear="all">
<div class="FG" id="F186-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="347" src="files/61e9fb2117eac23d616ee5c3338898dd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="61e9fb2117eac23d616ee5c3338898dd.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="347" DISPLAY="INLINE"></div>
<div class="P">Figure 11-186 <span class="emph_B">OSTEOCHONDROMA. Lateral Elbow.</span> Note the large, cauliflower exostosis arising from the radial tuberosity. Observe the flocculent calcification scattered throughout this cauliflower exostosis.</div>
</td></tr>
</table></div>
<div class="FG" id="F187-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="468" height="700" src="files/5bd9a8bda77361b1517011f55ae3cb96.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5bd9a8bda77361b1517011f55ae3cb96.gif" MIMETYPE="image/gif" WIDTH="468" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-187 <span class="emph_B">MULTIPLE OSTEOCHONDROMAS. Hand.</span> Observe the small osteochondromas scattered throughout the proximal phalanges (<span class="emph_I">arrows</span>). A clearly outlined osteochondroma seen en face is present in the proximal phalanx of the second digit (<span class="emph_I">arrowhead</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F188-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="756" src="files/1587b551dd69c3e658a32bcfda910833.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1587b551dd69c3e658a32bcfda910833.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="756" DISPLAY="INLINE"></div>
<div class="P">Figure 11-188 <span class="emph_B">BAYONET HAND DEFORMITY. A. Left Forearm. B. Right Forearm.</span> Observe the small osteochondromas, affecting the radius and ulna bilaterally. <span class="emph_I">COMMENT:</span> The bayonet hand deformity is found in approximately 30&#x0025; of patients with hereditary multiple exostosis affecting the wrist. This deformity occurs as a result of retardation of bone growth and is characterized by shortening of the ulna, outward bowing of the radius, and subluxation of the radioulnar joint.</div>
</td></tr>
</table></div>
<div class="FG" id="F189-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="323" height="700" src="files/a739d876841bafdabdf5ed4e1a5d07cf.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a739d876841bafdabdf5ed4e1a5d07cf.gif" MIMETYPE="image/gif" WIDTH="323" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-189 <span class="emph_B">PRESSURE EROSION FROM OSTEOCHONDROMA.</span> Note the large cauliflower exostosis occurring off the cortex of the distal tibia, which has produced a significant pressure erosion of the adjacent fibula.</div>
</td></tr>
</table></div>
<a name="PG1236"> </a><div class="pagenum"><div>P.1236</div></div>
<br clear="all">
<div class="FG" id="F190-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="225" src="files/192da6fc2c52f12a0bd6d191e5f6f869.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="192da6fc2c52f12a0bd6d191e5f6f869.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="225" DISPLAY="INLINE"></div>
<div class="P">Figure 11-190 <span class="emph_B">HEREDITARY MULTIPLE EXOSTOSIS (HME): SESSILE TYPE. A. AP Pelvis.</span> Observe the broad thickening of the metaphysis of both femora (<span class="emph_I">arrows</span>). This is a characteristic appearance for HME involving the proximal femur. <span class="emph_B">B. AP Pelvis.</span> Observe the multiple cauliflower exostoses along the anterior margins of the pelvis. Note the broad femoral necks, a characteristic sign of HME (<span class="emph_I">arrows</span>). In addition, there are sessile osteochondromas affecting the pubic rami bilaterally, creating a deformed and expanded appearance (<span class="emph_I">arrowheads</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F191-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="490" src="files/b0d1f077c6ee098bccbbdaeb4e56adf7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b0d1f077c6ee098bccbbdaeb4e56adf7.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="490" DISPLAY="INLINE"></div>
<div class="P">Figure 11-191 <span class="emph_B">OSTEOCHONDROMA: COSTOCHONDRAL JUNCTION. A. PA Chest.</span> Note the large, lobulated, and calcified osteochondroma present at the anterior surface of the second rib. Matrix calcification is present throughout the osteocartilaginous cap. <span class="emph_B">B. Lateral Chest.</span> Note that the calcified lesion is projected into the anterior mediastinum (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<div class="TB" id="T23-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-23 Radiologic Features of Hereditary Multiple Exostosis (HME)</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Multiple, painless lumps and bumps around joints</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Bayonet deformity of the wrist</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Broad metaphyses</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Calcified cauliflower cartilaginous caps</p></td>
</tr>
</table></td></tr>
</table></div>
<a name="PG1237"> </a><div class="pagenum"><div>P.1237</div></div>
<br clear="all">
<div class="FG" id="F192-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[2]/TLV3[2]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="474" height="700" src="files/05944ac91687bcdf01e9495ba0d46196.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="05944ac91687bcdf01e9495ba0d46196.gif" MIMETYPE="image/gif" WIDTH="474" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-192 <span class="emph_B">HEREDITARY MULTIPLE EXOSTOSIS: MALIGNANT DEGENERATION. Pelvis.</span> Observe the sessile osteochondromas affecting the proximal metaphysis of the right femur. There is a radiopaque density extending from the anterior midportion of the right ilium. This density represents malignant degeneration of an osteochondroma, with an associated soft tissue mass extending into the pelvic basin (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3686" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]">
<div class="HD">HEMANGIOMA</div>
<div class="TLV3" id="B01382540.0-3687" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Hemangioma, a primary benign neoplasm, is a slowly growing lesion of bone composed of newly formed capillary, cavernous, or venous blood vessels. Most lesions are clinically silent.</div>
</div>
<div class="TLV3" id="B01382540.0-3688" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Hemangiomas represent about 1&#x0025; of all primary bone tumors and 2-3&#x0025; of all radiographically perceptible spinal tumors. Schmorl and Junghans (<a class="LK" href="sid806035.html#R411-11">1</a>) found asymptomatic vertebral hemangiomas in 11&#x0025; of 3829 consecutive, serially sectioned vertebral columns removed at autopsy. Many of these lesions are not demonstrated on radiographs but are frequently seen on MRI. Hemangioma is the most common benign bone tumor of the spine. (<a class="LK" href="sid806035.html#R412-11">2</a>,<a class="LK" href="sid806035.html#R413-11">3</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3689" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3690" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Most spinal hemangiomas develop after puberty, and the majority of the lesions are seen in adults &#x003E; 40 years. There is a slightly higher incidence in female patients. (<a class="LK" href="sid806035.html#R413-11">3</a>)</div>
<div class="FG" id="F193-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[3]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="300" height="700" src="files/1c46c6dd9e47c7e69399f6c9c539bdd3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1c46c6dd9e47c7e69399f6c9c539bdd3.gif" MIMETYPE="image/gif" WIDTH="300" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-193 <span class="emph_B">SKELETAL DISTRIBUTION OF HEMANGIOMA.</span>
</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3691" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Most hemangiomas at any site are clinically silent. Symptomatic vertebral hemangiomas usually present with localized pain and surrounding muscle spasm. Neurological compromise may be noted with symptoms of hypesthesia, hyperesthesia, radiculitis, and localized pain owing to spinal stenosis. Those spinal lesions that become symptomatic do so as a result of cord compression, which may occur in any of four ways: (<span class="emph_I">a</span>) hypertrophy and ballooning of the vertebral body owing to angiomatous invasion, (<span class="emph_I">b</span>) extension of the hemangioma into the epidural space, (<span class="emph_I">c</span>) compression fracture of the involved vertebra, and (<span class="emph_I">d</span>) hemorrhage. (<a class="LK" href="sid806035.html#R413-11">3</a>) Most of the symptomatic spinal lesions are in the midthoracic region because the larger size of the cord relative to the size of the spinal canal in this region is a predisposing factor. Fracture of the involved vertebra causing spinal cord compression is a rare finding; a few sporadic cases have been reported. (<a class="LK" href="sid806035.html#R414-11">4</a>,<a class="LK" href="sid806035.html#R415-11">5</a>)</div>
<div class="P">Hemangiomas of the maxilla and mandible must be noted, particularly by dentists, because tooth extraction in the area of a hemangioma could prove fatal because of exsanguination. (<a class="LK" href="sid806035.html#R416-11">6</a>,<a class="LK" href="sid806035.html#R417-11">7</a>)</div>
<div class="P">Lesions of the long bones are rare but present, with dull, vague pains that gradually attract clinical attention.</div>
</div>
<a name="PG1238"> </a><div class="pagenum"><div>P.1238</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3692" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">The most common sites for hemangioma are the spine and skull, representing 75&#x0025; of lesions. (<a class="LK" href="sid806035.html#R418-11">8</a>) (<a class="LK" href="sid806035.html#F193-11">Fig. 11-193</a>) Spinal lesions are most common in the lower thoracic and upper lumbar area. Most lesions affect a portion or all of the vertebral body. Extension into the neural arch occurs in 10-15&#x0025; of the cases, usually following initial vertebral body involvement. (<a class="LK" href="sid806035.html#R419-11">9</a>) Most lesions in the skull affect the frontal bone. Sporadic cases have been reported in the cervical spine, long tubular bones, mandible and maxilla, patella, the metacarpals, ribs, scapula, and the soft tissues. (<a class="LK" href="sid806035.html#R415-11">5</a>,<a class="LK" href="sid806035.html#R418-11">8</a>,<a class="LK" href="sid806035.html#R419-11">9</a>,<a class="LK" href="sid806035.html#R420-11">10</a>,<a class="LK" href="sid806035.html#R421-11">11</a>,<a class="LK" href="sid806035.html#R422-11">12</a>) (<a class="LK" href="sid806035.html#F194-11">Fig. 11-194</a>)</div>
<div class="FG" id="F194-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="556" src="files/9d643f1e92cf61063f828af59b951432.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9d643f1e92cf61063f828af59b951432.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="556" DISPLAY="INLINE"></div>
<div class="P">Figure 11-194 <span class="emph_B">CERVICAL SPINE HEMANGIOMA. A. C3 Vertebral Body.</span> Note the characteristic coarsening of the trabecular patterns found within the C3 vertebral body, articular pillar, and lamina. This appearance is consistent with hemangioma. <span class="emph_B">B. C7 Vertebral Body.</span> Note the coarsening of the trabecular patterns, with bone expansion noted, and loss of bone density throughout the C7 vertebral body. The patient presented with no symptoms in this area, and the appearance is characteristic of hemangioma of bone. <span class="emph_B">C. C7 Vertebral Body.</span> Note the vertical striations scattered throughout the vertebral body, assuming a corduroy cloth appearance. There is no thickening of the endplate; however, expansion of the vertebral body is noted. There is minimal extension of the hemangiomatous process into the pedicle and superior articular pillar. This 42-year-old female presented with suboccipital headaches and an asymptomatic C7 cervical hemangioma. <span class="emph_B">D. Atlas.</span> Note the unilateral involvement of the lateral mass, evidenced by the coarse trabecular patterns and slight expansion (<span class="emph_I">arrow</span>). (Panel A courtesy of R. A. Fladland, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Milwaukee, Wisconsin. Special thanks to Gary A. Longmuir, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Phoenix, Arizona, for his assistance in obtaining this case. Panel B courtesy of Appa L. Anderson, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Portland, Oregon. Panel C reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Spinal hemangioma.</span> ACA J Chiro April, 1983. Courtesy of Karsten Hviid, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Arhus, Denmark. Panel D courtesy of Appa L. Anderson, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Portland, Oregon.)</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3693" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Pathologically, two types of hemangiomas of bone are recognized: <span class="emph_I">capillary</span> and <span class="emph_I">cavernous.</span> The capillary type consists of fine capillary loops tending to spread outward in a <span class="emph_I">sunburst</span> fashion; this type, when present, is usually encountered in flat bones
<a name="PG1239"> </a><div class="pagenum"><div>P.1239</div></div>
<br clear="all">
(ribs, innominate) and in the metaphyseal ends of long bones. Capillary hemangiomas are relatively uncommon. The cavernous type consists of large, thin-walled blood vessels and sinuses, lined by a single layer of endothelial cells, surrounded by resorbed bony trabeculae. The cavernous type is the most common type of hemangioma and frequently involves the vertebrae and skull. On occasion, reactive new bone may be observed in both the capillary and the cavernous types of hemangioma.</div>
</div>
<div class="TLV3" id="B01382540.0-3694" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">Hemangiomas in bone usually present a characteristic appearance; however, this varies with the anatomic site. (<a class="LK" href="sid806035.html#T24-11">Table 11-24</a>)</div>
<div class="TLV4" id="B01382540.0-3695" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[1]">
<div class="HD">Spine</div>
<div class="P">Most spinal hemangiomas are solitary; however, double or triple lesions have been reported. (<a class="LK" href="sid806035.html#R423-11">13</a>) (<a class="LK" href="sid806035.html#F195-11">Fig. 11-195</a>) The radiologic appearance of vertebral hemangioma includes coarse vertical striations in the vertebral body, separated by more lucent zones. There is a slight, overall loss of bone density to the affected vertebra, which occurs as a result of replacement of the normal architecture by the angiomatous vessels. The vertical striations create what has been called the <span class="emph_I">corduroy cloth appearance,</span> which is best appreciated in the lateral view. (<a class="LK" href="sid806035.html#R423-11">13</a>) (<a class="LK" href="sid806035.html#F196-11">Fig. 11-196</a>) This appearance has also been called the <span class="emph_I">striated vertebra.</span> (<a class="LK" href="sid806035.html#R424-11">14</a>) Most spinal lesions affect primarily the vertebral bodies, with but a few cases extending into the neural arch. Vertebral body
<a name="PG1240"> </a><div class="pagenum"><div>P.1240</div></div>
<br clear="all">
expansion is a rare occurrence in hemangioma but, when present, often leads to symptoms secondary to spinal stenosis. (<a class="LK" href="sid806035.html#R425-11">15</a>)</div>
<div class="FG" id="F195-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="550" src="files/624bbadd7ec20dbbfbb5a14dc3262122.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="624bbadd7ec20dbbfbb5a14dc3262122.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="550" DISPLAY="INLINE"></div>
<div class="P">Figure 11-195 <span class="emph_B">DOUBLE HEMANGIOMAS. A. AP L5. B. Lateral L5.</span> Observe the coarsened trabecular pattern, creating the corduroy cloth appearance of the L5 vertebral body. This has also been called the striated vertebra. <span class="emph_B">C. AP Thoracic Spine.</span> Note that in the same patient there is coarsening of the trabecular patterns characteristic of spinal hemangioma involving the T2 vertebral body. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Spinal hemangioma.</span> ACA J Chiro April, 1983.)</div>
</td></tr>
</table></div>
<div class="TB" id="T24-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[1]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-24 Radiologic Features of Hemangioma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Spine</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thoracolumbar region</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Vertebral body</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Coarse vertical striations (corduroy cloth or striated vertebra)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Paravertebral swelling</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Differential diagnosis: Paget&#x2019;s disease, osteoporosis</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Skull</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Frontal bone</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Round, oval</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Geographic lesion radiating spicules (sunray or spoked wheel)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Long bones</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansile</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Coarsened trabeculae (honeycomb)</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F196-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="491" height="700" src="files/fc7af39b7aab59e5be15ed79a185403a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fc7af39b7aab59e5be15ed79a185403a.gif" MIMETYPE="image/gif" WIDTH="491" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-196 <span class="emph_B">SPINAL HEMANGIOMA: CORDUROY CLOTH APPEARANCE. A. Lateral Lumbar Spine.</span> Observe the coarsened trabecular patterns throughout the L3 vertebral body. <span class="emph_B">B. Diagram. C. Lateral Thoracolumbar Spine.</span> Note the accentuation of the vertical trabecular patterns throughout the vertebral body of the L1 vertebra. This appearance is characteristic of spinal hemangioma and has been referred to as the striated vertebra. <span class="emph_B">D. T9 Vertebra.</span> Observe the coarsening of the trabecular patterns throughout the vertebral body of T9, consistent with an intraosseous spinal hemangioma. <span class="emph_I">COMMENT:</span> The most common sites for hemangioma are the spine and skull, making up 75&#x0025; of all such lesions. Spinal hemangiomas are most common in the lower thoracic and upper lumbar areas. Most lesions affect a portion or all of the vertebral body, with 10-15&#x0025; of the cases extending into the neural arch after initial vertebral body involvement. (Panel A courtesy of Stephen F. Kesler, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Salt Lake City, Utah.)</div>
</td></tr>
</table></div>
<a name="PG1241"> </a><div class="pagenum"><div>P.1241</div></div>
<br clear="all">
<div class="P">The roentgen pattern of hemangioma may be simulated by other conditions. One of the major disease processes that can mimic the coarsened trabecular patterns of spinal hemangioma is Paget&#x2019;s disease. Because hemangiomas rarely expand bone and vertebral Paget&#x2019;s disease often does, the differential diagnosis is usually made on the basis of bone expansion. (<a class="LK" href="sid806035.html#R419-11">9</a>) An additional sign supportive of Paget&#x2019;s disease is the thickening of the cortical endplates, which has been called the <span class="emph_I">picture frame appearance.</span> (<a class="LK" href="sid806035.html#F197-11">Fig. 11-197</a>) Cortical thickening is not a feature of hemangioma, leaving the vertebral endplates crisp and unaffected. (<a class="LK" href="sid806035.html#R419-11">9</a>) Patients with senile or postmenopausal osteoporosis may demonstrate prominent vertical trabeculae within the vertebral bodies. This occurs as a result of the preferential resorption of the transverse trabeculae and accentuation of the remaining vertical trabeculae. This process creates a <span class="emph_I">pseudo-hemangiomatous</span> appearance of multiple vertebrae in patients with diffuse osteoporosis. (<a class="LK" href="sid806035.html#R419-11">9</a>) One should hesitate to conclude that a geriatric patient has more than one vertebral hemangioma (on plain films) because it is more likely the patient has simple osteoporosis.</div>
<div class="P">An unusual roentgen sign that has been rarely seen is the presence of a paravertebral mass with spinal hemangioma. Only a few case studies have been reported. (<a class="LK" href="sid806035.html#R426-11">16</a>,<a class="LK" href="sid806035.html#R427-11">17</a>) The paravertebral mass may be large or only a localized bulge of the thoracic paraspinal line, usually on the left side. It may occur because of the extension of the tumor through the cortex of the vertebral body into the adjacent soft tissues. (<a class="LK" href="sid806035.html#R426-11">16</a>) On CT and MRI predominantly fatty stroma types are less likely to be associated with spinal cord compression. (<a class="LK" href="sid806035.html#R428-11">18</a>) Another possible cause is a compression fracture of the involved vertebra, which can lead to an increase in the transverse diameter of the vertebral body and a hematoma in the paravertebral space, causing a segmental bulge. (<a class="LK" href="sid806035.html#R427-11">17</a>)</div>
<div class="FG" id="F197-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="246" src="files/ce4a83aea5811bca6da9f4120bbf87fd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ce4a83aea5811bca6da9f4120bbf87fd.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="246" DISPLAY="INLINE"></div>
<div class="P">Figure 11-197 <span class="emph_B">HEMANGIOMA VERSUS PAGET&#x2019;S DISEASE: DIFFERENTIAL DIAGNOSIS. A. Hemangioma: AP Lumbar Spine. B. Lateral Lumbar Spine.</span> Observe the loss of bone density and accentuation of the vertical trabecular patterns throughout the L3 vertebral body. There is a loss of the anterior concavity of the vertebral body, caused by bony expansion. There is no thickening of the vertebral endplates. This appearance is characteristic of an expanding spinal hemangioma. <span class="emph_B">C. Paget&#x2019;s Disease: AP Lumbar Spine. D. Lateral Lumbar Spine.</span> Observe the thickening of the trabecular patterns throughout the vertebral body and neural arch of L3. This trabecular thickening is reminiscent of the changes characteristically found in the corduroy cloth appearance of spinal hemangioma. There is bone expansion noted, with significant thickening of the vertebral endplates, creating a <span class="emph_I">picture frame</span> appearance. There is central depression of the vertebral body, suggesting a pathologic fracture. These radiographic signs secure the diagnosis of Paget&#x2019;s disease. <span class="emph_I">COMMENT:</span> Because occasionally Paget&#x2019;s disease may mimic the appearance of a hemangioma in the vertebral body, differential diagnosis is essential. Cortical thickening at the vertebral endplates reminiscent of the <span class="emph_I">picture frame</span> appearance is characteristically seen in Paget&#x2019;s disease, but is not found in hemangioma. The vertebral endplates are crisp and unaffected in spinal hemangioma. The radiographic sign of bony expansion, which usually suggests Paget&#x2019;s disease, does occur in a small percentage of patients with hemangioma. The differential radiographic sign, therefore, is thickening of the vertebral endplates in Paget&#x2019;s disease, a sign not present with hemangioma.</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3696" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[2]">
<div class="HD">Skull</div>
<div class="P">Although hemangioma may occur anywhere in the skull, it is most commonly found in the frontal bone. (<a class="LK" href="sid806035.html#R429-11">19</a>) (<a class="LK" href="sid806035.html#F198-11">Fig. 11-198</a>) The lesion varies from 1 to 7 cm in diameter and is a round or oval radiolucency when viewed en face. The lytic defect often has dense, fine spicula radiating from its centrum, creating a <span class="emph_I">sunburst</span> or <span class="emph_I">spoked-wheel appearance.</span> (<a class="LK" href="sid806035.html#R419-11">9</a>,<a class="LK" href="sid806035.html#R429-11">19</a>) (<a class="LK" href="sid806035.html#F199-11">Fig. 11-199</a>) The intense nature of the radiating spicules of bone can mimic osteosarcoma, particularly in tangential or profile views. Ordinarily, the hemangioma extends outward, well beyond the normal contour of the bone. Often accompanying this external bulging is an erosion or disappearance of the outer table of the skull, while the integrity of the inner table is usually preserved. The profile view frequently discloses vertical striations, which produce the characteristic sunray effect. (<a class="LK" href="sid806035.html#R430-11">20</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3697" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[3]">
<div class="HD">Other Bones</div>
<div class="P">Involvement of bones other than the skull and spine is uncommon; however, the radiographic appearance is that of an expansile, lytic,
<a name="PG1242"> </a><div class="pagenum"><div>P.1242</div></div>
<br clear="all">
fine, lacy network or honeycombing lesion. The radiating coarse linear strands diverging from the center also occur, leaving a sunray appearance. (<a class="LK" href="sid806035.html#F200-11">Fig. 11-200</a>)</div>
<div class="FG" id="F198-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="231" src="files/3ebc76aedaa8805c03d25fdf1710c9cf.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3ebc76aedaa8805c03d25fdf1710c9cf.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="231" DISPLAY="INLINE"></div>
<div class="P">Figure 11-198 <span class="emph_B">HEMANGIOMA: FRONTAL BONE. A. PA Skull. B. Lateral Skull.</span> Observe the oval radiolucent defect in the frontal bone (<span class="emph_I">arrows</span>). The central portion of this radiolucency demonstrates a <span class="emph_I">sunburst</span> or <span class="emph_I">spoked-wheel</span> appearance, which is characteristic of hemangioma. <span class="emph_I">COMMENT:</span> Although hemangioma may occur anywhere in the skull, it is most commonly found in the frontal bone; this represents the second most common site of intraosseous hemangioma. The lesion varies from 1 to 7 cm in diameter and is a round or oval radiolucency when viewed en face.</div>
</td></tr>
</table></div>
<div class="FG" id="F199-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="426" src="files/1ac4faacaead6b13d99b943430ade3c6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1ac4faacaead6b13d99b943430ade3c6.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="426" DISPLAY="INLINE"></div>
<div class="P">Figure 11-199 <span class="emph_B">HEMANGIOMA: SUNBURST OR SPOKED-WHEEL APPEARANCE. A. PA Skull. B. Lateral Skull.</span> Note the circular radiolucent defect present primarily within the temporal bone, with minimal extension into the frontal bone. There is an intense, radiating spiculation of bone from the central portion of the lytic defect, creating the <span class="emph_I">sunburst</span> or <span class="emph_I">spoked-wheel</span> appearance of an intraosseous hemangioma. <span class="emph_B">C. Tangential Skull.</span> Observe the fine spicula radiating from the centrum of the lytic hemangioma. <span class="emph_B">D. CT Skull.</span> Observe the large, radiating hemangioma present within the table of the skull. <span class="emph_I">COMMENT:</span> Hemangiomas affecting the calvaria often present with dense, fine spicula radiating from the centrum, creating a <span class="emph_I">sunburst</span> or <span class="emph_I">spoked-wheel</span> appearance. The intense nature of the radiating spicules of bone can mimic osteosarcoma, particularly in tangential or profile views.</div>
</td></tr>
</table></div>
</div>
<a name="PG1243"> </a><div class="pagenum"><div>P.1243</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3698" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[4]">
<div class="HD">Soft Tissue Hemangioma</div>
<div class="P">Soft tissue hemangioma is the cause of a palpable soft tissue mass usually found in the forearm, lower leg, or paravertebral area. (<a class="LK" href="sid806035.html#F201-11">Figs. 11-201</a> and <a class="LK" href="sid806035.html#F202-11">11-202</a>) Spherical calcifications occur within the mass, representing phleboliths, and characterizing the vascular nature of the mass.</div>
<div class="FG" id="F200-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="433" src="files/62e36e8f17bf457d20de0b1f935ce9a7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="62e36e8f17bf457d20de0b1f935ce9a7.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="433" DISPLAY="INLINE"></div>
<div class="P">Figure 11-200 <span class="emph_B">HEMANGIOMA. AP Pelvis.</span> Observe the radiating trabecular patterns scattered throughout an oval hemangioma involving the ischium (<span class="emph_I">arrows</span>). Of incidental notation is an intrauterine device present in the pelvic basin (<span class="emph_I">arrowhead</span>). (Courtesy of Richard T. Coade, <a class="LK" href="sid108669.html#AB1-M15">MIR</a>, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Kempsey, New South Wales, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F201-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[5]/TLV4[4]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="587" src="files/1cbb30995c49a6731cbca6d08160a665.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1cbb30995c49a6731cbca6d08160a665.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="587" DISPLAY="INLINE"></div>
<div class="P">Figure 11-201 <span class="emph_B">SOFT TISSUE HEMANGIOMA. A. PA Forearm. B. Lateral Forearm.</span> Observe the multiple laminated soft tissue densities lying within the soft tissues, consistent with phleboliths. <span class="emph_I">COMMENT:</span> These are a characteristic finding of soft tissue hemangioma.</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3699" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Most hemangiomas are clinically silent, requiring no treatment. Symptomatic spinal lesions are either fractured or expanding bone, creating spinal stenosis and impending paraplegia. Surgical de
<a name="PG1244"> </a><div class="pagenum"><div>P.1244</div></div>
<br clear="all">
compression is to be performed only on those lesions that are creating cord compression.</div>
<div class="FG" id="F202-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="478" height="700" src="files/8efe37db2aa3f3d256002aca88b48fad.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8efe37db2aa3f3d256002aca88b48fad.gif" MIMETYPE="image/gif" WIDTH="478" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-202 <span class="emph_B">SOFT TISSUE HEMANGIOMA. Lateral Cervical Spine.</span> Observe the large hemangioma present in the soft tissue structures of the lower neck (<span class="emph_I">arrows</span>). There are small circular calcifications scattered throughout the soft tissue hemangioma that represent phleboliths (<span class="emph_I">arrowheads</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F203-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="490" height="700" src="files/b42eb1c9177ce14293ab991c2dcf8c89.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b42eb1c9177ce14293ab991c2dcf8c89.gif" MIMETYPE="image/gif" WIDTH="490" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-203 <span class="emph_B">HEMANGIOMA WITH ADJACENT COMPRESSION FRACTURE.</span> Observe the L1 hemangioma (<span class="emph_I">arrow</span>) and the subadjacent compression fracture at L2 (<span class="emph_I">arrowhead</span>). <span class="emph_I">COMMENT:</span> This attests to the inherent strength of the hemangioma. (Courtesy of Kevin J. La Londe, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Duxbury, Massachusetts.)</div>
</td></tr>
</table></div>
<div class="P">A question arises concerning the integrity of the spinal hemangioma and as to the incidence of compression fracture. Review of the literature finds &#x003C; 15 cases of hemangiomatous vertebral collapse. (<a class="LK" href="sid806035.html#R415-11">5</a>,<a class="LK" href="sid806035.html#R431-11">21</a>,<a class="LK" href="sid806035.html#R432-11">22</a>) Holta (<a class="LK" href="sid806035.html#R415-11">5</a>) stated that a hemangiomatous vertebra is reinforced by thick, sclerotic vertical trabeculae, secondary to appositional new bone formation and is, therefore, stronger than the adjacent normal vertebrae. (<a class="LK" href="sid806035.html#F203-11">Fig. 11-203</a>) Because so few of these lesions fracture, one wonders how valid it is to severely curb a patient&#x2019;s activities because of the mere presence of a vertebral body hemangioma.</div>
<div class="P">Occasionally, radiation therapy may be given to a symptomatic, inoperable vertebral hemangioma. Symptomatic hemangiomas of the skull are treated quite effectively by en bloc excision, with a low recurrence rate and favorable prognosis. (<a class="LK" href="sid806035.html#R433-11">23</a>) Such is also the case with hemangiomas in other sites. If the lesion is in a bone that can be spared (rib, nasal bone), local resection is indicated. (<a class="LK" href="sid806035.html#R433-11">23</a>)</div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3700" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Hemangioma</div>
<div class="TLV2" id="B01382540.0-3701" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A vascular solitary neoplasm that is slow growing and composed of newly formed capillary, cavernous, or venous blood vessels.</div></li>
<li class="LM"><div class="P">A benign neoplasm with no malignant potential.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3702" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents 1&#x0025; of all radiographically demonstrable primary bone tumors, 2-3&#x0025; of all spinal tumors.</div></li>
<li class="LM"><div class="P">Schmorl and Junghans found 11&#x0025; of 3829 sectioned autopsy specimens to have asymptomatic vertebral lesions; many of these lesions are not demonstrable on radiographs.</div></li>
<li class="LM"><div class="P">The most common benign bone tumor of the spine.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3703" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most lesions are seen in patients &#x003E; 40 years of age; however, lesions often develop after puberty and go undetected until later in life.</div></li>
<li class="LM"><div class="P">Slightly higher incidence in females exists.</div></li>
<li class="LM"><div class="P">Most lesions at any site are asymptomatic.</div></li>
<li class="LM"><div class="P">Most symptomatic spinal lesions are the result of expansion leading to the development of spinal stenosis. These patients may present with signs of impending paraplegia.</div></li>
<li class="LM"><div class="P">75&#x0025; of lesions occur in the spine and skull, the lower thoracic and upper lumbars are the target areas with the frontal bone being the most common bone affected in the skull.</div></li>
<li class="LM"><div class="P">Most spinal lesions are in the vertebral body, with 10-15&#x0025; extending into the neural arch.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3704" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM">
<div class="P">Two types exist.</div>
<ul class="LS listtype_U">
<li class="LM">
<div class="P">
<span class="emph_I">Capillary:</span> consists of fine capillary loops that spread outward in a sunburst fashion, usually affecting flat bones. This type is uncommon.</div>
<div class="P">
<span class="emph_I">Cavernous:</span> consists of large, thin-walled blood vessels and sinuses lined by endothelial cells. This is the most common type, frequently affecting the vertebrae and skull.</div>
</li>
</ul>
</li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3705" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The classic spinal lesion is one with coarse vertical striations within the vertebral body and has been called the <span class="emph_I">corduroy cloth</span> appearance or the <span class="emph_I">striated</span> vertebra.</div></li>
<li class="LM"><div class="P">Rarely, a paravertebral mass may be found associated with vertebral hemangioma.</div></li>
<li class="LM"><div class="P">A <span class="emph_I">pseudo-hemangiomatous</span> appearance occurs throughout the spine in patients with senile or postmenopausal osteoporosis. Because most lesions are solitary, the clinician should hesitate to conclude that a patient has multiple hemangiomas because it is usually as a result of the vertical trabecular accentuation of osteoporosis.</div></li>
<li class="LM"><div class="P">Vertebral expansion may rarely occur, creating a similar appearance to Paget&#x2019;s disease of the spine. Differentiation is made by the lack of the cortical endplate thickening in hemangioma, which is so characteristic of Paget&#x2019;s disease (<span class="emph_I">picture frame appearance</span>).</div></li>
<li class="LM"><div class="P">Most skull lesions are in the frontal bone, creating a round or oval radiolucency, a radiating <span class="emph_I">sunburst</span> or <span class="emph_I">spoked-wheel</span> appearance that extends from the center of the lytic defect.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3706" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[3]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most lesions are clinically silent and require no treatment.</div></li>
<li class="LM"><div class="P">Symptomatic spinal lesions are either fractured or are expanding bone creating spinal stenosis; surgical decompression may be necessary under these circumstances.</div></li>
<li class="LM"><div class="P">Radiation treatment may be used occasionally in inoperable vertebral hemangioma.</div></li>
<li class="LM"><div class="P">Skull lesions are easily treated by en bloc excision and have a favorable prognosis.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3707" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]">
<div class="HD">OSTEOMA</div>
<div class="TLV3" id="B01382540.0-3708" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Osteomas are benign bone tumors that arise in membranous bones. Because most osteomas are asymptomatic, their true incidence is not known. (<a class="LK" href="sid806035.html#R434-11">1</a>) Several studies of patients from otolaryngology clinics reveal a &#x003C; 1&#x0025; incidence; however, osteomas represent the most common benign tumor of the nose and paranasal sinuses. (<a class="LK" href="sid806035.html#R434-11">1</a>,<a class="LK" href="sid806035.html#R435-11">2</a>,<a class="LK" href="sid806035.html#R436-11">3</a>) Most lesions are clinically silent and occur in the frontal and ethmoid sinuses or affect the outer or inner tables of the skull. (<a class="LK" href="sid806035.html#R437-11">4</a>) (<a class="LK" href="sid806035.html#F204-11">Fig. 11-204</a>) If symptoms develop it is usually not until the 2nd-5th decades of life (<a class="LK" href="sid806035.html#R436-11">3</a>) and shows neither signs of progression nor malignant change. If the lesions interfere with the drainage of the involved sinus, they can lead to chronic sinusitis with retro-orbital pressure, headaches, mucoceles,
<a name="PG1245"> </a><div class="pagenum"><div>P.1245</div></div>
<br clear="all">
and, rarely, brain abscess. (<a class="LK" href="sid806035.html#R438-11">5</a>,<a class="LK" href="sid806035.html#R439-11">6</a>) Although infrequent, osteomas of the frontal sinus have been associated with posterior protrusion into the cranial cavity, resulting in life-threatening situations. (<a class="LK" href="sid806035.html#R440-11">7</a>)</div>
<div class="FG" id="F204-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="298" height="700" src="files/2d504dd10240431b0cbe374938740d64.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2d504dd10240431b0cbe374938740d64.gif" MIMETYPE="image/gif" WIDTH="298" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-204 <span class="emph_B">SKELETAL DISTRIBUTION OF OSTEOMA.</span>
</div>
</td></tr>
</table></div>
<div class="P">Most osteomas never reach a size &#x003E; 2 cm, and they are most often found by coincidence. Occasionally, these lesions can become large, nearly filling the entire sinus cavity (<span class="emph_I">giant osteomas</span>). (<a class="LK" href="sid806035.html#F205-11">Fig. 11-205</a>) These patients may experience a variety of ocular disturbances, including proptosis, headaches, and recurrent sinusitis. (<a class="LK" href="sid806035.html#R441-11">8</a>) Mandibular osteomas create mechanical and cosmetic problems (<a class="LK" href="sid806035.html#F206-11">Fig. 11-206</a>) and, rarely, may cause bizarre defects in vision and balance by virtue of their close proximity to the carotid sinus and internal carotid artery. (<a class="LK" href="sid806035.html#R441-11">8</a>) A 3:1 female to male ratio has been noted. (<a class="LK" href="sid806035.html#R442-11">9</a>) It is believed that these lesions develop in response to embryologic tissue growth defects, infection, or trauma. (<a class="LK" href="sid806035.html#R437-11">4</a>) Histologically, there are two types: the <span class="emph_I">ivory</span> or <span class="emph_I">compact</span> osteoma and the <span class="emph_I">trabecular</span> or <span class="emph_I">spongy</span> osteoma. They are differentiated by their point of origin within the bone.</div>
</div>
<div class="TLV3" id="B01382540.0-3709" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiographic appearance of osteoma is that of a round or oval, well-circumscribed, radiopaque structure. (<a class="LK" href="sid806035.html#R439-11">6</a>) (<a class="LK" href="sid806035.html#F207-11">Figs. 11-207</a> and <a class="LK" href="sid806035.html#F208-11">11-208</a>) Rarely does one attain a size &#x003E; 2 cm. (<a class="LK" href="sid806035.html#F209-11">Fig. 11-209</a>) If a sinus osteoma is large (<span class="emph_I">giant osteoma</span>), it occasionally causes expansion of the sinus walls. (<a class="LK" href="sid806035.html#T25-11">Table 11-25</a>) Rarely, osteoma may occur off of the outer skull table and can become quite large. (<a class="LK" href="sid806035.html#F210-11">Figs. 11-210</a>, <a class="LK" href="sid806035.html#F211-11">11-211</a> and <a class="LK" href="sid806035.html#F212-11">11-212</a>)</div>
<div class="FG" id="F205-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="370" height="700" src="files/d6a540c4785344d3be8e5fb7ad0eeb96.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d6a540c4785344d3be8e5fb7ad0eeb96.gif" MIMETYPE="image/gif" WIDTH="370" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-205 <span class="emph_B">GIANT OSTEOMA. A. PA Caldwell&#x2019;s Projection Sinus. B. Lateral Sinus. C. AP Waters&#x2019; Projection Sinus.</span> Observe the giant, ivory osteoma present in the frontal sinus. <span class="emph_I">COMMENT:</span> Patients with lesions of this magnitude often experience proptosis, a variety of ocular disturbances, and exophthalmos. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="P">The symptomatic osteomas are best treated by surgical excision. (<a class="LK" href="sid806035.html#R443-11">10</a>) Recurrence after excision seldom occurs. (<a class="LK" href="sid806035.html#R443-11">10</a>) Most osteomas require no treatment because they are asymptomatic lesions. (<a class="LK" href="sid806035.html#R443-11">10</a>,<a class="LK" href="sid806035.html#R444-11">11</a>)</div>
<a name="PG1246"> </a><div class="pagenum"><div>P.1246</div></div>
<br clear="all">
<div class="FG" id="F206-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="514" src="files/e31505c1f06dd77c937bf4f394f77fcb.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e31505c1f06dd77c937bf4f394f77fcb.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="514" DISPLAY="INLINE"></div>
<div class="P">Figure 11-206 <span class="emph_B">OSTEOMA: OBLIQUE MANDIBLE.</span> Note the large, lobulated, ivory osteoma projecting off the angle of the mandible. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F207-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="518" height="700" src="files/2559ad4ed1fed2703fe355dd92495e69.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2559ad4ed1fed2703fe355dd92495e69.gif" MIMETYPE="image/gif" WIDTH="518" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-207 <span class="emph_B">OSTEOMA: FRONTAL SINUS.</span> Observe the well-circumscribed radiopaque osteoma present within the frontal sinus. Of incidental notation is a plaque-like area of calcification present within the falx cerebri (<span class="emph_I">arrow</span>), a normal variant. (Courtesy of Thomas F. Bergmann, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Minneapolis, Minnesota.)</div>
</td></tr>
</table></div>
<div class="FG" id="F208-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="219" src="files/8ed006ef46b87347c361e008e7387430.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8ed006ef46b87347c361e008e7387430.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="219" DISPLAY="INLINE"></div>
<div class="P">Figure 11-208 <span class="emph_B">OSTEOMA: SPHENOID SINUS. A. AP Towne&#x2019;s Projection, Skull. B. Lateral Projection, Sinuses.</span> Observe the oval, well-circumscribed osteoma on the posterior surface of the sphenoid sinus (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="TB" id="T25-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-25 Radiologic Features of Osteoma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Arise in membranous bones</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Sinuses&#x2014;frontal, ethmoids</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Mandible</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Skull bones</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Homogeneously opaque</p></td>
</tr>
</table></td></tr>
</table></div>
<a name="PG1247"> </a><div class="pagenum"><div>P.1247</div></div>
<br clear="all">
<div class="FG" id="F209-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="423" src="files/b4dab086b3596f732d6b5072dd95028d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b4dab086b3596f732d6b5072dd95028d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="423" DISPLAY="INLINE"></div>
<div class="P">Figure 11-209 <span class="emph_B">GIANT OSTEOMA: FRONTAL SINUS. A. PA Caldwell&#x2019;s Projection: Frontal Sinuses. B. Lateral Close-Up of Frontal Sinus.</span> Observe the giant osteoma of the frontal sinus, with a lobulated peripheral margin (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F210-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="431" src="files/8d8a05ae8395d30f7e596d25cc20669b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8d8a05ae8395d30f7e596d25cc20669b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="431" DISPLAY="INLINE"></div>
<div class="P">Figure 11-210 <span class="emph_B">GIANT OSTEOMA: CALVARIA. A. Lateral Skull.</span> Note the homogeneous, ill-defined, radiopaque osteoma involving the frontal bone. This alters the shape and contour of the skull table. <span class="emph_B">B. Lateral Skull.</span> Observe the large, dense osteoma affecting the posterior portion of the parietal bone and extending into the occiput. Significant expansion of the outer table is noted. <span class="emph_B">C. Lateral Skull.</span> Note the gigantic ivory osteoma projecting from the posterior surface of the skull. Owing to the significant bony expansion and cosmetic deformity, this was surgically removed. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1248"> </a><div class="pagenum"><div>P.1248</div></div>
<br clear="all">
<div class="FG" id="F211-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="441" src="files/36ca46356ddc9b3fe914b6f5ab212e67.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="36ca46356ddc9b3fe914b6f5ab212e67.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="441" DISPLAY="INLINE"></div>
<div class="P">Figure 11-211 <span class="emph_B">OSTEOMA: TEMPORAL BONE.</span> Observe the well-circumscribed radiopaque osteoma affecting the temporal bone. This is a somewhat unusual location for an osteoma. (Courtesy of Klaus W. Weber, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Fort Wayne, Indiana.)</div>
</td></tr>
</table></div>
<div class="FG" id="F212-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[4]/TLV3[2]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="522" height="700" src="files/32f8125ea39af801504f0132034026da.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="32f8125ea39af801504f0132034026da.gif" MIMETYPE="image/gif" WIDTH="522" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-212 <span class="emph_B">OSTEOMA: OCCIPUT. A. AP Open Mouth. B. Lateral Cervical Spine.</span> Note the large, oval, radiopaque osteoma protruding from the outer table of the occiput. (Courtesy of Margaret A. Seron, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M3">DABCO</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3710" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[5]">
<div class="HD">GARDNER&#x2019;S SYNDROME</div>
<div class="TLV3" id="B01382540.0-3711" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[5]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Gardner&#x2019;s syndrome may be defined as a triad of abnormal growths: multiple osteomas, colonic polyposis, and soft tissue fibromas. (<a class="LK" href="sid806035.html#R445-11">1</a>) This syndrome is transmitted as an autosomal Mendelian dominant. Variable reports occur in the literature regarding the incidence of osseous manifestations. Approximately 45&#x0025; of patients with Gardner&#x2019;s display all of the classic lesions and symptoms. (<a class="LK" href="sid806035.html#R446-11">2</a>) In a survey of 280 patients with this syndrome, 40 (14&#x0025;) showed bone lesions. (<a class="LK" href="sid806035.html#R446-11">2</a>) The osteomas appear as protuberant, oval, dense, occasionally lobulated masses, which are usually attached to the cortex. (<a class="LK" href="sid806035.html#F213-11">Fig. 11-213</a>) These lesions are polyostotic and quite distinctive in appearance. The most common bones involved are the frontal, mandible (near the mandibular angle), maxilla, sphenoid, ethmoid, zygoma, and the small tubular bones of the hands and feet. It should be emphasized that, when present, the bone lesions usually precede the polyps and skin lesions. (<a class="LK" href="sid806035.html#F214-11">Fig. 11-214</a>)</div>
<div class="P">The polyposis of the colon should be considered premalignant, and any patient who has multiple osteomas should have the colon examined. (<a class="LK" href="sid806035.html#R447-11">3</a>) Other members of the family should be examined as well because of the inheritability of the condition. Prophylactic resection of the bowel is the treatment of choice.</div>
<div class="FG" id="F213-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[5]/TLV3[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="462" height="700" src="files/a738a0e75e4dfad136de6858d0a5272a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a738a0e75e4dfad136de6858d0a5272a.gif" MIMETYPE="image/gif" WIDTH="462" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-213 <span class="emph_B">GARDNER&#x2019;S SYNDROME. PA Hand.</span> Observe the small, well-defined osteomas projecting from the metacarpal bones (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> Gardner&#x2019;s syndrome may be defined as a triad of abnormal growths: multiple osteomas, colonic polyps, and soft tissue fibromas. The bones most commonly involved are the frontal, mandible, maxilla, and small tubular bones of the hands and feet. It should be emphasized that in Gardner&#x2019;s syndrome the bone lesions usually precede the colonic polyps and skin lesions. The polyps of the colon are considered premalignant, and any patient who has multiple osteomas should have a colon examination. Owing to the familial nature of this syndrome, all family members need to be evaluated.</div>
</td></tr>
</table></div>
<a name="PG1249"> </a><div class="pagenum"><div>P.1249</div></div>
<br clear="all">
<div class="FG" id="F214-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[5]/TLV3[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="616" src="files/4a82695f8014e94e6bcdc23e877d6397.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4a82695f8014e94e6bcdc23e877d6397.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="616" DISPLAY="INLINE"></div>
<div class="P">Figure 11-214 <span class="emph_B">GARDNER&#x2019;S SYNDROME: MANDIBLE AND FEMORA. A. AP Mandible. B. Lateral Mandible.</span> Observe the giant ivory-like osteoma projecting off the left mandible near its angle. <span class="emph_B">C. and D. Bilateral Femora.</span> Observe the large osteomas projecting off the medial and lateral cortices of the mid-diaphysis of both femora. (Courtesy of Mathew Pardy, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Department of Radiology, University Hospital, Denver, Colorado.)</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3712" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]">
<div class="HD">BONE ISLAND</div>
<div class="TLV3" id="B01382540.0-3713" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">A solitary discrete area of sclerosis in the skeleton, usually called a bone island (endosteoma), is an entity well known to the practitioner and radiologist. (<a class="LK" href="sid806035.html#F215-11">Fig. 11-215</a>) It is usually asymptomatic and in most cases an incidental finding. These bone islands are particularly common in the ischium, ilium, sacrum, and proximal femur but may be found in the humerus, vertebra, talus, scaphoid, and ribs. (<a class="LK" href="sid806035.html#F216-11">Fig. 11-216</a>, <a class="LK" href="sid806035.html#F217-11">11-217</a>, <a class="LK" href="sid806035.html#F218-11">11-218</a> and <a class="LK" href="sid806035.html#F219-11">11-219</a>) The only location in which bone islands do not occur is the skull. (<a class="LK" href="sid806035.html#R448-11">1</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3714" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[2]">
<div class="HD">Clinical Features</div>
<div class="P">Bone islands may be found at any age but are far more common in adults than in children. They are asymptomatic and clinically insignificant lesions. They are usually unchanged in size over many years but occasionally may grow. (<a class="LK" href="sid806035.html#R449-11">2</a>) (<a class="LK" href="sid806035.html#F220-11">Fig. 11-220</a>) Bone islands
<a name="PG1250"> </a><div class="pagenum"><div>P.1250</div></div>
<br clear="all">
are not generally thought to be active lesions, although a change in their size with prolonged observation has been well documented. (<a class="LK" href="sid806035.html#R450-11">3</a>) Onitsuka (<a class="LK" href="sid806035.html#R451-11">4</a>) reported a 31.9&#x0025; incidence of change in size in 138 bone islands for which sequential roentgenograms over intervals ranging from 1 to 23 years were available. Most of his patients showed an increase in size of the bone islands, although a few islands decreased in size. Included in his study were examples of bone islands enlarging in proportion to adolescent growth. In general, approximately 30&#x0025; enlarge over a period of years. Although most bone islands appear stable, changes in them may be so slow that observation over many years is necessary. Hoffman and Campbell (<a class="LK" href="sid806035.html#R452-11">5</a>) reported a case of a bone island that disappeared with the development of hyperparathyroidism, as a result of resorption of bone, and reappeared after treatment by removal of a benign parathyroid adenoma. This finding further emphasizes the fact that bone islands are not inert areas of sclerosis; rather, they are areas of dynamic compact bone and subject to the same metabolic influences that affect the skeletal system in general. (<a class="LK" href="sid806035.html#R453-11">6</a>)</div>
<div class="FG" id="F215-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="300" height="700" src="files/f17892f9ac48319148163182562d4b77.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f17892f9ac48319148163182562d4b77.gif" MIMETYPE="image/gif" WIDTH="300" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-215 <span class="emph_B">SKELETAL DISTRIBUTION OF BONE ISLAND.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F216-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="452" src="files/c22dd582928c7fa149c111bb433a07b0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c22dd582928c7fa149c111bb433a07b0.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="452" DISPLAY="INLINE"></div>
<div class="P">Figure 11-216 <span class="emph_B">BONE ISLAND. AP Ischium.</span> Note the oval radiopacity within the ischium, which represents a large bone island. Of incidental notation is a radiopaque ovarian shield seen obscuring the pelvic basin and a portion of the pelvic brim. (Courtesy of Gary M. Guebert, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, St. Louis, Missouri.)</div>
</td></tr>
</table></div>
<div class="FG" id="F217-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="465" height="700" src="files/b75670984abb76893961a4cb112060f3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b75670984abb76893961a4cb112060f3.gif" MIMETYPE="image/gif" WIDTH="465" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-217 <span class="emph_B">BONE ISLAND. AP Ilium.</span> Observe the large radiopaque bone island in the supra-acetabular area. (Courtesy of James R. Brandt, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M3">DABCO</a>, Coon Rapids, Minnesota.)</div>
</td></tr>
</table></div>
<div class="FG" id="F218-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="468" height="700" src="files/2ac50e094ca726032414954d263f807f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2ac50e094ca726032414954d263f807f.gif" MIMETYPE="image/gif" WIDTH="468" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-218 <span class="emph_B">BONE ISLAND. AP Sacrum.</span> Observe the large, lobulated bone island within the sacral ala. <span class="emph_I">COMMENT:</span> Bone islands, which are found in the ilium, sacrum, and lumbar spine, may mimic the appearance of early osteoblastic metastasis. To differentiate these two entities appropriately, serial radiographs may be helpful; however, the definitive evaluation to rule out osteoblastic metastatic disease is the bone scan. The majority of bone islands will not be active on bone scan, whereas metastatic osteoblastic lesions will appear as hot spots. (Courtesy of Kenneth E. Yochum, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, St. Louis, Missouri.)</div>
</td></tr>
</table></div>
<a name="PG1251"> </a><div class="pagenum"><div>P.1251</div></div>
<br clear="all">
<div class="FG" id="F219-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[2]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="483" height="700" src="files/69ff6c1b8684bd7aafc2369f737faebb.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="69ff6c1b8684bd7aafc2369f737faebb.gif" MIMETYPE="image/gif" WIDTH="483" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-219 <span class="emph_B">BONE ISLAND. Rib.</span> Note the oval bone island within the posterolateral surface of the rib (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F220-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[2]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="419" src="files/03a230d05815db527225481d6443bae4.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="03a230d05815db527225481d6443bae4.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="419" DISPLAY="INLINE"></div>
<div class="P">Figure 11-220 <span class="emph_B">GROWING BONE ISLAND. A. Ilium.</span> Note the small, oval bone island in the posterior portion of the ilium in an adult male patient (<span class="emph_I">arrow</span>). <span class="emph_B">B. 6-Year Follow-Up.</span> Observe the enlargement of the previously noted bone island. Observe the thorn-like radiating spicules of bone surrounding the peripheral border of the bone island (<span class="emph_I">arrows</span>). This thorn-like appearance strongly suggests a bone island rather than an osteoblastic metastatic focus. This lesion was asymptomatic. (Courtesy of Wolfgang Lediner, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Mountain Home, Arkansas.)</div>
</td></tr>
</table></div>
<div class="P">A routine blood profile shows no significant changes. The slow growth of bone islands results in normal levels of serum alkaline phosphatase. (<a class="LK" href="sid806035.html#R454-11">7</a>)</div>
<div class="P">The development of a bone island has little significance except for its recognition and differential diagnosis. (<a class="LK" href="sid806035.html#R455-11">8</a>) The cause of these lesions remains obscure and relatively unknown. (<a class="LK" href="sid806035.html#R455-11">8</a>,<a class="LK" href="sid806035.html#R456-11">9</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3715" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[3]">
<div class="HD">Pathologic Features</div>
<div class="P">A bone island represents a focus of compact lamellar bone located within normal spongiosa. The histologic appearance of a bone island is in fact the same as that seen in osteopoikilosis. The radiologic features of the two conditions are also similar, except that the former is usually solitary, whereas the latter consists of multiple areas of sclerosis. It has been observed that the sclerotic areas in osteopoikilosis can become more radiopaque with age but show no significant change in size over an extended number of years. (<a class="LK" href="sid806035.html#R450-11">3</a>) They produce sclerotic, well-defined intramedullary densities on radiographs. (<a class="LK" href="sid806035.html#F221-11">Fig. 11-221</a>)</div>
<a name="PG1252"> </a><div class="pagenum"><div>P.1252</div></div>
<br clear="all">
<div class="FG" id="F221-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="234" src="files/ee523c162cdc96e8745cb30c920f9faf.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ee523c162cdc96e8745cb30c920f9faf.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="234" DISPLAY="INLINE"></div>
<div class="P">Figure 11-221 <span class="emph_B">OSTEOPOIKILOSIS. A. AP Pelvis.</span> Observe the multiple, well-defined bone islands scattered throughout the pelvis, sacrum, and proximal femora. This appearance is characteristic of osteopoikilosis. <span class="emph_B">B. CT Pelvis.</span> Observe the small, spherical bone islands within the medullary portion of the ilium, representing osteopoikilosis (<span class="emph_I">arrows</span>). (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3716" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[4]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiologic findings in bone islands are usually intramedullary ovoid, round, or oblong radiopaque densities that are aligned with the long axis of the trabecular architecture. (<a class="LK" href="sid806035.html#R453-11">6</a>,<a class="LK" href="sid806035.html#R455-11">8</a>) (<a class="LK" href="sid806035.html#F222-11">Fig. 11-222</a>) The margins are sharply demarcated and in many cases have thorn-like radiating spicules of bone (<span class="emph_I">brush border</span>) intermingled with the trabeculae of the spongiosa. (<a class="LK" href="sid806035.html#F220-11">Fig. 11-220<span class="emph_I">B</span></a>) No protrusion from the cortical surface of the involved bones can be identified. The majority of small bone islands are seen in the femoral neck and the intertrochanteric space of the proximal femur. (<a class="LK" href="sid806035.html#F223-11">Fig. 11-223</a>) Distinctively, they are located either in the epiphysis or metaphysis but never in the diaphysis. Bone islands are notably rare in the spine. (<a class="LK" href="sid806035.html#R455-11">8</a>) When present, it is usually the lumbar vertebral body that is involved, though neural arch sites have been recorded. (<a class="LK" href="sid806035.html#R456-11">9</a>) (<a class="LK" href="sid806035.html#F224-11">Figs. 11-224</a> and <a class="LK" href="sid806035.html#F225-11">11-225</a>) Bone islands, especially in the pelvis, can be &#x003E; 1 cm and are referred to as <span class="emph_I">giant bone islands.</span> (<a class="LK" href="sid806035.html#R455-11">8</a>,<a class="LK" href="sid806035.html#R457-11">10</a>) (<a class="LK" href="sid806035.html#F217-11">Fig. 11-217</a>)</div>
<div class="TLV4" id="B01382540.0-3717" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[4]/TLV4[1]">
<div class="HD">Bone Scan</div>
<div class="P">The increased localization of bone-scanning agents in a variety of sclerotic bone lesions is well known, but uptake in a bone island has not been described with any great frequency in the literature. (<a class="LK" href="sid806035.html#R449-11">2</a>) (<a class="LK" href="sid806035.html#F225-11">Fig. 11-225</a>) Radionuclide bone scanning has been suggested as a means of differentiating bone islands from osteoblastic metastases and other lesions with focally increased bone density because this distinction cannot always be made by radiographs. The skeletal uptake of technetium-tagged phosphorus compounds is thought to be owing primarily to increased regional blood flow. Thus the usual absence of focal bone scan abnormality in bone islands has been attributed to normal regional blood flow resulting from presumed metabolic inactivity; however, instances of positive bone scans have been described in patients with growing and biopsyproven bone islands. (<a class="LK" href="sid806035.html#R450-11">3</a>,<a class="LK" href="sid806035.html#R453-11">6</a>) It would seem that increased new bone production should occur as a bone island is being formed, presumably accompanied by increased regional blood flow; however, this is usually slight because growth is slow. Relatively rapid growth periods have been reported in some bone islands, occasionally doubling or tripling in size in 5-7 years, rendering a positive, or hot, bone scan at the time of growth potential. (<a class="LK" href="sid806035.html#T26-11">Table 11-26</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3718" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]">
<div class="HD">Differential Diagnosis</div>
<div class="P">Anatomic location is an important factor in deciding whether or not a radionuclide study of a suspected bone island is necessary. The characteristic solitary lesion in the proximal third of the femur is classically of no clinical concern. However, regions of radiopacity in the sacrum, ilium, and lumbar vertebral bodies may be foci of osteoblastic metastasis. For that reason, a definitive diagnosis of benign bone island of the sacrum, ilium, or lumbar spine can be made only with the report of a negative bone scan.</div>
<div class="P">Although most bone islands are usually stable in size, some may exhibit growth, as noted earlier; therefore, the major importance in recognizing bone islands is the need to distinguish them from other, significant pathologic processes, such as the following.</div>
<div class="TLV4" id="B01382540.0-3719" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]/TLV4[1]">
<div class="HD"><span class="emph_I">Osteoblastic Metastasis.</span></div>
<div class="P">An osteoblastic metastasis is usually well defined and not as dense as a bone island. When a bone island shows <span class="emph_I">thorn-like</span> radiations, or a <span class="emph_I">brush border,</span> there is little problem in differentiation because these features are not commonly found in metastasis. Osteoblastic metastasis is often polyostotic, whereas the incidence of multiple bone islands is far less common. (<a class="LK" href="sid806035.html#R448-11">1</a>,<a class="LK" href="sid806035.html#R457-11">10</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3720" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]/TLV4[2]">
<div class="HD"><span class="emph_I">Osteoid Osteoma.</span></div>
<div class="P">Osteoid osteoma is not usually a diagnostic problem because patients with this disease complain of quite severe nocturnal pain. Commonly, a central nidus with or without calcification may be seen within an area of exuberant reactive sclerosis of bone. (<a class="LK" href="sid806035.html#R448-11">1</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3721" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]/TLV4[3]">
<div class="HD"><span class="emph_I">Osteoma.</span></div>
<div class="P">Osteomas protrude from the surface of the bone, whereas bone islands are within the spongiosa. The majority of osteomas are in the head and neck area, particularly within the frontal sinuses, but bone islands are distinctly unusual in the skull. In patients with the rare Gardner&#x2019;s syndrome, osteomas may be found in any part of the skeleton. (<a class="LK" href="sid806035.html#R448-11">1</a>)</div>
<a name="PG1253"> </a><div class="pagenum"><div>P.1253</div></div>
<br clear="all">
<div class="FG" id="F222-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="603" src="files/48f881a011820f563b2687263a956bce.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="48f881a011820f563b2687263a956bce.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="603" DISPLAY="INLINE"></div>
<div class="P">Figure 11-222 <span class="emph_B">BONE ISLANDS. A. Capitate. B. Talus. C. Calcaneus. D. Second Metatarsal Head.</span> (Panel C courtesy of Peter M. Davis, BAppSc (Chiro), Warnambool, Victoria, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F223-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="292" src="files/76e099b3b6cd9eaf80155c3874f087bb.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="76e099b3b6cd9eaf80155c3874f087bb.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="292" DISPLAY="INLINE"></div>
<div class="P">Figure 11-223 <span class="emph_B">BONE ISLAND. A. AP Femur.</span> Note the oval bone island in the intertrochanteric space of the proximal femur. This is the most common location for a bone island. <span class="emph_B">B. AP Femur.</span> Observe the oblong radiopacity representing a somewhat unusual radiographic presentation for a bone island. <span class="emph_B">C. AP Femur.</span> Observe the thorn-like border at the periphery of this lesion, suggesting the possibility of a bone island. Osteoblastic metastatic disease could mimic this appearance, and further clinical follow-up may be indicated in patients who present with lesions such as this and who have localized symptoms. (Panel A courtesy of Richard T. Coade, <a class="LK" href="sid108669.html#AB1-M15">MIR</a>, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Kempsey, New South Wales, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1254"> </a><div class="pagenum"><div>P.1254</div></div>
<br clear="all">
<div class="FG" id="F224-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]/TLV4[3]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="330" src="files/00e3b646486c1d27550a5747640e7039.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="00e3b646486c1d27550a5747640e7039.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="330" DISPLAY="INLINE"></div>
<div class="P">Figure 11-224 <span class="emph_B">BONE ISLAND. A. Lateral Lumbar Spine.</span> Note the large, circular bone island within the L3 vertebral body. <span class="emph_B">B. Lateral Lumbar Spine.</span> Note that two focal bone islands are seen in the L2 and L3 vertebral bodies, respectively (<span class="emph_I">arrows</span>). <span class="emph_B">C. Specimen Radiograph.</span> This specimen demonstrates clearly the discrete bone island present within the lumbar vertebral body (<span class="emph_I">arrow</span>). Spondylophyte formation is noted around the anterior surface of this vertebral body (<span class="emph_I">arrowheads</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F225-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]/TLV4[3]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="609" src="files/eff402be9df6da76e693d0c1eacfb2d0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="eff402be9df6da76e693d0c1eacfb2d0.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="609" DISPLAY="INLINE"></div>
<div class="P">Figure 11-225 <span class="emph_B">BONE ISLAND: THORACIC SPINE. A. Plain Film.</span> Note the oval bone island in the T1 vertebral body (<span class="emph_I">arrow</span>). <span class="emph_B">B. Bone Scan.</span> Note the even distribution of tracer uptake with no focal accumulation at T1. <span class="emph_I">COMMENT:</span> Bone islands in the cervical and thoracic spine are rare. A failure for bone islands to exhibit uptake is typical of these lesions, though, on occasion, especially with large lesions, some activity can be seen. (Courtesy of Lawrence T. Sellers, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Portland, Oregon.)</div>
</td></tr>
</table></div>
<div class="TB" id="T26-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[6]/TLV3[5]/TLV4[3]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-26 Radiologic Features of Bone Islands</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Epiphyseal, metaphyseal</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Medullary</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Round-oval: long axis oriented along lines of stress</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Smooth or radiating border</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Homogeneously opaque</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Normal adjacent cortex</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>May change size</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Occasionally positive on isotopic scanning</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="P">A large or growing bone island should be included in the differential diagnosis of any sclerotic bone lesion that is positive on bone scan. The absence of a primary tumor, the slow rate of growth of the sclerotic focus over years, the absence of pain at the site involved, and the presence of a clearly demarcated margin of the dense radiographic shadow favor the diagnosis of a growing bone island. If these criteria are applied, it should be possible to differentially diagnose a bone island from a primary or secondary bone tumor. In patients with a complicated history, as in those who present with a previous malignancy, the definitive diagnosis becomes more difficult. In some cases, the only definitive mechanism for final diagnosis may be biopsy.</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3722" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]">
<div class="HD">OSTEOID OSTEOMA</div>
<div class="TLV3" id="B01382540.0-3723" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Osteoid osteoma was first described by Henry Jaffe (<a class="LK" href="sid806035.html#R458-11">1</a>) in 1925; however, for several decades the orthopedic community rejected
<a name="PG1255"> </a><div class="pagenum"><div>P.1255</div></div>
<br clear="all">
his findings and considered osteoid osteoma to be a variant of osteomyelitis. (<a class="LK" href="sid806035.html#R459-11">2</a>,<a class="LK" href="sid806035.html#R460-11">3</a>) Osteoid osteoma has since been accepted as a distinct benign bone disorder, most likely a neoplasm. Well-documented radiographic findings of osteoid osteoma and a typical clinical presentation have been described in the literature (<a class="LK" href="sid806035.html#R461-11">4</a>,<a class="LK" href="sid806035.html#R462-11">5</a>); however, the typical radiographic and clinical patterns do not always occur, and often a confusing picture of a young patient with bone pain emerges, which presents a diagnostic dilemma to both the radiologist and the clinician.</div>
</div>
<div class="TLV3" id="B01382540.0-3724" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Osteoid osteoma makes up approximately 2.6&#x0025; of all excised bone tumors and approximately 11&#x0025; of all benign bone tumors. (<a class="LK" href="sid806035.html#R463-11">6</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3725" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3726" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">This lesion occurs predominantly in young patients between the ages of 10 and 25 years. The youngest patient reported was an 8-month-old child with a lesion in the tibia. (<a class="LK" href="sid806035.html#R464-11">7</a>) Approximately 12&#x0025; of cases occur before the age of 10, and 13&#x0025; after the age of 30. (<a class="LK" href="sid806035.html#R465-11">8</a>) The ratio of male to female is 2:1. (<a class="LK" href="sid806035.html#R462-11">5</a>,<a class="LK" href="sid806035.html#R465-11">8</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3727" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Pain is characteristic of this lesion and may be accompanied by vasomotor disturbances, primarily, profuse sweating and increased skin temperature in the affected region. The classic description is of a gradual onset of increasingly severe, deep, aching pain, which however, only 65&#x0025; of patients have the classic presentation of night pain relieved by aspirin. (<a class="LK" href="sid806035.html#R466-11">9</a>) Because of localized bone pain, many patients are seen initially by a rheumatologist for evaluation. The diagnosis usually is not readily apparent, and the clinical manifestations of osteoid osteoma resemble inflammatory arthritis, degenerative arthritis, and septic arthritis. In 30&#x0025; of patients the pain is referred to a nearby joint so that the roentgen examination may be misdirected. It is important to note that the clinical evidence of pain may be present many months before roentgen evidence of the lesion.</div>
<div class="P">Localized swelling and point tenderness are frequent findings. Limitation of motion, painful limp, stiffness, and weakness of nearby joints may be noted; muscle atrophy and limp occur as a result of joint involvement.</div>
<div class="P">Painful, rigid scoliosis resulting from a lesion located on the concave side of the curve is the classic clinical presentation of a lumbar or thoracic osteoid osteoma. When a cervical vertebra is involved, torticollis and secondary contracture of the sternocleidomastoid muscle may be noted. Lesions in the spinous processes do not produce torticollis or scoliosis, but rather localized pain and spinal stiffness. (<a class="LK" href="sid806035.html#R467-11">10</a>) A lesion of the proximal femur or lumbar vertebrae may simulate a herniated disc; however, on physical examination true sciatica is not demonstrated. (<a class="LK" href="sid806035.html#R468-11">11</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3728" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">Osteoid osteoma can occur in nearly any bone; however, 50&#x0025; of cases occur in the femur and tibia. (<a class="LK" href="sid806035.html#R469-11">12</a>) (<a class="LK" href="sid806035.html#F226-11">Figs. 11-226</a> and <a class="LK" href="sid806035.html#F227-11">11-227</a>) There is a predilection for the upper end of the femur, particularly the neck and trochanters. Approximately 10&#x0025; of cases occur within the spine, most of these affecting the neural arch. The lamina, pedicle, facet, and spinous process are involved in descending order of frequency. Other sites include the ribs, clavicle, humerus, fibula, mandible, skull, carpals, and thumb. (<a class="LK" href="sid806035.html#R470-11">13</a>,<a class="LK" href="sid806035.html#R471-11">14</a>,<a class="LK" href="sid806035.html#R472-11">15</a>,<a class="LK" href="sid806035.html#R473-11">16</a>) (<a class="LK" href="sid806035.html#F228-11">Fig. 11-228</a>)</div>
<div class="FG" id="F226-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="296" height="700" src="files/e0473e78fa0664efcbf56c0870e3a6b8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e0473e78fa0664efcbf56c0870e3a6b8.gif" MIMETYPE="image/gif" WIDTH="296" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-226 <span class="emph_B">SKELETAL DISTRIBUTION OF OSTEOID OSTEOMA.</span>
</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3729" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">The actual lesion of osteoid osteoma is a nidus that grossly appears as a soft, reddish brown, vascularized tumor that is usually &#x2264; 1 cm in diameter. The nidus appears radiolucent on the radiograph, and the second component of the osteoid osteoma is a significant reactive sclerosis with cortical thickening and a solid periosteal response encompassing the nidus. (<a class="LK" href="sid806035.html#F229-11">Fig. 11-229</a>) The nidus is initially uncalcified but, upon maturity, may develop a fleck of target calcification within the center of the nidus.</div>
<div class="P">The microscopic appearance of the nidus demonstrates small, spherical nodules of highly vascularized fibrous connective tissue, with benign giant cells within an interlacing network of osteoid trabeculae, which are usually thin and contain a variable amount of mineralization.</div>
<a name="PG1256"> </a><div class="pagenum"><div>P.1256</div></div>
<br clear="all">
<div class="FG" id="F227-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="666" src="files/03122e3bfe46a297217ea04445c40a3a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="03122e3bfe46a297217ea04445c40a3a.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="666" DISPLAY="INLINE"></div>
<div class="P">Figure 11-227 <span class="emph_B">OSTEOID OSTEOMA. A. AP Tibia.</span> Observe the radiolucent tumor nidus within the central medullary portion of the distal tibia (<span class="emph_I">arrow</span>). There is significant reactive sclerosis of bone surrounding the radiolucent nidus, some of which is periosteal new bone formation, assuming a solid pattern (<span class="emph_I">arrowheads</span>). <span class="emph_B">B. Lateral Tibia.</span> Note the significant cortical and periosteal new bone formation on the posterior surface of the distal tibia (<span class="emph_I">arrows</span>). The tumor nidus of the osteoid osteoma is not clearly visualized on this projection.</div>
</td></tr>
</table></div>
<div class="FG" id="F228-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[4]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="477" src="files/ff1cddc33364cf36b55ff74977e4edea.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ff1cddc33364cf36b55ff74977e4edea.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="477" DISPLAY="INLINE"></div>
<div class="P">Figure 11-228 <span class="emph_B">OSTEOID OSTEOMA. Clavicle.</span> Note the large, radiolucent tumor nidus in the mid-diaphysis of the clavicle (<span class="emph_I">arrow</span>). There is exuberant reactive sclerosis around the tumor nidus, creating bone expansion and enlargement of the clavicle (<span class="emph_I">arrowhead</span>). This is a rare location for osteoid osteoma. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="P">There are three specific anatomic locations for osteoid osteoma: cortical (most common), cancellous (intramedullary), and subperiosteal. Their histologic and radiographic appearances vary significantly, depending on the specific location.</div>
<div class="FG" id="F229-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[4]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="573" src="files/8df31bbf0ad22007db1920a844286dc3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8df31bbf0ad22007db1920a844286dc3.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="573" DISPLAY="INLINE"></div>
<div class="P">Figure 11-229 <span class="emph_B">OSTEOID OSTEOMA: TIBIA. A. AP Knee.</span> Note the ill-defined area of increased cortical new bone in the medial metaphysis of the proximal tibia (<span class="emph_I">arrow</span>). <span class="emph_B">B. Tomogram, AP Tibia.</span> Observe that the previously noted reactive sclerosis in the medial cortical surface of the tibia is visualized. A small radiolucent tumor nidus is also seen (<span class="emph_I">arrow</span>). <span class="emph_I">COMMENT:</span> This patient presented with pain that was worse at night and that was dramatically relieved by the use of aspirin. This is the characteristic history of patients with both osteoid osteoma and Brodie&#x2019;s abscess.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3730" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiographic appearance of a well-developed lesion is as a characteristic lucent nidus with surrounding florid perifocal reactive sclerosis. (<a class="LK" href="sid806035.html#R474-11">17</a>) (<a class="LK" href="sid806035.html#F230-11">Fig. 11-230</a>) This is the typical appearance of a cortically placed osteoid osteoma. The initial lesion is a small area of increased bony density that surrounds an oval or round lucent nidus usually &#x2264; 1 cm in diameter. (<a class="LK" href="sid806035.html#R475-11">18</a>) (<a class="LK" href="sid806035.html#F231-11">Fig. 11-231</a>) The osteoid osteoma can cause so much surrounding sclerosis that the nidus is obscured on a single roentgenographic view. (<a class="LK" href="sid806035.html#F232-11">Fig. 11-232</a>) Occasionally, a central fleck of calcification can be seen on plain films within the radiolucent nidus. (<a class="LK" href="sid806035.html#F233-11">Fig. 11-233</a>) When plain films are negative, CT or radioisotope bone scans are often necessary to identify the lesion.</div>
<div class="P">Intramedullary lesions that are intracapsular (such as those in the femoral neck) provoke much less reactive sclerosis because of the low rate of bone production from the intracapsular periosteum. Lesions in this location are much more difficult to detect because the lucent nidus is often the only abnormality visualized. (<a class="LK" href="sid806035.html#F234-11">Fig. 11-234</a>)</div>
<div class="P">Spinal osteoid osteomas are elusive lesions. (<a class="LK" href="sid806035.html#R476-11">19</a>,<a class="LK" href="sid806035.html#R477-11">20</a>) Patients often undergo numerous radiographic studies before the correct diagnosis is reached. Lumbosacral strain, psychogenic back pain, cervical strain, herniated nucleus pulposus, and biomechanical back pain are frequent prior diagnoses. As in other areas of the skeleton, osteoid osteomas may produce pain before radiographic changes, and in the spine the changes are difficult to detect on plain films. The neural arch is the classic location, and early lesions may be found only with the use of CT and bone scanning; CT through an area of increased radionuclide uptake may demonstrate the lucent nidus. The most common site for spinal osteoid
<a name="PG1257"> </a><div class="pagenum"><div>P.1257</div></div>
<br clear="all">
osteoma is the lumbar spine (60&#x0025;), with lesions less common in the cervical, thoracic, and sacral vertebrae (27&#x0025;, 12&#x0025;, and 2&#x0025;, respectively). (<a class="LK" href="sid806035.html#R478-11">21</a>) Vertebral body lesions are uncommon (7&#x0025;); most lesions are in the neural arch. (<a class="LK" href="sid806035.html#R478-11">21</a>) The initial radiographic sign is a lucent nidus, which often goes undetected. The more mature lesion incites reactive sclerosis, leaving a dense or ivory pedicle or lamina. (<a class="LK" href="sid806035.html#F235-11">Figs. 11-235</a> and <a class="LK" href="sid806035.html#F236-11">11-236</a>) Often, the lesion will be on the concave side of a painful scoliosis. (<a class="LK" href="sid806035.html#F237-11">Fig. 11-237</a>) This appearance must be differentiated from the stress response opposite a unilateral spondylolysis, congenital agenesis of the contralateral pedicle, osteoblastoma, and, rarely, osteoblastic metastatic carcinoma. (<a class="LK" href="sid806035.html#R479-11">22</a>,<a class="LK" href="sid806035.html#R480-11">23</a>,<a class="LK" href="sid806035.html#R481-11">24</a>) Vertebral body lesions may produce an ivory vertebra or focal sclerosis, usually close to the endplate. (<a class="LK" href="sid806035.html#F238-11">Fig. 11-238</a>)</div>
<div class="FG" id="F230-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="461" height="700" src="files/116346724aae6379fecc82b301d3485d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="116346724aae6379fecc82b301d3485d.gif" MIMETYPE="image/gif" WIDTH="461" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-230 <span class="emph_B">OSTEOID OSTEOMA. Femoral Neck.</span> Note the well-defined radiolucent tumor nidus within the neck of the proximal femur (<span class="emph_I">arrow</span>). A significant degree of reactive sclerosis of bone is seen adjacent to the tumor nidus (<span class="emph_I">arrowheads</span>), with the greatest changes seen caudal to the radiolucent nidus. This is a characteristic presentation for osteoid osteoma at this site. (Reprinted with permission from the <span class="emph_B">Center for Devices and Radiological Health, FDA, and the American College of Radiology:</span> <span class="emph_I">Learning File, Skeletal Section, SK-935.</span>)</div>
</td></tr>
</table></div>
<div class="FG" id="F231-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="633" src="files/012707075f8861a69ffc2e111de885cb.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="012707075f8861a69ffc2e111de885cb.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="633" DISPLAY="INLINE"></div>
<div class="P">Figure 11-231 <span class="emph_B">OSTEOID OSTEOMA: HAND. A. and B. Fifth Metacarpal.</span> Observe the well-defined radiolucent tumor nidus within the medullary component of the diaphysis of the fifth metacarpal (<span class="emph_I">arrows</span>). Reactive sclerosis and appositional periosteal new bone surround the tumor nidus (<span class="emph_I">arrowheads</span>). (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F232-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="473" src="files/6813fafd4f67725a2d9c1424e1e3c2e2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6813fafd4f67725a2d9c1424e1e3c2e2.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="473" DISPLAY="INLINE"></div>
<div class="P">Figure 11-232 <span class="emph_B">OSTEOID OSTEOMA. A. AP Tibia.</span> Note the significant reactive sclerosis of bone in the mid-diaphysis of the tibia. Periosteal new bone formation thickens the cortex and obscures the observer&#x2019;s ability to differentiate the medullary and cortical portions of the bone (<span class="emph_I">arrow</span>). <span class="emph_B">B. Lateral Tibia.</span> Observe the significant periosteal new bone formation, along with thickening of the cortex, in the posterior portion of the mid-diaphysis of the tibia (<span class="emph_I">arrows</span>). The radiolucent tumor nidus cannot be seen. <span class="emph_B">C. Radionuclide Study.</span> Note the significant uptake (hot spot) in the area of the osteoid osteoma involving the diaphysis of the tibia (<span class="emph_I">arrow</span>). (Courtesy of Keith H. Charlton, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Brisbane, Queensland, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1258"> </a><div class="pagenum"><div>P.1258</div></div>
<br clear="all">
<div class="FG" id="F233-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="461" src="files/d0d648c8e7af786752de3b6947427612.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d0d648c8e7af786752de3b6947427612.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="461" DISPLAY="INLINE"></div>
<div class="P">Figure 11-233 <span class="emph_B">OSTEOID OSTEOMA: THUMB. A. Hand.</span> Observe the soft tissue swelling present around the base of the thumb (<span class="emph_I">arrow</span>). This patient was complaining of pain, which was worse at night, aggravated by activity, and alleviated with the use of aspirin. <span class="emph_B">B. PA Thumb.</span> Note the small, radiolucent nidus within the medullary portion of the proximal phalanx (<span class="emph_I">arrow</span>). A florid reaction of periosteal new bone formation is present, creating enlargement of the phalanx (<span class="emph_I">arrowhead</span>). <span class="emph_B">C. Oblique Thumb.</span> Observe the radiolucent tumor nidus present in the central portion of the proximal phalanx. Close observation reveals a central fleck of calcification seen within the radiolucent tumor nidus, which is characteristic of osteoid osteoma (<span class="emph_I">arrow</span>). <span class="emph_B">D. 1-Month Postsurgery.</span> Note that the tumor nidus has been removed surgically. There is a moderate degree of periosteal new bone formation present in the area where the tumor nidus was located (<span class="emph_I">arrow</span>). The patient received dramatic relief of his pain following surgery. <span class="emph_B">E. 2-Year Follow-Up.</span> Note the area from which the tumor was removed still shows a moderate degree of cortical new bone (<span class="emph_I">arrow</span>). (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Osteoid osteoma of the thumb.</span> ACA Council Roent November, 1979. Courtesy of Mark Baum, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Miami, Florida.)</div>
</td></tr>
</table></div>
<div class="P">Angiography can be helpful in selected cases of osteoid osteoma for definitive diagnosis. (<a class="LK" href="sid806035.html#R482-11">25</a>) The area of the lesion is highly vascularized, with an intensely homogenous vascular blush appearing in the arterial phase and persisting late into the venous phase. This is the definitive means of distinguishing osteoid osteoma from a Brodie&#x2019;s abscess, which shows no such vascular blush within its necrotic cavity.</div>
<div class="P">In most cases of osteoid osteoma, plain roentgenograms are sufficient to demonstrate the lesion, providing the diagnosis in &#x003E; 75&#x0025; of cases. (<a class="LK" href="sid806035.html#R465-11">8</a>) CT may be helpful for localizing the nidus, especially where plain roentgenograms are equivocal. If the roentgenogram is negative but the clinical history suggests a lesion, then a bone scan or MRI should be performed. (<a class="LK" href="sid806035.html#R483-11">26</a>) Bone scans will show a regional increase in uptake with an intense
<a name="PG1259"> </a><div class="pagenum"><div>P.1259</div></div>
<br clear="all">
focal zone of uptake superimposed (<span class="emph_I">double-density sign</span>). (<a class="LK" href="sid806035.html#R466-11">9</a>,<a class="LK" href="sid806035.html#R484-11">27</a>) This is particularly true with spinal lesions. If the bone scan is positive, then CT is helpful in defining the nature of the lesion. If these studies are equivocal, angiography may be necessary to finally locate and provide the correct diagnosis. (<a class="LK" href="sid806035.html#T27-11">Table 11-27</a>) MRI usually exhibits surrounding marrow edema, which in turn may improve the conspicuity of the nidus. (<a class="LK" href="sid806035.html#R485-11">28</a>,<a class="LK" href="sid806035.html#R486-11">29</a>) In general, MRI is a reliable modality in the demonstration of the nidus. (<a class="LK" href="sid806035.html#R486-11">29</a>)</div>
<div class="FG" id="F234-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="478" height="700" src="files/ea216911d5ed42862287adaa735a44d6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ea216911d5ed42862287adaa735a44d6.gif" MIMETYPE="image/gif" WIDTH="478" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-234 <span class="emph_B">OSTEOID OSTEOMA IN A HARD-TO-SEE AREA. Proximal Femur.</span> Observe the subtle radiolucent tumor nidus just inferior to the lesser trochanter (<span class="emph_I">arrow</span>). The minimal reactive sclerosis that surrounds this lesion is hard to perceive because of the confluence of the cortex at this anatomic site. <span class="emph_I">COMMENT:</span> Osteoid osteomas that occur adjacent to the lesser trochanter are often difficult to visualize. This is a relatively common location for osteoid osteoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F235-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="466" height="700" src="files/0ace777e12b10ac60ae16acaa925bfd5.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="0ace777e12b10ac60ae16acaa925bfd5.gif" MIMETYPE="image/gif" WIDTH="466" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-235 <span class="emph_B">OSTEOID OSTEOMA. AP Lumbar Spine.</span> Observe the densely radiopaque pedicle of the L3 vertebra (<span class="emph_I">arrow</span>). This 12-year-old patient presented with pain that was worse at night and was dramatically alleviated by aspirin. (Courtesy of John E. MacRae, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Toronto, Ontario, Canada.)</div>
</td></tr>
</table></div>
<div class="FG" id="F236-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="611" src="files/a2c3d0877670d0445000317f5be3ab78.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a2c3d0877670d0445000317f5be3ab78.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="611" DISPLAY="INLINE"></div>
<div class="P">Figure 11-236 <span class="emph_B">OSTEOID OSTEOMA: THORACIC SPINE. A. AP Thoracic.</span> Observe the dense radiopacity affecting the pedicle of the T9 vertebra (<span class="emph_I">arrow</span>). <span class="emph_B">B. Tomogram, AP T9.</span> Tomographic evaluation clearly defines the sclerotic pedicle at T9 (<span class="emph_I">arrow</span>). <span class="emph_I">COMMENT:</span> Approximately 10&#x0025; of the cases of osteoid osteoma occur within the spine, with most of these affecting the neural arch. The lamina, pedicle, facet, and spinous process are involved, in descending order of frequency. The most common site for spinal osteoid osteoma is the lumbar region (60&#x0025;), with lesions less commonly found in the cervical, thoracic, and sacral vertebrae (27&#x0025;, 12&#x0025;, and 2&#x0025;, respectively).</div>
</td></tr>
</table></div>
<div class="FG" id="F237-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="490" height="700" src="files/e887220b661c79dc9a297712c0fe1d5d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e887220b661c79dc9a297712c0fe1d5d.gif" MIMETYPE="image/gif" WIDTH="490" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-237 <span class="emph_B">OSTEOID OSTEOMA. AP Lumbar Spine.</span> Observe the reactive sclerosis in the area of the lamina and pedicle of L3 (<span class="emph_I">arrow</span>). <span class="emph_I">COMMENT:</span> This patient presented with a painful scoliosis, and an osteoid osteoma involving the neural arch was found. The osteoid osteoma is on the concave side of the scoliosis, which is the classic presentation. (Courtesy of Jack Edeiken, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Houston, Texas.)</div>
</td></tr>
</table></div>
<a name="PG1260"> </a><div class="pagenum"><div>P.1260</div></div>
<br clear="all">
<div class="FG" id="F238-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[5]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="501" height="700" src="files/8f90fabb48484ed849700ee8f3e711b4.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8f90fabb48484ed849700ee8f3e711b4.gif" MIMETYPE="image/gif" WIDTH="501" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-238 <span class="emph_B">OSTEOID OSTEOMA. Vertebral Body.</span> Observe the radiolucent nidus in the sub-endplate region (<span class="emph_I">arrow</span>). Reactive sclerosis extends into the vertebral body. (Courtesy of Merritt L. Armstrong, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Freeport, Maine.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3731" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[6]">
<div class="HD">Differential Diagnosis</div>
<div class="TLV4" id="B01382540.0-3732" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[6]/TLV4[1]">
<div class="HD"><span class="emph_I">Garr&#x00E9;&#x2019;s Chronic Sclerosing Osteomyelitis.</span></div>
<div class="P">In the current literature Garr&#x00E9;&#x2019;s osteomyelitis has been disregarded as a singular and distinct disease process. (See <a class="LK" href="sid938315.html#B01382540-C12">Chapter 12</a>.) Although described by Garr&#x00E9; as chronic sclerosing osteomyelitis, it is considered probable that many of the lesions formerly regarded as being inflammatory in origin were in fact osteoid osteomas.</div>
</div>
<div class="TLV4" id="B01382540.0-3733" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[6]/TLV4[2]">
<div class="HD"><span class="emph_I">Brodie&#x2019;s Abscess.</span></div>
<div class="P">The clinical and radiologic presentation of Brodie&#x2019;s abscess may resemble osteoid osteoma. Pain that is worse at night and alleviated by aspirin is a characteristic shared by both osteoid osteoma and Brodie&#x2019;s abscess. The radiolucent nidus of Brodie&#x2019;s abscess is normally much larger (&#x003E; 1 cm and often closer to 2 cm in diameter) than that of osteoid osteoma. (<a class="LK" href="sid806035.html#R473-11">16</a>) The <span class="emph_I">halo rim</span> of sclerosis surrounding the radiolucent nidus of an abscess is frequently thicker and more irregular than that found associated with osteoid osteoma. The <span class="emph_I">vascular blush</span> on angiographic studies is found in osteoid osteoma and not Brodie&#x2019;s abscess. There are, of course, exceptions to these differential points, and Brodie&#x2019;s abscess must be considered in a differential diagnosis when the radiologic appearance seems to be that of osteoid osteoma and the clinical presentation is equally similar. (<a class="LK" href="sid806035.html#R473-11">16</a>)</div>
<div class="TB" id="T27-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[6]/TLV4[2]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-27 Radiologic Features of Osteoid Osteoma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="top" colspan="3" rowspan="1"><p>Spine</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Antalgic scoliosis, lesion on concave side</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Dense pedicle, facet, transverse process, lamina</p></td>
</tr>
<tr>
<td align="left" valign="top" colspan="3" rowspan="1"><p>Long bones</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Metaphyseal, diaphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>Geographic lesion (nidus)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Eccentric</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>&#x003C; 1 cm in size</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Central calcific fleck</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Surrounding rim of sclerosis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Adjacent solid periosteal response</p></td>
</tr>
<tr>
<td align="left" valign="top" colspan="3" rowspan="1"><p>Additional studies</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>
<i>Angiogram:</i> arterial blush, venous retention</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>
<i>Bone scan:</i> localized increased uptake</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>
<i>CT:</i> clear demonstration of the nidus</p></td>
</tr>
<tr>
<td align="left" valign="top" colspan="3" rowspan="1"><p>Differential diagnosis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" rowspan="1"><p>
<i>Brodie&#x2019;s abscess:</i> lacks angiographic changes, nidus usually &#x003E; 2 cm</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>
<i>Stress fracture:</i> linear fracture line demonstration, time sequence changes</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3734" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[6]/TLV4[3]">
<div class="HD"><span class="emph_I">Stress Fracture.</span></div>
<div class="P">A stress fracture frequently produces focal changes that may mimic osteoid osteoma clinically and radiologically. Sequential studies over time and images usually demonstrate healing of the fracture.</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3735" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">In general, most osteoid osteomas require no treatment because their natural history is self-limiting; however, in patients who will not comply or who are unwilling to sustain a regime of nonsteroidal anti-inflammatory drugs (NSAIDs) until the pain resolves, more invasive measures are available. (<a class="LK" href="sid806035.html#R487-11">30</a>) Radiotherapy and thermocoagulation have recently gained interest because they require less invasion of the tissues than does surgery. (<a class="LK" href="sid806035.html#R488-11">31</a>,<a class="LK" href="sid806035.html#R489-11">32</a>,<a class="LK" href="sid806035.html#R490-11">33</a>) Thermocoagulation has shown success rates of approximately 92&#x0025; in recent studies. (<a class="LK" href="sid806035.html#R490-11">33</a>) With respect to surgery, the treatment of choice, is wide en bloc excision with removal of a small portion of the surrounding sclerotic bone. (<a class="LK" href="sid806035.html#F239-11">Fig. 11-239</a>) Most patients have dramatic relief of symptoms after surgery, and recurrence is rare, provided complete excision of the nidus is accomplished. (<a class="LK" href="sid806035.html#R491-11">34</a>,<a class="LK" href="sid806035.html#R492-11">35</a>) Surgical procedures are becoming more effective with CT guidance to ensure removal of the nidus. (<a class="LK" href="sid806035.html#R493-11">36</a>,<a class="LK" href="sid806035.html#R494-11">37</a>) Some surgeons may delay surgery until the nidus is of adequate size to be clearly demonstrated by CT, to ensure effective surgical treatment. It is not necessary to remove the reactive sclerosis, even though this may form the major part of the radiologic presentation.</div>
<div class="P">Spontaneous regressions have been reported; however, an extended time span is necessary for this to occur, and most patients cannot tolerate the pain for this period of time (&#x003E; 10 years). (<a class="LK" href="sid806035.html#R495-11">38</a>) Spinal lesions are treated by excision, unless they occur in the vertebral body, in which case they are then treated with irradiation.</div>
<a name="PG1261"> </a><div class="pagenum"><div>P.1261</div></div>
<br clear="all">
<div class="FG" id="F239-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="670" src="files/827c5f010d6cc94017ea50aaa0df2914.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="827c5f010d6cc94017ea50aaa0df2914.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="670" DISPLAY="INLINE"></div>
<div class="P">Figure 11-239 <span class="emph_B">OSTEOID OSTEOMA: EN BLOC EXCISION. A. Lateral Tibia. B. AP Tibia.</span> Note the large, postsurgical defect on the anterior cortex of the mid-diaphysis of the tibia. This represents an en bloc excision for a previously diagnosed osteoid osteoma. (Courtesy of Jack Edeiken, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Houston, Texas.)</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3736" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Osteoid Osteoma</div>
<div class="TLV2" id="B01382540.0-3737" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">First described by Henry Jaffe in 1925.</div></li>
<li class="LM"><div class="P">Radiographic and clinical findings are characteristic.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3738" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Makes up 2.6&#x0025; of all excised bone tumors and approximately 11&#x0025; of all benign bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3739" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">There is a 2:1 male predominance; 10- to 25-year age range is most common.</div></li>
<li class="LM"><div class="P">Severe pain, worse at night, that is dramatically alleviated by the use of aspirin occurs in 65&#x0025; of cases.</div></li>
<li class="LM"><div class="P">Muscle atrophy and limp occur in long-standing lesions of the lower extremities.</div></li>
<li class="LM"><div class="P">Painful and rigid scoliosis, with the lesion on the concave side of the curve, usually occurs in the lumbar spine.</div></li>
<li class="LM"><div class="P">50&#x0025; occur in the femur and tibia; 10&#x0025; occur within the spine, usually in the neural arch.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3740" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The tumor consists of a nidus, that is usually &#x2264; 1 cm in diameter.</div></li>
<li class="LM"><div class="P">Target calcification may occur in the center of the radiolucent nidus.</div></li>
<li class="LM"><div class="P">The most common location within the bone is in the cortex, with intramedullary and subperiosteal lesions also occurring.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3741" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The characteristic appearance of a cortical lesion is as a radiolucent nidus surrounded by florid perifocal reactive sclerosis.</div></li>
<li class="LM"><div class="P">Often, CT and bone scans are necessary to demonstrate the nidus, especially in the spine.</div></li>
<li class="LM"><div class="P">Intramedullary lesions that are intracapsular (such as the femoral neck) provoke much less reactive sclerosis.</div></li>
<li class="LM"><div class="P">60&#x0025; of the spinal lesions are in the lumbar spine, usually creating an ivory pedicle or neural arch.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3742" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Differential Diagnosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Brodie&#x2019;s abscess is the prime clinical and radiographic disease entity to mimic osteoid osteoma. This differentiation cannot be made clinically because patients with either present with a similar history. Radiographic differentiation is suggested by observing the nidus, usually &#x003E; 2 cm in Brodie&#x2019;s abscess.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3743" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[7]/TLV3[7]/SIDEBAR[1]/TLV1[1]/TLV2[7]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">In surgically accessible lesions a wide en bloc excision is the treatment of choice.</div></li>
<li class="LM"><div class="P">It is not necessary to remove the reactive sclerosis, even though this may form the major part of the radiologic presentation.</div></li>
<li class="LM"><div class="P">Vertebral body lesions are often treated with irradiation.</div></li>
<li class="LM"><div class="P">Prognosis is good, with little chance of recurrence when complete surgical excision of the nidus is accomplished.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<a name="PG1262"> </a><div class="pagenum"><div>P.1262</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3744" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]">
<div class="HD">OSTEOBLASTOMA</div>
<div class="TLV3" id="B01382540.0-3745" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Osteoblastoma is a rare primary benign bone tumor that usually presents within the spine. In 1954 Dahlin and Johnson (<a class="LK" href="sid806035.html#R496-11">1</a>) described a large, benign neoplastic lesion, which on histology was similar to osteoid osteoma and which they defined as <span class="emph_I">giant osteoid osteoma.</span> A benign osteoblastic neoplasm with many similar morphologic features was designated a <span class="emph_I">benign osteoblastoma</span> by Jaffe (<a class="LK" href="sid806035.html#R497-11">2</a>) in 1956. For a long time these two entities (osteoblastoma and osteoid osteoma) have been considered separately. In fact, the two lesions differ in size, location, and roentgen appearance, but they share a common age range and similar microscopic appearance.</div>
</div>
<div class="TLV3" id="B01382540.0-3746" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Osteoblastoma is an uncommon tumor that accounts for about 1&#x0025; of all primary bone tumors, with approximately 400 cases reported in the literature. (<a class="LK" href="sid806035.html#R498-11">3</a>)</div>
<div class="FG" id="F240-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="430" src="files/d166846dee37e6772cf5280c47f29a50.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d166846dee37e6772cf5280c47f29a50.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="430" DISPLAY="INLINE"></div>
<div class="P">Figure 11-240 <span class="emph_B">OSTEOBLASTOMA: UPPER CERVICAL SPINE. A. Posterior Tubercle, Atlas.</span> Observe the expansile lytic lesion of the posterior tubercle of the atlas (<span class="emph_I">arrow</span>). The geographic destruction leaves a clearly defined peripheral cortical margin, suggesting the benign nature of the tumor. <span class="emph_B">B. Axis.</span> Note the destruction of the lamina and lucency of C2 body (<span class="emph_I">arrow</span>). Also note the prevertebral soft tissue swelling (<span class="emph_I">arrowhead</span>). <span class="emph_B">C. CT, Axis.</span> Note the expansile nature of the lesion (<span class="emph_I">arrow</span>). (Panel A reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Osteoblastoma.</span> ACA J Chiro May, 1982. Courtesy of Paul E. Siebert, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3747" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3748" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">The age range is from 3 to 78 years. (<a class="LK" href="sid806035.html#R499-11">4</a>) Approximately 70&#x0025; of the cases occur before the age of 20, with the peak range being 10-20 years of age. (<a class="LK" href="sid806035.html#R499-11">4</a>) There is a predilection for males in a ratio of 2:1.</div>
</div>
<div class="TLV4" id="B01382540.0-3749" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The chief complaint is pain that is less severe than that of osteoid osteoma. It is also not nocturnal and is not particularly relieved by aspirin. The duration of pain varies from a few months to as long as 2 years. Extremity lesions produce local tenderness and a palpable mass of increasing size. Spinal lesions in the thoracic and lumbar area present with a <span class="emph_I">painful scoliosis</span> in &#x003E; 50&#x0025; of cases. (<a class="LK" href="sid806035.html#R500-11">5</a>) Benign osteoblastoma and osteoid osteoma are the most common neoplastic causes of scoliosis provoked by pain. (<a class="LK" href="sid806035.html#R499-11">4</a>,<a class="LK" href="sid806035.html#R501-11">6</a>) Local muscle spasm and rigidity may be noted. Other symptoms of referred pain, paresthesias, weakness, or even paraplegia as a sequela of spinal stenosis may occur. (<a class="LK" href="sid806035.html#R502-11">7</a>)</div>
<a name="PG1263"> </a><div class="pagenum"><div>P.1263</div></div>
<br clear="all">
<div class="P">Osteoblastomas of the cervical spine most frequently present with non-specific, dull, aching pain and slight to moderate cervical tenderness of several months duration. Neurological signs are not common in cervical spine osteoblastomas because most of the lesions arise in the spinous process rather than in the neural arch, whereas the thoracic and lumbar lesions causing neurological symptoms arise from the laminae and pedicles. (<a class="LK" href="sid806035.html#R503-11">8</a>) In addition, the intervertebral canal is largest in the cervical region; and, despite the cervical cord enlargement, there is greatest room for expansion in this area before neural tissue is compressed. (<a class="LK" href="sid806035.html#R502-11">7</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3750" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">The most common location for osteoblastoma is the spine, femur, and foot and ankle, in order of frequency. (<a class="LK" href="sid806035.html#R504-11">9</a>) Within the spine, the neural arch is primarily affected, chiefly the spinous process, transverse process, and laminae. (<a class="LK" href="sid806035.html#R502-11">7</a>) The vertebral body is only rarely involved primarily but can be a site of secondary extension from a neural arch lesion. (<a class="LK" href="sid806035.html#R505-11">10</a>) A rare site in the cervical spine is the atlas. (<a class="LK" href="sid806035.html#R506-11">11</a>) (<a class="LK" href="sid806035.html#F240-11">Fig. 11-240</a>) The cervical segments most commonly involved are the C4, C5, and C6 vertebrae. The lower thoracic and upper lumbar areas are the target sites for osteoblastoma to occur (<a class="LK" href="sid806035.html#R505-11">10</a>) with only rare incidences at L5. (<a class="LK" href="sid806035.html#R503-11">8</a>) The long bones of the appendicular skeleton, usually the lower extremity, are involved in 30&#x0025; of cases. The metaphysis and diaphysis are the most common locations within the bone. There is a predilection for the dorsal surface of the talus when present in the foot. (<a class="LK" href="sid806035.html#R507-11">12</a>) Other sites include the small bones of the hands, the skull, maxilla, mandible, and ribs. (<a class="LK" href="sid806035.html#R507-11">12</a>,<a class="LK" href="sid806035.html#R508-11">13</a>,<a class="LK" href="sid806035.html#R509-11">14</a>,<a class="LK" href="sid806035.html#R510-11">15</a>,<a class="LK" href="sid806035.html#R511-11">16</a>) (<a class="LK" href="sid806035.html#F241-11">Figs. 11-241</a> and <a class="LK" href="sid806035.html#F242-11">11-242</a>) Rarely, multicentric osteoblastomas have been reported. (<a class="LK" href="sid806035.html#R512-11">17</a>)</div>
<div class="FG" id="F241-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="299" height="700" src="files/005bab65dad3fde2c41623bf303d1270.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="005bab65dad3fde2c41623bf303d1270.gif" MIMETYPE="image/gif" WIDTH="299" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-241 <span class="emph_B">SKELETAL DISTRIBUTION OF OSTEOBLASTOMA.</span>
</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3751" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">The gross appearance is as a violet red hemorrhagic, gritty, friable mass. The nidus is usually &#x003E; 2 cm and is softer than that of osteoid osteoma. The overall size of the lesion is usually from 2 to 10 cm. Microscopically, it may be nearly impossible to differentiate osteoblastoma from osteoid osteoma. The osteoblasts appear prominent and plump, surrounding woven bone, highly vascular tissue, and there is a more orderly pattern of broader and longer osteoid trabeculae than is found in osteoid osteoma. Most osteoblastomas produce thick trabeculae of osteoid and woven bone with irregular serrated borders. Cartilage has not been reported in association with the osteoblastoma, and unequivocal anaplasia is lacking. The lack of cellular anaplasia helps differentiate this lesion from a malignant osteosarcoma, which, on occasion, an inexperienced pathologist has mistakenly diagnosed.</div>
</div>
<div class="TLV3" id="B01382540.0-3752" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">In contrast to osteoid osteoma, plain roentgenograms are usually sufficient to confirm the diagnosis of osteoblastoma, but CT and, occasionally, a nuclear bone scan can also be helpful. The radiologic appearance of osteoblastoma varies, depending on the anatomic location of the lesion. (<a class="LK" href="sid806035.html#T28-11">Table 11-28</a>)</div>
<div class="FG" id="F242-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="439" src="files/067c5c4a6a60dfcc9866ca122b9ed4e8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="067c5c4a6a60dfcc9866ca122b9ed4e8.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="439" DISPLAY="INLINE"></div>
<div class="P">Figure 11-242 <span class="emph_B">OSTEOBLASTOMA. Rib.</span> Observe the large lytic defect within the midshaft of the sixth rib. A minimal degree of reactive sclerosis surrounds this lesion. This is an unusual site for osteoblastoma. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Osteoblastoma.</span> ACA J Chiro May, 1982. Courtesy of Paul E. Siebert, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<a name="PG1264"> </a><div class="pagenum"><div>P.1264</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3753" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]/TLV4[1]">
<div class="HD">Spine</div>
<div class="P">The characteristic appearance is that of an expansile lesion, usually affecting the neural arch, with a clearly defined, eggshell-thin cortical rim at the periphery of the lesion. (<a class="LK" href="sid806035.html#F243-11">Fig. 11-243</a>) Most spinal lesions are purely radiolucent; however, a mixture of mottled blastic and lytic changes, as well as radiopaque lesions, may occur. (<a class="LK" href="sid806035.html#F244-11">Figs. 11-244</a>, <a class="LK" href="sid806035.html#F245-11">11-245</a> and <a class="LK" href="sid806035.html#F246-11">11-246</a>) Most spinal lesions are 4-6 cm in size; occasionally, they can appear larger. CT imaging will better delineate the nature of the lesion, and MRI is useful for assessing the involvement of adjacent structures from the bony expansion. (<a class="LK" href="sid806035.html#F247-11">Fig. 11-247</a>) The lesion that can mimic the lytic form of osteoblastoma
<a name="PG1265"> </a><div class="pagenum"><div>P.1265</div></div>
<br clear="all">
in the spine is aneurysmal bone cyst (ABC). Both lesions favor involvement of the neural arch of the spine, with ABC having a greater tendency to create huge expansion with a soap bubble appearance. The sclerotic osteoblastomas are not a differential problem because ABC does not present in a sclerotic fashion. (<a class="LK" href="sid806035.html#R513-11">18</a>,<a class="LK" href="sid806035.html#R514-11">19</a>) (<a class="LK" href="sid806035.html#F246-11">Fig. 11-246</a>)</div>
<div class="TB" id="T28-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]/TLV4[1]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-28 Radiologic Features of Osteoblastoma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Spine</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Neural arch</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansile</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thin peripheral cortical rim</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Matrix usually lytic; occasionally mixed or purely sclerotic</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Long bones</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Metaphyseal, diaphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansile, lytic</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thin peripheral cortical rim</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x003E; 2 cm</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F243-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="753" src="files/d0a3535a96ab54497cadc75f1c5a5fec.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d0a3535a96ab54497cadc75f1c5a5fec.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="753" DISPLAY="INLINE"></div>
<div class="P">Figure 11-243 <span class="emph_B">OSTEOBLASTOMA. Lateral Cervical Spine.</span> Note the grossly expansile lytic lesion of the posterior tubercle of the atlas. The peripheral cortex of this huge osteoblastoma is clearly defined and eggshell thin (<span class="emph_I">arrows</span>). There is a slight osteoid matrix scattered throughout this radiolucent osteoblastoma. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F244-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]/TLV4[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="456" src="files/6c1785a6bbb4fc2c1ad7da96c70acf99.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6c1785a6bbb4fc2c1ad7da96c70acf99.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="456" DISPLAY="INLINE"></div>
<div class="P">Figure 11-244 <span class="emph_B">OSTEOBLASTOMA: THORACIC SPINE. A. AP Cervicothoracic Spine.</span> Note the lytic destruction of the pedicle, lamina, transverse process, and spinous process of the T1 vertebra (<span class="emph_I">arrows</span>). <span class="emph_B">B. Lateral Cervical Spine.</span> Observe the gross lytic destruction of the spinous process and lamina of the T1 vertebra (<span class="emph_I">arrows</span>). <span class="emph_B">C. Oblique Cervical Spine.</span> Note the gross lytic destruction of the neural arch and spinous process of the T1 vertebra (<span class="emph_I">arrows</span>). <span class="emph_B">D. Bone Scan.</span> Note the diffuse area of increased uptake of radionuclide substance (hot spot), which correlates with the lytic destructive osteoblastoma of the neural arch of T1. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F245-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]/TLV4[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="482" src="files/005272547efa408649137b569265c025.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="005272547efa408649137b569265c025.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="482" DISPLAY="INLINE"></div>
<div class="P">Figure 11-245 <span class="emph_B">OSTEOBLASTOMA: THORACIC SPINE. A. AP T12.</span> Note the lytic destruction of the pedicle, lamina, and vertebral body of T12 (<span class="emph_I">arrow</span>). <span class="emph_B">B. AP Tomogram, T12.</span> Observe the extensive osteolytic destruction of the pedicle, lamina, spinous process, and vertebral body of T12 (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> The majority of patients with osteoblastomas in the spine present with purely radiolucent lesions; however, a mixture of mottled blastic and lytic changes, as well as radiopaque lesions, may occur.</div>
</td></tr>
</table></div>
<div class="FG" id="F246-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]/TLV4[1]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="484" height="700" src="files/5d7a2a723469800d177ed76894768588.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5d7a2a723469800d177ed76894768588.gif" MIMETYPE="image/gif" WIDTH="484" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-246 <span class="emph_B">OSTEOBLASTOMA: CERVICAL SPINE.</span> Note the grossly expansile, radiopaque osteoblastoma involving the spinous process, lamina, and articular pillar, with extension into the vertebral body of the C6 vertebra. <span class="emph_I">COMMENT:</span> This is one of the few cases of osteoblastoma that present in a truly sclerotic form. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Osteoblastoma.</span> ACA J Chiro May, 1982. Courtesy of Trevor G. Williams, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Broken Hill, New South Wales, Australia.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3754" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[5]/TLV4[2]">
<div class="HD">Extremities</div>
<div class="P">Involvement of the tubular bones generally affects the metaphysis or diaphysis in a lytic and expansile fashion. (<a class="LK" href="sid806035.html#R513-11">18</a>,<a class="LK" href="sid806035.html#R514-11">19</a>) The epiphysis is usually spared. Often, the cortex is thin, as the lesion expands the bone, leaving a radiolucent nidus, which is usually &#x003E; 2 cm. (<a class="LK" href="sid806035.html#R513-11">18</a>,<a class="LK" href="sid806035.html#R514-11">19</a>) (<a class="LK" href="sid806035.html#F242-11">Fig. 11-242</a>) There is no surrounding dense halo of new bone adjacent to the nidus as is the case in osteoid osteoma. (<a class="LK" href="sid806035.html#R510-11">15</a>,<a class="LK" href="sid806035.html#R511-11">16</a>) Most lesions occur around the knee and hip.</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3755" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">With small lesions, simple excision or surgical curettage will suffice. Recurrence rates are low, averaging about 5&#x0025;. Spinal lesions that are large may require bone grafting. Radiation therapy may be used as a last resort if the spinal lesion is inoperably placed, making complete removal impossible.</div>
<a name="PG1266"> </a><div class="pagenum"><div>P.1266</div></div>
<br clear="all">
<div class="FG" id="F247-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="541" src="files/37efe7215665d81905883e9eb63f9b28.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="37efe7215665d81905883e9eb63f9b28.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="541" DISPLAY="INLINE"></div>
<div class="P">Figure 11-247 <span class="emph_B">OSTEOBLASTOMA: THORACIC SPINE. A. CT, Axial T9.</span> Note the expansile osteolytic lesion affecting the lamina of the T9 vertebra. Observe the bony matrix within the destructive lesion. <span class="emph_B">B. T1-Weighted MRI, Sagittal Thoracic Spine.</span> Observe the large expansile lesion in the T9 lamina. This has produced posterior compression on the subarachnoid space and spinal cord. A slight degree of marrow change is seen in the posteroinferior vertebral body of T9, suggesting tumor extension to this level. <span class="emph_I">COMMENT:</span> This 16-year-old patient complained of lower thoracic pain. Plain film radiographs detected an expansile lesion of the T9 lamina and spinous process, and more sophisticated imaging was then performed. Note the bony matrix within the lesion. (Courtesy of Matthew Evitts, <a class="LK" href="sid108669.html#AB1-M9">DO</a>, Department of Radiology, University Hospital, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3756" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Osteoblastoma</div>
<div class="TLV2" id="B01382540.0-3757" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Dahlin and Johnson described this lesion originally as a giant osteoid osteoma.</div></li>
<li class="LM"><div class="P">Jaffe coined the term osteoblastoma in 1956.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3758" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A rare primary benign bone tumor, representing 1&#x0025; of all primary bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3759" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">70&#x0025; occur before the age of 20; peak range is 10-20.</div></li>
<li class="LM"><div class="P">There is a 2:1 male predilection.</div></li>
<li class="LM"><div class="P">Localized pain, which is not nocturnal and is of less severity than osteoid osteoma.</div></li>
<li class="LM"><div class="P">Painful scoliosis in &#x003E; 50&#x0025; of cases.</div></li>
<li class="LM"><div class="P">Neurological deficit may occur with expansile spinal lesions creating spinal stenosis.</div></li>
<li class="LM"><div class="P">The neural arch of the spine is the most common location, with spinous process, transverse process, and laminae involved in 40&#x0025; of cases.</div></li>
<li class="LM"><div class="P">30&#x0025; of cases affect the long bones of the appendicular skeleton.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3760" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Microscopically, it may be nearly impossible to differentiate osteoblastoma from osteoid osteoma.</div></li>
<li class="LM"><div class="P">Produces thick trabeculae of osteoid and woven bone with irregular serrated borders.</div></li>
</ul>
</div>
<a name="PG1267"> </a><div class="pagenum"><div>P.1267</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3761" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Spinal lesions are usually radiolucent and expansile, affecting the neural arch.</div></li>
<li class="LM"><div class="P">Tubular bone involvement creates a metaphyseal or diaphyseal lytic lesion with a nidus &#x003E; 2 cm. There is no reactive sclerosis surrounding the radiolucent nidus.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3762" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[8]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Small lesions are treated effectively by curettage or simple excision.</div></li>
<li class="LM"><div class="P">5&#x0025; recurrence rate exists.</div></li>
<li class="LM"><div class="P">Spinal lesions are often inoperable and require radiation therapy.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3763" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]">
<div class="HD">SOLITARY ENCHONDROMA</div>
<div class="TLV3" id="B01382540.0-3764" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Solitary enchondroma is a common benign bone tumor arising in residual islands of cartilage left in the metaphysis as the physis grows away. It appears as a single lesion within the interior of the bone with a great predilection for the bones of the hand and foot, although it may occur in any bone preformed in cartilage. It is often found by the coincidence of trauma because most lesions of the hand are asymptomatic, unless pathologic fracture occurs secondary to structural weakening. It is also called a central chondroma.</div>
</div>
<div class="TLV3" id="B01382540.0-3765" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Solitary enchondroma represents the most common benign bone tumor of the hand. (<a class="LK" href="sid806035.html#R515-11">1</a>) It makes up 10&#x0025; of all benign bone tumors. (<a class="LK" href="sid806035.html#R516-11">2</a>) The second most common tumor of the hand that secondarily affects bone is pigmented villonodular synovitis. (<a class="LK" href="sid806035.html#R517-11">3</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3766" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3767" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">The tumor arises during the growth period, and most tumors are seen between the ages of 10 and 30 years; peak incidence is usually in the 3rd decade. Males and females are equally affected.</div>
</div>
<div class="TLV4" id="B01382540.0-3768" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The most frequent mode of presentation is that of a painless tumor, which is found in the hands and feet. Because the lesion has been present for an extended period of time before it creates any symptoms, the duration of symptoms is short. A pathologic fracture following some trivial trauma usually precipitates localized pain and swelling. (<a class="LK" href="sid806035.html#R518-11">4</a>) (<a class="LK" href="sid806035.html#F248-11">Fig. 11-248</a>) Many patients live a normal life span with an enchondroma in the hand or foot and never develop any symptoms or even take notice of its presence.</div>
<div class="P">Lesions affecting the long tubular bones (femur and humerus) may also be asymptomatic, but enchondromas in these locations tend to be more symptomatic than those of the small tubular bones of the hands and feet. Sudden onset of pain without any history of trauma may indicate active growth and herald the onset of malignant degeneration, an event that occurs much more frequently in long bone enchondromas than in the short tubular bones of the hands and feet. (<a class="LK" href="sid806035.html#R519-11">5</a>)</div>
<div class="FG" id="F248-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[3]/TLV4[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="466" height="700" src="files/f5d06fe5ef9b2061a397081fe81f9a17.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f5d06fe5ef9b2061a397081fe81f9a17.gif" MIMETYPE="image/gif" WIDTH="466" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-248 <span class="emph_B">PATHOLOGIC FRACTURE THROUGH AN ENCHONDROMA. Oblique Hand.</span> Observe the expansile, geographic lesion present in the proximal phalanx of the third finger. This enchondroma has weakened the bone and allowed a pathologic fracture to occur following trivial trauma (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3769" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">Approximately 50&#x0025; of all enchondromas occur in the small tubular bones of the hand, with the phalanges accounting for 40&#x0025; and the metacarpals 10&#x0025;. (<a class="LK" href="sid806035.html#R520-11">6</a>) (<a class="LK" href="sid806035.html#F249-11">Fig. 11-249</a>) Only rarely is the thumb affected. (<a class="LK" href="sid806035.html#R515-11">1</a>) Enchondromas occur more commonly on the ulnar than on the radial side of the hand. (<a class="LK" href="sid806035.html#R521-11">7</a>,<a class="LK" href="sid806035.html#R517-11">3</a>) With respect to the phalanges, distal phalanges involvement is rare (<a class="LK" href="sid806035.html#R522-11">8</a>), and the tumor is usually near the proximal end. (<a class="LK" href="sid806035.html#R523-11">9</a>) In the metacarpals the lesion is toward the distal end. (<a class="LK" href="sid806035.html#R523-11">9</a>) The proximal phalanges, distal metacarpals, and middle and distal phalanges are the involved areas, in decreasing order of incidence. Occasionally, the foot will be involved. (<a class="LK" href="sid806035.html#F250-11">Fig. 11-250</a>) Other sites include the femur (14&#x0025;), humerus (13&#x0025;), and ribs (13&#x0025;). (<a class="LK" href="sid806035.html#R520-11">6</a>) The malignant potential of enchondroma increases dramatically the closer the lesion is to the
<a name="PG1268"> </a><div class="pagenum"><div>P.1268</div></div>
<br clear="all">
axial skeleton. (<a class="LK" href="sid806035.html#R519-11">5</a>,<a class="LK" href="sid806035.html#R524-11">10</a>) Enchondromas have been documented within the patella. (<a class="LK" href="sid806035.html#R525-11">11</a>) Tumors of the patella are uncommon; however, when present they are usually benign and of cartilaginous origin. Other obscure sites documented are the mandible, skull base, and vertebrae. (<a class="LK" href="sid806035.html#R526-11">12</a>,<a class="LK" href="sid806035.html#R527-11">13</a>,<a class="LK" href="sid806035.html#R528-11">14</a>) Flat bones, such as the pelvis and sternum, are only rarely involved and carry a high potential for malignant degeneration. (<a class="LK" href="sid806035.html#R520-11">6</a>)</div>
<div class="FG" id="F249-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="296" height="700" src="files/d35ac4d171743a1077797187bb9011bd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d35ac4d171743a1077797187bb9011bd.gif" MIMETYPE="image/gif" WIDTH="296" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-249 <span class="emph_B">SKELETAL DISTRIBUTION OF SOLITARY ENCHONDROMA.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F250-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[3]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="480" src="files/94fd795b27e55f27c4ae2a633d8a24ff.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="94fd795b27e55f27c4ae2a633d8a24ff.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="480" DISPLAY="INLINE"></div>
<div class="P">Figure 11-250 <span class="emph_B">SOLITARY ENCHONDROMA. A. PA Foot. B. Oblique Foot.</span> Note the geographic, expansile lesion of the base of the proximal phalanx of the second toe. No pathologic fracture or stippled calcification is demonstrated. This lesion was asymptomatic and found upon radiographic examination to rule out fracture. (Courtesy of David M. Walker, <a class="LK" href="sid108669.html#AB1-M10">DPM</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3770" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">The gross characteristics are rarely evident in surgical specimens because the standard form of treatment is curettage of the lesion, and all that is received are small granules or <span class="emph_I">rice-like fragments</span> of cartilaginous material, sometimes embedded in spicules of bone, where the tumor abuts on the surrounding normal tissue. Histologically, the tumor is composed of small masses or nodules of hyaline cartilage, separated by a scant, sometimes richly vascularized fibrous stroma. Foci of calcification are sometimes encountered in the cartilage; this occurs in approximately 50&#x0025; of cases and can be seen on radiographs. All tumors of cartilage matrix have a great predilection for calcification, including other cartilaginous tumors, such as osteochondroma and chondroblastoma. It is often difficult to differentiate enchondromas from malignant cartilage tumors histologically. Correlation with the clinical and radiographic data, including CT, MRI, and bone scans, is absolutely necessary to avoid an incorrect diagnosis and needless surgery. (<a class="LK" href="sid806035.html#R529-11">15</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3771" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">Enchondroma presents as a geographic area of radiolucency that expands and may deform bone. (<a class="LK" href="sid806035.html#F251-11">Fig. 11-251</a>) The margins are well defined. The cortex remains intact, although it may be considerably
<a name="PG1269"> </a><div class="pagenum"><div>P.1269</div></div>
<br clear="all">
thinned because of endosteal scalloping and expansion. Most singular lesions are centrally placed, within the metaphysis; however, the occasional eccentric lesion is noted, which may create quite a large mass. (<a class="LK" href="sid806035.html#F252-11">Fig. 11-252</a>) Stippled or punctate matrix calcification is found scattered randomly throughout the lucent defect in 50&#x0025; of cases. (<a class="LK" href="sid806035.html#F253-11">Fig. 11-253</a>)</div>
<div class="FG" id="F251-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="476" height="700" src="files/1393cbe5bde6b6e4bb3517ad139b6e79.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1393cbe5bde6b6e4bb3517ad139b6e79.gif" MIMETYPE="image/gif" WIDTH="476" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-251 <span class="emph_B">SOLITARY ENCHONDROMA. PA Hand.</span> Observe the large geographic area of radiolucency within the mid-diaphysis of the fifth metacarpal. Significant expansion, endosteal scalloping, bone deformity, and pathologic fracture are noted (<span class="emph_I">arrows</span>). Matrix calcification is evident.</div>
</td></tr>
</table></div>
<div class="FG" id="F252-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="353" src="files/46154689255336672244a96649f820ba.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="46154689255336672244a96649f820ba.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="353" DISPLAY="INLINE"></div>
<div class="P">Figure 11-252 <span class="emph_B">SOLITARY ENCHONDROMA: ECCENTRIC EXPANSILE LESION. A. Foot.</span> Observe the eccentric, geographic, expansile lesion present in the metaphysis of the distal surface of the fifth metatarsal. <span class="emph_B">B. Hand.</span> Note the grossly expansile, radiolucent lesion involving the base of the proximal phalanx of the fifth digit. This lesion has broken the cortex and produced a rather large soft tissue mass. <span class="emph_B">C. Hand.</span> Observe the eccentric expansile lesion of the proximal phalanx of the third digit. Significant bony expansion has produced a large soft tissue mass and cosmetic deformity. The cortex is thin, and a small pathologic fracture is noted (<span class="emph_I">arrow</span>). (Panel A courtesy of Robin F. Birchall, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Lilydale, Victoria, Australia.)</div>
</td></tr>
</table></div>
<div class="P">Without such calcification enchondroma must be differentiated from fibrous dysplasia, simple bone cyst, chondroblastoma, giant cell tumor, and osteoblastoma. If the lesion is placed in the distal phalanx, an epidermoid inclusion cyst or glomus tumor is the prime differential consideration. (<a class="LK" href="sid806035.html#F254-11">Fig. 11-254</a>) Epidermoid inclusion cyst represents post-traumatic implantation of epidermoid tissue within the bone. This cyst is found most often in patients who do a lot of sewing and who are likely to have needles penetrate the skin. The lack of calcification and the history of trauma are helpful points to clarify the diagnosis; both lesions are often asymptomatic. The glomus tumor is a painful, lucent defect affecting the distal phalanx by means of pressure erosion. An abnormal dilatation of blood vessels in a tightly compartmentalized area like the distal phalanx creates the characteristic pressure destructive lesions. Bone scan evaluations may reveal increased radiotracer uptake in the areas of enchondromas. (<a class="LK" href="sid806035.html#R530-11">16</a>)</div>
<div class="P">In long bones it is important to be able to differentiate enchondroma with heavy calcification (<span class="emph_I">calcifying enchondroma</span>) (<a class="LK" href="sid806035.html#R528-11">14</a>) from a medullary bone infarct. The pattern of calcification is often helpful with the enchondroma providing so-called <span class="emph_I">rings</span> or <span class="emph_I">broken</span>
<a name="PG1270"> </a><div class="pagenum"><div>P.1270</div></div>
<br clear="all">
<span class="emph_I">rings</span>&#x2014;small, rounded calcification surrounded by a lucent matrix. In contrast, a bone infarct creates a streaky, roughened calcification with peripheral borders that have been called <span class="emph_I">serpiginous</span> in appearance. In addition, the infarct is often surrounded by a characteristic fibro-osseous margin, which may assume a well-defined straight line on one side of the lesion, a feature seldom observed in an enchondroma. The roentgen sign of bone expansion favors enchondroma because a medullary bone infarct does not expand bone. (<a class="LK" href="sid806035.html#F255-11">Fig. 11-255</a>; <a class="LK" href="sid806035.html#T29-11">Table 11-29</a>)</div>
<div class="FG" id="F253-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="274" src="files/de04702d4b9abf747756a2ff3f0d4dbe.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="de04702d4b9abf747756a2ff3f0d4dbe.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="274" DISPLAY="INLINE"></div>
<div class="P">Figure 11-253 <span class="emph_B">SOLITARY ENCHONDROMA: STIPPLED CALCIFICATION. A. Hand.</span> Observe the large, geographic, expansile lesion at the base of the proximal phalanx of the fourth digit. There is classic, heavy, stippled calcification scattered throughout the entire matrix of this enchondroma. There is also an associated pathologic fracture (<span class="emph_I">arrows</span>). <span class="emph_B">B. Humerus.</span> Observe the geographic radiolucency within the metaphysis of the proximal humerus. There is characteristic stippled calcification throughout this solitary enchondroma. <span class="emph_B">C. Rib.</span> Note the expansile solitary enchondroma, with heavy matrix calcification, in the anterior surface of the seventh rib (<span class="emph_I">arrow</span>). <span class="emph_B">D. Ilium.</span> Note the large, geographic radiolucency within the midportion of the iliac fossa. Note the moderate stippled calcification associated with this solitary enchondroma (<span class="emph_I">arrows</span>). (Panel A courtesy of Gerald A. Fitzgerald, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Sydney, Australia. Panel D courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F254-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="528" src="files/9e165209fcbfe488aa5e0b4313aac50e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9e165209fcbfe488aa5e0b4313aac50e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="528" DISPLAY="INLINE"></div>
<div class="P">Figure 11-254 <span class="emph_B">ENCHONDROMA. A. PA Hand. B. Lateral Hand.</span> Note the grossly expansile, radiolucent solitary enchondroma involving the base of the distal phalanx of the ring finger. Endosteal scalloping, with a slight interruption in the cortex, is noted. <span class="emph_I">COMMENT:</span> When solitary enchondromas are found in the distal phalanx, an epidermoid inclusion cyst or glomus tumor must be considered in the differential diagnosis. Epidermoid inclusion cysts represent post-traumatic implantation of epidermoid tissue in the bone. A glomus tumor is a painful lucent defect of the distal phalanx that is caused by pressure erosion from abnormal dilatation of blood vessels in this tightly compartmentalized space.</div>
</td></tr>
</table></div>
<div class="P">Malignant transformation of a solitary enchondroma to a chondrosarcoma is rare. It appears to occur in the bones closest to the axial skeleton. Malignant changes are more frequent in the long tubular bones than in the small bones of the hand or feet. (<a class="LK" href="sid806035.html#R531-11">17</a>) Patients develop unrelenting pain in a lesion that was previously asymptomatic. The radiologic features that suggest malignant transformation are cortical disruption, focal malignant periosteal reaction, a poor zone of transition, and a large, soft tissue mass. (<a class="LK" href="sid806035.html#F256-11">Figs. 11-256</a> and <a class="LK" href="sid806035.html#F257-11">11-257</a>)</div>
<div class="TB" id="T29-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-29 Radiologic Features of Enchondroma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Hands, feet</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Geographic lesion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Central</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Endosteal scalloping</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thinned cortex</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Stippled calcification (50&#x0025;)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pathologic fracture</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Occasional malignant transformation</p></td>
</tr>
</table></td></tr>
</table></div>
<a name="PG1271"> </a><div class="pagenum"><div>P.1271</div></div>
<br clear="all">
<div class="FG" id="F255-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="668" src="files/89344f02646eead5cb4c28eeda481a69.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="89344f02646eead5cb4c28eeda481a69.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="668" DISPLAY="INLINE"></div>
<div class="P">Figure 11-255 <span class="emph_B">BENIGN ENCHONDROMA VERSUS CHONDROSARCOMA OR BONE INFARCT. A. AP Humerus in 1984. B. Baby-Arm Humerus in 1997.</span> Observe the focal serpiginous calcification within the matrix of the proximal diaphysis and metaphysis of the left humeral head. Over the 13-year time frame the lesion has minimally enlarged. No obvious evidence of cortical breakthrough or soft tissue mass is identified. <span class="emph_B">C. Planar Bone Scan, 1997.</span> Note the intense focal uptake of radionuclide affecting the area of involvement in the humerus seen on the plain film. No other areas of uptake are identified. <span class="emph_B">D. T1-Weighted MRI, Semisagittal Left Humerus, 1997.</span> Observe the low signal intensity in the proximal humerus with marrow replacement (<span class="emph_I">arrow</span>). Part of the low signal intensity is related to the dense matrix calcification. There is no cortical breakthrough or soft tissue mass. <span class="emph_I">COMMENT:</span> Clinicians are often presented with areas of irregular calcification within the marrow of the distal femur, proximal tibia, or proximal humerus, which have the appearance of a bone infarct. The possibility of a slow-growing enchondroma or low-grade chondrosarcoma must be ruled out. The first examination of choice should be a bone scan. Because it is metabolically inactive, the diagnosis of bone infarct is easily made. If the bone scan is positive, an MRI study should be the next examination of choice to rule out soft tissue extension and cortical breakthrough. Biopsy of these lesions is often challenging for the pathologist because low-grade chondrosarcoma and enchondroma may be similar histologically. This patient&#x2019;s biopsy diagnosis was a benign enchondroma; at the 2003 follow-up examination, the patient&#x2019;s shoulder was asymptomatic.</div>
</td></tr>
</table></div>
<a name="PG1272"> </a><div class="pagenum"><div>P.1272</div></div>
<br clear="all">
<div class="FG" id="F256-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="433" height="700" src="files/f918797af5cb239e67632230eac11b48.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f918797af5cb239e67632230eac11b48.gif" MIMETYPE="image/gif" WIDTH="433" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-256 <span class="emph_B">SOLITARY ENCHONDROMA TO CHONDROSARCOMA: MALIGNANT DEGENERATION.</span> Observe the grossly expansile, primarily lytic lesion of the metaphysis and proximal diaphysis of the femur. There is characteristic stippled matrix calcification throughout the lesion (<span class="emph_I">arrows</span>). There is disruption of the cortex with the presence of a soft tissue mass on the medial surface of the femur (<span class="emph_I">arrowheads</span>). <span class="emph_I">COMMENT:</span> The radiographic signs of cortical disruption, a poor zone of transition surrounding the lesion, and a large soft tissue mass support the biopsy diagnosis of malignant degeneration of a pre-existing benign enchondroma to a secondary chondrosarcoma. Malignant degeneration of benign cartilaginous tumors occurs in bones closest to the axial skeleton and is much more common in the long tubular bones than in the small bones of the hands or feet.</div>
</td></tr>
</table></div>
<div class="FG" id="F257-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="458" src="files/c018fb9ceb402f450d3944d480d2f6f6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c018fb9ceb402f450d3944d480d2f6f6.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="458" DISPLAY="INLINE"></div>
<div class="P">Figure 11-257 <span class="emph_B">ENCHONDROMA TO CHONDROSARCOMA: MALIGNANT DEGENERATION. A. PA Hand.</span> Observe the expansile, lytic, highly destructive lesion of the proximal phalanx of the third digit of the hand. There is cortical destruction and the presence of a soft tissue mass. There is stippled calcification in the matrix of the lesion. <span class="emph_B">B. Planar Bone Scan.</span> Observe the intense uptake of the radionuclide within the area of the third digit. An additional area of uptake is seen at the base of the thumb, consistent with erosive osteoarthritis. A third area of small focal uptake is noted within the area of the elbow, consistent with the injection site. No other abnormalities are identified. <span class="emph_B">C. CT, Axial Midshaft of Proximal Phalanges of the Hand.</span> Observe the highly expansile destructive process affecting the proximal phalanx of the third digit along with considerable extension into the surrounding soft tissues. <span class="emph_I">COMMENT:</span> Malignant degeneration of a previously benign enchondroma is most commonly found in the axial skeleton and less frequently in the peripheral skeleton. The incidence of malignant degeneration of a solitary enchondroma is &#x2264; 1&#x0025;, whereas that of multiple enchondromatosis (Ollier&#x2019;s disease) has been reported as high as 50&#x0025;, but may more realistically be 10&#x0025;. (Courtesy of Sean Bryant, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Department of Radiology, University Hospital, Denver, Colorado.)</div>
</td></tr>
</table></div>
<a name="PG1273"> </a><div class="pagenum"><div>P.1273</div></div>
<br clear="all">
<div class="FG" id="F258-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[5]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="726" src="files/a46246c7a5c3e90af0e0f39f42dc759b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a46246c7a5c3e90af0e0f39f42dc759b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="726" DISPLAY="INLINE"></div>
<div class="P">Figure 11-257 (<span class="emph_I">continued</span>)</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3772" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Most lesions in the hands or feet that create no cosmetic deformity require no treatment at all; however, if pathologic fracture occurs, casting and curettage are usually recommended. (<a class="LK" href="sid806035.html#R532-11">18</a>,<a class="LK" href="sid806035.html#R533-11">19</a>) Enchondromas in the long tubular bones or that create significant expansion in the small tubular bones require careful curettage followed by cryosurgery with bone chips) or cement packing. (<a class="LK" href="sid806035.html#R534-11">20</a>,<a class="LK" href="sid806035.html#R535-11">21</a>) The closer the enchondroma is to the axial skeleton, the higher the potential for malignant degeneration; therefore, some surgeons will remove these lesions prophylactically when they are in this location. Irradiation of benign cartilaginous lesions is absolutely contraindicated.</div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3773" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Enchondroma</div>
<div class="TLV2" id="B01382540.0-3774" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">May form in any bone preformed in cartilage.</div></li>
<li class="LM"><div class="P">It is also called central chondroma.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3775" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most common benign bone tumor of the hand, making up 10&#x0025; of all benign bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3776" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">This tumor arises in the 10-30 age range.</div></li>
<li class="LM"><div class="P">No sex predilection exists.</div></li>
<li class="LM"><div class="P">This lesion is usually asymptomatic in the hands and feet until trauma draws attention to it.</div></li>
<li class="LM"><div class="P">Lesions of the long bones are usually more symptomatic.</div></li>
<li class="LM"><div class="P">50&#x0025; of all enchondromas occur in the hands and feet: phalanges, 40&#x0025;; metacarpals, 10&#x0025;. Other sites include femur, 14&#x0025;; humerus, 13&#x0025;; ribs, 13&#x0025;.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3777" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Histologically, composed of small masses of hyaline cartilage, separated by scant, sometimes richly vascularized fibrous stroma.</div></li>
<li class="LM"><div class="P">50&#x0025; of cases show matrix calcification via radiographs.</div></li>
</ul>
</div>
<a name="PG1274"> </a><div class="pagenum"><div>P.1274</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3778" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Patients present with a geographic, expansile lytic lesion usually of a phalanx of the hand.</div></li>
<li class="LM"><div class="P">The lesion usually occurs within the metaphysis of the bone, centrally placed.</div></li>
<li class="LM"><div class="P">Stippled or punctate matrix calcification is seen within the lesion.</div></li>
<li class="LM"><div class="P">Malignant degeneration to a chondrosarcoma appears to occur more often when the enchondromas are multiple and when they are closer to the axial skeleton; cortical disruption, malignant periosteal response, and a soft tissue mass are radiographic signs of malignant change.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3779" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[9]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most lesions require no treatment because they are usually asymptomatic.</div></li>
<li class="LM"><div class="P">Symptomatic lesions, usually in the long tubular bones, require careful curettage, followed by cryosurgery and bone chips.</div></li>
<li class="LM"><div class="P">Irradiation of benign cartilaginous lesions is contraindicated.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3780" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]">
<div class="HD">MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE)</div>
<div class="TLV3" id="B01382540.0-3781" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">The presence of central chondromas or enchondromas in multiple sites is referred to as enchondromatosis. The initial description of this condition was by a French physician who denoted a unilateral form of the disease that now bears his name, Ollier&#x2019;s disease. (<a class="LK" href="sid806035.html#R536-11">1</a>) Today, however, enchondromatosis occurs most often bilaterally, and Ollier&#x2019;s disease has also been used in association with bilateral lesions. Jaffe (<a class="LK" href="sid806035.html#R537-11">2</a>) preferred the term <span class="emph_I">multiple enchondromatosis</span> over Ollier&#x2019;s disease. Enchondromatosis is a cartilage dysplasia of bone representing an inborn anomaly of enchondral bone formation. (<a class="LK" href="sid806035.html#R538-11">3</a>) This anomalous malformation leaves unossified cartilage remnants in the diaphyses and metaphyses.</div>
</div>
<div class="TLV3" id="B01382540.0-3782" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[2]">
<div class="HD">Clinical Features</div>
<div class="P">Pain is rarely found associated with multiple enchondromas, unless there is superimposed trauma and pathologic fracture. If the lesions are large, deformity and loss of limb function may occur. The most frequent location is in the small bones of the hands and feet. (<a class="LK" href="sid806035.html#R539-11">4</a>) The femur and tibia are frequently affected, and the iliac crest is the most commonly involved flat bone. (<a class="LK" href="sid806035.html#R538-11">3</a>) (<a class="LK" href="sid806035.html#F259-11">Fig. 11-258</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3783" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]">
<div class="HD">Radiologic Features</div>
<div class="P">Radiographically, these lesions are similar to solitary enchondromas, with a round or oval radiolucency that creates a symmetric widening of the bone. (<a class="LK" href="sid806035.html#F260-11">Fig. 11-259</a>) Central matrix calcification is common. (<a class="LK" href="sid806035.html#F261-11">Figs. 11-260</a>, <a class="LK" href="sid806035.html#F262-11">11-261</a> and <a class="LK" href="sid806035.html#F263-11">11-262</a>) Occasionally, these lesions can be eccentrically placed, causing a larger expansion of bone. Often, with central metaphyseal lesions, <span class="emph_I">streak-like or vertical bands of radiolucencies</span> can be seen projecting toward the diaphysis of the bone. (<a class="LK" href="sid806035.html#R540-11">5</a>) (<a class="LK" href="sid806035.html#F264-11">Figs. 11-263</a> and <a class="LK" href="sid806035.html#F265-11">11-264</a>)</div>
<div class="P">Malignant degeneration of enchondromas in patients with enchondromatosis has been reported. (<a class="LK" href="sid806035.html#R541-11">6</a>) Jaffe (<a class="LK" href="sid806035.html#R537-11">2</a>) stated a rate of 50&#x0025;, which may be high; 10&#x0025; may be more realistic. (<a class="LK" href="sid806035.html#R542-11">7</a>) Malignant changes can occur in any bone; however, the pelvic bones and the shoulder girdle are the most common sites (<a class="LK" href="sid806035.html#F266-11">Fig. 11-265</a>). (<a class="LK" href="sid806035.html#R538-11">3</a>) MRI is useful in detecting any malignant transformation. (<a class="LK" href="sid806035.html#R543-11">8</a>)</div>
<div class="FG" id="F259-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="294" height="700" src="files/663e9d6cd5fd6934e17e16cc0f361885.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="663e9d6cd5fd6934e17e16cc0f361885.gif" MIMETYPE="image/gif" WIDTH="294" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-258 <span class="emph_B">SKELETAL DISTRIBUTION OF MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE).</span>
</div>
</td></tr>
</table></div>
<div class="P">The treatment for deforming or symptomatic lesions is surgical curettage or en bloc excision. (<a class="LK" href="sid806035.html#R544-11">9</a>)</div>
<a name="PG1275"> </a><div class="pagenum"><div>P.1275</div></div>
<br clear="all">
<div class="FG" id="F260-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="497" src="files/8b4e9ccddab32f6305df2911e0f74ad8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8b4e9ccddab32f6305df2911e0f74ad8.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="497" DISPLAY="INLINE"></div>
<div class="P">Figure 11-259 <span class="emph_B">MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE). A. Hand.</span> Observe the geographic, expansile, soap bubble lesions affecting nearly every bone visualized within the hand. Slight matrix calcification is noted in the metacarpal bones. <span class="emph_B">B. Foot.</span> Observe the multiple, geographic, expansile lesions scattered throughout the proximal phalanges of the foot. The first metatarsal and the diaphysis of the fourth metatarsal also contain expansile enchondromas. The expansion of bone has widened the diaphysis of most of the affected bones.</div>
</td></tr>
</table></div>
<div class="FG" id="F261-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="459" height="700" src="files/bc9a701d7024e3d4f4027a525d68dfa4.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="bc9a701d7024e3d4f4027a525d68dfa4.gif" MIMETYPE="image/gif" WIDTH="459" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-260 <span class="emph_B">MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE). Hand.</span> Note the multiple, geographic, expansile lesions scattered throughout nearly all of the tubular bones of the hand. There is gross eccentric expansion of the medial cortex of the middle and proximal phalanges of the second digit, creating a rather large soft tissue mass and cosmetic deformity (<span class="emph_I">arrows</span>). Similar expansion, but to a lesser extent, is seen throughout the metacarpal bones and proximal phalanges. Scattered matrix calcification is seen within several of the enchondromas. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1276"> </a><div class="pagenum"><div>P.1276</div></div>
<br clear="all">
<div class="FG" id="F262-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="452" src="files/c4cc527150f5a138034cc1267ec6c69c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c4cc527150f5a138034cc1267ec6c69c.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="452" DISPLAY="INLINE"></div>
<div class="P">Figure 11-261 <span class="emph_B">MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE): DIFFUSE SKELETAL INVOLVEMENT. A. Pelvis.</span> Observe the multiple enchondromas scattered throughout the pelvis and proximal femora. There is a heavy matrix of stippled calcification throughout these lesions. <span class="emph_B">B. Left Shoulder.</span> Note the extensive enchondromatosis involving the scapula, ribs, and proximal humerus. Dense, stippled calcification is seen associated with the multiple enchondromas. <span class="emph_B">C. Right Shoulder and Ribs.</span> Note the multiple enchondromas at the anterior surfaces of several ribs as well as in the scapula; these demonstrate classic punctate or stippled calcification. <span class="emph_B">D. Distal Femur.</span> Observe the gross expansion of the distal femur, with stippled calcification throughout the large enchondroma. <span class="emph_B">E. Radius and Ulna.</span> Observe the expansion of the distal radius and ulna, with stippled calcification within the radiolucent lesions. Additional enchondromas are seen in the distal humerus and in the radial head and tuberosity. <span class="emph_B">F. Hand.</span> Note the multiple enchondromas involving all of the tubular bones of the hand. Because of the gross expansile nature of these lesions, the peripheral cortex is poorly visualized throughout, giving the appearance of a malignant disorder. Advanced cases of multiple enchondromatosis, with gross expansion, may often present this pattern of bone destruction. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1277"> </a><div class="pagenum"><div>P.1277</div></div>
<br clear="all">
<div class="FG" id="F263-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="388" src="files/0abb91618c5d2d2c532d6c3240f23e47.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="0abb91618c5d2d2c532d6c3240f23e47.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="388" DISPLAY="INLINE"></div>
<div class="P">Figure 11-262 <span class="emph_B">ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE): ILIUM AND PROXIMAL FEMUR. A. AP Pelvis. B. AP Hip.</span> Observe the multiple enchondromas affecting the proximal femora and ilium. The characteristic punctate or stippled calcification is clearly demonstrated. <span class="emph_I">COMMENT:</span> Enchondroma of the ilium are somewhat unusual, although the proximal femur is a common site. (Courtesy of Michael T. Buehler, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Durango, Colorado.)</div>
</td></tr>
</table></div>
<div class="FG" id="F264-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="393" height="700" src="files/fa03aadc03e7cda9fa63a6982db21f8b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fa03aadc03e7cda9fa63a6982db21f8b.gif" MIMETYPE="image/gif" WIDTH="393" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-263 <span class="emph_B">MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE): STREAK-LIKE METAPHYSEAL VERTICAL RADIOLUCENCIES. AP Knee.</span> Observe the streak-like radiolucencies throughout the metaphysis of the distal femur and proximal tibia. This appearance is typical of the cartilaginous lesions affecting the metaphyses of long tubular bones in multiple enchondromatosis.</div>
</td></tr>
</table></div>
<div class="FG" id="F265-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="487" height="700" src="files/f19b5d59702ddbd58d145e7dd41cf02a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f19b5d59702ddbd58d145e7dd41cf02a.gif" MIMETYPE="image/gif" WIDTH="487" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-264 <span class="emph_B">MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE). AP Bilateral Lower Legs.</span> Observe the radiolucent streak-like appearance within the metaphysis of the proximal and distal femur, tibia, and fibula. <span class="emph_I">COMMENT:</span> The streak-like metaphyseal vertical radiolucencies seen in this case are characteristic of the early metaphyseal changes of Ollier&#x2019;s disease in pediatric patients, usually &#x003C; 3 years of age. (Courtesy of Douglas Elliott, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Department of Radiology, University Hospital, Denver, Colorado.).</div>
</td></tr>
</table></div>
<a name="PG1278"> </a><div class="pagenum"><div>P.1278</div></div>
<br clear="all">
<div class="FG" id="F266-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="466" src="files/487043509534f92b01b088d7e85266c8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="487043509534f92b01b088d7e85266c8.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="466" DISPLAY="INLINE"></div>
<div class="P">Figure 11-265 <span class="emph_B">MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE): MALIGNANT DEGENERATION. A. Humerus.</span> Note the destruction of the medial cortex (<span class="emph_I">arrow</span>). Note the multiple enchondromas of the proximal humerus and acromion. <span class="emph_B">B. Disease Progression 1 Year Later, Humerus.</span> Note that the lesion has progressed, with gross bone destruction and a large soft tissue mass. (Courtesy of Lawrence A. Cooperstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Pittsburgh, Pennsylvania.)</div>
</td></tr>
</table></div>
<div class="FG" id="F267-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[10]/TLV3[3]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="282" src="files/18d33ea08209238981ece2518a918876.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="18d33ea08209238981ece2518a918876.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="282" DISPLAY="INLINE"></div>
<div class="P">Figure 11-266 <span class="emph_B">MAFFUCCI&#x2019;S SYNDROME. A. PA Hand.</span> Observe the large soft tissue cavernous hemangiomas throughout the hand, with associated phlebolith calcification within the masses. These phleboliths appear as circular radiopacities within the soft tissue masses. <span class="emph_B">B. PA Wrist. C. Lateral Forearm.</span> Note the large, circular calcifications throughout the soft tissues of the wrist and forearm. These calcifications represent phleboliths within adjacent soft tissue cavernous hemangiomas. Note the relatively radiolucent center present within the calcifications, which is a characteristic presentation of phleboliths. <span class="emph_I">COMMENT:</span> Maffucci&#x2019;s syndrome is defined as multiple enchondromatosis with soft tissue cavernous hemangiomas. (Panel A courtesy of Jack Edeiken, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Houston, Texas.)</div>
</td></tr>
</table></div>
</div>
</div>
<a name="PG1279"> </a><div class="pagenum"><div>P.1279</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3784" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[11]">
<div class="HD">MAFFUCCI&#x2019;S SYNDROME</div>
<div class="TLV3" id="B01382540.0-3785" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[11]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">In 1881 Maffucci (<a class="LK" href="sid806035.html#R545-11">1</a>) described a syndrome of enchondromatosis of bone and soft tissue cavernous hemangiomas. This syndrome is quite rare and not of a hereditary nature. (<a class="LK" href="sid806035.html#R546-11">2</a>) Symptoms of the disease are not present at birth but will usually present before puberty. (<a class="LK" href="sid806035.html#R547-11">3</a>) There has been only 90 cases reported in the world literature. Most cases are seen in the hand, with multiple phalangeal enchondromas and an adjacent soft tissue cavernous hemangioma. The hemangiomas present as soft tissue masses containing phleboliths, which appear radiographically as radiopaque concretions around a relatively lucent center. (<a class="LK" href="sid806035.html#R548-11">4</a>) (<a class="LK" href="sid806035.html#F267-11">Fig. 11-266</a>) There is a greater tendency (as high as 25&#x0025;) toward malignant degeneration of the enchondromas in Maffucci&#x2019;s syndrome than there is in Ollier&#x2019;s disease (enchondromatosis without hemangiomas). (<a class="LK" href="sid806035.html#R548-11">4</a>,<a class="LK" href="sid806035.html#R549-11">5</a>) Except for the soft tissue hemangiomas, the radiographic features of Maffucci&#x2019;s syndrome are identical to those of Ollier&#x2019;s disease, which substantiates the necessity to search carefully for hemangiomas in any patient diagnosed with Ollier&#x2019;s disease. (<a class="LK" href="sid806035.html#R548-11">4</a>,<a class="LK" href="sid806035.html#R550-11">6</a>) One recent study recommends the use of full body MRI to avoid misdiagnosis and erroneous expectations of the prognosis. (<a class="LK" href="sid806035.html#R550-11">6</a>) The outcome of Maffucci&#x2019;s syndrome is widespread, ranging from minor lifestyle alterations to total incapacitation. (<a class="LK" href="sid806035.html#R551-11">7</a>)</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3786" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[12]">
<div class="HD">PERIOSTEAL CHONDROMA</div>
<div class="TLV3" id="B01382540.0-3787" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[12]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Periosteal chondroma is a slowly growing, benign cartilaginous tumor of limited size that develops within and beneath the periosteum on the surface of cortical bone. The first description of periosteal chondroma as a distinctive entity was by Lichtenstein and Hall in 1952. (<a class="LK" href="sid806035.html#R552-11">1</a>) Jaffe (<a class="LK" href="sid806035.html#R553-11">2</a>) in 1956 described additional cases and coined the term <span class="emph_I">juxtacortical chondroma,</span> which is synonymous with periosteal chondroma. Approximately 80 cases have been reported, with no sex predilection. Most patients present with a painless mass; however, a significant number may complain of mild pain, often of long duration. A bony lump may be palpable.</div>
<div class="FG" id="F268-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[12]/TLV3[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="524" src="files/f4ee935c446283533938bca7be9795c1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f4ee935c446283533938bca7be9795c1.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="524" DISPLAY="INLINE"></div>
<div class="P">Figure 11-267 <span class="emph_B">PERIOSTEAL CHONDROMA. A. Hand.</span> Observe the juxtacortical radiolucency present within the metaphysis of the proximal phalanx (<span class="emph_I">arrow</span>). There is a cortical indentation, with scalloping or a saucerized depression of the outer cortex and a well-defined inner margin. <span class="emph_B">B. Humerus.</span> Note the rather large cortical indentation with scalloped inner margins present on the medial aspect of the metaphysis of the proximal humerus. The classic cortical saucerized depression at the outer cortex, with a well-defined inner margin, is visualized at the caudal aspect of this lesion. This is a characteristic appearance for a periosteal chondroma (juxtacortical chondroma).</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3788" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[12]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">The most common location for periosteal chondroma is in the small bones of the hands and feet. (<a class="LK" href="sid806035.html#R554-11">3</a>) The humerus is also a common site, but other sites, such as the femur, tibia, radius, ulna, and fibula, have been reported. (<a class="LK" href="sid806035.html#R555-11">4</a>) These lesions occur most often in young adults and may reach 3-4 cm in diameter.</div>
</div>
<div class="TLV3" id="B01382540.0-3789" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[12]/TLV3[3]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiographic features of periosteal chondroma are somewhat characteristic. (<a class="LK" href="sid806035.html#R554-11">3</a>,<a class="LK" href="sid806035.html#R556-11">5</a>) The typical tumor presents as a metaphyseal lesion in a tubular bone that appears as an area of cortical indentation, resulting in a <span class="emph_I">scalloped, or saucerized depression</span> of the outer cortex, with a well-defined inner margin. The superior and inferior edges may be overhanging. (<a class="LK" href="sid806035.html#F268-11">Fig. 11-267</a>) Within this area of saucerization some recognizable cartilage matrix is often present; this is seen more frequently in the smaller lesions. A demonstrable soft tissue mass is present in approximately one third of patients. (<a class="LK" href="sid806035.html#R557-11">6</a>) A ledge or buttress of periosteal bone may extend from the adjacent cortex around a portion of the chondroma, especially at its proximal end, and a dense rind of lamellar bone usually separates the tumor from the medullary cavity. The lesions most likely to cause a problem in differential diagnosis are fibrous cortical defect, periosteal desmoid, periosteal chondrosarcoma, and aneurysmal bone cyst. (<a class="LK" href="sid806035.html#R554-11">3</a>,<a class="LK" href="sid806035.html#R557-11">6</a>,<a class="LK" href="sid806035.html#R558-11">7</a>)</div>
<a name="PG1280"> </a><div class="pagenum"><div>P.1280</div></div>
<br clear="all">
<div class="P">Knowledge of and familiarity with the radiographic features of periosteal chondroma are important, because in many cases, the final diagnosis must be made by combining the pathologic and radiographic features. (<a class="LK" href="sid806035.html#R559-11">8</a>) MRI can aid in the diagnosis because 100&#x0025; of the lesions are bordered by a hypointense rim and will reveal a soft tissue mass of hypointensity on T1-weighted sequences and hyperintensity on T2-weighted images. (<a class="LK" href="sid806035.html#R560-11">9</a>,<a class="LK" href="sid806035.html#R561-11">10</a>) Pressure erosions of the adjacent cortex will be well visualized. (<a class="LK" href="sid806035.html#R560-11">9</a>)</div>
<div class="P">Many periosteal chondromas are treated by en bloc excision, and wide excision is recommended for all tumors &#x003E; 3 cm owing to the difficulty in differentiating benign and malignant tumors. (<a class="LK" href="sid806035.html#R559-11">8</a>) Recurrence is rare; thus it is important that a radiographic diagnosis be available before biopsy to avoid unnecessary procedures. Although the three classic features of periosteal chondroma are not always seen in combination, the majority of cases present with sufficient scalloping of the outer cortex, a slight overhanging of bony edges, and an evident calcified cartilaginous matrix, allowing a proper diagnosis to be made. (<a class="LK" href="sid806035.html#R558-11">7</a>)</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3790" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]">
<div class="HD">CHONDROBLASTOMA</div>
<div class="TLV3" id="B01382540.0-3791" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Benign chondroblastoma is a rare primary benign bone tumor of cartilaginous origin. (<a class="LK" href="sid806035.html#R562-11">1</a>) It is usually seen before epiphyseal closure and primarily affects the long tubular bones of the lower extremity. Ewing (<a class="LK" href="sid806035.html#R563-11">2</a>) in 1928 was the first to focus on this tumor and called it a calcifying giant cell tumor. It has also been referred to as cartilage-containing giant cell tumor by Kolodny (<a class="LK" href="sid806035.html#R564-11">3</a>); and in 1931, when Codman (<a class="LK" href="sid806035.html#R565-11">4</a>) described the tumor in some detail, he too felt this lesion to be a giant cell variant and referred to it as an epiphyseal chondromatous giant cell tumor. It was not until 1942, through the work of Jaffe and Lichtenstein (<a class="LK" href="sid806035.html#R566-11">5</a>), that benign chondroblastoma became established as a separate and distinct entity. The basic concepts that they set forth at that time have since been firmly established. Chondroblastoma is often called Codman&#x2019;s tumor, a term that is still in use today.</div>
</div>
<div class="TLV3" id="B01382540.0-3792" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Chondroblastoma is rare, representing &#x003C; 1&#x0025; of all primary bone tumors. More than 550 cases are reported in the world literature. (<a class="LK" href="sid806035.html#R567-11">6</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3793" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3794" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Although the age range of patients is wide, most lesions occur in patients who are between 10 and 25 years old. (<a class="LK" href="sid806035.html#R568-11">7</a>) This lesion almost always develops and manifests itself in the 2nd decade of life. (<a class="LK" href="sid806035.html#R569-11">8</a>) That the chondroblastoma arises from the cells of the enchondral plate after the osseous nucleus is well developed is doubtless the reason it occurs so consistently in the 2nd decade of life. This lesion appears approximately twice as frequently in males. (<a class="LK" href="sid806035.html#R570-11">9</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3795" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Most patients present with the chief complaint of pain, which is often referred to the adjacent joint. (<a class="LK" href="sid806035.html#R571-11">10</a>) Local tenderness and swelling may also be encountered. Muscle atrophy and weakness may affect the involved limb because symptomatology of months&#x2019; or even years&#x2019; duration is often the case. The pain is usually mild and dull.</div>
</div>
<div class="TLV4" id="B01382540.0-3796" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">Classically, chondroblastomas present within the epiphyseal region of a long tubular bone, with occasional extension into the metaphyseal region. Diaphyseal lesions do not occur. The lesions vary in size, with 3-6 cm being average; 90&#x0025; of the lesions are found in the medullary cavity, and 10&#x0025; affect the cortex. (<a class="LK" href="sid806035.html#R572-11">11</a>) When the lesion affects both the metaphysis and the epiphysis, it is usually eccentric.</div>
<div class="P">The most common locations are proximal femur, including trochanters (23&#x0025;), distal femur (20&#x0025;), proximal tibia (17&#x0025;), proximal humerus (17&#x0025;), tarsal bones (9&#x0025;), and innominates (5&#x0025;). (<a class="LK" href="sid806035.html#R573-11">12</a>) (<a class="LK" href="sid806035.html#F269-11">Fig. 11-268</a>) Pelvic chondroblastoma has a marked predilection for the triradiate cartilage of the innominate bone. (<a class="LK" href="sid806035.html#R572-11">11</a>) Codman originally described this lesion to be almost exclusive to the humerus, which has since been shown to be incorrect. (<a class="LK" href="sid806035.html#R565-11">4</a>) He was the first, however, to appreciate the great predilection for the tuberosities of the humerus over the humeral head epiphysis.
<a name="PG1281"> </a><div class="pagenum"><div>P.1281</div></div>
<br clear="all">
(<a class="LK" href="sid806035.html#F270-11">Figs. 11-269</a> and <a class="LK" href="sid806035.html#F271-11">11-270</a>) This anatomic preference still holds true today. A similar situation exists with lesions in the upper end of the femur, where the lesion arises more often in the trochanters than adjacent to the articular surface of the femoral head. (<a class="LK" href="sid806035.html#F272-11">Fig. 11-271</a>)</div>
<div class="FG" id="F269-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="302" height="700" src="files/4b6c5b79ec7d6a0d321434557909e891.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4b6c5b79ec7d6a0d321434557909e891.gif" MIMETYPE="image/gif" WIDTH="302" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-268 <span class="emph_B">SKELETAL DISTRIBUTION OF CHONDROBLASTOMA.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F270-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[3]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="436" height="700" src="files/445023c7db2b391c7af0478f340c14bb.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="445023c7db2b391c7af0478f340c14bb.gif" MIMETYPE="image/gif" WIDTH="436" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-269 <span class="emph_B">CHONDROBLASTOMA. Greater Tuberosity of the Humerus.</span> Observe the oval, geographic lesion within the greater tuberosity apophysis (<span class="emph_I">arrows</span>). This is a characteristic location for chondroblastoma.</div>
</td></tr>
</table></div>
<div class="P">Sporadic cases have been reported in such unusual locations as the skull, mandibular condyle, mastoid, manubrium, vertebral column, metacarpals, finger, rib, and patella. (<a class="LK" href="sid806035.html#R574-11">13</a>,<a class="LK" href="sid806035.html#R575-11">14</a>,<a class="LK" href="sid806035.html#R576-11">15</a>,<a class="LK" href="sid806035.html#R577-11">16</a>,<a class="LK" href="sid806035.html#R578-11">17</a>) Generally, tumors of the patella are benign (73&#x0025;) and of cartilaginous origin. (<a class="LK" href="sid806035.html#R579-11">18</a>) Giant cell tumor is the most common benign bone tumor of the patella, followed by chondroblastoma. (<a class="LK" href="sid806035.html#R580-11">19</a>,<a class="LK" href="sid806035.html#R579-11">18</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3797" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Microscopic examination of the tissue reveals the lesion to consist of uniform, small polyhedral cells with sharp cytoplasmic margins. The lesion also includes giant cells, and small amounts of chondroid material presenting a <span class="emph_I">chicken wire calcification,</span> which is the hallmark of this lesion. (<a class="LK" href="sid806035.html#R581-11">20</a>) This calcification is associated with matrix secretion that stains positively with Alcian blue, helping differentiate it from the typical giant cell tumor. (<a class="LK" href="sid806035.html#R581-11">20</a>) The multinucleated giant cells seen histologically are secondary to the occurrence of hemorrhage and necrosis and may occasionally cloud the issue, allowing an erroneous diagnosis of giant cell tumor to be made. (<a class="LK" href="sid806035.html#R581-11">20</a>)</div>
<div class="P">Some cases of malignant chondroblastomas have been reported in patients without prior irradiation (<a class="LK" href="sid806035.html#R582-11">21</a>,<a class="LK" href="sid806035.html#R583-11">22</a>) with subsequent metastasis to the lung. (<a class="LK" href="sid806035.html#R562-11">1</a>) Perhaps those cases actually represented low-grade chondrosarcoma rather than benign chondroblastoma of bone. The issue of malignant chondroblastomas has not been resolved within the literature at this time.</div>
<div class="FG" id="F271-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="386" src="files/2228190ff7439bc2b728cdcda383d872.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2228190ff7439bc2b728cdcda383d872.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="386" DISPLAY="INLINE"></div>
<div class="P">Figure 11-270 <span class="emph_B">CHONDROBLASTOMA. Head of Humerus. A. Plain Film.</span> Note the geographic lesion within the epiphysis of this skeletally immature patient (<span class="emph_I">arrows</span>). No matrix calcification is visible. <span class="emph_B">B. Tomogram.</span> Observe the epiphyseal nature of the lesion (<span class="emph_I">arrows</span>). (Courtesy of Michael J. Silverstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, St. Louis, Missouri.)</div>
</td></tr>
</table></div>
<a name="PG1282"> </a><div class="pagenum"><div>P.1282</div></div>
<br clear="all">
<div class="FG" id="F272-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[4]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="482" height="700" src="files/f13c55ac5348fc71095027fc5aa2e7d0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f13c55ac5348fc71095027fc5aa2e7d0.gif" MIMETYPE="image/gif" WIDTH="482" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-271 <span class="emph_B">CHONDROBLASTOMA. Greater Trochanter of the Femur.</span> Note the oval, geographic lesion within the greater trochanter of the proximal femur. This appearance and location are characteristic for chondroblastoma.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3798" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">Radiologically, chondroblastoma characteristically consists of a medullary oval or round lytic lesion involving the epiphysis or neighboring metaphysis in a long bone of an adolescent patient. (<a class="LK" href="sid806035.html#R584-11">23</a>) (<a class="LK" href="sid806035.html#F273-11">Fig. 11-272</a>) Most lesions are eccentric, but a few can be centrally located. (<a class="LK" href="sid806035.html#F274-11">Fig. 11-273</a>) The zone of transition is quite sharp, along with a slight marginal rim of sclerosis, denoting the benign nature of the lesion. Most chondroblastomas are radiolucent lesions that are geographic in appearance and that lack any soap bubble compartmentalization of the interior, whereas up to 17&#x0025; may take a cystic appearance. (<a class="LK" href="sid806035.html#R585-11">24</a>) (<a class="LK" href="sid806035.html#F275-11">Fig. 11-274</a>) Like most cartilaginous tumors, matrix calcification occurs, leaving the lesion with a <span class="emph_I">punctate or stippled interior</span> or an appearance of <span class="emph_I">fluffy cotton wool.</span> (<a class="LK" href="sid806035.html#R586-11">25</a>) Edeiken (<a class="LK" href="sid806035.html#R587-11">26</a>) stated that approximately 50&#x0025; of chondroblastomas demonstrate calcification. MRI correlates these findings with a low signal intensity rim with low signal intensity foci stippled throughout the interior. (<a class="LK" href="sid806035.html#R588-11">27</a>)</div>
<div class="P">Periosteal bone apposition occurs in almost two thirds of patients. (<a class="LK" href="sid806035.html#R589-11">28</a>,<a class="LK" href="sid806035.html#R590-11">29</a>) Most epiphyseal lesions will show solid periosteal new bone formation on the metaphyseal portions of the bone, leaving a characteristic buttress type of response. (<a class="LK" href="sid806035.html#R589-11">28</a>) Pathologic fracture rarely occurs. As the lesions mature with growth, bone expansion and deformity are noted, coupled with peripheral sclerosis and fluffy matrix calcifications. (<a class="LK" href="sid806035.html#T30-11">Table 11-30</a>) Up to 15&#x0025; of cases are associated with an aneurysmal bone cyst. (<a class="LK" href="sid806035.html#R591-11">30</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3799" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]">
<div class="HD">Differential Diagnosis</div>
<div class="P">The key lesions to be differentiated are Brodie&#x2019;s abscess, eosinophilic granuloma, and ischemic necrosis of the epiphysis. In Brodie&#x2019;s abscess, the associated periosteal response is usually adjacent to the lesion, not in the adjacent metaphysis. Eosinophilic granuloma rarely affects the epiphysis; when it does, the lesions are usually more centrally placed. Eosinophilic granuloma and ischemic necrosis may not be radiographically separable, and biopsy may prove to be the definitive means of distinction. The early crescent sign and sharp step-off defects found in the lytic stage of ischemic necrosis provide adequate roentgen signs to allow differentiation because the lesions of chondroblastoma
<a name="PG1283"> </a><div class="pagenum"><div>P.1283</div></div>
<br clear="all">
are quite smooth and well marginated. Giant cell tumor is another epiphyseal lesion that usually presents as a geographic lucency, but it usually develops after closure of the epiphysis, whereas chondroblastoma develops while the growth plate is open.</div>
<div class="FG" id="F273-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="576" src="files/00085771b2d5d52f30891bff3f6b5b86.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="00085771b2d5d52f30891bff3f6b5b86.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="576" DISPLAY="INLINE"></div>
<div class="P">Figure 11-272 <span class="emph_B">CHONDROBLASTOMA: EPIPHYSEAL AND METAPHYSEAL EXTENSION. A. AP Ankle.</span> Note the oval, radiolucent lesion within the central portion of the tibial epiphysis. <span class="emph_B">B. AP Knee.</span> Observe the large chondroblastoma affecting the tibial epiphysis, with extension into the metaphysis. Observe the sharp zone of transition and clearly defined margins of this lesion. <span class="emph_I">COMMENT:</span> Chondroblastoma and giant cell tumor are the two most common neoplasms to affect the epiphysis.</div>
</td></tr>
</table></div>
<div class="FG" id="F274-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="472" height="700" src="files/b06bb3c0def2f7d285807b3e4e4fb9f3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b06bb3c0def2f7d285807b3e4e4fb9f3.gif" MIMETYPE="image/gif" WIDTH="472" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-273 <span class="emph_B">CHONDROBLASTOMA. Knee.</span> Note the multiloculated, geographic lesion within the medial tibial epiphysis. This lesion is somewhat eccentrically located and represents a chondroblastoma.</div>
</td></tr>
</table></div>
<div class="FG" id="F275-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="479" height="700" src="files/86dec7aa73a29592a03ebafdfcb7b47e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="86dec7aa73a29592a03ebafdfcb7b47e.gif" MIMETYPE="image/gif" WIDTH="479" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-274 <span class="emph_B">CHONDROBLASTOMA. Knee.</span> Note the geographic subarticular lesion involving the lateral surface of the medial condyle of the distal femur (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3800" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Chondroblastoma</div>
<div class="TLV2" id="B01382540.0-3801" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Jaffe and Lichtenstein established benign chondroblastoma as a distinct clinicoradiologic entity.</div></li>
<li class="LM"><div class="P">An often used synonym is Codman&#x2019;s tumor.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3802" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">A rare primary benign bone tumor representing &#x003C; 1&#x0025; of all primary bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3803" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">10- to 25-year age range is customary, with a 2:1 male predominance.</div></li>
<li class="LM"><div class="P">Chief complaint is pain referred to the adjacent joint.</div></li>
<li class="LM"><div class="P">Symptoms may be present for months or even years.</div></li>
<li class="LM"><div class="P">The classic location is the epiphysis, with occasional extension into the metaphysis.</div></li>
<li class="LM"><div class="P">Most lesions are 3-6 cm.</div></li>
<li class="LM"><div class="P">90&#x0025; are medullary; 10&#x0025; are cortical.</div></li>
<li class="LM"><div class="P">77&#x0025; of the lesions occur about the knee, hip, and shoulder.</div></li>
<li class="LM"><div class="P">Codman stressed the great anatomic preference for the tuberosities of the humerus rather than for the epiphysis of the humeral head. A similar predilection exists for the trochanters of the proximal femur.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3804" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Microscopically, a chicken wire type of calcification of the chondroid matrix is characteristic of chondroblastoma.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3805" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Oval or round lytic lesion in the epiphysis of a long tubular bone is characteristic.</div></li>
<li class="LM"><div class="P">Most lesions are eccentrically placed.</div></li>
<li class="LM"><div class="P">50&#x0025; of the lesions demonstrate a fluffy cotton wool calcification of the matrix.</div></li>
<li class="LM"><div class="P">Periosteal bone apposition occurs in the adjacent metaphysis in one third of patients.</div></li>
<li class="LM"><div class="P">Mature lesions will show bone expansion and marginal sclerosis.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3806" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Differential Diagnosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Brodie&#x2019;s abscess, eosinophilic granuloma, and ischemic necrosis of the epiphysis are the key lesions in differential diagnosis. Giant cell tumor, while radiologically similar, usually affects an older age group.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3807" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[7]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Curettage, accompanied by packing with cancellous bone chips, is recommended.</div></li>
<li class="LM"><div class="P">Resection is the form of treatment in expendable bones.</div></li>
<li class="LM"><div class="P">Local recurrence rate is 20&#x0025; in a 3-year follow-up period, recurrence being a reflection of inadequate initial treatment.</div></li>
</ul>
</div>
</div>
</div>
<div class="TB" id="T30-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[6]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-30 Radiologic Features of Chondroblastoma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Epiphyseal</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Geographic lesion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Eccentric</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Round, oval</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Sclerotic rim</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Central calcification (50&#x0025;)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Metaphyseal periostitis</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3808" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[13]/TLV3[7]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Surgical treatment of these tumors is effective, showing success in up to 90&#x0025; of cases. (<a class="LK" href="sid806035.html#R592-11">31</a>,<a class="LK" href="sid806035.html#R593-11">32</a>) Thorough curettage is performed, accompanied by packing of the cavity with cancellous bone chips. Resection is the best form of treatment in expendable bones, such as ribs, patella, or a digit. (<a class="LK" href="sid806035.html#R592-11">31</a>) Local recurrence is seen in 20&#x0025; of uncomplicated lesions in 3-year follow-up studies. (<a class="LK" href="sid806035.html#R571-11">10</a>) A higher rate of recurrence exists when lesions are inadequately resected in the area of the hip (femur, greater trochanter, and pelvis) (<a class="LK" href="sid806035.html#R594-11">33</a>) and in lesions complicated by secondary development of an aneurysmal bone cyst. Recently, percutaneous radiofrequency heat ablation techniques have been studied and have shown promising results as an alternative to invasive surgical interventions. (<a class="LK" href="sid806035.html#R595-11">34</a>)</div>
</div>
</div>
<a name="PG1284"> </a><div class="pagenum"><div>P.1284</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3809" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]">
<div class="HD">CHONDROMYXOID FIBROMA</div>
<div class="TLV3" id="B01382540.0-3810" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Chondromyxoid fibroma is a rare, benign primary neoplasm of bone composed of chondroid, fibrous, and myxoid tissues in varying proportions. The tumor was first described by Jaffe and Lichtenstein (<a class="LK" href="sid806035.html#R596-11">1</a>) in 1948; they reported eight cases and distinguished the neoplasm from chondrosarcoma, giving it the name it bears today. Despite its name, the neoplasm is generally classified as a tumor of cartilage origin, and the suggested alternative name of fibromyxoid chondroma is not generally accepted. (<a class="LK" href="sid806035.html#R597-11">2</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3811" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Chondromyxoid fibroma is a rare bone tumor; in total, it accounts for &#x003C; 1&#x0025; of all bone neoplasms, both benign and malignant. (<a class="LK" href="sid806035.html#R598-11">3</a>) The lesion is usually found within two distinct age ranges, with 60&#x0025; of the lesions occurring between the ages of 10 and 30. (<a class="LK" href="sid806035.html#R599-11">4</a>) Another peak in incidence generally occurs between 50 and 70 years of age. (<a class="LK" href="sid806035.html#R600-11">5</a>) No sex predilection exists.</div>
</div>
<div class="TLV3" id="B01382540.0-3812" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="P">The chief complaint is localized pain with occasional swelling. These symptoms are slow in evolving, sometimes taking months or years to become fully established. (<a class="LK" href="sid806035.html#R601-11">6</a>) Rarely, a patient may be totally asymptomatic, the lesion being discovered on routine radiographs taken for other reasons. Pathologic fracture is rare.</div>
<div class="P">The most common location is the tibia, usually the proximal third; Greenfield (<a class="LK" href="sid806035.html#R602-11">7</a>) stated that 50&#x0025; of the tumors occur in the tibia. At least 50&#x0025; of lesions occur at the knee. (<a class="LK" href="sid806035.html#R603-11">8</a>) Other common sites are the femur, humerus, fibula, ribs, innominate, and the small bones of the hands and feet. (<a class="LK" href="sid806035.html#R604-11">9</a>) (<a class="LK" href="sid806035.html#F276-11">Fig. 11-275</a>) Rarely, the vertebrae are affected, with only seven reported cases in the cervical spine. (<a class="LK" href="sid806035.html#R605-11">10</a>) In the tubular bones the origin of the lesion is primarily metaphyseal. (<a class="LK" href="sid806035.html#R606-11">11</a>) Extension into the epiphysis rarely occurs, whereas isolated diaphyseal involvement has been noted. (<a class="LK" href="sid806035.html#R607-11">12</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3813" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Histologically, the lesion consists of a varied mixture of elements, including a fibrous component, chondroid ground substance, and giant cells. The extreme variability of the chondroid, myxoid, and fibrous patterns associated with these lesions is characteristic, and giant cells may abound. The histologic features, although varied, are clearly benign and demonstrate minimal pleomorphism. (<a class="LK" href="sid806035.html#R597-11">2</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3814" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiographic features are that of a lucent lesion from 1 to 10 cm in diameter, with an average of 3 cm. (<a class="LK" href="sid806035.html#R598-11">3</a>) The typical presentation reveals an eccentric oval or round geographic lesion, usually metaphyseal in location. (<a class="LK" href="sid806035.html#R608-11">13</a>) (<a class="LK" href="sid806035.html#F277-11">Fig. 11-276</a>) Most lesions are in the tibia (proximal third). (<a class="LK" href="sid806035.html#F278-11">Fig. 11-277</a>) This ovoid lesion has its long axis parallel to the bone. (<a class="LK" href="sid806035.html#R609-11">14</a>) Many have a scalloped, sclerotic margin, which may be thinner on the cortical side, while remaining well defined and sclerotic on the medullary side. (<a class="LK" href="sid806035.html#R608-11">13</a>,<a class="LK" href="sid806035.html#R609-11">14</a>) Because the lesion grows in a lobular fashion, pressure erosion on the endosteum, creating a scalloped margin, is to be expected. (<a class="LK" href="sid806035.html#R603-11">8</a>,<a class="LK" href="sid806035.html#R610-11">15</a>) (<a class="LK" href="sid806035.html#F278-11">Figs. 11-277</a> and <a class="LK" href="sid806035.html#F279-11">11-278</a>) Tumors of a fibrous or cartilaginous nature have a great predilection for creating endosteal scalloping. (<a class="LK" href="sid806035.html#R609-11">14</a>,<a class="LK" href="sid806035.html#R610-11">15</a>) Often, the lesion will be trabeculated (chambered or soap bubbled) in appearance. These trabeculations do not exemplify the formation of true bony septa because they are incomplete, the result of ridges and grooves with scalloping at the periphery of the lesion. (<a class="LK" href="sid806035.html#R599-11">4</a>,<a class="LK" href="sid806035.html#R603-11">8</a>) They have been referred to as pseudo-trabeculations. (<a class="LK" href="sid806035.html#R598-11">3</a>) Calcification within the lesion that can be demonstrated on radiographs is rare but is seen in 25&#x0025; of cases microscopically. (<a class="LK" href="sid806035.html#R601-11">6</a>,<a class="LK" href="sid806035.html#R609-11">14</a>) (<a class="LK" href="sid806035.html#T31-11">Table 11-31</a>) MRI reveals low signal intensity on T1-weighted images and heterogeneous high signal intensity on T2-weighted images. (<a class="LK" href="sid806035.html#R611-11">16</a>)</div>
<div class="FG" id="F276-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="299" height="700" src="files/7e3aaf909cc7f193911850c5de5c6fff.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7e3aaf909cc7f193911850c5de5c6fff.gif" MIMETYPE="image/gif" WIDTH="299" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-275 <span class="emph_B">SKELETAL DISTRIBUTION OF CHONDROMYXOID FIBROMA.</span>
</div>
</td></tr>
</table></div>
<div class="P">Treatment by curettage or excision is usually successful, but occasionally the tumor recurs (10&#x0025; of cases). (<a class="LK" href="sid806035.html#R599-11">4</a>) Recurrence seems to be more likely in young patients, &#x003C; 15 years of age, and with tumors that contain much myxoid material and large, atypical nuclei. (<a class="LK" href="sid806035.html#R610-11">15</a>) Recurrent tumors are adequately treated by recurettage, coupled with cauterization or cryosurgery. (<a class="LK" href="sid806035.html#R610-11">15</a>)
<a name="PG1285"> </a><div class="pagenum"><div>P.1285</div></div>
<br clear="all">
Radiation therapy has shown to be of benefit when resection is not feasible; however, therapy of this nature increases the risk of future malignancies. (<a class="LK" href="sid806035.html#R600-11">5</a>)</div>
<div class="FG" id="F277-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="440" height="700" src="files/7c05928803956a7bcb0aa8def030e4d7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7c05928803956a7bcb0aa8def030e4d7.gif" MIMETYPE="image/gif" WIDTH="440" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-276 <span class="emph_B">CHONDROMYXOID FIBROMA. Distal Tibia.</span> Observe the large, radiolucent lesion in the distal metaphysis of the tibia. There is minimal cortical expansion, with a sharp zone of transition. <span class="emph_I">COMMENT:</span> One lesion that should be considered in the differential diagnosis of such a radiographic presentation in the tibia is a simple bone cyst.</div>
</td></tr>
</table></div>
<div class="FG" id="F278-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="450" height="700" src="files/2e3260e900dd64b4a7e064021b0936fe.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2e3260e900dd64b4a7e064021b0936fe.gif" MIMETYPE="image/gif" WIDTH="450" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-277 <span class="emph_B">CHONDROMYXOID FIBROMA. Proximal Tibia.</span> Note the eccentric, metaphyseal, geographic lesion in the proximal third of the tibia. Endosteal scalloping (<span class="emph_I">arrows</span>), along with bone expansion, is noted (<span class="emph_I">arrowhead</span>). <span class="emph_I">COMMENT:</span> The most common location for chondromyxoid fibroma is the proximal third of the tibia, as seen in this case. About 50&#x0025; of chondromyxoid fibromas occur in the tibia, with other common sites being the femur, humerus, fibula, ribs, and small bones of the hands and feet.</div>
</td></tr>
</table></div>
<div class="FG" id="F279-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="715" src="files/b8af96301b3c4e906f1e576b82b0474e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b8af96301b3c4e906f1e576b82b0474e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="715" DISPLAY="INLINE"></div>
<div class="P">Figure 11-278 <span class="emph_B">CHONDROMYXOID FIBROMA: DISTAL TIBIA. A. Medial Oblique Ankle.</span> Note the large, oval, radiolucent lesion filling the entire medullary surface of the distal tibia. There is minimal expansion of bone on its lateral surface. Endosteal scalloping is present throughout, denoting a cartilage or fibrous lesion (<span class="emph_I">arrows</span>). <span class="emph_B">B. Lateral Ankle.</span> Observe the sharp zone of transition around the large chondromyxoid fibroma of the distal tibia (<span class="emph_I">arrows</span>). The sharp zone of transition and sclerotic border denote a benign lesion.</div>
</td></tr>
</table></div>
<div class="TB" id="T31-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[14]/TLV3[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-31 Radiologic Features of Chondromyxoid Fibroma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Tibia (50&#x0025; occur here)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Metaphyseal</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Geographic lesion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Eccentric</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Oval, round</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Endosteal scalloping</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Soap bubble appearance</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Rarely, calcification in matrix</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3815" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]">
<div class="HD">FIBROUS XANTHOMA OF BONE: NON-OSSIFYING FIBROMA</div>
<div class="TLV3" id="B01382540.0-3816" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Fibrous xanthoma of bone is a term that encompasses several lesions known under two major names: non-ossifying fibroma (NOF) and fibrous cortical defect (FCD). Most researchers
<a name="PG1286"> </a><div class="pagenum"><div>P.1286</div></div>
<br clear="all">
believe that these two entities are the identical lesion seen in different age ranges and stages of growth. Indeed, the only differentiating factor is the patient&#x2019;s age, with fibrous cortical defect appearing in 4- to 8-year-olds and non-ossifying fibroma being seen in 8- to 20-year-olds. NOF has a number of synonyms: nonosteogenic fibroma, metaphyseal fibrous defect, solitary xanthoma, xanthogranuloma of bone, and fibrous medullary defect. (<a class="LK" href="sid806035.html#R612-11">1</a>,<a class="LK" href="sid806035.html#R613-11">2</a>) Jaffe (<a class="LK" href="sid806035.html#R614-11">3</a>) was the first to use the term non-ossifying fibroma, distinctly separating this lesion from the giant cell tumor variants. Dahlin (<a class="LK" href="sid806035.html#R615-11">4</a>), Aegerter and Kirkpatrick (<a class="LK" href="sid806035.html#R616-11">5</a>), and others noted that this lesion is entirely non-neoplastic and emphasized that the spontaneous resolution, which so often occurs, is supportive evidence that this lesion represents faulty ossification, rather than a true neoplasm.</div>
</div>
<div class="TLV3" id="B01382540.0-3817" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">The true incidence is difficult to determine because the majority of the lesions are asymptomatic and never discovered. (<a class="LK" href="sid806035.html#R617-11">6</a>) Between 30&#x0025; and 40&#x0025; of normal children have FCD, with NOF being somewhat less common. (<a class="LK" href="sid806035.html#R618-11">7</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3818" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3819" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">The usual age range is 8-20 years, with the average age being 14. (<a class="LK" href="sid806035.html#R619-11">8</a>) Males predominate in a 2:1 ratio.</div>
</div>
<div class="TLV4" id="B01382540.0-3820" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Most lesions are asymptomatic and found by coincidence when the patient is being radiographed for some other reason, usually following trauma. Large lesions, &#x003E; 8 cm, often cause persistent pain and may significantly weaken the bone, allowing pathologic fracture to occur, especially in active adolescents. (<a class="LK" href="sid806035.html#R620-11">9</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3821" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">This lesion commonly affects the bones of the lower extremity, with the distal tibia being the most frequent site. (<a class="LK" href="sid806035.html#R621-11">10</a>) Other sites include the proximal tibia, distal femur, fibula, and proximal humerus. (<a class="LK" href="sid806035.html#F280-11">Fig. 11-279</a>) Isolated cases are seen in the ribs and ilium. Most lesions are diametaphyseal and eccentric in position. The eccentric location on one side of the bone is characteristic but is not always identifiable in some of the thinner bones, particularly the fibula or ribs.</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3822" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">The histologic picture of an NOF and that of a FCD are identical. This consists of a whorled bundle of spindle-shaped, stromal connective tissue cells with varying amounts of intercellular, collagenous material interspersed. Foam cells containing lipid and giant cells are frequently present.</div>
<div class="FG" id="F280-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="302" height="700" src="files/b4440e56c5e730868fe22567468bc90a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b4440e56c5e730868fe22567468bc90a.gif" MIMETYPE="image/gif" WIDTH="302" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-279 <span class="emph_B">SKELETAL DISTRIBUTION OF NON-OSSIFYING FIBROMA.</span>
</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3823" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiographic appearance of NOF is so characteristic that biopsy is seldom necessary. The typical lesion is solitary, radiolucent, eccentric, and generally ovoid; it often thins and may expand the cortex. (<a class="LK" href="sid806035.html#F281-11">Fig. 11-280</a>) The margins are scalloped, and there is often a multilocular, bubbly appearance. (<a class="LK" href="sid806035.html#F282-11">Fig. 11-281</a>) The osteolytic area may vary from 2 to 7 cm in diameter and has a narrow zone of transition. The medullary portion of the lesion has a dense sclerotic border, leaving the cortical margin thin (<a class="LK" href="sid806035.html#F283-11">Fig. 11-282</a>). Larger lesions may actually involve the entire width of a long bone (e.g., the fibula). Periosteal response occurs only with pathologic fracture. (<a class="LK" href="sid806035.html#F284-11">Fig. 11-283</a>) Epiphyseal lesions are rare, and on occasion the metaphyseal lesion is carried by growth into the diaphysis of the long bone. Malignant transformation does not occur.</div>
<div class="P">Multiple NOFs do occur in association with neurofibromatosis. (<a class="LK" href="sid806035.html#R622-11">11</a>) Their appearance is that of rather large lesions that are somewhat bilateral and symmetrically involve the metaphyses of the lower extremity. (<a class="LK" href="sid806035.html#T32-11">Table 11-32</a>) In the absence of neurofibromatosis, NOFs may be multiple in 10&#x0025; of cases. (<a class="LK" href="sid806035.html#R623-11">12</a>) Healing of the lesion does occur and is characterized by sclerotic filling in of the matrix. (<a class="LK" href="sid806035.html#F285-11">Fig. 11-284</a>)</div>
<div class="P">NOF and FCD show minimal to mild uptake on bone scan examination. (<a class="LK" href="sid806035.html#R624-11">13</a>) The uptake is low compared with malignant
<a name="PG1287"> </a><div class="pagenum"><div>P.1287</div></div>
<br clear="all">
lesions and other benign tumors, such as osteoblastoma, osteoid osteoma, and aneurysmal bone cyst. The only distinguishing finding on MRI is a hypointense signal and septation on T2-weighted images. (<a class="LK" href="sid806035.html#R625-11">14</a>) Generally, the intensity of the signals found on MRI depend on the amount of fibrous tissue, hemosiderin, hemorrhage, collagen, histiocytes and bone trabeculae found within the lesion. (<a class="LK" href="sid806035.html#R625-11">14</a>)</div>
<div class="FG" id="F281-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="481" height="700" src="files/4e0e4bcd4618edd7c840cc52c91736ba.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4e0e4bcd4618edd7c840cc52c91736ba.gif" MIMETYPE="image/gif" WIDTH="481" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-280 <span class="emph_B">NON-OSSIFYING FIBROMA. Distal Tibia.</span> Note the eccentric, solitary, radiolucent lesion on the posterior surface of the distal tibia. This lesion demonstrates a bubbly appearance and an encapsulated sclerotic margin.</div>
</td></tr>
</table></div>
<div class="FG" id="F282-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="447" height="700" src="files/135f64666193bea9606e74d4fbfb1df1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="135f64666193bea9606e74d4fbfb1df1.gif" MIMETYPE="image/gif" WIDTH="447" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-281 <span class="emph_B">NON-OSSIFYING FIBROMA. Distal Tibia.</span> Note the eccentric, geographic radiolucency in the distal metaphysis of the tibia. Observe the well-delineated sclerotic margin, the endosteal scalloping, and the bubbly appearance in the matrix of the lesion. This location and radiographic presentation are typical for non-ossifying fibroma. <span class="emph_I">COMMENT:</span> These lesions are usually asymptomatic and found when patients are radiographed after trauma to rule out fracture. Most lesions spontaneously regress, filling in with new bone in a period of 4-5 years.</div>
</td></tr>
</table></div>
<div class="FG" id="F283-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="467" height="700" src="files/bfd8916b43fca2365f0f979b2003bbc6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="bfd8916b43fca2365f0f979b2003bbc6.gif" MIMETYPE="image/gif" WIDTH="467" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-282 <span class="emph_B">NON-OSSIFYING FIBROMA. Proximal Tibia.</span> Note the eccentric, geographic lesion in the medial metaphysis of the proximal tibia. Observe the sclerotic margin and endosteal scalloping, creating a bubbly matrix.</div>
</td></tr>
</table></div>
<div class="FG" id="F284-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="343" height="700" src="files/58e4d870ee3a32fbd2a993652b76b11d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="58e4d870ee3a32fbd2a993652b76b11d.gif" MIMETYPE="image/gif" WIDTH="343" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-283 <span class="emph_B">NON-OSSIFYING FIBROMA: PATHOLOGIC FRACTURE. Ankle.</span> Observe the eccentric non-ossifying fibroma in the distal metaphysis of the tibia. This patient experienced an inversion injury to the ankle and developed a pathologic fracture through a pre-existing, asymptomatic nonossifying fibroma (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<a name="PG1288"> </a><div class="pagenum"><div>P.1288</div></div>
<br clear="all">
<div class="TB" id="T32-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-32 Radiologic Features of Nonossifying Fibroma</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Lower extremity; distal femur, proximal and distal tibia</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Metaphyseal</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Geographic lesion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Eccentric</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Tapered distally and elongated (flame-shaped)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Oval</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thinned cortex</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Scalloped, sclerotic margin</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pathologic fracture</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Multiple in neurofibromatosis</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F285-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[5]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="494" height="700" src="files/2bdd2ab456385b7f5a8f9a23365d2835.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2bdd2ab456385b7f5a8f9a23365d2835.gif" MIMETYPE="image/gif" WIDTH="494" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-284 <span class="emph_B">NON-OSSIFYING FIBROMA: HEALED FORM. AP Ankle.</span> Note the characteristic eccentric, elongated nature of the lesion well demarcated with a sclerotic border (<span class="emph_I">arrow</span>). Evidence of healing is inferred from the overall increase in density of the lesion matrix.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3824" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Because most lesions are asymptomatic, no treatment or surgery is indicated. Spontaneous regression is the usual clinical outcome, taking from 2 to 5 years. NOFs, along with FCDs, are the only benign bone tumors known to consistently regress without treatment. As regression occurs, initially the lytic defect fills in with solid bone, leaving a dense sclerotic focus. Over a period of 4-5 years, this radiopaque area loses its density until it eventually blends in with the surrounding cortex.</div>
<div class="FG" id="F286-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[15]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="412" height="700" src="files/c1d45e8ac58a21cb7e2fdd76f319e7c1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c1d45e8ac58a21cb7e2fdd76f319e7c1.gif" MIMETYPE="image/gif" WIDTH="412" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-285 <span class="emph_B">NON-OSSIFYING FIBROMA: BONE CHIP THERAPY. AP Knee.</span> Observe the areas of increased bone density surrounding the previous non-ossifying fibroma. This patient&#x2019;s non-ossifying fibroma was surgically curetted, and bone chips were placed within the lesion. <span class="emph_I">COMMENT:</span> It is somewhat unusual for a non-ossifying fibroma to require surgery and bone chip therapy; however, if the lesion is persistently symptomatic or causes a great deal of bone expansion, this treatment is often used.</div>
</td></tr>
</table></div>
<div class="P">Large, symptomatic lesions are usually treated by curettage or block excision. (<a class="LK" href="sid806035.html#R620-11">9</a>) (<a class="LK" href="sid806035.html#F286-11">Fig. 11-285</a>) Those lesions with superimposed pathologic fracture may be treated conservatively by means of casting immobilization; most fractures will heal, leaving the lesion still present. (<a class="LK" href="sid806035.html#R626-11">15</a>) Occasionally, the lesion may get larger after trauma, and surgical intervention is then the treatment of choice. (<a class="LK" href="sid806035.html#R626-11">15</a>)</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3825" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]">
<div class="HD">FIBROUS XANTHOMA OF BONE: FIBROUS CORTICAL DEFECTS</div>
<div class="TLV3" id="B01382540.0-3826" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">FCD is sometimes referred to as subperiosteal cortical defect or Caffey&#x2019;s defect. (<a class="LK" href="sid806035.html#R627-11">1</a>) This lesion was originally described by Sontag and Pyle (<a class="LK" href="sid806035.html#R628-11">2</a>) when they evaluated 200 children by serial radiographs, finding a high incidence of metaphyseal lytic lesions in the lower extremities. Caffey (<a class="LK" href="sid806035.html#R627-11">1</a>) performed a more extensive clinical and radiologic study of 1000 healthy children and found 41.8&#x0025; of the boys and 31&#x0025; of the girls to have FCD.</div>
</div>
<a name="PG1289"> </a><div class="pagenum"><div>P.1289</div></div>
<br clear="all">
<div class="TLV3" id="B01382540.0-3827" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">Between 30&#x0025; and 40&#x0025; of children in the 4- to 8-year range have one or more FCDs.</div>
</div>
<div class="TLV3" id="B01382540.0-3828" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3829" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">The most common age range is 4-8 years, and the lesions are rarely found in children &#x003C; 2 years of age. (<a class="LK" href="sid806035.html#R629-11">3</a>) The duration of the lesions is longer in males (4 years) than in females (2 years). The lesion is seen more frequently in males in the ratio of 2:1.</div>
</div>
<div class="TLV4" id="B01382540.0-3830" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">These lesions are invariably asymptomatic and are usually discovered as an accidental finding because of a roentgen survey done for unrelated reasons.</div>
</div>
<div class="TLV4" id="B01382540.0-3831" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">The bones of the lower extremity are most commonly affected. (<a class="LK" href="sid806035.html#F287-11">Fig. 11-286</a>) The most common site is the posterior-medial surface of the distal femur. (<a class="LK" href="sid806035.html#F288-11">Fig. 11-287</a>) Other common sites include the tibia, fibula, proximal femur, proximal humerus, ribs, and ilium.</div>
<div class="FG" id="F287-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="299" height="700" src="files/ce59ccad310b42c9236d097b19e709e0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ce59ccad310b42c9236d097b19e709e0.gif" MIMETYPE="image/gif" WIDTH="299" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-286 <span class="emph_B">SKELETAL DISTRIBUTION OF FIBROUS CORTICAL DEFECT.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F288-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[3]/TLV4[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="511" src="files/f097a6e3f5a7426084e4c99a713beedb.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f097a6e3f5a7426084e4c99a713beedb.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="511" DISPLAY="INLINE"></div>
<div class="P">Figure 11-287 <span class="emph_B">FIBROUS CORTICAL DEFECT: DISTAL FEMUR. A. AP Knee. B. Lateral Knee.</span> Note the eccentric, radiolucent lesion within the distal medial metaphysis of the femur. Observe the sclerotic margin and sharp zone of transition around this lesion, suggesting a benign response. This fibrous cortical defect was asymptomatic and found coincidentally on radiographic examination to rule out a fracture.</div>
</td></tr>
</table></div>
</div>
</div>
<a name="PG1290"> </a><div class="pagenum"><div>P.1290</div></div>
<br clear="all">
<div class="TLV3" id="B01382540.0-3832" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">The cortical defects represent fibrous cell rests or originate from the underlying periosteum. More recently it has been proposed that the lesion is precipitated by avulsion fracture at a muscle attachment. (<a class="LK" href="sid806035.html#R630-11">4</a>) FCD and NOF are histologically identical.</div>
</div>
<div class="TLV3" id="B01382540.0-3833" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">FCDs are eccentric, lytic, geographic lesions that are located within the metaphysis of long tubular bones. Most lesions appear round and extend parallel to the long axis of the bone. Smaller lesions are purely lytic, whereas larger lesions may present with a bubbly appearance. (<a class="LK" href="sid806035.html#F289-11">Fig. 11-288</a>) The peripheral rim of the lesion usually is sclerotic, providing a sharp zone of transition, confirming its benign nature. The FCDs are often multiple in presentation, which is somewhat rare for NOFs, except when found in association with neurofibromatosis. (<a class="LK" href="sid806035.html#R631-11">5</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3834" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Because most lesions regress totally within 2 years, no treatment is necessary. (<a class="LK" href="sid806035.html#R632-11">6</a>) These lesions are rarely symptomatic and seldom require any medical care. FCDs and NOFs are the only benign bone tumors that heal spontaneously within 2-5 years. (<a class="LK" href="sid806035.html#R629-11">3</a>,<a class="LK" href="sid806035.html#R630-11">4</a>)</div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3835" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Non-ossifying Fibroma and Fibrous Cortical Defect (Fibrous Xanthomas)</div>
<div class="TLV2" id="B01382540.0-3836" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Thought to be faulty ossification and do not represent true neoplasms.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3837" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">30-40&#x0025; of normal children have FCD; NOF is slightly less common.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3838" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">8-20 years is the age range for NOF, 4-8 years is the range for FCD.</div></li>
<li class="LM"><div class="P">There is a 2:1 male predominance.</div></li>
<li class="LM"><div class="P">Most lesions are asymptomatic and found by coincidence when a patient is radiographed.</div></li>
<li class="LM"><div class="P">Large lesions, &#x003E; 8 cm, may be symptomatic and often lead to pathologic fracture, especially in active adolescents.</div></li>
<li class="LM"><div class="P">Distal tibia is the most common site for NOF, with distal femur, proximal tibia, humerus, and fibula also being affected.</div></li>
<li class="LM"><div class="P">Posterior medial surface of the distal femur is the most common site for FCD.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3839" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The histologic findings of NOF and FCD are identical, consisting of whorled bundles of spindle-shaped stromal connective tissue cells with intercellular collagenous material.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3840" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The radiographic appearance is such that biopsy is seldom necessary.</div></li>
<li class="LM"><div class="P">The lesion is solitary, eccentric, radiolucent ovoid, bubbly, usually located in the metaphysis.</div></li>
<li class="LM"><div class="P">Cortical expansion and thinning occurs.</div></li>
<li class="LM"><div class="P">Most lesions are 2-7 cm in diameter.</div></li>
<li class="LM"><div class="P">Periosteal response occurs only secondary to pathologic fracture.</div></li>
<li class="LM"><div class="P">Malignant transformation does not occur.</div></li>
<li class="LM"><div class="P">The presence of bilateral symmetric NOF may occur in association with neurofibromatosis.</div></li>
<li class="LM"><div class="P">It shows mild uptake on bone scan.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3841" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Most lesions are asymptomatic and never require any form of treatment.</div></li>
<li class="LM"><div class="P">The only benign bone tumors that consistently regress without treatment (2-5 years).</div></li>
</ul>
</div>
</div>
</div>
<div class="FG" id="F289-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[16]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="431" height="700" src="files/dd2d7cfae53ef5b4c12a5dd254e3d765.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="dd2d7cfae53ef5b4c12a5dd254e3d765.gif" MIMETYPE="image/gif" WIDTH="431" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-288 <span class="emph_B">FIBROUS CORTICAL DEFECT. Distal Tibia.</span> Observe the small, eccentric, geographic lesion surrounded by a heavy halo of sclerosis in the distal metaphysis of the tibia (<span class="emph_I">arrow</span>). This lesion is typical of fibrous cortical defect.</div>
</td></tr>
</table></div>
</div>
</div>
<a name="PG1291"> </a><div class="pagenum"><div>P.1291</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3842" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]">
<div class="HD">SIMPLE BONE CYST</div>
<div class="TLV3" id="B01382540.0-3843" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Simple bone cyst (SBC), sometimes referred to as a unicameral bone cyst (UBC), solitary bone cyst, or juvenile bone cyst, is not a true neoplasm of bone but rather a fluid-filled cyst that is lined with a thin layer of fibrous tissue. Nonetheless, it is frequently classified under the heading of primary bone tumors. Jaffe and Lichtenstein (<a class="LK" href="sid806035.html#R633-11">1</a>), who described the first cases in 1942, clearly delineated this cyst as a distinct disease entity, naming it unicameral bone cyst. The term <span class="emph_I">unicameral,</span> meaning &#x201C;one house,&#x201D; has actually created some confusion because many lesions present with a bubbly or chambered appearance; it is not single chambered at all. All of the cases that Jaffe and Lichtenstein originally reported were of the single-chamber cystic variety, which led them to use the term unicameral initially. However, many multichambered lesions have been reported since, which are better termed simple bone cysts rather than unicameral. In fact, histologically they are the same lesion.</div>
</div>
<div class="TLV3" id="B01382540.0-3844" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">SBCs represent slightly more than 3&#x0025; of biopsied primary bone tumors. (<a class="LK" href="sid806035.html#R634-11">2</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3845" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3846" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">An SBC most commonly occurs between the ages of 3 and 14 years (80&#x0025; of cases). (<a class="LK" href="sid806035.html#R635-11">3</a>) They have been reported in a 2-month-old infant (<a class="LK" href="sid806035.html#R636-11">4</a>) and in patients &#x003E; 50 years. (<a class="LK" href="sid806035.html#R636-11">4</a>) Males predominate 2:1.</div>
</div>
<div class="TLV4" id="B01382540.0-3847" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">Most lesions are totally asymptomatic until a pathologic fracture occurs, not uncommonly in athletic activities. (<a class="LK" href="sid806035.html#R637-11">5</a>,<a class="LK" href="sid806035.html#R638-11">6</a>) Approximately two thirds of the SBCs eventually undergo pathologic fracture. (<a class="LK" href="sid806035.html#R639-11">7</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3848" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">Most lesions occur in the proximal humerus and proximal femur (75&#x0025; of cases). (<a class="LK" href="sid806035.html#R640-11">8</a>) (<a class="LK" href="sid806035.html#F290-11">Fig. 11-289</a>) Humeral lesions are twice as common as those found in the femur. Of the patients who are &#x003C; 17 years of age, with open growth plates and who have SBCs, 81&#x0025; of the lesions occur in the humerus or femur; after 17 years of age with closure of the growth plate, 52&#x0025; occur in the pelvis and calcaneus. Sporadic cases are noted in the ribs (<a class="LK" href="sid806035.html#R641-11">9</a>), fibula, tibia, sacrum, clavicle, and the small bones of the hand. There is a predilection for involvement of the anterior portion of the calcaneus. (<a class="LK" href="sid806035.html#R642-11">10</a>)</div>
<div class="FG" id="F290-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="298" height="700" src="files/2559d688377103f67c9c4c7ea0075969.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2559d688377103f67c9c4c7ea0075969.gif" MIMETYPE="image/gif" WIDTH="298" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-289 <span class="emph_B">SKELETAL DISTRIBUTION OF SIMPLE BONE CYST.</span>
</div>
</td></tr>
</table></div>
<div class="P">The origin of the lesion is in the metaphysis, immediately adjacent to the epiphyseal cartilage plate. Most lesions are central, with the long axis parallel to the long axis of the host bone. SBCs in this location were called <span class="emph_I">active</span> by Jaffe and Lichtenstein (<a class="LK" href="sid806035.html#R633-11">1</a>), and they maintain their growth potential. Those cysts that are displaced from the growth plate by the normal process of enchondral bone growth are termed <span class="emph_I">latent</span> cysts. (<a class="LK" href="sid806035.html#R633-11">1</a>) The latent cysts are more mature and may occasionally reach the mid-diaphysis of the humerus or femur. (<a class="LK" href="sid806035.html#F291-11">Fig. 11-290</a>) It has been stated that the latent cysts carry no significant growth potential, compared with the active cysts within the metaphysis. (<a class="LK" href="sid806035.html#R633-11">1</a>,<a class="LK" href="sid806035.html#R641-11">9</a>) However, many latent cysts do retain their growth activity, even if they are a good distance from the growth plate, leaving a significant degree of normal bone interspersed. Perhaps the term latent cyst is inappropriate at this time.</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3849" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">SBC is a fluid-filled cavity located in the metaphyseal portion of the growing long bone. The lining of the cyst consists of fibrous connective tissue with a mesothelial surface and a layer of reactive
<a name="PG1292"> </a><div class="pagenum"><div>P.1292</div></div>
<br clear="all">
bone reinforcing the cavity margin. Multiple smaller spaces are often noted at the periphery of the larger central cyst. These are embedded in the adjacent connective tissue; are similarly lined by single-layered, flattened mesothelium; and are the source of the recurrent cysts if not removed at time of excision. The fibrous lining of the cyst is capable of metaplasia into osseous structures (<span class="emph_I">cementum-like product</span>), a change that suggests fibrous dysplasia. Myxoid tissue, giant cells, and cholesterol clefts may be present, and tissue from the cyst lining may occasionally become malignant. (<a class="LK" href="sid806035.html#R643-11">11</a>) The fluid within the cyst may be clear, straw yellow, or sanguinous, and there may be clots within the cavity.</div>
<div class="FG" id="F291-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="395" height="700" src="files/2fd4b310be06da474cef33591176d06e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2fd4b310be06da474cef33591176d06e.gif" MIMETYPE="image/gif" WIDTH="395" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-290 <span class="emph_B">SIMPLE BONE CYST: LATENT CYST. Humerus.</span> Note the large, expansile, geographic lesion within the diaphysis of the humerus. A multiloculated appearance is present throughout the matrix of the lesion. <span class="emph_I">COMMENT:</span> This represents a latent cyst because it has been displaced from the growth plate by the normal process of enchondral bone growth. Latent cysts are more mature and may occasionally reach into the mid-diaphysis of the humerus or femur.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3850" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The classic appearance is that of a geographic or cystic radiolucency that is broad at the metaphyseal end and narrower at the diaphyseal end. (<a class="LK" href="sid806035.html#F292-11">Fig. 11-291</a>) The long axis is greater than the diameter, leaving the formation of a truncated cone appearance. The lesion is radiolucent, except for the thin septa, which creates a bubbly or loculated appearance. The loculation is incomplete or pseudo because no complete septation occurs. Endosteal scalloping occurs, rather than true bony bridging, which aids in the production of the pseudo-loculation.</div>
<div class="P">Bone expansion frequently occurs but seldom extends beyond the diametric confines of the epiphyseal plate. (<a class="LK" href="sid806035.html#F293-11">Fig. 11-292</a>) Cortical disruption and soft tissue mass formation does not occur. No periosteal changes occur, except after a fracture. (<a class="LK" href="sid806035.html#F294-11">Fig. 11-293</a>) Matrix calcification is rare.</div>
<div class="FG" id="F292-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="385" src="files/26352209101588d70faf1c991dd00296.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="26352209101588d70faf1c991dd00296.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="385" DISPLAY="INLINE"></div>
<div class="P">Figure 11-291 <span class="emph_B">SIMPLE BONE CYST. Proximal Humerus.</span> Note the large, geographic, expansile lesion affecting the metaphysis and proximal diaphysis of the humerus. This cystic radiolucency deforms the medial metaphysis of the humerus and has weakened the bone to the extent that a pathologic fracture has occurred along with a <span class="emph_I">hinged fragment sign</span> (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<div class="P">A characteristic radiologic sign may be seen when a pathologic fracture complicates this lesion. This is the <span class="emph_I">fallen fragment sign</span> (<a class="LK" href="sid806035.html#R644-11">12</a>,<a class="LK" href="sid806035.html#R645-11">13</a>) and represents a small, detached, floating bone fragment, which will change position within the lytic defect from the recumbent to the upright position. This sign is seen in 10&#x0025; of the SBCs that fracture. (<a class="LK" href="sid806035.html#R646-11">14</a>) (<a class="LK" href="sid806035.html#F295-11">Fig. 11-294</a>) If the fragment remains attached, it may swing into the cavity and may even move (<span class="emph_I">hinged fragment sign</span>). (<a class="LK" href="sid806035.html#R638-11">6</a>) (<a class="LK" href="sid806035.html#F296-11">Fig. 11-295</a>)</div>
<div class="P">It is interesting to note that SBC of the calcaneus has a characteristic radiographic appearance and location: a geographic
<a name="PG1293"> </a><div class="pagenum"><div>P.1293</div></div>
<br clear="all">
lesion placed at the base of the calcaneal neck just inferior to the anterior portion of the posterior facet. (<a class="LK" href="sid806035.html#R634-11">2</a>) (<a class="LK" href="sid806035.html#F297-11">Fig. 11-296</a>) The anterior margin of the cyst is usually straight and vertical, whereas the posterior border is typically curvilinear. The cyst is purely lytic, being completely void of bone structure. Most of these lesions are asymptomatic and seldom fracture or need treatment. On the axial projection, the cysts are noted to be consistently lateral to the midline and only rarely are medial or central. (<a class="LK" href="sid806035.html#R634-11">2</a>) This location may be helpful in the differential diagnosis of other lytic lesions in this region, such as chondroblastoma and giant cell tumor, which tend to be central lesions, as seen on the axial projection. (<a class="LK" href="sid806035.html#R634-11">2</a>) (<a class="LK" href="sid806035.html#T33-11">Table 11-33</a>) A common variant in the calcaneus is a triangular lucency with the apex directed superiorly, which often is a demonstration of a central vascular nutrient foramen. (<a class="LK" href="sid806035.html#R647-11">15</a>)</div>
<div class="FG" id="F293-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="498" height="700" src="files/e66bea45672b8ca9db0874125d881f76.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e66bea45672b8ca9db0874125d881f76.gif" MIMETYPE="image/gif" WIDTH="498" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-292 <span class="emph_B">SIMPLE BONE CYST. Proximal Femur.</span> Note the large, oval, geographic lesion expanding the femoral neck and metaphysis of the proximal femur. The zone of transition is clear and distinct, and there is no evidence of pathologic fracture.</div>
</td></tr>
</table></div>
<div class="FG" id="F294-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="392" height="700" src="files/d4c1e1406fe723d0175062bd4f5c5c97.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d4c1e1406fe723d0175062bd4f5c5c97.gif" MIMETYPE="image/gif" WIDTH="392" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-293 <span class="emph_B">SIMPLE BONE CYST. Distal Radius.</span> Note the radiolucent defect filling the entire medullary portion of the distal diaphysis of the radius. The central matrix of this lesion is somewhat bubbly, and the peripheral cortical margins demonstrate a pathologic fracture.</div>
</td></tr>
</table></div>
<div class="FG" id="F295-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="502" src="files/72160f10b10bbf4fad1a7e7bc7614204.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="72160f10b10bbf4fad1a7e7bc7614204.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="502" DISPLAY="INLINE"></div>
<div class="P">Figure 11-294 <span class="emph_B">SIMPLE BONE CYST (SBC): FALLEN FRAGMENT SIGN. A. AP Humerus.</span> Observe the large metaphyseal SBC with a cortical fracture (<span class="emph_I">arrow</span>). The fractured fragment is demonstrated in the most caudal portion of the radiolucent defect, representing a fallen fragment sign (<span class="emph_I">arrowhead</span>). <span class="emph_B">B. AP Humerus.</span> Observe the radiolucent SBC with soap-bubbled matrix located centrally within the proximal metaphysis of the humerus. There is a small cortical fracture (<span class="emph_I">arrow</span>) with a fallen fragment sign within the cystic radiolucencies (<span class="emph_I">arrowhead</span>). <span class="emph_I">COMMENT:</span> About 10&#x0025; of patients with SBC present with a fallen fragment sign.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3851" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">The traditional treatment of choice has been surgical curettage with cauterization of the cyst. Newer techniques allow curettage to be performed by endoscopic procedures reducing the incisional area and invasion of the skin. (<a class="LK" href="sid806035.html#R648-11">16</a>) Packing of the hollow cavity with bone chips following surgery is necessary. (<a class="LK" href="sid806035.html#F298-11">Fig. 11-297</a>) As with the curettage techniques, percutaneous injection of demineralized bone matrix can be accomplished to reduce invasiveness. (<a class="LK" href="sid806035.html#R649-11">17</a>,<a class="LK" href="sid806035.html#R650-11">18</a>) However, recurrence rates with this technique have been high, 30-40&#x0025;. (<a class="LK" href="sid806035.html#R651-11">19</a>) More recently, the injection of steroids has significantly reduced the recurrence rates, thus providing effective treatment for the cyst. (<a class="LK" href="sid806035.html#R638-11">6</a>,<a class="LK" href="sid806035.html#R652-11">20</a>,<a class="LK" href="sid806035.html#R653-11">21</a>,<a class="LK" href="sid806035.html#R654-11">22</a>)</div>
<a name="PG1294"> </a><div class="pagenum"><div>P.1294</div></div>
<br clear="all">
<div class="FG" id="F296-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="529" height="700" src="files/94d6ee63aee69fae4ad52ecb4dbc1eb8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="94d6ee63aee69fae4ad52ecb4dbc1eb8.gif" MIMETYPE="image/gif" WIDTH="529" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-295 <span class="emph_B">SIMPLE BONE CYST: HINGED FRAGMENT SIGN. Humerus.</span> Note the characteristic lesion within the proximal metaphysis. Observe the pathologic fracture extending through the lesion and the displaced cortical bone flake remaining attached to the adjacent cortex, referred to as the <span class="emph_I">hinged fragment sign</span> (<span class="emph_I">arrow</span>). (Courtesy of Lawrence A. Cooperstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Pittsburgh, Pennsylvania.)</div>
</td></tr>
</table></div>
<div class="FG" id="F297-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="492" src="files/c99c551f491bd2bb61226d23f670bdf3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c99c551f491bd2bb61226d23f670bdf3.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="492" DISPLAY="INLINE"></div>
<div class="P">Figure 11-296 <span class="emph_B">SIMPLE BONE CYST. Lateral Calcaneus.</span> Note the oval, geographic radiolucency in the subtalar region of the anterior calcaneus. This radiographic appearance, along with its location, is characteristic of simple bone cyst.</div>
</td></tr>
</table></div>
<div class="TB" id="T33-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-33 Radiologic Features of Simple Bone Cyst</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Proximal humerus, proximal femur, calcaneus</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Metaphyseal, diaphyseal (latent)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Geographic lesion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Central</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Elongated lesion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion (truncated)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Endosteal scalloping</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>No periosteal reaction</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pathologic fracture</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Fallen fragment sign (10&#x0025; of cases)</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F298-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="471" height="700" src="files/b65753c6fa4a7445e26799d13bf62cb3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b65753c6fa4a7445e26799d13bf62cb3.gif" MIMETYPE="image/gif" WIDTH="471" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-297 <span class="emph_B">SIMPLE BONE CYST: BONE CHIP THERAPY. AP Femur.</span> Note that a previously recognized cyst of the proximal third of the femur was present. The lesion was drained of its serous fluid, and struts of bone were placed within the hollow cavity.</div>
</td></tr>
</table></div>
<a name="PG1295"> </a><div class="pagenum"><div>P.1295</div></div>
<br clear="all">
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3852" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Simple Bone Cyst</div>
<div class="TLV2" id="B01382540.0-3853" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Synonyms are unicameral bone cyst, solitary bone cyst, and juvenile bone cyst.</div></li>
<li class="LM"><div class="P">Not a true neoplasm.</div></li>
<li class="LM"><div class="P">Jaffe and Lichtenstein in 1942 described and named this lesion unicameral bone cyst.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3854" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents slightly &#x003E; 3&#x0025; of primary bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3855" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">80&#x0025; occur in the 3- to 14-year age range, with a 2:1 male predominance.</div></li>
<li class="LM"><div class="P">Most lesions are clinically silent until pathologic fracture occurs, which occurs in two thirds of cases.</div></li>
<li class="LM"><div class="P">75&#x0025; of lesions occur in the humerus and proximal femur, humeral lesions being twice as common as those found in the femur.</div></li>
<li class="LM"><div class="P">Active cysts are metaphyseal in origin and are centrally located, immediately adjacent to the epiphyseal plate, maintaining their growth potential.</div></li>
<li class="LM"><div class="P">Latent cysts represent those that are displaced from the growth plate and may reach the mid-diaphysis. Their growth potential is somewhat less than the active cysts.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3856" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The cystic lesion is lined with fibrous connective tissue of a mesothelial nature.</div></li>
<li class="LM"><div class="P">The lesion is filled with fluid, which may be clear, straw yellow, or sanguinous.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3857" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The classic lesion is an expansile, geographic defect that is pseudo-loculated.</div></li>
<li class="LM"><div class="P">The metaphyseal end of the lesion is larger than the diaphyseal end, creating a truncated cone appearance.</div></li>
<li class="LM"><div class="P">Bony expansion frequently occurs but seldom extends beyond the diametric confines of the epiphyseal plate.</div></li>
<li class="LM"><div class="P">Matrix calcification is rare.</div></li>
<li class="LM"><div class="P">10&#x0025; of cases show a <span class="emph_I">fallen fragment sign</span> after pathologic fracture, representing a cortical fragment of bone that falls to the dependent portion of the lesion.</div></li>
<li class="LM"><div class="P">An incomplete cortical fracture may show a <span class="emph_I">hinged fragment sign.</span>
</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3858" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[17]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Surgical curettage and bone chip replacement has been the usual mode.</div></li>
<li class="LM"><div class="P">Recurrence rate for curettage is 30-40&#x0025;.</div></li>
<li class="LM"><div class="P">Steroid injection appears to be the most effective recent treatment, with a much lower recurrence rate.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3859" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]">
<div class="HD">ANEURYSMAL BONE CYST</div>
<div class="TLV3" id="B01382540.0-3860" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">ABC is a non-neoplastic solitary lesion of bone consisting of a cystic cavity filled with blood. (<a class="LK" href="sid806035.html#R655-11">1</a>) Before 1942, ABC was regarded as a variant of giant cell tumor of bone. (<a class="LK" href="sid806035.html#R656-11">2</a>) In 1942, while reporting cases of SBC, Jaffe and Lichtenstein (<a class="LK" href="sid806035.html#R657-11">3</a>) used the term <span class="emph_I">aneurysmal bone cyst</span> to describe two cases. In the 1950s, the term became popular. ABC is the only bone lesion that derives its name from its roentgen appearance rather than from its histology. (<a class="LK" href="sid806035.html#R658-11">4</a>) The lesion is neither an aneurysm nor a true cyst but is made of channels containing flowing blood. The cut surface has a spongelike appearance without elastic properties. The true pathogenesis of aneurysmal bone cyst is still unknown. (<a class="LK" href="sid806035.html#R659-11">5</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3861" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">ABCs represent approximately 1&#x0025; of biopsied primary bone tumors. (<a class="LK" href="sid806035.html#R659-11">5</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3862" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3863" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">ABC occurs in patients between 5 and 20 years of age in 75&#x0025; of the cases. (<a class="LK" href="sid806035.html#R660-11">6</a>) Approximately 60&#x0025; occur in females. (<a class="LK" href="sid806035.html#R659-11">5</a>,<a class="LK" href="sid806035.html#R660-11">6</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3864" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The chief complaint of patients with ABC is acute onset of pain at the affected site with a rapid increase in severity over a short period of time. (<a class="LK" href="sid806035.html#R661-11">7</a>) Pathologic fractures are frequent, particularly with markedly destructive and expanding lesions. (<a class="LK" href="sid806035.html#R661-11">7</a>) Spinal ABCs may produce neurological deficits and even complete paraplegia. (<a class="LK" href="sid806035.html#R662-11">8</a>,<a class="LK" href="sid806035.html#R663-11">9</a>) This occurs because of the lesion&#x2019;s marked predilection for the neural arch, resulting in spinal stenosis and an extradural defect or complete block on myelographic investigation. (<a class="LK" href="sid806035.html#R664-11">10</a>) Systemic signs and symptoms, such as anorexia, fever, and an increased ESR, are generally absent. An antecedent history of trauma is not infrequently obtained in a young patient presenting with an ABC.</div>
</div>
<div class="TLV4" id="B01382540.0-3865" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[3]/TLV4[3]">
<div class="HD">Location</div>
<div class="P">In 80&#x0025; of cases the cysts are in the long tubular bones and spine. (<a class="LK" href="sid806035.html#R665-11">11</a>) (<a class="LK" href="sid806035.html#F299-11">Fig. 11-298</a>) The remainder affect the flat bones and short tubular bones. The femur and tibia are the most common long tubular bones affected. (<a class="LK" href="sid806035.html#R660-11">6</a>) The thoracic and lumbar spine are the most common spinal areas, with a great predilection for the neural arch (spinous process, transverse process, and lamina). (<a class="LK" href="sid806035.html#R666-11">12</a>) Vertebral body involvement is not frequent; however, when present, it is usually associated with an already existing neural arch lesion.</div>
<div class="P">Most lesions in the long tubular bones are primarily eccentric lesions affecting the metaphysis, but also appearing in the diaphysis. Lesions of the short tubular bones are usually central and
<a name="PG1296"> </a><div class="pagenum"><div>P.1296</div></div>
<br clear="all">
diaphyseal in location. (<a class="LK" href="sid806035.html#R667-11">13</a>) Aneurysmal bone cyst is the most common benign bone tumor of the clavicle. (<a class="LK" href="sid806035.html#R660-11">6</a>,<a class="LK" href="sid806035.html#R668-11">14</a>) Other sporadic sites of occurrence are the fibula, patella, calvaria (most common bone is the occiput), orbit, and ribs. (<a class="LK" href="sid806035.html#R668-11">14</a>,<a class="LK" href="sid806035.html#R669-11">15</a>,<a class="LK" href="sid806035.html#R670-11">16</a>,<a class="LK" href="sid806035.html#R671-11">17</a>,<a class="LK" href="sid806035.html#R672-11">18</a>)</div>
<div class="FG" id="F299-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[3]/TLV4[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="298" height="700" src="files/c0b6a07d2f0ea2368f86b3574c2d579e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c0b6a07d2f0ea2368f86b3574c2d579e.gif" MIMETYPE="image/gif" WIDTH="298" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-298 <span class="emph_B">SKELETAL DISTRIBUTION OF ANEURYSMAL BONE CYST.</span>
</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3866" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">ABC represents a proliferation of the vascular component of the marrow, with bone erosion and cyst formation secondary to pressure on the adjacent osseous structures. The gross pathologic findings consist of a bulging shell of bone containing large, blood-filled, cystic cavities. Distended thin-walled blood spaces are identified, without blood clot.</div>
<div class="P">ABC has been designated as <span class="emph_I">primary</span> and <span class="emph_I">secondary,</span> the latter term being used when the histology indicates a co-existing lesion, either benign or malignant. A primary ABC is defined histologically as anastomosing fibrous-walled channels or lacunae that are blood filled. Some authors have suggested a hereditary component to the formation of primary ABC&#x2019;s. (<a class="LK" href="sid806035.html#R673-11">19</a>) The blood-filled channels may have either a complete or an incomplete lining of endothelial cells; but unlike true blood vessels, they contain no elastic lamina or muscle layer. Typically, the fibrous walls contain red blood cells, granules of hemosiderin, foreign-body giant cells, and spicules of reactive bone. A secondary ABC has the same microscopic characteristics but with additional histologic findings indicating another entity. It is not known whether the second entity develops before, after, or simultaneously with the ABC. The relationship of the two is unknown. The bone lesions occurring in conjunction with a secondary ABC are, in the order of decreasing frequency, giant cell tumor, osteosarcoma, simple (unicameral) bone cyst, NOF, and fibrous dysplasia. (<a class="LK" href="sid806035.html#R668-11">14</a>)</div>
<div class="FG" id="F300-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="294" src="files/ae21bfb7951eb19c087cb9a65bd3176a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ae21bfb7951eb19c087cb9a65bd3176a.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="294" DISPLAY="INLINE"></div>
<div class="P">Figure 11-299 <span class="emph_B">ANEURYSMAL BONE CYST (ABC): TYPICAL LOCATIONS. A. Proximal Fibula.</span> Note the large, geographic expansion of the metaphysis of the proximal fibula, creating a lytic lesion with a thin cortical margin. This lesion demonstrates the characteristic radiographic sign of a blown-out appearance of bone. <span class="emph_B">B. Proximal Humerus.</span> Observe the eccentric, cortical expansion of the medial metaphysis of the proximal humerus. <span class="emph_B">C. Distal Clavicle.</span> Note the significant expansion of the distal third of the clavicle associated with a multiloculated radiolucent ABC. ABC is the most common benign bone tumor of the clavicle. (Panel A reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Aneurysmal bone cyst&#x2014;A case study.</span> ACA J Chiro January, 1982. Panel C reprinted with permission from <span class="emph_B">Center for Devices and Radiological Health, FDA, and the American College of Radiology:</span> <span class="emph_I">The Learning File, Skeletal Section, SK-215.</span>)</div>
</td></tr>
</table></div>
</div>
<a name="PG1297"> </a><div class="pagenum"><div>P.1297</div></div>
<br clear="all">
<div class="TLV3" id="B01382540.0-3867" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiologic features may vary, but the basic pattern usually consists of an expanding, rapidly growing, saccular lytic lesion in the involved bone, sharply demarcated by a thin subperiosteal shell. (<a class="LK" href="sid806035.html#F300-11">Fig. 11-299</a>) In long bones the lesion tends to be eccentric, creating a saccular protrusion with multiple fine septae internally and sharply demarcated, bulging, scalloped borders. (<a class="LK" href="sid806035.html#F301-11">Fig. 11-300</a>) Most lesions are metaphyseal; however, they extend to the epiphyseal end of the bone after the growth plate has closed. Rarely, ABC crosses the growth plate to involve the epiphysis secondarily. ABC is the only benign bone tumor known to do this. (<a class="LK" href="sid806035.html#R668-11">14</a>)</div>
<div class="P">Many lesions may reach 8-10 cm in size. The characteristic cortical change is a marked ballooning of a thinned cortex. This cortical bulge has been described as having a <span class="emph_I">blown-out appearance</span> or as the <span class="emph_I">finger-in-the-balloon sign.</span> (<a class="LK" href="sid806035.html#R674-11">20</a>) (<a class="LK" href="sid806035.html#F302-11">Fig. 11-301</a>) Most lesions are purely osteolytic; however, on occasion a soap bubble pattern within the lesion, caused by residual or newly formed ridges of cortex, may be observed. Periosteal new bone formation near the margins of the lesion, creating a buttressing effect, is characteristic of ABC, thus helping differentiate an SBC. (<a class="LK" href="sid806035.html#F303-11">Fig. 11-302</a>) The peripheral edges of this lesion are outlined by a paper thin, or <span class="emph_I">eggshell,</span> rim of new bone formation. (<a class="LK" href="sid806035.html#R674-11">20</a>) Gross distension of the cortex to the point of it almost becoming invisible may occur with rapidly growing lesions. Therefore, because of its markedly expansive and destructive quality, ABC may simulate a malignant neoplasm.</div>
<div class="P">On CT and MRI several fluid levels (<span class="emph_I">fluid-fluid</span>) can be seen within this multicystic lesion. (<a class="LK" href="sid806035.html#R675-11">21</a>,<a class="LK" href="sid806035.html#R676-11">22</a>) These are probably owing to settling of degraded blood products and can also be seen in osteosarcoma, giant cell tumor, and chondroblastoma. On these modalities individual chambers are separated by septae surrounded by a thin peripheral rim of low signal intensity on T1- and T2-weighted images. (<a class="LK" href="sid806035.html#R676-11">22</a>)</div>
<div class="FG" id="F301-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="416" height="700" src="files/7b0036c49611055c0904426679f0fb45.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7b0036c49611055c0904426679f0fb45.gif" MIMETYPE="image/gif" WIDTH="416" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-300 <span class="emph_B">ANEURYSMAL BONE CYST (ABC): THE ECCENTRIC LESION. Distal Radius.</span> Observe the long, eccentric radiolucency present within the distal metaphysis of the radius. Significant expansion of bone with a bubbly appearance of the central matrix is noted. This is a typical radiographic appearance of ABC.</div>
</td></tr>
</table></div>
<div class="FG" id="F302-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="432" src="files/1533c0ce05da1cf8082262f7594f1afc.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1533c0ce05da1cf8082262f7594f1afc.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="432" DISPLAY="INLINE"></div>
<div class="P">Figure 11-301 <span class="emph_B">ANEURYSMAL BONE CYST (ABC): THE BLOWN-OUT APPEARANCE.</span> Note the grossly expansile, radiolucent lesion affecting the pelvic brim, medial acetabulum, and ischium. The peripheral cortical margin of this lesion is intact. This is a typical radiographic appearance of an ABC involving the pelvis. (Courtesy of Richard T. Coade, <a class="LK" href="sid108669.html#AB1-M15">MIR</a>, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Kempsey, New South Wales, Australia.)</div>
</td></tr>
</table></div>
<div class="P">A spinal ABC creates a grossly expansile lytic lesion, usually of the neural arch (spinous process, transverse process, or lamina), which usually lacks any septation. (<a class="LK" href="sid806035.html#F304-11">Fig. 11-303</a>) This appearance may be called the <span class="emph_I">inflated spine.</span> (<a class="LK" href="sid806035.html#F305-11">Fig. 11-304</a>) The thoracic and lumbar spine are predisposed. The other major entity in the differential diagnosis of neural arch spinal expansile lesions is
<a name="PG1298"> </a><div class="pagenum"><div>P.1298</div></div>
<br clear="all">
osteoblastoma. The age range i have greater expansile properties. An osteoblastoma may present as a radiopaque lesion occasionally, facilitating the differential diagnosis. Most osteoblastomas in the spine, however, are lytic lesions, and a biopsy may be the only means of final differentiation. (<a class="LK" href="sid806035.html#T34-11">Table 11-34</a>)</div>
<div class="FG" id="F303-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="584" src="files/f8c28e957d69e04ce2825e38259eb607.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f8c28e957d69e04ce2825e38259eb607.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="584" DISPLAY="INLINE"></div>
<div class="P">Figure 11-302 <span class="emph_B">ANEURYSMAL BONE CYST (ABC): THE PERIOSTEAL BUTTRESS. A. Distal Ulna.</span> Note the large, expansile ABC affecting the distal portion of the ulna. Periosteal new bone formation near the peripheral margins of the lesion creates a buttressing effect, which is characteristic of ABC (<span class="emph_I">arrows</span>). <span class="emph_B">B. Proximal Fibula.</span> Observe the large, geographic, expansile ABC of the proximal fibula. The typical periosteal buttressing effect is present at the proximal surface of the lytic lesion (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F304-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="319" src="files/bb6606b3c3ddea67606a50210fd374a0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="bb6606b3c3ddea67606a50210fd374a0.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="319" DISPLAY="INLINE"></div>
<div class="P">Figure 11-303 <span class="emph_B">ANEURYSMAL BONE CYST (ABC): C4 VERTEBRA. A. Lateral Cervical.</span> Note the grossly destructive, expansile lytic lesion in the articular pillar, lamina, and spinous process of the C4 vertebra (<span class="emph_I">arrows</span>). <span class="emph_B">B. Oblique Cervical.</span> Note the extensive lytic destruction of the articular pillar (<span class="emph_I">arrow</span>) and pedicle (<span class="emph_I">arrowhead</span>) of the C4 vertebra. <span class="emph_B">C. Axial CT: C4.</span> Observe the large, expansile ABC affecting the lamina and spinous process of the C4 vertebra (<span class="emph_I">arrows</span>). Osseous debris is scattered throughout the radiolucent lesion.</div>
</td></tr>
</table></div>
<div class="FG" id="F305-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[5]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="464" height="700" src="files/48ba5b2ab1df348d4433514fa67bb771.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="48ba5b2ab1df348d4433514fa67bb771.gif" MIMETYPE="image/gif" WIDTH="464" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-304 <span class="emph_B">ANEURYSMAL BONE CYST (ABC): THE INFLATED SPINE. AP Lumbar.</span> Note the grossly expansile, geographic lesion affecting the pedicle and transverse process of the L4 vertebra. The gross expansion of a neural arch by an ABC may be referred to as the <span class="emph_I">inflated</span> spine. <span class="emph_I">COMMENT:</span> ABCs, when affecting the spine, have a great predilection to destroy the neural arch, as do osteoblastomas. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Aneurysmal bone cyst&#x2014;A case study.</span> ACA J Chiro January, 1982. Courtesy of Robin Canterbury, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Davenport, Iowa.)</div>
</td></tr>
</table></div>
<div class="TB" id="T34-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-34 Radiologic Features of Aneurysmal Bone Cyst</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Long bones: metaphysis, diaphysis</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Spine: neural arch, inflated spine</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Geographic</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Eccentric</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansile</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Very thin peripheral cortex</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Light septations</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Marginal periosteal buttress</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Fluid-fluid levels on MRI</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3868" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[6]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">Surgical curettage with bone chip replacement is currently the usual mode of therapy; however recent research is identifying less invasive measures for treatment. (<a class="LK" href="sid806035.html#R677-11">23</a>,<a class="LK" href="sid806035.html#R678-11">24</a>) Studies have suggested that intralesional injection with Ethibloc (<a class="LK" href="sid806035.html#R679-11">25</a>) or calcitonin and methylprednisolone (<a class="LK" href="sid806035.html#R680-11">26</a>) are promising treatments without surgical intervention. Furthermore, with more invasive surgical measures, recurrence rates are high, often approaching 50&#x0025;. (<a class="LK" href="sid806035.html#R681-11">27</a>)
<a name="PG1299"> </a><div class="pagenum"><div>P.1299</div></div>
<br clear="all">
Radiation therapy creates sclerosis of the vessels, helping reduce recurrence rates. Most spinal lesions are treated with a 2000- to 3000-rad tumor dose because they are often inoperable. Radiation therapy must be used cautiously because it carries with it a potential for postradiation sarcoma as a sequela many years later. Therefore, surgical curettage remains the treatment of choice. Most patients have a favorable prognosis for complete restoration of normal function.</div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3869" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[6]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Aneurysmal Bone Cyst</div>
<div class="TLV2" id="B01382540.0-3870" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Jaffe and Lichtenstein offered the term aneurysmal bone cyst in describing two cases.</div></li>
<li class="LM"><div class="P">The only bone lesion that derives its name from its roentgen appearance rather than from its histology.</div></li>
<li class="LM"><div class="P">The true pathogenesis is unknown.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3871" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents 1&#x0025; of biopsied primary bone tumors.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3872" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">75&#x0025; of cases present between the ages of 5 and 20 years.</div></li>
<li class="LM"><div class="P">60&#x0025; occur in females.</div></li>
<li class="LM"><div class="P">Pain at the site, which is of a relatively acute onset, occurs.</div></li>
<li class="LM"><div class="P">An antecedent history of trauma is common.</div></li>
<li class="LM"><div class="P">Spinal lesions may produce neurological deficits or paraplegia as a result of the grossly expansile tumor in the neural arch causing spinal stenosis and cord compression.</div></li>
<li class="LM"><div class="P">80&#x0025; of the lesions are in the long tubular bones (femur and tibia) and spine.</div></li>
<li class="LM"><div class="P">Spinal lesions affect the neural arch, spinous process, transverse process, and lamina. The thoracic and lumbar spine are the most common regions involved.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3873" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents a proliferation of the vascular component of the marrow, with removal of bone and cyst formation.</div></li>
<li class="LM"><div class="P">Two types exist: primary and secondary (ABC plus a superimposed benign or malignant tumor).</div></li>
<li class="LM"><div class="P">Gross findings are a bulging shell of bone lined by periosteum and new bone, containing large, blood-filled, cystic cavities.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3874" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">In long bones the lesion is an eccentric, metaphyseal, saccular protrusion of the bone.</div></li>
<li class="LM"><div class="P">The only benign bone tumor known to cross the epiphyseal plate.</div></li>
<li class="LM"><div class="P">Some lesions may reach 8-10 cm and are purely lytic.</div></li>
<li class="LM"><div class="P">The cortical ballooning has been termed the <span class="emph_I">blown-out appearance</span> or the <span class="emph_I">finger-in-the-balloon sign.</span>
</div></li>
<li class="LM"><div class="P">Periosteal buttressing at the edge of the lesion is characteristic.</div></li>
<li class="LM"><div class="P">Spinal lesions in the neural arch must be differentiated from osteoblastoma. ABC is usually more expansile and will not present as a radiopaque lesion, which osteoblastoma may occasionally do.</div></li>
<li class="LM"><div class="P">MRI demonstrates a classic <span class="emph_I">fluid-fluid</span> level.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3875" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[18]/TLV3[6]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Surgical curettage, along with replacement bone chip therapy, is still the mode of therapy.</div></li>
<li class="LM"><div class="P">Recurrence rates are as high as 50&#x0025; following curettage.</div></li>
<li class="LM"><div class="P">Occasionally, radiation therapy is used with inoperable lesions, usually in the spine.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3876" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]">
<div class="HD">INTRAOSSEOUS LIPOMA</div>
<div class="TLV3" id="B01382540.0-3877" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Primary intraosseous lipoma is a rare cause of a lytic lesion, actually representing the rarest primary benign bone tumor. (<a class="LK" href="sid806035.html#R682-11">1</a>) Approximately 200 cases have been reported in the world literature. (<a class="LK" href="sid806035.html#R683-11">2</a>) DeLee (<a class="LK" href="sid806035.html#R684-11">3</a>) reported the first case in 1901. Soft tissue and subperiosteal lipomas are more common than the intraosseous lesions and can secondarily involve the skeleton by extrinsic pressure on the cortex. (<a class="LK" href="sid806035.html#R685-11">4</a>) (<a class="LK" href="sid806035.html#F306-11">Fig. 11-305</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3878" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">A wide age range exists, between 5 and 70 years of age. The peak decade is the 4th. (<a class="LK" href="sid806035.html#R685-11">4</a>) No sex predilection exists. Most lesions are asymptomatic and are discovered accidentally when radiographs are taken for other reasons. Occasionally, the patient presents with pain, the duration of symptoms being variable. (<a class="LK" href="sid806035.html#R686-11">5</a>) The most common anatomic sites are the metaphyses of long bones, particularly the tibia and fibula, calcaneus and metatarsals. (<a class="LK" href="sid806035.html#R687-11">6</a>,<a class="LK" href="sid806035.html#R688-11">7</a>) (<a class="LK" href="sid806035.html#F307-11">Fig. 11-306</a>) They are rare in the spine. (<a class="LK" href="sid806035.html#R689-11">8</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3879" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[3]">
<div class="HD">Pathologic Features</div>
<div class="P">Pathologically, the gross specimens show lesions of variable size (2-13 cm), bright yellow in color, which are well demarcated from the rest of the bone. (<a class="LK" href="sid806035.html#R690-11">9</a>) The composition of the fatty tissue is identical to the frequently occurring soft tissue lipomas. (<a class="LK" href="sid806035.html#R684-11">3</a>,<a class="LK" href="sid806035.html#R686-11">5</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3880" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]">
<div class="HD">Radiologic Features</div>
<div class="P">Radiologically, the intraosseous lipoma produces an osteolytic lesion with a well-defined and&#x002F;or sclerotic border. (<a class="LK" href="sid806035.html#R691-11">10</a>) A narrow zone of transition indicates the slow growth pattern of this nonaggressive neoplasm. A metaphyseal predilection exists, and in half of the reported cases the lesion expands the bone at the expense of the inner margin of the cortex. A characteristic appearance in long bones is an ovoid, elongated appearance with a wedgeshaped end on its diaphyseal surface.</div>
<a name="PG1300"> </a><div class="pagenum"><div>P.1300</div></div>
<br clear="all">
<div class="FG" id="F306-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="444" src="files/d20b86340eb09b64dd7e3864e9583728.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d20b86340eb09b64dd7e3864e9583728.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="444" DISPLAY="INLINE"></div>
<div class="P">Figure 11-305 <span class="emph_B">SOFT TISSUE LIPOMAS. A. AP Femur. B. Lateral Femur.</span> Note the large, radiolucent soft tissue lipoma within the anterior soft tissues of the thigh (<span class="emph_I">arrows</span>). <span class="emph_B">C. Lateral Humerus.</span> Observe the well-defined, radiolucent, soft tissue lipoma anterior to the distal diaphysis of the humerus (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> Soft tissue lipomas appear radiographically as large, radiolucent lesions since fat appears as a radiolucent or black density on the final radiograph. The radiopaque densities surrounding the above lipomas represent the normal soft tissue density of water in the adjacent musculature.</div>
</td></tr>
</table></div>
<div class="FG" id="F307-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="300" height="700" src="files/c58e5073758bb9e98e4c9f9e8ea95019.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c58e5073758bb9e98e4c9f9e8ea95019.gif" MIMETYPE="image/gif" WIDTH="300" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-306 <span class="emph_B">SKELETAL DISTRIBUTION OF INTRAOSSEOUS LIPOMA.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F308-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="585" height="747" src="files/d68faa9e504a7f73c4811aaae90601e2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d68faa9e504a7f73c4811aaae90601e2.gif" MIMETYPE="image/gif" WIDTH="585" HEIGHT="747" DISPLAY="INLINE"></div>
<div class="P">Figure 11-307 <span class="emph_B">INTRAOSSEOUS LIPOMA. A. Lateral Calcaneus. B. Tomogram, Lateral Calcaneus.</span> Note the well-defined, geographic lesion in the subtalar anterior surface of the calcaneus. A characteristic target or doughnut-shaped sequestrum calcification is present within the central portion of the intraosseous lipoma. (Courtesy of Steven P. Brownstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Springfield, New Jersey.)</div>
</td></tr>
</table></div>
<a name="PG1301"> </a><div class="pagenum"><div>P.1301</div></div>
<br clear="all">
<div class="FG" id="F309-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="424" src="files/91789c31abf1d23990b4a0f747bc2082.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="91789c31abf1d23990b4a0f747bc2082.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="424" DISPLAY="INLINE"></div>
<div class="P">Figure 11-308 <span class="emph_B">INTRAOSSEOUS LIPOMA. Calcaneus.</span> Note the well-defined geographic lytic expansile lesion in the subtalar region of the calcaneus. Note the convex expansion of the floor of the calcaneus. Observe the small area of central target or doughnut-shaped sequestrum calcification within the lesion. <span class="emph_I">COMMENT:</span> The most common bones affected by interosseous lipoma are the tibia and fibula, as well as the calcaneus. The main differential diagnosis for a calcaneal lytic expansile lesions is simple bone cyst; however, they do not have a target central calcification. (Courtesy of John Duda, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Department of Radiology, University Hospital, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="P">The shape of the calcaneal lesion is also unusual in that it is trapezoidal, with a broad base and a narrow, truncated superior surface. (<a class="LK" href="sid806035.html#R692-11">11</a>) They usually appear in the base of the calcaneal neck (<a class="LK" href="sid806035.html#R693-11">12</a>) and an additional radiologic sign of intraosseous lipoma is the <span class="emph_I">target</span> or <span class="emph_I">doughnut-shaped sequestrum,</span> which represents a radiopacity of central necrosis. (<a class="LK" href="sid806035.html#F308-11">Figs. 11-307</a> and <a class="LK" href="sid806035.html#F309-11">11-308</a>) This central, round density of the lipoma differs from the calcification of the cartilage tumors, which are characterized by small multiple rings or broken rings, and also differs from the calcification of infarcts, which is peripheral rather than central in location. Thus a well-defined, ovoid, lobulated, expanding intramedullary lesion, particularly with a central density, should suggest the possibility of an intraosseous lipoma. (<a class="LK" href="sid806035.html#F310-11">Fig. 11-309</a>) Occasionally, the lipoma may not show a target calcific nidus. (<a class="LK" href="sid806035.html#R694-11">13</a>)</div>
<div class="P">CT offers a definitive means of diagnosis by measuring the attenuation numbers of the lesion, which fall within the range of fatty tissue. (<a class="LK" href="sid806035.html#R695-11">14</a>) Those lipomas that do not have central calcification are often called SBCs from plain films. (<a class="LK" href="sid806035.html#R695-11">14</a>) A CT or MRI
<a name="PG1302"> </a><div class="pagenum"><div>P.1302</div></div>
<br clear="all">
examination should give the correct diagnosis in these cases, with MRI revealing high signal intensities on both T1- and T2-weighted images. (<a class="LK" href="sid806035.html#R695-11">14</a>,<a class="LK" href="sid806035.html#R696-11">15</a>)</div>
<div class="FG" id="F310-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="212" src="files/6eb2ff55c5bc472ae4576bbf59fbba7e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6eb2ff55c5bc472ae4576bbf59fbba7e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="212" DISPLAY="INLINE"></div>
<div class="P">Figure 11-309 <span class="emph_B">INTRAOSSEOUS LIPOMA. A. AP Pubic Bone.</span> Note the lytic lesion expanding and deforming the pubic bone, with a heavy area of intraosseous calcification (<span class="emph_I">arrow</span>). Of incidental notation are the circular phleboliths present near the pubic rami (<span class="emph_I">arrowheads</span>). These are a frequent finding and are of no clinical significance to the patient. <span class="emph_B">B. Tomogram, Pubic Bone.</span> Note that the tomographic projection of the pubic articulation clearly defines the lytic expansile lesion, with a target calcified nidus (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> This young female patient presented with back pain, and the asymptomatic expansile lesion within the pubic bone was found coincidentally on initial radiographs. This lesion was initially thought to represent an enchondroma or perhaps a low-grade chondrosarcoma, and biopsy surprised all concerned when an intraosseous lipoma was confirmed. This is a rare location for intraosseous lipoma. (Courtesy of Steven B. Klayman, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Austin, Texas.)</div>
</td></tr>
</table></div>
<div class="TB" id="T35-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-35 Preferential Site of Origin of Various Bone Tumors</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Epiphysis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chondroblastoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Giant cell tumor after fusion of growth plate</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Metaphysis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteosarcoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Parosteal sarcoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chondrosarcoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Enchondroma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chondromyxoid fibroma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Fibrosarcoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Non-ossifying fibroma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Giant cell tumor before fusion of growth plate</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Simple bone cyst</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Aneurysmal bone cyst</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoblastoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteochondroma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Bone island (long bone)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Diaphysis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Myeloma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ewing&#x2019;s tumor</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Non-Hodgkin&#x2019;s lymphoma</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Adamantinoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Adapted from <b>Greenfield GB:</b> <i>Radiology of Bone Diseases,</i> ed 3. Philadelphia, JB Lippincott, 1980.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TB" id="T36-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-36 Preferential Time of Occurrence of Various Bone Tumors</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Tumor</b></p></th>
<th align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Age of Maximum Incidence (decades)</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteosarcoma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>2, 3 (smaller peak at 7)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Parosteal sarcoma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>4, 5</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chondrosarcoma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>4, 5, 6</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Fibrosarcoma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>4</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Giant cell tumor</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>3, 4</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ewing&#x2019;s tumor</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>2</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Non-Hodgkin&#x2019;s lymphoma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>3, 4</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Multiple myeloma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>5, 6, 7</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chondroblastoma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>2</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chondromyxoid fibroma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>2, 3</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Non-ossifying fibroma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>2</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoid osteoma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>2, 3</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoblastoma</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>2, 3</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Simple bone cyst</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>1, 2</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Aneurysmal bone cyst</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>2, 3</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Adapted from <b>Greenfield GB:</b> <i>Radiology of Bone Diseases,</i> ed 3. Philadelphia, JB Lippincott, 1980.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="P">Symptomatic lesions require curettage and bone packing into the defect. (<a class="LK" href="sid806035.html#R693-11">12</a>) Asymptomatic lesions are best left alone. (<a class="LK" href="sid806035.html#R697-11">16</a>)</div>
<div class="P">
<a class="LK" href="sid806035.html#T35-11">Tables 11-35</a>, <a class="LK" href="sid806035.html#T36-11">11-36</a> and <a class="LK" href="sid806035.html#T37-11">11-37</a> briefly outline the sites of origin and preferential time of occurrence of primary bone tumors.</div>
<div class="TB" id="T37-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[4]/TLV2[19]/TLV3[4]/TB[3]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-37 Most Common Locations of Bone Tumors</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Type</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Tumor</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Skeletal Sites</b></p></th>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Malignant</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Chondrosarcoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Pelvis, scapula, sternum, femur, humerus</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Chordoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Sacrococcygeal, skull base, C2</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Ewing&#x2019;s sarcoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Pelvis, femur, humerus</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Fibrosarcoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, tibia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Multiple myeloma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Pelvis, spine, sternum, femur, humerus, skull</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteosarcoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, tibia, humerus</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Parosteal sarcoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Non-Hodgkin&#x2019;s lymphoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, humerus, pelvis, spine</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Quasi-malignant</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Giant cell tumor</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, tibia, radius</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Benign</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Aneurysmal bone cyst</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, tibia, humerus, spine (neural arch)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Bone island</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Pelvis, femur</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Chondroblastoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Humerus, femur</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Chondromyxoid fibroma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Tibia, rib, ulna</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Enchondroma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Metacarpals, phalanges, metatarsals, femur</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Fibrous cortical defect</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, tibia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Hemangioma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Spine, skull</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Non-ossifying fibroma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, tibia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteoblastoma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, humerus, spine (neural arch)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteochondroma</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Femur, tibia, humerus</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Osteoid osteoma</p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Femur, tibia, spine</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
</div>
</div>
<div class="TLV1" id="B01382540.0-3881" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]">
<div class="HD">TUMOR-LIKE PROCESSES</div>
<div class="TLV2" id="B01382540.0-3882" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]">
<div class="HD">PAGET&#x2019;S DISEASE</div>
<div class="TLV3" id="B01382540.0-3883" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Paget&#x2019;s disease, named osteitis deformans by Sir James Paget (<a class="LK" href="sid806035.html#R698-11">1</a>) in 1877, is a bone disease of unknown origin characterized by osteolysis followed by extensive attempts at repair. It should be remembered that Sir James identified and described this disease without the use of radiographs, and his initial discussions were with five patients. (<a class="LK" href="sid806035.html#R698-11">1</a>) He called this slowly progressive entity <span class="emph_I">osteitis deformans,</span> thinking a chronic inflammatory process led to the deformity. It is most commonly found in the axial skeleton, but it has been found in nearly every bone of the human skeleton. Because of its unique ability throughout the various stages of the disease process to mimic many other diseases, Paget&#x2019;s disease, together with fibrous dysplasia, has been referred to as the &#x201C;great imitators of bone disease.&#x201D;</div>
</div>
<a name="PG1303"> </a><div class="pagenum"><div>P.1303</div></div>
<br clear="all">
<div class="TLV3" id="B01382540.0-3884" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[2]">
<div class="HD">Historic Note: Sir James Paget</div>
<div class="P">James Paget was born in Yarmouth, England, in 1814, the son of a wealthy merchant banker. At the age of 15 he was apprenticed to a local general practitioner with whom he pursued studies both in medicine and in botany. When he was 21, he became an anatomy demonstrator at St. Bartholomew&#x2019;s Hospital in London, teaching medical students anatomy and physiology while pursuing his own interests of pathology and surgery. At the early age of 30, he was among the first people to be elected a Fellow of the Royal College of Surgeons and at the age of 33 was appointed Professor of Anatomy and Pathology at the Royal College of Surgeons in London. He became a Fellow of the Royal Society at 37 years of age and was knighted 6 years later, at which time he commenced his observations on the first patient with the bone disease that was later to bear his name. At the age of 47 he was appointed Senior Assistant Surgeon at St. Bartholomew&#x2019;s Hospital and 6 years later became Surgeon to Queen Victoria and the Prince of Wales. At the time he presented his first patient with osteitis deformans in London he considered the bone lesion to be inflammatory. He died on December 30, 1899, by which time he had recorded 23 patients with osteitis deformans, 5 of whom had died from malignant degeneration.</div>
</div>
<div class="TLV3" id="B01382540.0-3885" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[3]">
<div class="HD">Incidence</div>
<div class="P">The true prevalence of Paget&#x2019;s disease is difficult to determine because it is most often asymptomatic and is usually detected when roentgenograms are obtained for other reasons. The most effective and reliable data in the literature on the incidence of Paget&#x2019;s disease can be found in the work of Schmorl (<a class="LK" href="sid806035.html#R699-11">2</a>) of Germany. Schmorl found 138 cases of Paget&#x2019;s disease out of 4614 necroscopies of an unselected population &#x003E; 40 years of age, representing an incidence of 3&#x0025;. (<a class="LK" href="sid806035.html#R698-11">1</a>) Up to 12&#x0025; will have a first-degree relative with Paget&#x2019;s disease, a percentage that is seven times greater than the normal population. (<a class="LK" href="sid806035.html#R700-11">3</a>)</div>
<div class="P">The incidence of Paget&#x2019;s disease is low in some countries, such as Asia, Africa, and Scandinavia, whereas in the United Kingdom, Australia, and New Zealand it is high. (<a class="LK" href="sid806035.html#R701-11">4</a>) Although the incidence of Paget&#x2019;s disease varies throughout certain regions of the United Kingdom, the mean incidence is 5&#x0025;, the highest in the world. (<a class="LK" href="sid806035.html#R702-11">5</a>) The prevalence in Australia and New Zealand may be explained by the original colonization of these countries with immigrants from the United Kingdom. This hypothesis is supported by evidence that the prevalence of Paget&#x2019;s disease is slightly higher among recent immigrants to Australia than in offspring born in Australia. (<a class="LK" href="sid806035.html#R702-11">5</a>) The disease has been found only once in an Australian Aborigine. (<a class="LK" href="sid806035.html#R703-11">6</a>) Variable prevalence within the United States is present, with the northern states having a higher incidence than the southern states (New York, 3.8&#x0025;; Atlanta, Georgia, 1.1&#x0025;). (<a class="LK" href="sid806035.html#R702-11">5</a>) In both centers the prevalence among blacks and whites is approximately equal. This contrasts sharply to the apparent rarity of the bone disease in African blacks, whereas Paget&#x2019;s disease is clearly recognized in white immigrants into Southern Africa. The incidence in the Scandinavian countries is 0.4&#x0025;. (<a class="LK" href="sid806035.html#R702-11">5</a>)</div>
<div class="P">These geographic variations suggest that an environmental factor may be operating. Because there is good radiologic evidence from Anglo-Saxon skeletons that the disease has been present in the United Kingdom for at least 1000 years, it seems highly unlikely that there could be an environmental agent associated with modern industries unless these are producing naturally occurring end products. In support of this are pagetic changes noted in the skull of a Neanderthal man (<a class="LK" href="sid806035.html#R704-11">7</a>) and in a skeleton in an ancient Egyptian tomb. (<a class="LK" href="sid806035.html#R705-11">8</a>) An analysis of Beethoven&#x2019;s skeletal remains has suggested that Paget&#x2019;s disease may have contributed to the composer&#x2019;s loss of hearing. (<a class="LK" href="sid806035.html#R706-11">9</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3886" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[4]">
<div class="HD">Cause</div>
<div class="P">There have been many hypotheses as to the cause of Paget&#x2019;s disease; however, none has been properly substantiated. Thus the origin of this disease remains unknown. (<a class="LK" href="sid806035.html#R707-11">10</a>) (<a class="LK" href="sid806035.html#T38-11">Table 11-38</a>) Theories proposed are that of an inflammatory disorder, endocrine disorder, autoimmune disorder, inborn error of connective tissue metabolism, vascular disorder, and neoplasm. (<a class="LK" href="sid806035.html#R698-11">1</a>,<a class="LK" href="sid806035.html#R708-11">11</a>,<a class="LK" href="sid806035.html#R709-11">12</a>,<a class="LK" href="sid806035.html#R710-11">13</a>,<a class="LK" href="sid806035.html#R711-11">14</a>,<a class="LK" href="sid806035.html#R712-11">15</a>) Some investigators have classified Paget&#x2019;s disease as a metabolic disorder; however, it is not generalized, and normal bone can always be identified. (<a class="LK" href="sid806035.html#R713-11">16</a>) The fact that Paget&#x2019;s disease is localized to some, but not all, bones is offered as strong evidence against its being a metabolic or endocrine disorder. (<a class="LK" href="sid806035.html#R713-11">16</a>)</div>
<div class="P">More recent studies using the electron microscope have shown that characteristic fibrillar intranuclear inclusions are present in the osteoclasts of patients with Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R714-11">17</a>) These inclusions resemble the measles virus nucleocapsids, suggesting that a slow virus infection is the causal agent. The paramyxovirus family has been strongly implicated. (<a class="LK" href="sid806035.html#R715-11">18</a>) These inclusions have also been reported in patients with giant cell tumor, which on occasion occurs with Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R716-11">19</a>) The long incubation period of some viruses may explain the geographic variation in migrant populations and the late onset and slow progression of the disease. (<a class="LK" href="sid806035.html#R714-11">17</a>,<a class="LK" href="sid806035.html#R716-11">19</a>) Further research and studies may prove Sir James Paget correct in his suggestion of nearly a century ago that the cause of this disease is inflammatory in nature. Paget&#x2019;s disease is included in this text as a tumor-like process of bone, which should not be misinterpreted as suggesting its definitive cause.</div>
</div>
<div class="TLV3" id="B01382540.0-3887" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3888" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Paget&#x2019;s disease is a common skeletal disorder, particularly in the middle-aged and geriatric patient. It is rare before the age of 40, and affects 3-4&#x0025; of the population &#x003E; 40 years of age. (<a class="LK" href="sid806035.html#R717-11">20</a>) Most patients are &#x003E; 55 years of age at the time of diagnosis. (<a class="LK" href="sid806035.html#R718-11">21</a>) There is a 2:1 male prevalence in Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R718-11">21</a>)</div>
<div class="TB" id="T38-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[1]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-38 Causal Theories for Paget&#x2019;s Disease of Bone</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Inflammatory disorder</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Endocrine disorder</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Autoimmune disorder</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Inborn error of connective tissue metabolism</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Vascular disorder</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Metabolic disorder</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Neoplasm</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Chronic viral infection: measleslike virus<i><sup><a class="a" href="sid806035.html#N1-T38-C11">a</a></sup></i>
</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>
<i><sup><a name="N1-T38-C11" shape="rect" target="_blank">a </a></sup></i> The most current theory.</p></td>
</tr>
</table></td></tr>
</table></div>
<a name="PG1304"> </a><div class="pagenum"><div>P.1304</div></div>
<br clear="all">
<div class="FG" id="F311-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="312" src="files/4a76eb0959dccaa2685ba504b021d732.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4a76eb0959dccaa2685ba504b021d732.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="312" DISPLAY="INLINE"></div>
<div class="P">Figure 11-310 <span class="emph_B">PAGET&#x2019;S DISEASE: EXPANSILE MANIFESTATIONS. A. AP Femur.</span> Observe the thickening of the cortex, affecting the diaphysis of the femur. <span class="emph_B">B. L4 Vertebral Body.</span> Note the significant expansion of the L4 vertebral body, along with the typical changes of an ivory vertebra. <span class="emph_B">C. AP Tibia and Fibula.</span> Observe the gross expansion and cortical thickening of the tibia, with subarticular involvement of its distal surface. The mottled radiopacities noted within the medullary portion of the tibia represent the characteristic cotton wool appearance. <span class="emph_B">D. AP Elbow.</span> Observe the expansion of the proximal radius, affecting its subarticular surface. (Panel B courtesy of Joseph W. Howe, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Los Angeles, California.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3889" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The onset of Paget&#x2019;s disease is insidious, and up to 90&#x0025; of patients are asymptomatic. (<a class="LK" href="sid806035.html#R719-11">22</a>,<a class="LK" href="sid806035.html#R720-11">23</a>) The most common symptom is pain of a dull nature, which ensues from several factors, including stress owing to mechanical disruption of bone, joint destruction, increased blood flow through the bone, and multiple microscopic fractures. (<a class="LK" href="sid806035.html#R721-11">24</a>) This pain is of low intensity, boring in nature, present both at rest and at night, and not aggravated by exertion. The diagnosis is frequently made on routine radiographs obtained for other purposes.</div>
<div class="P">Because of hypervascularity, temperature differences of up to 5&#x00B0;C may be found between a normal and an affected side of the body. (<a class="LK" href="sid806035.html#R722-11">25</a>) Enlargement of bone is a common feature of Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#F311-11">Fig. 11-310</a>) Patients with Paget&#x2019;s disease of the skull may complain of a continuously enlarging hat size. (<a class="LK" href="sid806035.html#R723-11">26</a>) Similarly, in the foot, enlargement of the heel may prevent a patient from fitting into normal-size shoes. (<a class="LK" href="sid806035.html#F312-11">Fig. 11-311</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3890" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]">
<div class="HD">Complications</div>
<div class="P">See <a class="LK" href="sid806035.html#T39-11">Table 11-39</a> for a compilation of the complications of Paget&#x2019;s disease.</div>
<div class="TLV5" id="B01382540.0-3891" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[1]">
<div class="HD"><span class="emph_I">Deformity.</span></div>
<div class="P">A common problem for which patients with Paget&#x2019;s disease seek care is deformity. (<a class="LK" href="sid806035.html#F313-11">Fig. 11-312</a>) This usually occurs in weight-bearing bones, with bowing of the femur or tibia a common finding. The femoral neck usually yields under pressure, creating a coxa vara and the <span class="emph_I">shepherd&#x2019;s crook deformity.</span> Anterior bowing of the tibia occurs and has been called <span class="emph_I">sabre shin deformity.</span> (<a class="LK" href="sid806035.html#F314-11">Fig. 11-313</a>) Occasionally, lateral bowing of the femur and tibia create a genu varum deformity (<span class="emph_I">bowleg</span>). Other deformities include basilar invagination, protrusio acetabuli, and leontiasis ossea (lion-like facies), which is a result of facial bone involvement and increased frontal and parietal bossing. (<a class="LK" href="sid806035.html#R724-11">27</a>) (<a class="LK" href="sid806035.html#F315-11">Fig. 11-314</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3892" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[2]">
<div class="HD"><span class="emph_I">Basilar Invagination.</span></div>
<div class="P">The weight of the enlarged, softened calvaria and brain leads to molding of the skull base upon the upper cervical segments, creating basilar invagination. This complication occurs in approximately one third of patients and is more common
<a name="PG1305"> </a><div class="pagenum"><div>P.1305</div></div>
<br clear="all">
in skulls with the mixed form of Paget&#x2019;s disease. The degree of involvement at the base does not necessarily parallel the involvement of the vault. Basilar invagination may lead to brainstem compression, syringomyelia, or obstructive hydrocephalus. (<a class="LK" href="sid806035.html#R723-11">26</a>,<a class="LK" href="sid806035.html#R725-11">28</a>)</div>
<div class="FG" id="F312-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="582" src="files/d7c5bd41b520be4fec05082990135df0.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d7c5bd41b520be4fec05082990135df0.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="582" DISPLAY="INLINE"></div>
<div class="P">Figure 11-311 <span class="emph_B">PAGET&#x2019;S DISEASE: TALUS AND CALCANEUS.</span> Note the classic Paget&#x2019;s disease affecting the talus and calcaneus, creating significant expansion of the anterior surface of the talus near its articulation with the tarsal navicular.</div>
</td></tr>
</table></div>
<div class="TB" id="T39-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[2]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-39 Complications of Paget&#x2019;s Disease</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" colspan="2" rowspan="1"><p><b>Common</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Uncommon</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Deformities</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Anemia</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Shepherd&#x2019;s crook<i><sup><a class="a" href="sid806035.html#N1-T39-C11">a</a></sup></i>
</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>High-output cardiac failure</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Saber shin</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Otto&#x2019;s pelvis</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ureteric colic</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Leontiasis ossea</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Pseudo-fractures</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Basilar invagination</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Spinal stenosis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Genu varum</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Joint degeneration</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Pathologic fracture (banana-like in type)</p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Malignant degeneration (0.9-2&#x0025;)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>
<i><sup><a name="N1-T39-C11" shape="rect" target="_blank">a </a></sup></i> The most common complication that usually affects the proximal femur.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="FG" id="F313-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="606" src="files/77858de2ea062f851d9dc430fbd62128.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="77858de2ea062f851d9dc430fbd62128.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="606" DISPLAY="INLINE"></div>
<div class="P">Figure 11-312 <span class="emph_B">PAGET&#x2019;S DISEASE: BONE DEFORMITY. A. AP Humerus.</span> Observe the significant lateral bowing of the entire surface of the humerus. Note the cortical thickening and accentuated trabecular patterns consistent with Paget&#x2019;s disease. There is a transverse pathologic fracture noted in the distal surface of the humerus (<span class="emph_I">arrows</span>). <span class="emph_B">B. Lateral Forearm.</span> Note the significant dorsal bowing deformity of the entire radius, as a result of underlying Paget&#x2019;s disease.</div>
</td></tr>
</table></div>
<div class="P">Symptoms from these changes tend to be gradual in development and progressive in character. Cranial nerve palsies involving the third, sixth, and seventh nerves may occur. Nerve deafness may be complicated by severe auditory canal stenosis from bone expansion. In doubtful cases, where symptoms might be a result of basilar invagination, use of the spinographic measurement of Chamberlain&#x2019;s line may be helpful. Generally, the tip of the odontoid should not lie &#x003E; 3 mm above this line, which takes as its points of origin the posterior surface of the hard palate and the inner margin of the foramen magnum. (<a class="LK" href="sid806035.html#F316-11">Fig. 11-315</a>) The main cause of an osseous-induced basilar artery syndrome in the adult is extensive Paget&#x2019;s disease of the skull. This may cause various neurological symptoms, such as headaches, giddiness, or vertigo, including signs of ischemia of the spinal cord.</div>
<div class="FG" id="F314-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="409" height="700" src="files/85ac14ba35bfcb70d0a82b94d60fb992.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="85ac14ba35bfcb70d0a82b94d60fb992.gif" MIMETYPE="image/gif" WIDTH="409" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-313 <span class="emph_B">PAGET&#x2019;S DISEASE: SABER SHIN DEFORMITY.</span> Observe the significant anterior bowing of the tibia, along with cortical thickening and expansion of bone, creating the characteristic saber shin deformity from Paget&#x2019;s disease. Pseudo-fractures affecting the anterior surface of the tibia are also noted (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F315-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="494" src="files/5a32fa42ddd68cd7299f06f5c09118db.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5a32fa42ddd68cd7299f06f5c09118db.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="494" DISPLAY="INLINE"></div>
<div class="P">Figure 11-314 <span class="emph_B">PAGET&#x2019;S DISEASE: PROTRUSIO ACETABULI.</span> Note the extensive Paget&#x2019;s disease affecting the bones of the pelvis. Bilateral medial progression of the femoral heads through the deformed acetabuli, secondary to Paget&#x2019;s disease, is noted. This deformity is referred to as protrusio acetabuli. A porcelain gallbladder is incidentally noted in the right lower portion of the abdomen (<span class="emph_I">arrow</span>). An artifact is present above the hip joint (<span class="emph_I">arrowhead</span>).</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3893" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[3]">
<div class="HD"><span class="emph_I">Pathologic Fracture.</span></div>
<div class="P">This represents the most common complication of Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R726-11">29</a>) The fractures are usually transverse
<a name="PG1306"> </a><div class="pagenum"><div>P.1306</div></div>
<br clear="all">
in their orientation and, when the tubular bones are involved, have been referred to as <span class="emph_I">banana-like</span> in type. (<a class="LK" href="sid806035.html#R727-11">30</a>) (<a class="LK" href="sid806035.html#F317-11">Figs. 11-316</a> and <a class="LK" href="sid806035.html#F318-11">11-317</a>) The most common sites are those areas that are under the greatest weight-bearing stress. The most frequently affected site is the proximal third of the femur, in particular, the femoral neck and subtrochanteric region. (<a class="LK" href="sid806035.html#R702-11">5</a>) (<a class="LK" href="sid806035.html#F319-11">Fig. 11-318</a>) Fractures of the lumbar vertebral bodies and tibia are also common sites. (<a class="LK" href="sid806035.html#R727-11">30</a>) Most of the fractures occur during the mixed (biphasic) or sclerotic phase of the disease and not in the lytic (destructive) phase. (<a class="LK" href="sid806035.html#R702-11">5</a>)</div>
<div class="FG" id="F316-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="593" src="files/d18d69a674c338953a75c2a47a478fc2.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d18d69a674c338953a75c2a47a478fc2.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="593" DISPLAY="INLINE"></div>
<div class="P">Figure 11-315 <span class="emph_B">PAGET&#x2019;S DISEASE: BASILAR INVAGINATION. Lateral Skull.</span> Observe the typical, cotton wool pagetoid changes affecting primarily the frontal and parietal portion of the calvaria. Involvement of the skull base has allowed basilar invagination to occur. This is demonstrated by the odontoid process migrating significantly above Chamberlain&#x2019;s line.</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3894" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[4]">
<div class="HD"><span class="emph_I">Pseudo-Fractures.</span></div>
<div class="P">Pseudo-fractures (Looser&#x2019;s lines, increment fractures, Milkman&#x2019;s syndrome, umbau zonen) are local areas of demineralization within the bone, which are replaced by fibrous tissue. They may represent healing reactions to infractions and are often asymptomatic. Occasionally, they may predispose the patient to complete transverse fractures (<span class="emph_I">banana-like</span>). (<a class="LK" href="sid806035.html#F313-11">Fig. 11-312</a>) The most common sites involved are the femoral neck, subtrochanteric region of the femur, scapula, pubic and ischial rami, and proximal ulna and tibia. (<a class="LK" href="sid806035.html#R727-11">30</a>) Frequently, they present as bilateral and symmetric radiolucent bands. Those affecting the subtrochanteric region of the femur do so on the convex surface of the outer cortex. (<a class="LK" href="sid806035.html#F320-11">Fig. 11-319</a>) Pseudo-fractures are also present in the following diseases: osteomalacia, florid rickets, fibrous dysplasia, and hyperphosphatasia, as well as in diseases in which osteomalacia is a secondary feature (e.g., Wilson&#x2019;s disease).</div>
</div>
<div class="TLV5" id="B01382540.0-3895" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[5]">
<div class="HD"><span class="emph_I">Spinal Stenosis.</span></div>
<div class="P">Because of the expansile capacity of Paget&#x2019;s disease, vertebral body and neural arch involvement can lead to compressive neuropathy. It is estimated that about one third of all patients with spinal involvement will have stenosis. (<a class="LK" href="sid806035.html#R728-11">31</a>) Spinal cord and nerve root compression may result from the pressure of distorted soft bones or pathologic fractures. In the former instance symptoms are slow in appearance; in the latter they are rapid. It is most frequent in the upper thoracic spine; however, cases in the cervical spine, at the axis, and in the lumbar spine, causing cauda equina syndrome, are also recorded. (<a class="LK" href="sid806035.html#R729-11">32</a>,<a class="LK" href="sid806035.html#R730-11">33</a>,<a class="LK" href="sid806035.html#R731-11">34</a>,<a class="LK" href="sid806035.html#R732-11">35</a>) (<a class="LK" href="sid806035.html#F321-11">Figs. 11-320</a>, <a class="LK" href="sid806035.html#F322-11">11-321</a> and <a class="LK" href="sid806035.html#F323-11">11-322</a>) The upper thoracic spine predilection
<a name="PG1307"> </a><div class="pagenum"><div>P.1307</div></div>
<br clear="all">
is owing to the fact that the cord is largest at this level and the spinal canal is the smallest.</div>
<div class="FG" id="F317-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="569" src="files/b34d79f92c343fe0c9fffc9207a99b5d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b34d79f92c343fe0c9fffc9207a99b5d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="569" DISPLAY="INLINE"></div>
<div class="P">Figure 11-316 <span class="emph_B">PAGET&#x2019;S DISEASE: PATHOLOGIC FRACTURE. A. AP Humerus.</span> Note the transverse fracture of the mid-diaphysis of the humerus. This fracture occurs through pagetoid bone and has been referred to as <span class="emph_I">banana-like</span> in patients with fractures complicating Paget&#x2019;s disease. <span class="emph_B">B. AP Humerus.</span> Note the extensive Paget&#x2019;s disease affecting the entire surface of the humerus, which has allowed the pathologic fracture to occur in its distal surface (<span class="emph_I">arrows</span>). (Courtesy of Alf Turner, <a class="LK" href="sid108669.html#AB1-M15">MIR</a>, BAppSc (Chiro), <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Bournemouth, England.)</div>
</td></tr>
</table></div>
<div class="FG" id="F318-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="603" src="files/018462db8a98f2395444ab0f2bffcc59.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="018462db8a98f2395444ab0f2bffcc59.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="603" DISPLAY="INLINE"></div>
<div class="P">Figure 11-317 <span class="emph_B">PAGET&#x2019;S DISEASE: COMPLICATING PATHOLOGIC FRACTURE. A. AP Elbow. B. Lateral Elbow.</span> Note the two pathologic fractures through the pagetoid bone affecting the distal humerus (<span class="emph_I">arrows</span>). Significant malalignment associated with the transverse pathologic fracture is present, affecting the distal portion of the humerus.</div>
</td></tr>
</table></div>
<div class="FG" id="F319-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="524" src="files/2a7b29da154c50f106fc82061c26126e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2a7b29da154c50f106fc82061c26126e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="524" DISPLAY="INLINE"></div>
<div class="P">Figure 11-318 <span class="emph_B">PAGET&#x2019;S DISEASE: PATHOLOGIC FRACTURE. A. Proximal Femur.</span> Note the transverse, <span class="emph_I">banana-like</span> pathologic fracture affecting the intratrochanteric area of the proximal femur. This is the most frequent site for pathologic fracture in Paget&#x2019;s disease. <span class="emph_B">B. Distal Femur.</span> Observe the spiral pathologic fracture of the distal metadiaphyseal surface of the femur.</div>
</td></tr>
</table></div>
<div class="FG" id="F320-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="649" src="files/353a3c00709d51c8378caa22820a8087.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="353a3c00709d51c8378caa22820a8087.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="649" DISPLAY="INLINE"></div>
<div class="P">Figure 11-319 <span class="emph_B">PAGET&#x2019;S DISEASE: PSEUDO-FRACTURES. A. AP Femur.</span> Note the extensive Paget&#x2019;s disease of the entire visualized surface of the femur. Observe the radiolucent defects affecting the cortex of the lateral convex surface of the femur, which is characteristic of pseudo-fractures (<span class="emph_I">arrows</span>). <span class="emph_B">B. AP Femur.</span> Observe the large areas of pseudofracture formation through the pagetoid bone.</div>
</td></tr>
</table></div>
<div class="FG" id="F321-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[5]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="543" src="files/f30cc9cf12f06bc16187196d46eb81d3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f30cc9cf12f06bc16187196d46eb81d3.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="543" DISPLAY="INLINE"></div>
<div class="P">Figure 11-320 <span class="emph_B">PAGET&#x2019;S DISEASE: SPINAL STENOSIS. A. AP Thoracic Spine.</span> Observe the ivory vertebra affecting the midthoracic spine (<span class="emph_I">arrow</span>). There is significant expansion and involvement of the pedicle (<span class="emph_I">arrowhead</span>) of the affected vertebra. Of incidental notation are metallic surgical clips following decompressive laminectomy. <span class="emph_B">B. Lateral Thoracic Spine.</span> Note the expansion of the involved thoracic ivory vertebra (<span class="emph_I">arrows</span>). This bone expansion, along with neural arch involvement, created spinal stenosis in this patient, requiring surgical decompression.</div>
</td></tr>
</table></div>
<div class="P">Most patients are between 40 and 60 years of age. The specific neurological symptoms are varied and may manifest as weakness of the legs, urinary incontinence, or sensory disturbance. (<a class="LK" href="sid806035.html#R729-11">32</a>) Rarely, ossification of extradural fat has caused the cauda equina syndrome in patients with Paget&#x2019;s disease. These changes in the size of the spinal canal are best demonstrated by CT scans. (<a class="LK" href="sid806035.html#R733-11">36</a>,<a class="LK" href="sid806035.html#R734-11">37</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3896" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[6]">
<div class="HD"><span class="emph_I">Anemia.</span></div>
<div class="P">Patients with long-standing Paget&#x2019;s disease may develop anemia because of bone marrow replacement by fibrous tissue. This complication is not common, though, because of the abundance of hematopoietic reserves. (<a class="LK" href="sid806035.html#R735-11">38</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3897" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[7]">
<div class="HD"><span class="emph_I">Joint Degeneration.</span></div>
<div class="P">Paget&#x2019;s disease may also give rise to an arthritis that is particularly common about the hip (Paget&#x2019;s coxopathy). The arthritis is thought to be secondary to accelerated enchondral ossification and replacement of cartilage by pagetic bone. (<a class="LK" href="sid806035.html#R736-11">39</a>,<a class="LK" href="sid806035.html#R737-11">40</a>) The joint space narrowing is usually concentric or symmetric, affecting both the femur and acetabulum. A further feature is protrusio acetabuli, which predisposes the patient to premature secondary degenerative joint disease. (<a class="LK" href="sid806035.html#F324-11">Fig. 11-323</a>) Other causes for the joint space narrowing are cartilage necrosis over the diseased bone and secondary to accelerated subchondral ossification owing to increased vascularity of the underlying bone. In addition to the hip, the knee may demonstrate joint changes resulting from Paget&#x2019;s disease. Intradiscal invasion and fusion in the spine can produce intersegmental ankylosis. (<a class="LK" href="sid806035.html#R738-11">41</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3898" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[8]">
<div class="HD"><span class="emph_I">Ureteric Colic.</span></div>
<div class="P">Paget&#x2019;s disease predisposes to urinary calculus formation. This is associated with the hypercalcemia and hypercalciuria that may occur in Paget&#x2019;s disease, particularly at times of immobilization. It is suggested that the incidence of urinary calculus formation is 10 times the expected incidence in Paget&#x2019;s disease, compared with an otherwise normal population of this age range. (<a class="LK" href="sid806035.html#R702-11">5</a>)</div>
<a name="PG1308"> </a><div class="pagenum"><div>P.1308</div></div>
<br clear="all">
<div class="FG" id="F322-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[8]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="489" src="files/93709a643d938d491f793cd61c7d9910.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="93709a643d938d491f793cd61c7d9910.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="489" DISPLAY="INLINE"></div>
<div class="P">Figure 11-321 <span class="emph_B">PAGET&#x2019;S DISEASE: SPINAL STENOSIS. A. AP Lumbar Spine. B. Lateral Lumbar Spine.</span> Observe the significant expansion of the L3 vertebral body, with an ivory appearance. There is central depression of the vertebral endplates, suggestive of fracture. Observe the ivory density of the pedicle and lamina of L3, indicating pagetoid involvement. <span class="emph_I">COMMENT:</span> This patient presented with signs and symptoms suggestive of a large central disc herniation, mimicking cauda equina syndrome. A laminectomy was performed. (Courtesy of Gary G. Coleman, <a class="LK" href="sid108669.html#AB1-M15">MIR</a>, BAppSc (Chiro), Traralgon, Victoria, Australia)</div>
</td></tr>
</table></div>
<div class="FG" id="F323-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[8]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="410" src="files/72ed81c2d3a0e5540c57e454a6fe38df.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="72ed81c2d3a0e5540c57e454a6fe38df.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="410" DISPLAY="INLINE"></div>
<div class="P">Figure 11-322 <span class="emph_B">PAGETIC SPINAL STENOSIS MIMICKING CAUDA EQUINA SYNDROME. A. AP Lumbar Spine.</span> Observe the ivory vertebra affecting L2, with expansion of the spinous process (<span class="emph_I">arrows</span>). <span class="emph_B">B. Lateral Lumbar Spine.</span> Observe the characteristic changes of Paget&#x2019;s disease, creating an ivory vertebra at L2. Cortical thickening with expansion of the posterior vertebral endplates is noted (<span class="emph_I">arrows</span>). Observe the increase in density in the pedicle and lamina area suggestive of pagetoid extension to the neural arch (<span class="emph_I">arrowheads</span>). <span class="emph_B">C. Normal Axial CT, L1.</span> Note the normal circumference of the spinal canal at L1. <span class="emph_B">D. Axial CT, L2 Ivory Vertebra.</span> Observe the significant reduction of the dimensions of the spinal canal secondary to the extensive expansion of the vertebral body and neural arch from pagetoid involvement. <span class="emph_I">COMMENT:</span> This 42-year-old patient presented with symptoms of an L2-L3 disc mimicking cauda equina syndrome. Patients with spinal stenosis, as demonstrated in this case, usually require emergency decompression laminectomy. (Courtesy of Lawrence A. Cooperstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Pittsburgh, Pennsylvania.)</div>
</td></tr>
</table></div>
<a name="PG1309"> </a><div class="pagenum"><div>P.1309</div></div>
<br clear="all">
<div class="FG" id="F324-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[8]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="437" src="files/2231f58aa9ebedf0a4264b77c8f5df0b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2231f58aa9ebedf0a4264b77c8f5df0b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="437" DISPLAY="INLINE"></div>
<div class="P">Figure 11-323 <span class="emph_B">PAGET&#x2019;S DISEASE: DEGENERATIVE CHANGES.</span> Note the extensive pagetoid involvement of the hemipelvis, with classic cortical thickening and bone expansion. There is uniform narrowing of the hip joint as a result of premature degenerative joint disease, which is a frequent complication of Paget&#x2019;s disease. Of incidental notation is degenerative arthrosis of the pubic articulation.</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3899" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[3]/TLV5[9]">
<div class="HD"><span class="emph_I">High-Output Cardiac Failure.</span></div>
<div class="P">Pagetic bone develops a vastly increased blood supply, perhaps 20 times the normal vascularity, and the presence of microscopic multiple arteriovenous shunts has been noted. In patients with extensive involvement, this may lead to high output type of cardiac congestive failure. At least one third of the skeleton must be involved to produce congestive heart failure (<a class="LK" href="sid806035.html#R702-11">5</a>); however, lesser degrees of skeletal involvement may result in a hyperdynamic circulation. This is a rare complication of Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R726-11">29</a>)</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3900" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]">
<div class="HD">Malignant Degeneration</div>
<div class="P">In the original description of this basic disorder of bone, Sir James noted an association of sarcoma in 2 of the 5 original cases. (<a class="LK" href="sid806035.html#R698-11">1</a>) By 1889 he had collected a total of 23 cases, 5 of which had undergone malignant degeneration. (<a class="LK" href="sid806035.html#R739-11">42</a>)</div>
<div class="TLV5" id="B01382540.0-3901" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[1]">
<div class="HD"><span class="emph_I">Incidence.</span></div>
<div class="P">Because the exact incidence of uncomplicated Paget&#x2019;s disease is not known, it is extremely difficult to establish an accurate statistic for the percentage of malignant degeneration of this disease process. The incidence suggested in the literature ranges from 0.9&#x0025; to 20&#x0025;. The reason for this wide range is the biased patient population source used in the early articles written on this topic. When only patients with advanced, polyostotic, and clinically obvious or symptomatic Paget&#x2019;s disease have been included in a study (as has been the case throughout the early articles in the literature), the frequency of sarcomatous degeneration climbs to 7-20&#x0025;. (<a class="LK" href="sid806035.html#R740-11">43</a>) However, when large numbers of patients with asymptomatic Paget&#x2019;s disease of minimal extent are included, the recorded frequency is considerably less, ranging from 0.9 to 2&#x0025;. (<a class="LK" href="sid806035.html#R741-11">44</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3902" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[2]">
<div class="HD"><span class="emph_I">Age and Sex Distribution.</span></div>
<div class="P">Paget&#x2019;s sarcoma is rare before the age of 40 (<a class="LK" href="sid806035.html#R741-11">44</a>), most authorities agree, with a general range for the average age being 57-66 years. (<a class="LK" href="sid806035.html#R740-11">43</a>) There is an approximate 2:1 male preponderance.</div>
</div>
<div class="TLV5" id="B01382540.0-3903" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[3]">
<div class="HD"><span class="emph_I">Signs and Symptoms.</span></div>
<div class="P">The most common presenting symptoms of malignant degeneration are those of severe localized pain, creating local disability, and an occasional pulsatile mass. Because Paget&#x2019;s disease is often asymptomatic, unless weight-bearing deformities create localized discomfort, the onset of pain in the patient known to have Paget&#x2019;s disease should seriously suggest the development of a sarcoma of bone. (<a class="LK" href="sid806035.html#R740-11">43</a>) The duration of symptoms varies from 1 to 8 months, with an average of 4.5 months. (<a class="LK" href="sid806035.html#R742-11">45</a>) Spontaneous or pathologic fractures as a result of trivial trauma are dramatic features in patients with Paget&#x2019;s disease, both in the early and late phases. Schajowicz et al. (<a class="LK" href="sid806035.html#R743-11">46</a>) have reported a 21&#x0025; incidence of pathologic fractures after reviewing 62 cases of Paget&#x2019;s sarcoma.</div>
</div>
<div class="TLV5" id="B01382540.0-3904" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[4]">
<div class="HD"><span class="emph_I">Site Distribution.</span></div>
<div class="P">Sarcoma complicating Paget&#x2019;s disease has a distribution similar to uncomplicated Paget&#x2019;s disease, except for the relatively high incidence of neoplasia in the humerus and the relatively low frequency in the vertebrae. (<a class="LK" href="sid806035.html#R740-11">43</a>) The femur is the most commonly involved bone, followed, in decreasing order of frequency, by the humerus, innominate bone, skull, and tibia. (<a class="LK" href="sid806035.html#R740-11">43</a>) (<a class="LK" href="sid806035.html#F325-11">Figs. 11-324</a>, <a class="LK" href="sid806035.html#F326-11">11-325</a>, <a class="LK" href="sid806035.html#F327-11">11-326</a>, <a class="LK" href="sid806035.html#F328-11">11-327</a>, <a class="LK" href="sid806035.html#F329-11">11-328</a>, <a class="LK" href="sid806035.html#F330-11">11-329</a>, <a class="LK" href="sid806035.html#F331-11">11-330</a>, <a class="LK" href="sid806035.html#F332-11">11-331</a> and <a class="LK" href="sid806035.html#F333-11">11-332</a>) Unusual sites include the calcaneus, talus, rib, fibula, ulna, and radius. (<a class="LK" href="sid806035.html#R740-11">43</a>) (<a class="LK" href="sid806035.html#F334-11">Figs. 11-333</a> and <a class="LK" href="sid806035.html#F335-11">11-334</a>) Most lesions affect the diaphyseal medullary canal. Vertebral Paget&#x2019;s sarcoma is rare. (<a class="LK" href="sid806035.html#R740-11">43</a>,<a class="LK" href="sid806035.html#R742-11">45</a>) Only eight cases involving the spine have been reported, with the lumbar spine being the most common site. (<a class="LK" href="sid806035.html#R740-11">43</a>,<a class="LK" href="sid806035.html#R741-11">44</a>,<a class="LK" href="sid806035.html#R742-11">45</a>,<a class="LK" href="sid806035.html#R743-11">46</a>,<a class="LK" href="sid806035.html#R744-11">47</a>) (<a class="LK" href="sid806035.html#F336-11">Fig. 11-335</a>) Huang et al. (<a class="LK" href="sid806035.html#R744-11">47</a>) reported a 63-year-old male with Paget&#x2019;s sarcoma involving the L4 vertebral body. Records show two cases in the thoracic spine and one in the cervical spine. (<a class="LK" href="sid806035.html#R740-11">43</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3905" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[5]">
<div class="HD"><span class="emph_I">Pathologic Findings.</span></div>
<div class="P">The most common histologic tumor type complicating Paget&#x2019;s disease is osteosarcoma. (<a class="LK" href="sid806035.html#R743-11">46</a>) The second most common tumor type is fibrosarcoma, with chondrosarcoma, malignant fibrous histiocytoma, and reticulosarcoma representing a small number in the cell types of malignant degeneration of Paget&#x2019;s disease. The gross appearance and microscopic characteristics of Paget&#x2019;s sarcoma are no different from those of osteosarcoma arising in a bone unaffected by Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R745-11">48</a>) Giant cell tumor has also been found to complicate Paget&#x2019;s disease as a benign or malignant neoplasm.</div>
</div>
<div class="TLV5" id="B01382540.0-3906" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[6]">
<div class="HD"><span class="emph_I">Radiologic Findings.</span></div>
<div class="P">The most common radiologic presentation is a focal lytic area of destruction as a result of neoplastic proliferation of fibrous stromal tissue. The earliest radiographic feature is a small focus of subcortical destruction of bone. (<a class="LK" href="sid806035.html#F337-11">Fig. 11-336</a>) The typical lesion stands out clearly as a small or large oval area of radiolucency blanketed against a background of pagetic bone. (<a class="LK" href="sid806035.html#F338-11">Fig. 11-337</a>) Although the lytic type of presentation predominates (&#x003E; 50&#x0025;), both a mixed and sclerotic presentation also exist, with the sclerotic form representing approximately 25&#x0025; of cases. (<a class="LK" href="sid806035.html#R740-11">43</a>) (<a class="LK" href="sid806035.html#F339-11">Fig. 11-338</a>) Periosteal response is usually absent. Pathologic fracture and soft tissue mass formation are common signs in advanced cases. (<a class="LK" href="sid806035.html#F340-11">Fig. 11-339</a>) Patients frequently develop <span class="emph_I">cannonball metastasis</span> to the lung, leading to early death.</div>
</div>
<div class="TLV5" id="B01382540.0-3907" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]">
<div class="HD"><span class="emph_I">Treatment and Prognosis.</span></div>
<div class="P">Standard treatment for Paget&#x2019;s sarcoma is surgical resection or, occasionally, radiation therapy. These approaches are often followed by chemotherapy in an attempt to limit metastatic disease. The use of radiation therapy as a primary therapeutic approach is reserved only for such tumors that are not amenable to surgery. Paget&#x2019;s sarcoma is the most threatening sarcoma of bone (<a class="LK" href="sid806035.html#R746-11">49</a>) with a 5-year survival rate of only 8&#x0025;.
<a name="PG1310"> </a><div class="pagenum"><div>P.1310</div></div>
<br clear="all">
(<a class="LK" href="sid806035.html#R747-11">50</a>) The prognosis for Paget&#x2019;s sarcoma is grave and often rapidly fatal. (<a class="LK" href="sid806035.html#R740-11">43</a>)</div>
<div class="FG" id="F325-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="497" src="files/62244de31ba5a64b3b77b89d476cc191.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="62244de31ba5a64b3b77b89d476cc191.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="497" DISPLAY="INLINE"></div>
<div class="P">Figure 11-324 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. A. AP Hip.</span> Observe the pagetoid changes seen throughout the proximal femur. There is cortical destruction of the lesser trochanter (<span class="emph_I">arrow</span>), along with a soft tissue mass (<span class="emph_I">arrowhead</span>), as a result of malignant degeneration of the preexisting benign Paget&#x2019;s disease. <span class="emph_B">B. Oblique Hip.</span> Note the extensive sarcomatous destruction of the lesser trochanter is noted (<span class="emph_I">arrow</span>). <span class="emph_I">COMMENT:</span> The incidence of malignant degeneration of Paget&#x2019;s disease is 0.9-2.0&#x0025;. (Courtesy of Gerald A. Fitzgerald, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Sydney, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F326-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="469" height="700" src="files/f5283c001480b391ac49c31922dbab1b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f5283c001480b391ac49c31922dbab1b.gif" MIMETYPE="image/gif" WIDTH="469" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-325 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. AP Hip.</span> Observe the extensive expansion of the proximal femur, with a lateral bowing deformity. There is cortical destruction present in the area of the femoral neck and lesser trochanter, with a large soft tissue mass (<span class="emph_I">arrows</span>), suggesting sarcomatous degeneration. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<div class="FG" id="F327-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="513" height="700" src="files/4fb9a65907fba3395fc10e16490a81cd.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4fb9a65907fba3395fc10e16490a81cd.gif" MIMETYPE="image/gif" WIDTH="513" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-326 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. AP Shoulder.</span> Note the extensive Paget&#x2019;s disease affecting the entire proximal humerus. Observe the pathologic fractures through the area of malignant degeneration of the preexisting benign Paget&#x2019;s disease. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<a name="PG1311"> </a><div class="pagenum"><div>P.1311</div></div>
<br clear="all">
<div class="FG" id="F328-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="453" src="files/d44f2d541530a6277d76630a9d948d65.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d44f2d541530a6277d76630a9d948d65.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="453" DISPLAY="INLINE"></div>
<div class="P">Figure 11-327 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. AP Pelvis.</span> Note the extensive destruction of the acetabulum and pelvic rim as a result of malignant degeneration of Paget&#x2019;s disease. Observe the lack of destruction of the femoral head, which negates the possibility of septic arthritis. Note also the increase in density of the remaining superior pubic rami and ischial tuberosity characteristic of Paget&#x2019;s disease. Similar changes of Paget&#x2019;s disease affect the opposite pelvis and iliopectineal line. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<div class="FG" id="F329-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="481" height="700" src="files/e093345c66144ff7c464be36a3575819.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e093345c66144ff7c464be36a3575819.gif" MIMETYPE="image/gif" WIDTH="481" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-328 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. AP Hip.</span> Observe the pagetoid changes present within the ilium, with cortical destruction of the supraacetabular area, suggestive of malignant change (<span class="emph_I">arrow</span>). There is a large soft tissue extension creating a well-defined mass (<span class="emph_I">arrowheads</span>) associated with the malignant degeneration. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<div class="FG" id="F330-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="473" height="700" src="files/cd641ea77241b079d09bf31383264654.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="cd641ea77241b079d09bf31383264654.gif" MIMETYPE="image/gif" WIDTH="473" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-329 <span class="emph_B">PAGET&#x2019;S DISEASE, ILIUM: MALIGNANT DEGENERATION. AP Hip.</span> Note the extensive Paget&#x2019;s disease affecting the sacrum, entire ilium, and proximal femur. There is cortical destruction affecting the ilium in the supraacetabular area (<span class="emph_I">arrow</span>). Some bone debris secondary to the malignant degeneration is seen in the soft tissue mass (<span class="emph_I">arrowhead</span>). (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F331-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="424" src="files/e2f06cfc6b17a2844ec2978e732a4e7f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="e2f06cfc6b17a2844ec2978e732a4e7f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="424" DISPLAY="INLINE"></div>
<div class="P">Figure 11-330 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. Lateral Skull.</span> Note the extensive Paget&#x2019;s disease affecting the visualized calvaria. There is cortical destruction and soft tissue mass formation of the frontal bone as a result of malignant degeneration (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<a name="PG1312"> </a><div class="pagenum"><div>P.1312</div></div>
<br clear="all">
<div class="FG" id="F332-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="606" src="files/c7ff4cbdecec1eb0b44252b3fe787616.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c7ff4cbdecec1eb0b44252b3fe787616.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="606" DISPLAY="INLINE"></div>
<div class="P">Figure 11-331 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. A. AP Tibia. B. Lateral Tibia.</span> Observe the pagetoid changes affecting the tibia. There is extensive cortical destruction and a large sarcomatous soft tissue mass present on the posterior proximal surface of the tibia (<span class="emph_I">arrows</span>). This soft tissue mass demonstrates a sunburst periosteal response, which is somewhat atypical in Paget&#x2019;s sarcoma. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<div class="FG" id="F333-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="384" height="700" src="files/d3a22dfbb9639c55c60eef617031c856.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d3a22dfbb9639c55c60eef617031c856.gif" MIMETYPE="image/gif" WIDTH="384" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-332 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. Lateral Tibia.</span> There is extensive pagetoid involvement of the proximal tibia. Note the characteristic cortical thickening present on the posterior surface of the tibia, with destruction of the anterior tibial cortex as a result of malignant degeneration. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<div class="FG" id="F334-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[10]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="465" src="files/09ed6782048fac619f746ea3171d6c50.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="09ed6782048fac619f746ea3171d6c50.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="465" DISPLAY="INLINE"></div>
<div class="P">Figure 11-333 <span class="emph_B">MULTIFOCAL PAGET&#x2019;S SARCOMA. Lateral Ankle.</span> Note the extensive Paget&#x2019;s disease involving the entire talus and calcaneus. Observe the cortical destruction secondary to malignant degeneration affecting the superior aspect of the calcaneus (<span class="emph_I">arrow</span>) and the neck of the talus (<span class="emph_I">arrowhead</span>). <span class="emph_I">COMMENT:</span> Multifocal involvement of Paget&#x2019;s sarcoma is extremely rare. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<div class="FG" id="F335-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[11]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="726" src="files/3ba8855f7aae90b856df8d5c4a801b1e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3ba8855f7aae90b856df8d5c4a801b1e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="726" DISPLAY="INLINE"></div>
<div class="P">Figure 11-334 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. A. PA Forearm.</span> Observe the cortical thickening of the distal shaft of the ulna, suggesting pagetoid change (<span class="emph_I">arrow</span>). There is a large, lytic lesion within the mid-diaphysis of the ulna, with cortical disruption (<span class="emph_I">arrowhead</span>). <span class="emph_B">B. Lateral Forearm.</span> Observe the large soft tissue mass associated with the lytic destructive lesion in the ulna (<span class="emph_I">arrows</span>). (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<a name="PG1313"> </a><div class="pagenum"><div>P.1313</div></div>
<br clear="all">
<div class="FG" id="F336-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[12]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="466" height="700" src="files/b149691c0ca17de309f9f16953ae7d5a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b149691c0ca17de309f9f16953ae7d5a.gif" MIMETYPE="image/gif" WIDTH="466" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-335 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. L3 Vertebra.</span> Observe the pagetoid changes in the L3 vertebral body, creating an increase in bone density. A large soft tissue mass is associated with the malignant degeneration of the pagetoid ivory vertebra (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> Paget&#x2019;s sarcoma of the spine is rare, with &#x003C; 10 cases reported. The majority of cases reported are in the lumbar spine. (Courtesy of Sharon A. Jaeger, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Los Angeles, California.)</div>
</td></tr>
</table></div>
<div class="FG" id="F337-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[13]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="718" src="files/861ad9dd6642156a5c5f92fe7448ebc6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="861ad9dd6642156a5c5f92fe7448ebc6.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="718" DISPLAY="INLINE"></div>
<div class="P">Figure 11-336 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. Sacrum.</span> Observe the pagetoid changes throughout the entire sacrum. There is a lytic area of destruction within the midportion of the sacrum (<span class="emph_I">arrow</span>) at the site of malignant degeneration. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F338-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[14]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="500" src="files/bd8b00aef7660d5107f2d156380b5ae1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="bd8b00aef7660d5107f2d156380b5ae1.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="500" DISPLAY="INLINE"></div>
<div class="P">Figure 11-337 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION, A SERIAL STUDY. A. AP Pelvis.</span> Observe the typical changes of Paget&#x2019;s disease affecting the entire hemipelvis and sacrum. <span class="emph_B">B. 1-Year Follow-Up, AP Pelvis.</span> Note the large lytic defects present within the midportion of the hemipelvis (<span class="emph_I">arrows</span>). The lytic areas represent focal malignant degeneration of Paget&#x2019;s disease. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<a name="PG1314"> </a><div class="pagenum"><div>P.1314</div></div>
<br clear="all">
<div class="FG" id="F339-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[15]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="449" height="700" src="files/01287c59f8431451d3e9176611fb1f85.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="01287c59f8431451d3e9176611fb1f85.gif" MIMETYPE="image/gif" WIDTH="449" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-338 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. Femur.</span> Observe the dense, radiopaque changes within the femoral neck and proximal diaphysis. A large, soft tissue mass is noted along the inner surface of the femoral neck and shaft. These changes represent the sclerotic presentation of malignant degeneration of Paget&#x2019;s disease to an osteosarcoma. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.)</div>
</td></tr>
</table></div>
<div class="FG" id="F340-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[16]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="436" height="700" src="files/4b27d43e59d72f6132f4d17b52deaa0f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4b27d43e59d72f6132f4d17b52deaa0f.gif" MIMETYPE="image/gif" WIDTH="436" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-339 <span class="emph_B">PAGET&#x2019;S DISEASE: MALIGNANT DEGENERATION. Pathologic Fracture of the Femur.</span> Observe the pagetoid changes present throughout the mid-diaphysis of the femur. A pathologic fracture has occurred through a site of malignant degeneration. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Victoria, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F341-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[4]/TLV5[7]/FG[17]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="535" src="files/adb0d093960a2bc9ae93f0522cb4e98f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="adb0d093960a2bc9ae93f0522cb4e98f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="535" DISPLAY="INLINE"></div>
<div class="P">Figure 11-340 <span class="emph_B">POLYOSTOTIC PAGET&#x2019;S DISEASE. A. Nuclear Bone Scan.</span> Observe all dark regions of the visualized skeleton corresponding to sites of Paget&#x2019;s disease, other than the bladder and sacroiliac joints. <span class="emph_B">B. Cervical Spine.</span> Note that Paget&#x2019;s disease involves the contiguous segments C2-C4 and has also produced intradiscal fusion (<span class="emph_I">arrow</span>). <span class="emph_B">C. T1-Weighted MRI, Sagittal Cervical.</span> Observe that the Paget&#x2019;s diseased segments show low signal intensity (<span class="emph_I">arrows</span>). <span class="emph_B">D. Tibia.</span> Note the characteristic cortical thickening and trabecular accentuation (<span class="emph_I">arrow</span>). <span class="emph_B">E. Lumbar Spine.</span> Note that the T12 and L3 vertebrae are increased in density and expanded (<span class="emph_I">arrow</span>). <span class="emph_B">F. Manubrium.</span> Note the manubrium is sclerotic and expanded (<span class="emph_I">arrows</span>). (Courtesy of Gary L. Smith, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Portland, Oregon.)</div>
</td></tr>
</table></div>
</div>
</div>
<a name="PG1315"> </a><div class="pagenum"><div>P.1315</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3908" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[5]">
<div class="HD">Location</div>
<div class="P">Paget&#x2019;s disease is often found at initial presentation to be polyostotic. (<a class="LK" href="sid806035.html#F341-11">Fig. 11-340</a>) The bones most commonly affected by Paget&#x2019;s disease, in diminishing order of frequency, are the pelvis (including the sacrum), femur, skull, tibia, vertebrae, clavicle, humerus, and ribs. (<a class="LK" href="sid806035.html#F342-11">Figs. 11-341</a>, <a class="LK" href="sid806035.html#F343-11">11-342</a>, <a class="LK" href="sid806035.html#F344-11">11-343</a>, <a class="LK" href="sid806035.html#F345-11">11-344</a> and <a class="LK" href="sid806035.html#F346-11">11-345</a>) The lesions vary in their distribution from a single bone to a widespread, almost complete skeletal involvement. The fibula is the bone least likely to be involved; involvement of all other bones, including those of the hand, foot (usually the calcaneus or talus), as well as the patella, and other sesamoid bones has been reported. Within the spine there is a definite variation in distribution, with preferential involvement of the L3 and L4 vertebrae, lower thoracic vertebrae, and the upper two cervical vertebrae. (<a class="LK" href="sid806035.html#R747-11">50</a>,<a class="LK" href="sid806035.html#R748-11">51</a>,<a class="LK" href="sid806035.html#R749-11">52</a>,<a class="LK" href="sid806035.html#R750-11">53</a>,<a class="LK" href="sid806035.html#R751-11">54</a>) (<a class="LK" href="sid806035.html#F347-11">Figs. 11-346</a>, <a class="LK" href="sid806035.html#F348-11">11-347</a>, <a class="LK" href="sid806035.html#F349-11">11-348</a>, <a class="LK" href="sid806035.html#F350-11">11-349</a>, <a class="LK" href="sid806035.html#F351-11">11-350</a>, <a class="LK" href="sid806035.html#F352-11">11-351</a> and <a class="LK" href="sid806035.html#F353-11">11-352</a>) The involvement of the lower extremity is more than twice that of the upper extremity. There is also a tendency for the right side of the skeleton to be involved more than the left. (<a class="LK" href="sid806035.html#R702-11">5</a>)</div>
<div class="P">In tubular bones involvement invariably includes the subarticular end of the bone; seldom does the lesion stop at the metaphysis. (<a class="LK" href="sid806035.html#F354-11">Fig. 11-353</a>) The extent of the lesion usually reaches the mid-diaphysis. This subarticular location is a helpful differential point when fibrous dysplasia is being considered because these lesions usually stop at the metaphysis.</div>
<div class="FG" id="F342-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="297" height="700" src="files/9f9596fb4866b770419f2b4faf68089a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9f9596fb4866b770419f2b4faf68089a.gif" MIMETYPE="image/gif" WIDTH="297" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-341 <span class="emph_B">SKELETAL DISTRIBUTION OF PAGET&#x2019;S DISEASE.</span>
</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3909" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]">
<div class="HD">Laboratory Findings</div>
<div class="P">The serum alkaline phosphatase is almost invariably raised in Paget&#x2019;s disease. This enzyme is liberated by osteoblasts and is produced in great quantity as accelerated new bone formation attempts to compensate for the increased rate of bone resorption. In the active polyostotic state these values may be as high as 20 times that of normal values (<a class="LK" href="sid806035.html#R752-11">55</a>); however, in the monostotic involvement the levels may be slightly elevated or normal. The increased rate of osteoclastic resorption causes destruction of bone collagen and a concomitant increase in urinary excretion of hydroxyproline.</div>
<div class="P">Ordinarily, the serum calcium and inorganic phosphorus values are normal in cases of Paget&#x2019;s disease. One would expect to find the serum calcium levels to be elevated in generalized
<a name="PG1316"> </a><div class="pagenum"><div>P.1316</div></div>
<br clear="all">
Paget&#x2019;s disease during the destructive stage, yet this is usually not the case. This may be explained by the fact that in the natural course of the disease new osteoid is laid down and mineralized in the wake of the destructive process. This new bone probably uses most of the calcium that is liberated. (<a class="LK" href="sid806035.html#R753-11">56</a>)</div>
<div class="FG" id="F343-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="522" height="700" src="files/32a30d1e3b10ea5e3dc203771610f015.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="32a30d1e3b10ea5e3dc203771610f015.gif" MIMETYPE="image/gif" WIDTH="522" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-342 <span class="emph_B">PAGET&#x2019;S DISEASE. A. AP Clavicle.</span> Observe the pagetoid expansion and cortical thickening of the entire clavicle. Note the subarticular involvement at both ends of the clavicle. <span class="emph_B">B. Bilateral Clavicles.</span> Observe the extensive cortical thickening and bone expansion at both the medial and distal portions of the clavicles. Pagetoid changes are also noted in both scapulae, with significant expansion of the coracoid processes. There are some changes in the ribs that are also suggestive of Paget&#x2019;s disease.</div>
</td></tr>
</table></div>
<div class="FG" id="F344-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="510" src="files/f8f308e9e4014490cd06978d950da987.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f8f308e9e4014490cd06978d950da987.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="510" DISPLAY="INLINE"></div>
<div class="P">Figure 11-343 <span class="emph_B">PAGET&#x2019;S DISEASE: HUMERUS. A. Bilateral AP Shoulders.</span> Observe the pagetoid changes of cortical thickening, radiolucent cystic changes, bone expansion, and subarticular involvement affecting the humeral head and proximal diaphysis (<span class="emph_I">arrow</span>). The opposite shoulder in this patient was normal. <span class="emph_B">B. AP Shoulder.</span> Observe the extensive cortical thickening and subarticular pagetoid changes in the visualized humerus. Similar changes of Paget&#x2019;s disease are present in the visualized portion of the scapula, particularly the coracoid process, which is expanded.</div>
</td></tr>
</table></div>
<div class="FG" id="F345-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="480" height="700" src="files/198c38dc8a0b679b7622ecf47f4a7d49.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="198c38dc8a0b679b7622ecf47f4a7d49.gif" MIMETYPE="image/gif" WIDTH="480" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-344 <span class="emph_B">PAGET&#x2019;S DISEASE. Thorax and Shoulder.</span> Observe the pagetoid changes involving the clavicle, scapula, humeral head, and ribs.</div>
</td></tr>
</table></div>
<div class="FG" id="F346-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="454" height="700" src="files/fd421c8731187c2a937fee2e58783add.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fd421c8731187c2a937fee2e58783add.gif" MIMETYPE="image/gif" WIDTH="454" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-345 <span class="emph_B">PAGET&#x2019;S DISEASE. Rib.</span> Note the cortical thickening and an increase in density of the posterolateral surface of the fifth rib consistent with Paget&#x2019;s disease (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F347-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="556" src="files/1f414093ad5ddb9f6d73cff143122c4f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1f414093ad5ddb9f6d73cff143122c4f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="556" DISPLAY="INLINE"></div>
<div class="P">Figure 11-346 <span class="emph_B">PAGET&#x2019;S DISEASE. A and B. Bilateral Tibia and Fibula.</span> Observe the extensive cortical thickening of the tibia and coarsening of the trabecular patterns of both the tibia and fibula. Bone expansion is also noted. <span class="emph_I">COMMENT:</span> The fibula is the bone least likely to be involved in Paget&#x2019;s disease; however, when present, the radiographic changes are consistent with all other sites. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<a name="PG1317"> </a><div class="pagenum"><div>P.1317</div></div>
<br clear="all">
<div class="FG" id="F348-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="326" src="files/5421f7323da893e1f72c27aac8de88d9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="5421f7323da893e1f72c27aac8de88d9.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="326" DISPLAY="INLINE"></div>
<div class="P">Figure 11-347 <span class="emph_B">PAGET&#x2019;S DISEASE. A. PA Hand: Monostotic Involvement.</span> Note the extensive cortical thickening, increase in density, with subarticular extension of the pagetoid process involving the entire third metacarpal bone. Compare the thin cortices of the normal metacarpals adjacent with the thickened cortices of the pagetoid third metacarpal. <span class="emph_B">B. PA Hand: Polyostotic Involvement.</span> Observe the increase in bone density, bone expansion, and subarticular involvement of Paget&#x2019;s disease involving the fourth metacarpal and proximal phalanx of the third digit. Of incidental notation is a bone island in the distal phalanx of the fourth digit. <span class="emph_B">C. PA Hand: Polyostotic Involvement.</span> Observe the coarsening of the trabecular patterns, cortical thickening, and subarticular extension of the pagetoid changes affecting the first, second, third, and fourth metacarpals, as well as the proximal phalanx of the fifth digit. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F349-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="534" src="files/fdac5b9d16838100419862e3f1759049.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fdac5b9d16838100419862e3f1759049.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="534" DISPLAY="INLINE"></div>
<div class="P">Figure 11-348 <span class="emph_B">PAGET&#x2019;S DISEASE: FOOT. A. Great Toe.</span> Observe the pagetoid changes involving the proximal phalanx of the great toe. There is significant expansion of the base of the proximal phalanx, with coarsening of the trabecular patterns. <span class="emph_B">B. Dorsal Plantar Foot.</span> Observe the ivorylike density of the first cuneiform. Significant expansion of the first cuneiform, along with the sclerotic changes, supports the diagnosis of Paget&#x2019;s disease (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F350-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="540" src="files/bb5efc5bcd7dee3739c331abd44542ca.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="bb5efc5bcd7dee3739c331abd44542ca.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="540" DISPLAY="INLINE"></div>
<div class="P">Figure 11-349 <span class="emph_B">PAGET&#x2019;S DISEASE: PATELLA. A. AP Knee. B. Lateral Knee.</span> Note the sclerotic alteration of the trabecular patterns affecting the entire patella, creating significant expansion. (Courtesy of John W. Hawrylak, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Phoenix, Arizona.)</div>
</td></tr>
</table></div>
<a name="PG1318"> </a><div class="pagenum"><div>P.1318</div></div>
<br clear="all">
<div class="FG" id="F351-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="535" src="files/6b25987abf13fc7eee0fbaeadd410a01.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6b25987abf13fc7eee0fbaeadd410a01.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="535" DISPLAY="INLINE"></div>
<div class="P">Figure 11-350 <span class="emph_B">PAGET&#x2019;S DISEASE: GIANT PATELLA. A. AP Knee.</span> Observe the significant expansion and cortical thickening of the patella. Pagetoid changes are also noted in the proximal tibia. <span class="emph_B">B. Lateral Knee.</span> Note the pathologic fracture through the midportion of the pagetoid patella. Observe the pagetoid changes in the proximal tibia. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F352-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[10]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="502" height="700" src="files/ef8e68f5706e3988730f3e5803ac83b1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ef8e68f5706e3988730f3e5803ac83b1.gif" MIMETYPE="image/gif" WIDTH="502" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-351 <span class="emph_B">PAGET&#x2019;S DISEASE: CERVICAL SPINE.</span> Note the accentuation of the trabecular patterns affecting the vertebral body and neural arch of C2. Observe the significant expansion of the vertebral body of C2. Similar trabecular changes of Paget&#x2019;s disease are noted in the posterior arch and tubercle of C1, along with the occiput. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F353-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[5]/TLV4[6]/FG[11]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="464" height="700" src="files/83b2b2e4f4bd809c0ad65cff8decf899.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="83b2b2e4f4bd809c0ad65cff8decf899.gif" MIMETYPE="image/gif" WIDTH="464" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-352 <span class="emph_B">PAGET&#x2019;S DISEASE: ATLAS. A. AP Open Mouth.</span> Observe the accentuation of the trabecular patterns and bone expansion affecting the lateral masses of the atlas. <span class="emph_B">B. Lateral Cervical Spine.</span> Observe the cortical trabecular changes and expansion of bone affecting the posterior arch and tubercle of the atlas. These changes are consistent with Paget&#x2019;s disease.</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3910" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]">
<div class="HD">Pathologic Features</div>
<div class="P">The lesions of Paget&#x2019;s disease are characterized by marked vascularity and fibrosis. In the early osteolytic stage normal bone is replaced by fibrous tissue and osteoid, which may be completely calcified, and hemorrhage and necrosis also occur. Because destruction and repair occur repeatedly in the same areas, there is a bizarre and pattern-less arrangement of the cement lines, which has been called the <span class="emph_I">mosaic structure of Paget&#x2019;s disease.</span> In the bone- forming phase, considerable new bone formation occurs, with a predominance of cortical accretion. As the new bone grows into the spongiosa, the demarcation line between the cortex and the spongiosa is obliterated and an actual increase in the size of the affected bone takes place. The lesions are generally highly vascular, particularly the osteolytic lesions, with a high rate of bone metabolism reflected by an elevated uptake of bone-seeking radionuclides. It has been suggested that the excessive vascularity is associated with multiple, microscopic arteriovenous malformations in the affected bone. This hypervascularity may result in high-output cardiac failure in rare instances.</div>
<a name="PG1319"> </a><div class="pagenum"><div>P.1319</div></div>
<br clear="all">
<div class="FG" id="F354-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="475" src="files/284c7fb2ec039a81f8d1d7631361f16c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="284c7fb2ec039a81f8d1d7631361f16c.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="475" DISPLAY="INLINE"></div>
<div class="P">Figure 11-353 <span class="emph_B">PAGET&#x2019;S DISEASE: SUBARTICULAR EXTENSION. A. Distal Radius.</span> Observe the pagetoid expansion and coarsening of the trabecular patterns involving the subarticular surface of the distal radius. <span class="emph_B">B. Lateral Elbow, Paget&#x2019;s Disease.</span> Note the pagetoid expansion of the olecranon process, with subarticular extension of the disease process. <span class="emph_B">C. Lateral Elbow, Fibrous Dysplasia.</span> Note the radiographic changes of fibrous dysplasia noted within the olecranon process, which are limited proximally, at the level of the metaphysis, without extending to the full distal subarticular surface of the ulna (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<div class="TLV4" id="B01382540.0-3911" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]/TLV4[1]">
<div class="HD">Stages of Paget&#x2019;s Disease</div>
<div class="P">The four stages of Paget&#x2019;s disease are well documented and are outlined as follows (<a class="LK" href="sid806035.html#T40-11">Table 11-40</a>):</div>
<div class="TLV5" id="B01382540.0-3912" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[1]">
<div class="HD"><span class="emph_I">Stage One: Osteolytic, Destructive, or Monophasic Stage.</span></div>
<div class="P">In stage one of pagetic involvement, osteoclastic overactivity creates gross loss of bone density. This destructive phase is frequently associated with the radiographic sign <span class="emph_I">osteoporosis circumscripta.</span> (<a class="LK" href="sid806035.html#F355-11">Fig. 11-354</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3913" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[2]">
<div class="HD"><span class="emph_I">Stage Two: Combined, Mixed, or Biphasic Stage.</span></div>
<div class="P">Stage two is the one most frequently encountered clinically. It is a reflection of both underlying destruction and production of bone. It is characterized by cortical thickening, with an overall increased radiopacity and accentuation of trabecular patterns with lucent areas intermixed. Bone expansion is a common finding. The entire process is basically one of extensive repair, with cheap fibrous bone replacement secondary to the osteoclastic lytic destruction. (<a class="LK" href="sid806035.html#R707-11">10</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3914" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[3]">
<div class="HD"><span class="emph_I">Stage Three: Sclerotic or Ivory Stage.</span></div>
<div class="P">In stage three there is a uniform thickening of trabeculae with increased radiopacity simulating an ivory appearance of the bone. Bone expansion may or may not be present. This stage is most commonly seen in the innominate or the vertebrae.</div>
<div class="TB" id="T40-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[3]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-40 Four Stages of Paget&#x2019;s Disease</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Stage one: osteolytic, destructive, or monophasic</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Stage two: combined, mixed, or biphasic</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Stage three: sclerotic or ivory</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Stage four: malignant degeneration</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3915" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]/TLV4[1]/TLV5[4]">
<div class="HD"><span class="emph_I">Stage Four: Malignant Degeneration.</span></div>
<div class="P">Stage four is the lethal stage and is discussed thoroughly under &#x201C;Complications.&#x201D;</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3916" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[6]/TLV4[2]">
<div class="HD">Metastatic Disease and Paget&#x2019;s Disease</div>
<div class="P">It is of interest to note the relative infrequency of metastatic disease superimposed on pre-existing uncomplicated Paget&#x2019;s disease. One might expect that, because of the pathologic state of hypervascularity in pagetic bone, the incidence of metastatic disease would be higher in bones affected by Paget&#x2019;s disease than in the normal skeleton. (<a class="LK" href="sid806035.html#R740-11">43</a>) In fact, pagetic bone is much less likely to develop metastatic lesions than normal bone. It has been suggested that as a result of the rapid osteoclastic and osteoblastic response in pagetic bone the environment or soil for the proliferation of secondary tumor cells is poor. (<a class="LK" href="sid806035.html#R740-11">43</a>) In addition, patients who develop primary carcinoma with metastasis are usually elderly. Perhaps by this time the pagetoid changes are more quiescent and the vascular supply is lessened. The definitive answer to this question remains unknown. The literature to date offers but a few case reports of metastatic disease developing in pre-existing uncomplicated Paget&#x2019;s disease, the largest series (12 cases) being reported by Wilner and Sherman. (<a class="LK" href="sid806035.html#R754-11">57</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3917" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]">
<div class="HD">Radiologic Features</div>
<div class="P">The radiologic features of Paget&#x2019;s disease strikingly mirror the pathologic changes. Plain film radiography is usually adequate; however, bone scans may be helpful in seeking the location of
<a name="PG1320"> </a><div class="pagenum"><div>P.1320</div></div>
<br clear="all">
additional lesions once a single bony site has been observed. Because pagetic bone has an increased metabolic activity, as much as five times that of adjacent normal bone, lesions of Paget&#x2019;s disease will render a positive, or hot, bone scan. (<a class="LK" href="sid806035.html#R755-11">58</a>) (<a class="LK" href="sid806035.html#F356-11">Fig. 11-355</a>) It should be reemphasized that bone scans are sensitive to abnormal areas of bone metabolism but are totally non-specific. Therefore, areas that show increased radionuclide uptake on a bone scan should be followed by routine radiologic examination to confirm Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R755-11">58</a>)</div>
<div class="FG" id="F355-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="339" src="files/c5ecd6c401d26b8028b9789afb9448c7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c5ecd6c401d26b8028b9789afb9448c7.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="339" DISPLAY="INLINE"></div>
<div class="P">Figure 11-354 <span class="emph_B">PAGET&#x2019;S DISEASE: OSTEOPOROSIS CIRCUMSCRIPTA. A. PA Skull.</span> Observe the sharply demarcated area of radiolucency present throughout the frontal bone (<span class="emph_I">arrows</span>), which is characteristic of the osteolytic phase of Paget&#x2019;s disease (<span class="emph_I">osteoporosis circumscripta</span>). <span class="emph_B">B. AP Tibia. C. Lateral Tibia.</span> Observe the sharply circumscribed area of loss of bone density present within the mid-diaphysis of the tibia. This radiolucency has been called the <span class="emph_I">candle flame, V-shaped,</span> or <span class="emph_I">blade of grass appearance.</span>
</div>
</td></tr>
</table></div>
<div class="FG" id="F356-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="267" src="files/3080e7f063d00f24da7bda2eabcfd1eb.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3080e7f063d00f24da7bda2eabcfd1eb.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="267" DISPLAY="INLINE"></div>
<div class="P">Figure 11-355 <span class="emph_B">PAGET&#x2019;S DISEASE: POSITIVE BONE SCAN. A. PA Skull. B. Lateral Skull.</span> Observe the focal area of increased uptake of the radionuclide substance consistent with an area of increased metabolic activity (<span class="emph_I">arrows</span>). This patient&#x2019;s plain films demonstrated characteristic radiographic signs of Paget&#x2019;s disease.</div>
</td></tr>
</table></div>
<div class="TLV4" id="B01382540.0-3918" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[1]">
<div class="HD">General Features</div>
<div class="P">The radiologic features of Paget&#x2019;s disease vary in appearance, depending on the stage of involvement and the bone affected; however, distinctive signs of Paget&#x2019;s disease include changes in bone density, coarsened trabeculae, cortical thickening, bone expansion, subarticular distribution, pseudo-fractures, bowing deformities, and pathologic fracture. (<a class="LK" href="sid806035.html#T41-11">Table 11-41</a>) In the initial acute osteolytic phase, a typical sharply defined lytic area with
<a name="PG1321"> </a><div class="pagenum"><div>P.1321</div></div>
<br clear="all">
a narrow zone of transition is observed. Consonant with the general predilection of Paget&#x2019;s disease for hematopoietic areas of the skeleton, the calvaria, innominates, and long bones are most often affected. Occasionally, other areas, such as the tubular bones of the hand and foot, may be involved. In the calvaria and pelvis, the lytic area tends to be spherical, whereas in a long bone the radiolucent lesion is often elongated, ending in a V with a sharp border and giving a <span class="emph_I">flame-shaped appearance.</span> The lesion virtually always starts in the end of a long bone (subarticular location) and progresses shaftward, if it does not remain stationary. An osteolytic lesion may be highly expansile as it thins and balloons the cortices. Pathologic fracture through a lesion is not uncommon. A periosteal reaction may be observed in highly aggressive lesions. In this acute phase, partially calcified osteoid may also be detected.</div>
<div class="TB" id="T41-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[1]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-41 General Radiographic Features of Paget&#x2019;s Disease</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thickened cortex</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Coarsened trabeculae</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Bone expansion</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Increased or decreased density</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Subarticular extension</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Long lesion</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Deformity</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TB" id="T42-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[1]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-42 Named Radiographic Signs of Paget&#x2019;s Disease</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Skull</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteoporosis circumscripta</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Cotton wool appearance</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Spine</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Picture frame appearance</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Ivory vertebra</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Pelvis</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Brim or rim sign obliterating Kohler&#x2019;s teardrop</p></td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Femur and tibia</p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Blade of grass appearance, V lesion, or candle flame appearance</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="P">In the spine well-defined lytic areas are unusual in the osteolytic phase. More commonly observed are one or several collapsed vertebral bodies, with the vertebral appendages frequently involved in the process. Of aid in distinguishing osteolytic Paget&#x2019;s disease of a vertebra from other causes (e.g., metastasis, plasmacytoma) is the early appearance of new bone in the Paget&#x2019;s lesion with subsequent enlargement of the vertebra.</div>
</div>
<div class="TLV4" id="B01382540.0-3919" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]">
<div class="HD">Specific Locations</div>
<div class="P">The radiographic signs of Paget&#x2019;s disease are best described by regional location. (<a class="LK" href="sid806035.html#T42-11">Table 11-42</a>)</div>
<div class="TLV5" id="B01382540.0-3920" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[1]">
<div class="HD"><span class="emph_I">Skull.</span></div>
<div class="P">The skull is commonly involved in the polyostotic form of this disease. The disease begins as a maplike or geographic
<a name="PG1322"> </a><div class="pagenum"><div>P.1322</div></div>
<br clear="all">
resorption of bone, most commonly in the frontal and occipital areas, progressing gradually to encompass the entire calvaria. The outer table is destroyed from within, whereas the inner table is spared, and the suture lines provide no barrier to the bone destruction. This process has been referred to as <span class="emph_I">osteoporosis circumscripta</span> and is representative of the early, lytic stage of Paget&#x2019;s disease of the skull. (<a class="LK" href="sid806035.html#R718-11">21</a>) (<a class="LK" href="sid806035.html#F357-11">Fig. 11-356</a>)</div>
<div class="FG" id="F357-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="486" src="files/f8f1e13cb1b0bc33d138aa0496e9153c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="f8f1e13cb1b0bc33d138aa0496e9153c.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="486" DISPLAY="INLINE"></div>
<div class="P">Figure 11-356 <span class="emph_B">PAGET&#x2019;S DISEASE: VARIED MANIFESTATIONS OF OSTEOPOROSIS CIRCUMSCRIPTA. A. Lateral Skull.</span> Note the large areas of map-like radiolucencies scattered throughout the skull table, representing osteoporosis circumscripta (<span class="emph_I">arrows</span>). <span class="emph_B">B. AP Towne&#x2019;s Projection. C. Lateral Skull.</span> Observe the large areas of loss of bone density throughout the bony calvaria, consistent with the lytic phase of Paget&#x2019;s disease (<span class="emph_I">arrows</span>). (<span class="emph_I">continued</span>)</div>
</td></tr>
</table></div>
<div class="FG" id="F358-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="240" src="files/16f3c9a07f688bc628e6290286fc1222.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="16f3c9a07f688bc628e6290286fc1222.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="240" DISPLAY="INLINE"></div>
<div class="P">Figure 11-356 (<span class="emph_I">continued</span>) <span class="emph_B">D. PA Caldwell&#x2019;s Projection.</span> Note the well-demarcated area of radiolucency throughout the frontal and parietal bone, which represents osteoporosis circumscripta of Paget&#x2019;s disease (<span class="emph_I">arrows</span>). This should not be confused with the normal landmarks of the frontal sinus (<span class="emph_I">arrowheads</span>). <span class="emph_B">E. Lateral Skull.</span> Observe the lytic areas affecting the frontal and parietal bone, characteristic of osteoporosis circumscripta of Paget&#x2019;s disease (<span class="emph_I">arrows</span>). Of incidental notation is a metallic density seen superimposed over the mastoid air cells, which represents the patient&#x2019;s hearing aid (<span class="emph_I">arrowhead</span>).</div>
</td></tr>
</table></div>
<div class="P">In the second stage (combined phase), reparative processes begin as a sclerosis of the inner table. At this stage the disease becomes quiescent, with irregular patches of radiopacity in the thickened diploe. This pattern in the skull is characteristic and diagnostic of Paget&#x2019;s disease; it is termed the <span class="emph_I">cotton wool appearance</span> because of the fuzzy, poorly defined edges of the sclerotic areas. (<a class="LK" href="sid806035.html#R718-11">21</a>) (<a class="LK" href="sid806035.html#F359-11">Fig. 11-357</a>)</div>
<div class="FG" id="F359-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="490" src="files/a5d392afd5c86534c30905c494a98fad.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a5d392afd5c86534c30905c494a98fad.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="490" DISPLAY="INLINE"></div>
<div class="P">Figure 11-357 <span class="emph_B">PAGET&#x2019;S DISEASE: COTTON WOOL APPEARANCE. A. Lateral Skull.</span> Observe the ill-defined patches of radiopacity scattered throughout the bony calvaria. These changes, with some areas of mixed radiolucencies, represent the characteristic <span class="emph_I">cotton wool</span> appearance of Paget&#x2019;s disease affecting the skull. <span class="emph_B">B. Lateral Skull.</span> Note the extensive pagetoid expansion of the bony calvaria, with the skull being involved in the mixed phase of Paget&#x2019;s disease, creating the <span class="emph_I">cotton wool</span> appearance. Observe the platybasia deformity present at the skull base, with the odontoid process being above Chamberlain&#x2019;s line. <span class="emph_B">C. Axial CT Skull.</span> Observe the extensive thickening of the tables of the skull as a result of Paget&#x2019;s disease.</div>
</td></tr>
</table></div>
</div>
<a name="PG1323"> </a><div class="pagenum"><div>P.1323</div></div>
<br clear="all">
<div class="TLV5" id="B01382540.0-3921" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[2]">
<div class="HD"><span class="emph_I">Spine.</span></div>
<div class="P">The lumbar spine is commonly involved in the mixed stages of Paget&#x2019;s disease and may involve a single vertebra or affect multiple vertebrae. (<a class="LK" href="sid806035.html#F360-11">Figs. 11-358</a> and <a class="LK" href="sid806035.html#F361-11">11-359</a>) The vertebral body is enlarged with a rim of thickened cortex, giving the appearance of a <span class="emph_I">squared-off, picture frame vertebra.</span> (<a class="LK" href="sid806035.html#R727-11">30</a>) (<a class="LK" href="sid806035.html#F362-11">Fig. 11-360</a>) Accentuation of the trabecular pattern, especially in the vertical plane, may simulate the <span class="emph_I">striated</span> appearance of a vertebral hemangioma.</div>
<div class="FG" id="F360-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="486" height="700" src="files/c7f4512d4e83b656619027735bdaeb6f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c7f4512d4e83b656619027735bdaeb6f.gif" MIMETYPE="image/gif" WIDTH="486" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-358 <span class="emph_B">POLYOSTOTIC SPINAL PAGET&#x2019;S DISEASE. Thoracic Spine.</span> Note the pagetoid changes in the T1, T3, T4, T5, and T6 vertebral bodies. Observe the coarsening of the trabecular patterns throughout these vertebral segments and, more specifically, the significant expansion of the spinous process of T1 (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F361-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="486" src="files/32f870f511ded3d2648576ef74c8c0db.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="32f870f511ded3d2648576ef74c8c0db.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="486" DISPLAY="INLINE"></div>
<div class="P">Figure 11-359 <span class="emph_B">POLYOSTOTIC PAGET&#x2019;S DISEASE: LUMBAR SPINE. A and B. Lateral Lumbar Spine.</span> Note the extensive pagetoid change, creating significant vertebral body expansion, along with coarsening of the trabecular patterns throughout the entire lumbar spine of both patients.</div>
</td></tr>
</table></div>
<div class="P">Monostotic Paget&#x2019;s disease of the spine may also be seen in the sclerotic stage. (<a class="LK" href="sid806035.html#F363-11">Fig. 11-361</a>) The vertebral body and posterior elements appear extensively radiopaque, giving the characteristic <span class="emph_I">ivory vertebra</span> appearance. (<a class="LK" href="sid806035.html#R754-11">57</a>) Although this is a classic appearance, it must be differentiated from other diseases that can develop a dense vertebral body. The three most common causes for an <span class="emph_I">ivory vertebra</span> are (<span class="emph_I">a</span>) osteoblastic metastatic carcinoma (usually from the prostate gland), (<span class="emph_I">b</span>) Paget&#x2019;s disease (osteitis deformans), and (<span class="emph_I">c</span>) Hodgkin&#x2019;s disease (lymphoma). (<a class="LK" href="sid806035.html#F364-11">Fig. 11-362</a>, <a class="LK" href="sid806035.html#T43-11">Tables 11-43</a> and <a class="LK" href="sid806035.html#T44-11">11-44</a>) With a singular vertebral body involved and no other bones affected, differentiation is essential.</div>
<div class="P">The radiographic differential diagnosis of a solitary <span class="emph_I">ivory vertebra</span> may sometimes be accomplished by inspecting the anterior aspect of the vertebra. The normal concavity of the vertebral body will be unaltered in patients with osteoblastic metastasis because bone expansion is not a common feature. Paget&#x2019;s disease, however, usually creates a squaring off or bulging of the anterior surface of the vertebral body as a result of the inherent cortical thickening and bone expansion. Rarely, Paget&#x2019;s disease may not expand the vertebral body and, if no other bony lesions are present, a biopsy may be required for final diagnosis.</div>
<div class="P">The sclerotic changes of the vertebral body affected by Hodgkin&#x2019;s occur secondary to hematogenous metastases. In Hodgkin&#x2019;s lymphoma there is often anterior scalloping of the ivory vertebral body, thus accentuating the anterior vertebral concavity. The pathogenesis of this is thought to be from contiguous lymph nodal tissue pressing on the vertebral body as a result of transmitted aortic pulsations. Not all ivory vertebrae from Hodgkin&#x2019;s disease will demonstrate anterior scalloping; however, it is a classic sign when present and should always be searched for. Clinical information is also helpful because most Hodgkin&#x2019;s patients are generally much younger (20- to 40-year age range),
<a name="PG1324"> </a><div class="pagenum"><div>P.1324</div></div>
<br clear="all">
whereas Paget&#x2019;s disease and osteoblastic metastatic carcinoma both occur in the &#x003E; 50-year age group. The alkaline phosphatase blood test is elevated in all three conditions, but the acid phosphatase should be elevated only when the blastic lesions are from the prostate gland as a primary source.</div>
<div class="FG" id="F362-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="340" src="files/d596eee524b3855ae648c1189d59a69b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d596eee524b3855ae648c1189d59a69b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="340" DISPLAY="INLINE"></div>
<div class="P">Figure 11-360 <span class="emph_B">PAGET&#x2019;S DISEASE: PICTURE FRAME VERTEBRA. A. AP Lumbar Spine.</span> Note the accentuation of the trabecular patterns throughout the L3 vertebra, with significant bone expansion, creating the characteristic <span class="emph_I">picture frame</span> appearance (<span class="emph_I">arrow</span>). <span class="emph_B">B. Lateral Lumbar Spine.</span> Observe the characteristic picture frame vertebra at the L4 vertebra. Considerable thickening of the vertebral endplates (<span class="emph_I">arrows</span>) and loss of the anterior concavity of the vertebral body, suggesting bone expansion (<span class="emph_I">arrowhead</span>), are characteristic signs of Paget&#x2019;s disease. <span class="emph_B">C. Lateral Lumbar Spine.</span> Observe the characteristic <span class="emph_I">picture frame</span> appearance at the L4 vertebra (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3922" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[3]">
<div class="HD"><span class="emph_I">Pelvis.</span></div>
<div class="P">The pelvis is one of the more common sites of pagetoid change and is usually affected by the combined stages of the disease. The involvement may affect only half of the pelvis, or the whole pelvis including the sacrum. (<a class="LK" href="sid806035.html#F365-11">Fig. 11-363</a>) The characteristic findings are cortical thickening and expansion of the pubis and ischium. The roentgen appearance is one of patchy areas of sclerosis, with intermittent lucent defects and increased trabecular markings. There is usually a thickening of cortical margins along the pelvic rim and obliteration of K&#x00F6;hler&#x2019;s teardrop, which is called the <span class="emph_I">rim,</span> or <span class="emph_I">brim, sign.</span> (<a class="LK" href="sid806035.html#R718-11">21</a>,<a class="LK" href="sid806035.html#R727-11">30</a>) (<a class="LK" href="sid806035.html#F366-11">Fig. 11-364</a>) Weakening of the pelvic bones may result in protrusio acetabuli. Sacral involvement as a monostotic presentation is also quite common. (<a class="LK" href="sid806035.html#R727-11">30</a>) (<a class="LK" href="sid806035.html#F367-11">Fig. 11-365</a>)</div>
<div class="FG" id="F363-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="474" height="700" src="files/2c6f02c7fb084e2a72b27af431f9dded.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="2c6f02c7fb084e2a72b27af431f9dded.gif" MIMETYPE="image/gif" WIDTH="474" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-361 <span class="emph_B">PAGET&#x2019;S DISEASE: IVORY VERTEBRA. Lumbar Spine.</span> Observe the diffuse radiopacity throughout the L2 vertebral body, with associated bony expansion of the spinous process.</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3923" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[4]">
<div class="HD"><span class="emph_I">Femur.</span></div>
<div class="P">The femur is usually involved in the mixed stage of this disease process. The disease begins as a subarticular lesion extending into the metaphysis and diaphysis of the bone. (<a class="LK" href="sid806035.html#F368-11">Fig. 11-366</a>) This subarticular location is characteristically found in pagetoid involvement of long or short tubular bones. It provides a strong differential point between fibrous dysplasia and other disease processes that do not include subarticular bone involvement. The roentgenographic appearance is one of expanded femoral cortices with coarse trabecular patterns, particularly in the vertical plane, and obliteration of the marrow cavity in advanced stages. (<a class="LK" href="sid806035.html#F369-11">Fig. 11-367</a>) Pseudo-fractures may be present in the subtrochanteric region of the femur, usually on the lateral or convex surface of the cortex. Bone softening results in a varus deformity of the hip, referred to as the <span class="emph_I">shepherd&#x2019;s crook deformity.</span>
</div>
</div>
<div class="TLV5" id="B01382540.0-3924" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]">
<div class="HD"><span class="emph_I">Tibia.</span></div>
<div class="P">The tibia is the second most common site of lytic Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R727-11">30</a>) The radiologic appearance is one of a radiolucent defect beginning in the subarticular end of the proximal tibia and extending down the shaft in a characteristic <span class="emph_I">candle flame</span> or V-shaped appearance, which is often referred to as a <span class="emph_I">blade of grass appearance.</span> (<a class="LK" href="sid806035.html#F370-11">Fig. 11-368</a>) This flame-shaped lytic defect indicates the advancing edge of osteoclastic resorption of bone. (<a class="LK" href="sid806035.html#F371-11">Fig. 11-369</a>) With extensive involvement anterior bowing of
<a name="PG1325"> </a><div class="pagenum"><div>P.1325</div></div>
<br clear="all">
the tibia occurs and has been called the <span class="emph_I">saber shin deformity</span> (a similar deformity is found in congenital syphilis). (<a class="LK" href="sid806035.html#F297-11">Fig. 11-296</a>) Rarely, an avulsion fracture of the tibial tuberosity can occur. (<a class="LK" href="sid806035.html#F372-11">Fig. 11-370</a>)</div>
<div class="FG" id="F364-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="647" src="files/c1bbfb194316fcf99a3cea7e97e10a60.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c1bbfb194316fcf99a3cea7e97e10a60.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="647" DISPLAY="INLINE"></div>
<div class="P">Figure 11-362 <span class="emph_B">IVORY VERTEBRA: DIFFERENTIAL DIAGNOSIS. A. Paget&#x2019;s Disease: Lateral Lumbar Spine.</span> Note the solitary ivory vertebra at the L4 vertebral body. Vertebral body expansion, with loss of the anterior concavity (<span class="emph_I">arrow</span>), suggests the diagnosis of Paget&#x2019;s disease. <span class="emph_B">B-D. Osteoblastic Metastasis: Lateral Lumbar Spine.</span> Observe the solitary or multiple ivory vertebrae throughout these lumbar spines. Preservation of the anterior concavity of the vertebral body, without evidence of cortical thickening or vertebral body expansion, suggests the diagnosis of a malignant ivory vertebra. <span class="emph_B">E. Hodgkin&#x2019;s Lymphoma: Lower Thoracic Spine.</span> Observe the solitary ivory vertebra affecting the T12 vertebral segment. There is deep anterior scalloping of the vertebral body, which accentuates the anterior concavity of this vertebral segment and occurs as a result of direct extension from malignant lymphadenopathy. (Panel A courtesy of Joseph W. Howe, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Los Angeles, California. Panel E courtesy of Paul E. Siebert, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="TB" id="T43-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-43 Differential Diagnosis of an Ivory Vertebra</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Factor</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>
<b>Blastic</b><br><b>Metastases</b>
</p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>
<b>Paget&#x2019;s</b><br><b>Disease</b>
</p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>
<b>Hodgkin&#x2019;s</b><br><b>Disease</b>
</p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Age</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x003E; 45</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x003E; 50</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>20-40</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Increased density</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Expansion</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Anterior scalloping</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Acid phosphatase</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;<i><sup><a class="a" href="sid806035.html#N1-T43-C11">a</a></sup></i>
</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
<td align="center" valign="bottom" rowspan="1" colspan="1"><p>&#x2014;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Alkaline phosphatase</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x002B;&#x002B;&#x002B;</p></td>
<td align="center" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>&#x002B;&#x002B;</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="4" rowspan="1"><p>
<i><sup><a name="N1-T43-C11" shape="rect" target="_blank">a </a></sup></i> Males, prostate.</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="4" rowspan="1"><p>&#x2014;, Does not occur; &#x002B;, seldom occurs; &#x002B;&#x002B;, often occurs; &#x002B;&#x002B;&#x002B;, very commonly occurs.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TB" id="T44-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-44 Solitary Ivory Vertebra</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Common Causes</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Uncommon Causes</b></p></th>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoblastic metastasis</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Sarcoidosis</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Hodgkin&#x2019;s lymphoma</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Chordoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Paget&#x2019;s disease</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Myeloma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Degenerative sclerosis</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteosarcoma</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteomyelitis (fungal or chronic)</p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ewing&#x2019;s sarcoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoid osteoma</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Osteoblastoma</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Bone island</p></td>
</tr>
</table></td></tr>
</table></div>
<a name="PG1326"> </a><div class="pagenum"><div>P.1326</div></div>
<br clear="all">
<div class="FG" id="F365-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="466" src="files/d752d97cc086d26e467c1059658af87d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d752d97cc086d26e467c1059658af87d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="466" DISPLAY="INLINE"></div>
<div class="P">Figure 11-363 <span class="emph_B">PAGET&#x2019;S DISEASE: DIFFUSE INVOLVEMENT. A. AP Pelvis.</span> Observe the coarsened, irregular trabecular patterns scattered throughout the pelvis, sacrum, and proximal femora. Of incidental notation are calcified mesenteric lymph nodes (<span class="emph_I">arrows</span>) and vascular calcifications (<span class="emph_I">arrowheads</span>) within the pelvic basin. <span class="emph_B">B. AP Pelvis.</span> Note this example of the diffuse coarsening of the trabecular patterns seen in extensive Paget&#x2019;s disease of all of the bones of the pelvis and proximal femora. <span class="emph_B">C. AP Pelvis.</span> Observe the Paget&#x2019;s disease within the pelvis, sacrum, and proximal femora. Because of the extensive alteration in weight bearing present within the hip joint articulations, there is premature degenerative joint disease.</div>
</td></tr>
</table></div>
<div class="FG" id="F366-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="223" src="files/6c635e9fa0945924053aae2d45ed9b1a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6c635e9fa0945924053aae2d45ed9b1a.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="223" DISPLAY="INLINE"></div>
<div class="P">Figure 11-364 <span class="emph_B">PAGET&#x2019;S DISEASE: BRIM SIGN AND OBLITERATION OF K&#x00D6;HLER&#x2019;S TEARDROP. A. AP Hip: Normal.</span> Observe the normal pelvic rim at the area of the iliopectineal line (<span class="emph_I">arrow</span>). The caudal aspect of the iliopectineal line forms the normal K&#x00F6;hler&#x2019;s teardrop (<span class="emph_I">arrowhead</span>). Observe also the trabecular patterns and cortical margins of the normal skeleton. <span class="emph_B">B. AP Hip.</span> Note the extensive pagetoid thickening of the trabecular patterns as it affects the iliopectineal line, creating the brim sign (<span class="emph_I">arrow</span>). Obliteration of K&#x00F6;hler&#x2019;s teardrop (<span class="emph_I">arrowhead</span>) as a result of pagetoid changes in the pubic rami and ischial tuberosity is noted. Compare the trabecular changes and increase in bone density of the pagetoid portion of the pelvis to the normal cortical trabecular patterns, K&#x00F6;hler&#x2019;s teardrop, pubic rami, and ischial tuberosities of the opposite side. For observers with a Sherlock Holmes eye, note the pagetoid subarticular involvement of the proximal femur in the opposite femoral head (<span class="emph_I">crossed arrow</span>). (Courtesy of Kenneth E. Yochum, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, St. Louis, Missouri.)</div>
</td></tr>
</table></div>
<a name="PG1327"> </a><div class="pagenum"><div>P.1327</div></div>
<br clear="all">
<div class="FG" id="F367-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="525" height="700" src="files/13920e657477922930b597abc09a5948.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="13920e657477922930b597abc09a5948.gif" MIMETYPE="image/gif" WIDTH="525" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-365 <span class="emph_B">PAGET&#x2019;S DISEASE. A. AP Sacrum.</span> Note the extensive coarsening of the trabecular patterns throughout the sacrum. The expansion of the sacral ala has distorted the appearance of the sacroiliac joint, giving the appearance of ankylosis. <span class="emph_B">B. AP Sacrum.</span> Observe the sclerotic changes of the sacrum, along with bony expansion, consistent with Paget&#x2019;s disease.</div>
</td></tr>
</table></div>
<div class="FG" id="F368-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="498" src="files/0211636938b688a323513a4366a0d416.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="0211636938b688a323513a4366a0d416.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="498" DISPLAY="INLINE"></div>
<div class="P">Figure 11-366 <span class="emph_B">PAGET&#x2019;S DISEASE: SUBARTICULAR INVOLVEMENT. A. AP Knee. B. Lateral Knee.</span> Observe the sclerotic appearance of the visualized distal femur, with subarticular extension of the pagetoid process. There is extensive cortical thickening noted in the distal diaphysis of the femur (<span class="emph_I">arrows</span>), compared with the normal cortical width on the posterior surface of the proximal tibia (<span class="emph_I">arrowhead</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F369-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="524" src="files/1f77e55482f691b134edd21394b97337.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="1f77e55482f691b134edd21394b97337.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="524" DISPLAY="INLINE"></div>
<div class="P">Figure 11-367 <span class="emph_B">PAGET&#x2019;S DISEASE: FEMUR. A. AP Hip.</span> Note the coarsening of the trabecular patterns, particularly in the vertical plane, seen throughout the femoral head and neck. Of incidental notation is extensive vascular calcification in the soft tissues of the inner thigh (<span class="emph_I">arrows</span>). <span class="emph_B">B. AP Hip.</span> Observe the increase in radiopacity involving the femoral head and cortices of the diaphysis. Coarsening of the trabecular patterns, along with expansion of bone, is a sign of Paget&#x2019;s disease.</div>
</td></tr>
</table></div>
<div class="FG" id="F370-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="438" height="700" src="files/ee07fb263b5e64f4f758253a23465651.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ee07fb263b5e64f4f758253a23465651.gif" MIMETYPE="image/gif" WIDTH="438" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-368 <span class="emph_B">PAGET&#x2019;S DISEASE: BLADE OF GRASS APPEARANCE. Tibia.</span> Observe the radiolucent defect at the caudal aspect of the pagetoid tibia (<span class="emph_I">arrow</span>). This presentation in Paget&#x2019;s disease has been referred to as the <span class="emph_I">blade of grass appearance</span> or <span class="emph_I">candle flame</span> or <span class="emph_I">V-shaped</span> lytic defect. (Courtesy of Joseph W. Howe, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Fellow, ACCR, Los Angeles, California.)</div>
</td></tr>
</table></div>
<a name="PG1328"> </a><div class="pagenum"><div>P.1328</div></div>
<br clear="all">
<div class="FG" id="F371-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[7]/TLV4[2]/TLV5[5]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="613" src="files/05478a3a6fec3bc3c254e11a74381dd5.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="05478a3a6fec3bc3c254e11a74381dd5.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="613" DISPLAY="INLINE"></div>
<div class="P">
<span class="emph_B">Figure 11-369 PAGET&#x2019;S DISEASE: CANDLE FLAME OR V-SHAPED LYTIC DEFECT. A. AP Ankle.</span> Note the extensive deossification of bone affecting the distal portion of the tibia and fibula. Observe the advancing flame-shaped lytic defect present in the proximal portion of the tibia and fibula, which indicates the advancing edge of osteoclastic resorption of bone (<span class="emph_I">osteoporosis circumscripta</span>). There is a malalignment of the distal fibula, suggesting an area of previous fracture. <span class="emph_B">B. Lateral Tibia and Fibula.</span> Observe the focal osteoporosis present in the middle and lower diaphysis of the tibia. The sharp border to this lytic defect assumes a <span class="emph_I">candle flame</span> or <span class="emph_I">V-shaped</span> appearance. This is typical of the early lytic phase of Paget&#x2019;s disease, particularly in the tibia.</div>
</td></tr>
</table></div>
</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3925" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[8]">
<div class="HD">Differential Diagnosis</div>
<div class="P">Paget&#x2019;s disease should be included in a differential diagnosis in any osteosclerotic condition of the skeletal system in adults because the most common presentation of Paget&#x2019;s disease is in the mixed stage (<a class="LK" href="sid806035.html#F373-11">Fig. 11-371</a>). However, it must be remembered that radiology is only one method of diagnosis and clinical correlation is essential.</div>
<div class="P">The two most common entities that may be difficult in differentiation are osteolytic or osteoblastic metastatic carcinoma and, in the spine, hemangioma of bone. The main diagnostic differential points in metastatic carcinoma are the lack of thickening of the cortex and frequent disruption of the cortex as a result of aggressive destruction. There is also a characteristic lack of significant bone expansion found with metastasis, which is usually one of the classic radiologic signs found in Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#F374-11">Fig. 11-372</a>) In addition, a lesion in a tubular bone that is not located in the subarticular region is less likely to be Paget&#x2019;s disease.</div>
<div class="P">Hemangioma of the vertebral bodies produces a vertically striated pattern, which may closely mimic the coarse vertical trabeculae of Paget&#x2019;s disease. A small percentage of the capillary type of hemangioma of the vertebral bodies may also allow expansion of bone. When this occurs, the differential diagnosis of a monostotic lesion of Paget&#x2019;s disease from a hemangioma may be extremely difficult. A helpful roentgen sign is the lack of cortical
<a name="PG1329"> </a><div class="pagenum"><div>P.1329</div></div>
<br clear="all">
thickening of the vertebral endplate in hemangioma, the presence of which is often the hallmark of spinal Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#F375-11">Fig. 11-373</a>) Most solitary hemangiomas are of the cavernous type and show no significant expansion of bone, providing a useful differential point. (<a class="LK" href="sid806035.html#R751-11">54</a>)</div>
<div class="FG" id="F372-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[8]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="412" height="700" src="files/b5f3e5262312c5a374915d3ffc37d95e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b5f3e5262312c5a374915d3ffc37d95e.gif" MIMETYPE="image/gif" WIDTH="412" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-370 <span class="emph_B">PAGET&#x2019;S DISEASE: AVULSION FRACTURE. Lateral Tibia.</span> Observe the pagetoid changes present in the proximal portion of the tibia. An avulsion of the tibial tuberosity is noted (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F373-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[8]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="469" height="700" src="files/3dede2b912da648fd3c401d10194d5c1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="3dede2b912da648fd3c401d10194d5c1.gif" MIMETYPE="image/gif" WIDTH="469" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-371 <span class="emph_B">PAGET&#x2019;S DISEASE OCCURRING WITHIN A BLOCK VERTEBRA. Lateral Cervical Spine.</span> There is a congenital block vertebra present at C4 and C5 with fusion of the vertebral bodies, facets, lamina, and spinous processes. Paget&#x2019;s disease has developed at C4 and C5 with complete involvement of each vertebra. (Courtesy of Michael T. Buehler, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Durango, Colorado.)</div>
</td></tr>
</table></div>
<div class="FG" id="F374-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[8]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="506" src="files/9c649effc883dea3f2bf82670ef7bed4.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9c649effc883dea3f2bf82670ef7bed4.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="506" DISPLAY="INLINE"></div>
<div class="P">Figure 11-372 <span class="emph_B">PAGET&#x2019;S DISEASE VERSUS OSTEOBLASTIC METASTATIC DISEASE. A. Lateral Lumbar Spine.</span> Observe the homogeneous ivory vertebra at the L3 level (<span class="emph_I">arrow</span>). There is preservation of the anterior concavity of the vertebral body, without bone expansion. These signs suggest a malignant, metastatic, ivory vertebra. Observe the cortical thickening of the vertebral endplates, coarsening of the trabecular patterns, and loss of the anterior concavity of the L2 vertebra (<span class="emph_I">arrowhead</span>). These radiographic signs confirm Paget&#x2019;s disease. Of incidental notation is diffuse atherosclerotic plaquing in the abdominal aorta. <span class="emph_B">B. Lateral Thoracolumbar Spine.</span> Observe the nodular, radiopaque, metastatic lesions, creating an ivory appearance within the T11 and T12 vertebral bodies (<span class="emph_I">arrows</span>), representing osteoblastic metastatic disease. There is cortical thickening, with posterior vertebral endplate expansion at the L1 vertebral body, consistent with the radiographic signs of Paget&#x2019;s disease (<span class="emph_I">arrowhead</span>). The radiopaque densities in the spinal canal represent residual contrast media from a previous myelographic examination. <span class="emph_I">COMMENT:</span> The cardinal radiographic features differentiating osteoblastic metastatic disease from Paget&#x2019;s disease are cortical thickening and bone expansion in Paget&#x2019;s disease, signs seldom found in osteoblastic metastasis.</div>
</td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3926" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]">
<div class="HD">Treatment and Prognosis</div>
<div class="P">The main thrust in the medical treatment of Paget&#x2019;s disease has been to inhibit bone resorption with the use of salmon and human calcitonin. (<a class="LK" href="sid806035.html#R756-11">59</a>) Paget&#x2019;s disease arises when some unknown stimulus causes a considerable increase in the number and activity of osteoclasts. The ability of calcitonin to inhibit osteoclastic bone resorption by decreasing the activity and proliferation of osteoclasts led to the proposal that it be used in the treatment of Paget&#x2019;s disease, and experience over the last 10 years has in fact confirmed its therapeutic effect. (<a class="LK" href="sid806035.html#R756-11">59</a>)</div>
<div class="P">Calcitonin has proved effective in giving pain relief, beginning usually between 2 and 8 weeks after the initiation of treatment. If pain relief has not been achieved within 3 months of starting treatment with calcitonin, it is almost certainly not going to be accomplished. For that reason, when using therapeutic trials of calcitonin for pain, a period of 3 months has been chosen as the optimum time. There seems no point in providing calcitonin treatment for any shorter period in Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#R756-11">59</a>)</div>
<div class="P">Generally, most drug therapy (calcitonin and diphosphonate) is used to suppress osteoclastic activity with the hope that osteoblastic activity will normalize soon after. Preradiographic and postradiographic changes showing improvement in patients with Paget&#x2019;s disease on medication have been demonstrated by numerous authors. There are, however, a number of patients who do not respond; the explanation for this is not presently available. (<a class="LK" href="sid806035.html#R756-11">59</a>)</div>
<div class="P">Supportive braces to prevent extensive bone deformity in the weight-bearing bones is an adjunctive aid to the clinician in managing patients with extensive Paget&#x2019;s disease.</div>
<div class="P">The natural progress of Paget&#x2019;s disease is extremely slow and poorly documented. It is exceedingly difficult to predict the behavior of Paget&#x2019;s, as it is quite certain that many of the monostotic lesions of this disease may be asymptomatic throughout life. The radiologic appearance may remain static for a decade or more. The normal course for the disease seems to be one of slow progression over many years, with increasing sclerosis, bony enlargement, and deformity. Until the true cause of this disease is ascertained, treatment will remain limited and prognosis uncertain. Further research is necessary to establish the specific origin of this peculiar and relatively common disease.</div>
<a name="PG1330"> </a><div class="pagenum"><div>P.1330</div></div>
<br clear="all">
<div class="FG" id="F375-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="631" src="files/7fffe960200158adcb5361486843961e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7fffe960200158adcb5361486843961e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="631" DISPLAY="INLINE"></div>
<div class="P">Figure 11-373 <span class="emph_B">PAGET&#x2019;S DISEASE VERSUS HEMANGIOMA: DIFFERENTIAL DIAGNOSIS. A. AP Lumbar Spine: Paget&#x2019;s Disease.</span> Note the extensive coarsening of the trabecular patterns in the vertical distribution throughout the vertebral body. <span class="emph_B">B. Lateral Lumbar Spine: Paget&#x2019;s Disease.</span> Note the vertical accentuation of the trabecular patterns, accompanied by thickening of the vertebral endplates (<span class="emph_I">arrowheads</span>) and an overall expansion of the vertebral body and visualized neural arch (<span class="emph_I">arrows</span>). There is distinct loss of the anterior concavity of the vertebral body associated with bone expansion (crossed <span class="emph_I">arrow</span>). <span class="emph_B">C. Lateral Lumbar Spine: Hemangioma.</span> Note the accentuation of the vertical trabecular patterns throughout the vertebral body of L2. There is also loss of the concavity of the anterior surface of the vertebral body as a result of bony expansion (<span class="emph_I">arrow</span>). Observe the normal width of the vertebral endplates of the affected L2 vertebral body. This appearance within the vertebra has been referred to as the <span class="emph_I">corduroy cloth</span> appearance of hemangioma. <span class="emph_B">D. Lateral Lumbar Spine: Hemangioma.</span> Observe the characteristic <span class="emph_I">corduroy cloth</span> appearance of a vertebral body hemangioma affecting the L3 segment (<span class="emph_I">arrow</span>). The normal anterior concavity of the vertebral body is preserved, with no bony expansion noted. Of incidental notation is scattered atherosclerotic plaquing throughout the abdominal aorta. <span class="emph_I">COMMENT:</span> The cardinal roentgen signs for the differential diagnosis of hemangioma versus Paget&#x2019;s disease in its combined phase of presentation in the spine are (<span class="emph_I">a</span>) a lack of cortical thickening of the vertebral endplate in hemangioma is contrasted to extensive endplate thickening in Paget&#x2019;s disease and (<span class="emph_I">b</span>) the radiographic sign of vertebral body expansion may be found in both Paget&#x2019;s disease and hemangioma; however, it is more commonly found in Paget&#x2019;s disease. (Panel D courtesy of Stephen F. Kesler, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Salt Lake City, Utah.)</div>
</td></tr>
</table></div>
<a name="PG1331"> </a><div class="pagenum"><div>P.1331</div></div>
<br clear="all">
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3927" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Paget&#x2019;s Disease</div>
<div class="TLV2" id="B01382540.0-3928" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Sir James Paget in 1877 described a disorder of bone that today bears his name.</div></li>
<li class="LM"><div class="P">Also known as osteitis deformans, it is a great imitator of bone diseases, along with fibrous dysplasia.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3929" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">3&#x0025; of the adult population &#x003E; 40 years old have the disease.</div></li>
<li class="LM"><div class="P">Highest incidence is in United Kingdom (5&#x0025; of the population); high in Australia and New Zealand; rare in Asia, Africa, and Scandinavia.</div></li>
<li class="LM"><div class="P">In the United States it is more common in the northern states and is somewhat uncommon in the southern states.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3930" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Cause</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Many theories have been offered, but none substantiated: inflammatory disorder, endocrine disorder, autoimmune disorder, inborn error of connective tissue metabolism, vascular disorder, metabolic disorder, neoplasm, and chronic viral infection&#x2014;a measles-like virus, which is the most current theory.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3931" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">2:1 male predominance.</div></li>
<li class="LM"><div class="P">Rare before age 40, most common after 55.</div></li>
<li class="LM"><div class="P">90&#x0025; of patients are asymptomatic.</div></li>
<li class="LM"><div class="P">Pain, when present, is of low intensity and may be associated with bowing deformities or fractures.</div></li>
<li class="LM"><div class="P">An increasing hat size is common because of enlargement of the calvaria.</div></li>
<li class="LM"><div class="P">The most common bones affected in uncomplicated disease are the pelvis, vertebrae, clavicle, humerus, and ribs; the fibula is the bone least likely to be involved.</div></li>
<li class="LM"><div class="P">Subarticular location is characteristic, which usually extends into the diaphysis.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3932" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Complications</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Deformity of bone is a common complication, including shepherd&#x2019;s crook deformity of the proximal femur (coxa vara), saber shin deformity (anterior tibial bowing), protrusio acetabuli, leontiasis ossea, frontal and parietal bossing, and basilar invagination.</div></li>
<li class="LM"><div class="P">Pathologic fracture of the vertebral body and transverse banana-like fracture of long bones is common.</div></li>
<li class="LM"><div class="P">Pseudo-fractures are noted representing local areas of demineralization within the bone, which are replaced by fibrous tissue.</div></li>
<li class="LM"><div class="P">Spinal stenosis may occur as a result of bony expansion of a vertebra, leading to compressive neuropathy.</div></li>
<li class="LM"><div class="P">Anemia may rarely occur as a result of fibrous tissue replacing the bone marrow.</div></li>
<li class="LM"><div class="P">Paget&#x2019;s coxopathy represents articular cartilage destruction with secondary degenerative changes.</div></li>
<li class="LM"><div class="P">Ureteric colic occurs secondary to hypercalcemia and hypercalcuria, creating urinary calculus formation, which seems to occur more readily in patients who have been immobilized.</div></li>
<li class="LM"><div class="P">High-output cardiac failure is a rare complication, occurring when at least one third of the skeleton is involved.</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Malignant degeneration:</span> incidence is 0.9 to 2&#x0025;; rare under age 40, average age, 57-66. Symptoms of localized pain in a patient with known Paget&#x2019;s disease may herald the development of malignant degeneration; most common bones are the femur, humerus, innominate, skull, and tibia; only nine cases are reported in the vertebrae. Osteosarcoma is the most common tumor to complicate Paget&#x2019;s disease (50&#x0025; of cases); radiologically, 50&#x0025; of lesions are lytic, 25&#x0025; sclerotic, and 25&#x0025; mixed; treatment is radiation therapy or surgical resection; 5year survival rate is poor (8&#x0025;).</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3933" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[6]">
<div class="HD">Laboratory Findings</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Owing to osteoclastic resorption there is an enhanced destruction of bone collagen, leading to an increase in urinary excretion of hydroxyproline.</div></li>
<li class="LM"><div class="P">A significant increase in alkaline phosphatase occurs, occasionally 20 times the normal values.</div></li>
<li class="LM"><div class="P">Hypercalcemia may occur.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3934" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[7]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">The pattern-less replacement of normal bone by pagetic, vascular, and fibrotic bone has been called the mosaic structure of Paget&#x2019;s disease.</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Four stages:</span> stage one&#x2014;osteolytic, destructive, monophasic; stage two&#x2014;combined, mixed, biphasic; stage three&#x2014;sclerotic or ivory; stage four&#x2014;malignant degeneration.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3935" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[8]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">
<span class="emph_I">Bone scan:</span> pagetic lesions will be hot on bone scan.</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Skull:</span> early skull lesions demonstrate the lytic stage of osteoporosis circumscripta, whereas more advanced changes of the combined stage create the cotton wool appearance.</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Spine:</span> vertebral involvement causes a thickened and enlarged vertebral endplate, creating the squared-off, picture frame vertebra; these changes occur in the biphasic stage.</div></li>
<li class="LM"><div class="P">Homogenous increase in radiopacity of a vertebral body creates the ivory vertebra. The three most common causes for an ivory vertebra are osteoblastic metastatic carcinoma, Paget&#x2019;s disease, and Hodgkin&#x2019;s lymphoma.</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Pelvis:</span> the fundamental roentgen signs of Paget&#x2019;s disease are cortical thickening and bone expansion. These changes are classically manifested in the pelvis with thickening of the iliopectineal line, obliterating K&#x00F6;hler&#x2019;s teardrop, which has been called the rim or brim sign.</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Long bones:</span> the tibia is the second most common site of lytic Paget&#x2019;s disease (the skull being the most common). The changes of a radiolucent defect usually begin in the subarticular end of the proximal tibia, extending down the shaft in a characteristic candle flame or V-shaped appearance, often referred to as a blade of grass appearance.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3936" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[1]/TLV3[9]/SIDEBAR[1]/TLV1[1]/TLV2[9]">
<div class="HD">Treatment and Prognosis</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Medical treatment has consisted of salmon and human calcitonin, an osteoclast inhibitor.</div></li>
<li class="LM"><div class="P">Supportive braces to prevent extensive bone deformity are helpful.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
<a name="PG1332"> </a><div class="pagenum"><div>P.1332</div></div>
<br clear="all">
<div class="TLV2" id="B01382540.0-3937" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]">
<div class="HD">FIBROUS DYSPLASIA</div>
<div class="TLV3" id="B01382540.0-3938" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Fibrous dysplasia of bone is a disorder of unknown cause in which skeletal aberrations constitute the cardinal feature. Certain endocrinopathies and abnormal pigmentations of the skin may form a part of the total disease process. Because of this, three basic forms of the disease are currently recognized: the monostotic form (affecting one bone), the polyostotic form (affecting many bones), and the polyostotic form with associated endocrine abnormalities.</div>
<div class="P">Fibrous dysplasia of bone is a fairly common, well-recognized, locally circumscribed, slowly progressing, benign disorder of fibro-osseous tissue. Fibrous dysplasia was not recognized as a distinct clinical entity until Lichtenstein (<a class="LK" href="sid806035.html#R757-11">1</a>) in 1938 reported eight cases with detailed studies of bone lesions. He proposed the term fibrous dysplasia, or polyostotic fibrous dysplasia in the presence of multiple bone lesions. Although recognized clinically as a distinct entity only in recent decades, fibrous dysplasia has affected the human skeleton for centuries. Several reports of the disease have appeared in literature of paleontopathology. In the years before 1938 many patients who actually had fibrous dysplasia of bone were diagnosed as having osteitis fibrosa cystica (von Recklinghausen). Because both diseases produce significant deossification of the skeleton with multiple cyst-like accumulations in bone, it is easy to understand how these two diseases could have been originally poorly differentiated. Similarly, cases of hyperparathyroidism producing multiple osseous brown tumors were also mistakenly diagnosed as fibrous dysplasia before a full understanding of these diseases was gained. (<a class="LK" href="sid806035.html#R758-11">2</a>) The present and outdated terms for fibrous dysplasia, hyperparathyroidism, and neurofibromatosis are outlined in <a class="LK" href="sid806035.html#T45-11">Table 11-45</a>. Because of their varied radiographic manifestations and ability to mimic other disease processes, fibrous dysplasia and Paget&#x2019;s disease have been referred to as the &#x201C;<span class="emph_I">great imitators</span> of bone disease.&#x201D;</div>
</div>
<div class="TLV3" id="B01382540.0-3939" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">The fact that the number of reported cases exceeded 1500 by 1971 confirms that fibrous dysplasia is a common disease. (<a class="LK" href="sid806035.html#R759-11">3</a>) Available data seem to indicate that the monostotic form accounts for about 70&#x0025;, the polyostotic form without endocrine disturbances about 27&#x0025;, and the polyostotic form with endocrine disturbances (McCune-Albright syndrome) about 3&#x0025;. (<a class="LK" href="sid806035.html#R760-11">4</a>) The actual incidence of each form, however, cannot be assessed precisely because the monostotic form may remain asymptomatic, only to be detected accidentally, and thus can often escape clinical detection. Even the polyostotic form may occasionally exist unnoticed for decades and present as an incidental finding.</div>
<div class="TB" id="T45-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[2]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-45 Terms Used to Describe Fibrous Dysplasia</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Present</b></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Past</b></p></th>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Monostotic fibrous dysplasia</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteitis fibrosa cystica localisata</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Polyostotic fibrous dysplasia and Albright&#x2019;s syndrome</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteitis fibrosa cystica disseminata</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Hyperparathyroidism</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Osteitis fibrosa cystica generalisata or von Recklinghausen&#x2019;s disease of bone</p></td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Neurofibromatosis of von Recklinghausen</p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Fibrocystic disease (multiple)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Adapted from <b>Wilner D:</b> <i>Radiology of Bone Tumors and Related Disorders.</i> Philadelphia, WB Saunders, 1982.</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<div class="TLV3" id="B01382540.0-3940" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3941" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Fibrous dysplasia generally makes its appearance in late childhood; some severe forms, however, may manifest themselves in infancy. Each form of the disease has a different average age of onset. The monostotic form manifests itself initially around the age of 14, the polyostotic form without endocrine disorders, around the age of 11, and the polyostotic form associated with endocrine disturbances, around the age of 8. (<a class="LK" href="sid806035.html#R761-11">5</a>) Although it is not uncommon for certain lesions to be detected during later decades of life, there is good evidence that the majority, if not all, bone lesions develop during the period of skeletal growth. (<a class="LK" href="sid806035.html#R762-11">6</a>)</div>
<div class="P">According to Uehlinger (<a class="LK" href="sid806035.html#R763-11">7</a>), monostotic and polyostotic fibrous dysplasia not accompanied by endocrine disorders reveals an even sex distribution. By contrast, polyostotic fibrous dysplasia with endocrine disorders displays an obvious predilection for females.</div>
</div>
<div class="TLV4" id="B01382540.0-3942" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[2]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The symptoms of fibrous dysplasia depend on the location of the lesion and often its size. Many lesions are completely asymptomatic and are found accidentally after a radiologic examination is initiated for some other reason. Lesions in the upper end of the femur often present with a limp and complaints of intermittent pain. Persistent pain with long bone involvement often occurs as a result of pathologic fracture.</div>
<div class="P">Polyostotic disease usually presents with a more pronounced deformity and bowing of the bones and a greater tendency toward pathologic fracture. Harris et al. (<a class="LK" href="sid806035.html#R764-11">8</a>) found leg length discrepancy to be the most common physical deformity, this being the result of an extreme coxa vara and bowing deformity of the femur. This appearance has been referred to as the <span class="emph_I">shepherd&#x2019;s crook deformity.</span> (<a class="LK" href="sid806035.html#R761-11">5</a>)</div>
<div class="P">Asymmetric enlargement and deformity of the cranial and facial bones may lead to unilateral cranial hyperostosis. Asymmetric enlargement and deformity of the cranial and facial bones may lend the face a <span class="emph_I">leonine</span> appearance. <span class="emph_I">Leontiasis ossea,</span> however, occurs in a number of other skeletal disorders and is, therefore, not a specific feature of this disease. Rib involvement may produce a localized bony prominence in the thoracic cage. In rare instances a lesion can reach enormous proportions, to the extent that enlargement of a single rib can obliterate a large portion of the thoracic cavity. (<a class="LK" href="sid806035.html#R765-11">9</a>) Occasionally, involvement of the ethmoid and sphenoid bone can cause obstruction of the entire nasal cavity.</div>
</div>
<div class="TLV4" id="B01382540.0-3943" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[3]">
<div class="HD">Cutaneous Abnormalities</div>
<div class="TLV5" id="B01382540.0-3944" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[3]/TLV5[1]">
<div class="HD"><span class="emph_I">Caf&#x00E9; au Lait Spots.</span></div>
<div class="P">Abnormal cutaneous pigmentation is the most common of the extraskeletal expressions of fibrous dysplasia. These pigmented skin macules are referred to as <span class="emph_I">caf&#x00E9; au lait</span>
<a name="PG1333"> </a><div class="pagenum"><div>P.1333</div></div>
<br clear="all">
<span class="emph_I">spots</span> and may occasionally be confused with those found in neurofibromatosis. The pigmented areas are caused by an increased amount of melanin in the basal cells of the epidermis. The color varies from dark brown to chestnut or yellowish. They are not raised above the adjacent skin, and they are generally distributed about the midline. The most common locations for the lesions are the lower lumbar region, buttocks, back of the neck, shoulders, chest, and oral mucosa. (<a class="LK" href="sid806035.html#R760-11">4</a>) Their margins are irregular and they are few in number. Their size, however, may vary considerably and, generally, their location coincides with the side of skeletal involvement. Similarly, when the bone lesions are distributed bilaterally, so are the skin pigmentations. (<a class="LK" href="sid806035.html#R760-11">4</a>) The irregular margins have been referred to as the <span class="emph_I">coast of Maine appearance,</span> which is in contrast to the smooth, well-defined margins found in the caf&#x00E9; au lait spots of neurofibromatosis, representing the <span class="emph_I">coast of California appearance.</span> (<a class="LK" href="sid806035.html#F376-11">Fig. 11-374</a>) The lesions found in fibrous dysplasia tend to be somewhat darker than the caf&#x00E9; au lait spots of neurofibromatosis. In order for the clinician to feel confident that the skin pigmentations of neurofibromatosis actually represent caf&#x00E9; au lait spots, there must be a minimum of six lesions, each being 1.5 cm or larger in size. Therefore, the irregularity of the margins of the caf&#x00E9; au lait spots and, histologically, the absence of the giant pigment granules in the malpighian cells or melanocytes differentiates caf&#x00E9; au lait spots in fibrous dysplasia from the similar pigmented skin areas encountered in neurofibromatosis. (<a class="LK" href="sid806035.html#R760-11">4</a>)</div>
<div class="P">The caf&#x00E9; au lait spots are usually present at birth, but may develop later and precede the skeletal and endocrinologic manifestations. Although quite unusual, caf&#x00E9; au lait spots may be found in the monostotic form. (<a class="LK" href="sid806035.html#R764-11">8</a>) In the polyostotic form without endocrine disturbances, they are present in &#x003E; 30&#x0025; of patients. In the polyostotic form with endocrine disturbances, they are found in nearly all patients. (<a class="LK" href="sid806035.html#R760-11">4</a>)</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3945" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[4]">
<div class="HD">Location and Distribution</div>
<div class="P">Fibrous dysplasia may present as a solitary lesion (monostotic form) or as multiple lesions in several bones (polyostotic form). (<a class="LK" href="sid806035.html#F377-11">Fig. 11-375</a>) Polyostotic fibrous dysplasia may be limited to a
<a name="PG1334"> </a><div class="pagenum"><div>P.1334</div></div>
<br clear="all">
single limb (monomelic distribution) or may involve both sides of the skeleton (bilateral distribution).</div>
<div class="FG" id="F376-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="356" src="files/9a4dfddb909b64967d675675497a890d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9a4dfddb909b64967d675675497a890d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="356" DISPLAY="INLINE"></div>
<div class="P">Figure 11-374 <span class="emph_B">CAF&#x0026;Eacute; AU LAIT SPOTS IN FIBROUS DYSPLASIA. A. Fibrous Dysplasia.</span> Observe the large caf&#x00E9; au lait spot surrounding the thorax of this patient with fibrous dysplasia. Note the irregular margins, which have been referred to as the <span class="emph_I">coast of Maine appearance</span> in fibrous dysplasia. <span class="emph_B">B. Neurofibromatosis.</span> Observe the multiple caf&#x00E9; au lait spots on this patient&#x2019;s back. The margins to these skin lesions are smooth, representing the <span class="emph_I">coast of California appearance</span> of caf&#x00E9; au lait spots in neurofibromatosis. <span class="emph_I">COMMENT:</span> Note those spots in fibrous dysplasia tend to be larger than neurofibromatosis.</div>
</td></tr>
</table></div>
<div class="FG" id="F377-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[4]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="297" height="700" src="files/7172e1250dee8ae91665aaa049697e55.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="7172e1250dee8ae91665aaa049697e55.gif" MIMETYPE="image/gif" WIDTH="297" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-375 <span class="emph_B">SKELETAL DISTRIBUTION OF FIBROUS DYSPLASIA (POLYOSTOTIC).</span>
</div>
</td></tr>
</table></div>
<div class="TLV5" id="B01382540.0-3946" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[4]/TLV5[1]">
<div class="HD"><span class="emph_I">Monostotic Fibrous Dysplasia.</span></div>
<div class="P">The monostotic form is neither a forme fruste nor a precursor of the polyostotic form. So far, there has been no report of a transition from a monostotic to a polyostotic manifestation of fibrous dysplasia. In spite of an identical histologic appearance, the two forms are different clinically; the monostotic form is much less likely to develop fractures and deformities. It would, therefore, appear appropriate to regard the two forms as relatively independent clinical entities.</div>
<div class="P">Of patients with monostotic fibrous dysplasia 75&#x0025; present with lesions in the ribs, femur (proximal), tibia, or skull. An additional 10&#x0025; of lesions are found within the pelvis and humerus. With monostotic involvement of the jaws the maxilla is usually twice as frequently affected (64&#x0025;) as the mandible (36&#x0025;). A rare, cortical form of fibrous dysplasia exists, which is in direct contrast to the usual diametaphyseal medullary location. This cortical fibrous dysplasia occurs in the anterior proximal surface of the tibia. (<a class="LK" href="sid806035.html#F378-11">Fig. 11-376</a>) Fibrous dysplasia of the rib is the most common benign rib lesion and usually measures &#x003E; 4 cm in length. (<a class="LK" href="sid806035.html#F379-11">Fig. 11-377</a>) Isolated cases in the clavicle, scapula, tarsal and carpal bones, other long bones, and the spine (<a class="LK" href="sid806035.html#R766-11">10</a>,<a class="LK" href="sid806035.html#R767-11">11</a>) have been reported. (<a class="LK" href="sid806035.html#F380-11">Fig. 11-378</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3947" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[4]/TLV5[2]">
<div class="HD"><span class="emph_I">Polyostotic Fibrous Dysplasia.</span></div>
<div class="P">The polyostotic form most commonly affects the femur, skull, tibia, humerus, ribs, fibula, radius, and ulna, in decreasing order of incidence. This form distinguishes itself from the monostotic form by the following features: (<span class="emph_I">a</span>) in the extension of the skeletal involvement to the shoulder and pelvic girdle and in the more frequent involvement of the craniofacial skeleton and vertebral column; (<span class="emph_I">b</span>) in the tendency to affect entire limbs; (<span class="emph_I">c</span>) in the severity of deformities, which may lead to extensive crippling (e.g., shepherd&#x2019;s crook deformity of the proximal femur); and (<span class="emph_I">d</span>) in the higher incidence of spontaneous and often recurrent fractures. (<a class="LK" href="sid806035.html#R763-11">7</a>)</div>
<div class="P">Spinal changes in polyostotic fibrous dysplasia are somewhat uncommon; when present, however, they usually affect more than one spinal segment, and then they affect the vertebral body.</div>
<div class="P">The number of bones involved in polyostotic fibrous dysplasia varies; it may be high. Hopf (<a class="LK" href="sid806035.html#R768-11">12</a>) described a 43-year-old female with 79 separate lesions involving 75 bones, who was followed radiographically for &#x003E; 20 years. This represents about a 39&#x0025; in
<a name="PG1335"> </a><div class="pagenum"><div>P.1335</div></div>
<br clear="all">
volvement of the entire skeleton. In some instances of monomelic distribution, every bone of the entire extremity may be involved. The incidence of craniofacial involvement is about 10&#x0025; in monostotic disease and about 50&#x0025; in polyostotic disease with moderate skeletal involvement, but reaches 100&#x0025; in polyostotic disease with extensive skeletal involvement. (<a class="LK" href="sid806035.html#R769-11">13</a>,<a class="LK" href="sid806035.html#R770-11">14</a>) The majority of the cranial lesions display an asymmetric distribution and include the mandible in approximately 20&#x0025; of cases. (<a class="LK" href="sid806035.html#R769-11">13</a>)</div>
<div class="FG" id="F378-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[4]/TLV5[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="585" height="653" src="files/fdc54c7bccd26a70349e7bd09c1888f9.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fdc54c7bccd26a70349e7bd09c1888f9.gif" MIMETYPE="image/gif" WIDTH="585" HEIGHT="653" DISPLAY="INLINE"></div>
<div class="P">Figure 11-376 <span class="emph_B">CORTICAL FIBROUS DYSPLASIA. Tibia.</span> Observe the geographic, radiolucent lesions in the anterior tibial cortex (<span class="emph_I">arrow</span>). <span class="emph_I">COMMENT:</span> The anterior proximal surface of the tibia is the most common site for cortical fibrous dysplasia, which is rare.</div>
</td></tr>
</table></div>
<div class="FG" id="F379-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[4]/TLV5[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="491" src="files/fbddd956ab6445b94f7f39da8d8b4764.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fbddd956ab6445b94f7f39da8d8b4764.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="491" DISPLAY="INLINE"></div>
<div class="P">Figure 11-377 <span class="emph_B">FIBROUS DYSPLASIA: RIB INVOLVEMENT. A. PA Ribs.</span> Observe the radiolucent, expansile lesion present within the midportion of the left eighth rib (<span class="emph_I">arrows</span>). Observe the <span class="emph_I">ground glass appearance</span> of the matrix of this lesion. <span class="emph_B">B. PA Rib.</span> Observe the geographic, expansile lesion in the anterior surface of the right fourth rib (<span class="emph_I">arrow</span>). The central matrix of the lesion is <span class="emph_I">ground glass</span> in appearance. The peripheral cortical border of this lesion is thin; however, no disruption in the cortex is noted. <span class="emph_I">COMMENT:</span> Fibrous dysplasia of the rib is the most common benign rib lesion; it usually measures &#x003E; 4 cm in length. The most common sites for monostotic fibrous dysplasia are the proximal femur and the rib structures.</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3948" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[5]">
<div class="HD">Endocrine Abnormalities</div>
<div class="P">McCune-Albright syndrome is defined as polyostotic fibrous dysplasia associated with skin pigmentation and precocious sexual development. There is a tendency for the bone lesions in this syndrome to be unilateral in distribution. The area of skin pigmentation may be large and affects primarily the neck, chest, back, shoulder, and pelvic girdle. McCune-Albright syndrome is encountered almost exclusively in females. Precocious sexual development manifests itself in females by premature occurrence of irregular menstrual bleedings at the age of 5-6 years, and occasionally much earlier. The development of secondary sexual characteristics follows the precocious menarche. There is good evidence to support the fact that the precocious sexual development represents true precocious puberty. Benedict (<a class="LK" href="sid806035.html#R771-11">15</a>) collected five cases of McCune-Albright syndrome in males, which is quite unusual. The prognosis for patients with McCune-Albright syndrome is generally poor. (<a class="LK" href="sid806035.html#R772-11">16</a>)</div>
<div class="FG" id="F380-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[5]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="445" height="700" src="files/009ff44fbd0be85d537c4750da1cee07.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="009ff44fbd0be85d537c4750da1cee07.gif" MIMETYPE="image/gif" WIDTH="445" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-378 <span class="emph_B">FIBROUS DYSPLASIA: INVOLVEMENT OF THE GREAT TOE. PA Foot.</span> Note the expansion and alteration of the trabecular patterns of the proximal phalanx of the great toe. A mottled area of radiopacity throughout this radiolucent lesion is noted, as a result of the characteristic <span class="emph_I">ground glass appearance. COMMENT:</span> Most tubular bone involvement in fibrous dysplasia does not extend to the subarticular surface of the bone; however, when a small tubular bone is involved, the subarticular extension point of differentiation from Paget&#x2019;s disease is no longer applicable.</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3949" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[6]">
<div class="HD">Laboratory Findings</div>
<div class="P">Laboratory studies are usually within normal values, except for the occasional elevation of serum alkaline phosphatase and osteocalcin. (<a class="LK" href="sid806035.html#R773-11">17</a>) This slight elevation usually occurs during periods of exacerbation of the disease process or consolidation of a spontaneous fracture. The serum calcium and phosphorus levels are normal.</div>
</div>
<div class="TLV4" id="B01382540.0-3950" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[3]/TLV4[7]">
<div class="HD">Cherubism</div>
<div class="P">Cherubism is a familial fibrous dysplasia of the jaws (<a class="LK" href="sid806035.html#R774-11">18</a>) characterized by swelling of the lower face. It is inherited as an autosomal dominant trait, with an 80&#x0025; penetrance. It is usually recognized between the ages of 18 months and 2 years, and then becomes stationary and regresses spontaneously during puberty. (<a class="LK" href="sid806035.html#R774-11">18</a>) It affects primarily the mandible but occasionally the maxilla. Multilocular cystic lesions with asymmetric distribution in the mandible and maxilla are responsible for the characteristic changes in facial configuration. (<a class="LK" href="sid806035.html#R775-11">19</a>) (<a class="LK" href="sid806035.html#F381-11">Fig. 11-379</a>) Swelling of the cheeks stretches the skin and retracts the lower eyelids, which in turn produces a slight upward turning of the eyes, so that the lower half of the sclera is exposed abnormally. The eyes then appear to assume an <span class="emph_I">eyes-raised-to-heaven attitude.</span> (<a class="LK" href="sid806035.html#R776-11">20</a>) Histologically, cherubism is indistinguishable from giant cell reparative granuloma. (<a class="LK" href="sid806035.html#R777-11">21</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3951" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">Fibrous dysplasia is an abnormality in which normal bone under-going physiologic resorption is replaced by an abnormal proliferation of an isomorphous fibrous tissue of spindle cells and poorly formed bony trabeculae of woven bone. (<a class="LK" href="sid806035.html#R778-11">22</a>) Recent studies have suggested the cause of the disease stems from mutagenic change in the <span class="emph_I">GNAS1</span> gene of a somatic cell. (<a class="LK" href="sid806035.html#R779-11">23</a>) The trabeculae have an irregular size, form, or distribution; they display no orientation or apparent relation to the function of the affected cylindrical or flat bone. The disease has been considered as an arrest of bone maturation
<a name="PG1336"> </a><div class="pagenum"><div>P.1336</div></div>
<br clear="all">
at the immature stage of woven bone, as a disturbance of postnatal cancellous bone maintenance, or as a misdifferentiation of the bone-forming mesenchyme. (<a class="LK" href="sid806035.html#R762-11">6</a>,<a class="LK" href="sid806035.html#R780-11">24</a>,<a class="LK" href="sid806035.html#R781-11">25</a>) This proliferation process may sooner or later extend beyond normal boundaries and give rise to expansion, distortion, and structural weakness. It involves primarily the cancellous and seldom the cortical bone formation. Lesions replace normal cortex by erosion from within, creating endosteal scalloping, but in most instances are covered with a shell, however thin, of normal cortical bone.</div>
<div class="FG" id="F381-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[4]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="474" src="files/b76050ff236b83c49755384ccd2068f7.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b76050ff236b83c49755384ccd2068f7.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="474" DISPLAY="INLINE"></div>
<div class="P">Figure 11-379 <span class="emph_B">FIBROUS DYSPLASIA: CHERUBISM. Mandible.</span> Observe the diffuse sclerosis and expansion of the mandible secondary to extensive fibrous dysplasia. (Courtesy of Norman W. Kettner, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, St. Louis, Missouri.)</div>
</td></tr>
</table></div>
<div class="P">The macroscopic appearance of bones affected by fibrous dysplasia is that of a fusiform or spherical enlargement, with a surface of thin, intact, cortical bone. The enlargement may measure up to several centimeters in diameter. On a longitudinal section the cancellous bone has been replaced by a yellowish white, resilient tissue, which occasionally includes small cysts filled with an amber fluid. The transition to normal bone is usually quite abrupt. A cross section of a tubular bone with a fibrous dysplastic lesion generally reveals a widening of the shaft and a thinning of the cortex, with significant endosteal scalloping. Endosteal scalloping of bone is a characteristic pathologic and radiologic sign of fibrous or cartilaginous lesions of bone. Replacement of the medulla by connective tissue eccentrically expands the bone and leaves a firm and rubbery substance irregularly scattered throughout. Disseminated throughout the fibrous lesion are various spicules of bone, creating a radiopaque appearance to some lesions of fibrous dysplasia. Radiographically, this results in the <span class="emph_I">ground glass appearance.</span> As a rule, the fibrous tissue may be readily cut with a knife. The poorly ossified bone spicules lend it a certain elastic, gritty consistency comparable to <span class="emph_I">sand embedded in putty.</span> A cut surface of a dysplastic lesion in general reveals a grayish or whitish color and considerable variation in vascularity.</div>
<div class="P">Lesions in the base of the skull or maxilla generally possess a firmer consistency than those in the ribs or long bones because they include a greater amount of bone spicules. Skull lesions, therefore, commonly display a much greater radiopacity than lesions seen in the tubular bones or flat bones of the pelvis. Aside from the bones of the skull, the olecranon process is the only other site where fibrous dysplasia consistently appears significantly more radiopaque than in other bony structures. (<a class="LK" href="sid806035.html#F382-11">Figs. 11-380</a> and <a class="LK" href="sid806035.html#F383-11">11-381</a>)</div>
<div class="P">The histologic appearance of fibrous dysplasia presents a fairly characteristic picture of irregular trabeculae of woven bone varying in size, shape, and distribution, without apparent functional orientation. These trabeculae are embedded in a loosely or densely textured, cellular, and vascular connective tissue stroma. This histologic appearance is the end result of a probable metaplasia proliferating connective tissue. The matrix surrounding the bony trabeculae is made up of cellular fibrovascular connective tissue. The morphologic pattern of the stroma varies with the age of the lesion. In a younger lesion, the stroma displays a looser arrangement, and there is less collagen formation. In an older lesion, the stroma is usually quite dense.</div>
<div class="TLV4" id="B01382540.0-3952" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[4]/TLV4[1]">
<div class="HD">Sarcomatous Transformation</div>
<div class="P">In rare instances fibrous dysplasia may be associated with malignant change. (<a class="LK" href="sid806035.html#R782-11">26</a>) This phenomenon was first described by Coley and Stewart. (<a class="LK" href="sid806035.html#R783-11">27</a>) The true incidence of sarcomatous transformation in fibrous dysplasia is 0.5&#x0025;. (<a class="LK" href="sid806035.html#R784-11">28</a>) This percentage might be somewhat high, considering that there are presently no accurate
<a name="PG1337"> </a><div class="pagenum"><div>P.1337</div></div>
<br clear="all">
figures available on incidence of clinically manifested, asymptomatic forms of the disease. The age range at which sarcomatous transformation has been recognized varies from 8 to 61 years, with a mean of 32 years. The latency period between the diagnosis of fibrous dysplasia and subsequent sarcomatous degeneration varies between 2 and 30 years. The sarcoma, on the average, develops within 14 years after the initial diagnosis of fibrous dysplasia. It is somewhat more prevalent among males, and the incidence is higher in the polyostotic form. In the monostotic form the facial bones and bones of the cranial vault are most frequently affected (50&#x0025;). In the polyostotic form, the femur is the common site (62&#x0025;). (<a class="LK" href="sid806035.html#F384-11">Figs. 11-382</a> and <a class="LK" href="sid806035.html#F385-11">11-383</a>) Other sites for malignant degeneration include the tibia, humerus, scapula, pelvis, and fibula. Fibrosarcoma and osteosarcoma are the most common malignant tumors to complicate fibrous dysplasia.</div>
<div class="FG" id="F382-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[4]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="319" height="700" src="files/0f4e65917bdd2697885fe44de9d6b864.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="0f4e65917bdd2697885fe44de9d6b864.gif" MIMETYPE="image/gif" WIDTH="319" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-380 <span class="emph_B">SCLEROTIC FIBROUS DYSPLASIA. A. PA Skull.</span> Observe the sclerotic changes associated with fibrous dysplasia of the temporoparietal area of the skull (<span class="emph_I">arrows</span>). <span class="emph_B">B. Lateral Skull.</span> Note a significant area of increased radiopacity as a result of fibrous dysplasia affecting the temporal area of the skull (<span class="emph_I">arrows</span>). <span class="emph_B">C. AP Elbow.</span> Observe the expansion of the medullary portion of the proximal ulna as a result of extensive fibrous dysplasia. The lesion in the ulna demonstrates a characteristic <span class="emph_I">ground glass appearance,</span> with a heavier osteoid matrix, creating a sclerotic presentation. Note the lack of subarticular extension of fibrous dysplasia in the proximal portion of the olecranon process (<span class="emph_I">arrow</span>). This is a helpful point in differentiating fibrous dysplasia from Paget&#x2019;s disease in tubular bones. Paget&#x2019;s disease usually extends to the subarticular surface of the bone.</div>
</td></tr>
</table></div>
<div class="FG" id="F383-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[4]/TLV4[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="440" src="files/a206bf23712bf07f93b383b136934c7e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a206bf23712bf07f93b383b136934c7e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="440" DISPLAY="INLINE"></div>
<div class="P">Figure 11-381 <span class="emph_B">SCLEROTIC FIBROUS DYSPLASIA MIMICKING OSTEOBLASTIC METASTASIS.</span> Observe the diffuse areas of increased radiopacity, with mottled radiolucencies affecting the posterior surfaces of the ilium bilaterally. There is no involvement of the sacrum or sacroiliac joints. These lesions were initially thought to represent metastatic tumors, with symptoms in the local area. This was a biopsy-confirmed sclerotic fibrous dysplasia. (Courtesy of Lynton G. F. Giles, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M16">PhD</a>, Townsville, Queensland, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F384-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[4]/TLV4[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="500" src="files/fe9ab45095297e24cab085a57f349b3f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fe9ab45095297e24cab085a57f349b3f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="500" DISPLAY="INLINE"></div>
<div class="P">Figure 11-382 <span class="emph_B">FIBROUS DYSPLASIA: MALIGNANT DEGENERATION. A. AP Hip.</span> Observe the large, geographic lesion, with a heavy rind or rim of sclerosis encapsulating it, which is characteristic of benign fibrous dysplasia. <span class="emph_B">B. 11-Year Follow-Up: AP Hip.</span> Note the pathologic fracture and extensive destruction of bone affecting the femoral head, neck, and proximal diaphysis. The radiographic presentation suggests malignant degeneration. This was a biopsy-confirmed malignant degeneration of fibrous dysplasia to fibrosarcoma.</div>
</td></tr>
</table></div>
<div class="P">The clinical features of malignant transformation include pain, local swelling, and radiologically demonstrable bone destruction with cortical disruption. (<a class="LK" href="sid806035.html#R761-11">5</a>,<a class="LK" href="sid806035.html#R763-11">7</a>) The cause of malignant transformation is still unknown. In a few instances radiation therapy may be a precipitating factor. In the majority of instances, however, the same unidentified factor that induces the proliferation of the fibro-osseous tissue might also produce a sarcomatous transformation. (<a class="LK" href="sid806035.html#R784-11">28</a>)</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3953" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The skeletal lesions of fibrous dysplasia are not usually present at birth; they are present, however, several years before puberty and often progress throughout the entire life of the patient. Because of the progressive turnover of bone, patients with fibrous dysplasia will have a positive bone scan. (<a class="LK" href="sid806035.html#R785-11">29</a>) All of the bones of the body may be involved; however, there is a particular site predilection for monostotic and polyostotic involvement. (<a class="LK" href="sid806035.html#T46-11">Table 11-46</a>)</div>
<div class="TLV4" id="B01382540.0-3954" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[1]">
<div class="HD">Monostotic Fibrous Dysplasia</div>
<div class="P">The most common location for monostotic fibrous dysplasia is in the proximal third of the femur and the ribs. (<a class="LK" href="sid806035.html#R786-11">30</a>) Most lesions
<a name="PG1338"> </a><div class="pagenum"><div>P.1338</div></div>
<br clear="all">
affecting the long bones are placed in the diametaphysis and spare the subarticular surface of the bone. This anatomic predilection is helpful in the differential diagnosis of Paget&#x2019;s disease. Paget&#x2019;s disease on occasion may mimic fibrous dysplasia; however, involvement of the tubular bones in Paget&#x2019;s disease invariably extends to include subarticular bone. (<a class="LK" href="sid806035.html#F386-11">Fig. 11-384</a>)</div>
<div class="FG" id="F385-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="339" src="files/a2d660d8af6ac4921843e797724c9474.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a2d660d8af6ac4921843e797724c9474.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="339" DISPLAY="INLINE"></div>
<div class="P">Figure 11-383 <span class="emph_B">FIBROSARCOMA COMPLICATING FIBROUS DYSPLASIA. A. AP Femur.</span> Note the large, expansile lesion of fibrous dysplasia within the proximal diaphysis of the femur. This patient experienced a pathologic fracture before these radiographs were taken, and an intermedullary pin had been placed to immobilize the lesion. Observe the remnant electroplating of the bone from the previously placed intramedullary pin (<span class="emph_I">arrows</span>). <span class="emph_B">B. 3-Year Follow-Up: AP Femur.</span> Observe the cortical destruction as a result of underlying malignant degeneration. The patient presented with localized pain in the area of the inner thigh. <span class="emph_B">C. AP Femur.</span> Observe that as a result of malignant degeneration to fibrosarcoma, this patient received an amputation of the lesion. Unfortunately, postsurgical infection and tumor recurrence in the soft tissue areas complicated the surgical procedure. (Courtesy of Bryan Hartley, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="TB" id="T46-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[1]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-46 Radiologic Features of Fibrous Dysplasia</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>Monostotic</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Proximal femur, ribs</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Diametaphyseal</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Geographic</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Lucent, smoky (ground glass)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Thick sclerotic margin (rind)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Occasionally septated (soap bubble)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Expansion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Cortical thinning and scalloping</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Elongated lesion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pathologic fracture</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>Polyostotic</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Multiple lesions; may be unilateral</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pseudo-fractures</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Deformities</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Femur: coxa vara, shepherd&#x2019;s crook</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Rib: extrapleural sign</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Pelvis: protrusio acetabulae</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Spine rarely involved</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>Complications</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Malignancy (0.5&#x0025;)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Fractures</p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Deformities</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="P">The lesions of monostotic fibrous dysplasia are usually radiolucent, often having a loculated or trabeculated appearance. (<a class="LK" href="sid806035.html#F387-11">Fig. 11-385</a>) Scattered throughout the fibrous lesion, there is an appearance of radiopacity. (<a class="LK" href="sid806035.html#F388-11">Fig. 11-386</a>) This represents the classic <span class="emph_I">ground glass</span> or <span class="emph_I">smoky appearance</span> of bone. As described earlier, this represents a base matrix of fibrous tissue with scattered osteoid, which Murrary and Jacobson (<a class="LK" href="sid806035.html#R787-11">31</a>) so appropriately called the <span class="emph_I">wipe out of the trabecular patterns appearance.</span> Many students of radiology have struggled with the phrase <span class="emph_I">ground glass appearance of bone.</span> After hearing numerous explanations, the most plausible one offered suggests the appearance of glass after a grinder is used on its surface to disturb its glistening sheen. This renders a homogenous, ill-defined density across the surface of the glass, which is characteristic of the appearance within the medullary canal of the bones involved in fibrous dysplasia.</div>
<div class="P">These geographic cystic lesions are often well demarcated and, in the monostotic form, usually have a thick, sclerotic border, referred to by Murray and Jacobson (<a class="LK" href="sid806035.html#R787-11">31</a>) as the <span class="emph_I">rind of sclerosis.</span> (<a class="LK" href="sid806035.html#F389-11">Fig. 11-387</a>) There is a widening of the medullary canal, and the endosteum is often thinned and scalloped. Expansion of bone is a common finding. Deformity of bone, particularly in weight-bearing bones, is often found and occasionally is associated with pathologic fracture. There is no evidence of periosteal response, except in those cases following pathologic fracture or malignant change. Most of these lesions render a typical and characteristic appearance, allowing the radiologist to establish the correct diagnosis in a high percentage of cases. In questionable
<a name="PG1339"> </a><div class="pagenum"><div>P.1339</div></div>
<br clear="all">
circumstances, bone scintigraphy may aid in the confirmation of fibrous dysplasia. Bone scanning will generally reveal an area of marked uptake. (<a class="LK" href="sid806035.html#R773-11">17</a>) When only slight or no radiotracer uptake is present fibrous dysplasia should be ruled out of the differential. (<a class="LK" href="sid806035.html#R788-11">32</a>)</div>
<div class="FG" id="F386-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[1]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="489" src="files/927df29df32a09b3962b604104406f1a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="927df29df32a09b3962b604104406f1a.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="489" DISPLAY="INLINE"></div>
<div class="P">Figure 11-384 <span class="emph_B">ANATOMIC DISTRIBUTION OF FIBROUS DYSPLASIA VERSUS PAGET&#x2019;S DISEASE. A. PA Hand: Fibrous Dysplasia.</span> Observe expansion of the second metacarpal bone, with the characteristic <span class="emph_I">ground glass</span> or <span class="emph_I">smoky appearance.</span> Note the lack of subarticular extension of the disease process, since it stops at the distal metaphysis (<span class="emph_I">arrows</span>). <span class="emph_B">B. PA Hand: Paget&#x2019;s Disease.</span> Observe the typical changes of Paget&#x2019;s disease, with cortical thickening and coarsening of the trabecular patterns and full extension of the disease process to the subarticular portions of the first through fourth metacarpal bones. Observe also the pagetoid changes present in the proximal phalanx of the fifth digit.</div>
</td></tr>
</table></div>
<div class="FG" id="F387-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[1]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="502" src="files/c9c18d83d468a4afea517231f0f61eb8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c9c18d83d468a4afea517231f0f61eb8.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="502" DISPLAY="INLINE"></div>
<div class="P">Figure 11-385 <span class="emph_B">MONOSTOTIC FIBROUS DYSPLASIA. A. AP Femur. B. Oblique Femur.</span> Observe the large, geographic, multiloculated lesion present in the intertrochanteric region of the femur. This lesion is asymptomatic and is characteristic of monostotic fibrous dysplasia.</div>
</td></tr>
</table></div>
<a name="PG1340"> </a><div class="pagenum"><div>P.1340</div></div>
<br clear="all">
<div class="FG" id="F388-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[1]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="347" src="files/4d9225514b72c73304a65df8dd4d56e3.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4d9225514b72c73304a65df8dd4d56e3.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="347" DISPLAY="INLINE"></div>
<div class="P">Figure 11-386 <span class="emph_B">MONOSTOTIC FIBROUS DYSPLASIA: VARIED MANIFESTATIONS. A-C. AP Hip.</span> Observe the varied manifestations of mixed sclerosis and radiolucency in these three patients.</div>
</td></tr>
</table></div>
<div class="FG" id="F389-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[1]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="485" src="files/8a49bc5b5ce91d64ace5d4d6960a2e08.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8a49bc5b5ce91d64ace5d4d6960a2e08.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="485" DISPLAY="INLINE"></div>
<div class="P">Figure 11-387 <span class="emph_B">MONOSTOTIC FIBROUS DYSPLASIA: RIND OF SCLEROSIS. A. AP Hip. B. Oblique Hip.</span> Observe the large, geographic radiolucency within the intertrochanteric space of the femur. There is a dense encapsulated <span class="emph_I">rind</span> or rim of sclerosis. <span class="emph_I">COMMENT:</span> The intertrochanteric space of the proximal femur is the most common location for monostotic fibrous dysplasia. The ribs are the second most common site. The <span class="emph_I">rind</span> of sclerosis around the fibrous dysplastic lesion is characteristic. These lesions usually are asymptomatic.</div>
</td></tr>
</table></div>
</div>
<div class="TLV4" id="B01382540.0-3955" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]">
<div class="HD">Polyostotic Fibrous Dysplasia</div>
<div class="P">Lesions of polyostotic fibrous dysplasia are more often symptomatic than those of the monostotic form. This is the result of bowing deformities and pathologic fracture. (<a class="LK" href="sid806035.html#F390-11">Fig. 11-388</a>) Most
<a name="PG1341"> </a><div class="pagenum"><div>P.1341</div></div>
<br clear="all">
bowing deformities occur in weight-bearing bones, particularly the proximal femur, where the classic <span class="emph_I">shepherd&#x2019;s crook deformity</span> occurs. This <span class="emph_I">shepherd&#x2019;s crook deformity</span> represents a reduction in the femoral angle of incidence to near 90&#x00B0;, creating a coxa vara deformity. (<a class="LK" href="sid806035.html#F391-11">Fig. 11-389</a>) The lesions of polyostotic fibrous dysplasia most often involve the entire diaphysis of the long tubular bone, creating widening of the medullary canal with thinning and scalloping of the endosteum. These lesions more often demonstrate the <span class="emph_I">ground glass appearance</span> rather than the characteristic, completely radiolucent lesion that is seen so often in the monostotic form. (<a class="LK" href="sid806035.html#F392-11">Fig. 11-390</a>) Incomplete septa or ridges create loculation throughout the lesion.</div>
<div class="FG" id="F390-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="381" height="700" src="files/c279efcbce1a18fe32f553879541d3c6.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c279efcbce1a18fe32f553879541d3c6.gif" MIMETYPE="image/gif" WIDTH="381" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-388 <span class="emph_B">PATHOLOGIC FRACTURE IN FIBROUS DYSPLASIA. AP Tibia and Fibula.</span> Observe the extensive diaphyseal involvement of both the tibia and the fibula, with the characteristic <span class="emph_I">ground glass appearance.</span> There is a pathologic fracture present through the proximal diaphysis of the tibia (<span class="emph_I">arrow</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F391-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="528" src="files/dcfec83151099534cb2c11da40b216da.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="dcfec83151099534cb2c11da40b216da.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="528" DISPLAY="INLINE"></div>
<div class="P">Figure 11-389 <span class="emph_B">FIBROUS DYSPLASIA: SHEPHERD&#x2019;S CROOK DEFORMITY. A. AP Hip. B. Oblique (Frog-Leg) Hip.</span> Observe the polyostotic lesions, consistent with fibrous dysplasia, present within the ilium, proximal femur, and diaphysis of the femur. There is a coxa vara deformity present, creating the characteristic <span class="emph_I">shepherd&#x2019;s crook deformity.</span> A typical <span class="emph_I">ground glass appearance</span> of the mid-diaphyseal area of the femur is noted.</div>
</td></tr>
</table></div>
<div class="FG" id="F392-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="423" height="700" src="files/863f6e581f721bff46e381a99c694fd1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="863f6e581f721bff46e381a99c694fd1.gif" MIMETYPE="image/gif" WIDTH="423" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-390 <span class="emph_B">POLYOSTOTIC FIBROUS DYSPLASIA: TYPICAL GROUND GLASS APPEARANCE.</span> Observe the significant expansion of the mid-diaphysis of the tibia and fibula, with the characteristic <span class="emph_I">ground glass appearance</span> to the matrix of the fibrous dysplastic lesions.</div>
</td></tr>
</table></div>
<div class="P">In the polyostotic form of fibrous dysplasia, pseudo-fractures (increment fractures) occur affecting the weight-bearing bones
<a name="PG1342"> </a><div class="pagenum"><div>P.1342</div></div>
<br clear="all">
usually on the convex surface of the deformed cortex. The phrase <span class="emph_I">increment fractures</span> refers to the regular intervals at which these pseudo-fractures occur along the length of the bone. Similar pseudo-fractures are found in Paget&#x2019;s disease, osteomalacia, and rickets.</div>
<div class="FG" id="F393-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="447" src="files/4e8771d99ef96c67074090c5f727dd09.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="4e8771d99ef96c67074090c5f727dd09.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="447" DISPLAY="INLINE"></div>
<div class="P">Figure 11-391 <span class="emph_B">FIBROUS DYSPLASIA. AP Pelvis.</span> Observe the geographic, multiloculated lesion affecting the medial portion of the acetabulum and ischial tuberosity (<span class="emph_I">arrows</span>). This lesion is characteristic of fibrous dysplasia.</div>
</td></tr>
</table></div>
<div class="P">The bones more frequently involved in polyostotic fibrous dysplasia are those of the pelvis, lower extremity, upper extremity, ribs, and skull. In the pelvis, as elsewhere in the skeleton, the disease tends toward a unilateral distribution, and often one side is much more severely involved. (<a class="LK" href="sid806035.html#F393-11">Fig. 11-391</a>) If the pelvis is involved on one side, invariably, the proximal femur will be as well. (<a class="LK" href="sid806035.html#F394-11">Fig. 11-392</a>) Rib lesions produce the characteristic <span class="emph_I">extrapleural sign;</span> gross expansion with loculation of bone is often the presentation. (<a class="LK" href="sid806035.html#F395-11">Fig. 11-393</a>) The involvement may be unilateral or bilateral in distribution, but is often asymmetric. In general, most rib lesions remain asymptomatic, only to be detected incidentally during routine chest films. Spontaneous fracture may also bring the lesion to attention. Fibrous dysplasia is said to be the most common cause of a benign long lesion of a rib (&#x003E; 4 cm). (<a class="LK" href="sid806035.html#R786-11">30</a>,<a class="LK" href="sid806035.html#R787-11">31</a>) (<a class="LK" href="sid806035.html#F396-11">Fig. 11-394</a>) Bone scans are of use to identify the
<a name="PG1343"> </a><div class="pagenum"><div>P.1343</div></div>
<br clear="all">
location of the lesions in the polyostotic form of the disease. (<a class="LK" href="sid806035.html#F397-11">Fig. 11-395</a>)</div>
<div class="FG" id="F394-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="443" src="files/57e1e548168e0201419f4f19daa47626.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="57e1e548168e0201419f4f19daa47626.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="443" DISPLAY="INLINE"></div>
<div class="P">Figure 11-392 <span class="emph_B">POLYOSTOTIC FIBROUS DYSPLASIA. AP Pelvis.</span> Observe the polyostotic, multiloculated, geographic lesions scattered throughout the pelvis, pubic rami, and proximal femora. These lesions are typical of fibrous dysplasia.</div>
</td></tr>
</table></div>
<div class="FG" id="F395-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="497" src="files/6093a3d276c9898733c78f4945afaf63.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="6093a3d276c9898733c78f4945afaf63.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="497" DISPLAY="INLINE"></div>
<div class="P">Figure 11-393 <span class="emph_B">POLYOSTOTIC FIBROUS DYSPLASIA: CREATING THE EXTRAPLEURAL SIGN. A. PA Ribs. B. Oblique Ribs.</span> Observe the polyostotic changes of fibrous dysplasia within the lateral margins of the ribs, creating the characteristic <span class="emph_I">extrapleural sign</span> (panel A, <span class="emph_I">arrows</span>). There is significant fibrous replacement of bone, creating the <span class="emph_I">ground glass</span> or <span class="emph_I">smoky appearance</span> to the matrix of these rib lesions (panel B, <span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<div class="FG" id="F396-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="436" height="700" src="files/17ee8746c226107e14bd4b8c03491cd1.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="17ee8746c226107e14bd4b8c03491cd1.gif" MIMETYPE="image/gif" WIDTH="436" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-394 <span class="emph_B">FIBROUS DYSPLASIA. Rib.</span> Observe the considerable expansion of nearly the entire left fourth rib from extensive fibrous dysplasia (<span class="emph_I">arrows</span>). This lesion is &#x003E; 4 cm and is characteristic for the long lesion presentation of fibrous dysplasia. <span class="emph_I">COMMENT:</span> Lesions of fibrous dysplasia within the rib structures can be aggressive in appearance and, at times, may mimic malignant neoplasms. This was the case in this patient because the peripheral cortical margins are poorly demonstrated. The presence of other skeletal lesions of fibrous dysplasia often helps in the definitive diagnosis of fibrous dysplasia.</div>
</td></tr>
</table></div>
<div class="P">Pseudo-arthrosis has been documented in fibrous dysplasia, usually affecting the bones of the lower extremity as a complication of pathologic fracture that has not healed. Neurofibromatosis and fibrous dysplasia are the two most common disorders of bone to produce pseudo-arthrosis.</div>
<div class="P">Involvement of the skull by polyostotic fibrous dysplasia occasionally may mimic the combined biphasic form of Paget&#x2019;s disease. Lesions of the lytic variety, leading to loculations and expansion of bone, most commonly occurring in the skull vertex, create no differential diagnostic problem with Paget&#x2019;s disease (<a class="LK" href="sid806035.html#R787-11">31</a>); however, fibrous dysplasia involving the skull base often is bone forming and sclerotic, as are the changes of Paget&#x2019;s disease. (<a class="LK" href="sid806035.html#F398-11">Figs. 11-396</a> and <a class="LK" href="sid806035.html#F399-11">11-397</a>) Often, the bones of the maxilla and mandible are involved, which provides some aid in differential diagnosis because these bones are much less commonly involved in Paget&#x2019;s disease. The broadened calvaria often displays localized, diffuse areas of radiolucency and increased radiopacity side by side. This co-existence of bone resorption and sclerosis strongly resembles Paget&#x2019;s disease. It is the thinning of the external table in fibrous dysplasia versus cortical thickening in Paget&#x2019;s disease that aids in the definitive differential diagnosis. (<a class="LK" href="sid806035.html#R789-11">33</a>)</div>
<div class="FG" id="F397-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="310" height="700" src="files/b4c808bb4c19ac374c4d6d8f834f37ac.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b4c808bb4c19ac374c4d6d8f834f37ac.gif" MIMETYPE="image/gif" WIDTH="310" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-395 <span class="emph_B">FIBROUS DYSPLASIA: POSITIVE BONE SCAN.</span> Note that this adult with polyostotic fibrous dysplasia shows intense uptake in multiple lesions throughout the entire skeleton. Active lesions in polyostotic fibrous dysplasia will show intense uptake on nuclear medicine scans. (Courtesy of Reza Sazgari, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Department of Radiology, University Hospital, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="P">The vertebral column is infrequently involved in fibrous dysplasia. If present, it is invariably found associated with the polyostotic form of the disease. Most lesions affect the vertebral body but may occasionally extend into the neural arch. (<a class="LK" href="sid806035.html#F400-11">Fig. 11-398</a>) Vertebral collapse is most commonly found in the lumbar spine, as are the majority of the lesions. The vertebral lesions appear homogeneously radiolucent, lacking the classic <span class="emph_I">ground glass appearance.</span> Murray and Jacobson (<a class="LK" href="sid806035.html#R787-11">31</a>) stated that narrowing of the disc spaces is common with spinal involvement in polyostotic fibrous dysplasia. No explanation as to the pathogenesis of this radiographic sign is offered. Although we have seen this sign associated with polyostotic fibrous dysplasia, there are many cases with spinal involvement that lack disc space narrowing.</div>
<div class="P">It should be emphasized that there are no radiographic findings that rule out the presence of one or more specific endocrine disorders known to occur in association with fibrous dysplasia.</div>
<a name="PG1344"> </a><div class="pagenum"><div>P.1344</div></div>
<br clear="all">
<div class="FG" id="F398-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="570" src="files/fae83a10beeb886b524d54a92a116653.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fae83a10beeb886b524d54a92a116653.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="570" DISPLAY="INLINE"></div>
<div class="P">Figure 11-396 <span class="emph_B">FIBROUS DYSPLASIA. A. PA Skull.</span> Observe the sclerotic and lytic lesions of fibrous dysplasia affecting half of the skull table and facial bones. These changes have distorted the orbit, creating a dense appearance to its floor (<span class="emph_I">arrows</span>). <span class="emph_B">B. Lateral Skull.</span> Observe the well-delineated lesions of fibrous dysplasia throughout the frontal and parietal bones. Extensive facial bone involvement has produced bony expansion, with a well-defined cortical margin (<span class="emph_I">arrows</span>). <span class="emph_B">C. Coronal CT Scan.</span> Note the dense ground glass appearance to the matrix of the lesion extending along the petrous ridge of the temporal bone (<span class="emph_I">arrow</span>) into the ethmoid sinuses. (Courtesy of Joan Sutcliffe, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="FG" id="F399-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[10]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="525" src="files/d094c1358fff9fe060d0035f5590f63c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="d094c1358fff9fe060d0035f5590f63c.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="525" DISPLAY="INLINE"></div>
<div class="P">Figure 11-397 <span class="emph_B">FIBROUS DYSPLASIA: MANDIBLE.</span> Observe the large, geographic, expansile lesion of the mandible, representing fibrous dysplasia.</div>
</td></tr>
</table></div>
<a name="PG1345"> </a><div class="pagenum"><div>P.1345</div></div>
<br clear="all">
<div class="FG" id="F400-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/FG[11]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="321" src="files/333cbdbf094272b0809554c89d510a35.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="333cbdbf094272b0809554c89d510a35.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="321" DISPLAY="INLINE"></div>
<div class="P">Figure 11-398 <span class="emph_B">FIBROUS DYSPLASIA: VERTEBRAL INVOLVEMENT. A. Lateral Lumbar Spine. B. Oblique Lumbar Spine.</span> Observe the large, geographic lesion within the vertebral body of L3. There is a characteristic thick, encapsulated rim of sclerosis associated with this vertebral body lesion, creating the <span class="emph_I">rind of sclerosis</span> appearance (<span class="emph_I">arrows</span>). <span class="emph_B">C. Oblique Lumbar Spine.</span> Observe the polyostotic lesions of fibrous dysplasia affecting the vertebral body and neural arch of the lower thoracic segments and lumbar spine. There is significant expansion of the vertebral body of L2 (<span class="emph_I">arrow</span>), along with vertebral arch involvement. <span class="emph_I">COMMENT:</span> Fibrous dysplasia of the vertebrae is uncommon.</div>
</td></tr>
</table></div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3956" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Fibrous Dysplasia</div>
<div class="TLV2" id="B01382540.0-3957" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Lichtenstein in 1938 was the first to recognize and name the disease entity.</div></li>
<li class="LM"><div class="P">Originally, this disease was confused with hyperparathyroidism.</div></li>
<li class="LM"><div class="P">It has been called a <span class="emph_I">great imitator</span> of bone disease along with Paget&#x2019;s disease.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3958" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Not an uncommon disorder; however, the actual incidence is difficult to ascertain, since most lesions are asymptomatic.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3959" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Age of presentation varies from 8 to 14 years.</div></li>
<li class="LM"><div class="P">An even sex distribution, except for the associated McCune-Albright syndrome, which is almost exclusively found in females.</div></li>
<li class="LM"><div class="P">Most lesions are asymptomatic. Bowing deformities and pathologic fracture are the most common causes of symptoms (i.e., shepherd&#x2019;s crook deformity).</div></li>
<li class="LM"><div class="P">
<span class="emph_I">Caf&#x00E9; au lait spots:</span> chestnut-pigmented, non-elevated macules, present in 30&#x0025; of patients with polyostotic fibrous dysplasia. The serrated irregular margins have been referred to as the coast of Maine appearance. Also found in neurofibromatosis, but these margins are smooth and are referred to as the coast of California appearance.</div></li>
<li class="LM"><div class="P">Monostotic fibrous dysplasia (solitary lesion) is most commonly found in the ribs, femur (proximal), tibia (anterior cortex), and skull (75&#x0025; of cases).</div></li>
<li class="LM"><div class="P">Polyostotic fibrous dysplasia (multiple bones) is most commonly found in the femur, skull, tibia, humerus, ribs, fibula, radius, and ulna.</div></li>
<li class="LM"><div class="P">Vertebral involvement is rare; when present, it affects the vertebral body rather than the arch and is found usually in the polyostotic form of the disease.</div></li>
<li class="LM"><div class="P">McCune-Albright syndrome represents polyostotic fibrous dysplasia associated with skin pigmentation and precocious sexual development.</div></li>
<li class="LM"><div class="P">Cherubism represents a familial fibrous dysplasia of the jaws.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3960" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Represents an abnormality in which normal bone undergoes physiologic resorption and replacement with abnormal proliferation of fibrous tissue.</div></li>
<li class="LM"><div class="P">The fibrous lesion often creates widening of the medullary canal, thinning of the cortex, and endosteal scalloping; scalloping of the endosteum is a sign seen in lesions of fibrous and cartilaginous matrix.</div></li>
<li class="LM"><div class="P">The fundamental lesion of fibrous dysplasia is that of a fibrous-based matrix with scattered bony spicules intermixed. This renders an increase in radiopacity to the existing
<a name="PG1346"> </a><div class="pagenum"><div>P.1346</div></div>
<br clear="all">
radiolucent lesion and has been called the ground glass appearance.</div></li>
<li class="LM"><div class="P">Sarcomatous transformation is rare (0.5&#x0025;). The femur and skull are the target sites, with fibrosarcoma and osteosarcoma being the most common complicating tumor types.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3961" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[2]/TLV3[5]/TLV4[2]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Skeletal lesions are not present at birth; they occur several years before puberty.</div></li>
<li class="LM"><div class="P">Most lesions are radiolucent, loculated, or trabeculated in appearance.</div></li>
<li class="LM"><div class="P">Ground glass or smoky appearance of the radiolucent lesion is classic. Murray and Jacobson called this the wipe out of the trabecular patterns.</div></li>
<li class="LM"><div class="P">Most lesions demonstrate an encapsulated sclerotic border around the geographic lesion, which has been called the rind of sclerosis.</div></li>
<li class="LM"><div class="P">Bone expansion with widening of the medullary canal, endosteal thinning, and scalloping occurs.</div></li>
<li class="LM"><div class="P">Shepherd&#x2019;s crook deformity of the femur is common.</div></li>
<li class="LM"><div class="P">Expansile rib lesions often create the extrapleural sign.</div></li>
<li class="LM"><div class="P">Pseudo-arthrosis occurs as a complication of pathologic fracture and non-union. The lower extremity is most often affected. Neurofibromatosis and fibrous dysplasia are the two most common disorders of bone to produce pseudo-arthrosis.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="TLV2" id="B01382540.0-3962" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]">
<div class="HD">NEUROFIBROMATOSIS</div>
<div class="TLV3" id="B01382540.0-3963" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[1]">
<div class="HD">General Considerations</div>
<div class="P">Neurofibromatosis (NF) is an inherited disorder, transmitted as an autosomal dominant, with variable gene expression. (<a class="LK" href="sid806035.html#R790-11">1</a>) Although original reports of Tiresius (<a class="LK" href="sid806035.html#R791-11">2</a>) in 1773 and Smith (<a class="LK" href="sid806035.html#R792-11">3</a>) in 1849 antedated that of von Recklinghausen (<a class="LK" href="sid806035.html#R793-11">4</a>) in 1882, he was given credit for drawing the association of neural and cutaneous fibrous elements to this disease.</div>
<div class="P">Neurofibromatosis is classified into two clinical forms: neurofibromatosis 1 (von Recklinghausen&#x2019;s: caf&#x00E9; au lait spots, neurofibromas, bone changes) and neurofibromatosis 2 (acoustic nerve tumors). Neurofibromatosis 1 is a neuroectodermal and mesodermal dysplasia. It is characterized by a triad of pigmented cutaneous lesions (caf&#x00E9; au lait spots), multiple soft, elevated, cutaneous tumors (fibroma molluscum), and various osseous alterations of the axial and appendicular skeleton. The extent of involvement ranges from minimal to an extensive generalized deforming disease process. The condition affects primarily the peripheral nerves; however, the central nervous system may rarely be involved, occasionally leaving the patient mentally retarded.</div>
</div>
<div class="TLV3" id="B01382540.0-3964" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[2]">
<div class="HD">Incidence</div>
<div class="P">The incidence of neurofibromatosis is estimated as 1&#x002F;3000 births, and a family history of neurofibromatosis can be found in approximately 60&#x0025; of patients, inherited as an autosomal dominant trait. (<a class="LK" href="sid806035.html#R794-11">5</a>)</div>
</div>
<div class="TLV3" id="B01382540.0-3965" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]">
<div class="HD">Clinical Features</div>
<div class="TLV4" id="B01382540.0-3966" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[1]">
<div class="HD">Age and Sex Distribution</div>
<div class="P">Neurofibromatosis occurs with equal incidence in both male and female, as well as white and black, patients. Patients with neurofibromatosis are born with this disorder; however, some may not manifest signs at birth, only developing the classic signs in early childhood. Diagnosis is made based on clinical criteria. (<a class="LK" href="sid806035.html#R790-11">1</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3967" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[2]">
<div class="HD">Cutaneous Abnormalities</div>
<div class="TLV5" id="B01382540.0-3968" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[2]/TLV5[1]">
<div class="HD"><span class="emph_I">Caf&#x00E9; au Lait Spots.</span></div>
<div class="P">The cutaneous macules are non-elevated chestnut, melaniferous pigmentations most commonly found on the back, chest, and abdomen and represent the second most common skin manifestation of this disorder. Most patients have smoothly marginated caf&#x00E9; au lait spots (<span class="emph_I">coast of California appearance,</span> which is geographically smooth), in contrast to the jagged margins of the caf&#x00E9; au lait spots found in fibrous dysplasia (<span class="emph_I">coast of Maine appearance,</span> which is geographically jagged). (<a class="LK" href="sid806035.html#R795-11">6</a>) (<a class="LK" href="sid806035.html#F401-11">Fig. 11-399</a>) Caf&#x00E9; au lait spots develop in 50&#x0025; of patients with neurofibromatosis; however, 15&#x0025; of the normal population will have one or two caf&#x00E9; au lait spots as a normal variant, and 1&#x0025; of the normal population will have more than two. Strict criteria are necessary to establish the diagnosis of neurofibromatosis. (<a class="LK" href="sid806035.html#R795-11">6</a>,<a class="LK" href="sid806035.html#R796-11">7</a>) Six or more caf&#x00E9; au lait spots measuring 1.5 cm or more in diameter provide an essential factor in establishing the diagnosis of neurofibromatosis. (<a class="LK" href="sid806035.html#R794-11">5</a>) It should be noted that caf&#x00E9; au lait spots are age related because they are not always present at birth; they tend to increase in number, size, and pigmentation up to the 3rd decade. Occasionally, they may fade in intensity with age. Caf&#x00E9; au lait spots are also found in patients with fibrous dysplasia (33&#x0025; of cases) and less commonly in tuberous sclerosis. (<a class="LK" href="sid806035.html#R796-11">7</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3969" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[2]/TLV5[2]">
<div class="HD"><span class="emph_I">Fibroma Molluscum.</span></div>
<div class="P">Fibroma molluscum are multiple, asymptomatic cutaneous nodules, which are usually elevated above the skin surface. They are soft, nipplelike, pedunculated, or sessile skin tabs that vary in size from tiny pinhead dots to masses of 5 cm or more. They may be few and widely dispersed or virtually may cover the entire body. (<a class="LK" href="sid806035.html#F402-11">Fig. 11-400</a>) Fibroma molluscum represents the most frequent and best diagnostic cutaneous feature of neurofibromatosis. (<a class="LK" href="sid806035.html#R797-11">8</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3970" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[2]/TLV5[3]">
<div class="HD"><span class="emph_I">Elephantiasis Neuromatosa.</span></div>
<div class="P">The term applied to the large soft tissue masses that create skin folds is elephantiasis neuromatosa. These masses actually represent diffuse plexiform neurofibromas. Plexiform neurofibromas are currently included in the
<a name="PG1347"> </a><div class="pagenum"><div>P.1347</div></div>
<br clear="all">
diagnostic criteria for neurofibromatosis (<a class="LK" href="sid806035.html#R798-11">9</a>) and may lead to massive enlargement of the skin, soft tissues, and underlying bony structures (focal giantism). Other than creating a disfiguring appearance plexiform neurofibromas are associated with functional impairment and substantial morbidity. (<a class="LK" href="sid806035.html#R799-11">10</a>) Transformation into malignant peripheral nerve sheath tumors is a complication and surgical resection is the treatment of choice. (<a class="LK" href="sid806035.html#R799-11">10</a>)</div>
<div class="FG" id="F401-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[2]/TLV5[3]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="342" src="files/c3299b81e169d04c398f5254d80622d5.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c3299b81e169d04c398f5254d80622d5.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="342" DISPLAY="INLINE"></div>
<div class="P">Figure 11-399 <span class="emph_B">CAF&#x0026;Eacute; AU LAIT SPOTS. A. Neurofibromatosis.</span> Observe the multiple caf&#x00E9; au lait spots on this patient&#x2019;s back, which are smoothly marginated and assume the characteristic <span class="emph_I">coast of California appearance.</span> <span class="emph_B">B. Fibrous Dysplasia.</span> Observe the large, geographically jagged caf&#x00E9; au lait spot present on this patient&#x2019;s thorax, creating the characteristic <span class="emph_I">coast of Maine appearance. COMMENT:</span> Caf&#x00E9; au lait spots are the second most common skin manifestation of neurofibromatosis; fibroma molluscum is the most common. Of patients with neurofibromatosis, 50&#x0025; develop caf&#x00E9; au lait spots; 30&#x0025; of patients with the polyostotic form of fibrous dysplasia develop these spots. Six or more caf&#x00E9; au lait spots measuring 1.5 cm or more in diameter present an essential fact in establishing the diagnosis of neurofibromatosis. Of the normal population, 15&#x0025; will have one or two caf&#x00E9; au lait spots, as a normal variant.</div>
</td></tr>
</table></div>
<div class="FG" id="F402-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[2]/TLV5[3]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="297" src="files/fec45ca31e10bd7a484a2fce3792009f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="fec45ca31e10bd7a484a2fce3792009f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="297" DISPLAY="INLINE"></div>
<div class="P">Figure 11-400 <span class="emph_B">NEUROFIBROMATOSIS: FIBROMA MOLLUSCUM. A. Thorax: Physical Presentation.</span> Observe the multiple, asymptomatic nodules that are characteristic of fibroma molluscum in patients with neurofibromatosis. <span class="emph_B">B. Lower Leg: Physical Presentation.</span> Observe the multiple fibroma molluscum affecting the anterior thigh and lower leg. <span class="emph_B">C. PA Axilla.</span> Observe the large fibroma molluscum in the axilla area of this patient with neurofibromatosis (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3971" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[3]">
<div class="HD">Signs and Symptoms</div>
<div class="P">The signs and symptoms of neurofibromatosis are widely varied. The specific symptoms will depend on the location of the abnormality.</div>
<div class="TLV5" id="B01382540.0-3972" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[3]/TLV5[1]">
<div class="HD"><span class="emph_I">Skull.</span></div>
<div class="P">Neurofibroma of the optic nerve may produce blurred vision, scotoma, and transient blindness. A defect in the posterior
<a name="PG1348"> </a><div class="pagenum"><div>P.1348</div></div>
<br clear="all">
superior orbital wall may allow drooping of the upper eyelid, dislocation of the eyeball, or even pulsating exophthalmos. Pulsating exophthalmos occurs as a result of direct contact with the meninges, cerebrospinal fluid pulsations, and the orbital contents. The absence of the bony separation allows for transmission of intracranial vascular pulsation to the globe. (<a class="LK" href="sid806035.html#R800-11">11</a>) There is no suggestion within the literature that pulsating exophthalmos associated with neurofibromatosis is progressive or that there is any long-term threat to vision. Ocular pulsation may also be found with intraorbital aneurysms and vascular anomalies, and these conditions should be considered in the differential diagnosis of pulsating exophthalmos. (<a class="LK" href="sid806035.html#R800-11">11</a>) Facial asymmetry is often present, representing more of a cosmetic problem than a functional one.</div>
</div>
<div class="TLV5" id="B01382540.0-3973" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[3]/TLV4[3]/TLV5[2]">
<div class="HD"><span class="emph_I">Spine.</span></div>
<div class="P">Neurofibromas affecting the spinal nerves often render localized pain and various motor symptoms, including, in advanced cases, paraplegia. Severe kyphoscoliosis, so frequently found in neurofibromatosis, may be asymptomatic or be complicated by cord compression and paraplegia. (<a class="LK" href="sid806035.html#R801-11">12</a>) Rarely, laxity of the ligaments supporting the atlantoaxial joints occurs in neurofibromatosis, leading to atlantoaxial subluxation. (<a class="LK" href="sid806035.html#R802-11">13</a>,<a class="LK" href="sid806035.html#R803-11">14</a>) This creates symptoms of suboccipital headache and motor weakness to the upper extremities.</div>
</div>
</div>
</div>
<div class="TLV3" id="B01382540.0-3974" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[4]">
<div class="HD">Pathologic Features</div>
<div class="P">The typical neurofibroma is indistinguishable from a schwannoma (neurinoma) or neuroma and grossly appears as a grayish brown or gray, firm, rubbery mass. Histologically, interlacing strands of elongated foam cells and pigment are arranged in a characteristic palisading pattern. The rate of malignant degeneration in neurofibromatosis is reported to be approximately 5&#x0025; (<a class="LK" href="sid806035.html#R804-11">15</a>); most transform to a neurofibrosarcoma, and clinical suspicion of malignant degeneration should be raised if there is progressive enlargement and pain related to a mass lesion. (<a class="LK" href="sid806035.html#R805-11">16</a>) This transformation occurs more often in internal tissues than in superficial cutaneous lesions. (<a class="LK" href="sid806035.html#R805-11">16</a>) It has been suggested that repeated biopsies of these lesions predisposes to malignant degeneration.</div>
</div>
<div class="TLV3" id="B01382540.0-3975" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]">
<div class="HD">Radiologic Features</div>
<div class="P">The most frequently involved areas are the spine and skull, and characteristic radiographic changes often allow the clinician to establish the diagnosis of neurofibromatosis. (<a class="LK" href="sid806035.html#F403-11">Fig. 11-401</a>) Approximately 50&#x0025; of the patients with neurofibromatosis develop skeletal lesions. (<a class="LK" href="sid806035.html#R797-11">8</a>) (<a class="LK" href="sid806035.html#T47-11">Table 11-47</a>)</div>
<div class="TLV4" id="B01382540.0-3976" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[1]">
<div class="HD">Spine</div>
<div class="P">The most common radiographic feature of neurofibromatosis is the development of a scoliosis, occurring in approximately 50&#x0025; of patients. (<a class="LK" href="sid806035.html#R797-11">8</a>,<a class="LK" href="sid806035.html#R806-11">17</a>,<a class="LK" href="sid806035.html#R807-11">18</a>) Classically, the scoliosis involves a short segment (5-7 vertebrae) and is acutely angular in presentation. Kyphoscoliosis is the most common form and usually affects the lower thoracic spine. (<a class="LK" href="sid806035.html#R801-11">12</a>,<a class="LK" href="sid806035.html#R807-11">18</a>) The cause of the scoliosis is unknown, and paraplegia may accompany advanced cases.</div>
<div class="P">Cervical kyphosis is a common feature of neurofibromatosis, creating an acutely angular reversal of the normal lordosis. (<a class="LK" href="sid806035.html#R796-11">7</a>,<a class="LK" href="sid806035.html#R807-11">18</a>) Posterior vertebral body scalloping is usually seen, along with deformity of the vertebral bodies, as a result of the underlying
<a name="PG1349"> </a><div class="pagenum"><div>P.1349</div></div>
<br clear="all">
mesodermal dysplasia. (<a class="LK" href="sid806035.html#F404-11">Fig. 11-402</a>) This appearance could be confused with spinal tuberculosis; however, lack of disc space narrowing and the presence of posterior vertebral body scalloping strongly suggest the diagnosis of neurofibromatosis.</div>
<div class="FG" id="F403-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[1]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="298" height="700" src="files/8c4f9294a11361af84f64dadf874f0d8.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8c4f9294a11361af84f64dadf874f0d8.gif" MIMETYPE="image/gif" WIDTH="298" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-401 <span class="emph_B">SKELETAL DISTRIBUTION OF NEUROFIBROMATOSIS.</span>
</div>
</td></tr>
</table></div>
<div class="TB" id="T47-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[1]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-47 Radiologic Features of Neurofibromatosis</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p><b>Spine</b></p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Scoliosis: short, angular, kyphosis</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Vertebral scalloping</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Posterocentral</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Eccentric unilateral</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Intrathoracic meningocele</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p><b>Skull</b></p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Orbital defects</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Sphenoid wing agenesis (bare orbit)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Optic canal expansion</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Lambdoidal defect or asterion defect</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Macrocranium</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p><b>Ribs</b></p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Scalloped, irregular (twisted ribbons)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p><b>Long bones</b></p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Pseudo-arthrosis (tibia)</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Non-ossifying fibromas</p></td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" rowspan="1"><p>Focal giantism</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p><b>Extraskeletal</b></p></td>
</tr>
<tr>
<td valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></td>
<td align="left" valign="bottom" colspan="2" style="border-bottom: 1px solid black;" rowspan="1"><p>Multisystem involvement</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TLV5" id="B01382540.0-3977" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[1]/TLV5[1]">
<div class="HD"><span class="emph_I">Vertebral Scalloping.</span></div>
<div class="P">Scalloping of the posterior surface of the vertebral body commonly occurs in neurofibromatosis. (<a class="LK" href="sid806035.html#R801-11">12</a>,<a class="LK" href="sid806035.html#R808-11">19</a>) Two forms of erosive defects exist: posterocentral and eccentric, unilateral scalloping. Posterocentral scalloping, usually affecting more than one vertebral level, is secondary to dural ectasia, which is a recognized manifestation of neurofibromatosis. (<a class="LK" href="sid806035.html#F405-11">Fig. 11-403</a>) Eccentric unilateral scalloping may also occur. This pattern is suggestive of a localized, dumbbell neurofibroma arising from a spinal nerve root and protruding through the adjacent intervertebral foramina (IVF). (<a class="LK" href="sid806035.html#R809-11">20</a>) (<a class="LK" href="sid806035.html#F406-11">Fig. 11-404</a>) This usually affects an isolated level, and the cervical, lower thoracic, and upper lumbar areas are most often involved. (<a class="LK" href="sid806035.html#F407-11">Fig. 11-405</a>) Erosion of the posterior body and adjacent pedicle results in an enlarged IVF. (<a class="LK" href="sid806035.html#F408-11">Fig. 11-406</a>) Similar extrinsic erosions can occur from neurofibromas affecting the extremities. (<a class="LK" href="sid806035.html#F409-11">Fig. 11-407</a>) A paraspinal mass is seen on the AP thoracic or PA chest radiograph as a result of either a large, dumbbell neurofibroma or, more frequently, an intrathoracic meningocele. (<a class="LK" href="sid806035.html#F410-11">Fig. 11-408</a>)</div>
</div>
<div class="TLV5" id="B01382540.0-3978" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[1]/TLV5[2]">
<div class="HD"><span class="emph_I">Intrathoracic Meningocele.</span></div>
<div class="P">Intrathoracic meningocele is a protrusion of the dura and arachnoid through a thoracic intervertebral foramen and posterior aspect of the rib cage into the extrapleural thoracic cavity. (<a class="LK" href="sid806035.html#R797-11">8</a>) These lesions occur in approximately 66&#x0025; of cases and vary in size from 1 to 6 cm. (<a class="LK" href="sid806035.html#R810-11">21</a>) Most lesions are first seen as an asymptomatic posterior mediastinal mass and are erroneously interpreted as a neurofibroma. Most meningoceles occur laterally, on the right side. (<a class="LK" href="sid806035.html#R797-11">8</a>) Myelography reveals filling with contrast material of the meningocele; this does not occur in a neurofibroma, which is a solid tumor. (<a class="LK" href="sid806035.html#F411-11">Fig. 11-409</a>) Because saccular dilatation of the meninges extends into the chest through the intervertebral foramen in the same manner as a dumbbell neurofibroma, it is capable of producing enlargement of the intervertebral foramen, erosion of the posterior surface of the vertebral body, and pressure defects on the pedicles and posterior ribs at the level of the meningocele. (<a class="LK" href="sid806035.html#R797-11">8</a>) (<a class="LK" href="sid806035.html#F412-11">Fig. 11-410</a>)</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3979" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[2]">
<div class="HD">Skull</div>
<div class="TLV5" id="B01382540.0-3980" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[2]/TLV5[1]">
<div class="HD"><span class="emph_I">Orbital Defects.</span></div>
<div class="P">Agenesis or hypoplasia of the posterior wall of the orbit, wings of the sphenoid, and the orbital plate of the frontal bone is a common finding in neurofibromatosis. This creates what has been referred to as the <span class="emph_I">bare orbit.</span> (<a class="LK" href="sid806035.html#R797-11">8</a>) (<a class="LK" href="sid806035.html#F413-11">Fig. 11-411</a>) This abnormality allows direct contact of the temporal lobe of the brain and its meninges with the orbital soft tissues. This anatomic relationship often creates pulsating exophthalmos. These changes are usually unilateral.</div>
<div class="P">Neurofibroma affecting the optic nerve may lead to enlargement of the optic foramen. Detailed radiographs of the orbit, often including CT, are necessary to visualize these changes. Approximately 20&#x0025; of patients with an optic glioma have neurofibromatosis.</div>
</div>
<div class="TLV5" id="B01382540.0-3981" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[2]/TLV5[2]">
<div class="HD"><span class="emph_I">Lambdoidal Defect.</span></div>
<div class="P">A radiolucent defect is sometimes seen in the calvaria adjacent to the lambdoidal suture, just posterior to the parietal-mastoid and occipital-mastoid sutures, and is virtually diagnostic of neurofibromatosis. (<a class="LK" href="sid806035.html#F414-11">Fig. 11-412</a>) This defect is more common on the left side. Because neurofibromatous tissue is characteristically lacking within the calvarial defect, this
<a name="PG1350"> </a><div class="pagenum"><div>P.1350</div></div>
<br clear="all">
actually represents an area of hypoplasia or agenesis of bone. Radiographically, it appears as a geographic loss of bone density, which may vary in size, occasionally reaching 10 cm. Hypoplasia of the ipsilateral mastoid process has been associated. (<a class="LK" href="sid806035.html#R811-11">22</a>) This lambdoidal calvarial lesion has been referred to as the <span class="emph_I">asterion defect.</span> (<a class="LK" href="sid806035.html#R812-11">23</a>)</div>
<div class="FG" id="F404-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[2]/TLV5[2]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="300" src="files/ee4e835cd221992bdefacf8378dc4368.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ee4e835cd221992bdefacf8378dc4368.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="300" DISPLAY="INLINE"></div>
<div class="P">Figure 11-402 <span class="emph_B">NEUROFIBROMATOSIS: CERVICAL SPINE. A. AP Cervicothoracic.</span> Observe the deviation of the trachea (<span class="emph_I">arrows</span>) as the result of a large intrathoracic meningocele in the right upper lung apex (<span class="emph_I">arrowheads</span>). <span class="emph_B">B. Lateral Cervical.</span> Observe the acute angular reversal of the normal cervical lordosis, associated with dysplastic changes of the vertebral bodies of C4, C5, and C6 as a result of underlying neurofibromatosis. There is posterior vertebral body scalloping (<span class="emph_I">arrows</span>). <span class="emph_B">C. Oblique Cervical.</span> Observe the extensive vertebral body scalloping and the pedicle destruction at the first thoracic segment (<span class="emph_I">arrow</span>). The pedicle destruction at the T1 vertebra creates a large intervertebral foramina at this level. (Reprinted with permission from <span class="emph_B">Yochum TR:</span> <span class="emph_I">Neurofibromatosis or von Recklinghausen&#x2019;s disease&#x2014;A case study.</span> ACA J Chiro June, 1980. Courtesy of Clayton F. Thomsen, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Sydney, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F405-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[2]/TLV5[2]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="329" src="files/9de336110862b5fea3645c2a53f3fc5f.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="9de336110862b5fea3645c2a53f3fc5f.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="329" DISPLAY="INLINE"></div>
<div class="P">Figure 11-403 <span class="emph_B">NEUROFIBROMATOSIS: SCALLOPED VERTEBRAE. A. Myelogram, Lateral Lumbar Spine.</span> Observe the fine sclerotic margins, representing scalloping of the posterior vertebral body margins in neurofibromatosis (<span class="emph_I">arrows</span>). <span class="emph_B">B. Lateral Lumbar Spine.</span> Note the extensive posterior vertebral body scalloping secondary to neurofibromatosis. <span class="emph_B">C. Lateral Lumbar Spine.</span> Observe the deep, posterior vertebral body indentations secondary to scalloping from the mesodermal dysplasia, associated with neurofibromatosis. <span class="emph_I">COMMENT:</span> Posterocentral vertebral body scalloping in neurofibromatosis that affects more than one vertebral level is secondary to the pathologic changes of dural ectasia. (Panel B reprinted with permission: <span class="emph_B">Yochum TR:</span> <span class="emph_I">A radiographic anthology of vertebral names.</span> J Manipulative Physiol Ther 8:87, 1985. Panel C courtesy of Reed B. Phillips, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, <a class="LK" href="sid108669.html#AB1-M16">PhD</a>, Los Angeles, California.)</div>
</td></tr>
</table></div>
</div>
<div class="TLV5" id="B01382540.0-3982" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[2]/TLV5[3]">
<div class="HD"><span class="emph_I">Macrocranium.</span></div>
<div class="P">A poorly recognized but frequently present radiographic sign of neurofibromatosis is macrocranium and macroencephaly. Actually, this sign was one of the more prominent features in one of the earliest documented cases of neurofibromatosis, the so-called elephant man reported by Treves. (<a class="LK" href="sid806035.html#R813-11">24</a>)</div>
</div>
</div>
<div class="TLV4" id="B01382540.0-3983" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[3]">
<div class="HD">Ribs</div>
<div class="P">An additional expression of neurofibromatosis is the thin, irregular, scalloped, attenuated appearance of the ribs. This deformity of the ribs has been called the <span class="emph_I">twisted ribbon appearance.</span> (<a class="LK" href="sid806035.html#R801-11">12</a>,<a class="LK" href="sid806035.html#R806-11">17</a>) Intercostal neurofibromas may produce erosions on the inferior surface of the ribs, occasionally mimicking coarctation of the aorta. Mesodermal dysplasia and hypoplasia may also play a part in the rib deformities because often no neurofibromas can be isolated in the neighboring structures. A similar twisted appearance can occur in the small tubular bones of the extremities. (<a class="LK" href="sid806035.html#F415-11">Fig. 11-413</a>)</div>
</div>
<div class="TLV4" id="B01382540.0-3984" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[4]">
<div class="HD">Pseudo-Arthrosis of a Long Bone</div>
<div class="P">Pseudo-arthrosis is an entity characterized by pathologic fracture and inability to form normal callus in healing; deossification and bending of weight-bearing bones may also occur. (<a class="LK" href="sid806035.html#F416-11">Fig. 11-414</a>) Of patients with pseudo-arthrosis, 50&#x0025; manifest some stigmata of neurofibromatosis. The tibia in its lower two thirds is the most commonly affected bone. There is no evidence of neurofibromatous tissue in or near the site of the deformed pseudo-arthrosis. (<a class="LK" href="sid806035.html#F417-11">Fig. 11-415</a>) Rarely, fibrous dysplasia patients may develop similar pseudo-arthrosis lesions in bone.</div>
</div>
<div class="TLV4" id="B01382540.0-3985" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[5]">
<div class="HD">Association of Multiple Non-Ossifying Fibromas</div>
<div class="P">Neurofibromatosis may occasionally present with cystic central or intramedullary lesions in the metaphysis of the long tubular bones. (<a class="LK" href="sid806035.html#F418-11">Fig. 11-416</a>) Histologically, most of these lesions prove to be non-ossifying fibromas and are often multiple, bilateral, and much larger than the typical lesion. (<a class="LK" href="sid806035.html#R814-11">25</a>) The bones of the lower extremities are the most frequently affected.</div>
</div>
<div class="TLV4" id="B01382540.0-3986" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]">
<div class="HD">Focal Giantism</div>
<div class="P">Localized skeletal enlargement or focal giantism is perhaps the most bizarre and fascinating aspect of neurofibromatosis. The hypertrophy may involve a single bone or the entire extremity. (<a class="LK" href="sid806035.html#F419-11">Fig. 11-417</a>) The bones are usually normal in shape, and the associated muscles and joints are proportionately enlarged, along with the surface soft tissues. The pathogenesis is the result of chronic hyperemia owing to hemangiomas and lymphangiomatous lesions associated with neurofibromatosis.</div>
<a name="PG1351"> </a><div class="pagenum"><div>P.1351</div></div>
<br clear="all">
<div class="FG" id="F406-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[1]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="427" src="files/806a49c4fc5bc1ffa359bd62bc3e71ef.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="806a49c4fc5bc1ffa359bd62bc3e71ef.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="427" DISPLAY="INLINE"></div>
<div class="P">Figure 11-404 <span class="emph_B">THE DUMBBELL NEUROFIBROMA. A. AP Thoracic Spine.</span> Observe the destruction of the caudal aspect of the T10 pedicle (<span class="emph_I">arrow</span>). <span class="emph_B">B. 3-Year Follow-Up: AP Thoracic Spine.</span> Note the nearly complete destruction of the pedicle at the T10 vertebra (<span class="emph_I">arrow</span>). <span class="emph_B">C. Axial CT, T10.</span> Observe the extensive pressure erosions affecting the pedicle, lamina, and transverse process of the involved vertebra (<span class="emph_I">arrows</span>). <span class="emph_B">D. Axial CT, T10.</span> Observe the significant enlargement of the neuroforamina (<span class="emph_I">arrow</span>) as a result of complete destruction of the pedicle of T10 on the involved side. (Courtesy of Margaret A. Seron, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, <a class="LK" href="sid108669.html#AB1-M11">FACO</a>, <a class="LK" href="sid108669.html#AB1-M6">DACBR</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="FG" id="F407-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[2]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="270" src="files/cacb4224cc8e91511b88cf419eb71f01.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="cacb4224cc8e91511b88cf419eb71f01.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="270" DISPLAY="INLINE"></div>
<div class="P">Figure 11-405 <span class="emph_B">VERTEBRAL EROSION ASSOCIATED WITH A DUMBBELL NEUROFIBROMA. A. AP Lumbar Spine.</span> Observe the unilateral destruction of the pedicle of the L5 vertebra (<span class="emph_I">arrow</span>) secondary to a localized neurofibroma. <span class="emph_B">B. Lateral Lumbar Spine.</span> Observe the posterior vertebral body scalloping of L5, with an anterior sclerotic margin (<span class="emph_I">arrows</span>). <span class="emph_B">C. Lateral Thoracolumbar Spine.</span> Observe the deep posterior vertebral body scalloping affecting the T12 vertebra (<span class="emph_I">arrow</span>). <span class="emph_B">D. Oblique Cervical Spine.</span> Note the significant enlargement of the intervertebral foramina between C3 and C4. There is destruction of the pedicle unilaterally at C3 and scalloping of the posterior margin of the body of C3 (<span class="emph_I">arrow</span>). Observe the sclerotic margin around the enlarged intervertebral foramina (<span class="emph_I">arrowhead</span>). (Panel B courtesy of Lawrence A. Cooperstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Pittsburgh, Pennsylvania.)</div>
</td></tr>
</table></div>
<a name="PG1352"> </a><div class="pagenum"><div>P.1352</div></div>
<br clear="all">
<div class="FG" id="F408-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[3]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="503" src="files/86a54ae7ad74d09fb0f1ad23a5c09d77.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="86a54ae7ad74d09fb0f1ad23a5c09d77.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="503" DISPLAY="INLINE"></div>
<div class="P">Figure 11-406 <span class="emph_B">NEUROFIBROMATOSIS: EXTENSIVE VERTEBRAL INVOLVEMENT. A. AP Lumbar Spine. B. Lateral Lumbar Spine.</span> Observe the extensive posterior vertebral body erosion and expansion of the intervertebral foramina affecting the entire lumbar spine and lower thoracic vertebrae. (Courtesy of Lawrence A. Cooperstein, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Pittsburgh, Pennsylvania.)</div>
</td></tr>
</table></div>
<div class="FG" id="F409-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[4]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="484" src="files/ed182aad5a09f4b67f1ed8afaf295554.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="ed182aad5a09f4b67f1ed8afaf295554.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="484" DISPLAY="INLINE"></div>
<div class="P">Figure 11-407 <span class="emph_B">EXTRINSIC SKELETAL EROSIONS FROM NEUROFIBROMA. A. AP Knee. B. Lateral Knee.</span> Observe the extrinsic pressure erosions on the posterolateral aspect of the tibia (<span class="emph_I">arrows</span>). These have occurred secondary to a slowly growing neurofibroma.</div>
</td></tr>
</table></div>
<a name="PG1353"> </a><div class="pagenum"><div>P.1353</div></div>
<br clear="all">
<div class="FG" id="F410-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[5]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="432" src="files/732588d44ee0a77f81027562607def8c.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="732588d44ee0a77f81027562607def8c.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="432" DISPLAY="INLINE"></div>
<div class="P">Figure 11-408 <span class="emph_B">NEUROFIBROMA PRESENTING AS A POSTERIOR MEDIASTINAL MASS. PA Chest.</span> Observe the dense radiopaque nodular lesion seen through the left ventricle of the heart (<span class="emph_I">arrows</span>). This lesion is in the posterior mediastinum and represents a neurofibroma.</div>
</td></tr>
</table></div>
<div class="FG" id="F411-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[6]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="477" height="700" src="files/91040b63f95a6b8d6358db55e24afc88.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="91040b63f95a6b8d6358db55e24afc88.gif" MIMETYPE="image/gif" WIDTH="477" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-409 <span class="emph_B">NEUROFIBROMATOSIS: INTRATHORACIC MENINGOCELE. AP Thoracic Myelogram.</span> Note the protrusion of the dura and arachnoid through a midthoracic intervertebral foramen into the posterior aspect of the rib cage (<span class="emph_I">arrows</span>). This represents an intrathoracic meningocele associated with neurofibromatosis.</div>
</td></tr>
</table></div>
<div class="FG" id="F412-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[7]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="458" height="700" src="files/8f8f5b7dc19db448b9c9eaedb95847ac.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="8f8f5b7dc19db448b9c9eaedb95847ac.gif" MIMETYPE="image/gif" WIDTH="458" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-410 <span class="emph_B">NEUROFIBROMATOSIS: VERTEBRAL EROSION SECONDARY TO MENINGOCELES.</span> Note the large, posterior vertebral body scalloped erosions present affecting the T12, L1, and L2 vertebral bodies (<span class="emph_I">arrows</span>). The radiopaque density present in the spinal canal represents residual contrast material from the previous myelographic investigation (<span class="emph_I">arrowheads</span>). (Courtesy of Antonio Baciocco, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, and Peter Christensson, <a class="LK" href="sid108669.html#AB1-M8">DC</a>, Rome, Italy.)</div>
</td></tr>
</table></div>
<a name="PG1354"> </a><div class="pagenum"><div>P.1354</div></div>
<br clear="all">
<div class="FG" id="F413-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[8]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="411" src="files/afd5e8c4c3520be764573f408d6eb231.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="afd5e8c4c3520be764573f408d6eb231.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="411" DISPLAY="INLINE"></div>
<div class="P">Figure 11-411 <span class="emph_B">NEUROFIBROMATOSIS: BARE ORBIT. A. PA Skull.</span> Note the hypoplasia of the posterior wall of the orbit as a result of underdevelopment of the sphenoid bone (<span class="emph_I">arrows</span>). <span class="emph_B">B. PA Skull.</span> Observe the distortion of the greater and lesser wing of the sphenoid (<span class="emph_I">arrows</span>) as a result of hypoplasia. Close observation of the central portion of the involved orbit reveals distortion of the normal landmarks, giving the appearance of the orbit being bare of its normal anatomic landmarks. <span class="emph_I">COMMENT:</span> Agenesis or hypoplasia of the posterior wall of the orbit, the wings of the sphenoid bone, and the orbital plate of the frontal bone is a common finding in neurofibromatosis. This creates what has been referred to as the bare orbit, which may allow direct contact of the temporal lobe with the bone, creating pulsating exophthalmos. These changes are usually unilateral.</div>
</td></tr>
</table></div>
<div class="FG" id="F414-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[9]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="231" src="files/0c385b5b453ec6cf0a6d83796e45b22e.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="0c385b5b453ec6cf0a6d83796e45b22e.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="231" DISPLAY="INLINE"></div>
<div class="P">Figure 11-412 <span class="emph_B">NEUROFIBROMATOSIS: LAMBDOIDAL DEFECT OR ASTERION DEFECT. A. AP Towne&#x2019;s Projection, Skull.</span> Observe the rather sharply demarcated area of radiolucency present near the lambdoidal suture (<span class="emph_I">arrows</span>). <span class="emph_B">B. Lateral Skull.</span> Note the focal area of radiolucency associated with the lambdoid suture (<span class="emph_I">arrows</span>). This represents the lambdoidal defect of neurofibromatosis and has been referred to as the <span class="emph_I">asterion defect. COMMENT:</span> This radiolucent defect is seen adjacent to the lambdoidal suture, just posterior to the parietal mastoid and occipital mastoid sutures and is virtually diagnostic of neurofibromatosis. The defect actually represents an area of hypoplasia or agenesis because no neurofibromatous tissue is seen within the calvarial defect. Hypoplasia of the ipsilateral mastoid process has been associated, a radiographic finding that was not present in this case.</div>
</td></tr>
</table></div>
<a name="PG1355"> </a><div class="pagenum"><div>P.1355</div></div>
<br clear="all">
<div class="FG" id="F415-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[10]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="472" height="700" src="files/bfdf3180f4fa1448046d4690278f9088.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="bfdf3180f4fa1448046d4690278f9088.gif" MIMETYPE="image/gif" WIDTH="472" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-413 <span class="emph_B">NEUROFIBROMATOSIS: FOOT.</span> Observe the thin, irregular, scalloped appearance of the metatarsal bones. This deformity in the metatarsal bones is likened to the twisted ribbon appearance seen affecting the ribs in neurofibromatosis. Mesodermal dysplasia is the underlying pathologic process allowing this radiographic appearance to occur in neurofibromatosis.</div>
</td></tr>
</table></div>
<div class="FG" id="F416-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[11]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="256" height="700" src="files/53dd86b77a8e42ac48c8b3c0c31ae34a.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="53dd86b77a8e42ac48c8b3c0c31ae34a.gif" MIMETYPE="image/gif" WIDTH="256" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-414 <span class="emph_B">NEUROFIBROMATOSIS: DEFORMITY.</span> Observe the bowing deformity of the tibia, with alteration of the bony texture as a result of the underlying changes of neurofibromatosis. (Courtesy of C. H. Quay, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F417-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[12]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="633" src="files/a4667a047ca292dbd7ebf4f5cbc3ab1b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a4667a047ca292dbd7ebf4f5cbc3ab1b.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="633" DISPLAY="INLINE"></div>
<div class="P">Figure 11-415 <span class="emph_B">NEUROFIBROMATOSIS: PSEUDO-ARTHROSIS. A and B. Ulna.</span> Observe the pseudo-arthrosis in the mid-diaphysis of the ulna (<span class="emph_I">arrows</span>). <span class="emph_I">COMMENT:</span> Of patients with pseudo-arthrosis, 50&#x0025; manifest some stigmata of neurofibromatosis. The tibia in its lower two thirds is the most commonly affected bone. There is no evidence of neurofibromatous tissue in or near the site of the deformed pseudo-arthrosis. Rarely, fibrous dysplasia patients may develop similar pseudo-arthrosis lesions in bone.</div>
</td></tr>
</table></div>
<div class="FG" id="F418-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[13]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="446" src="files/c2ba08215dbe42cca3e0315480355541.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="c2ba08215dbe42cca3e0315480355541.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="446" DISPLAY="INLINE"></div>
<div class="P">Figure 11-416 <span class="emph_B">NEUROFIBROMATOSIS: MULTIPLE NONOSSIFYING FIBROMAS.</span> Note the distinctive, multiple, eccentrically elongated lesions in the lower extremity bilaterally (<span class="emph_I">arrows</span>).</div>
</td></tr>
</table></div>
<a name="PG1356"> </a><div class="pagenum"><div>P.1356</div></div>
<br clear="all">
<div class="FG" id="F419-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[14]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="434" height="700" src="files/b5466dfdf6951797c736c55586dedb7b.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="b5466dfdf6951797c736c55586dedb7b.gif" MIMETYPE="image/gif" WIDTH="434" HEIGHT="700" DISPLAY="INLINE"></div>
<div class="P">Figure 11-417 <span class="emph_B">FOCAL GIANTISM IN NEUROFIBROMATOSIS.</span> Observe the localized skeletal enlargement or focal giantism, affecting the skeletal structures of the third digit. Soft tissue hypertrophy is also noted. <span class="emph_I">COMMENT:</span> Focal giantism is perhaps the most bizarre and fascinating aspect of neurofibromatosis. The hypertrophy may involve a single bone or the entire extremity. The bones are usually normal in shape, and the associated muscles and joints are proportionately enlarged, along with the surface soft tissues. The pathogenesis is the result of chronic hyperemia owing to hemangiomas and lymphangiomatous lesions associated with neurofibromatosis. (Courtesy of David P. Thomas, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Melbourne, Australia.)</div>
</td></tr>
</table></div>
<div class="FG" id="F420-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/FG[15]"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><td valign="top" class="FIGURE-COL1"><img border="0" width="650" height="330" src="files/a7fe4022b4cabd1e1c6fda22c0aeb26d.gif"></td></tr>
<tr><td valign="top" class="FIGURE-COL2">
<div class="P" NAME="a7fe4022b4cabd1e1c6fda22c0aeb26d.gif" MIMETYPE="image/gif" WIDTH="650" HEIGHT="330" DISPLAY="INLINE"></div>
<div class="P">Figure 11-418 <span class="emph_B">NEUROFIBROMATOSIS: MALIGNANT DEGENERATION, NEUROFIBROSARCOMA. A. AP Lumbar Spine.</span> Note the destruction of the L3 and L4 spinous processes (<span class="emph_I">arrows</span>). <span class="emph_B">B. T2-Weighted MRI, Sagittal Lumbar Spine with Contrast.</span> Observe the soft tissue mass in the paraspinal musculature (<span class="emph_I">arrows</span>). <span class="emph_B">C. T1-Weighted MRI, Axial Lumbar Spine.</span> Note the soft tissue mass in the midline (<span class="emph_I">arrows</span>). (Courtesy of Joan Sutcliffe, <a class="LK" href="sid108669.html#AB1-M14">MD</a>, Denver, Colorado.)</div>
</td></tr>
</table></div>
<div class="TB" id="T48-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/TB[1]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-48 Propensity of Malignant Degeneration in Benign Skeletal Tumors and Tumor-Like Processes</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<th valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></th>
<th valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p></p></th>
<th align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p><b>Reference<i><sup><a class="a" href="sid806035.html#N1-T48-C11">a</a></sup></i></b></p></th>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Solitary osteochondroma</p></td>
<td align="center" valign="top" rowspan="1" colspan="1"><p>1.0&#x0025;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Dahlin (<a class="a" href="sid806035.html#R806-11">17</a>)</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>HME</p></td>
<td align="center" valign="top" rowspan="1" colspan="1"><p>20&#x0025;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Dahlin (<a class="a" href="sid806035.html#R796-11">7</a>)</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Solitary enchondroma</p></td>
<td align="center" valign="top" rowspan="1" colspan="1"><p>Rare (&#x003C; 1.0&#x0025;)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Hamlin (<a class="a" href="sid806035.html#R801-11">12</a>)</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Multiple enchondromatosis (Ollier&#x2019;s disease)</p></td>
<td align="center" valign="top" rowspan="1" colspan="1"><p>50&#x0025;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Jaffe (<a class="a" href="sid806035.html#R791-11">2</a>)</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Maffucci&#x2019;s syndrome</p></td>
<td align="center" valign="top" rowspan="1" colspan="1"><p>&#x003E; 50&#x0025;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Howard (<a class="a" href="sid806035.html#R791-11">2</a>)</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Paget&#x2019;s disease</p></td>
<td align="center" valign="top" rowspan="1" colspan="1"><p>0.9-2.0&#x0025;</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>McKenna (35)</p></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Fibrous dysplasia</p></td>
<td align="center" valign="top" rowspan="1" colspan="1"><p>Rare (0.5&#x0025;)</p></td>
<td align="left" valign="top" rowspan="1" colspan="1"><p>Huvos (<a class="a" href="sid806035.html#R808-11">19</a>)</p></td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Neurofibromatosis</p></td>
<td align="center" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>5&#x0025;</p></td>
<td align="left" valign="top" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Patel (<a class="a" href="sid806035.html#R800-11">11</a>)</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>
<i><sup><a name="N1-T48-C11" shape="rect" target="_blank">a </a></sup></i> Numbers refer to the section in which the particular disease entity is discussed.</p></td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3" rowspan="1"><p>HME, hereditary multiple exostosis.</p></td>
</tr>
</table></td></tr>
</table></div>
<div class="TB" id="T49-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[6]/TB[2]" T="OVID"><table class="FIGURE" cellpadding="0" cellspacing="0">
<tr><th valign="top" class="FIGURE-COL2"><div class="TI"><span class="emph_B">Table 11-49 Differential Diagnosis of Polyostotic Benign Tumor or Tumor-Like Conditions of Bone (TRY 7)</span></div></th></tr>
<tr><td valign="top" class="FIGURE-COL1"><table cellpadding="0" cellspacing="0" border="0">
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Paget&#x2019;s disease</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Fibrous dysplasia</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Histiocytosis X</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Neurofibromatosis</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Hereditary multiple exostoses</p></td>
</tr>
<tr>
<td align="left" valign="bottom" rowspan="1" colspan="1"><p>Ollier&#x2019;s disease</p></td>
</tr>
<tr>
<td align="left" valign="bottom" style="border-bottom: 1px solid black;" rowspan="1" colspan="1"><p>Brown&#x2019;s tumors (hyperparathyroidism)</p></td>
</tr>
</table></td></tr>
</table></div>
</div>
<a name="PG1357"> </a><div class="pagenum"><div>P.1357</div></div>
<br clear="all">
<div class="TLV4" id="B01382540.0-3987" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]">
<div class="HD">Extraskeletal Manifestations</div>
<div class="P">Extraskeletal manifestations of neurofibromatosis are varied and relatively common, as a result of the widespread mesodermal nature of this disease. They include intracranial neurofibromas and intramural gastrointestinal lesions, as well as lesions in the lung, mediastinum, and soft tissues throughout the body. Renal artery stenosis occurs, which predisposes these patients to the development of renal hypertension. (<a class="LK" href="sid806035.html#R815-11">26</a>) In addition, there is a strong association between the presence of adrenal pheochromocytoma and neurofibromatosis; 20&#x0025; of patients with this neoplasm also have neurofibromatosis. However, only 1&#x0025; of patients with neurofibromatosis develop pheochromocytoma. Malignant degeneration to neurofibrosarcoma does occur. (<a class="LK" href="sid806035.html#F420-11">Fig. 11-418</a>) Therefore, a hypertensive adult patient with neurofibromatosis should be carefully investigated for renal artery stenosis and pheochromocytoma as an organic cause for their hypertension. (<a class="LK" href="sid806035.html#R815-11">26</a>) Osteomalacia, presumably owing to renal tubular dysfunction, is rarely found in patients with long-standing neurofibromatosis. The radiographic signs of osteomalacia in an adult or rickets in a child do not provide a means for determining the presence or absence of neurofibromatosis. (<a class="LK" href="sid806035.html#T48-11">Table 11-48</a>) Neurofibromatosis is one of seven bone disorders to be considered in the differential diagnosis of benign polyostotic tumor-like lesions. (<a class="LK" href="sid806035.html#T49-11">Table 11-49</a>)</div>
<div class="SIDEBAR KEY">
<div class="TLV1" id="B01382540.0-3988" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]/SIDEBAR[1]/TLV1[1]">
<div class="HD">CAPSULE SUMMARY Neurofibromatosis</div>
<div class="TLV2" id="B01382540.0-3989" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]/SIDEBAR[1]/TLV1[1]/TLV2[1]">
<div class="HD">General Considerations</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">An inherited disorder, transmitted as an autosomal dominant.</div></li>
<li class="LM"><div class="P">In 1882 von Recklinghausen drew the first association of neural and cutaneous fibrous elements in a disease called neurofibromatosis.</div></li>
<li class="LM"><div class="P">A triad of findings is characteristic: caf&#x00E9; au lait spots, fibroma molluscum, and osseous deformities and lesions.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3990" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]/SIDEBAR[1]/TLV1[1]/TLV2[2]">
<div class="HD">Incidence</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">1&#x002F;3000 births is the approximate incidence of neurofibromatosis.</div></li>
<li class="LM"><div class="P">60&#x0025; of patients have a familial history.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3991" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]/SIDEBAR[1]/TLV1[1]/TLV2[3]">
<div class="HD">Clinical Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Equal male to female ratio.</div></li>
<li class="LM"><div class="P">50&#x0025; of patients with neurofibromatosis develop caf&#x00E9; au lait spots.</div></li>
<li class="LM"><div class="P">Caf&#x00E9; au lait spots are non-elevated, chestnut skin pigmentations, which are smoothly marginated (coast of California).</div></li>
<li class="LM"><div class="P">The presence of six or more caf&#x00E9; au lait spots measuring 1.5 cm or more is considered diagnostic of neurofibromatosis.</div></li>
<li class="LM"><div class="P">15&#x0025; of the normal population has one or two caf&#x00E9; au lait spots.</div></li>
<li class="LM"><div class="P">1&#x0025; of the normal population may have more than two caf&#x00E9; au lait spots.</div></li>
<li class="LM"><div class="P">Fibroma molluscum is a multiple asymptomatic cutaneous nodule, which is elevated above the skin&#x2019;s surface; this is the most common cutaneous manifestation of neurofibromatosis.</div></li>
<li class="LM"><div class="P">Elephantiasis neuromatosa represents thick large soft tissue folds in neurofibromatosis.</div></li>
<li class="LM"><div class="P">Pulsating exophthalmos may be a presenting sign occurring as a result of a temporal lobe herniation through the deficient posterior surface of the orbit.</div></li>
<li class="LM"><div class="P">Spinal involvement may include paraplegia, kyphoscoliosis, and atlantoaxial subluxation.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3992" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]/SIDEBAR[1]/TLV1[1]/TLV2[4]">
<div class="HD">Pathologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Grossly, the lesions of neurofibroma appear as a grayish brown, firm, rubbery mass.</div></li>
<li class="LM"><div class="P">Histologically, interlacing strands of elongated cells are arranged in a palisading pattern, containing foam cells and pigment.</div></li>
<li class="LM"><div class="P">Malignant degeneration to neurofibrosarcoma occurs in 5&#x0025; of cases; a higher incidence of sarcomatous degeneration occurs with those lesions that have been repeatedly biopsied.</div></li>
</ul>
</div>
<div class="TLV2" id="B01382540.0-3993" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]/SIDEBAR[1]/TLV1[1]/TLV2[5]">
<div class="HD">Radiologic Features</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">50&#x0025; of cases develop skeletal lesions.</div></li>
<li class="LM"><div class="P">Kyphoscoliosis is the most common spinal roentgen sign, occurring in 50&#x0025; of patients. The kyphoscoliosis is classically acutely angular and is short segmented (5 to 7 vertebrae), usually affecting the lower thoracic spine.</div></li>
<li class="LM"><div class="P">Scalloping of the posterior surface of the vertebral bodies is characteristic. Two types of scalloping exist: posterocentral scalloping at multiple levels that is secondary to dural ectasia, and eccentric unilateral scalloping usually at a single level occurs as a result of a dumbbell neurofibroma, creating enlargement of the IVF.</div></li>
<li class="LM"><div class="P">An eccentric paraspinal mass is often seen on the AP thoracic or PA chest radiograph.</div></li>
<li class="LM"><div class="P">Intrathoracic meningoceles represent a common cause for the presence of a posterior mediastinal mass in a patient with neurofibromatosis. Most meningoceles occur laterally and on the right side.</div></li>
<li class="LM"><div class="P">Unilateral agenesis or hypoplasia affecting the sphenoid portion of the posterior wall of the orbit, creating a bare orbit, is characteristic. It is this bony abnormality that allows pulsating exophthalmos to occur.</div></li>
<li class="LM"><div class="P">A radiolucent defect in the lambdoidal suture represents underlying hypoplasia of bone and not neurofibromatous erosion. This lesion is most common on the left side and may have hypoplasia of the ipsilateral mastoid process associated. This associated lambdoidal lesion has been called the asterion defect.</div></li>
<li class="LM"><div class="P">Scalloping irregularities of the ribs create the twisted ribbon appearance.</div></li>
<li class="LM"><div class="P">Pseudo-arthrosis of the tibia occurs in 50&#x0025; of cases.</div></li>
<li class="LM"><div class="P">Multiple large bilateral non-ossifying fibromas have been documented to occur in association.</div></li>
<li class="LM"><div class="P">Focal giantism (local overgrowth or hypertrophy of both the skeletal and soft tissue structures), usually of the lower extremities, is perhaps the most bizarre and fascinating roentgen sign.</div></li>
<li class="LM"><div class="P">Renal artery stenosis occurs in association, creating hypertension.</div></li>
<li class="LM"><div class="P">1&#x0025; of patients with neurofibromatosis have a pheochromocytoma; 20&#x0025; of patients with pheochromocytoma have neurofibromatosis.</div></li>
<li class="LM"><div class="P">Osteomalacia may rarely occur in association, owing to renal tubular dysfunction.</div></li>
</ul>
</div>
</div>
</div>
<a name="PG1358"> </a><div class="pagenum"><div>P.1358</div></div>
<br clear="all">
<div class="SIDEBAR IMPLICATIONS">
<div class="TLV1" id="B01382540.0-3994" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]/SIDEBAR[2]/TLV1[1]">
<div class="HD">Medicolegal Implications</div>
<div class="TLV2" id="B01382540.0-3995" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/TBD[1]/TLV1[5]/TLV2[3]/TLV3[5]/TLV4[7]/SIDEBAR[2]/TLV1[1]/TLV2[1]">
<div class="HD">
<img border="0" align="left" style="padding: 0 8px 2px 0" height="51" width="41" src="files/ee3de1a9df91cb9eb05810acd9947de5.gif">SKELETAL TUMORS</div>
<ul class="LS listtype_B">
<li class="LM"><div class="P">Recognition of bone tumors requires the clinical decision to obtain a radiograph. Key points in the history must be sought, including past history of malignancy, loss of appetite, weight loss, and night pain. Unresponsiveness to care and worsening of symptoms are clinical indicators that necessitate further consideration. Failure to recognize these important red flags results in a delay in appropriate patient management.</div></li>
<li class="LM"><div class="P">Even though plain films are relatively insensitive, requiring between 30&#x0025; and 50&#x0025; loss of bone mass before it becomes radiographically visible, they remain, for the most part, the best initial study for these lesions.</div></li>
<li class="LM"><div class="P">Knowledge of the locations, age frequencies, and appearance of individual bone tumors is essential for appropriate recognition and clinical decision making.</div></li>
<li class="LM"><div class="P">Radiographs need to be of the highest quality, with adequate views. Failure to fulfill these criteria is a medicolegal risk.</div></li>
<li class="LM"><div class="P">The interpreter should be able to accurately describe the lesion and make some conclusions on the behavior of the lesion. The necessity for second opinion review depends on the individual circumstances, but it is to be encouraged wherever there is doubt on the patient&#x2019;s status or if a tumor is suspected.</div></li>
<li class="LM"><div class="P">Advanced imaging (e.g., bone scan, CT, MRI) should be given consideration when the radiographs are normal and the clinical findings don&#x2019;t resolve or progressively worsen with conservative management.</div></li>
<li class="LM"><div class="P">Sophisticated imaging modalities don&#x2019;t render a histologic diagnosis but rather provide further characterization of the lesion, as well as the extent of tumor infiltration. This aids in surgical planning and helps monitor the patient&#x2019;s response to the chosen therapy.</div></li>
</ul>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="ED"><div class="EDS" LG="ENGLISH" id="B01382540.0-3996" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]">
<div class="HD"><span class="emph_I">References</span></div>
<div class="SUBEDS1" id="B01382540.0-3997" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]">
<div class="HD">METASTATIC BONE TUMORS</div>
<div class="RF" id="R1-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[1]">1. <span class="URF"><span class="emph_B">Jaffe HJ:</span> <span class="emph_I">Tumors and Tumorous Conditions of the Bones and Joints.</span> Philadelphia, Lea &#x0026; Febiger, 1958.</span>
</div>
<div class="RF" id="R2-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Abrams HL, Spiro R, Goldstein N:</span> <span class="emph_I">Metastases in carcinoma: Analysis of 1000 autopsied cases.</span> Cancer 3:74, 1950.</span></span>
</div>
<div class="RF" id="R3-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Johnson AD:</span> <span class="emph_I">Pathology of metastatic tumors in bone.</span> Clin Orthop 73:8, 1970.</span></span>
</div>
<div class="RF" id="R4-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[4]">4. <span class="URF"><span class="emph_B">Radford M, Gibbons CL:</span> <span class="emph_I">Management of skeletal metastases.</span> Hosp Med 63(12):772, 2002.</span>
</div>
<div class="RF" id="R5-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[5]">5. <span class="URF"><span class="emph_B">Willis RA:</span> <span class="emph_I">The Spread of Tumors in the Human Body.</span> London, Butterworths, 1973.</span>
</div>
<div class="RF" id="R6-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Napoli LD, Hansen HH, Muggia FM:</span> <span class="emph_I">The incidence of osseous involvement in lung cancer, with special reference to the development of osteoblastic changes.</span> Radiology 108:17, 1973.</span></span>
</div>
<div class="RF" id="R7-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[7]">7. <span class="URF"><span class="emph_B">Kanis JA, McCloskey EV, Powles T, et al.:</span> <span class="emph_I">A high incidence of vertebral fracture in women with breast cancer.</span> Br J Cancer 79(7-8): 1179, 1999.</span>
</div>
<div class="RF" id="R8-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[8]">8. <span class="URF"><span class="emph_B">Kriteman L, Sanders WH:</span> <span class="emph_I">Normal alkaline phosphatase levels in patients with bone metastases due to renal cell carcinoma.</span> Urology 51(3):397, 1998.</span>
</div>
<div class="RF" id="R9-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[9]">9. <span class="URF"><span class="emph_B">Ataus S, Citci A, Alici B, et al.:</span> <span class="emph_I">The value of serum prostate specific antigen and other parameters in detecting bone metastases in prostate cancer.</span> Int Urol Nephrol 31(4):481, 1999.</span>
</div>
<div class="RF" id="R10-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[10]">10. <span class="URF"><span class="emph_B">Wymenga LF, Boomsma JH, Groenier K, et al.:</span> <span class="emph_I">Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.</span> Br J Urol Int 88(3):226, 2001.</span>
</div>
<div class="RF" id="R11-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[11]">11. <span class="URF"><span class="emph_B">Lin K, Szabo Z, Chin BB, Civelek AC:</span> <span class="emph_I">The value of baseline bone scan in patients with newly diagnosed prostate cancer.</span> Clin Nucl Med 24(8):579, 1999.</span>
</div>
<div class="RF" id="R12-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Batson OV:</span> <span class="emph_I">The function of the vertebral veins and their role in the spread of metastases.</span> Ann Surg 112:138, 1940.</span></span>
</div>
<div class="RF" id="R13-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Deutsch A, Resnick D:</span> <span class="emph_I">Eccentric cortical metastases to the skeleton from bronchogenic carcinoma.</span> Radiology 137:49, 1980.</span></span>
</div>
<div class="RF" id="R14-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Hendrix RW, Rogers LF, Davis TM Jr:</span> <span class="emph_I">Cortical bone metastasis.</span> Radiology 181:409, 1991.</span></span>
</div>
<div class="RF" id="R15-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Milch RA, Changus GW:</span> <span class="emph_I">Response to tumor invasion.</span> Cancer 9:340, 1956.</span></span>
</div>
<div class="RF" id="R16-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">McDougall IR:</span> <span class="emph_I">Skeletal scintigraphy.</span> West J Med 130:503, 1979.</span></span>
</div>
<div class="RF" id="R17-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[17]">17. <span class="URF"><span class="emph_B">Galasko CSB:</span> <span class="emph_I">The pathological basis for skeletal scintigraphy.</span> J Bone Joint Surg 57A:353, 1975.</span>
</div>
<div class="RF" id="R18-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[18]">18. <span class="URF"><span class="emph_B">Litterer WE:</span> <span class="emph_I">Nuclear bone scanning&#x2014;Skeletal imaging.</span> J Clin Chiro 3(2):7, 1980.</span>
</div>
<div class="RF" id="R19-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[19]">19. <span class="URF"><span class="emph_B">Wu PS, Chiu NT, Lee BF, et al.:</span> <span class="emph_I">Clinical significance of solitary rib hot spots on bone scans in patients with extraskeletal cancer: Correlation with other clinical manifestations.</span> Clin Nucl Med 27(8):567, 2002.</span>
</div>
<div class="RF" id="R20-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[20]">20. <span class="URF"><span class="emph_B">Han LJ, Au-Yong TK, Tong WC, et al.:</span> <span class="emph_I">Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain.</span> Eur J Nucl Med 25(6):635, 1998.</span>
</div>
<div class="RF" id="R21-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Citrin DL, Hougen C, Zweibel W:</span> <span class="emph_I">Use of serial bone scans in assessing response of bone metastases to systemic treatment.</span> Cancer 47:680, 1981.</span></span>
</div>
<div class="RF" id="R22-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[22]">22. <span class="JRF"><span class="DRF"><span class="emph_B">Lee YTN:</span> <span class="emph_I">Bone scanning in patients with early breast carcinoma: Should it be a routine staging procedure?</span> Cancer 47:486, 1981.</span></span>
</div>
<div class="RF" id="R23-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Charkes ND, Malmud LS, Caswell T:</span> <span class="emph_I">Preoperative bone scans: Use in women with early breast cancer.</span> JAMA 233:516, 1975.</span></span>
</div>
<div class="RF" id="R24-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[24]">24. <span class="URF"><span class="emph_B">DeSantos LA, Libshitz HI:</span> <span class="emph_I">Adult bone.</span> In: HI Libshitz HI, ed, <span class="emph_I">Diagnostic Roentgenology of Radiotherapy Change.</span> Baltimore, Williams &#x0026; Wilkins, 1979.</span>
</div>
<div class="RF" id="R25-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[25]">25. <span class="JRF"><span class="DRF"><span class="emph_B">Bachman AS, Sproul EE:</span> <span class="emph_I">Correlation of radiographic and autopsy findings in suspected metastases in the spine.</span> Bull NY Acad Med 44:169, 1940.</span></span>
</div>
<div class="RF" id="R26-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[26]">26. <span class="URF"><span class="emph_B">Sedonja I, Budihna NV:</span> <span class="emph_I">The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine.</span> Clin Nucl Med 24(6):407, 1999.</span>
</div>
<div class="RF" id="R27-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[27]">27. <span class="URF"><span class="emph_B">Krishnamurthy GT, et al.:</span> <span class="emph_I">Distribution pattern of metastatic bone disease. A need for total body skeletal image.</span> JAMA 237:2504, 1977.</span>
</div>
<div class="RF" id="R28-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[28]">28. <span class="URF"><span class="emph_B">Steinborn MM, Heuck AF, Tiling R, et al.:</span> <span class="emph_I">Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system.</span> J Comput Assist Tomogr 23(1):123, 1999.</span>
</div>
<div class="RF" id="R29-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[29]">29. <span class="URF"><span class="emph_B">Mysorekar VV, Dandekar CP, Rao SG:</span> <span class="emph_I">Metastatic bone tumors.</span> J Indian Med Assoc 96(3):74, 1998.</span>
</div>
<div class="RF" id="R30-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[30]">30. <span class="JRF"><span class="DRF"><span class="emph_B">Yuh WTC, Zachar CK, Barloon TJ, et al.:</span> <span class="emph_I">Vertebral compression fractures: Distinction between benign and malignant causes with MR imaging.</span> Radiology 172:215, 1989.</span></span>
</div>
<div class="RF" id="R31-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[31]">31. <span class="URF"><span class="emph_B">Shih TT, Huang KM, Li YW:</span> <span class="emph_I">Solitary vertebral collapse: Distinction between benign and malignant causes using MR patterns.</span> J Magn Reson Imaging 9(5):635, 1999.</span>
</div>
<a name="PG1359"> </a><div class="pagenum"><div>P.1359</div></div>
<br clear="all">
<div class="RF" id="R32-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[32]">32. <span class="URF"><span class="emph_B">Fourney DR, Schomer DF, Nader R, et al.:</span> <span class="emph_I">Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients.</span> J Neurosurg 98(1 Suppl):21, 2003.</span>
</div>
<div class="RF" id="R33-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[33]">33. <span class="URF"><span class="emph_B">Resnick D, Niwayama G:</span> <span class="emph_I">Diagnosis of Bone and Joint Disorders,</span> ed 2. Philadelphia, WB Saunders, 1988.</span>
</div>
<div class="RF" id="R34-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[34]">34. <span class="JRF"><span class="DRF"><span class="emph_B">Abdelwahab IF, Miller TT, Herman G, et al.:</span> <span class="emph_I">Transarticular invasion of joints by bone tumors: Hypothesis.</span> Skeletal Radiol 20:279, 1991.</span></span>
</div>
<div class="RF" id="R35-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[35]">35. <span class="JRF"><span class="DRF"><span class="emph_B">Silberstein M, Hennessy O, Lau L:</span> <span class="emph_I">Neoplastic involvement of the sacroiliac joint: MR and CT features.</span> Australas Radiol 36:334, 1992.</span></span>
</div>
<div class="RF" id="R36-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[36]">36. <span class="JRF"><span class="DRF"><span class="emph_B">Algra PR, Heimans JJ, Valk J, et al.:</span> <span class="emph_I">Do metastases in vertebrae begin in the body or the pedicles? Imaging study in 45 patients.</span> AJR 158:1275, 1992.</span></span>
</div>
<div class="RF" id="R37-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[37]">37. <span class="URF"><span class="emph_B">Greenfield GB:</span> <span class="emph_I">Radiology of Bone Diseases,</span> ed 3. Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R38-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[38]">38. <span class="URF"><span class="emph_B">Macnab I:</span> <span class="emph_I">Backache.</span> Baltimore, Williams &#x0026; Wilkins, 1977.</span>
</div>
<div class="RF" id="R39-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[39]">39. <span class="URF"><span class="emph_B">Wackenheim A:</span> <span class="emph_I">Radiodiagnosis of the Vertebra in Adults.</span> Chicago, Yearbook, 1983.</span>
</div>
<div class="RF" id="R40-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[40]">40. <span class="URF"><span class="emph_B">Albers VL:</span> <span class="emph_I">Congenital absence of a lumbar pedicle with sclerosis and hypertrophy of the contralateral pedicle.</span> ACA J Chiro, 1984.</span>
</div>
<div class="RF" id="R41-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[41]">41. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Case of the missing pedicle.</span> ACA Council Roentgenol, 1981.</span>
</div>
<div class="RF" id="R42-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[42]">42. <span class="URF"><span class="emph_B">Genant HK, Wilson JS, Bovill EG, et al.:</span> <span class="emph_I">Computed tomography of the musculoskeletal system.</span> J Bone Joint Surg 61A: 1088, 1980.</span>
</div>
<div class="RF" id="R43-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[43]">43. <span class="JRF"><span class="DRF"><span class="emph_B">LaBan MM, Newman JM:</span> <span class="emph_I">Occult sternal metastasis identified by laminography in patients with chest pain.</span> Arch Phys Med Rehabil 65:203, 1984.</span></span>
</div>
<div class="RF" id="R44-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[44]">44. <span class="JRF"><span class="DRF"><span class="emph_B">Phillips CD, Pope TL, Jones JE, et al.:</span> <span class="emph_I">Nontraumatic avulsion of the lesser trochanter: A pathognomonic sign of metastatic disease?</span> Skeletal Radiol 17:106, 1988.</span></span>
</div>
<div class="RF" id="R45-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[45]">45. <span class="JRF"><span class="DRF"><span class="emph_B">Wu KK, Guise ER:</span> <span class="emph_I">Metastatic tumors of the foot.</span> South Med J 71:807, 1978.</span></span>
</div>
<div class="RF" id="R46-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[46]">46. <span class="JRF"><span class="DRF"><span class="emph_B">Moeller FA:</span> <span class="emph_I">Pulmonary adenocarcinoma: Metastasis to a lesser toe.</span> J Am Pod Assoc 61:297, 1971.</span></span>
</div>
<div class="RF" id="R47-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[47]">47. <span class="JRF"><span class="DRF"><span class="emph_B">Strang R:</span> <span class="emph_I">Phalangeal metastases as a first clinical sign of bronchogenic carcinoma.</span> Br J Surg 39:372, 1952.</span></span>
</div>
<div class="RF" id="R48-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[48]">48. <span class="JRF"><span class="DRF"><span class="emph_B">Mulvey RB:</span> <span class="emph_I">Peripheral bone metastasis.</span> AJR 91:155, 1964.</span></span>
</div>
<div class="RF" id="R49-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[49]">49. <span class="JRF"><span class="DRF"><span class="emph_B">Johnson LC:</span> <span class="emph_I">A general theory of bone tumors.</span> Bull NY Acad Med 29:164, 1953.</span></span>
</div>
<div class="RF" id="R50-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[50]">50. <span class="JRF"><span class="DRF"><span class="emph_B">Galmarini CM, Kertesz A, Oliva R, et al.:</span> <span class="emph_I">Metastasis of bronchogenic carcinoma to the thumb.</span> Med Oncol 4:282, 1998.</span></span>
</div>
<div class="RF" id="R51-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[51]">51. <span class="JRF"><span class="DRF"><span class="emph_B">Lehrer HZ, Maxfield WS, Nice CM:</span> <span class="emph_I">The periosteal &#x201C;sunburst&#x201D; pattern in metastatic bone tumors.</span> AJR 108:154, 1970.</span></span>
</div>
<div class="RF" id="R52-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[52]">52. <span class="JRF"><span class="DRF"><span class="emph_B">Hove B, Gyldensted C:</span> <span class="emph_I">Spiculated vertebral metastases from prostate carcinoma. Report of first two cases.</span> Neuroradiology 32:337, 1990.</span></span>
</div>
<div class="RF" id="R53-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[53]">53. <span class="JRF"><span class="DRF"><span class="emph_B">Clain A:</span> <span class="emph_I">Secondary malignant disease of bone.</span> Br J Cancer 19:15, 1965.</span></span>
</div>
<div class="RF" id="R54-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[54]">54. <span class="JRF"><span class="DRF"><span class="emph_B">Fidler M:</span> <span class="emph_I">Incidence of fracture through metastases in long bones.</span> Acta Orthop Scand 52:623, 1981.</span></span>
</div>
<div class="RF" id="R55-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[55]">55. <span class="JRF"><span class="DRF"><span class="emph_B">Berquist TH, Ehman RL, King BF, et al.:</span> <span class="emph_I">Value of MR imaging in differentiating benign from malignant soft tissue masses: Study of 95 lesions.</span> AJR 155:1251, 1990.</span></span>
</div>
<div class="RF" id="R56-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[56]">56. <span class="JRF"><span class="DRF"><span class="emph_B">Coombes RC, Dady P, Parsons C, et al.:</span> <span class="emph_I">Assessment of response of bone metastases to systemic treatment in patients with breast cancer.</span> Cancer 52:610, 1983.</span></span>
</div>
<div class="RF" id="R57-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[57]">57. <span class="URF"><span class="emph_B">Perez EA:</span> <span class="emph_I">Metastatic bone disease in breast cancer: the patient&#x2019;s perspective.</span> Semin Oncol 28(Suppl 11):60, 2001.</span>
</div>
<div class="RF" id="R58-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[58]">58. <span class="URF"><span class="emph_B">Finley RS:</span> <span class="emph_I">Bisphophonates in the treatment of bone metastases.</span> Semin Oncol 29(Suppl 4):132, 2002.</span>
</div>
<div class="RF" id="R59-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[59]">59. <span class="URF"><span class="emph_B">Ciray I, Astrom G, Andreasson I, et al.:</span> <span class="emph_I">Evaluation of new sclerotic bone metastases in breast cancer patients during treatment.</span> Acta Radiol 41(2):178, 2000.</span>
</div>
<div class="RF" id="R60-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[60]">60. <span class="JRF"><span class="DRF"><span class="emph_B">Rossleigh MA, Lovegrove FTA, Reynolds PM, et al.:</span> <span class="emph_I">The assessment of response to therapy of bone metastases in breast cancer.</span> Aust NZ J Med 14:19, 1984.</span></span>
</div>
<div class="RF" id="R61-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/RF[61]">61. <span class="URF"><span class="emph_B">Janjan NA, Payne R, Gillis T, et al.:</span> <span class="emph_I">Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases.</span> J Pain Symptoms Manage 16(3):171, 1998.</span>
</div>
<div class="SUBEDS2" id="B01382540.0-3998" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/SUBEDS2[1]">
<div class="HD">NEUROBLASTOMA</div>
<div class="RF" id="R62-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/SUBEDS2[1]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Groncy P, Finkelstein JZ:</span> <span class="emph_I">Neuroblastoma.</span> Pediatr Ann 7:548, 1978.</span></span>
</div>
<div class="RF" id="R63-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/SUBEDS2[1]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Eklof O, Gooding CA:</span> <span class="emph_I">Intrathoracic neuroblastoma.</span> AJR 100: 202, 1967.</span></span>
</div>
<div class="RF" id="R64-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/SUBEDS2[1]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Bond JV:</span> <span class="emph_I">Clinical features of neuroblastoma.</span> Br J Hosp Med 145: 43, 1975.</span></span>
</div>
<div class="RF" id="R65-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/SUBEDS2[1]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Eklof O, Gooding CA:</span> <span class="emph_I">Paravertebral widening in cases of neuroblastoma.</span> Br J Radiol 40:358, 1967.</span></span>
</div>
<div class="RF" id="R66-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[1]/SUBEDS2[1]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Johnson LC:</span> <span class="emph_I">A general theory of bone tumors.</span> Bull NY Acad Med 29:164, 1953.</span></span>
</div>
</div>
</div>
<div class="SUBEDS1" id="B01382540.0-3999" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]">
<div class="HD">PRIMARY MALIGNANT BONE TUMORS</div>
<div class="SUBEDS2" id="B01382540.0-4000" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]">
<div class="HD">MULTIPLE MYELOMA</div>
<div class="RF" id="R67-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Clamp JR:</span> <span class="emph_I">Some aspects of the first recorded case of multiple myeloma.</span> Lancet 2:1354, 1967.</span></span>
</div>
<div class="RF" id="R68-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Bence Jones H:</span> <span class="emph_I">On a new substance occurring in the urine of a patient with mollities ossium.</span> Philos Trans R Soc Lond (Biol) 1:55, 1848.</span></span>
</div>
<div class="RF" id="R69-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">von Rustizky J:</span> <span class="emph_I">Multiples myeloma.</span> Dtsch Z Chir 3:162, 1873.</span></span>
</div>
<div class="RF" id="R70-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Kahler O:</span> <span class="emph_I">Zur Symptomatologie des multiplen Myeloms.</span> Wien Med Presse 30:209, 1889.</span></span>
</div>
<div class="RF" id="R71-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Longsworth LG, Shedlovsky T, MacInnes DA:</span> <span class="emph_I">Electrophoretic patterns of normal and pathological human blood serum and plasma.</span> J Exp Med 70:399, 1939.</span></span>
</div>
<div class="RF" id="R72-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Grabar P, Williams CA:</span> <span class="emph_I">Methode permettant l&#x2019;etude coniugu;aaee des proprietes electrophoretiques et immunochimiques d&#x2019;un m;aaelange de proteines: Application au serum sanguin.</span> Biochem Biophys Acta 10:193, 1953.</span></span>
</div>
<div class="RF" id="R73-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[7]">7. <span class="URF"><span class="emph_B">Mirra JM:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis and Treatment.</span> Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R74-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Kyle RA:</span> <span class="emph_I">Multiple myeloma&#x2014;Review of 869 cases.</span> Mayo Clin Proc 50:29, 1975.</span></span>
</div>
<div class="RF" id="R75-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Hewell GM, Alexanian R:</span> <span class="emph_I">Multiple myeloma in young persons.</span> Ann Intern Med 84:441, 1976.</span></span>
</div>
<div class="RF" id="R76-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[10]">10. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R77-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[11]">11. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R78-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[12]">12. <span class="URF"><span class="emph_B">Kyle RA:</span> <span class="emph_I">Clinical aspects of multiple myeloma and related disorders including amyloidosis.</span> Pathol Biol (Paris) 47(2):148, 1999.</span>
</div>
<div class="RF" id="R79-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[13]">13. <span class="URF"><span class="emph_B">Zaidi AA, Vesole DH:</span> <span class="emph_I">Multiple myeloma: an old disease with new hope for the future.</span> CA Cancer J Clin 51(5):273, 2001.</span>
</div>
<div class="RF" id="R80-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[14]">14. <span class="URF"><span class="emph_B">Irish AB, Winearls CG, Littlewood T:</span> <span class="emph_I">Presentation and survival of patients with severe renal failure and myeloma.</span> Q J Med 90(12): 773, 1997.</span>
</div>
<div class="RF" id="R81-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Gordon DA, Pruzanski T, Waldemar F, et al.:</span> <span class="emph_I">Amyloid arthritis simulating rheumatoid disease in five patients with multiple myeloma.</span> Am J Med 55:142, 1973.</span></span>
</div>
<div class="RF" id="R82-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Wiernik PH:</span> <span class="emph_I">Amyloid joint disease.</span> Medicine 51:465, 1972.</span></span>
</div>
<div class="RF" id="R83-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Mulder JD, van Rijssel THG:</span> <span class="emph_I">Amyloid tumor of the sternum as part of a solitary plasmacytoma</span> &#x005B;Case Report 233&#x005D;. Skeletal Radiol 10:53, 1983.</span></span>
</div>
<div class="RF" id="R84-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Ludwig H, Kumpan W, Sinzinger H:</span> <span class="emph_I">Radiography and bone scintigraphy in multiple myeloma: A comparative analysis.</span> Br J Radiol 55:173, 1982.</span></span>
</div>
<div class="RF" id="R85-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Leonard RCF, Owen JP, Proctor SJ, et al.:</span> <span class="emph_I">Multiple myeloma: Radiology or bone scanning?</span> Clin Radiol 32:291, 1981.</span></span>
</div>
<div class="RF" id="R86-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Heiser S, Schartzman JJ:</span> <span class="emph_I">Variations in roentgen appearance of skeletal system in myeloma.</span> Radiology 58:178, 1952.</span></span>
</div>
<div class="RF" id="R87-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[21]">21. <span class="URF"><span class="emph_B">Murray RO, Jacobson HG:</span> <span class="emph_I">The Radiology of Skeletal Disorders,</span> ed 2. New York, Churchill Livingstone, 1977.</span>
</div>
<div class="RF" id="R88-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[22]">22. <span class="JRF"><span class="DRF"><span class="emph_B">Jacobson HG, Poppel MH, Shapiro JH, et al.:</span> <span class="emph_I">The vertebral pedicle sign. A roentgen finding to differentiate metastatic carcinoma from multiple myeloma.</span> AJR 80:817, 1958.</span></span>
</div>
<div class="RF" id="R89-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Cohen DM, Svien HJ, Dahlin DC:</span> <span class="emph_I">Long-term survival of patients with myeloma of the vertebral column.</span> JAMA 187:914, 1964.</span></span>
</div>
<div class="RF" id="R90-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[24]">24. <span class="URF"><span class="emph_B">Brown TS, Paterson CR:</span> <span class="emph_I">Osteosclerosis in myeloma.</span> J Bone Joint Surg 55B:621, 1973.</span>
</div>
<a name="PG1360"> </a><div class="pagenum"><div>P.1360</div></div>
<br clear="all">
<div class="RF" id="R91-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[25]">25. <span class="JRF"><span class="DRF"><span class="emph_B">Clarisse PDT, Staple TW:</span> <span class="emph_I">Diffuse bone sclerosis in multiple myeloma.</span> Radiology 99:327, 1971.</span></span>
</div>
<div class="RF" id="R92-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[26]">26. <span class="JRF"><span class="DRF"><span class="emph_B">Schreiman JS, McLeod RA, Kyle RA, et al.:</span> <span class="emph_I">Multiple myeloma: Evaluation by CT.</span> Radiology 154:483, 1985.</span></span>
</div>
<div class="RF" id="R93-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[27]">27. <span class="JRF"><span class="DRF"><span class="emph_B">Libshitz HI, Malthouse SR, Cunningham D, et al.:</span> <span class="emph_I">Multiple myeloma: Appearance at MR imaging.</span> Radiology 182:833, 1992.</span></span>
</div>
<div class="RF" id="R94-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[28]">28. <span class="URF"><span class="emph_B">Yochum TR, Molyneux TP:</span> <span class="emph_I">Multiple myeloma.</span> ACA J Chiro, 1983.</span>
</div>
<div class="RF" id="R95-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[29]">29. <span class="URF"><span class="emph_B">Kyle RA, Gertz MA, Witzig TE, et al.:</span> <span class="emph_I">Review of 1027 patients with newly diagnosed multiple myeloma.</span> Mayo Clin Proc 78(1):21, 2003.</span>
</div>
<div class="RF" id="R96-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[30]">30. <span class="URF"><span class="emph_B">Corso A, Klersy C, Lazzarino M, Bernasconi C:</span> <span class="emph_I">Multiple myeloma in younger patients: The role of age as a prognostic factor.</span> Ann Hematol 76(2):67, 1998.</span>
</div>
<div class="RF" id="R97-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[31]">31. <span class="URF"><span class="emph_B">Weber DM:</span> <span class="emph_I">Newly diagnosed multiple myeloma.</span> Curr Treat Options Oncol 3(3):235, 2002.</span>
</div>
<div class="RF" id="R98-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[1]/RF[32]">32. <span class="URF"><span class="emph_B">Berenson JR:</span> <span class="emph_I">Myeloma&#x2014;The therapeutic challenge.</span> Med Klin 95(Suppl 2):19, 2000.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4001" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]">
<div class="HD">SOLITARY PLASMACYTOMA</div>
<div class="RF" id="R99-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[1]">1. <span class="URF"><span class="emph_B">Mirra JM:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis and Treatment.</span> Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R100-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Lane SL:</span> <span class="emph_I">Plasmacytoma of the mandible.</span> Oral Surg 5:434, 1952.</span></span>
</div>
<div class="RF" id="R101-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[3]">3. <span class="URF"><span class="emph_B">Ganesh M, Sankar NS, Jagannathan R:</span> <span class="emph_I">Extramedullary plasmacytoma presenting as upper back pain.</span> J R Soc Health 120(4):262, 2000.</span>
</div>
<div class="RF" id="R102-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Roberts M, Rinaudo PA, Vilinskas J, et al.:</span> <span class="emph_I">Solitary sclerosing plasma-cell myeloma of the spine.</span> J Neurosurg 40:125, 1974.</span></span>
</div>
<div class="RF" id="R103-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[5]">5. <span class="URF"><span class="emph_B">Tanaka M, Shibui S, Nomura K, Nakanishi Y:</span> <span class="emph_I">Solitary plasmacytoma of the skull: A case report.</span> Jpn J Clin Oncol 28(10):626, 1998.</span>
</div>
<div class="RF" id="R104-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[6]">6. <span class="URF"><span class="emph_B">Baba H, Maezawa Y, Furusawa N, et al.:</span> <span class="emph_I">Solitary plasmacytoma of the spine associated with neurological complications.</span> Spinal Cord 36(7):470, 1998.</span>
</div>
<div class="RF" id="R105-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[7]">7. <span class="URF"><span class="emph_B">Miller FR, Lavertu P, Wanamaker JR, et al.:</span> <span class="emph_I">Plasmacytomas of the head and neck.</span> Otolaryngol Head Neck Surg 119(6):614, 1998.</span>
</div>
<div class="RF" id="R106-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[8]">8. <span class="URF"><span class="emph_B">Liebross RH, Ha CS, Cox JD, et al.:</span> <span class="emph_I">Clinical course of solitary extramedullary plasmacytoma.</span> Radiother Oncol 52(3):245, 1999.</span>
</div>
<div class="RF" id="R107-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[2]/RF[9]">9. <span class="URF"><span class="emph_B">Alexiou C, Kau RJ, Dietzfelbinger H, et al.:</span> <span class="emph_I">Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts.</span> Cancer 85(11):2305, 1999.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4002" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]">
<div class="HD">CENTRAL OSTEOSARCOMA</div>
<div class="RF" id="R108-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[1]">1. <span class="URF"><span class="emph_B">Edeiken J:</span> <span class="emph_I">Roentgen Diagnosis of Diseases of Bone,</span> ed 3. Baltimore, Williams &#x0026; Wilkins, 1981.</span>
</div>
<div class="RF" id="R109-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[2]">2. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R110-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[3]">3. <span class="URF"><span class="emph_B">Dahlin DC, Coventry MB:</span> <span class="emph_I">Osteogenic sarcoma&#x2014;A study of 600 cases.</span> J Bone Joint Surg 49A:101, 1967.</span>
</div>
<div class="RF" id="R111-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[4]">4. <span class="URF"><span class="emph_B">Chindia ML:</span> <span class="emph_I">Osteosarcoma of the jaw bones.</span> Oral Oncol 37(7): 545, 2001.</span>
</div>
<div class="RF" id="R112-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Cade S:</span> <span class="emph_I">Osteogenic sarcoma.</span> JR Coll Surg Edinb 1:79, 1955.</span></span>
</div>
<div class="RF" id="R113-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Siegal GP, Dahlin DC, Sim FH:</span> <span class="emph_I">Osteoblastic osteogenic sarcoma in a 35-month-old girl. Report of a case.</span> Am J Clin Pathol 63:886, 1975.</span></span>
</div>
<div class="RF" id="R114-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Scranton PE Jr, DeCicco FA, Totten RS, et al.:</span> <span class="emph_I">Prognostic factors in osteosarcoma. A review of 20 years&#x2019; experience at the University of Pittsburgh Health Center Hospitals.</span> Cancer 36:2179, 1975.</span></span>
</div>
<div class="RF" id="R115-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Fraumeni JF Jr:</span> <span class="emph_I">Stature and malignant tumors of bone in childhood and adolescence.</span> Cancer 20:967, 1967.</span></span>
</div>
<div class="RF" id="R116-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[9]">9. <span class="URF"><span class="emph_B">Widhe B, Widhe T:</span> <span class="emph_I">Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma.</span> J Bone Joint Surg 82A:667, 2000.</span>
</div>
<div class="RF" id="R117-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Ewing J:</span> <span class="emph_I">Bulkley lecture: Modern attitude toward traumatic cancer.</span> Arch Pathol 19:690, 1935.</span></span>
</div>
<div class="RF" id="R118-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[11]">11. <span class="URF"><span class="emph_B">McKenna RJ, Schwinn CP, Soong KY, et al.:</span> <span class="emph_I">Sarcomata of the osteogenic series&#x2014;An analysis of 552 cases.</span> J Bone Joint Surg 48A:1, 1966.</span>
</div>
<div class="RF" id="R119-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[12]">12. <span class="URF"><span class="emph_B">Levine AM, Chretien P:</span> <span class="emph_I">Deep venous occlusion as the initial presentation of osteogenic sarcoma of the sacrum.</span> J Bone Joint Surg 61A:775, 1979.</span>
</div>
<div class="RF" id="R120-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Gold RH, Mirra JH:</span> <span class="emph_I">Highly anaplastic epiphyseal osteosarcoma.</span> Skeletal Radiol 3:69, 1978.</span></span>
</div>
<div class="RF" id="R121-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Findelstein JB:</span> <span class="emph_I">Osteosarcoma of the jaw bones.</span> Radiol Clin North Am 8:425, 1970.</span></span>
</div>
<div class="RF" id="R122-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Salmon M:</span> <span class="emph_I">Osteosarcome de l&#x2019;omoplate chez une enfant. Radiotherapie&#x2014;Scapulectomie.</span> Chirurgie 99:887, 1973.</span></span>
</div>
<div class="RF" id="R123-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[16]">16. <span class="URF"><span class="emph_B">Carrol RE:</span> <span class="emph_I">Osteogenic sarcoma in the hand.</span> J Bone Joint Surg 39A:325, 1957.</span>
</div>
<div class="RF" id="R124-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[17]">17. <span class="URF"><span class="emph_B">Marsh HO, Choi CB:</span> <span class="emph_I">Primary osteogenic sarcoma of the cervical spine originally mistaken for benign osteoblastoma&#x2014;A case report.</span> J Bone Joint Surg 52A:1467, 1970.</span>
</div>
<div class="RF" id="R125-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Espinosa GA, Platt H:</span> <span class="emph_I">Two cases of osteosarcoma of the spine arising from Pagetic bone.</span> App Radiol 12:59, 1983.</span></span>
</div>
<div class="RF" id="R126-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.</span></span>
</div>
<div class="RF" id="R127-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">McKenna RF, Schwinn CP, Soong KY, et al.:</span> <span class="emph_I">Osteogenic sarcoma arising in Paget&#x2019;s disease.</span> Cancer 17:42, 1964.</span></span>
</div>
<div class="RF" id="R128-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Fuchs B, Pritchard DJ:</span> <span class="emph_I">Etiology of osteosarcoma.</span> Clin Orthop 397:40-52, 2002.</span></span>
</div>
<div class="RF" id="R129-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[22]">22. <span class="JRF"><span class="DRF"><span class="emph_B">St. James AT:</span> <span class="emph_I">Resection of multiple metastatic pulmonary lesions of osteogenic sarcoma.</span> JAMA 169:943, 1959.</span></span>
</div>
<div class="RF" id="R130-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[23]">23. <span class="URF"><span class="emph_B">Wuisman P, Enneking WF:</span> <span class="emph_I">Prognosis for patients who have osteosarcoma with skip metastasis.</span> J Bone Joint Surg 72A:60, 1990.</span>
</div>
<div class="RF" id="R131-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[24]">24. <span class="JRF"><span class="DRF"><span class="emph_B">Price CHG, Jeffree GM:</span> <span class="emph_I">Metastatic spread of osteosarcoma.</span> Br J Cancer 28:515, 1973.</span></span>
</div>
<div class="RF" id="R132-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[25]">25. <span class="JRF"><span class="DRF"><span class="emph_B">Kumar R, David R, Madewell JE, et al.:</span> <span class="emph_I">Radiographic spectrum of osteogenic sarcoma.</span> AJR 148:767, 1987.</span></span>
</div>
<div class="RF" id="R133-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[26]">26. <span class="URF"><span class="emph_B">Goodwin MA:</span> <span class="emph_I">Primary osteosarcoma of the patella.</span> J Bone Joint Surg 43B:338, 1961.</span>
</div>
<div class="RF" id="R134-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[27]">27. <span class="JRF"><span class="DRF"><span class="emph_B">Norton KI, Hermann G, Abdelwahab IF, et al.:</span> <span class="emph_I">Epiphyseal involvement in osteosarcoma.</span> Radiology 180:813, 1991.</span></span>
</div>
<div class="RF" id="R135-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[28]">28. <span class="JRF"><span class="DRF"><span class="emph_B">Hingorani CB, Sharma OP:</span> <span class="emph_I">Osteosarcoma&#x2014;A roentgenographic study.</span> Indian J Cancer 10:285, 1973.</span></span>
</div>
<div class="RF" id="R136-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[29]">29. <span class="JRF"><span class="DRF"><span class="emph_B">Holscher HC, Bloem JL, Vanel D, et al.:</span> <span class="emph_I">Osteosarcoma: Chemotherapy-induced changes at MR imaging.</span> Radiology 182:839, 1992.</span></span>
</div>
<div class="RF" id="R137-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[30]">30. <span class="JRF"><span class="DRF"><span class="emph_B">Carsi B, Rock MG:</span> <span class="emph_I">Primary osteosarcoma in adults older than 40 years.</span> Clin Orthop 397:53, 2002.</span></span>
</div>
<div class="RF" id="R138-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[31]">31. <span class="JRF"><span class="DRF"><span class="emph_B">Sweetnam R, Knowelden J, Jedden H:</span> <span class="emph_I">Bone sarcoma; treatment by irradiation, amputation, or a combination of the two.</span> Br Med J 2:363, 1971.</span></span>
</div>
<div class="RF" id="R139-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[32]">32. <span class="JRF"><span class="DRF"><span class="emph_B">Copeland MM:</span> <span class="emph_I">Primary malignant tumors of bone&#x2014;Evaluation of current diagnosis and treatment.</span> Cancer 20:738, 1967.</span></span>
</div>
<div class="RF" id="R140-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[33]">33. <span class="JRF"><span class="DRF"><span class="emph_B">Price CHG:</span> <span class="emph_I">The prognosis of osteosarcoma&#x2014;An analytical study.</span> Br J Radiol 39:181, 1966.</span></span>
</div>
<div class="RF" id="R141-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[34]">34. <span class="JRF"><span class="DRF"><span class="emph_B">Smith J, Huvos AG, et al.:</span> <span class="emph_I">Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy.</span> Radiology 143:355, 1982.</span></span>
</div>
<div class="RF" id="R142-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[3]/RF[35]">35. <span class="JRF"><span class="DRF"><span class="emph_B">Unni KK:</span> <span class="emph_I">Osteosarcoma of bone.</span> J Orthop Sci 3:287, 1998.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4003" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[4]">
<div class="HD">MULTICENTRIC OSTEOSARCOMA</div>
<div class="RF" id="R143-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[4]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Amstutz HC:</span> <span class="emph_I">Multiple osteogenic sarcomata&#x2014;Metastatic or multicentric? Report of two cases and review of the literature.</span> Cancer 24:923, 1969.</span></span>
</div>
<div class="RF" id="R144-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[4]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Hopper KD, Moser RP, Haseman DB, et al.:</span> <span class="emph_I">Osteosarcomatosis.</span> Radiology 175:233, 1990.</span></span>
</div>
<div class="RF" id="R145-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[4]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Owen LB, Eskey CW, Kashatus WC, et al.:</span> <span class="emph_I">Multiosseous osteosarcoma: Report of one case and review of the literature.</span> Radiol Clin Biol 35:43, 1966.</span></span>
</div>
<div class="RF" id="R146-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[4]/RF[4]">4. <span class="URF"><span class="emph_B">Price CHG, Truscott DE:</span> <span class="emph_I">Multifocal osteogenic sarcoma. Report of a case.</span> J Bone Joint Surg 39B:524, 1957.</span>
</div>
<div class="RF" id="R147-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[4]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Silverman G:</span> <span class="emph_I">Multiple osteogenic sarcoma.</span> Arch Pathol 21:88, 1936.</span></span>
</div>
<div class="RF" id="R148-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[4]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Lowbeer L:</span> <span class="emph_I">Multifocal osteosarcomatosis&#x2014;A rare entity.</span> Bull Pathol 9:52, 1968.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4004" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]">
<div class="HD">PAROSTEAL SARCOMA</div>
<div class="RF" id="R149-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Lichtenstein L:</span> <span class="emph_I">Tumors of periosteal origin.</span> Cancer 8:1060, 1955.</span></span>
</div>
<div class="RF" id="R150-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[2]">2. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<a name="PG1361"> </a><div class="pagenum"><div>P.1361</div></div>
<br clear="all">
<div class="RF" id="R151-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Unni KK, Dahlin DC, Beabout JW, et al.:</span> <span class="emph_I">Parosteal osteogenic sarcoma.</span> Cancer 37:2466, 1976.</span></span>
</div>
<div class="RF" id="R152-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Sanchis Olmos V, Ferrer Torelles M, Fernandez Criado M:</span> <span class="emph_I">Osteoma parostal de clavicula.</span> Acta Orthop Traumatol Iber 4:471, 1956.</span></span>
</div>
<div class="RF" id="R153-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[5]">5. <span class="URF"><span class="emph_B">Stark HH, Jones FE, Jernstrom P:</span> <span class="emph_I">Parosteal osteogenic sarcoma of a metacarpal bone. A case report.</span> J Bone Joint Surg 53A:147, 1971.</span>
</div>
<div class="RF" id="R154-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Som M, Peimer R:</span> <span class="emph_I">Juxtacortical osteogenic sarcoma of the mandible.</span> Arch Otolaryngol 74:532, 1961.</span></span>
</div>
<div class="RF" id="R155-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[7]">7. <span class="URF"><span class="emph_B">Lodwick GS:</span> <span class="emph_I">The Bones and Joints.</span> Chicago, Year Book Medical, 1973.</span>
</div>
<div class="RF" id="R156-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[8]">8. <span class="URF"><span class="emph_B">Edeiken J, et al.:</span> <span class="emph_I">Parosteal sarcoma.</span> AJR 3:579, 1971.</span>
</div>
<div class="RF" id="R157-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Hudson TM, Springfield DS, Benjamin M, et al.:</span> <span class="emph_I">Computed tomography of parosteal osteosarcoma.</span> AJR 144:961, 1985.</span></span>
</div>
<div class="RF" id="R158-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Kenan S, Abdelwahab IF, Klein MJ, et al.:</span> <span class="emph_I">Parosteal osteosarcoma involving the left radius. Case report 835.</span> Skeletal Radiol 23:229, 1994.</span></span>
</div>
<div class="RF" id="R159-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[11]">11. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Post traumatic myositis ossificans.</span> ACA J Chiro, 1982.</span>
</div>
<div class="RF" id="R160-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[5]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Unni KK, Beabout JW, et al.:</span> <span class="emph_I">High-grade surface osteosarcomas.</span> Am J Surg Pathol 8:81, 1984.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4005" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[6]">
<div class="HD">SECONDARY OSTEOSARCOMA</div>
<div class="RF" id="R161-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[6]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.</span></span>
</div>
<div class="RF" id="R162-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[6]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Castle WB, Drinker KR, Drinker CK:</span> <span class="emph_I">Necrosis of the jaw in workers employed in applying a luminous paint containing radium.</span> J Indust Hyg 7:371, 1925.</span></span>
</div>
<div class="RF" id="R163-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[6]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Yoneyama T, Greenlaw RH:</span> <span class="emph_I">Osteogenic sarcoma following radiotherapy for retinoblastoma.</span> Radiology 93:1185, 1969.</span></span>
</div>
<div class="RF" id="R164-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[6]/RF[4]">4. <span class="URF"><span class="emph_B">Martland HS, et al.:</span> <span class="emph_I">The late effects of internally deposited radioactive materials in man.</span> Medicine 31:221, 1952.</span>
</div>
<div class="RF" id="R165-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[6]/RF[5]">5. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R166-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[6]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Tsuya A, Tanaka T, Mori T, et al.:</span> <span class="emph_I">Four cases of Thorotrast injury and estimation of absorbed tissue dose in critical organs.</span> J Radiat Res 4:126, 1963.</span></span>
</div>
<div class="RF" id="R167-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[6]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Lorigan JG, Libshitz HI, Peuchot M:</span> <span class="emph_I">Radiation-induced sarcoma of bone: CT findings in 19 cases.</span> AJR 153:791, 1989.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4006" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[7]">
<div class="HD">EXTRAOSSEOUS OSTEOSARCOMA</div>
<div class="RF" id="R168-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[7]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Das Guptz TK, Hajdu SI, Foote FW Jr:</span> <span class="emph_I">Extraosseous osteogenic sarcoma.</span> Ann Surg 168:1011, 1968.</span></span>
</div>
<div class="RF" id="R169-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[7]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Lowry K Jr, Haynes CD:</span> <span class="emph_I">Osteogenic sarcoma of extraskeletal soft tissues: A case report.</span> Am Surg 30:97, 1964.</span></span>
</div>
<div class="RF" id="R170-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[7]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Salm R:</span> <span class="emph_I">A case of primary osteogenic sarcoma of extraskeletal soft tissue.</span> Br J Cancer 13:614, 1959.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4007" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]">
<div class="HD">CHONDROSARCOMA</div>
<div class="RF" id="R171-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[1]">1. <span class="URF"><span class="emph_B">Greenfield GB:</span> <span class="emph_I">Radiology of Bone Diseases,</span> ed 3. Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R172-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[2]">2. <span class="URF"><span class="emph_B">Jaffe HJ:</span> <span class="emph_I">Tumors and Tumorous Conditions of the Bones and Joints.</span> Philadelphia, Lea &#x0026; Febiger, 1969.</span>
</div>
<div class="RF" id="R173-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Lichtenstein L, Jaffe HL:</span> <span class="emph_I">Chondrosarcoma of bone.</span> Am J Pathol 19:553, 1943.</span></span>
</div>
<div class="RF" id="R174-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">O&#x2019;Neal LW, Ackerman LV:</span> <span class="emph_I">Chondrosarcoma of bone.</span> Cancer 5:551, 1952.</span></span>
</div>
<div class="RF" id="R175-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[5]">5. <span class="URF"><span class="emph_B">Marcove RC, Mike V, Hutter RVP, et al.:</span> <span class="emph_I">Chondrosarcoma of the pelvis and upper end of the femur. An analysis of factors influencing survival time in 113 cases.</span> J Bone Joint Surg 54A:561, 1972.</span>
</div>
<div class="RF" id="R176-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Dahlin DC, Salvador AH:</span> <span class="emph_I">Chondrosarcomas of the bones of the hands and feet&#x2014;A study of 30 cases.</span> Cancer 34:755, 1974.</span></span>
</div>
<div class="RF" id="R177-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[7]">7. <span class="URF"><span class="emph_B">Roberts PH, Price CHG:</span> <span class="emph_I">Chondrosarcoma of the bones of the hand.</span> J Bone Joint Surg 59B:213, 1977.</span>
</div>
<div class="RF" id="R178-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Blaylock RL, Kempe LG:</span> <span class="emph_I">Chondrosarcoma of the cervical spine</span> &#x005B;Case Report 44&#x005D;. J Neurosurg 4:500, 1976.</span></span>
</div>
<div class="RF" id="R179-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[9]">9. <span class="URF"><span class="emph_B">Camins MB, Duncan AW, Smith J, et al.:</span> <span class="emph_I">Chondrosarcoma of the spine.</span> Spine 3(3):202, 1978.</span>
</div>
<div class="RF" id="R180-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[10]">10. <span class="URF"><span class="emph_B">Lo EP, Pollak R, Harvey CK:</span> <span class="emph_I">Chondrosarcoma of the foot.</span> J Am Podiatr Med Assoc 90(4):203, 2000.</span>
</div>
<div class="RF" id="R181-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Present D, Bacchini P, Pignatti G, et al.:</span> <span class="emph_I">Clear cell chondrosarcoma of bone. A report of 8 cases.</span> Skeletal Radiol 20:187, 1991.</span></span>
</div>
<div class="RF" id="R182-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Palmieri TJ:</span> <span class="emph_I">Chondrosarcoma of the hand.</span> J Hand Surg 9:332, 1984.</span></span>
</div>
<div class="RF" id="R183-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Scott WW, Fishman EK, Lubbe WJ:</span> <span class="emph_I">Chondrosarcoma of the right trapezoid bone</span> &#x005B;Case Report 259&#x005D;. Skeletal Radiol 11:137, 1984.</span></span>
</div>
<div class="RF" id="R184-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[14]">14. <span class="URF"><span class="emph_B">Granberry WM, Bryan W:</span> <span class="emph_I">Chondrosarcoma of the trapezium</span> &#x005B;Case Report 3&#x005D;. J Hand Surg 3(3):277, 1978.</span>
</div>
<div class="RF" id="R185-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[15]">15. <span class="URF"><span class="emph_B">Somers J, Faber LP:</span> <span class="emph_I">Chondroma and chondrosarcoma.</span> Semin Thorac Cardiovasc Surg 11(3):270, 1999.</span>
</div>
<div class="RF" id="R186-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Smith J, McLachlan DL, Huvos AG, et al.:</span> <span class="emph_I">Primary tumors of the clavicle and scapula.</span> Am J Roentgenol Radium Ther Nucl Med 124:113, 1975.</span></span>
</div>
<div class="RF" id="R187-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Martini N, Huvos AG, Smith J, et al.:</span> <span class="emph_I">Primary malignant tumors of the sternum.</span> Surg Gynecol Obstet 138:391, 1974.</span></span>
</div>
<div class="RF" id="R188-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[18]">18. <span class="URF"><span class="emph_B">Somville J, Van Bouwel S:</span> <span class="emph_I">Surgery for primary bone sarcomas of the pelvis.</span> Acta Orthop Belg 67(5):442, 2001.</span>
</div>
<div class="RF" id="R189-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[19]">19. <span class="URF"><span class="emph_B">Feldman F:</span> <span class="emph_I">Cartilaginous tumors and cartilage forming tumor-like conditions of the bones and soft tissues.</span> In: K Ranniger, ed, <span class="emph_I">Encyclopedia of Medical Radiology.</span> Vol 5, part 6. Berlin: Springer, 1977.</span>
</div>
<div class="RF" id="R190-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Sweet DE, Madewell JE, Ragsdale BD:</span> <span class="emph_I">Radiologic and pathologic analysis of solitary bone lesions. Part III: Matrix patterns.</span> Radiol Clin North Am 19:785, 1981.</span></span>
</div>
<div class="RF" id="R191-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[21]">21. <span class="URF"><span class="emph_B">Lichtenstein L:</span> <span class="emph_I">Bone Tumors,</span> ed 4. St. Louis, CV Mosby, 1972.</span>
</div>
<div class="RF" id="R192-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[22]">22. <span class="URF"><span class="emph_B">Schajowicz F, Aravjo ES, Berenstein A:</span> <span class="emph_I">Sarcoma complicating Paget&#x2019;s disease of bone.</span> J Bone Joint Surg 65B:299, 1983.</span>
</div>
<div class="RF" id="R193-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.</span></span>
</div>
<div class="RF" id="R194-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[24]">24. <span class="URF"><span class="emph_B">Huvos AG, Higinbotham NL, Miller TR:</span> <span class="emph_I">Bone sarcomas arising in fibrous dysplasia.</span> J Bone Joint Surg 54A:1047, 1972.</span>
</div>
<div class="RF" id="R195-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[25]">25. <span class="URF"><span class="emph_B">Fitzwater JE, Cabaud HE, Farr GH:</span> <span class="emph_I">Irradiation induced chondrosarcoma.</span> J Bone Joint Surg 58A:1037, 1976.</span>
</div>
<div class="RF" id="R196-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[26]">26. <span class="JRF"><span class="DRF"><span class="emph_B">Norman A, Sissons HA:</span> <span class="emph_I">Radiographic hallmarks of peripheral chondrosarcoma.</span> Radiology 151:589, 1984.</span></span>
</div>
<div class="RF" id="R197-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[27]">27. <span class="URF"><span class="emph_B">York JE, Berk RH, Fuller GN, et al.:</span> <span class="emph_I">Chondrosarcoma of the spine: 1954 to 1997.</span> J Neurosurg 90(1 Suppl):73, 1999.</span>
</div>
<div class="RF" id="R198-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[28]">28. <span class="URF"><span class="emph_B">Rizzo M, Ghert MA, Harrelson JM, Scully SP:</span> <span class="emph_I">Chondrosarcoma of bone: Analysis of 108 cases and evaluation for predictors of outcome.</span> Clin Orthop (391):224, 2001.</span>
</div>
<div class="RF" id="R199-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[29]">29. <span class="JRF"><span class="DRF"><span class="emph_B">Eriksson AI, Schiller A, Mankin HJ:</span> <span class="emph_I">The management of chondrosarcoma of bone.</span> Clin Orthop 153:44, 1980.</span></span>
</div>
<div class="RF" id="R200-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[30]">30. <span class="URF"><span class="emph_B">Sanerkin NG, Gallagher P:</span> <span class="emph_I">A review of the behavior of chondrosarcoma of bone.</span> J Bone Joint Surg 61B:395, 1979.</span>
</div>
<div class="RF" id="R201-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[31]">31. <span class="URF"><span class="emph_B">Bruns J, Elbracht M, Niggemeyer O:</span> <span class="emph_I">Chondrosarcoma of bone: An oncological and functional follow-up study.</span> Ann Oncol 12(6): 859, 2001</span>
</div>
<div class="RF" id="R202-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[32]">32. <span class="URF"><span class="emph_B">Fiorenza F, Abudu A, Grimer RJ, et al.:</span> <span class="emph_I">Risk factors for survival and local control in chondrosarcoma of bone.</span> J Bone Joint Surg 84B:93, 2002.</span>
</div>
<div class="RF" id="R203-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[8]/RF[33]">33. <span class="URF"><span class="emph_B">Rozeman LB, Hogendoorn PC, Bovee JV:</span> <span class="emph_I">Diagnosis and prognosis of chondrosarcoma of bone.</span> Expert Rev Mol Diagn 2(5):461, 2002.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4008" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]">
<div class="HD">EWING&#x2019;S SARCOMA</div>
<div class="RF" id="R204-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[1]">1. <span class="URF"><span class="emph_B">Ewing J:</span> <span class="emph_I">Diffuse endothelioma of bone.</span> Proc Pathol Soc 21(n.s.):17, 1921.</span>
</div>
<div class="RF" id="R205-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Oberling C:</span> <span class="emph_I">Les reticulo sarcomes et les reticulo endotheliosarcomes de la moelle osseuse (sarcomes d&#x2019;Ewing).</span> Bull Assoc Fr Etude Cancer 17:259, 1928.</span></span>
</div>
<div class="RF" id="R206-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Fraumenti JF Jr, Glass AG:</span> <span class="emph_I">Rarity of Ewing&#x2019;s sarcoma among U.S. Negro children</span> &#x005B;Letter&#x005D;. Lancet 1:366, 1970.</span></span>
</div>
<div class="RF" id="R207-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Coley BL, Higinbotham NL, Bowden L:</span> <span class="emph_I">Endothelioma of bone (Ewing&#x2019;s sarcoma).</span> Ann Surg 128:533, 1948.</span></span>
</div>
<div class="RF" id="R208-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[5]">5. <span class="URF"><span class="emph_B">Bhansali SK, Desai PB:</span> <span class="emph_I">Ewing&#x2019;s sarcoma. Observations on 107 cases.</span> J Bone Joint Surg 45A:541, 1955.</span>
</div>
<div class="RF" id="R209-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[6]">6. <span class="URF"><span class="emph_B">Widhe B, Widhe T:</span> <span class="emph_I">Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma.</span> J Bone Joint Surg 82A:667, 2000.</span>
</div>
<div class="RF" id="R210-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Lichtenstein L, Jaffe HL:</span> <span class="emph_I">Ewing&#x2019;s sarcoma of bone.</span> Am J Pathol 23:43, 1947.</span></span>
</div>
<div class="RF" id="R211-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[8]">8. <span class="URF"><span class="emph_B">Aegerter E, Kirkpatrick JA Jr:</span> <span class="emph_I">Orthopedic Diseases,</span> ed 4. Philadelphia, WB Saunders, 1975.</span>
</div>
<a name="PG1362"> </a><div class="pagenum"><div>P.1362</div></div>
<br clear="all">
<div class="RF" id="R212-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[9]">9. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R213-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Rosen G, Caparros B, Huvos AG, et al.:</span> <span class="emph_I">Ewing&#x2019;s sarcoma. Ten years&#x2019; experience with adjuvant chemotherapy.</span> Cancer 47:2204, 1981.</span></span>
</div>
<div class="RF" id="R214-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[11]">11. <span class="URF"><span class="emph_B">Li WK, Lane JM, Rosen G, et al.:</span> <span class="emph_I">Pelvic Ewing&#x2019;s sarcoma.</span> J Bone Joint Surg 65A:738, 1983.</span>
</div>
<div class="RF" id="R215-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Kozlowski K, Campbell J, Beluffi G, et al.:</span> <span class="emph_I">Primary bone tumors of the pelvis in childhood&#x2014;Ewing&#x2019;s sarcoma of the ilium, pubis and ischium. (Report of 30 cases). Part 1.</span> Australas Radiol 33:354, 1989.</span></span>
</div>
<div class="RF" id="R216-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Levine E, Levine C:</span> <span class="emph_I">Ewing tumor of rib: Radiologic findings and computed tomography contribution.</span> Skeletal Radiol 9:227, 1983.</span></span>
</div>
<div class="RF" id="R217-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Staalman CR:</span> <span class="emph_I">Ewing&#x2019;s sarcoma in rib.</span> J Belgisch Radiol 65:329, 1982.</span></span>
</div>
<div class="RF" id="R218-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[15]">15. <span class="URF"><span class="emph_B">Dahlin DC:</span> <span class="emph_I">Ewing&#x2019;s tumor. Bone Tumors,</span> ed 3. Springfield, Charles C. Thomas, 1978.</span>
</div>
<div class="RF" id="R219-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Whitehouse GH, Griffiths GJ:</span> <span class="emph_I">Roentgenologic aspects of spinal involvement by primary and metastatic Ewing&#x2019;s tumor.</span> J Can Assoc Radiol 27:290, 1976.</span></span>
</div>
<div class="RF" id="R220-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Grubb MR, Currier BL, Pritchard DJ, et al.:</span> <span class="emph_I">Primary Ewing&#x2019;s sarcoma of the spine.</span> Spine 19:309, 1994.</span></span>
</div>
<div class="RF" id="R221-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Bonanone V, Cardani R:</span> <span class="emph_I">An unusual case of Ewing&#x2019;s tumor on the foot.</span> Minerva Ortop 24:441, 1973.</span></span>
</div>
<div class="RF" id="R222-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Dunn EJ, Yuska KH, Judge DM, et al.:</span> <span class="emph_I">Ewing&#x2019;s sarcoma of the great toe. A case report.</span> Clin Orthop 16:203, 1976.</span></span>
</div>
<div class="RF" id="R223-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Potdar GG:</span> <span class="emph_I">Ewing&#x2019;s tumor of the jaws.</span> J Oral Surg 29:505, 1970.</span></span>
</div>
<div class="RF" id="R224-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Blakemore JR, Stein M:</span> <span class="emph_I">Primary Ewing&#x2019;s sarcoma of the mandible: Report of a case.</span> J Oral Surg 33:376, 1975.</span></span>
</div>
<div class="RF" id="R225-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[22]">22. <span class="URF"><span class="emph_B">West DC:</span> <span class="emph_I">Ewing sarcoma family of tumors.</span> Curr Opin Oncol 12(4):323, 2000.</span>
</div>
<div class="RF" id="R226-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[23]">23. <span class="URF"><span class="emph_B">Schajowicz F:</span> <span class="emph_I">Ewing&#x2019;s sarcoma and reticulum cell sarcoma of bone. With special reference to the histochemical demonstration of glycogen as an aid to differential diagnosis.</span> J Bone Joint Surg 41A:349, 1959.</span>
</div>
<div class="RF" id="R227-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[24]">24. <span class="JRF"><span class="DRF"><span class="emph_B">Frostad B, Tani E, Brosjo O, et al.:</span> <span class="emph_I">Fine needle aspiration cytology in the diagnosis and management of children and adolescents with Ewing sarcoma and peripheral primitive neuroectodermal tumor.</span> Med Pediatr Oncol 38:33, 2002.</span></span>
</div>
<div class="RF" id="R228-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[25]">25. <span class="JRF"><span class="DRF"><span class="emph_B">Shirley SK, Gilula LA, Siegal GP, et al.:</span> <span class="emph_I">Roentgenographicpathologic correlation of diffuse sclerosis in Ewing sarcoma of bone.</span> Skeletal Radiol 12:69, 1984.</span></span>
</div>
<div class="RF" id="R229-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[26]">26. <span class="JRF"><span class="DRF"><span class="emph_B">Aufranc OE, Jones WN, Turner RH:</span> <span class="emph_I">Pathologic fracture of the proximal femur.</span> JAMA 199:107, 1967.</span></span>
</div>
<div class="RF" id="R230-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[27]">27. <span class="JRF"><span class="DRF"><span class="emph_B">Garber CZ:</span> <span class="emph_I">Reactive bone formation in Ewing&#x2019;s sarcoma.</span> Cancer 4:839, 1951.</span></span>
</div>
<div class="RF" id="R231-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[28]">28. <span class="URF"><span class="emph_B">Geschickter CF, Maseritz IH:</span> <span class="emph_I">Ewing&#x2019;s sarcoma.</span> J Bone Joint Surg 21A:26, 1939.</span>
</div>
<div class="RF" id="R232-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[29]">29. <span class="JRF"><span class="DRF"><span class="emph_B">Telles NC, Rabson AS, Pomeroy TC:</span> <span class="emph_I">Ewing&#x2019;s sarcoma: An autopsy study.</span> Cancer 41:2321, 1978.</span></span>
</div>
<div class="RF" id="R233-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[30]">30. <span class="URF"><span class="emph_B">Sundaram M, Merenda G, McGuire MM:</span> <span class="emph_I">A skip lesion in association with Ewing sarcoma.</span> J Bone Joint Surg 71A:764, 1989.</span>
</div>
<div class="RF" id="R234-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[31]">31. <span class="URF"><span class="emph_B">Hoffmann C, Ahrens S, Dunst J, et al.:</span> <span class="emph_I">Pelvic Ewing sarcoma: A retrospective analysis of 241 cases.</span> Cancer 85(4):869, 1999.</span>
</div>
<div class="RF" id="R235-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[32]">32. <span class="JRF"><span class="DRF"><span class="emph_B">Dwyer AJ, Glaubiger DL, Ecker JG, et al.:</span> <span class="emph_I">The radiographic follow-up of patients with Ewing sarcoma: A demonstration of a general method.</span> Radiology 145:327, 1982.</span></span>
</div>
<div class="RF" id="R236-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[33]">33. <span class="URF"><span class="emph_B">Jenkin RD, Al-Fawaz I, Al-Shabanah MO, et al.:</span> <span class="emph_I">Metastatic Ewing sarcoma&#x002F;PNET of bone at diagnosis: prognostic factors&#x2014;A report from Saudi Arabia.</span> Med Pediatr Oncol 37(4):383, 2001.</span>
</div>
<div class="RF" id="R237-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[34]">34. <span class="JRF"><span class="DRF"><span class="emph_B">Cotterill SJ, Ahrens S, Paulussen M, et al.:</span> <span class="emph_I">Prognostic factors in Ewing&#x2019;s tumor of bone: Analysis of 975 patients from the European Intergroup cooperative Ewing&#x2019;s Sarcoma Study Group.</span> J Clin Oncol 18:3108, 2000.</span></span>
</div>
<div class="RF" id="R238-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[9]/RF[35]">35. <span class="URF"><span class="emph_B">Shankar AG, Ashley S, Craft AW, Pinkerton CR:</span> <span class="emph_I">Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.</span> Med Pediatr Oncol 40(3):141, 2003.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4009" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]">
<div class="HD">FIBROSARCOMA</div>
<div class="RF" id="R239-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[1]">1. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R240-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[2]">2. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R241-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[3]">3. <span class="URF"><span class="emph_B">Papagelopoulos PJ, Galanis EC, Trantafyllidis P, et al.:</span> <span class="emph_I">Clinicopathologic features, diagnosis, and treatment of fibrosarcoma of bone.</span> Am J Orthop 31(5):253, 2002.</span>
</div>
<div class="RF" id="R242-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[4]">4. <span class="URF"><span class="emph_B">Larsson SE, Lorentzon R, Boquist L:</span> <span class="emph_I">Fibrosarcoma of bone.</span> J Bone Joint Surg 58B:412, 1976.</span>
</div>
<div class="RF" id="R243-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[5]">5. <span class="URF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Tumors and Tumorous Conditions of the Bones and Joints.</span> Philadelphia, Lea &#x0026; Febiger, 1958.</span>
</div>
<div class="RF" id="R244-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Dahlin DC:</span> <span class="emph_I">Fibrosarcoma of bone. A study of 114 cases.</span> Cancer 23:35, 1969.</span></span>
</div>
<div class="RF" id="R245-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Cunningham MP, Arlen M:</span> <span class="emph_I">Medullary fibrosarcoma of bone.</span> Cancer 21:31, 1968.</span></span>
</div>
<div class="RF" id="R246-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[8]">8. <span class="URF"><span class="emph_B">Kabukcuoglu Y, Kabukcuoglu F, Carter S, et al.:</span> <span class="emph_I">Multiple diffuse fibrosarcoma of bone.</span> Am J Orthop 28(12):715, 1999.</span>
</div>
<div class="RF" id="R247-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Tarasov BP:</span> <span class="emph_I">Diagnosis of fibrosarcoma of the bone.</span> Arkh Patol 32:23, 1969.</span></span>
</div>
<div class="RF" id="R248-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[10]">10. <span class="URF"><span class="emph_B">Antonescu CR, Erlandson RA, Huvos AG:</span> <span class="emph_I">Primary fibrosarcoma and malignant fibrous histiocytoma of bone&#x2014;A comparative ultrastructural study: Evidence of a spectrum of fibroblastic differentiation.</span> Ultrastruct Pathol 24(2):83, 2000.</span>
</div>
<div class="RF" id="R249-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[11]">11. <span class="URF"><span class="emph_B">Smith SE, Kransdorf MJ:</span> <span class="emph_I">Primary musculoskeletal tumors of fibrous origin.</span> Semin Musculoskelet Radiol 4(1):73, 2000.</span>
</div>
<div class="RF" id="R250-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[12]">12. <span class="URF"><span class="emph_B">Greenfield GB:</span> <span class="emph_I">Radiology of Bone Diseases,</span> ed 3. Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R251-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[13]">13. <span class="URF"><span class="emph_B">Lichtenstein L:</span> <span class="emph_I">Bone Tumors,</span> ed 4. St. Louis, CV Mosby, 1972.</span>
</div>
<div class="RF" id="R252-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[14]">14. <span class="URF"><span class="emph_B">Eyre-Brook AL, Price CHG:</span> <span class="emph_I">Fibrosarcoma of bone.</span> J Bone Joint Surg 51B:20, 1969.</span>
</div>
<div class="RF" id="R253-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[15]">15. <span class="URF"><span class="emph_B">Huvos AG, Higinbotham NL, Miller TR:</span> <span class="emph_I">Bone sarcomas arising in fibrous dysplasia.</span> J Bone Joint Surg 54A:1047, 1972.</span>
</div>
<div class="RF" id="R254-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologie 24:428, 1984.</span></span>
</div>
<div class="RF" id="R255-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[17]">17. <span class="URF"><span class="emph_B">Akbarnia BA, Wirth CR, Colman N:</span> <span class="emph_I">Fibrosarcoma arising from chronic osteomyelitis.</span> J Bone Joint Surg 58A:123, 1976.</span>
</div>
<div class="RF" id="R256-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[18]">18. <span class="URF"><span class="emph_B">Dorfman HD, Norman A, Wolf H:</span> <span class="emph_I">Fibrosarcoma complicating bone infarction in a caisson worker. A case report.</span> J Bone Joint Surg 48A:528, 1966.</span>
</div>
<div class="RF" id="R257-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[19]">19. <span class="URF"><span class="emph_B">Heselson NG, Med M, Price SK:</span> <span class="emph_I">Two malignant fibrous histiocytomas in bone infarcts&#x2014;Case report.</span> J Bone Joint Surg 65A:166, 1983.</span>
</div>
<div class="RF" id="R258-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Ros PR, Viamonte M Jr, Rywlin AM:</span> <span class="emph_I">Malignant fibrous histiocytoma: Mesenchymal tumor of ubiquitous origin.</span> AJR 142:753, 1984.</span></span>
</div>
<div class="RF" id="R259-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[10]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Papagelopoulos PJ, Galanis E, Frassica FJ, et al.</span> <span class="emph_I">Primary fibrosarcoma of bone. Outcome after primary surgical treatment.</span> Clin Orthop 373:88, 2000.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4010" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]">
<div class="HD">CHORDOMA</div>
<div class="RF" id="R260-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[1]">1. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R261-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[2]">2. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R262-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Higinbotham NL, Phillips RF, Farr HW, et al.:</span> <span class="emph_I">Chordoma: Thirty-five-year study at Memorial Hospital.</span> Cancer 20:1841, 1967.</span></span>
</div>
<div class="RF" id="R263-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Smith J, Ludwig RL, Marcove RC:</span> <span class="emph_I">Sacrococcygeal chordoma. A clinicoradiolical study of 60 patients.</span> Skeletal Radiol 16:37, 1987.</span></span>
</div>
<div class="RF" id="R264-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Dahlin DC, MacCarty CS:</span> <span class="emph_I">Chordoma: A study of fifty-nine cases.</span> Cancer 5:1170, 1952.</span></span>
</div>
<div class="RF" id="R265-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Utne JR, Pugh DG:</span> <span class="emph_I">The roentgenologic aspects of chordoma.</span> AJR 74:593, 1955.</span></span>
</div>
<div class="RF" id="R266-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Kamrin RP, Potanos JN, Pool JL:</span> <span class="emph_I">An evaluation of the diagnosis and treatment of chordoma.</span> J Neurol Neurosurg Psychiatry 27:157, 1964.</span></span>
</div>
<div class="RF" id="R267-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Mabrey RE:</span> <span class="emph_I">Chordoma: A study of 150 cases.</span> Am J Cancer 25:501, 1935.</span></span>
</div>
<div class="RF" id="R268-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Seaton RW, Weaver EN:</span> <span class="emph_I">The chordoma.</span> VA Med Mon 89:34, 1962.</span></span>
</div>
<div class="RF" id="R269-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[10]">10. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Chordoma of the sacrum.</span> ACA J Chiro, 1983.</span>
</div>
<a name="PG1363"> </a><div class="pagenum"><div>P.1363</div></div>
<br clear="all">
<div class="RF" id="R270-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[11]">11. <span class="URF"><span class="emph_B">Topsakal C, Bulut S, Erol FS, et al.:</span> <span class="emph_I">Chordoma of the thoracic spine&#x2014;Case report.</span> Neurol Med Chiro (Tokyo) 42(4):175, 2002.</span>
</div>
<div class="RF" id="R271-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Tashiro T, Fukuda T, Inoue Y, et al.:</span> <span class="emph_I">Intradural chordoma: Case report and review of the literature.</span> Neuroradiology 36:313, 1994.</span></span>
</div>
<div class="RF" id="R272-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Crapanzano JP, Ali SZ, Ginsberg MS, Zakowski MF:</span> <span class="emph_I">Chordoma: A cytologic study with histologic and radiologic correlation.</span> Cancer 93:40, 2001.</span></span>
</div>
<div class="RF" id="R273-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[14]">14. <span class="URF"><span class="emph_B">Warakaulle DR, Anslow P:</span> <span class="emph_I">A unique presentation of retroclival chordoma.</span> J Postgrad Med 48(4):285, 2002.</span>
</div>
<div class="RF" id="R274-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[15]">15. <span class="URF"><span class="emph_B">Mindell ER:</span> <span class="emph_I">Chordoma&#x2014;Current concepts review.</span> J Bone Joint Surg 63A:501, 1981.</span>
</div>
<div class="RF" id="R275-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Meyer JE, Lepke RA, Lindfors KK, et al.:</span> <span class="emph_I">Chordomas: Their CT appearance in the cervical, thoracic, and lumbar spine.</span> Radiology 153:693, 1984.</span></span>
</div>
<div class="RF" id="R276-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[17]">17. <span class="URF"><span class="emph_B">Manzone P, Fiore N, Forlino D, et al.:</span> <span class="emph_I">Chordoma of the lumbar L2 vertebra: Case report and review of the literature.</span> Eur Spine J 7(3):252, 1998.</span>
</div>
<div class="RF" id="R277-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[18]">18. <span class="URF"><span class="emph_B">McMaster ML, Goldstein AM, Bromley CM,, et al.:</span> <span class="emph_I">Chordoma: incidence and survival patterns in the United States: 1973-1995.</span> Cancer Causes Control 12(1):1, 2001.</span>
</div>
<div class="RF" id="R278-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">York JE, Kaczaraj A, Abi-Said D,, et al.:</span> <span class="emph_I">Sacral chordoma: 40-year experience at a major cancer center.</span> Neurosurgery 44:74, 1999. &#x005B;Discussion 44:79, 1999.&#x005D;</span></span>
</div>
<div class="RF" id="R279-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Gunterberg B, Romanus B, Stener B:</span> <span class="emph_I">Pelvic strength after major amputation of the sacrum.</span> Acta Orthop 47:635, 1976.</span></span>
</div>
<div class="RF" id="R280-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Stener B, Gunterberg B:</span> <span class="emph_I">High amputation of the sacrum for extirpation of tumors.</span> Spine 3:351, 1978.</span></span>
</div>
<div class="RF" id="R281-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[22]">22. <span class="JRF"><span class="DRF"><span class="emph_B">Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr:</span> <span class="emph_I">Lumbosacral chordoma. Prognostic factors and treatment.</span> Spine Aug 24:1639, 1999.</span></span>
</div>
<div class="RF" id="R282-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Colli B, Al-Mefty O:</span> <span class="emph_I">Chordomas of the craniocervical junction: follow-up review and prognostic factors.</span> J Neurosurg 95:933, 2001.</span></span>
</div>
<div class="RF" id="R283-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[11]/RF[24]">24. <span class="JRF"><span class="DRF"><span class="emph_B">Iwasa Y, Nakashima Y, Okajima H, Morishita S:</span> <span class="emph_I">Sacral chordoma in early childhook: Clinicopathological and immunohistochemical study.</span> Pediatr Dev Pathol 1:420, 1998.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4011" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]">
<div class="HD">NON-HODGKIN&#x2019;S LYMPHOMA OF BONE (RETICULUM CELL SARCOMA)</div>
<div class="RF" id="R284-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[1]">1. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R285-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Parker F Jr, Jackson H Jr:</span> <span class="emph_I">Primary reticulum cell sarcoma of bone.</span> Surg Gynecol Obstet 68:45, 1939.</span></span>
</div>
<div class="RF" id="R286-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[3]">3. <span class="URF"><span class="emph_B">Dranitsaris G:</span> <span class="emph_I">Treatment of non-Hodgkin&#x2019;s lymphoma.</span> Anticancer Drugs 9(10):879, 1998.</span>
</div>
<div class="RF" id="R287-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[4]">4. <span class="URF"><span class="emph_B">Murray RO, Jacobson HG:</span> <span class="emph_I">The Radiology of Skeletal Disorders,</span> ed 2. New York, Churchill Livingstone, 1977.</span>
</div>
<div class="RF" id="R288-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Ivins JC, Dahlin DC:</span> <span class="emph_I">Malignant lymphoma (reticulum cell sarcoma).</span> Proc Mayo Clin 38:375, 1963.</span></span>
</div>
<div class="RF" id="R289-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Coles WC, Schultz MD:</span> <span class="emph_I">Bone involvement in malignant lymphoma.</span> Radiology 50:458, 1948.</span></span>
</div>
<div class="RF" id="R290-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[7]">7. <span class="URF"><span class="emph_B">Baar J, Burkes RL, Gospodarowicz M:</span> <span class="emph_I">Primary non-Hodgkin&#x2019;s lymphoma of bone.</span> Semin Oncol 26(3):270, 1999.</span>
</div>
<div class="RF" id="R291-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Wang CC, Fleischli DJ:</span> <span class="emph_I">Primary reticulum cell sarcoma of bone: With emphasis on radiation therapy.</span> Cancer 22:994, 1968.</span></span>
</div>
<div class="RF" id="R292-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[9]">9. <span class="URF"><span class="emph_B">Jones D, Kraus MD, Dorfman DM:</span> <span class="emph_I">Lymphoma presenting as a solitary bone lesion.</span> Am J Clin Pathol 111(2):171, 1999.</span>
</div>
<div class="RF" id="R293-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Sherman RS, Snyder RE:</span> <span class="emph_I">The roentgen appearance of primary reticulum cell sarcoma of bone.</span> AJR 58:291, 1947.</span></span>
</div>
<div class="RF" id="R294-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Wilson TW, Pugh DG:</span> <span class="emph_I">Primary reticulum cell sarcoma of bone, with emphasis on roentgen aspects.</span> Radiology 65:343, 1955.</span></span>
</div>
<div class="RF" id="R295-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[12]">12. <span class="URF"><span class="emph_B">Edeiken J:</span> <span class="emph_I">Roentgen Diagnosis of Diseases of Bone,</span> ed 3. Baltimore, Williams &#x0026; Wilkins, 1981.</span>
</div>
<div class="RF" id="R296-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Ackerman L, Drunen MV, Reyes CV:</span> <span class="emph_I">Malignant large cell lymphoma of sacrum</span> &#x005B;Case report 836&#x005D;. Skeletal Radiol 23:232, 1994.</span></span>
</div>
<div class="RF" id="R297-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[14]">14. <span class="URF"><span class="emph_B">Israel O, Mekel M, Bar-Shalom R, et al.:</span> <span class="emph_I">Bone lymphoma: 67 Ga scintigraphy and CT for prediction of outcome after treatment.</span> J Nucl Med 43(10):1295, 2002.</span>
</div>
<div class="RF" id="R298-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[12]/RF[15]">15. <span class="URF"><span class="emph_B">Francis KC, Higinbotham NL, Coley BL:</span> <span class="emph_I">Primary reticulum cell sarcoma of bone. Report of 44 cases.</span> Surg Gynecol Obstet 92(2): 142, 1954.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4012" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]">
<div class="HD">HODGKIN&#x2019;S LYMPHOMA OF BONE</div>
<div class="RF" id="R299-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Fucilla IS, Hamann A:</span> <span class="emph_I">Hodgkin&#x2019;s disease in bone.</span> Radiology 77:53, 1961.</span></span>
</div>
<div class="RF" id="R300-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Dyttert V:</span> Primary osseous lymphogranuloma. A contribution. Neoplasma 13:105, 1966.</span></span>
</div>
<div class="RF" id="R301-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[3]">3. <span class="URF"><span class="emph_B">Donaldson SS:</span> <span class="emph_I">Pediatric Hodgkin&#x2019;s disease&#x2014;Up, up, and beyond.</span> Int J Radiat Oncol Biol Phys 54(1)1, 2002.</span>
</div>
<div class="RF" id="R302-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Stuhlbarg J, Ellis FW:</span> <span class="emph_I">Hodgkin&#x2019;s disease of bone. Favorable prognostic significance?</span> AJR 93:568, 1965.</span></span>
</div>
<div class="RF" id="R303-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Clark A, Stanish WD:</span> <span class="emph_I">An unusual cause of back pain in a young athlete. A case report.</span> Am J Sports Med 13:51, 1985.</span></span>
</div>
<div class="RF" id="R304-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Conn HO:</span> <span class="emph_I">Alcohol-induced pain as a manifestation of Hodgkin&#x2019;s disease.</span> Arch Intern Med 100:241, 1957.</span></span>
</div>
<div class="RF" id="R305-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[7]">7. <span class="URF"><span class="emph_B">Callahan BC, Coe R, Place HM:</span> <span class="emph_I">Hodgkin&#x2019;s disease of the spine presenting as alcohol-related pain.</span> J Bone Joint Surg 76A:119, 1994.</span>
</div>
<div class="RF" id="R306-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[8]">8. <span class="URF"><span class="emph_B">Chandi L, Kumar L, Kochupillai V, et al.:</span> <span class="emph_I">Hodgkin&#x2019;s disease: A retrospective analysis of 15 years experience at a large referral center.</span> Natl Med J India 11(5):212, 1998.</span>
</div>
<div class="RF" id="R307-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Rowe LJ:</span> <span class="emph_I">Hodgkin&#x2019;s lymphoma of the thoracic spine.</span> J Can Chiro Assoc 28:212, 1984.</span></span>
</div>
<div class="RF" id="R308-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Granger W, Whitaker R:</span> <span class="emph_I">Hodgkin&#x2019;s disease in bone, with special reference to periosteal reaction.</span> Br J Radiol 40:939, 1967.</span></span>
</div>
<div class="RF" id="R309-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Pear BL:</span> <span class="emph_I">Skeletal manifestations of the lymphomas and leukemias.</span> Semin Roentgenol 9:229, 1974.</span></span>
</div>
<div class="RF" id="R310-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Hulten O:</span> <span class="emph_I">Ein Fall von &#x201C;Elfenbeinwirbel&#x201D; bei Lymphogranulomatose.</span> Acta Radiol 8:245, 1927.</span></span>
</div>
<div class="RF" id="R311-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[13]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Newcomer LN, Silverstein MB, Cadman EC, et al.:</span> <span class="emph_I">Bone involvement in Hodgkin&#x2019;s disease.</span> Cancer 49:338, 1982.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4013" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]">
<div class="HD">SYNOVIAL SARCOMA</div>
<div class="RF" id="R312-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Mackenzie DH:</span> <span class="emph_I">Synovial sarcoma, a review of 58 cases.</span> Cancer 19:169, 1966.</span></span>
</div>
<div class="RF" id="R313-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Lazarus JA, Marks MS:</span> <span class="emph_I">Synovial sarcoma.</span> Surgery 13:290, 1943.</span></span>
</div>
<div class="RF" id="R314-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Lewis RW:</span> <span class="emph_I">Roentgen recognition of synovioma.</span> AJR 44:170, 1940.</span></span>
</div>
<div class="RF" id="R315-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[4]">4. <span class="URF"><span class="emph_B">Blacksin MF, Siegel JR, Benevenia J, Aisner SC:</span> <span class="emph_I">Synovial sarcoma: frequency of nonaggressive MR characteristics.</span> J Comput Assist Tomogr 21(5):785, 1997.</span>
</div>
<div class="RF" id="R316-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Morton MJ, Berquist TH, McLeod RA, et al.:</span> <span class="emph_I">MR imaging of synovial sarcoma.</span> AJR 156:337, 1991.</span></span>
</div>
<div class="RF" id="R317-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Raben M, Calabrese A, Higinbotham NL, et al.:</span> <span class="emph_I">Malignant synovioma.</span> AJR 93:145, 1965.</span></span>
</div>
<div class="RF" id="R318-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[7]">7. <span class="URF"><span class="emph_B">Wright PH, Sim FH, Soule EH, et al.:</span> <span class="emph_I">Synovial sarcoma.</span> J Bone Joint Surg 64A:112, 1982.</span>
</div>
<div class="RF" id="R319-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[8]">8. <span class="URF"><span class="emph_B">Skytting BT, Bauer HC, Perfekt R, et al.:</span> <span class="emph_I">Clinical course in synovial sarcoma: a Scandinavian sarcoma group study of 104 patients.</span> Acta Orthop Scand 70(6):536, 1999.</span>
</div>
<div class="RF" id="R320-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[14]/RF[9]">9. <span class="URF"><span class="emph_B">Valenzuela RF, Kim EE, Seo JG, et al.:</span> <span class="emph_I">A revisit of MRI analysis for synovial sarcoma.</span> Clin Imaging 24(4):231, 2000.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4014" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]">
<div class="HD">ADAMANTINOMA</div>
<div class="RF" id="R321-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[1]">1. <span class="URF"><span class="emph_B">Judmaier W, Peer S, Drejzi T, et al.:</span> <span class="emph_I">MR findings in tibial adamantinoma. A case report.</span> Acta Radiol 39(3):276, 1998.</span>
</div>
<div class="RF" id="R322-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[2]">2. <span class="URF"><span class="emph_B">Lichtenstein L:</span> <span class="emph_I">Bone Tumors,</span> ed 5. St. Louis, CV Mosby, 1977.</span>
</div>
<div class="RF" id="R323-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Fischer B:</span> <span class="emph_I">&#x00DC;ber ein prim&#x00E4;res adamantinoma der tibia.</span> Frankfurter Zeitschr Pathol 12:422, 1913.</span></span>
</div>
<div class="RF" id="R324-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Unni KK, Dahlin DC, Beabout JW, et al.:</span> <span class="emph_I">Adamantinomas of long bones.</span> Cancer 34:1796, 1974.</span></span>
</div>
<div class="RF" id="R325-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[5]">5. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R326-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[6]">6. <span class="URF"><span class="emph_B">Nerubay J, Chechick A, Horoszowski H, et al.:</span> <span class="emph_I">Adamantinoma of the spine.</span> J Bone Joint Surg 70A:467, 1988.</span>
</div>
<div class="RF" id="R327-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[7]">7. <span class="URF"><span class="emph_B">Sarisozen B, Durak K, Ozturk C:</span> <span class="emph_I">Adamantinoma of the tibia in a nine-year-old child.</span> Acta Orthop Belg 68(4):412, 2002.</span>
</div>
<div class="RF" id="R328-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[8]">8. <span class="URF"><span class="emph_B">Huvos AG, Marcove RC:</span> <span class="emph_I">Adamantinoma of long bones.</span> J Bone Joint Surg 57A:148, 1975.</span>
</div>
<div class="RF" id="R329-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Kuruvilla G, Steiner GC:</span> <span class="emph_I">Osteofibrous dysplasia-like adamantinoma of bone: a report of five cases with immunohistochemical and ultrastructural studies.</span> Hum Pathol 29:809, 1998.</span></span>
</div>
<a name="PG1364"> </a><div class="pagenum"><div>P.1364</div></div>
<br clear="all">
<div class="RF" id="R330-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Bloem JL, van der Heul RO, Schuttevaer HM, et al.:</span> <span class="emph_I">Fibrous dysplasia vs adamantinoma of the tibia: Differentiation based on discriminant analysis of clinical and plain film findings.</span> AJR 156:1017, 1991.</span></span>
</div>
<div class="RF" id="R331-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Torriani M, Derkigil SS, Etchebehere M, Amstalden EM:</span> <span class="emph_I">Magnetic resonance imaging of tibial classic adamantinoma at 2 tesla.</span> J Comput Assist Tomogr 26:844, 2002.</span></span>
</div>
<div class="RF" id="R332-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[2]/SUBEDS2[15]/RF[12]">12. <span class="URF"><span class="emph_B">Qureshi AA, Shott S, Mallin BA, Gitelis S:</span> <span class="emph_I">Current trends in the management of adamantinoma of long bones. An international study.</span> J Bone Joint Surg 82A:1122, 2000.</span>
</div>
</div>
</div>
<div class="SUBEDS1" id="B01382540.0-4015" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]">
<div class="HD">PRIMARY QUASI-MALIGNANT BONE TUMOR</div>
<div class="SUBEDS2" id="B01382540.0-4016" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]">
<div class="HD">GIANT CELL TUMOR</div>
<div class="RF" id="R333-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[1]">1. <span class="URF"><span class="emph_B">Cooper A, Travers B:</span> <span class="emph_I">Surgical Essays,</span> ed 3. London, Cox &#x0026; Son, 1818.</span>
</div>
<div class="RF" id="R334-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L, Portis RB:</span> <span class="emph_I">Giant cell tumor of bone; its pathologic appearance, grading, supposed variants, and treatment.</span> Arch Pathol 30:993, 1940.</span></span>
</div>
<div class="RF" id="R335-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L, Sutro CJ:</span> <span class="emph_I">Pigmented villonodular synovitis, bursitis, and tenosynovitis.</span> Arch Pathol 31:731, 1941.</span></span>
</div>
<div class="RF" id="R336-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L:</span> <span class="emph_I">Benign chondroblastoma of bone.</span> Am J Pathol 18:969, 1942.</span></span>
</div>
<div class="RF" id="R337-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L:</span> <span class="emph_I">Non-osteogenic fibroma of bone.</span> Am J Pathol 18:205, 1942.</span></span>
</div>
<div class="RF" id="R338-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L:</span> <span class="emph_I">Chondromyxoid fibroma of bone.</span> Arch Pathol 45:541, 1948.</span></span>
</div>
<div class="RF" id="R339-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Lichtenstein L:</span> <span class="emph_I">Aneurysmal bone cyst, a pathological entity commonly mistaken for giant cell tumor and occasionally for hemangioma and osteogenic sarcoma.</span> Cancer 3:279, 1950.</span></span>
</div>
<div class="RF" id="R340-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[8]">8. <span class="URF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Tumors and Tumorous Conditions of the Bones and Joints.</span> Philadelphia, Lea &#x0026; Febiger, 1958.</span>
</div>
<div class="RF" id="R341-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Stewart MJ:</span> <span class="emph_I">The histogenesis of myeloid sarcoma.</span> Lancet 2:1106, 1922.</span></span>
</div>
<div class="RF" id="R342-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[10]">10. <span class="URF"><span class="emph_B">Schajowicz F:</span> <span class="emph_I">Tumors and Tumor-Like Lesions of Bone and Joints.</span> New York, Springer-Verlag, 1981.</span>
</div>
<div class="RF" id="R343-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[11]">11. <span class="URF"><span class="emph_B">Dahlin DC:</span> <span class="emph_I">Giant cell tumor. Bone Tumors,</span> ed 2. Springfield, Charles C Thomas, 1967.</span>
</div>
<div class="RF" id="R344-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Hutter RVP, Worcester JN Jr, Francis KC, et al.:</span> <span class="emph_I">Benign and malignant giant cell tumors of bone. A clinicopathological analysis of the natural history of the disease.</span> Cancer 15:653, 1962.</span></span>
</div>
<div class="RF" id="R345-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Gebhart M, Vandeweyer E, Nemec E:</span> <span class="emph_I">Patet&#x2019;s disease of bone complicated by giant cell tumor.</span> Clin Orthop 352:187, 1998.</span></span>
</div>
<div class="RF" id="R346-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Magitsky S, Lipton JF, Reidy J, et al.:</span> <span class="emph_I">Ultrastructural features of giant cell tumors in Patet&#x2019;s disease.</span> Clin Orthop 401:213, 2002.</span></span>
</div>
<div class="RF" id="R347-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[15]">15. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R348-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Sheth RD, Shah SN:</span> <span class="emph_I">Osteoclastoma of the os calcis.</span> Int Surg 57: 748, 1972.</span></span>
</div>
<div class="RF" id="R349-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Locher GW, Kaiser G:</span> <span class="emph_I">Giant-cell tumors and aneurysmal bone cysts of ribs in childhood.</span> J Pediatr Surg 10:103, 1975.</span></span>
</div>
<div class="RF" id="R350-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Fitzpatrick DJ, Bullough PG:</span> <span class="emph_I">Giant cell tumor of the lunate bone: A case report.</span> J Hand Surg 2:269, 1977.</span></span>
</div>
<div class="RF" id="R351-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Srivastava TP, Tuli SM, Varma BP, et al.:</span> <span class="emph_I">Giant cell tumor of metacarpals.</span> Indian J Cancer 12:164, 1975.</span></span>
</div>
<div class="RF" id="R352-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[20]">20. <span class="URF"><span class="emph_B">Kelikian H, Clayton I:</span> <span class="emph_I">Giant-cell tumor of the patella.</span> J Bone Joint Surg 39A:414, 1957.</span>
</div>
<div class="RF" id="R353-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Mercuri M, Casadei R:</span> <span class="emph_I">Patellar tumors.</span> Clin Orthop 389:35, 2001.</span></span>
</div>
<div class="RF" id="R354-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[22]">22. <span class="URF"><span class="emph_B">Faris WF, Rubin BD, Fielding JW:</span> <span class="emph_I">Aneurysmal bone cyst of the patella.</span> J Bone Joint Surg 60A:711, 1978.</span>
</div>
<div class="RF" id="R355-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Singson R, Feldman F:</span> <span class="emph_I">Multicentric giant cell tumors of bone</span> &#x005B;Case report 229&#x005D;. Skeletal Radiol 9:276, 1983.</span></span>
</div>
<div class="RF" id="R356-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[24]">24. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R357-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[25]">25. <span class="JRF"><span class="DRF"><span class="emph_B">Roux S:</span> <span class="emph_I">Giant cell tumors of bone.</span> Rev Rhum Engl Educ 65:139, 1998.</span></span>
</div>
<div class="RF" id="R358-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[26]">26. <span class="URF"><span class="emph_B">Chakravarti A, Spiro IJ, Hug EB, et al.:</span> <span class="emph_I">Megavoltage radiation therapy for axial and inoperable giant-cell tumor of bone.</span> J Bone Joint Surg 81A:1566, 1999.</span>
</div>
<div class="RF" id="R359-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[27]">27. <span class="JRF"><span class="DRF"><span class="emph_B">Fidler NW:</span> <span class="emph_I">Surgical treatment of giant cell tumours of the thoracic and lumbar spine: Report of nine patients.</span> Eur Spine J 10:69, 2001.</span></span>
</div>
<div class="RF" id="R360-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[28]">28. <span class="URF"><span class="emph_B">Verhagen WI, Bartels RH, Schaafsma HE, Rob de Jong TH:</span> <span class="emph_I">A giant cell tumor of the sacrum or a soft tissue giant cell tumor. A case report.</span> Spine 23(14):1609, 1998.</span>
</div>
<div class="RF" id="R361-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[29]">29. <span class="URF"><span class="emph_B">Miszczyk L. Wydmanski J, Spindel J:</span> <span class="emph_I">Efficacy of radiotherapy for giant cell tumor of bone: Given either postoperatively or as sole treatment.</span> Int J Radiat Oncol Biol Phys 49(5):1239 2001.</span>
</div>
<div class="RF" id="R362-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[30]">30. <span class="URF"><span class="emph_B">Briccoli A, Malaguti C, Iannetti C, et al.:</span> <span class="emph_I">Giant cell tumor of the rib.</span> Skeletal Radiol 32(2):107, 2003.</span>
</div>
<div class="RF" id="R363-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[31]">31. <span class="URF"><span class="emph_B">Garcia-Bravo A, Sanchez-Enriquez J, Mendez-Suarez JL, et al.:</span> <span class="emph_I">Secondary tetraplegia due to giant-cell tumors of the cervical spine.</span> Neurochirurgie 48(6):527, 2002.</span>
</div>
<div class="RF" id="R364-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[32]">32. <span class="URF"><span class="emph_B">Goldenberg RR, Campell CJ, Bonfiglio M:</span> <span class="emph_I">Giant cell tumor of bone.</span> J Bone Joint Surg 52A:619, 1970.</span>
</div>
<div class="RF" id="R365-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[33]">33. <span class="JRF"><span class="DRF"><span class="emph_B">Hudson TM, Schiebler M, Springfield DS, et al.:</span> <span class="emph_I">Radiology of giant cell tumors of bone: Computed tomography, arthro-tomography, and scintigraphy.</span> Skeletal Radiol 11:85, 1984.</span></span>
</div>
<div class="RF" id="R366-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[34]">34. <span class="URF"><span class="emph_B">Wada T, Kaya M, Nagoya S, et al.:</span> <span class="emph_I">Complications associated with bone cementing for the treatment of giant cell tumors of bone.</span> J Orthop Sci 7(2):194, 2002.</span>
</div>
<div class="RF" id="R367-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[35]">35. <span class="URF"><span class="emph_B">Kitano K, Shiraishi T, Okabayashi K, et al.:</span> <span class="emph_I">A lung metastasis from giant cell tumor of bone at eight years after primary resection.</span> Jpn J Thorac Cardiovasc Surg 47(12):617, 1999.</span>
</div>
<div class="RF" id="R368-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[36]">36. <span class="URF"><span class="emph_B">Masui F, Ushigome S, Fujii K:</span> <span class="emph_I">Giant cell tumor of bone: A clinicopathologic study of prognostic factors.</span> Pathol Int 48(9):723, 1998.</span>
</div>
<div class="RF" id="R369-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[3]/SUBEDS2[1]/RF[37]">37. <span class="URF"><span class="emph_B">Anract P, De Pinieux G, Cottias P, et al.:</span> <span class="emph_I">Malignant giant-cell tumours of bone. Clinico-pathological types and prognosis: a review of 29 cases.</span> Int Orthop 22(1):19, 1998.</span>
</div>
</div>
</div>
<div class="SUBEDS1" id="B01382540.0-4017" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]">
<div class="HD">PRIMARY BENIGN BONE TUMORS</div>
<div class="SUBEDS2" id="B01382540.0-4018" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]">
<div class="HD">SOLITARY OSTEOCHONDROMA</div>
<div class="RF" id="R370-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[1]">1. <span class="URF"><span class="emph_B">Cooper A:</span> <span class="emph_I">Exostosis.</span> In: A Cooper, B Travers, eds, <span class="emph_I">Surgical Essays,</span> ed 3. London, Cox &#x0026; Son, 1818.</span>
</div>
<div class="RF" id="R371-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Cannon JF:</span> <span class="emph_I">Hereditary multiple exostosis.</span> Am J Hum Genet 6: 419, 1954.</span></span>
</div>
<div class="RF" id="R372-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[3]">3. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R373-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Harsha WN:</span> <span class="emph_I">The natural history of osteocartilaginous exostoses (osteochondroma).</span> Am Surg 20:65, 1954.</span></span>
</div>
<div class="RF" id="R374-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Gokay H, Bucy PC:</span> <span class="emph_I">Osteochondroma of lumbar spine. Report of a case.</span> J Neurosurg 12:72, 1955.</span></span>
</div>
<div class="RF" id="R375-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[6]">6. <span class="URF"><span class="emph_B">Fiumara E, Scarabino T, Guglielmi G, et al.:</span> <span class="emph_I">Osteochondroma of the L-5 vertebra: A rare cause of sciatic pain. Case report.</span> J Neurosurg 91(2 Suppl):219, 1999.</span>
</div>
<div class="RF" id="R376-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Jose Alcaraz Mexia M, Izquierdo Nunez E, Santonja Garriga C, Maria Salgodo Salinas R:</span> <span class="emph_I">Osteochondroma of the thoracic spine and scoliosis.</span> Spine 26:1082, 2001.</span></span>
</div>
<div class="RF" id="R377-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[8]">8. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R378-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Rose EF, Fekete A:</span> <span class="emph_I">Odontoid osteochondroma causing sudden death. Report of a case and review of the literature.</span> Am J Clin Pathol 42:606, 1964.</span></span>
</div>
<div class="RF" id="R379-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Lee FA:</span> <span class="emph_I">Solitary cartilaginous exostosis of the ilium presenting as an abdominal mass.</span> Am J Dis Child 114:195, 1967.</span></span>
</div>
<div class="RF" id="R380-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[11]">11. <span class="URF"><span class="emph_B">Mehta M, White LM, Knapp T, et al.:</span> <span class="emph_I">MR imaging of symptomatic osteochondromas with pathological correlation.</span> Skeletal Radiol 27(8):427, 1998.</span>
</div>
<div class="RF" id="R381-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[12]">12. <span class="URF"><span class="emph_B">Woertler K, Lindner N, Gosheger G, et al.:</span> <span class="emph_I">Osteochondroma: MR imaging of tumor-related complications.</span> Eur Radiol 10(5):832, 2000.</span>
</div>
<div class="RF" id="R382-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[13]">13. <span class="URF"><span class="emph_B">Mirra JM:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis and Treatment.</span> Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R383-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Mangini U:</span> <span class="emph_I">Tumors of the skeleton of the hand.</span> Bull Hosp Joint Dis 28:61, 1967.</span></span>
</div>
<div class="RF" id="R384-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Eller DJ, Blakemore JR, Stein M, et al.:</span> <span class="emph_I">Transoral resection of a condylar osteochondroma: Report of a case.</span> J Oral Surg 35:409, 1977.</span></span>
</div>
<a name="PG1365"> </a><div class="pagenum"><div>P.1365</div></div>
<br clear="all">
<div class="RF" id="R385-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">List CF:</span> <span class="emph_I">Osteochondromas arising from base of skull.</span> Surg Gynecol Obstet 76:480, 1943.</span></span>
</div>
<div class="RF" id="R386-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Milch RA:</span> <span class="emph_I">Osteochondroma of the astragalus.</span> Am J Surg 87:145, 1954.</span></span>
</div>
<div class="RF" id="R387-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Ilgenfritz HC:</span> <span class="emph_I">Vertebral osteochondroma.</span> Am Surg 17:917, 1951.</span></span>
</div>
<div class="RF" id="R388-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Inglis AE, Rubin RM, Lewis RJ, et al.:</span> <span class="emph_I">Osteochondroma of the cervical spine. Case report.</span> Clin Orthop 126:127, 1977.</span></span>
</div>
<div class="RF" id="R389-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Wouters HW, Szepesi K, Kullmann L:</span> <span class="emph_I">Solitary osteochondroma of the scapula. A report on six cases.</span> Arch Chir Neerl 26:63, 1974.</span></span>
</div>
<div class="RF" id="R390-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[21]">21. <span class="URF"><span class="emph_B">Reichmister J, Reeder JD, Gold DL:</span> <span class="emph_I">Osteochondroma of the distal clavicle: An unusual cause of rotator cuff impingement.</span> Am J Orthop 29(10):807, 2000.</span>
</div>
<div class="RF" id="R391-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[22]">22. <span class="URF"><span class="emph_B">Dahlin DC:</span> <span class="emph_I">Bone Tumors: General Aspects and Data on 6,221 Cases,</span> ed 3. Springfield, Charles C Thomas, 1978.</span>
</div>
<div class="RF" id="R392-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Coley BI, Higinbotham NL:</span> <span class="emph_I">Secondary chondrosarcoma.</span> Ann Surg 139:547, 1954.</span></span>
</div>
<div class="RF" id="R393-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[24]">24. <span class="JRF"><span class="DRF"><span class="emph_B">Hudson TM, Springfield DS, Spanier SS, et al.:</span> <span class="emph_I">Benign exostoses and exostotic chondrosarcomas: Evaluation of cartilage thickness by CT.</span> Radiology 152:595, 1984.</span></span>
</div>
<div class="RF" id="R394-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[25]">25. <span class="URF"><span class="emph_B">Greenfield GB:</span> <span class="emph_I">Radiology of Bone Diseases,</span> ed 3. Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R395-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[26]">26. <span class="JRF"><span class="DRF"><span class="emph_B">Lee JK, Yao L, Wirth CR:</span> <span class="emph_I">MR imaging of solitary osteochondromas: Report of eight cases.</span> AJR 149:557, 1987.</span></span>
</div>
<div class="RF" id="R396-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[27]">27. <span class="JRF"><span class="DRF"><span class="emph_B">Lokiec F, Ezra E, Krasin E, et al.:</span> <span class="emph_I">A simple and efficient surgical technique for subungual exostosis.</span> J Pediatr Orthop 21:76, 2001.</span></span>
</div>
<div class="RF" id="R397-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[28]">28. <span class="URF"><span class="emph_B">Letts M, Davidson D, Nizalik E:</span> <span class="emph_I">Subungual exostosis: Diagnosis and treatment in children.</span> J Trauma 44(2):346, 1998.</span>
</div>
<div class="RF" id="R398-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[1]/RF[29]">29. <span class="JRF"><span class="DRF"><span class="emph_B">Evison G, Price CH:</span> <span class="emph_I">Subungual exostosis.</span> Br J Radiol 39:451, 1966.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4019" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]">
<div class="HD">HEREDITARY MULTIPLE EXOSTOSIS</div>
<div class="RF" id="R399-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[1]">1. <span class="URF"><span class="emph_B">Kivioja A, Ervasti H, Kinnunen J, et al.:</span> <span class="emph_I">Chondrosarcoma in a family with multiple hereditary exostoses.</span> J Bone Joint Surg 82B(2): 261, 2000.</span>
</div>
<div class="RF" id="R400-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[2]">2. <span class="URF"><span class="emph_B">Boyer A:</span> <span class="emph_I">Traite des Maladies Chirurgicales.</span> Vol 3. Paris, VeMigneret, 1814.</span>
</div>
<div class="RF" id="R401-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Keith A:</span> <span class="emph_I">Studies on the anatomical changes which accompany certain growth disorders of the human body. The nature of the structural alterations in the disorder known as multiple exostoses.</span> J Anat 54:101, 1920.</span></span>
</div>
<div class="RF" id="R402-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[4]">4. <span class="URF"><span class="emph_B">Ellis UH, Taylor JG:</span> <span class="emph_I">Diaphyseal aclasis.</span> J Bone Joint Surg 33B: 100, 1951.</span>
</div>
<div class="RF" id="R403-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Harsha WN:</span> <span class="emph_I">The natural history of osteocartilaginous exostoses (osteochondroma).</span> Am Surg 20:65, 1954.</span></span>
</div>
<div class="RF" id="R404-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[6]">6. <span class="URF"><span class="emph_B">Porter DE, Emerton ME, Villanueva-Lopez F, Simpson AH:</span> <span class="emph_I">Clinical and radiographic analysis of osteochondromas and growth disturbance in hereditary multiple exostoses.</span> J Pediatr Orthop 20(2):246, 2000.</span>
</div>
<div class="RF" id="R405-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[7]">7. <span class="URF"><span class="emph_B">Felix NA, Mazur JM, Loveless EA:</span> <span class="emph_I">Acetabular dysplasia associated with hereditary multiple exostoses. A case report.</span> J Bone Joint Surg 82B:555, 2000.</span>
</div>
<div class="RF" id="R406-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[8]">8. <span class="URF"><span class="emph_B">Paik NJ, Han TR, Lim SJ:</span> <span class="emph_I">Multiple peripheral nerve compressions related to malignantly transformed hereditary multiple exostoses.</span> Muscle Nerve 23(8):1290, 2000.</span>
</div>
<div class="RF" id="R407-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[9]">9. <span class="URF"><span class="emph_B">Madigan R, Worral T, McClain EJ:</span> <span class="emph_I">Cervical cord compression in hereditary multiple exostosis.</span> J Bone Joint Surg 56A:401, 1974.</span>
</div>
<div class="RF" id="R408-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Flatt AE:</span> <span class="emph_I">Chondrosarcoma supervening on diaphyseal aclasis.</span> Br J Surg 43:85, 1955.</span></span>
</div>
<div class="RF" id="R409-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[11]">11. <span class="URF"><span class="emph_B">Dahlin DC:</span> <span class="emph_I">Bone Tumors: General Aspects and Data on 6,221 Cases,</span> ed 3. Springfield, Charles C Thomas, 1978.</span>
</div>
<div class="RF" id="R410-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[2]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Garrison RC, Dahlin DC, Unni KK, et al.:</span> <span class="emph_I">Chondrosarcoma arising in osteochondroma.</span> Cancer 49:1890, 1982.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4020" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]">
<div class="HD">HEMANGIOMA</div>
<div class="RF" id="R411-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[1]">1. <span class="URF"><span class="emph_B">Schmorl G, Junghans H:</span> <span class="emph_I">The Human Spine in Health and Disease,</span> ed 2. New York, Grune &#x0026; Stratton, 1971.</span>
</div>
<div class="RF" id="R412-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Bailey P, Bucy PC:</span> <span class="emph_I">Cavernous hemangioma of the vertebrae.</span> JAMA 92:1748, 1929.</span></span>
</div>
<div class="RF" id="R413-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Mohan V, Gupta SK, Tuli SM, et al.:</span> <span class="emph_I">Symptomatic vertebral hemangiomas.</span> Clin Radiol 31:575, 1980.</span></span>
</div>
<div class="RF" id="R414-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Manning HJ:</span> <span class="emph_I">Symptomatic hemangioma of the spine.</span> Radiology 56:58, 1951.</span></span>
</div>
<div class="RF" id="R415-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Holta O:</span> <span class="emph_I">Hemangioma of the cervical vertebra with fracture and compression myelomalacia.</span> Acta Radiol 23:423, 1942.</span></span>
</div>
<div class="RF" id="R416-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Broderick RA, Round H:</span> <span class="emph_I">Cavernous angioma of the maxilla. Fatal hemorrhage after teeth extraction.</span> Lancet 2:13, 1933.</span></span>
</div>
<div class="RF" id="R417-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Macansh JD, Owen MD:</span> <span class="emph_I">Central cavernous hemangioma of the mandible.</span> J Oral Surg 30:293, 1972.</span></span>
</div>
<div class="RF" id="R418-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Ogose A, Hotta T, Morita T, et al.:</span> <span class="emph_I">Solitary osseous hemangioma outside the spinal and craniofacial bones.</span> Arch Orthop Trauma Surg 120:262, 2000.</span></span>
</div>
<div class="RF" id="R419-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[9]">9. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Spinal hemangiomas.</span> ACA J Chiro, 1983.</span>
</div>
<div class="RF" id="R420-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Lund BA, Dahlin DC:</span> <span class="emph_I">Hemangiomas of the mandible and maxilla.</span> J Oral Surg 22:234, 1964.</span></span>
</div>
<div class="RF" id="R421-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[11]">11. <span class="URF"><span class="emph_B">Bansal VP, Singh PC, Grewal DS, et al.:</span> <span class="emph_I">Hemangioma of the patella. A report of two cases.</span> J Bone Joint Surg 56B:139, 1974.</span>
</div>
<div class="RF" id="R422-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Tunon BJ, Gonzalez PF:</span> <span class="emph_I">Angiomatosis of the metacarpal skeleton.</span> Hand 9:88, 1977.</span></span>
</div>
<div class="RF" id="R423-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Sherman RS, Wilner D:</span> <span class="emph_I">The roentgen diagnosis of hemangioma of bone.</span> AJR 86:1146, 1961.</span></span>
</div>
<div class="RF" id="R424-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[14]">14. <span class="URF"><span class="emph_B">Wackenheim A:</span> <span class="emph_I">Radiodiagnosis of the Vertebra in Adults.</span> New York, Springer-Verlag, 1983.</span>
</div>
<div class="RF" id="R425-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">McAllister VL, Kendall BE, Bull JWD:</span> <span class="emph_I">Symptomatic vertebral hemangiomas.</span> Brain 98:71, 1975.</span></span>
</div>
<div class="RF" id="R426-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Bery K, Chawla S:</span> <span class="emph_I">Hemangioma of the spine with compression of the cord.</span> Indian J Radiol 21:117, 1967.</span></span>
</div>
<div class="RF" id="R427-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[17]">17. <span class="URF"><span class="emph_B">Mohan V:</span> Roentgen evaluation of thoracic paraspinal line in health and disease &#x005B;Thesis&#x005D;. Banaras Hindu University, 1975.</span>
</div>
<div class="RF" id="R428-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Laredo JD, Assouline E, Gelbert F, et al.:</span> <span class="emph_I">Vertebral hemangiomas: Fat content as a sign of aggressiveness.</span> Radiology 177:467, 1990.</span></span>
</div>
<div class="RF" id="R429-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Kelemen G, Holmes EM:</span> <span class="emph_I">Cavernous hemangioma of the frontal bone.</span> J Laryngol Otol 72:557, 1948.</span></span>
</div>
<div class="RF" id="R430-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[20]">20. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R431-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Bell RL:</span> <span class="emph_I">Hemangioma of a dorsal vertebra with collapse and compression myelopathy.</span> J Neurosurg 12:570, 1955.</span></span>
</div>
<div class="RF" id="R432-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[22]">22. <span class="JRF"><span class="DRF"><span class="emph_B">Bergstrand A, Hook O, Lidvall H:</span> <span class="emph_I">Vertebral hemangiomas compressing the spinal cord.</span> Acta Neurol Scand 39:59, 1963.</span></span>
</div>
<div class="RF" id="R433-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[3]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Cushing H:</span> <span class="emph_I">Surgical end results in general with case of cavernous hemangioma of skull in particular.</span> Surg Gynecol Obstet 36:303, 1923.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4021" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]">
<div class="HD">OSTEOMA</div>
<div class="RF" id="R434-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Childrey JH:</span> <span class="emph_I">Osteomas of the sinuses, of the frontal and sphenoid bone.</span> Arch Otolaryngol 30:63, 1939.</span></span>
</div>
<div class="RF" id="R435-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Schertel L:</span> <span class="emph_I">Die H;auohlenosteome.</span> Radiologie 15:62, 1975.</span></span>
</div>
<div class="RF" id="R436-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[3]">3. <span class="URF"><span class="emph_B">Kim AW, Foster JA, Papay FA, Wright KW:</span> <span class="emph_I">Orbital extension of a frontal sinus osteoma in a thirteen-year-old girl.</span> JAAPOS 4(2):122, 2000.</span>
</div>
<div class="RF" id="R437-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[4]">4. <span class="URF"><span class="emph_B">Namdar I, Edelstein DR, Huo J, et al.:</span> <span class="emph_I">Management of osteomas of the paranasal sinuses.</span> Am J Rhinol 12(6):393, 1998.</span>
</div>
<div class="RF" id="R438-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Shady JA, Bland LI, Kazee AM, et al.:</span> <span class="emph_I">Osteoma of the frontoethmoid sinus with secondary brain abscess and intracranial mucocele: Case report.</span> Neurosurgery 34:920, 1994.</span></span>
</div>
<div class="RF" id="R439-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Greenspan A:</span> <span class="emph_I">Benign bone-forming lesions: Osteoma, osteoid osteoma, and osteoblastoma.</span> Skeletal Radiol 22:485, 1993.</span></span>
</div>
<div class="RF" id="R440-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Johnson D, Tan L:</span> <span class="emph_I">Intraparenchymal tension pneumatocele complicating frontal sinus osteoma: case report.</span> Neurosurgery 50:878, 2002. &#x005B;Discussion 50;880, 2002.&#x005D;</span></span>
</div>
<div class="RF" id="R441-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Bullough PG:</span> <span class="emph_I">Ivory exostosis of the skull.</span> Postgrad Med J 41:277, 1965.</span></span>
</div>
<div class="RF" id="R442-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Maclennan WD, Brown RD:</span> <span class="emph_I">Osteoma of the mandible.</span> Br J Oral Surg 12:219, 1974.</span></span>
</div>
<div class="RF" id="R443-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Montgomery WW:</span> <span class="emph_I">Osteoma of the frontal sinus.</span> Ann Otol Rhinol Laryngol 69:245, 1960.</span></span>
</div>
<div class="RF" id="R444-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[4]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Lautenbach E:</span> <span class="emph_I">Klinische und histologische Studien an Osteomen.</span> Dtsch Zahn Mund Kieferheilkd 43:434, 1964.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4022" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[5]">
<div class="HD">GARDNER&#x2019;S SYNDROME</div>
<div class="RF" id="R445-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[5]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Gardner EJ:</span> <span class="emph_I">Discovery of the Gardner syndrome.</span> Birth Defects 13:48, 1972.</span></span>
</div>
<a name="PG1366"> </a><div class="pagenum"><div>P.1366</div></div>
<br clear="all">
<div class="RF" id="R446-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[5]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Watne AL, Core SK, Carrier JM:</span> <span class="emph_I">Gardner&#x2019;s syndrome.</span> Surg Gynecol Obstet 141:53, 1975.</span></span>
</div>
<div class="RF" id="R447-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[5]/RF[3]">3. <span class="URF"><span class="emph_B">McNab AA:</span> <span class="emph_I">Orbital osteoma in Gardner&#x2019;s syndrome.</span> Aust N Z J Ophthalmol 26(2):169, 1998.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4023" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]">
<div class="HD">BONE ISLAND</div>
<div class="RF" id="R448-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Smith J:</span> <span class="emph_I">Giant bone islands.</span> Radiology 107:35, 1973.</span></span>
</div>
<div class="RF" id="R449-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[2]">2. <span class="URF"><span class="emph_B">Trombetti A, Noel E:</span> <span class="emph_I">Giant bone islands: a case with 31 years of follow-up.</span> Joint Bone Spine 69(1):81, 2002.</span>
</div>
<div class="RF" id="R450-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Blank N, Lieber A:</span> <span class="emph_I">The significance of growing bone islands.</span> Radiology 85:508, 1965.</span></span>
</div>
<div class="RF" id="R451-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Onitsuka H:</span> <span class="emph_I">Roentgenologic aspects of bone islands.</span> Radiology 123:607, 1977.</span></span>
</div>
<div class="RF" id="R452-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Hoffman RR Jr, Campbell RE:</span> <span class="emph_I">Roentgenologic bone island instability in hyperparathyroidism.</span> Radiology 103:307, 1972.</span></span>
</div>
<div class="RF" id="R453-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Sickle EA, Genant HK, Hoffer PB:</span> <span class="emph_I">Increased localization of 99M TE-Pyrophosphate in a bone island: Case report.</span> J Nucl Med 17:113, 1976.</span></span>
</div>
<div class="RF" id="R454-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Davies JA, Hall FM, Goldberg RP, et al.:</span> <span class="emph_I">Positive bone scans in bone islands.</span> J Bone Joint Surg 61a:6, 1979.</span></span>
</div>
<div class="RF" id="R455-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Greenspan A, Steiner G, Knutzon R:</span> <span class="emph_I">Bone island (enostosis): Clinical significance and radiologic and pathologic correlations.</span> Skeletal Radiol 20:85, 1991.</span></span>
</div>
<div class="RF" id="R456-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Gower DJ, Tytle T, Brumback R:</span> <span class="emph_I">Enlarging endostoma (bone island) of the spinous process.</span> Neurosurgery 30:608, 1992.</span></span>
</div>
<div class="RF" id="R457-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[6]/RF[10]">10. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Giant bone island of the right innominate with osteolytic metastatic carcinoma of the right innominate from a previous malignant breast neoplasm.</span> ACA J Chiro, 1981.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4024" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]">
<div class="HD">OSTEOID OSTEOMA</div>
<div class="RF" id="R458-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Osteoid osteoma&#x2014;A benign osteoblastic tumor composed of osteoid and atypical bone.</span> Arch Surg 31:709, 1935.</span></span>
</div>
<div class="RF" id="R459-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Freiberger RH, Loitman BS, Helpern M:</span> <span class="emph_I">Osteoid osteoma: A report on 80 cases.</span> AJR 82:194, 1959.</span></span>
</div>
<div class="RF" id="R460-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Byers PD:</span> <span class="emph_I">Solitary benign osteoblastic lesions of bone: Osteoid osteoma and benign osteoblastoma.</span> Cancer 22:43, 1968.</span></span>
</div>
<div class="RF" id="R461-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[4]">4. <span class="URF"><span class="emph_B">Sim FH, Dahlin DC, Beabout JW:</span> <span class="emph_I">Osteoid osteoma: Diagnostic problems.</span> J Bone Joint Surg 57A:154, 1975.</span>
</div>
<div class="RF" id="R462-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Schajowicz F, Lemos C:</span> <span class="emph_I">Osteoid osteoma and osteoblastoma.</span> Acta Orthop Scand 41:272, 1970.</span></span>
</div>
<div class="RF" id="R463-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[6]">6. <span class="URF"><span class="emph_B">Dahlin DC:</span> <span class="emph_I">Bone Tumors,</span> ed 3. Springfield, Charles C Thomas, 1978.</span>
</div>
<div class="RF" id="R464-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[7]">7. <span class="URF"><span class="emph_B">Habermann ET, Stern RE:</span> <span class="emph_I">Osteoid osteoma of the tibia in an eightmonth-old boy. A case report.</span> J Bone Joint Surg 56A:633, 1974.</span>
</div>
<div class="RF" id="R465-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[8]">8. <span class="URF"><span class="emph_B">Cohen MD, Harrington TM, Ginsburg WW:</span> <span class="emph_I">Osteoid osteoma: 95 cases and a review of the literature.</span> Semin Arthritis Rheumatol 12(3):265, 1983.</span>
</div>
<div class="RF" id="R466-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Helms CA, Hattner RS, Vogler JB III:</span> <span class="emph_I">Osteoid osteoma: Radionuclide diagnosis.</span> Radiology 151:779, 1984.</span></span>
</div>
<div class="RF" id="R467-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Paus BC, Kim TK:</span> <span class="emph_I">Osteoid osteoma of the spine.</span> Acta Orthop Scand 33:24, 1963.</span></span>
</div>
<div class="RF" id="R468-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Flaherty RA, Pugh DG, Dockerty MB:</span> <span class="emph_I">Osteoid osteoma.</span> AJR 76:1041, 1956.</span></span>
</div>
<div class="RF" id="R469-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Sabannos AO, Bickel WH, Moe JH:</span> <span class="emph_I">Natural history of osteoid osteoma.</span> Am J Surg 91:880, 1956.</span></span>
</div>
<div class="RF" id="R470-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Foss EL, Dockerty MB, Good CA:</span> <span class="emph_I">Osteoid osteoma of the mandible.</span> Cancer 8:592, 1955.</span></span>
</div>
<div class="RF" id="R471-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Reinhardt K:</span> <span class="emph_I">Osteoid osteom im os parietale.</span> Fortschr Geb Roentgenstr Nuklearmed 116:563, 1972.</span></span>
</div>
<div class="RF" id="R472-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Arazi M, Memik R, Yel M, Ogun TC:</span> <span class="emph_I">Osteoid osteoma of the carpal bones.</span> Arch Orthop Trauma Surg 121:119, 2001.</span></span>
</div>
<div class="RF" id="R473-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[16]">16. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Osteoid osteoma of the thumb</span> &#x005B;Roentgen Brief&#x005D;. ACA Council, Nov 1979.</span>
</div>
<div class="RF" id="R474-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Greenspan A:</span> <span class="emph_I">Benign bone-forming lesions: osteoma, osteoid osteoma, and osteoblastoma.</span> Skeletal Radiol 22:485, 1993.</span></span>
</div>
<div class="RF" id="R475-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Osteoid osteoma of bone.</span> Radiology 45:319, 1945.</span></span>
</div>
<div class="RF" id="R476-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[19]">19. <span class="URF"><span class="emph_B">Macleelan DI, Wilson FC Jr:</span> <span class="emph_I">Osteoid osteoma of the spine.</span> J Bone Joint Surg 49A:111, 1967.</span>
</div>
<div class="RF" id="R477-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Caldicott WJH:</span> <span class="emph_I">Diagnosis of spinal osteoid osteoma.</span> Radiology 92:1192, 1969.</span></span>
</div>
<div class="RF" id="R478-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Gamba JL, Martinez S, Apple J, et al.:</span> <span class="emph_I">Computed tomography of axial skeletal osteoid osteomas.</span> AJR 142:769, 1984.</span></span>
</div>
<div class="RF" id="R479-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[22]">22. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Reactive sclerosis of a pedicle due to unilateral spondylolysis&#x2014;A case study.</span> ACA J Chiro, 1980.</span>
</div>
<div class="RF" id="R480-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[23]">23. <span class="URF"><span class="emph_B">Albers VL:</span> <span class="emph_I">Congenital absence of a lumbar pedicle with sclerosis and hypertrophy of the contralateral pedicle.</span> ACA J Chiro, 1984.</span>
</div>
<div class="RF" id="R481-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[24]">24. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Case of the missing pedicle</span> &#x005B;Roentgen Brief&#x005D;. ACA Council Roentgenol, Feb 1981.</span>
</div>
<div class="RF" id="R482-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[25]">25. <span class="JRF"><span class="DRF"><span class="emph_B">Lindbom A, Lindvall W, Soderberg G, et al.:</span> <span class="emph_I">Angiography in osteoid osteoma.</span> Acta Radiol 54:327, 1960.</span></span>
</div>
<div class="RF" id="R483-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[26]">26. <span class="URF"><span class="emph_B">Georgoulis AD, Papageorgiou CD, Moebius UG, et al.:</span> <span class="emph_I">The diagnostic dilemma created by osteoid osteoma that presents as knee pain.</span> Arthoscopy 18(1):32, 2002.</span>
</div>
<div class="RF" id="R484-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[27]">27. <span class="JRF"><span class="DRF"><span class="emph_B">Swee RG, McLeod RA, Beabout JW:</span> <span class="emph_I">Osteoid osteoma: Detection, diagnosis, localization.</span> Radiology 130:117, 1979.</span></span>
</div>
<div class="RF" id="R485-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[28]">28. <span class="JRF"><span class="DRF"><span class="emph_B">Azouz EM:</span> <span class="emph_I">Bone marrow edema in osteoid osteoma</span> &#x005B;Letter&#x005D;. Skeletal Radiol 23:53, 1994.</span></span>
</div>
<div class="RF" id="R486-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[29]">29. <span class="URF"><span class="emph_B">Spouge AR, Thain LM:</span> <span class="emph_I">Osteoid osteoma: MR imaging revisited.</span> Clin Imaging 24(1):19, 2000.</span>
</div>
<div class="RF" id="R487-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[30]">30. <span class="URF"><span class="emph_B">Ilyas I, Younge DA:</span> <span class="emph_I">Medical management of osteoid osteoma.</span> Can J Surg 45(6):435, 2002.</span>
</div>
<div class="RF" id="R488-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[31]">31. <span class="URF"><span class="emph_B">Torriani M, Rosenthal DI:</span> <span class="emph_I">Percutaneous radiofrequency treatment of osteoid osteoma.</span> Pediatr Radiol 32(8):615, 2002.</span>
</div>
<div class="RF" id="R489-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[32]">32. <span class="URF"><span class="emph_B">Osti OL, Sebben R:</span> <span class="emph_I">High-frequency radio-wave ablation of osteoid osteoma in the lumbar spine.</span> Eur Spine J 7(5):422, 1998.</span>
</div>
<div class="RF" id="R490-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[33]">33. <span class="JRF"><span class="DRF"><span class="emph_B">Vanderschueren GM, Taminiau AH, Obermann WR, Bloem JL:</span> <span class="emph_I">Osteiod osteoma: Clinical results with thermocoagulation.</span> Radiology 224:82, 2002.</span></span>
</div>
<div class="RF" id="R491-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[34]">34. <span class="URF"><span class="emph_B">Sluga M, Windhager R, Pfeiffer M, et al.:</span> <span class="emph_I">Peripheral osteoid osteoma. Is there still place for traditional surgery?</span> J Bone Joint Surg 84B:249, 2002.</span>
</div>
<div class="RF" id="R492-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[35]">35. <span class="URF"><span class="emph_B">Buhler M, Binkert C, Exner GU:</span> <span class="emph_I">Osteoid osteoma: Technique of computed tomography-controlled percutaneous resection using standard equipment available in most orthopaedic operating rooms.</span> Arch Orthop Trauma Surg 121(8):458, 2001.</span>
</div>
<div class="RF" id="R493-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[36]">36. <span class="URF"><span class="emph_B">Katz K, Kornreich L, David R, et al.:</span> <span class="emph_I">Osteoid osteoma: Resection with CT guidance.</span> Isr Med Assoc J 2(2):151, 2000.</span>
</div>
<div class="RF" id="R494-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[37]">37. <span class="URF"><span class="emph_B">Parlier-Cuau C, Champsaur P, Nizard R, et al.:</span> <span class="emph_I">Percutaneous removal of osteoid osteoma.</span> Radiol Clin North Am 36(3):559, 1998.</span>
</div>
<div class="RF" id="R495-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[7]/RF[38]">38. <span class="URF"><span class="emph_B">Vickers CW, Pugh DC, Ivins JC:</span> <span class="emph_I">Osteoid osteoma. A 15-year follow-up of an untreated patient.</span> J Bone Joint Surg 41A:357, 1959.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4025" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]">
<div class="HD">OSTEOBLASTOMA</div>
<div class="RF" id="R496-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[1]">1. <span class="URF"><span class="emph_B">Dahlin DC, Johnson EW Jr:</span> <span class="emph_I">Giant osteoid osteoma.</span> J Bone Joint Surg 36A:559, 1954.</span>
</div>
<div class="RF" id="R497-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Benign osteoblastoma.</span> Bull Hosp Joint Dis 17:141, 1956.</span></span>
</div>
<div class="RF" id="R498-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[3]">3. <span class="URF"><span class="emph_B">Lichtenstein L, Sawyer WR:</span> <span class="emph_I">Benign osteoblastoma. Further observations and report of twenty additional cases.</span> J Bone Joint Surg 46A:755, 1964.</span>
</div>
<div class="RF" id="R499-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">McLeod RA, Dahlin DC, Beabout JW:</span> <span class="emph_I">The spectrum of osteoblastoma.</span> AJR 126:321, 1976.</span></span>
</div>
<div class="RF" id="R500-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[5]">5. <span class="URF"><span class="emph_B">Mehdian H, Faraj AA, Weatherley C:</span> <span class="emph_I">Painful scoliosis secondary to osteoblastoma of the vertebral body.</span> Eur Spine J 7(3):246, 1998.</span>
</div>
<div class="RF" id="R501-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Mehta MH, Murray RO:</span> <span class="emph_I">Scoliosis provoked by painful vertebral lesions.</span> Skeletal Radiol 1:223, 1977.</span></span>
</div>
<div class="RF" id="R502-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[7]">7. <span class="URF"><span class="emph_B">MacClellan DI, Wilson FC Jr:</span> <span class="emph_I">Osteoid osteoma of the spine.</span> J Bone Joint Surg 49A:111, 1967.</span>
</div>
<div class="RF" id="R503-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[8]">8. <span class="URF"><span class="emph_B">Sonel B, Yagmuriu B, Tuncer S, et al.:</span> <span class="emph_I">Osteoblastoma of the lumbar spine as a cause of chronic low back pain.</span> Rheumatol Int 21(6): 253, 2002.</span>
</div>
<div class="RF" id="R504-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[9]">9. <span class="URF"><span class="emph_B">Temple HT, Mizel MS, Murphey MD, Sweet DE:</span> <span class="emph_I">Osteoblastoma of the foot and ankle.</span> Foot Ankle Int 19(10):698, 1998.</span>
</div>
<div class="RF" id="R505-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[10]">10. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Osteoblastoma.</span> ACA J Chiro, 1982.</span>
</div>
<div class="RF" id="R506-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[11]">11. <span class="URF"><span class="emph_B">Gelberman RH, Olson CO:</span> <span class="emph_I">Benign osteoblastoma of the atlas.</span> J Bone Joint Surg 56A:808, 1974.</span>
</div>
<a name="PG1367"> </a><div class="pagenum"><div>P.1367</div></div>
<br clear="all">
<div class="RF" id="R507-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Maar D, Dornetzhuber V:</span> <span class="emph_I">Benign osteoblastoma ossis tali resembling ostiitis tuberculosa.</span> Acta Chir Orthop Traumatol Cech 41:362, 1974.</span></span>
</div>
<div class="RF" id="R508-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Ronis ML, Obando M, Bucko MI, et al.:</span> <span class="emph_I">Benign osteoblastoma of the temporal bone.</span> Laryngoscope 84:857, 1974.</span></span>
</div>
<div class="RF" id="R509-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Borello ED, Sedano HO:</span> <span class="emph_I">Giant osteoid osteoma of the maxilla.</span> Oral Surg 23:563, 1967.</span></span>
</div>
<div class="RF" id="R510-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Brady CL, Browne RM:</span> <span class="emph_I">Benign osteoblastoma of the mandible.</span> Cancer 30:329, 1972.</span></span>
</div>
<div class="RF" id="R511-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Rosensweig J, Mikail M, Mayman A:</span> <span class="emph_I">Benign osteoblastoma: Report of an unusual rib tumor and review of the literature.</span> Can Med Assoc J 89:1189, 1963.</span></span>
</div>
<div class="RF" id="R512-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Schajowicz F, Lemos C:</span> <span class="emph_I">Osteoid osteoma and osteoblastoma. Closely related entities of osteoblastic derivation.</span> Acta Orthop Scand 41:272, 1970.</span></span>
</div>
<div class="RF" id="R513-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[18]">18. <span class="URF"><span class="emph_B">Marsh BW, Bonfiglio M, Brady LP, et al.:</span> <span class="emph_I">Benign osteoblastoma: Range of manifestations.</span> J Bone Joint Surg 57A:1, 1975.</span>
</div>
<div class="RF" id="R514-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[8]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Pochaczevsky R, Yen YM, Sherman RS:</span> <span class="emph_I">The roentgen appearance of benign osteoblastoma.</span> Radiology 75:429, 1960.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4026" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]">
<div class="HD">SOLITARY ENCHONDROMA</div>
<div class="RF" id="R515-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[1]">1. <span class="URF"><span class="emph_B">Takigawa K:</span> <span class="emph_I">Chondroma of the bones of the hand&#x2014;A review of 110 cases.</span> J Bone Joint Surg 53A:1591, 1971.</span>
</div>
<div class="RF" id="R516-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[2]">2. <span class="URF"><span class="emph_B">Dahlin DC:</span> <span class="emph_I">Bone Tumors,</span> ed 2. Springfield, Charles C Thomas, 1967.</span>
</div>
<div class="RF" id="R517-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[3]">3. <span class="URF"><span class="emph_B">Poznanski AK:</span> <span class="emph_I">The Hand in Radiologic Diagnosis.</span> Philadelphia, WB Saunders, 1974.</span>
</div>
<div class="RF" id="R518-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[4]">4. <span class="URF"><span class="emph_B">Ablove RH, Moy OJ, Peimer CA, Wheeler DR:</span> <span class="emph_I">Early verses delayed treatment of enchondroma.</span> Am J Orthop 29(10):771, 2000.</span>
</div>
<div class="RF" id="R519-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Levy WM, Aegerter EE, Kirkpatrick JA Jr:</span> <span class="emph_I">The nature of cartilaginous tumors.</span> Radiol Clin North Am 2:327, 1964.</span></span>
</div>
<div class="RF" id="R520-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[6]">6. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R521-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Montero LM, Ikuta Y, Ishida O, et al.:</span> <span class="emph_I">Enchondroma in the hand retrospective study&#x2014;Recurrence cases.</span> Hand Surg 7:7, 2002.</span></span>
</div>
<div class="RF" id="R522-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[8]">8. <span class="URF"><span class="emph_B">Chandy J, Wade PJ, Chen K:</span> <span class="emph_I">Malignant transformation of a solitary enchondroma.</span> Hosp Med 62(3):180, 2001.</span>
</div>
<div class="RF" id="R523-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[9]">9. <span class="URF"><span class="emph_B">Edeiken J:</span> <span class="emph_I">Roentgen Diagnosis of Diseases of Bone,</span> ed 3. Baltimore, Williams &#x0026; Wilkins, 1981.</span>
</div>
<div class="RF" id="R524-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[10]">10. <span class="URF"><span class="emph_B">Braddock GTF, Hadlow VD:</span> <span class="emph_I">Osteosarcoma in enchondromatosis (Ollier&#x2019;s disease). Report of a case.</span> J Bone Joint Surg 48B:145, 1966.</span>
</div>
<div class="RF" id="R525-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[11]">11. <span class="URF"><span class="emph_B">Lammot TR:</span> <span class="emph_I">Enchondroma of the patella. A case report.</span> J Bone Joint Surg 14A:1230, 1968.</span>
</div>
<div class="RF" id="R526-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Potdar GG, Srikhande SS:</span> <span class="emph_I">Chondrogenic tumors of the jaws.</span> Oral Surg 30:649, 1970.</span></span>
</div>
<div class="RF" id="R527-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Bell MS:</span> <span class="emph_I">Benign cartilaginous tumors of the spine.</span> Br J Surg 58: 707, 1971.</span></span>
</div>
<div class="RF" id="R528-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[14]">14. <span class="URF"><span class="emph_B">Laurence W, Franklin EL:</span> <span class="emph_I">Calcifying enchondroma of long bones.</span> J Bone Joint Surg 35B:224, 1953.</span>
</div>
<div class="RF" id="R529-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[15]">15. <span class="URF"><span class="emph_B">Flemming DJ, Murphey MD:</span> <span class="emph_I">Enchondroma and chondrosarcoma.</span> Semin Musculoskelet Radiol 4(1):59, 2000.</span>
</div>
<div class="RF" id="R530-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[16]">16. <span class="URF"><span class="emph_B">Dobert N, Menzel C, Ludwig R, et al.:</span> <span class="emph_I">Enchondroma: A benign osseous lesion with high F-18 FDG uptake.</span> Clin Nucl Med 27(10): 695, 2002.</span>
</div>
<div class="RF" id="R531-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Hamlin JA, Adler L, Greenbaum EI:</span> <span class="emph_I">Central enchondroma&#x2014;A precursor to chondrosarcoma?</span> J Can Assoc Radiol 22:206, 1971.</span></span>
</div>
<div class="RF" id="R532-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[18]">18. <span class="URF"><span class="emph_B">Marco RA, Gitelis S, Brebach GT, Healey JH:</span> <span class="emph_I">Cartilage tumors: Evaluation and treatment.</span> J Am Acad Orthop Surg 8(5):292, 2000.</span>
</div>
<div class="RF" id="R533-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[19]">19. <span class="URF"><span class="emph_B">McVey MJ, Kettner NW:</span> <span class="emph_I">Pathologic fracture of metacarpal enchondroma: Case study and differential diagnosis.</span> J Manipulative Physiol Ther 25(5):340, 2002.</span>
</div>
<div class="RF" id="R534-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[20]">20. <span class="URF"><span class="emph_B">Jewusiak EM, Spence KF, Sell KW:</span> <span class="emph_I">Solitary benign enchondroma of the long bones of the hand. Results of curettage and packing with freeze-dried cancellous bone allograft.</span> J Bone Joint Surg 53A:1587, 1971.</span>
</div>
<div class="RF" id="R535-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[9]/RF[21]">21. <span class="URF"><span class="emph_B">Bickets J, Wittig JC, Kollender Y, et al.:</span> <span class="emph_I">Enchondromas of the hand: treatment with curettage and cemented internal fixation.</span> J Hand Surg 27A:870, 2002.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4027" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]">
<div class="HD">MULTIPLE ENCHONDROMATOSIS (OLLIER&#x2019;S DISEASE)</div>
<div class="RF" id="R536-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Ollier M:</span> <span class="emph_I">Dyschondroplasie.</span> Lyon Med 93:23, 1900.</span></span>
</div>
<div class="RF" id="R537-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[2]">2. <span class="URF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Tumors and Tumorous Conditions of the Bones and Joints.</span> Philadelphia, Lea &#x0026; Febiger, 1958.</span>
</div>
<div class="RF" id="R538-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[3]">3. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R539-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[4]">4. <span class="URF"><span class="emph_B">Mosher JF:</span> <span class="emph_I">Multiple enchondromatosis of the hand. A case report.</span> J Bone Joint Surg 58A:717, 1976.</span>
</div>
<div class="RF" id="R540-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Mainzer F, Minagi H, Steinbach HL:</span> <span class="emph_I">The variable manifestations of multiple enchondromatosis.</span> Radiology 99:377, 1971.</span></span>
</div>
<div class="RF" id="R541-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Cowan WK:</span> <span class="emph_I">Malignant change and multiple metastases in Ollier&#x2019;s disease.</span> J Clin Pathol 18:650, 1965.</span></span>
</div>
<div class="RF" id="R542-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[7]">7. <span class="URF"><span class="emph_B">Schwartz HS, Zimmerman MA:</span> <span class="emph_I">The malignant potential of enchondromatosis.</span> J Bone Joint Surg 69A:269, 1987.</span>
</div>
<div class="RF" id="R543-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Unger EC, Kessler HB, Kowalyshyn MJ, et al.:</span> <span class="emph_I">MR imaging of Maffucci syndrome.</span> AJR 150:351, 1988.</span></span>
</div>
<div class="RF" id="R544-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[10]/RF[9]">9. <span class="URF"><span class="emph_B">Giannikas AC:</span> <span class="emph_I">Treatment of metacarpal enchondromata. Report of three cases.</span> J Bone Joint Surg 48B:333, 1966.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4028" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[11]">
<div class="HD">MAFFUCCI&#x2019;S SYNDROME</div>
<div class="RF" id="R545-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[11]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Maffucci A:</span> <span class="emph_I">Di un caso di encondroma ed angioma multiplo. Contribuzione alla genesi embrionale dei tumori.</span> Mov Med Chir 13:399, 1881.</span></span>
</div>
<div class="RF" id="R546-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[11]/RF[2]">2. <span class="URF"><span class="emph_B">McDermott AL, Dutt SN, Chavda SV, Morgan DW:</span> <span class="emph_I">Maffucci&#x2019;s syndrome: Clinical and radiological features of a rare condition.</span> J Laryngol Otol 114(10):845, 2001.</span>
</div>
<div class="RF" id="R547-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[11]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Nakamura K, Matsushita T, Haga N, et al.:</span> <span class="emph_I">Swelling of the dorsum of the hand and&#x002F;or foot can be a first sign of Maffacci syndrome.</span> Arch Orthop Trauma Surg 119:470, 1999.</span></span>
</div>
<div class="RF" id="R548-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[11]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Howard FM, Lee RE Jr:</span> <span class="emph_I">The hand in Maffucci&#x2019;s syndrome.</span> Arch Surg 103:752, 1971.</span></span>
</div>
<div class="RF" id="R549-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[11]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Unger EC, Kessler HB, Kowalyshyn MJ, et al.:</span> <span class="emph_I">MR imaging of Maffucci syndrome.</span> AJR 150:351, 1988.</span></span>
</div>
<div class="RF" id="R550-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[11]/RF[6]">6. <span class="URF"><span class="emph_B">Ahmed SK, Lee WC, Irving RM, Walsh AR:</span> <span class="emph_I">Is Ollier&#x2019;s disease an understaging of Maffucci&#x2019;s syndrome?</span> J Laryngol Otol 113(9):861, 1999.</span>
</div>
<div class="RF" id="R551-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[11]/RF[7]">7. <span class="URF"><span class="emph_B">Kuwahara RT, Skinner RB Jr:</span> <span class="emph_I">Maffucci syndrome: a case report.</span> Cutis 69(1):21, 2002.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4029" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]">
<div class="HD">PERIOSTEAL CHONDROMA</div>
<div class="RF" id="R552-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Lichtenstein L, Hall JE:</span> <span class="emph_I">Periosteal chondroma. A distinctive benign cartilage tumor.</span> J Bone Joint Surg 34a:691, 1952.</span></span>
</div>
<div class="RF" id="R553-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Juxtacortical chondroma.</span> Bull Hosp Joint Dis 17:20, 1956.</span></span>
</div>
<div class="RF" id="R554-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[3]">3. <span class="URF"><span class="emph_B">deSantos LA, Spjut HJ:</span> <span class="emph_I">Periosteal chondroma: A radiographic spectrum.</span> Skeletal Radiol 6:15, 1981.</span>
</div>
<div class="RF" id="R555-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Meyer R:</span> <span class="emph_I">Juxtacortical chondroma.</span> Br J Radiol 31:106, 1958.</span></span>
</div>
<div class="RF" id="R556-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Bauer TW, Dorfman HD, Latham JT Jr:</span> <span class="emph_I">Periosteal chondroma.</span> Am J Surg Pathol 6:631, 1982.</span></span>
</div>
<div class="RF" id="R557-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[6]">6. <span class="URF"><span class="emph_B">Rockwell MA, Saiter ET, Enneking WF:</span> <span class="emph_I">Periosteal chondroma.</span> J Bone Joint Surg 54A:102, 1972.</span>
</div>
<div class="RF" id="R558-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[7]">7. <span class="URF"><span class="emph_B">Boriani S, Bacchini P, Bertoni F, et al.:</span> <span class="emph_I">Periosteal chondroma.</span> J Bone Joint Surg 65A:205, 1983.</span>
</div>
<div class="RF" id="R559-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[8]">8. <span class="URF"><span class="emph_B">Robinson P, White LM, Sundaram M, et al.:</span> <span class="emph_I">Periosteal chondroid tumors: radiologic evaluation with pathologic correlation.</span> AJR Am J Roentgenol 177(5):1183, 2001.</span>
</div>
<div class="RF" id="R560-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Woertler K, Blasius S, Brinkschmidt C, et al.:</span> <span class="emph_I">Periosteal chondroma: MR characteristics.</span> J Comput Assist Tomogr 25:425, 2001.</span></span>
</div>
<div class="RF" id="R561-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[12]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Yamamoto T, Nagira K, Kurosaka M:</span> <span class="emph_I">Periosteal chondroma presenting as a subcutaneous mass in the thumb.</span> Clin Imaging 25: 432, 2001.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4030" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]">
<div class="HD">CHONDROBLASTOMA</div>
<div class="RF" id="R562-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[1]">1. <span class="URF"><span class="emph_B">Masui F, Ushigome S, Kamitani K, et al.:</span> <span class="emph_I">Chondroblastoma: A study of 11 cases.</span> Eur J Surg Oncol 28(8):869, 2002.</span>
</div>
<div class="RF" id="R563-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[2]">2. <span class="URF"><span class="emph_B">Ewing J:</span> <span class="emph_I">Neoplastic Diseases. A Treatise on Tumors,</span> ed 3. Philadelphia, WB Saunders, 1928.</span>
</div>
<div class="RF" id="R564-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Kolodny A:</span> <span class="emph_I">Bone sarcoma.</span> Surg Gynecol Obstet 44:1, 1927.</span></span>
</div>
<a name="PG1368"> </a><div class="pagenum"><div>P.1368</div></div>
<br clear="all">
<div class="RF" id="R565-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Codman EA:</span> <span class="emph_I">Epiphyseal chondromatous giant cell tumors of the upper end of the humerus.</span> Surg Gynecol Obstet 52:543, 1931.</span></span>
</div>
<div class="RF" id="R566-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L:</span> <span class="emph_I">Benign chondroblastoma of bone. A reinterpretation of the so-called calcifying or chondromatous giant cell tumor.</span> Am J Pathol 18:969, 1942.</span></span>
</div>
<div class="RF" id="R567-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[6]">6. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R568-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[7]">7. <span class="URF"><span class="emph_B">Kunkel MG, Dahlin DC, Young HH:</span> <span class="emph_I">Benign chondroblastoma.</span> J Bone Joint Surg 38A:817, 1956.</span>
</div>
<div class="RF" id="R569-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[8]">8. <span class="URF"><span class="emph_B">Trebse R, Rotter A, Pisot V:</span> <span class="emph_I">Chondroblastoma of the patella associated with and aneurysmal bone cyst.</span> Acta Orthop Belg 67(3): 290, 2001.</span>
</div>
<div class="RF" id="R570-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[9]">9. <span class="URF"><span class="emph_B">Treasure ER:</span> <span class="emph_I">Benign chondroblastoma of bone.</span> J Bone Joint Surg 37B:462, 1955.</span>
</div>
<div class="RF" id="R571-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">McBryde A Jr, Goldner JL:</span> <span class="emph_I">Chondroblastoma of bone.</span> Am Surg 36:94, 1970.</span></span>
</div>
<div class="RF" id="R572-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">McLeod RA, Beabout JW:</span> <span class="emph_I">The roentgenographic features of chondroblastoma.</span> AJR 118:464, 1973.</span></span>
</div>
<div class="RF" id="R573-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[12]">12. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R574-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[13]">13. <span class="URF"><span class="emph_B">Ilaslan H, Sundaram M, Unni KK:</span> <span class="emph_I">Vertebral chondroblastoma.</span> Skeletal Radiol 32(2):66, 2003.</span>
</div>
<div class="RF" id="R575-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[14]">14. <span class="URF"><span class="emph_B">Kudo T, Okada K, Hirano Y, Sageshima M:</span> <span class="emph_I">Chondroblastoma of a metacarpal bone mimicking an aneurysmal bone cyst: A case report and a review of the literature.</span> Tohoku J Exp Med 194(4):251, 2001.</span>
</div>
<div class="RF" id="R576-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[15]">15. <span class="URF"><span class="emph_B">Neviaser RJ, Wilson JN:</span> <span class="emph_I">Benign chondroblastoma of the finger.</span> J Bone Joint Surg 54A:389, 1972.</span>
</div>
<div class="RF" id="R577-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[16]">16. <span class="URF"><span class="emph_B">Assor D:</span> <span class="emph_I">Chondroblastoma of the rib. Report of a case.</span> J Bone Joint Surg 55A:208, 1973.</span>
</div>
<div class="RF" id="R578-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[17]">17. <span class="URF"><span class="emph_B">Cohen J, Cahen I:</span> <span class="emph_I">Benign chondroblastoma of the patella; a case report.</span> J Bone Joint Surg 45A:824, 1963.</span>
</div>
<div class="RF" id="R579-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Mercuri M, Casadei R:</span> <span class="emph_I">Patellar tumors.</span> Clin Orthop 389:35, 2001.</span></span>
</div>
<div class="RF" id="R580-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[19]">19. <span class="URF"><span class="emph_B">Kelikian H, Clayton I:</span> <span class="emph_I">Giant cell tumor of the patella.</span> J Bone Joint Surg 39A:414, 1957.</span>
</div>
<div class="RF" id="R581-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[20]">20. <span class="URF"><span class="emph_B">Mirra J:</span> <span class="emph_I">Bone Tumors, Diagnosis and Treatment.</span> Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R582-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Kahn LB, Wood FM, Ackerman LV:</span> <span class="emph_I">Malignant chondroblastoma. Report of two cases and review of the literature.</span> Arch Pathol 88:371, 1969.</span></span>
</div>
<div class="RF" id="R583-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[22]">22. <span class="URF"><span class="emph_B">Sirsat MV, Doctor VM:</span> <span class="emph_I">Benign chondroblastoma of bone: Report of a case of malignant transformation.</span> J Bone Joint Surg 52B:741, 1970.</span>
</div>
<div class="RF" id="R584-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Rischke B, Engels C, Pietsch E, et al.:</span> &#x005B;<span class="emph_I">Chondroblastoma of the patella with pathological fracture</span>&#x005D; Unfallchirurg 103:898, 2000.</span></span>
</div>
<div class="RF" id="R585-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[24]">24. <span class="URF"><span class="emph_B">Otsuka T, Kobayashi M, Yonezawa M, et al.:</span> <span class="emph_I">Treatment of chondroblastoma of the calcaneus with a secondary aneurysmal bone cyst using endoscopic curettage without bone grafting.</span> Arthroscopy 18(4):430, 2002.</span>
</div>
<div class="RF" id="R586-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[25]">25. <span class="URF"><span class="emph_B">Greenfield GB:</span> <span class="emph_I">Radiology of Bone Diseases,</span> ed 3. Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R587-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[26]">26. <span class="URF"><span class="emph_B">Edeiken J:</span> <span class="emph_I">Roentgen Diagnosis of Diseases of Bone,</span> ed 3. Baltimore, Williams &#x0026; Wilkins, 1981.</span>
</div>
<div class="RF" id="R588-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[27]">27. <span class="URF"><span class="emph_B">Oxtoby JW, Davies AM:</span> <span class="emph_I">MRI characteristics of chondroblastoma.</span> Clin Radiol 51(1):22, 1996.</span>
</div>
<div class="RF" id="R589-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[28]">28. <span class="JRF"><span class="DRF"><span class="emph_B">Braunstein E, Martel W, Weatherbee L:</span> <span class="emph_I">Periosteal bone apposition in chondroblastoma.</span> Skeletal Radiol 4:34, 1979.</span></span>
</div>
<div class="RF" id="R590-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[29]">29. <span class="JRF"><span class="DRF"><span class="emph_B">Brower AC, Moser RP, Kransdorf MJ:</span> <span class="emph_I">The frequency and diagnostic significance of periostitis in chondroblastoma.</span> AJR 154:309, 1990.</span></span>
</div>
<div class="RF" id="R591-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[30]">30. <span class="URF"><span class="emph_B">Crim JR, Gold RH, Mirra JM, Eckardt J:</span> <span class="emph_I">Case report 748: Chondroblastoma of the femur with an aneurysmal bone cyst.</span> Skeletal Radiol 21(6):403, 1992.</span>
</div>
<div class="RF" id="R592-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[31]">31. <span class="JRF"><span class="DRF"><span class="emph_B">Varma BP, Gupta IM:</span> <span class="emph_I">Atypical chondroblastoma of tibia. Report of recurrent lesion.</span> Clin Orthop 89:241, 1972.</span></span>
</div>
<div class="RF" id="R593-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[32]">32. <span class="URF"><span class="emph_B">Blitch E, Mendicino RW:</span> <span class="emph_I">Chondroblastoma of the calcaneus: literature review and case presentation.</span> J Foot Ankle Surg 35(3):250, 1996</span>
</div>
<div class="RF" id="R594-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[33]">33. <span class="URF"><span class="emph_B">Ramappa AJ, Lee FY, Tang P, et al.:</span> <span class="emph_I">Chondroblastoma of bone.</span> J Bone Joint Surg 82A(8):1140, 2000.</span>
</div>
<div class="RF" id="R595-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[13]/RF[34]">34. <span class="URF"><span class="emph_B">Erickson JK, Rosenthal DI, Zaleske DJ, et al.:</span> <span class="emph_I">Primary treatment of chondroblastoma with percutaneous radio-frequency heat ablation: Report of three cases.</span> Radiology 221(2):463, 2001.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4031" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]">
<div class="HD">CHONDROMYXOID FIBROMA</div>
<div class="RF" id="R596-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L:</span> <span class="emph_I">Chondromyxoid fibroma of bone. A distinctive benign tumor likely to be mistaken especially for chondrosarcoma.</span> Arch Pathol 45:541, 1948.</span></span>
</div>
<div class="RF" id="R597-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[2]">2. <span class="URF"><span class="emph_B">Schajowicz F, Gallardo H:</span> <span class="emph_I">Chondromyxoid fibroma (fibromyxoid chondroma) of bone.</span> J Bone Joint Surg 53B:198, 1971.</span>
</div>
<div class="RF" id="R598-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Feldman F, Hecht HL, Johnston AD:</span> <span class="emph_I">Chondromyxoid fibroma of bone.</span> Radiology 94:249, 1970.</span></span>
</div>
<div class="RF" id="R599-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[4]">4. <span class="URF"><span class="emph_B">Huvos AG:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis, Treatment and Prognosis.</span> Philadelphia, WB Saunders, 1979.</span>
</div>
<div class="RF" id="R600-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Durr HR, Lienemann A, Nerlich A, et al.:</span> <span class="emph_I">Chondromyxoid fibroma of bone.</span> Arch Orthop Trauma Surg 120:42, 2000.</span></span>
</div>
<div class="RF" id="R601-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Rahimi A, Beabout JW, Ivins JC, et al.:</span> <span class="emph_I">Chondromyxoid fibroma: A clinicopathologic study of 76 cases.</span> Cancer 30:726, 1972.</span></span>
</div>
<div class="RF" id="R602-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[7]">7. <span class="URF"><span class="emph_B">Greenfield GB:</span> <span class="emph_I">Radiology of Bone Diseases,</span> ed 3. Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R603-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Wilson AJ, Kyriakos M, Ackerman LV:</span> <span class="emph_I">Chondromyxoid fibroma: Radiographic appearance in 38 cases and in a review of the literature.</span> Radiology 179:513, 1991.</span></span>
</div>
<div class="RF" id="R604-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Hau MA, Fox EJ, Rosenberg AE, Mankin HJ:</span> <span class="emph_I">Chondromyxoid fibroma of the metacarpal.</span> Skeletal Radiol 30:719, 2001.</span></span>
</div>
<div class="RF" id="R605-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[10]">10. <span class="URF"><span class="emph_B">Lopez-Ben R, Siegal GP, Hadley MN:</span> <span class="emph_I">Chondromyxoid fibroma of the cervical spine: Case report.</span> Neurosurgery 50(2):409, 2002.</span>
</div>
<div class="RF" id="R606-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[11]">11. <span class="URF"><span class="emph_B">Feit EM, Dobbs BM:</span> <span class="emph_I">Chondromyxoid fibroma of the fourth metatarsal.</span> J Am Posdiatr Med Assoc 90(4):211, 2000.</span>
</div>
<div class="RF" id="R607-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[12]">12. <span class="URF"><span class="emph_B">Ralph LL:</span> <span class="emph_I">Chondromyxoid fibroma of bone.</span> J Bone Joint Surg 44B:7, 1962.</span>
</div>
<div class="RF" id="R608-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Turcotte B, Pugh DG, Dahlin DC:</span> <span class="emph_I">The roentgenologic aspects of chondromyxoid fibroma of bone.</span> AJR 87:1085, 1962.</span></span>
</div>
<div class="RF" id="R609-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Murphy NB, Price CHG:</span> <span class="emph_I">The radiological aspects of chondromyxoid fibroma of bone.</span> Clin Radiol 22:261, 1971.</span></span>
</div>
<div class="RF" id="R610-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Beggs IG, Stoker DJ:</span> <span class="emph_I">Chondromyxoid fibroma of bone.</span> Clin Radiol 33:671, 1982.</span></span>
</div>
<div class="RF" id="R611-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[14]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Park SH, Kong KY, Chung HW, et al.:</span> <span class="emph_I">Juxtacortical chondromyxoid fibroma arising in an apophysis.</span> Skeletal Radiol 29:466, 2000.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4032" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]">
<div class="HD">FIBROUS XANTHOMA OF BONE: NON-OSSIFYING FIBROMA</div>
<div class="RF" id="R612-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Lefebvre J, Hassan M:</span> <span class="emph_I">Fibromes non ossifiants.</span> Rev Prat 19:2133, 1969.</span></span>
</div>
<div class="RF" id="R613-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Adams JP, Goldner JL:</span> <span class="emph_I">Fibrous lesions of bone.</span> South Med J 46: 529, 1953.</span></span>
</div>
<div class="RF" id="R614-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[3]">3. <span class="URF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Tumors and Tumorous Conditions of the Bones and Joints.</span> Philadelphia, Lea &#x0026; Febiger, 1948.</span>
</div>
<div class="RF" id="R615-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[4]">4. <span class="URF"><span class="emph_B">Dahlin DC:</span> <span class="emph_I">Bone Tumors,</span> ed 3. Springfield, Charles C Thomas, 1978.</span>
</div>
<div class="RF" id="R616-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[5]">5. <span class="URF"><span class="emph_B">Aegerter E, Kirkpatrick JA Jr:</span> <span class="emph_I">Orthopedic Diseases,</span> ed 4. Philadelphia, WB Saunders, 1975.</span>
</div>
<div class="RF" id="R617-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Compere CL, Coleman SS:</span> <span class="emph_I">Nonosteogenic fibroma of bone.</span> Surg Gynecol Obstet 105:588, 1957.</span></span>
</div>
<div class="RF" id="R618-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Caffey J:</span> <span class="emph_I">On fibrous defects in cortical walls of growing tubular bones.</span> Adv Pediatr 7:13, 1955.</span></span>
</div>
<div class="RF" id="R619-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[8]">8. <span class="URF"><span class="emph_B">Maudsley RH, Stansfeld AG:</span> <span class="emph_I">Nonosteogenic fibroma of bone.</span> J Bone Joint Surg 38B:714, 1956.</span>
</div>
<div class="RF" id="R620-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Drennan DB, Maylahn DJ, Fahey JJ:</span> <span class="emph_I">Fractures through large nonossifying fibromas.</span> Clin Orthop 103:82, 1974.</span></span>
</div>
<div class="RF" id="R621-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Young JWR, Levine AM, Dorfman HD:</span> <span class="emph_I">Nonossifying fibroma of the tibia</span> &#x005B;Case Report 293&#x005D;. Skeletal Radiol 12:294, 1984.</span></span>
</div>
<div class="RF" id="R622-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Goodnough CP, Kuhlmann RP, Stark E:</span> <span class="emph_I">Von Recklinghausen&#x2019;s neurofibromatosis&#x2014;With nonosteogenic fibroma.</span> NY State J Med 75:2407, 1975.</span></span>
</div>
<div class="RF" id="R623-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Kumar R, Swischuk LE, Madewell JE:</span> <span class="emph_I">Benign cortical defect: Site for an avulsion fracture.</span> Skeletal Radiol 15:553, 1986.</span></span>
</div>
<a name="PG1369"> </a><div class="pagenum"><div>P.1369</div></div>
<br clear="all">
<div class="RF" id="R624-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Brenner RJ, Hattner RS, Lilien D:</span> <span class="emph_I">Scintigraphic features of nonosteogenic fibroma.</span> Radiology 131:727, 1979.</span></span>
</div>
<div class="RF" id="R625-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Jee WH, Choe BY, Kang HS, et al.:</span> <span class="emph_I">Nonossifying fibroma: Characteristics at MR imaging with pathologic correlation.</span> Radiology 209:197, 1998.</span></span>
</div>
<div class="RF" id="R626-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[15]/RF[15]">15. <span class="URF"><span class="emph_B">Arata MA, Peterson HA, Dahlin DC:</span> <span class="emph_I">Pathological fractures through nonossifying fibromas.</span> J Bone Joint Surg 63A:980, 1981.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4033" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[16]">
<div class="HD">FIBROUS XANTHOMA OF BONE: FIBROUS CORTICAL DEFECTS</div>
<div class="RF" id="R627-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[16]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Caffey J:</span> <span class="emph_I">On fibrous defects in cortical walls of growing tubular bones.</span> Adv Pediatr 7:13, 1955.</span></span>
</div>
<div class="RF" id="R628-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[16]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Sontag LW, Pyle SI:</span> <span class="emph_I">The appearance and nature of cystlike areas in the distal femoral metaphysis of children.</span> AJR 46:185, 1941.</span></span>
</div>
<div class="RF" id="R629-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[16]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Marek FM:</span> <span class="emph_I">Fibrous cortical defect.</span> Bull Hosp Joint Dis 16:77, 1955.</span></span>
</div>
<div class="RF" id="R630-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[16]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Moser RP, Sweet DE, Haseman DB, et al.:</span> <span class="emph_I">Multiple skeletal fibroxanthomas: Radiologic-pathologic correlation of 72 cases.</span> Skeletal Radiol 16:353, 1987.</span></span>
</div>
<div class="RF" id="R631-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[16]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Goodnough CP, Kuhlmann RP, Stark E:</span> <span class="emph_I">Von Recklinghausen&#x2019;s neurofibromatosis&#x2014;With nonosteogenic fibroma.</span> NY State J Med 75:2407, 1975.</span></span>
</div>
<div class="RF" id="R632-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[16]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Bullough PG, Walley J:</span> <span class="emph_I">Fibrous cortical defect and nonossifying fibroma.</span> Postgrad Med J 41:672, 1965.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4034" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]">
<div class="HD">SIMPLE BONE CYST</div>
<div class="RF" id="R633-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L:</span> <span class="emph_I">Solitary unicameral bone cyst, with emphasis on the roentgen picture, the pathologic appearance and the pathogenesis.</span> Arch Surg 44:1, 1942.</span></span>
</div>
<div class="RF" id="R634-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[2]">2. <span class="URF"><span class="emph_B">Mirra JM:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis and Treatment.</span> Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R635-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[3]">3. <span class="URF"><span class="emph_B">Margau R, Babyn P, Cole W, et al.:</span> <span class="emph_I">MR imaging of simple bone cysts in children: Not so simple.</span> Pediatr Radiol 30(8):551, 2000.</span>
</div>
<div class="RF" id="R636-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[4]">4. <span class="URF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">Tumors and Tumorous Conditions of the Bones and Joints.</span> Philadelphia, Lea &#x0026; Febiger, 1958.</span>
</div>
<div class="RF" id="R637-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[5]">5. <span class="URF"><span class="emph_B">Garceau GJ, Gregory CF:</span> <span class="emph_I">Solitary unicameral bone cyst.</span> J Bone Joint Surg 36A:267, 1954.</span>
</div>
<div class="RF" id="R638-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Rowe LJ, Brandt JR:</span> <span class="emph_I">Simple bone cysts in athletes.</span> Chiro Sports Med 2:33, 1988.</span></span>
</div>
<div class="RF" id="R639-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[7]">7. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R640-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Hagberg S:</span> <span class="emph_I">The solitary bone cyst.</span> Acta Chir Scand 138:25, 1967.</span></span>
</div>
<div class="RF" id="R641-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Shulman HS, Wilson SR, Cruickshank KB, et al.:</span> <span class="emph_I">Unicameral bone cyst in a rib of a child.</span> AJR 128:1058, 1977.</span></span>
</div>
<div class="RF" id="R642-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Abdelwahab IF, Lewis MM, Klein MJ, et al.:</span> <span class="emph_I">Simple (solitary) bone cyst of the calcaneus. Case report 515.</span> Skeletal Radiol 17: 607, 1989.</span></span>
</div>
<div class="RF" id="R643-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[11]">11. <span class="URF"><span class="emph_B">Jaffe HL, Lichtenstein L:</span> <span class="emph_I">Solitary unicameral bone cyst.</span> J Bone Joint Surg 36A:267, 1954.</span>
</div>
<div class="RF" id="R644-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Johnson LC, Vetter H, Putschar WGJ:</span> <span class="emph_I">Sarcomas arising in bone cysts.</span> Virchows Arch Pathol Anat 335:428, 1962.</span></span>
</div>
<div class="RF" id="R645-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">McGlynn FJ, Mickelson MR, El-Khoury GY:</span> <span class="emph_I">The fallen fragment sign in unicameral bone cyst.</span> Clin Orthop 156:157, 1981.</span></span>
</div>
<div class="RF" id="R646-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Reynolds J:</span> <span class="emph_I">The &#x201C;fallen fragment sign&#x201D; in the diagnosis of unicameral bone cysts.</span> Radiology 92:949, 1969.</span></span>
</div>
<div class="RF" id="R647-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Keats TE, Harrison RB:</span> <span class="emph_I">The calcaneal nutrient foramen: A useful sign in the differentiation of true from simulated cysts.</span> Skeletal Radiol 3:239, 1979.</span></span>
</div>
<div class="RF" id="R648-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[16]">16. <span class="URF"><span class="emph_B">Bonnel F, Canovas F, Faure P:</span> <span class="emph_I">Treatment of a simple bone cyst of the calcaneus by endoscopic curettage with cancellous bone injection.</span> Acta Orthop Belg 65(4):528, 1999.</span>
</div>
<div class="RF" id="R649-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[17]">17. <span class="URF"><span class="emph_B">Killian JT, Wilkinson L, White S, Brassard M:</span> <span class="emph_I">Treatment of unicameral bone cyst with demineralized bone matrix.</span> J Pediatr Orthop 18(5):621, 1998.</span>
</div>
<div class="RF" id="R650-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[18]">18. <span class="URF"><span class="emph_B">Rougraff BT, Kling TJ:</span> <span class="emph_I">Treatment of active unicameral bone cysts with percutaneous injection of demineralized bone matrix and autogenous bone marrow.</span> J Bone Joint Surg 84A(6):921, 2002.</span>
</div>
<div class="RF" id="R651-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[19]">19. <span class="URF"><span class="emph_B">Smith RW, Smith CF:</span> <span class="emph_I">Solitary unicameral bone cyst of the calcaneus.</span> J Bone Joint Surg 56A:49, 1974.</span>
</div>
<div class="RF" id="R652-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Capanna R, Albisinni U, Campanacci M, et al.:</span> <span class="emph_I">Contrast examination as a prognostic factor in the treatment of solitary bone cyst by cortisone injection.</span> Skeletal Radiol 12:97, 1984.</span></span>
</div>
<div class="RF" id="R653-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Capanna R, DalMonte A, Campanacci M:</span> <span class="emph_I">The natural history of unicameral bone cyst after steroid injection.</span> Clin Orthop 166:204, 1982.</span></span>
</div>
<div class="RF" id="R654-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[17]/RF[22]">22. <span class="JRF"><span class="DRF"><span class="emph_B">Scaglietti O, Marchetti PG, Bartolozzi P:</span> <span class="emph_I">Final results obtained in the treatment of bone cysts with methylprednisolone acetate (depomedral) and a discussion of results achieved in other bone lesions.</span> Clin Orthop 165:33, 1982.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4035" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]">
<div class="HD">ANEURYSMAL BONE CYST</div>
<div class="RF" id="R655-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[1]">1. <span class="URF"><span class="emph_B">Papagelopoulos PJ, Choudhury SN, Frassica FJ, et al.:</span> <span class="emph_I">Treatment of aneurysmal bone cysts of the pelvis and sacrum.</span> J Bone Joint Surg 83A:1674, 2001.</span>
</div>
<div class="RF" id="R656-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[2]">2. <span class="URF"><span class="emph_B">Ewing J:</span> <span class="emph_I">Neoplastic Diseases: A Treatise on Tumors,</span> ed 4. Philadelphia, WB Saunders, 1940.</span>
</div>
<div class="RF" id="R657-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL, Lichtenstein L:</span> <span class="emph_I">Solitary unicameral bone cyst, with emphasis on the roentgen picture, the pathologic appearance, and the pathogenesis.</span> Arch Surg 44:1, 1942.</span></span>
</div>
<div class="RF" id="R658-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Carson DH, Wilkinson RH, Bhakkaviziam A:</span> <span class="emph_I">Aneurysmal bone cysts in children.</span> AJR 116:644, 1972.</span></span>
</div>
<div class="RF" id="R659-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[5]">5. <span class="URF"><span class="emph_B">Donaldson WF:</span> <span class="emph_I">Aneurysmal bone cyst.</span> J Bone Joint Surg 44A:25, 1962.</span>
</div>
<div class="RF" id="R660-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Tillman BP, Dahlin DC, Lipscomb PR, et al.:</span> <span class="emph_I">Aneurysmal bone cyst: An analysis of ninety-five cases.</span> Mayo Clin Proc 43:478, 1968.</span></span>
</div>
<div class="RF" id="R661-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Bollini G, Jouve JL, Cottalorda J, et al.:</span> <span class="emph_I">Aneurysmal bone cyst in children: analysis of twenty-seven patients.</span> J Pediatr Orthop B 7:274, 1998.</span></span>
</div>
<div class="RF" id="R662-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[8]">8. <span class="URF"><span class="emph_B">Chen SH, Huang TJ, Hsueh S, et al.:</span> <span class="emph_I">Unusual bleeding of aneurysmal bone cyst in the upper thoracic spine.</span> Chang Gung Med J 25(3): 183, 2002.</span>
</div>
<div class="RF" id="R663-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[9]">9. <span class="URF"><span class="emph_B">Chan MS, Wong YC, Yuen MK, Lam D:</span> <span class="emph_I">Spinal aneurysmal bone cyst causing acute cord compression without vertebral collapse: CT and MRI findings.</span> Pediatr Radiol 32(8):601, 2002.</span>
</div>
<div class="RF" id="R664-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Besse BE Jr, Dahlin DC, Pugh DG, et al.:</span> <span class="emph_I">Aneurysmal bone cysts: Additional considerations.</span> Clin Orthop 7:93, 1956.</span></span>
</div>
<div class="RF" id="R665-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[11]">11. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R666-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[12]">12. <span class="URF"><span class="emph_B">Hay MC, Paterson D, Taylor TKF:</span> <span class="emph_I">Aneurysmal bone cysts of the spine.</span> J Bone Joint Surg 60B:406, 1978.</span>
</div>
<div class="RF" id="R667-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Burkhalter WC, Schroeder FC, Eversmann WW Jr:</span> <span class="emph_I">Aneurysmal bone cysts occurring in the metacarpals.</span> J Hand Surg 3:579, 1978.</span></span>
</div>
<div class="RF" id="R668-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[14]">14. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">The aneurysmal bone cyst (fibula).</span> ACA J Chiro, 1982.</span>
</div>
<div class="RF" id="R669-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[15]">15. <span class="URF"><span class="emph_B">Faris WF, Rubin BD, Fielding JW:</span> <span class="emph_I">Aneurysmal bone cyst of the patella.</span> J Bone Joint Surg 60A:711, 1978.</span>
</div>
<div class="RF" id="R670-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[16]">16. <span class="URF"><span class="emph_B">Burns-Cox CJ, Higgins AT:</span> <span class="emph_I">Aneurysmal bone cyst of the frontal bone.</span> J Bone Joint Surg 51B:344, 1969.</span>
</div>
<div class="RF" id="R671-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[17]">17. <span class="URF"><span class="emph_B">Hino N, Ohtsuka K, Hashimoto M, Sakata M:</span> <span class="emph_I">Radiographic features of an aneurysmal bone cyst of the orbit.</span> Ophthalmologica 212(3):198, 1998.</span>
</div>
<div class="RF" id="R672-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Bossart PA, Fitzpatrick HF:</span> <span class="emph_I">Aneurysmal bone cyst of rib.</span> Arch Surg 88:229, 1964.</span></span>
</div>
<div class="RF" id="R673-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[19]">19. <span class="URF"><span class="emph_B">DiCaprio MR, Murphy MJ, Camp RL:</span> <span class="emph_I">Aneurysmal bone cyst of the spine with familial incidence.</span> Spine 25(12):1589, 2000.</span>
</div>
<div class="RF" id="R674-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[20]">20. <span class="URF"><span class="emph_B">Mirra JM:</span> <span class="emph_I">Bone Tumors&#x2014;Diagnosis and Treatment.</span> Philadelphia, JB Lippincott, 1980.</span>
</div>
<div class="RF" id="R675-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[21]">21. <span class="URF"><span class="emph_B">Vilanova JC, Dolz JL, Maestro de Leon JL, et al.:</span> <span class="emph_I">MR imaging of a malignant schwannoma and an osteoblastoma with fluid-fluid levels. Report of two new cases.</span> Eur Radiol 8(8):1359, 1998.</span>
</div>
<div class="RF" id="R676-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[22]">22. <span class="JRF"><span class="DRF"><span class="emph_B">Munk PL, Helms CA, Holt RG, et al.:</span> <span class="emph_I">MR imaging of aneurysmal bone cysts.</span> AJR 153:99, 1989.</span></span>
</div>
<div class="RF" id="R677-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[23]">23. <span class="URF"><span class="emph_B">Otsuka T, Kobayashi M, Sekiya I, et al.:</span> <span class="emph_I">A new treatment of aneurysmal bone cyst by endoscopic curettage without bone grafting.</span> Arthroscopy 17(7):E28, 2001.</span>
</div>
<div class="RF" id="R678-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[24]">24. <span class="URF"><span class="emph_B">Ramirez N, Perez C, Rivera YC:</span> <span class="emph_I">Distal third fibular aneurysmal bone cyst: en bloc resection and proximal third fibular reconstruction.</span> Am J Orthop 30(3):237, 2001.</span>
</div>
<a name="PG1370"> </a><div class="pagenum"><div>P.1370</div></div>
<br clear="all">
<div class="RF" id="R679-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[25]">25. <span class="URF"><span class="emph_B">Garg NK, Carty H, Walsh HP, et al.:</span> <span class="emph_I">Percutaneous Ethibloc injection in aneurysmal bone cysts.</span> Skeletal Radiol 29(4):211, 2000.</span>
</div>
<div class="RF" id="R680-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[26]">26. <span class="JRF"><span class="DRF"><span class="emph_B">Gladden ML Jr, Gillingham BL, Hennrikus W, Vaughan LM:</span> <span class="emph_I">Aneurysmal bone cyst of the first cervical vertebrae in a child treated with percutaneous intralesional injection of calcitonin and methylprednisolone. A case report.</span> Spine 25:527, 2000. &#x005B;Discussion 25:531, 2000.&#x005D;</span></span>
</div>
<div class="RF" id="R681-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[18]/RF[27]">27. <span class="URF"><span class="emph_B">Murray RO, Jacobson HG:</span> <span class="emph_I">The Radiology of Skeletal Disorders,</span> ed 2. London, Churchill Livingston, 1977.</span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4036" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]">
<div class="HD">INTRAOSSEOUS LIPOMA</div>
<div class="RF" id="R682-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Yamamoto T, Akisue T, Marui T, et al.:</span> <span class="emph_I">Intraosseous lipoma of the humeral head: MR appearance.</span> Clin Imaging 25:428, 2001.</span></span>
</div>
<div class="RF" id="R683-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[2]">2. <span class="URF"><span class="emph_B">Yildiz HY, Altinok D, Saglik Y:</span> <span class="emph_I">Bilateral calcaneal intraosseous lipoma: A case report.</span> Foot Ankle Int 23(1):60, 2002.</span>
</div>
<div class="RF" id="R684-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[3]">3. <span class="URF"><span class="emph_B">DeLee JC:</span> <span class="emph_I">Intraosseous lipoma of the proximal part of the femur.</span> J Bone Joint Surg 61A:601, 1973.</span>
</div>
<div class="RF" id="R685-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[4]">4. <span class="URF"><span class="emph_B">Hart JAL.:</span> <span class="emph_I">Intraosseous lipoma.</span> J Bone Joint Surg 55B:624, 1973.</span>
</div>
<div class="RF" id="R686-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Smith WE, Feinberg R:</span> <span class="emph_I">Intraosseous lipoma of bone.</span> Cancer 10:1151, 1957.</span></span>
</div>
<div class="RF" id="R687-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[6]">6. <span class="URF"><span class="emph_B">Onguru O, Pabuccu Y, Celasun B:</span> <span class="emph_I">Intraosseous lipoma of the fibula.</span> Clin Imaging 26(1):55, 2002.</span>
</div>
<div class="RF" id="R688-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[7]">7. <span class="URF"><span class="emph_B">Weinfeld GD, Yu GV, Good JJ:</span> <span class="emph_I">Intraosseous lipoma of the calcaneus: a review and report of four cases.</span> J Foot Ankle Surg 41(6): 398, 2002.</span>
</div>
<div class="RF" id="R689-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Milgram JW:</span> <span class="emph_I">Intraosseous lipomas: Radiologic and pathologic manifestations.</span> Radiology 167:155, 1988.</span></span>
</div>
<div class="RF" id="R690-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Matsubayashi T, Nakajima M, Tskada M:</span> <span class="emph_I">Intraosseous lipoma</span> &#x005B;Case Report 118&#x005D;. Skeletal Radiol 5:131, 1980.</span></span>
</div>
<div class="RF" id="R691-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[10]">10. <span class="JRF"><span class="DRF"><span class="emph_B">Milgram JW:</span> <span class="emph_I">Involuted intraosseous lipoma of the sacrum.</span> Spine 16:243, 1991.</span></span>
</div>
<div class="RF" id="R692-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Poussa M, Holmstrom T:</span> <span class="emph_I">Intraosseous lipoma of the calcaneus.</span> Acta Orthop Scand 47:570, 1976.</span></span>
</div>
<div class="RF" id="R693-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[12]">12. <span class="URF"><span class="emph_B">Bertram C, Popken F, Rutt J:</span> <span class="emph_I">Intraosseous lipoma of the calcaneus.</span> Langenbecks Arch Surg 386(5):313, 2001.</span>
</div>
<div class="RF" id="R694-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Appenzeller J, Weitzner S:</span> <span class="emph_I">Intraosseous lipoma of the os calcis.</span> Clin Orthop 101:171, 1974.</span></span>
</div>
<div class="RF" id="R695-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[14]">14. <span class="URF"><span class="emph_B">Ketyer S, Brownstein S, Cholankeril J:</span> <span class="emph_I">CT diagnosis of intraosseous lipoma of the calcaneus.</span> J Comput Assist Tomogr 7(3):546, 1983.</span>
</div>
<div class="RF" id="R696-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[15]">15. <span class="URF"><span class="emph_B">Hatori M, Hosaka M, Ehara S, Kokubun S:</span> <span class="emph_I">Imaging features of intraosseous lipomas of the calcaneus.</span> Arch Orthop Trauma Surg 121(8):429, 2001.</span>
</div>
<div class="RF" id="R697-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[4]/SUBEDS2[19]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Goldman AB, Marcove RC, Huvos AG, et al.:</span> <span class="emph_I">Intraosseous lipoma of the tibia</span> &#x005B;Case Report 280&#x005D;. Skeletal Radiol 12:209, 1984.</span></span>
</div>
</div>
</div>
<div class="SUBEDS1" id="B01382540.0-4037" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]">
<div class="HD">TUMOR-LIKE PROCESSES</div>
<div class="SUBEDS2" id="B01382540.0-4038" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]">
<div class="HD">PAGET&#x2019;S DISEASE</div>
<div class="RF" id="R698-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Paget J:</span> <span class="emph_I">On a form of chronic inflammation of bones (osteitis deformans).</span> Med Chir Trans 60:37, 1877. &#x005B;Rpt Clin Orthop 49:12, 1966.&#x005D;</span></span>
</div>
<div class="RF" id="R699-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[2]">2. <span class="URF"><span class="emph_B">Schmorl G:</span> <span class="emph_I">&#x00FC;ber ostitis deformans Paget.</span> Virchows Arch Pathol Anat Physiol 283:694, 1932.</span>
</div>
<div class="RF" id="R700-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Siris E:</span> <span class="emph_I">Epidemiological aspects of Paget&#x2019;s disease: Family history and relationship to other medical conditions.</span> Semin Arthritis Rheum 23:222, 1994.</span></span>
</div>
<div class="RF" id="R701-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[4]">4. <span class="JRF"><span class="DRF"><span class="emph_B">Rosenbaum HD, Hanson DJ:</span> <span class="emph_I">Geographical variation in the prevalence of Paget&#x2019;s disease of bone.</span> Radiology 92:959, 1969.</span></span>
</div>
<div class="RF" id="R702-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Guyer PB:</span> <span class="emph_I">Research into Paget&#x2019;s disease&#x2014;Clues to the etiology and clinical significance.</span> Radiography 48:185, 1982.</span></span>
</div>
<div class="RF" id="R703-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[6]">6. <span class="URF"><span class="emph_B">Barry HC:</span> <span class="emph_I">Paget&#x2019;s Disease of Bone.</span> London, Churchill Livingstone, 1969.</span>
</div>
<div class="RF" id="R704-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[7]">7. <span class="JRF"><span class="DRF"><span class="emph_B">Butlin T:</span> <span class="emph_I">Pathological Society of London&#x2014;Osteitis deformans.</span> Lancet 1:519, 1885.</span></span>
</div>
<div class="RF" id="R705-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[8]">8. <span class="JRF"><span class="DRF"><span class="emph_B">Hutchinson J:</span> <span class="emph_I">On osteitis deformans.</span> Illus Med News 2:169, 1889.</span></span>
</div>
<div class="RF" id="R706-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Naiken VS:</span> <span class="emph_I">Did Beethoven have Paget&#x2019;s disease?</span> Ann Intern Med 74:995, 1971.</span></span>
</div>
<div class="RF" id="R707-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[10]">10. <span class="URF"><span class="emph_B">Edeiken J:</span> <span class="emph_I">Roentgen Diagnosis of Disease of Bone,</span> ed 3. Baltimore, Williams &#x0026; Wilkins, 1981.</span>
</div>
<div class="RF" id="R708-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Berman L:</span> <span class="emph_I">The endocrine treatment of Paget&#x2019;s disease.</span> Endocrinology 16:109, 1932.</span></span>
</div>
<div class="RF" id="R709-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Luxton RW:</span> <span class="emph_I">Paget&#x2019;s disease of bone associated with Hashimoto&#x2019;s stroma lymphomatosa. A clue to the pathogenesis of Paget&#x2019;s disease.</span> Lancet 1:441, 1957.</span></span>
</div>
<div class="RF" id="R710-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Francis MJO, Smith R:</span> <span class="emph_I">Evidence of a generalized connective tissue defect in Paget&#x2019;s disease of bone.</span> Lancet 1:841, 1974.</span></span>
</div>
<div class="RF" id="R711-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[14]">14. <span class="URF"><span class="emph_B">Moore S:</span> <span class="emph_I">Osteitis deformans. A theory of its etiology.</span> J Bone Joint Surg 33A:421, 1951.</span>
</div>
<div class="RF" id="R712-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[15]">15. <span class="URF"><span class="emph_B">Rassmussen H, Bordier P:</span> <span class="emph_I">The Physiology and Cellular Basis of Metabolic Bone Disease.</span> Baltimore, Williams &#x0026; Wilkins, 1974.</span>
</div>
<div class="RF" id="R713-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[16]">16. <span class="URF"><span class="emph_B">Albright F, Reifenstein EC Jr:</span> <span class="emph_I">The Parathyroid Glands and Metabolic Bone Disease. Selected Studies.</span> Baltimore, Williams &#x0026; Wilkins, 1948.</span>
</div>
<div class="RF" id="R714-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Mills BG, Singer FR:</span> <span class="emph_I">Nuclear inclusions in Paget&#x2019;s disease of bone.</span> Science 194:201, 1976.</span></span>
</div>
<div class="RF" id="R715-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[18]">18. <span class="JRF"><span class="DRF"><span class="emph_B">Rima BK:</span> <span class="emph_I">Paramyxoviruses and their role in disease.</span> Semin Arthritis Rheum 23:230, 1994.</span></span>
</div>
<div class="RF" id="R716-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Welsh RA, Meyer AT:</span> <span class="emph_I">Nuclear fragmentations and associated fibrils in giant cell tumor of bone.</span> Lab Invest 22:63, 1970.</span></span>
</div>
<div class="RF" id="R717-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Smith SE, Murphey MD, Motamedi K, et al.:</span> <span class="emph_I">From the archives of the AFIP. Radiologic spectrum of Paget&#x2019;s disease of bone and its complications with pathologic correlation.</span> Radiographics 22:1191, 2002.</span></span>
</div>
<div class="RF" id="R718-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Edeiken J, DePalma AF, Hodes PJ:</span> <span class="emph_I">Paget&#x2019;s disease: Osteitis deformans.</span> Clin Orthop 146:141, 1966.</span></span>
</div>
<div class="RF" id="R719-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[22]">22. <span class="URF"><span class="emph_B">Schneider D, Hofmann MT, Peterson JA:</span> <span class="emph_I">Diagnosis and treatment of Paget&#x2019;s disease of bone.</span> Am Fam Physician 65(10):2069, 2002.</span>
</div>
<div class="RF" id="R720-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[23]">23. <span class="JRF"><span class="DRF"><span class="emph_B">Dalinka MK, Aronchik JM, Haddad JG Jr:</span> <span class="emph_I">Paget&#x2019;s disease.</span> Orthop Clin North Am 14:243, 1983.</span></span>
</div>
<div class="RF" id="R721-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[24]">24. <span class="JRF"><span class="DRF"><span class="emph_B">Steinbach HL:</span> <span class="emph_I">Some features of Paget&#x2019;s disease.</span> AJR 86:950, 1961.</span></span>
</div>
<div class="RF" id="R722-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[25]">25. <span class="URF"><span class="emph_B">Snapper I:</span> <span class="emph_I">Bone Diseases in Medical Practice,</span> ed 3. New York, Grune &#x0026; Stratton, 1957.</span>
</div>
<div class="RF" id="R723-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[26]">26. <span class="JRF"><span class="DRF"><span class="emph_B">Siris ES, Jacobs JP, Canfield RE:</span> <span class="emph_I">Paget&#x2019;s disease of bone.</span> Bull NY Acad Med 56:285, 1980.</span></span>
</div>
<div class="RF" id="R724-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[27]">27. <span class="JRF"><span class="DRF"><span class="emph_B">Jaffe HL:</span> <span class="emph_I">The classic Paget&#x2019;s disease of bone.</span> Clin Orthop 127:4, 1977.</span></span>
</div>
<div class="RF" id="R725-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[28]">28. <span class="JRF"><span class="DRF"><span class="emph_B">Pryce AP, Wiener SN:</span> <span class="emph_I">Syringomyelia associated with Paget&#x2019;s disease of the skull.</span> AJR 155:881, 1990.</span></span>
</div>
<div class="RF" id="R726-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[29]">29. <span class="URF"><span class="emph_B">Theros EG:</span> <span class="emph_I">Professional Self-Evaluation and Continuing Education Program, Set 2: Bone disease syllabus, ACR.</span> Chicago, Waverly Press, 1972.</span>
</div>
<div class="RF" id="R727-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[30]">30. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s disease&#x2014;A clinical review.</span> J Clin Chiro 3(2):68, 1980.</span>
</div>
<div class="RF" id="R728-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[31]">31. <span class="URF"><span class="emph_B">Hadjipavlou AG, Gaitanis LN, Katonis PG, Lander P:</span> <span class="emph_I">Paget&#x2019;s disease of the spine and its management.</span> Eur Spine J 10(5):370, 2001.</span>
</div>
<div class="RF" id="R729-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[32]">32. <span class="JRF"><span class="DRF"><span class="emph_B">Clarke PR:</span> <span class="emph_I">Neurological manifestations of Paget&#x2019;s disease.</span> J Neurol Sci 38:171, 1978.</span></span>
</div>
<div class="RF" id="R730-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[33]">33. <span class="JRF"><span class="DRF"><span class="emph_B">Ramaamurthi B, Visvanathan GS:</span> <span class="emph_I">Paget&#x2019;s disease of the axis causing quadraplegia.</span> J Neurosurg 14:580, 1957.</span></span>
</div>
<div class="RF" id="R731-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[34]">34. <span class="URF"><span class="emph_B">Klenerman L:</span> <span class="emph_I">Cauda equina and spinal cord compression in Paget&#x2019;s disease.</span> J Bone Joint Surg 48B:365, 1966.</span>
</div>
<div class="RF" id="R732-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[35]">35. <span class="URF"><span class="emph_B">Alpers BJ, Mancall EL:</span> <span class="emph_I">Clinical Neurology,</span> ed 6. Philadelphia, FA Davis, 1971.</span>
</div>
<div class="RF" id="R733-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[36]">36. <span class="JRF"><span class="DRF"><span class="emph_B">Clarke PR, Williams HI:</span> <span class="emph_I">Ossification in extradural fat in Paget&#x2019;s disease of the spine.</span> Br J Surg 62:571, 1975.</span></span>
</div>
<div class="RF" id="R734-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[37]">37. <span class="JRF"><span class="DRF"><span class="emph_B">Hadjipavlou A, Shaffer N, Lander P, et al.:</span> <span class="emph_I">Pagetic spinal stenosis with extradural pagetoid ossification.</span> Spine 13:128, 1988.</span></span>
</div>
<div class="RF" id="R735-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[38]">38. <span class="URF"><span class="emph_B">Aegerter E, Kirkpatrick JA:</span> <span class="emph_I">Orthopedic Diseases,</span> ed 4. Philadelphia, WB Saunders, 1975.</span>
</div>
<div class="RF" id="R736-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[39]">39. <span class="JRF"><span class="DRF"><span class="emph_B">Machtey I, Rodnan GP, Benedek TG:</span> <span class="emph_I">Paget&#x2019;s disease of the hip joint.</span> Am J Med Sci 251:524, 1966.</span></span>
</div>
<div class="RF" id="R737-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[40]">40. <span class="JRF"><span class="DRF"><span class="emph_B">Altman RD:</span> <span class="emph_I">Articular complications of Paget&#x2019;s disease of bone.</span> Semin Arthritis Rheum 23:248, 1994.</span></span>
</div>
<div class="RF" id="R738-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[41]">41. <span class="JRF"><span class="DRF"><span class="emph_B">Lander P, Hadjipavlou A:</span> <span class="emph_I">Intradiscal invasion of Paget&#x2019;s disease of the spine.</span> Spine 16:46, 1991.</span></span>
</div>
<div class="RF" id="R739-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[42]">42. <span class="JRF"><span class="DRF"><span class="emph_B">Paget J:</span> <span class="emph_I">Remarks on osteitis deformans.</span> Illus Med News 2:181, 1889.</span></span>
</div>
<a name="PG1371"> </a><div class="pagenum"><div>P.1371</div></div>
<br clear="all">
<div class="RF" id="R740-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[43]">43. <span class="JRF"><span class="DRF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Paget&#x2019;s sarcoma of bone.</span> Radiologe 24:428, 1984.</span></span>
</div>
<div class="RF" id="R741-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[44]">44. <span class="JRF"><span class="DRF"><span class="emph_B">McKenna RJ, Schwinn CP, Soong KY, et al.:</span> <span class="emph_I">Osteogenic sarcoma arising in Paget&#x2019;s disease.</span> Cancer 17:42, 1964.</span></span>
</div>
<div class="RF" id="R742-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[45]">45. <span class="URF"><span class="emph_B">Porretta CA, Dahlin DC, Janes JM:</span> <span class="emph_I">Sarcoma in Paget&#x2019;s disease of bone.</span> J Bone Joint Surg 39A:1314, 1957.</span>
</div>
<div class="RF" id="R743-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[46]">46. <span class="URF"><span class="emph_B">Schajowicz F, Aravjo ES, Berenstein A:</span> <span class="emph_I">Sarcoma complicating Paget&#x2019;s disease of bone.</span> J Bone Joint Surg 65B:299, 1983.</span>
</div>
<div class="RF" id="R744-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[47]">47. <span class="JRF"><span class="DRF"><span class="emph_B">Huang TL, Cohen NJ, Sahgal S, et al.:</span> <span class="emph_I">Osteosarcoma complicating Paget&#x2019;s disease.</span> Clin Orthop 141:50, 1979.</span></span>
</div>
<div class="RF" id="R745-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[48]">48. <span class="JRF"><span class="DRF"><span class="emph_B">Dehner LP, Anderson JT, Brown D:</span> <span class="emph_I">Orthopedic and pathologic aspects of Paget&#x2019;s disease.</span> Minn Med 60:422, 1977.</span></span>
</div>
<div class="RF" id="R746-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[49]">49. <span class="URF"><span class="emph_B">Jattiot F, Goupille P, Azais I, et al.:</span> <span class="emph_I">Fourteen cases of sarcomatous degeneration in Paget&#x2019;s disease.</span> J Rheumatol 26(1):150, 1999.</span>
</div>
<div class="RF" id="R747-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[50]">50. <span class="JRF"><span class="DRF"><span class="emph_B">Friedman AC, Orcutt J, Madewell JE:</span> <span class="emph_I">Paget&#x2019;s disease of the hand: Radiographic spectrum.</span> AJR 138:691, 1982.</span></span>
</div>
<div class="RF" id="R748-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[51]">51. <span class="JRF"><span class="DRF"><span class="emph_B">Rubin RP, Adler JJ, Adler DP:</span> <span class="emph_I">Paget&#x2019;s disease of the calcaneus.</span> J Am Pod Assoc 73:263, 1983.</span></span>
</div>
<div class="RF" id="R749-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[52]">52. <span class="JRF"><span class="DRF"><span class="emph_B">Weinert CR, Wiss DA:</span> <span class="emph_I">Paget&#x2019;s disease of the patella.</span> Clin Orthop 142:139, 1979.</span></span>
</div>
<div class="RF" id="R750-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[53]">53. <span class="URF"><span class="emph_B">Brown HP, LaRocca H, Wickstrom JK:</span> <span class="emph_I">Paget&#x2019;s disease of the atlas and axis.</span> J Bone Joint Surg 53A:1441, 1971.</span>
</div>
<div class="RF" id="R751-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[54]">54. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Cervical Paget&#x2019;s disease.</span> ACA J Chiro 1982.</span>
</div>
<div class="RF" id="R752-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[55]">55. <span class="URF"><span class="emph_B">Hadley LA:</span> <span class="emph_I">Anatomico&#x2014;Roentgenographic Studies of the Spine,</span> ed 3. Springfield, Charles C Thomas, 1976.</span>
</div>
<div class="RF" id="R753-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[56]">56. <span class="JRF"><span class="DRF"><span class="emph_B">Krane SM:</span> <span class="emph_I">Paget&#x2019;s disease of bone.</span> Clin Orthop 127:24, 1977.</span></span>
</div>
<div class="RF" id="R754-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[57]">57. <span class="JRF"><span class="DRF"><span class="emph_B">Wilner D, Sherman RS:</span> <span class="emph_I">Roentgen diagnosis of Paget&#x2019;s disease (osteitis deformans).</span> Med Radiogr Photogr 42:35, 1966.</span></span>
</div>
<div class="RF" id="R755-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[58]">58. <span class="JRF"><span class="DRF"><span class="emph_B">Miller SW, Castronovo FP Jr, Pendergrass HP, et al.:</span> <span class="emph_I">Technetium 99m labeled diphosphonate bone scanning in Paget&#x2019;s disease.</span> Am J Roentgenol Radium Ther Nucl Med 121:177, 1974.</span></span>
</div>
<div class="RF" id="R756-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[1]/RF[59]">59. <span class="JRF"><span class="DRF"><span class="emph_B">Martin TJ:</span> <span class="emph_I">Treatment of Paget&#x2019;s with calcitonins.</span> Aust NZ J Med 9:36, 1979.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4039" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]">
<div class="HD">FIBROUS DYSPLASIA</div>
<div class="RF" id="R757-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[1]">1. <span class="JRF"><span class="DRF"><span class="emph_B">Lichtenstein L:</span> <span class="emph_I">Polyostotic fibrous dysplasia.</span> Arch Surg 36:874, 1938.</span></span>
</div>
<div class="RF" id="R758-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[2]">2. <span class="JRF"><span class="DRF"><span class="emph_B">Hunter D, Turnbull HL:</span> <span class="emph_I">Hyperparathyroidism: Generalized osteitis fibroma.</span> Br J Surg 32:203, 1931.</span></span>
</div>
<div class="RF" id="R759-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[3]">3. <span class="JRF"><span class="DRF"><span class="emph_B">Slow IN, Stern D, Friedman EW:</span> <span class="emph_I">Osteogenic sarcoma arising in pre-existing fibrous dysplasia: Report of a case.</span> J Oral Surg 29:126, 1971.</span></span>
</div>
<div class="RF" id="R760-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[4]">4. <span class="URF"><span class="emph_B">Van Tilburg W:</span> <span class="emph_I">Fibrous dysplasia.</span> In: PJ Vinken, GW Bruyn, eds, <span class="emph_I">Handbook of Clinical Neurology.</span> Vol 14, Amsterdam, North Holland, 1972.</span>
</div>
<div class="RF" id="R761-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[5]">5. <span class="JRF"><span class="DRF"><span class="emph_B">Van Horn PE Jr, Dahlin DC, Bickel WH:</span> <span class="emph_I">Fibrous dysplasia: A clinical pathologic study of orthopedic surgical cases.</span> Proc Mayo Clin 38:175, 1963.</span></span>
</div>
<div class="RF" id="R762-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[6]">6. <span class="JRF"><span class="DRF"><span class="emph_B">Lichtenstein L, Jaffe HL:</span> <span class="emph_I">Fibrous dysplasia of bone.</span> Arch Pathol 33:777, 1942.</span></span>
</div>
<div class="RF" id="R763-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[7]">7. <span class="URF"><span class="emph_B">Uehlinger E:</span> <span class="emph_I">Fibrose dysplasia.</span> In: HR Schinz, WE Baensch, W Frommhold, et al., eds, <span class="emph_I">Lehrbuch der R;auontgendiagnostik,</span> ed 6. Stuttgart, Georg Thieme Verlag, 1979.</span>
</div>
<div class="RF" id="R764-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[8]">8. <span class="URF"><span class="emph_B">Harris WH, Dudley HR Jr, Barry JR:</span> <span class="emph_I">Natural history of fibrous dysplasia.</span> J Bone Joint Surg 44A:207, 1962.</span>
</div>
<div class="RF" id="R765-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[9]">9. <span class="JRF"><span class="DRF"><span class="emph_B">Fries JW:</span> <span class="emph_I">The roentgen features of fibrous dysplasia of the skull and facial bones: A critical analysis of thirty-nine pathologically proven cases.</span> AJR 77:71, 1957.</span></span>
</div>
<div class="RF" id="R766-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[10]">10. <span class="URF"><span class="emph_B">Isefuku S, Hatori M, Ehara S, et al.:</span> <span class="emph_I">Fibrous dysplasia arising from the calcaneus.</span> Tohoku J Exp Med 189(3):227, 1999.</span>
</div>
<div class="RF" id="R767-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Resnik CS, Lininger JR:</span> <span class="emph_I">Monostotic fibrous dysplasia of the cervical spine: Case report.</span> Radiology 151:49, 1984.</span></span>
</div>
<div class="RF" id="R768-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[12]">12. <span class="JRF"><span class="DRF"><span class="emph_B">Hopf M:</span> <span class="emph_I">Zur Kenntnis der polyostotischen fibrosen Dysplasie.</span> Radiol Clin (Basel) 28:129, 1949.</span></span>
</div>
<div class="RF" id="R769-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[13]">13. <span class="URF"><span class="emph_B">Gurler T, Alper M, Gencosmanoglu R, et al.:</span> <span class="emph_I">McCune-Albright syndrome progressing with sever fibrous dysplasia.</span> J Craniofac Surg 9(1):79, 1998.</span>
</div>
<div class="RF" id="R770-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Windolz F:</span> <span class="emph_I">Cranial manifestations of fibrous lesions of bone.</span> AJR 58:51, 1947.</span></span>
</div>
<div class="RF" id="R771-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Benedict PH:</span> <span class="emph_I">Sexual precocity and polyostotic fibrous dysplasia.</span> Am J Dis Child 111:426, 1966.</span></span>
</div>
<div class="RF" id="R772-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Keijser LC, Van Tienen TG, Schreuder HW, et al.:</span> <span class="emph_I">Fibrous dysplasia of bone: management and outcome of 20 cases.</span> J Surg Oncol 76:157, 2001. &#x005B;Discussion 767:167, 2001.&#x005D;</span></span>
</div>
<div class="RF" id="R773-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[17]">17. <span class="URF"><span class="emph_B">Di Leo C, Ardemagni A, Bestetti A, et al.:</span> <span class="emph_I">A rare case of poly-ostotic fibrous dysplasia assessed by bone scintigraphy with Tc-99m methylene diphosphonate (MDP).</span> Nuklearmedizin 38(5):169, 1999.</span>
</div>
<div class="RF" id="R774-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[18]">18. <span class="URF"><span class="emph_B">Yucel OT, Genc E, Kaya S:</span> <span class="emph_I">Cherubism: A radiological and clinical presentation.</span> Turk J Pediatr 40(3):453, 1998.</span>
</div>
<div class="RF" id="R775-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Cornelius EA, McClenden JL:</span> <span class="emph_I">Cherubism&#x2014;Hereditary fibrous dysplasia of the jaws.</span> AJR 104:136, 1969.</span></span>
</div>
<div class="RF" id="R776-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[20]">20. <span class="URF"><span class="emph_B">Jones WA, Gerrie J, Pritchard J:</span> <span class="emph_I">Cherubism&#x2014;A familial fibrous dysplasia of the jaws.</span> J Bone Joint Surg 32B:334, 1950.</span>
</div>
<div class="RF" id="R777-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Yamaguchi T, Dorfman HD, Eisig S:</span> <span class="emph_I">Cherubism: Clinicopathologic features.</span> Skeletal Radiol 28:350, 1999.</span></span>
</div>
<div class="RF" id="R778-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[22]">22. <span class="URF"><span class="emph_B">Sirvanci M, Karaman K, Onoat L, et al.:</span> <span class="emph_I">Monostatic fibrous dysplasia of the clivus: MRI and CT findings.</span> Neuroradiology 44(10): 847, 2002.</span>
</div>
<div class="RF" id="R779-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[23]">23. <span class="URF"><span class="emph_B">Cohen MM Jr, Howell RE:</span> <span class="emph_I">Etiology of fibrous dysplasia and McCune-Albright syndrome.</span> Int J Oral Maxillofac Surg 28(5):366, 1999.</span>
</div>
<div class="RF" id="R780-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[24]">24. <span class="JRF"><span class="DRF"><span class="emph_B">Reed RJ:</span> <span class="emph_I">Fibrous dysplasia of bone.</span> Arch Pathol 75:480, 1963.</span></span>
</div>
<div class="RF" id="R781-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[25]">25. <span class="URF"><span class="emph_B">Aegerter EE, Kirkpatrick JA Jr:</span> <span class="emph_I">Orthopedic Diseases,</span> ed 3. Philadelphia, WB Saunders, 1968.</span>
</div>
<div class="RF" id="R782-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[26]">26. <span class="JRF"><span class="DRF"><span class="emph_B">Kaushik S, Smoker WR, Frable WJ:</span> <span class="emph_I">Malignant transformation of fibrous dysplasia into chondroblastic osteosarcoma.</span> Skeletal Raiol 31:103, 2002.</span></span>
</div>
<div class="RF" id="R783-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[27]">27. <span class="JRF"><span class="DRF"><span class="emph_B">Coley RL, Stewart FW:</span> <span class="emph_I">Bone sarcoma in polyostotic fibrous dysplasia.</span> Ann Surg 121:872, 1945.</span></span>
</div>
<div class="RF" id="R784-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[28]">28. <span class="URF"><span class="emph_B">Huvos AG, Higinbotham NL, Miller TR:</span> <span class="emph_I">Bone sarcomas arising in fibrous dysplasia.</span> J Bone Joint Surg 54A:1047, 1972.</span>
</div>
<div class="RF" id="R785-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[29]">29. <span class="URF"><span class="emph_B">Edeiken J:</span> <span class="emph_I">Roentgen Diagnosis of Diseases of Bone,</span> ed 3. Baltimore, Williams &#x0026; Wilkins, 1981.</span>
</div>
<div class="RF" id="R786-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[30]">30. <span class="JRF"><span class="DRF"><span class="emph_B">Gibson MJ, Middlemiss JH:</span> <span class="emph_I">Fibrous dysplasia of bone.</span> Br J Radiol 44:1, 1971.</span></span>
</div>
<div class="RF" id="R787-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[31]">31. <span class="URF"><span class="emph_B">Murray RO, Jacobson HG:</span> <span class="emph_I">The Radiology of Skeletal Disorders,</span> ed 2. London, Churchill Livingstone, 1977.</span>
</div>
<div class="RF" id="R788-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[32]">32. <span class="URF"><span class="emph_B">Han J, Ryu JS, Shin MJ, et al.:</span> <span class="emph_I">Fibrous dysplasia with barely increased uptake on bone scan: a case report.</span> Clin Nucl Med 25(10): 785, 2000.</span>
</div>
<div class="RF" id="R789-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[2]/RF[33]">33. <span class="JRF"><span class="DRF"><span class="emph_B">Tehranzadeh J, Fung Y, Donohue M, et al.:</span> <span class="emph_I">Computed tomography of Paget&#x2019;s disease of the skull versus fibrous dysplasia.</span> Skeletal Radiol 27:664, 1998.</span></span>
</div>
</div>
<div class="SUBEDS2" id="B01382540.0-4040" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]">
<div class="HD">NEUROFIBROMATOSIS</div>
<div class="RF" id="R790-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[1]">1. <span class="URF"><span class="emph_B">Korf BR:</span> <span class="emph_I">Diagnosis and management of neurofibromatosis type 1.</span> Curr Neurol Neurosci Rep 1(2):162, 2001.</span>
</div>
<div class="RF" id="R791-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[2]">2. <span class="URF"><span class="emph_B">Tiresius TWC:</span> <span class="emph_I">Historia Pathologica Singularius Cutis Turpitudinis.</span> Leipzig, SL Crusius, 1793.</span>
</div>
<div class="RF" id="R792-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[3]">3. <span class="URF"><span class="emph_B">Smith RW:</span> <span class="emph_I">A Treatise on the Pathology, Diagnosis and Treatment of Neuroma.</span> Dublin, Hodges &#x0026; Smith, 1849.</span>
</div>
<div class="RF" id="R793-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[4]">4. <span class="URF"><span class="emph_B">von Recklinghausen K:</span> <span class="emph_I">&#x00DC;ber die Multiplen Fibrome der Haut und ihre Beziehung zu den Multiplen Neuromen.</span> Berlin, A Hirschwald, 1882.</span>
</div>
<div class="RF" id="R794-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[5]">5. <span class="URF"><span class="emph_B">Crowe FW, Schull WJ, Neel JV:</span> <span class="emph_I">A Clinical, Pathological, and Genetic Study of Multiple Neurofibromatosis.</span> Springfield, Charles C Thomas, 1956.</span>
</div>
<div class="RF" id="R795-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[6]">6. <span class="URF"><span class="emph_B">Albright F, Reifenstein EC Jr:</span> <span class="emph_I">The Parathyroid Glands and Metabolic Bone Disease: Selected Studies.</span> Baltimore, Williams &#x0026; Wilkins, 1948.</span>
</div>
<div class="RF" id="R796-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[7]">7. <span class="URF"><span class="emph_B">Yochum TR:</span> <span class="emph_I">Neurofibromatosis or von Recklinghausen&#x2019;s disease.</span> ACA J Chiro 1980.</span>
</div>
<div class="RF" id="R797-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[8]">8. <span class="URF"><span class="emph_B">Wilner D:</span> <span class="emph_I">Radiology of Bone Tumors and Allied Disorders.</span> Philadelphia, WB Saunders, 1982.</span>
</div>
<div class="RF" id="R798-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[9]">9. <span class="URF"><span class="emph_B">Blitz NM, Hutchinson B, Grabowski MV:</span> <span class="emph_I">Pedal plixiform neurofibroma: Review of the literature and case report.</span> J Foot Ankle Surg 41(2):117, 2002.</span>
</div>
<a name="PG1372"> </a><div class="pagenum"><div>P.1372</div></div>
<br clear="all">
<div class="RF" id="R799-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[10]">10. <span class="URF"><span class="emph_B">Korf BR:</span> <span class="emph_I">Plexiform neurofibromas.</span> Am J Med Genet 89(1):31, 1999.</span>
</div>
<div class="RF" id="R800-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[11]">11. <span class="JRF"><span class="DRF"><span class="emph_B">Wiesenfeld D, James PL:</span> <span class="emph_I">Pulsating exophthalamos associated with neurofibromatosis.</span> J Max Fac Surg 12:11, 1984.</span></span>
</div>
<div class="RF" id="R801-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[12]">12. <span class="URF"><span class="emph_B">Funasaki H, Winter RB, Lonstein JB, et al.:</span> <span class="emph_I">Pathophysiology of spinal deformities in neurofibromatosis.</span> J Bone Joint Surg 76A:692, 1994.</span>
</div>
<div class="RF" id="R802-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[13]">13. <span class="JRF"><span class="DRF"><span class="emph_B">Samoto T, Watanabe Y, Suda A, et al.:</span> <span class="emph_I">Atlantoaxial dislocation with neurofibromatosis&#x2014;A case report.</span> Orthop Traum Surg 24:289, 1981.</span></span>
</div>
<div class="RF" id="R803-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[14]">14. <span class="JRF"><span class="DRF"><span class="emph_B">Isu T, Miyasaka K, Abe H:</span> <span class="emph_I">Atlantoaxial dislocation associated with neurofibromatosis&#x2014;Report of three cases.</span> J Neurosurg 58:451, 1983.</span></span>
</div>
<div class="RF" id="R804-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[15]">15. <span class="JRF"><span class="DRF"><span class="emph_B">Patel YD, Morehouse HT:</span> <span class="emph_I">Neurofibrosarcomas in neurofibromatosis: Role of CT scanning and angiography.</span> Clin Radiol 33:555, 1982.</span></span>
</div>
<div class="RF" id="R805-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[16]">16. <span class="JRF"><span class="DRF"><span class="emph_B">Hunt K, Jager RM, Garreston HD, et al.:</span> <span class="emph_I">Neurofibrosarcoma complicating von Recklinghausen&#x2019;s disease.</span> J Kentucky Med Assoc 74:346, 1976.</span></span>
</div>
<div class="RF" id="R806-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[17]">17. <span class="JRF"><span class="DRF"><span class="emph_B">Holt JF, Wright EM:</span> <span class="emph_I">Radiologic features of neurofibromatosis.</span> Radiology 51:647, 1948.</span></span>
</div>
<div class="RF" id="R807-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[18]">18. <span class="URF"><span class="emph_B">Edeiken J:</span> <span class="emph_I">Roentgen Diagnosis of Diseases of Bone.</span> ed 3. Baltimore, Williams &#x0026; Wilkins, 1981.</span>
</div>
<div class="RF" id="R808-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[19]">19. <span class="JRF"><span class="DRF"><span class="emph_B">Casselman ES, Mandell GA:</span> <span class="emph_I">Vertebral scalloping in neurofibromatosis.</span> Radiology 131:89, 1979.</span></span>
</div>
<div class="RF" id="R809-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[20]">20. <span class="JRF"><span class="DRF"><span class="emph_B">Angtuaco EJC, Binet EF, Flanigan S:</span> <span class="emph_I">Value of computed tomographic myelography in neurofibromatosis.</span> J Neurosurg 13:666, 1983.</span></span>
</div>
<div class="RF" id="R810-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[21]">21. <span class="JRF"><span class="DRF"><span class="emph_B">Biondetti PR, Vigo M, Fiore D, et al.:</span> <span class="emph_I">CT appearance of generalized von Recklinghausen neurofibromatosis.</span> J Comput Assist Tomogr 5:866, 1983.</span></span>
</div>
<div class="RF" id="R811-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[22]">22. <span class="JRF"><span class="DRF"><span class="emph_B">Klatte EC, Franken EA, Smith JA:</span> <span class="emph_I">The radiographic spectrum in neurofibromatosis.</span> Semin Roentgenol 11:17, 1976.</span></span>
</div>
<div class="RF" id="R812-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[23]">23. <span class="URF"><span class="emph_B">Reeder MM, Felson B:</span> <span class="emph_I">Gamuts in Radiology.</span> Cincinnati, Audiovisual Radiology of Cincinnati, 1975.</span>
</div>
<div class="RF" id="R813-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[24]">24. <span class="JRF"><span class="DRF"><span class="emph_B">Treves F:</span> <span class="emph_I">Congenital deformity.</span> Br Med J 2:1140, 1884.</span></span>
</div>
<div class="RF" id="R814-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[25]">25. <span class="JRF"><span class="DRF"><span class="emph_B">Goodnough CP, Kuhlmann RP, Stark E:</span> <span class="emph_I">von Recklinghausen&#x2019;s neurofibromatosis&#x2014;With nonosteogenic fibroma.</span> NY State J Med 75:2407, 1975.</span></span>
</div>
<div class="RF" id="R815-11" id_xpath="/OVIDBOOK[1]/TXTBKBD[1]/CHAPTER[11]/ED[1]/EDS[1]/SUBEDS1[5]/SUBEDS2[3]/RF[26]">26. <span class="JRF"><span class="DRF"><span class="emph_B">Halpern M, Currarino G:</span> <span class="emph_I">Vascular lesions causing hypertension in neurofibromatosis.</span> N Engl J Med 273:248, 1965.</span></span>
</div>
</div>
</div>
</div></div>
</div>
<div class="navlinks">
<span><a href="sid653929.html" title="Arthritic Disorders">&#8592;</a></span><span><a href="index.html" title="Top">&#8593;</a></span><span><a href="sid938315.html" title="Infection">&#8594;</a></span>
</div>
<section class="mbr-section" style="padding-top: 20px; padding-bottom: 20px;">
    <div class="container">
        <div><input type="hidden" name="IL_IN_TAG" value="2"></div>
    </div>
</section>
<script src="/assets/web/assets/jquery/jquery.min.js"></script>
<script src="/assets/tether/tether.min.js"></script>
<script src="/assets/bootstrap/js/bootstrap.min.js"></script>
<script src="/assets/smooth-scroll/SmoothScroll.js"></script>
<script src="/assets/dropdown/js/script.min.js"></script>
<script src="/assets/touchSwipe/jquery.touchSwipe.min.js"></script>
<script src="/assets/theme/js/script.js"></script>
<script src="/add/post.js"></script>
</body>
</html>
